data_2i9s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2i9s _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.4 tptp . . . . . 0 N--CA 1.432 -1.343 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 8.0 m -67.44 116.77 8.55 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.679 ' O ' HD13 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -120.52 116.9 26.3 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.524 -2.399 . . . . 0.0 104.524 -177.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.5 ptm -89.32 133.96 34.26 Favored 'General case' 0 C--N 1.28 -2.435 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.271 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.477 ' HE1' ' NE1' ' A' ' 72' ' ' TRP . 8.0 ttm -123.58 121.71 36.3 Favored 'General case' 0 N--CA 1.405 -2.715 0 C-N-CA 116.246 -2.181 . . . . 0.0 112.944 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -94.54 126.16 39.64 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.226 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 61' ' ' ALA . 0.2 OUTLIER -120.83 130.55 74.49 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-O 121.191 0.52 . . . . 0.0 110.071 -178.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 1.095 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 78.1 m -95.66 132.04 41.25 Favored 'General case' 0 N--CA 1.397 -3.093 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 172.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 1.078 HG23 ' HB2' ' A' ' 82' ' ' ASP . 2.5 p -131.41 127.83 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.077 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -172.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.537 ' HB3' ' OD2' ' A' ' 59' ' ' ASP . 15.5 p -142.69 33.01 1.43 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 121.726 2.057 . . . . 0.0 115.356 -170.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.65 -34.76 90.8 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 171.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.529 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 22.3 m-80 -118.13 122.69 30.13 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 171.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.67 28.89 0.41 Allowed 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.763 2.308 . . . . 0.0 112.792 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.0 p -137.78 -157.13 0.75 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.447 ' O ' ' HB ' ' A' ' 33' ' ' THR . 39.9 mt-10 -87.99 5.2 41.95 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-O 119.263 -0.398 . . . . 0.0 111.384 175.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.6 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 5.7 tmtt? -70.92 -38.77 72.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.361 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 27' ' ' ASN . 6.2 tp10 -74.25 -41.04 61.93 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 96.5 m -44.6 -59.37 2.5 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.181 170.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.2 pt-20 -61.43 -45.7 93.2 Favored 'General case' 0 C--O 1.25 1.107 0 C-N-CA 122.935 0.494 . . . . 0.0 112.082 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -52.91 -59.03 5.03 Favored 'General case' 0 C--O 1.254 1.317 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.739 HG23 ' CE3' ' A' ' 40' ' ' TRP . 2.0 mp -67.17 -46.18 84.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.53 -1.213 . . . . 0.0 113.352 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.737 HG22 HG12 ' A' ' 55' ' ' ILE . 31.0 p -62.24 -52.61 63.05 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.1 m -70.82 -44.63 66.15 Favored 'General case' 0 C--O 1.26 1.646 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.973 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.0 tp -71.21 -43.55 67.14 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.431 -176.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.739 ' CE3' HG23 ' A' ' 36' ' ' ILE . 43.8 m0 -76.07 -60.34 2.37 Favored 'General case' 0 C--O 1.161 -3.594 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.057 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.663 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.404 0.0 OUTLIER -65.71 -22.23 66.6 Favored 'General case' 0 C--O 1.255 1.356 0 C-N-CA 117.017 -1.873 . . . . 0.0 112.044 -173.078 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.86 -54.13 39.5 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.658 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 27.8 p -70.38 -27.3 64.21 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 117.257 0.528 . . . . 0.0 111.976 177.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.791 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 17.5 mt -61.51 -31.79 71.8 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.301 0.64 . . . . 0.0 109.351 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.435 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 72.8 t80 -92.68 -28.33 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.355 174.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.658 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 10.2 t30 -68.43 -28.88 67.45 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.047 0.451 . . . . 0.0 111.564 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.4 12.12 19.42 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.373 0.606 . . . . 0.0 109.726 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.0 p30 48.25 48.7 18.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.888 1.675 . . . . 0.0 114.74 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -91.45 159.58 15.88 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.62 88.81 3.71 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 120.606 1.548 . . . . 0.0 109.83 -176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 1.014 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.7 m -146.79 169.83 4.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.559 -169.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.504 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 17.3 mt-30 -131.86 123.7 28.04 Favored 'General case' 0 C--O 1.2 -1.516 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 176.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.791 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -130.62 135.4 47.84 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.503 -173.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.687 ' H ' HG12 ' A' ' 62' ' ' ILE . 56.0 m-85 -133.83 153.19 51.91 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -165.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.737 HG12 HG22 ' A' ' 37' ' ' THR . 22.9 mt -87.24 108.23 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 168.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.717 HG23 ' HB3' ' A' ' 60' ' ' ARG . 15.6 m -113.28 -11.73 11.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.711 -175.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.14 176.95 41.33 Favored Glycine 0 CA--C 1.504 -0.631 0 C-N-CA 117.163 -2.446 . . . . 0.0 115.362 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 m -68.36 110.78 4.26 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.537 ' OD2' ' HB3' ' A' ' 25' ' ' SER 0.257 0.0 OUTLIER 78.37 17.46 1.14 Allowed 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 122.947 1.356 . . . . 0.0 109.938 -178.45 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.717 ' HB3' HG23 ' A' ' 56' ' ' VAL . 7.3 mpt_? -133.18 127.44 33.84 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.173 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 22' ' ' VAL . . . -137.25 165.81 25.27 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.687 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.6 pt -144.53 157.81 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.336 0 C-N-CA 117.962 -1.495 . . . . 0.0 110.62 168.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.597 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -132.1 105.89 7.65 Favored 'General case' 0 N--CA 1.414 -2.233 0 O-C-N 126.595 2.434 . . . . 0.0 105.979 164.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.405 ' HB2' HD12 ' A' ' 62' ' ' ILE . 25.1 ttt -92.19 103.97 16.39 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 1.046 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.277 0.0 OUTLIER -96.06 146.32 24.74 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -171.834 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.491 ' C ' ' HD3' ' A' ' 66' ' ' ARG 0.354 1.1 tmt_? -120.98 -59.09 1.76 Allowed 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -46.18 -9.25 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 117.996 2.591 . . . . 0.0 117.996 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.87 28.96 64.07 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 119.793 1.179 . . . . 0.0 113.668 -174.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.8 p -149.34 43.43 0.94 Allowed 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.609 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -173.49 -3.85 0.01 OUTLIER 'General case' 0 C--N 1.378 1.818 0 N-CA-C 117.732 2.494 . . . . 0.0 117.732 -176.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 1.046 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -74.31 -35.41 63.68 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -168.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.477 ' NE1' ' HE1' ' A' ' 20' ' ' MET 0.478 5.4 m-90 -88.23 -11.24 47.23 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -169.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.84 -38.71 70.08 Favored 'General case' 0 C--O 1.262 1.719 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 167.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.609 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 25.5 mt -64.7 -36.93 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.277 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.809 ' HE2' HG13 ' A' ' 87' ' ' VAL . 55.2 tttm -58.14 -42.58 86.16 Favored 'General case' 0 C--O 1.291 3.275 0 CA-C-O 122.081 0.943 . . . . 0.0 110.617 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -58.42 -46.98 85.41 Favored 'General case' 0 C--O 1.264 1.867 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.288 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 11.0 m-85 -55.96 -43.99 78.06 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.264 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.634 ' HG ' ' HA ' ' A' ' 75' ' ' LYS . 11.5 mt -50.09 -64.61 0.76 Allowed 'General case' 0 CA--C 1.446 -3.05 0 O-C-N 123.835 0.71 . . . . 0.0 109.719 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . 0.303 25.7 m -77.24 -5.49 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 C-N-CA 118.113 -1.435 . . . . 0.0 114.42 -171.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m -86.35 -22.33 26.74 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.758 167.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -117.26 -35.19 4.11 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 1.078 ' HB2' HG23 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -80.28 24.95 0.41 Allowed 'General case' 0 N--CA 1.516 2.875 0 CA-C-N 119.811 1.187 . . . . 0.0 111.52 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 73.46 -81.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -155.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.422 ' HA ' ' OD1' ' A' ' 82' ' ' ASP . 11.5 p 159.6 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.595 1.558 . . . . 0.0 112.305 171.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . 0.363 . . -109.31 -78.86 0.59 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 119.122 3.008 . . . . 0.0 119.122 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 1.095 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 33.8 tt0 -148.41 126.56 12.13 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 121.089 1.768 . . . . 0.0 112.993 -165.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.809 HG13 ' HE2' ' A' ' 75' ' ' LYS . 2.5 p -111.38 123.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.782 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 20' ' ' MET 0.258 25.9 p -123.39 110.5 15.22 Favored 'General case' 0 C--O 1.264 1.834 0 CA-C-O 122.702 1.239 . . . . 0.0 113.042 171.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 87' ' ' VAL . 1.7 mp . . . . . 0 C--N 1.291 -1.945 0 CA-C-N 112.687 -2.052 . . . . 0.0 107.117 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.1 tptp . . . . . 0 N--CA 1.428 -1.537 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.697 HG23 ' HE2' ' A' ' 64' ' ' MET . 90.2 m -68.44 121.46 16.38 Favored 'General case' 0 N--CA 1.411 -2.403 0 O-C-N 124.114 0.884 . . . . 0.0 109.34 176.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.717 HD13 ' SD ' ' A' ' 20' ' ' MET . 0.2 OUTLIER -133.56 116.49 15.98 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 176.052 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.515 ' HE3' ' HD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -113.57 140.99 47.71 Favored 'General case' 0 C--N 1.274 -2.708 0 O-C-N 120.921 -1.112 . . . . 0.0 109.306 179.059 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.717 ' SD ' HD13 ' A' ' 18' ' ' LEU . 2.9 mpp? -118.69 127.43 53.56 Favored 'General case' 0 CA--C 1.447 -3.006 0 C-N-CA 120.334 -0.547 . . . . 0.0 111.33 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.515 ' HD2' ' HE3' ' A' ' 19' ' ' MET 0.293 30.4 p90 -98.87 123.42 43.12 Favored 'General case' 0 N--CA 1.413 -2.317 0 C-N-CA 117.354 -1.739 . . . . 0.0 106.729 168.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.9 p -114.89 122.15 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 CA-C-N 114.647 -1.16 . . . . 0.0 113.815 -167.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 1.062 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 24.4 m -75.32 135.76 40.88 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 171.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.48 HG23 ' CD1' ' A' ' 36' ' ' ILE . 7.9 p -121.52 127.7 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.681 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -162.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.653 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 29.5 t 71.26 -48.78 0.68 Allowed 'General case' 0 C--N 1.374 1.663 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 164.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.11 -16.74 6.76 Favored Glycine 0 N--CA 1.421 -2.319 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -173.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.42 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.0 t-20 -72.39 110.22 7.61 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -85.7 23.65 0.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.89 2.393 . . . . 0.0 113.015 -172.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -123.32 -170.91 2.2 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -91.61 9.41 32.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.58 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 3.9 tmtt? -67.52 -54.7 17.78 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.252 0.548 . . . . 0.0 110.395 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.653 ' HG2' ' HB3' ' A' ' 25' ' ' SER . 3.4 tp10 -69.0 -40.14 78.91 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -175.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -46.8 -56.29 6.5 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.668 171.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 15.4 pt-20 -62.78 -49.06 76.47 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 122.585 0.354 . . . . 0.0 111.628 -175.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -48.62 -58.48 4.65 Favored 'General case' 0 C--O 1.254 1.32 0 C-N-CA 125.656 1.583 . . . . 0.0 108.335 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.685 HG22 ' CE3' ' A' ' 40' ' ' TRP . 43.6 mt -72.24 -43.34 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 CA-C-N 111.647 -2.524 . . . . 0.0 113.617 -173.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.857 HG22 HG12 ' A' ' 55' ' ' ILE . 22.7 p -63.76 -48.77 75.64 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.241 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.5 p -63.69 -62.98 1.3 Allowed 'General case' 0 C--O 1.263 1.766 0 O-C-N 123.323 0.39 . . . . 0.0 110.774 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.14 -46.7 86.01 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.685 ' CE3' HG22 ' A' ' 36' ' ' ILE . 29.4 m0 -74.89 -59.67 2.63 Favored 'General case' 0 C--O 1.165 -3.38 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.612 -176.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.724 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.375 0.0 OUTLIER -64.58 -25.56 68.02 Favored 'General case' 0 C--O 1.252 1.222 0 C-N-CA 117.214 -1.794 . . . . 0.0 112.027 -172.199 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.19 -53.71 42.47 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.518 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 35.5 p -70.89 -28.51 64.6 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 116.881 0.34 . . . . 0.0 111.732 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.993 HD13 ' HG2' ' A' ' 53' ' ' ARG . 18.2 mt -61.18 -35.13 76.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.276 0.631 . . . . 0.0 109.378 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.615 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 60.9 t80 -87.59 -30.14 20.72 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.913 177.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.2 t-20 -69.02 -27.71 65.92 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.134 0.492 . . . . 0.0 111.481 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.11 1.03 52.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.994 0.426 . . . . 0.0 110.557 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 60.34 35.06 20.69 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.686 1.194 . . . . 0.0 112.266 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -65.56 -2.35 3.36 Favored 'General case' 0 CA--C 1.611 3.31 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 59.7 71.74 0.56 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.396 1.478 . . . . 0.0 111.108 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.547 HG21 ' HD2' ' A' ' 53' ' ' ARG . 6.4 m -147.66 176.21 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.725 -170.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.619 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 12.8 mt-30 -135.96 133.35 37.49 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 174.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.993 ' HG2' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.36 135.42 37.0 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -174.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.746 ' H ' HG12 ' A' ' 62' ' ' ILE . 36.7 t80 -134.36 151.57 51.3 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 117.797 -1.561 . . . . 0.0 113.737 -163.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.857 HG12 HG22 ' A' ' 37' ' ' THR . 25.7 mt -89.5 96.13 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 170.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 60' ' ' ARG . 7.4 p -94.61 -25.43 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-O 120.605 0.241 . . . . 0.0 110.912 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.67 173.52 45.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 118.667 -1.73 . . . . 0.0 114.706 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 21.0 m -70.57 117.94 12.74 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 58' ' ' SER . 14.2 t70 82.47 9.98 0.7 Allowed 'General case' 0 C--O 1.188 -2.139 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.646 ' HB3' HG13 ' A' ' 56' ' ' VAL . 5.5 mpt_? -138.78 117.84 12.56 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 122.247 1.022 . . . . 0.0 113.525 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.59 168.44 12.62 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 125.046 1.339 . . . . 0.0 107.445 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.746 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.5 pt -138.06 157.43 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.256 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.072 171.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -130.82 102.96 6.3 Favored 'General case' 0 N--CA 1.422 -1.841 0 O-C-N 126.807 2.567 . . . . 0.0 107.929 166.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.697 ' HE2' HG23 ' A' ' 17' ' ' THR . 1.0 OUTLIER -87.98 117.29 26.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.802 ' HG ' ' HB3' ' A' ' 71' ' ' ALA 0.429 0.0 OUTLIER -121.03 148.46 44.1 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.646 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.324 26.3 ttp180 -112.64 -57.2 2.31 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -169.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.546 ' HB2' ' CE1' ' A' ' 70' ' ' TYR . 1.7 m-20 -50.23 -13.85 0.13 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 175.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.15 29.11 62.21 Favored Glycine 0 C--N 1.36 1.887 0 CA-C-N 120.475 1.488 . . . . 0.0 115.702 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.5 m -151.99 44.34 0.73 Allowed 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 118.733 1.266 . . . . 0.0 112.949 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 67' ' ' ASP . 14.8 p90 178.99 16.75 0.0 OUTLIER 'General case' 0 C--N 1.365 1.279 0 CA-C-N 119.075 0.852 . . . . 0.0 111.97 -169.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.802 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . . . -100.11 -33.96 10.25 Favored 'General case' 0 C--O 1.267 1.995 0 CA-C-O 122.372 1.082 . . . . 0.0 113.867 -170.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.531 ' HE1' ' HE3' ' A' ' 20' ' ' MET 0.496 13.0 m0 -89.19 -9.62 50.14 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 116.88 -1.928 . . . . 0.0 112.447 -172.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -73.04 -26.66 61.38 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.356 164.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.623 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.0 mt -64.89 -38.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.37 1.462 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 171.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.611 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 29.1 ttpp -57.7 -41.46 81.76 Favored 'General case' 1 C--O 1.317 4.607 0 CA-C-O 122.831 1.301 . . . . 0.0 110.829 175.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -57.72 -44.95 86.31 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 118.881 -1.128 . . . . 0.0 110.47 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.78 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 17.1 m-85 -62.13 -27.7 69.12 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.543 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.611 ' HG ' ' HA ' ' A' ' 75' ' ' LYS . 39.8 mt -56.19 -59.32 5.1 Favored 'General case' 0 C--O 1.275 2.446 0 CA-C-O 122.082 0.944 . . . . 0.0 109.199 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.656 HG13 ' SG ' ' A' ' 84' ' ' CYS 0.277 1.2 m -77.04 -4.43 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 C-N-CA 117.467 -1.693 . . . . 0.0 113.134 178.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.78 ' HB3' ' HA ' ' A' ' 77' ' ' PHE . 9.9 t -88.65 -14.32 37.68 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.41 171.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.569 ' HG3' ' NE1' ' A' ' 40' ' ' TRP . 78.3 mm-40 -90.44 -43.42 10.29 Favored 'General case' 0 C--N 1.38 1.892 0 C-N-CA 117.328 -1.749 . . . . 0.0 109.182 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.378 29.3 t70 -176.23 -82.52 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.662 1.226 . . . . 0.0 113.181 173.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -127.27 147.67 50.23 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 120.649 1.568 . . . . 0.0 109.399 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.656 ' SG ' HG13 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -133.51 164.49 27.04 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 178.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.37 -51.12 0.15 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 1.062 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.1 tt0 -143.19 121.22 12.09 Favored 'General case' 0 CA--C 1.496 -1.13 0 O-C-N 120.757 -1.214 . . . . 0.0 112.103 -172.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.6 m -111.83 121.69 64.78 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.871 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 20' ' ' MET 0.293 22.3 p -106.36 114.41 28.52 Favored 'General case' 0 N--CA 1.406 -2.675 0 C-N-CA 117.348 -1.741 . . . . 0.0 109.656 165.044 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.501 HD11 ' CG ' ' A' ' 20' ' ' MET . 1.5 mm? . . . . . 0 N--CA 1.407 -2.603 0 CA-C-N 110.858 -2.883 . . . . 0.0 108.138 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.772 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 0.7 OUTLIER . . . . . 0 CA--C 1.515 -0.394 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.8 m -83.96 125.44 32.05 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 174.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -133.22 112.76 11.96 Favored 'General case' 0 C--O 1.19 -2.055 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.483 -175.143 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 27.4 ptm -84.04 127.62 34.01 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 119.444 -0.902 . . . . 0.0 108.762 174.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.611 ' HE3' HD13 ' A' ' 89' ' ' LEU . 27.3 ttm -101.06 107.91 19.48 Favored 'General case' 0 N--CA 1.424 -1.739 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.947 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -94.1 114.39 26.53 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.5 p -127.15 125.65 66.62 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -169.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 1.045 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 18.8 m -84.71 142.07 30.12 Favored 'General case' 0 CA--C 1.588 2.419 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.608 174.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.567 HG22 HD12 ' A' ' 36' ' ' ILE . 8.5 p -125.82 129.39 72.51 Favored 'Isoleucine or valine' 0 C--N 1.378 1.829 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.84 29.49 1.89 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 115.385 -2.526 . . . . 0.0 114.104 -166.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.44 -34.45 25.68 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 1.018 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 13.9 t-20 -116.95 121.64 32.39 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -85.43 27.28 0.61 Allowed 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 123.087 2.525 . . . . 0.0 114.067 -173.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 p -144.9 -160.74 1.17 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -174.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.472 ' HA ' ' HB ' ' A' ' 33' ' ' THR . 40.4 tt0 -89.12 1.76 55.14 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.017 -177.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 5.9 tmtt? -68.08 -50.46 54.88 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.896 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 1.018 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.7 tp10 -70.82 -42.37 70.34 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 118.575 -1.25 . . . . 0.0 107.703 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 59.9 m -42.49 -51.58 4.99 Favored 'General case' 0 C--O 1.199 -1.591 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.557 171.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 13.7 pt-20 -71.89 -48.37 46.15 Favored 'General case' 0 C--O 1.252 1.22 0 O-C-N 121.781 -0.574 . . . . 0.0 112.476 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -47.69 -57.77 5.12 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.522 1.529 . . . . 0.0 107.501 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.72 HG21 ' CD2' ' A' ' 40' ' ' TRP . 14.7 mt -69.14 -43.95 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 CA-C-N 111.452 -2.613 . . . . 0.0 113.551 -176.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.53 ' HB ' HG12 ' A' ' 55' ' ' ILE . 19.8 p -67.5 -42.08 83.44 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 120.533 1.515 . . . . 0.0 111.315 -174.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.0 p -66.05 -55.64 15.61 Favored 'General case' 0 N--CA 1.425 -1.691 0 O-C-N 123.974 0.796 . . . . 0.0 110.138 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 tp -60.75 -46.17 91.47 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.76 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 44.0 m0 -68.67 -69.97 0.3 Allowed 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.36 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.74 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.321 0.0 OUTLIER -69.31 -21.86 63.83 Favored 'General case' 0 C--O 1.255 1.377 0 C-N-CA 117.918 -1.513 . . . . 0.0 111.968 -171.462 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.11 -51.47 54.95 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 p -68.19 -32.66 73.05 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 117.191 0.495 . . . . 0.0 110.545 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.877 HD12 ' HG2' ' A' ' 53' ' ' ARG . 33.4 mt -60.53 -33.15 72.23 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.005 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.627 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 78.0 t80 -91.08 -30.13 16.92 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.991 175.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -66.06 -32.77 74.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.68 1.89 53.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.25 0.548 . . . . 0.0 109.802 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 t30 49.37 60.49 3.73 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 125.65 1.58 . . . . 0.0 112.763 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -74.02 12.63 0.67 Allowed 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 50.22 67.26 0.94 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.901 1.28 . . . . 0.0 112.517 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.596 HG22 ' HD2' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -146.88 174.23 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.245 -177.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.46 ' HB3' ' HB3' ' A' ' 64' ' ' MET . 7.9 tt0 -131.1 117.97 19.85 Favored 'General case' 0 C--O 1.191 -1.986 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.877 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -128.17 141.17 51.55 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.213 -170.261 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.761 ' H ' HG12 ' A' ' 62' ' ' ILE . 16.8 m-85 -133.72 151.96 51.76 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -168.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.53 HG12 ' HB ' ' A' ' 37' ' ' THR . 21.5 mt -93.03 96.64 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 167.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.57 HG21 ' HB3' ' A' ' 60' ' ' ARG . 8.2 m -91.1 -31.25 4.95 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.535 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.33 173.73 45.68 Favored Glycine 0 CA--C 1.49 -1.493 0 C-N-CA 117.028 -2.51 . . . . 0.0 114.191 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.506 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 33.2 m -66.71 118.95 10.98 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.506 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER 85.25 9.08 0.36 Allowed 'General case' 0 C--N 1.363 1.173 0 CA-C-O 122.138 0.97 . . . . 0.0 109.129 -178.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.57 ' HB3' HG21 ' A' ' 56' ' ' VAL . 8.1 mpt_? -140.21 131.63 26.88 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.13 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.05 165.92 26.05 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.761 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -143.51 157.23 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.99 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.914 170.355 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.592 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -135.65 104.81 5.92 Favored 'General case' 0 N--CA 1.428 -1.552 0 O-C-N 126.196 2.185 . . . . 0.0 107.321 162.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 26.7 ttt -87.2 116.66 25.43 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.164 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.625 ' HG ' ' HB1' ' A' ' 71' ' ' ALA . 3.8 mp -82.88 145.55 29.37 Favored 'General case' 0 C--O 1.256 1.415 0 C-N-CA 126.077 1.751 . . . . 0.0 112.288 -175.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.298 72.3 ttt180 -110.15 -61.77 1.61 Allowed 'General case' 0 CA--C 1.587 2.395 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 175.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -57.03 -10.95 1.28 Allowed 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.772 ' HA3' ' H ' ' A' ' 16' ' ' LYS . . . 56.61 26.71 53.45 Favored Glycine 0 C--N 1.36 1.89 0 CA-C-N 119.491 1.041 . . . . 0.0 114.501 -173.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.0 m -143.06 38.93 1.45 Allowed 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -179.56 -176.18 0.37 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -167.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.625 ' HB1' ' HG ' ' A' ' 65' ' ' LEU . . . 98.06 -30.89 0.02 OUTLIER 'General case' 0 C--N 1.376 1.718 0 C-N-CA 126.574 1.95 . . . . 0.0 115.016 173.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.676 ' HH2' ' HG ' ' A' ' 18' ' ' LEU 0.294 17.5 m-90 -71.32 -30.17 65.89 Favored 'General case' 0 C--O 1.277 2.502 0 CA-C-O 121.794 0.807 . . . . 0.0 111.803 -177.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -66.16 -40.13 90.29 Favored 'General case' 0 C--O 1.266 1.963 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.45 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.563 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 23.3 mt -54.98 -45.83 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.05 175.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.713 ' HE3' HG23 ' A' ' 87' ' ' VAL . 12.5 tmtt? -58.8 -42.88 90.14 Favored 'General case' 0 C--O 1.266 1.954 0 CA-C-O 121.372 0.606 . . . . 0.0 110.242 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.3 -42.96 96.6 Favored 'General case' 0 C--O 1.277 2.529 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.636 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.563 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 14.5 m-85 -55.85 -45.45 78.44 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.722 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 20.1 mt -58.84 -46.82 86.8 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.673 HG22 ' HB3' ' A' ' 84' ' ' CYS . 2.1 t -70.29 -20.44 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.826 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.8 t -90.55 -8.16 50.97 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -88.04 -38.39 15.5 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.317 6.6 t70 -155.02 -104.35 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.727 176.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 83' ' ' ARG . 23.5 tpt180 -143.32 84.35 1.81 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 121.115 1.78 . . . . 0.0 112.406 176.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.673 ' HB3' HG22 ' A' ' 79' ' ' VAL . 6.0 t -86.27 160.74 19.06 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.82 -40.33 0.09 Allowed 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -167.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 1.045 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 45.3 tt0 -126.49 116.67 21.47 Favored 'General case' 0 CA--C 1.47 -2.101 0 C-N-CA 118.187 -1.405 . . . . 0.0 109.719 -172.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.954 HG12 HD22 ' A' ' 89' ' ' LEU . 24.2 t -110.35 98.26 6.82 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.797 -175.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.572 ' C ' HD21 ' A' ' 89' ' ' LEU . 38.6 p -111.08 142.73 42.85 Favored 'General case' 0 C--O 1.261 1.692 0 CA-C-O 121.657 0.742 . . . . 0.0 111.251 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.954 HD22 HG12 ' A' ' 87' ' ' VAL . 2.9 mm? . . . . . 0 N--CA 1.405 -2.704 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.967 -166.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.665 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 27.0 tptp . . . . . 0 CA--C 1.532 0.274 0 CA-C-O 120.947 0.404 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.8 m -65.81 125.5 25.55 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.814 HD12 ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -124.74 109.03 12.61 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.371 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 22.3 ptm -96.6 102.98 14.86 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.723 ' HE1' HD11 ' A' ' 18' ' ' LEU . 7.4 ptp -114.75 135.14 54.5 Favored 'General case' 0 C--O 1.272 2.271 0 C-N-CA 116.789 -1.965 . . . . 0.0 112.83 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.563 ' HA ' HG22 ' A' ' 62' ' ' ILE . 3.6 t80 -97.46 118.52 34.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.85 2.46 . . . . 0.0 107.71 -173.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.63 124.42 70.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.825 ' HA ' ' HG3' ' A' ' 60' ' ' ARG . 83.4 m -88.81 121.32 31.05 Favored 'General case' 0 CA--C 1.605 3.06 0 C-N-CA 125.923 1.689 . . . . 0.0 112.275 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.69 HG12 ' HB2' ' A' ' 83' ' ' ARG 0.305 56.4 t -111.01 130.54 64.26 Favored 'Isoleucine or valine' 0 C--N 1.378 1.813 0 C-N-CA 127.668 2.387 . . . . 0.0 104.714 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.5 m -121.92 -5.86 9.03 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-N 122.658 2.481 . . . . 0.0 115.998 -169.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.31 -44.72 21.14 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 121.452 -0.404 . . . . 0.0 112.817 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 4.7 m-20 -106.07 154.16 39.75 Favored Pre-proline 0 CA--C 1.514 -0.436 0 CA-C-N 117.757 0.779 . . . . 0.0 109.271 172.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -111.12 40.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 123.883 3.056 . . . . 0.0 110.882 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.3 p -131.89 -105.08 0.26 Allowed 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.647 -0.658 . . . . 0.0 112.72 -168.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.718 ' HA ' ' O ' ' A' ' 58' ' ' SER . 30.0 tt0 -167.19 15.74 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.907 2.083 . . . . 0.0 106.669 170.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 9.5 tmtt? -86.78 -31.68 20.77 Favored 'General case' 0 C--O 1.259 1.556 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.359 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.949 ' HG3' HD11 ' A' ' 36' ' ' ILE . 7.1 tp10 -73.32 -44.69 58.5 Favored 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 104.303 -2.481 . . . . 0.0 104.303 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.856 ' OG1' ' HA ' ' A' ' 59' ' ' ASP . 59.6 m -44.2 -51.14 8.42 Favored 'General case' 0 C--O 1.179 -2.64 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.391 167.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.7 pt-20 -63.39 -52.33 62.09 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 119.631 1.105 . . . . 0.0 112.42 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -53.6 -60.03 3.83 Favored 'General case' 0 C--O 1.263 1.798 0 CA-C-O 123.315 1.531 . . . . 0.0 107.978 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.949 HD11 ' HG3' ' A' ' 32' ' ' GLU . 1.3 mt -60.43 -45.03 97.37 Favored 'Isoleucine or valine' 0 C--O 1.163 -3.464 0 CA-C-N 112.095 -2.32 . . . . 0.0 112.745 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.749 HG21 HG12 ' A' ' 55' ' ' ILE . 19.2 p -68.76 -34.53 75.73 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-N 121.071 1.76 . . . . 0.0 110.869 -176.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.4 m -63.06 -51.13 67.88 Favored 'General case' 0 N--CA 1.407 -2.588 0 C-N-CA 119.551 -0.859 . . . . 0.0 109.819 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.5 mp -71.71 -43.06 66.59 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.366 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.69 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 43.4 m0 -62.44 -76.58 0.06 Allowed 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 123.757 0.661 . . . . 0.0 111.251 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.645 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.323 0.0 OUTLIER -71.74 -19.66 62.01 Favored 'General case' 0 C--O 1.254 1.337 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.976 -172.386 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.58 -51.82 55.1 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.741 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 32.0 t -72.47 -25.29 61.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.797 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 31.1 mt -62.78 -34.37 77.11 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.81 0.338 . . . . 0.0 110.242 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.556 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 70.8 t80 -91.24 -24.43 19.89 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.926 175.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.741 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 8.1 t30 -67.24 -31.62 72.1 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.698 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.22 5.08 48.79 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.271 0.558 . . . . 0.0 109.583 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.5 t30 46.67 55.39 7.74 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.516 1.927 . . . . 0.0 112.905 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -67.51 1.6 2.25 Favored 'General case' 0 CA--C 1.594 2.661 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t70 56.58 69.48 0.74 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.188 1.395 . . . . 0.0 110.951 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.859 HG21 ' HD2' ' A' ' 53' ' ' ARG . 6.7 m -147.44 176.06 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.629 -172.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.538 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 25.7 tt0 -133.78 126.23 30.19 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.859 ' HD2' HG21 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -134.69 140.78 46.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 108.784 -170.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.669 ' H ' HG12 ' A' ' 62' ' ' ILE . 38.1 m-85 -133.8 153.15 51.93 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 -166.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.749 HG12 HG21 ' A' ' 37' ' ' THR . 76.6 mt -86.42 112.42 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 166.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.8 m -130.12 -26.68 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -171.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.765 ' HA3' ' HB2' ' A' ' 60' ' ' ARG . . . -138.41 174.83 21.79 Favored Glycine 0 CA--C 1.48 -2.127 0 C-N-CA 118.643 -1.741 . . . . 0.0 112.058 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.718 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 5.2 m -39.02 -71.1 0.09 Allowed 'General case' 0 C--N 1.367 1.364 0 O-C-N 125.654 1.444 . . . . 0.0 109.417 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.856 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 21.4 m-20 -126.64 65.55 1.26 Allowed 'General case' 1 N--CA 1.363 -4.775 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 168.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.825 ' HG3' ' HA ' ' A' ' 23' ' ' THR . 4.1 mpt_? -134.18 137.0 44.14 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 112.896 -1.956 . . . . 0.0 108.823 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.56 169.59 17.06 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.669 HG12 ' H ' ' A' ' 54' ' ' PHE . 9.8 pt -136.56 157.64 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.065 0 C-N-CA 118.472 -1.291 . . . . 0.0 109.553 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.498 ' HZ ' ' HB2' ' A' ' 75' ' ' LYS 0.28 6.7 p90 -125.81 109.38 12.47 Favored 'General case' 0 N--CA 1.408 -2.55 0 O-C-N 126.394 2.309 . . . . 0.0 107.909 164.159 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 21.4 ttt -100.04 104.5 16.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.416 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.898 ' HG ' ' HB1' ' A' ' 71' ' ' ALA 0.34 0.0 OUTLIER -99.75 147.15 25.75 Favored 'General case' 0 CA--C 1.462 -2.405 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.041 -178.962 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.367 20.8 ttp180 -105.13 -68.61 0.85 Allowed 'General case' 0 C--N 1.264 -3.147 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -164.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.881 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 37.4 t70 -44.48 -24.51 0.19 Allowed 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.665 ' HA3' ' H ' ' A' ' 16' ' ' LYS . . . 69.78 12.29 67.36 Favored Glycine 0 C--N 1.366 2.196 0 CA-C-N 120.224 1.374 . . . . 0.0 115.996 -175.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.4 t -121.38 32.53 5.87 Favored 'General case' 0 CA--C 1.563 1.463 0 CA-C-N 118.649 1.224 . . . . 0.0 111.905 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.881 ' HE1' ' HB3' ' A' ' 67' ' ' ASP . 45.0 p90 175.13 137.96 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -174.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.898 ' HB1' ' HG ' ' A' ' 65' ' ' LEU . . . 169.27 -33.3 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.881 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.677 ' CZ2' HD12 ' A' ' 89' ' ' LEU 0.622 10.5 m0 -82.5 -11.73 58.28 Favored 'General case' 0 C--O 1.263 1.778 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 -168.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 43.6 tt0 -74.08 -36.82 64.32 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 170.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.464 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 63.9 mt -55.11 -46.29 77.44 Favored 'Isoleucine or valine' 0 C--O 1.278 2.565 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.514 ' HB2' ' HD1' ' A' ' 72' ' ' TRP . 13.9 tmtt? -56.73 -48.97 76.58 Favored 'General case' 0 C--O 1.282 2.793 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.124 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.31 -47.39 83.84 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.211 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 15.8 m-85 -52.59 -53.75 42.37 Favored 'General case' 0 C--N 1.371 1.54 0 O-C-N 123.73 0.644 . . . . 0.0 109.661 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.629 HD21 ' CD2' ' A' ' 40' ' ' TRP . 14.0 mt -60.46 -55.06 38.03 Favored 'General case' 0 C--O 1.302 3.816 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 75' ' ' LYS 0.308 27.4 m -78.29 -5.7 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 C-N-CA 117.986 -1.486 . . . . 0.0 113.217 -174.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.7 m -108.47 5.1 24.94 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.726 165.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 7.9 tp-100 -82.26 -45.1 15.46 Favored 'General case' 0 CA--C 1.456 -2.643 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.391 4.6 p30 -163.72 -94.14 0.02 OUTLIER 'General case' 0 C--O 1.245 0.863 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 175.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.69 ' HB2' HG12 ' A' ' 24' ' ' VAL . 21.2 mmt180 -91.22 129.77 37.17 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.406 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 11.8 p -150.71 152.17 33.51 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.677 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.79 -36.71 0.1 Allowed 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 123.301 0.64 . . . . 0.0 110.316 170.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.714 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 41.2 tt0 -154.29 129.95 10.0 Favored 'General case' 0 C--O 1.207 -1.135 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.647 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.491 HG11 ' CD2' ' A' ' 89' ' ' LEU . 58.6 t -117.4 98.32 6.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 171.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 16.9 p -100.01 136.14 40.38 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 122.708 1.242 . . . . 0.0 111.848 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.814 ' HB3' HD12 ' A' ' 18' ' ' LEU . 6.8 mt . . . . . 0 N--CA 1.398 -3.053 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.078 -168.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HE3' ' O ' ' A' ' 17' ' ' THR . 49.6 tptt . . . . . 0 N--CA 1.437 -1.085 0 CA-C-O 120.919 0.39 . . . . 0.0 111.54 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.597 HG21 ' HD2' ' A' ' 66' ' ' ARG . 30.3 m -69.73 115.16 8.65 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 1.072 HD13 ' HB3' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -110.96 102.9 11.34 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.853 1.311 . . . . 0.0 108.365 -176.433 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.573 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 6.2 ttt -84.84 119.62 25.53 Favored 'General case' 0 C--N 1.27 -2.859 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.737 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.777 ' HE3' HD23 ' A' ' 89' ' ' LEU . 26.0 ttm -110.46 110.04 20.64 Favored 'General case' 0 N--CA 1.415 -2.215 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.077 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -91.77 115.93 28.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -128.72 130.69 68.82 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -169.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 1.114 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 18.3 m -84.9 143.63 28.89 Favored 'General case' 0 CA--C 1.604 3.034 0 O-C-N 124.77 1.294 . . . . 0.0 110.946 174.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.405 HG22 HD11 ' A' ' 36' ' ' ILE 0.288 6.9 t -126.74 135.48 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.66 0 C-N-CA 130.069 3.348 . . . . 0.0 104.326 -176.287 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -117.13 -21.26 8.92 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-N 122.921 2.601 . . . . 0.0 117.062 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.05 -45.19 62.66 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.021 0.828 . . . . 0.0 114.217 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.86 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.5 t-20 -116.18 116.82 39.56 Favored Pre-proline 0 N--CA 1.433 -1.313 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -88.36 30.84 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.901 2.401 . . . . 0.0 113.147 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 p -139.1 -174.84 3.96 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.53 ' O ' ' HB ' ' A' ' 33' ' ' THR . 32.7 tt0 -77.27 0.37 22.31 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.573 0.624 . . . . 0.0 111.727 -173.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.408 ' C ' ' HD3' ' A' ' 31' ' ' LYS . 6.7 tmtt? -68.26 -43.35 78.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 122.049 -0.407 . . . . 0.0 110.601 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.86 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.7 OUTLIER -71.29 -39.32 71.58 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 118.086 -1.445 . . . . 0.0 108.314 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 61.1 m -45.04 -54.21 6.91 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 124.407 1.083 . . . . 0.0 111.482 172.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.63 -43.02 70.1 Favored 'General case' 0 C--O 1.265 1.882 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -52.72 -55.32 23.55 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.675 HG23 ' CE3' ' A' ' 40' ' ' TRP . 27.3 mt -62.59 -35.68 71.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.549 0 CA-C-N 112.574 -2.103 . . . . 0.0 112.932 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.2 m -61.77 -55.18 32.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.399 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.506 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 34.2 m -65.54 -48.51 72.19 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.592 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.0 -57.22 8.27 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.112 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.675 ' CE3' HG23 ' A' ' 36' ' ' ILE . 36.4 m0 -69.22 -74.03 0.14 Allowed 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.248 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.765 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.405 0.0 OUTLIER -72.05 -15.74 62.03 Favored 'General case' 0 C--O 1.253 1.28 0 C-N-CA 116.957 -1.897 . . . . 0.0 112.773 -168.01 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 38' ' ' SER . . . -67.23 -51.3 39.15 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 171.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 39.9 t -70.32 -27.47 64.39 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.775 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 16.2 mt -64.2 -28.71 69.93 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.038 0.447 . . . . 0.0 110.075 177.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.543 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 75.9 t80 -94.31 -28.44 15.57 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.108 0.48 . . . . 0.0 110.43 174.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.448 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 20.8 t-20 -72.79 -29.73 63.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -176.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.96 11.94 19.01 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.5 44.62 9.95 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.751 1.62 . . . . 0.0 114.158 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -82.3 151.41 26.76 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.92 87.62 7.36 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.726 1.603 . . . . 0.0 110.503 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.845 HG12 ' HA ' ' A' ' 65' ' ' LEU . 3.1 m -147.89 175.53 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.955 -173.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.519 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 26.8 tt0 -140.02 123.29 16.92 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.775 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -136.07 135.89 39.74 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -170.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.761 ' H ' HG12 ' A' ' 62' ' ' ILE . 16.7 m-85 -134.46 153.99 51.63 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -165.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.502 HG22 HD13 ' A' ' 55' ' ' ILE . 80.2 mt -80.03 124.75 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 165.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.98 -15.46 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 120.83 0.348 . . . . 0.0 110.739 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.506 ' HA3' ' HG2' ' A' ' 60' ' ' ARG . . . -166.32 163.64 37.03 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 118.051 -2.023 . . . . 0.0 113.905 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 37.3 m -77.91 45.85 0.54 Allowed 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 124.668 1.187 . . . . 0.0 111.579 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 58' ' ' SER . 3.1 p-10 158.63 14.92 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.745 0 C-N-CA 126.904 2.082 . . . . 0.0 106.496 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.506 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -149.02 147.76 28.93 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-O 121.669 0.747 . . . . 0.0 112.344 177.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.45 169.88 16.84 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 125.736 1.614 . . . . 0.0 106.874 -172.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.761 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.7 pt -136.19 157.82 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.778 0 C-N-CA 118.377 -1.329 . . . . 0.0 109.559 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.562 ' CE2' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -134.33 109.23 8.67 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 126.434 2.334 . . . . 0.0 106.362 162.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.573 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 23.3 ttt -97.83 108.96 21.79 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.347 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.986 HD13 ' HB3' ' A' ' 71' ' ' ALA 0.306 2.3 pt? -98.47 147.94 24.23 Favored 'General case' 0 CA--C 1.464 -2.359 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -176.127 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.597 ' HD2' HG21 ' A' ' 17' ' ' THR 0.26 12.6 mmm180 -100.28 -53.41 3.13 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 111.578 -2.555 . . . . 0.0 113.576 -174.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -45.47 -27.46 0.72 Allowed 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.95 -31.31 5.37 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 119.663 1.12 . . . . 0.0 111.936 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.261 40.6 t -98.17 -61.61 1.36 Allowed 'General case' 0 CA--C 1.588 2.43 0 N-CA-C 118.29 2.7 . . . . 0.0 118.29 -175.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.406 ' CD1' HD11 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -64.42 34.46 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 -168.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.986 ' HB3' HD13 ' A' ' 65' ' ' LEU . . . -103.16 -22.47 13.74 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.768 ' HH2' ' HG ' ' A' ' 18' ' ' LEU 0.504 13.6 m-90 -82.16 -28.93 31.84 Favored 'General case' 0 C--O 1.284 2.921 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -170.259 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.15 -27.57 63.64 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.65 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.8 mt -62.22 -39.97 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.756 ' HA ' HD11 ' A' ' 78' ' ' LEU . 26.2 ttpp -58.54 -43.3 89.21 Favored 'General case' 0 C--O 1.288 3.089 0 CA-C-O 121.445 0.641 . . . . 0.0 110.595 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.41 -45.96 80.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.209 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.65 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 10.0 m-85 -60.38 -39.71 88.22 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.321 -177.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.756 HD11 ' HA ' ' A' ' 75' ' ' LYS 0.275 21.5 mt -52.46 -59.74 4.07 Favored 'General case' 0 CA--C 1.45 -2.877 0 C-N-CA 123.077 0.551 . . . . 0.0 110.205 177.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' A' ' 84' ' ' CYS . 1.6 t -77.94 -9.26 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.684 -172.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.2 t -92.83 -12.24 31.62 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.615 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -107.15 -39.11 5.81 Favored 'General case' 0 CA--C 1.473 -1.989 0 C-N-CA 117.799 -1.56 . . . . 0.0 108.637 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -141.43 -169.45 2.87 Favored 'General case' 0 N--CA 1.389 -3.488 0 CA-C-N 113.419 -1.719 . . . . 0.0 107.06 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -108.32 76.92 1.06 Allowed 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 119.905 1.23 . . . . 0.0 110.645 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.688 ' HB3' HG22 ' A' ' 79' ' ' VAL . 3.8 t -70.49 157.53 37.68 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 113.518 -1.673 . . . . 0.0 109.645 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.75 -35.59 0.09 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 1.114 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.4 tt0 -135.51 125.22 25.38 Favored 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.42 -171.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.413 ' HB ' HD21 ' A' ' 89' ' ' LEU . 18.7 m -123.26 113.12 36.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.42 ' C ' HD22 ' A' ' 89' ' ' LEU . 3.4 p -107.31 128.27 54.29 Favored 'General case' 0 CA--C 1.477 -1.831 0 CA-C-O 122.36 1.076 . . . . 0.0 109.841 168.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 1.072 ' HB3' HD13 ' A' ' 18' ' ' LEU . 3.3 mt . . . . . 0 C--N 1.259 -3.366 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.731 -168.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? . . . . . 0 CA--C 1.549 0.916 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -78.61 124.27 27.99 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.777 ' HB3' HD21 ' A' ' 65' ' ' LEU . 25.6 tp -131.2 115.4 16.3 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.008 -174.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.669 ' HB3' ' SD ' ' A' ' 64' ' ' MET . 20.0 ptm -84.31 105.99 15.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.602 0.715 . . . . 0.0 112.282 176.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.871 ' HG3' ' HA ' ' A' ' 89' ' ' LEU . 3.6 mpp? -86.29 125.22 33.44 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.554 0.692 . . . . 0.0 112.261 176.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.638 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 47.2 t80 -106.06 112.92 26.17 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 127.246 2.218 . . . . 0.0 106.116 -176.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.78 130.36 74.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -168.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.853 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 89.5 m -93.05 131.14 38.32 Favored 'General case' 0 CA--C 1.611 3.295 0 C-N-CA 126.151 1.781 . . . . 0.0 111.883 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.42 HG11 ' HG2' ' A' ' 32' ' ' GLU . 71.6 t -132.14 113.44 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.358 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -105.77 -18.98 13.89 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 122.01 2.187 . . . . 0.0 115.185 -164.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -39.17 -49.08 2.78 Favored Glycine 0 N--CA 1.487 2.035 0 O-C-N 123.419 0.449 . . . . 0.0 113.612 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 1.117 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 26.9 t-20 -115.86 104.74 52.35 Favored Pre-proline 0 N--CA 1.421 -1.881 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.14 33.74 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 123.888 3.059 . . . . 0.0 112.71 -174.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -148.43 -165.27 2.23 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 33' ' ' THR . 39.6 tt0 -81.05 -18.47 46.57 Favored 'General case' 0 C--O 1.19 -2.039 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -173.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 3.4 tmtt? -58.96 -41.25 87.03 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-N 119.032 0.833 . . . . 0.0 111.491 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 1.117 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 5.9 tp10 -66.42 -61.49 1.97 Allowed 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 31.5 m -34.35 -50.25 0.41 Allowed 'General case' 0 C--O 1.19 -2.073 0 C-N-CA 127.158 2.183 . . . . 0.0 113.026 172.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 12.8 pt-20 -71.99 -49.66 35.26 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 118.124 0.42 . . . . 0.0 112.031 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -54.24 -54.15 43.89 Favored 'General case' 0 C--O 1.263 1.801 0 CA-C-O 123.045 1.402 . . . . 0.0 107.296 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.998 HD11 ' HG3' ' A' ' 32' ' ' GLU . 1.5 mt -66.83 -38.99 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.584 0 CA-C-N 111.622 -2.536 . . . . 0.0 113.541 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.853 HG22 HG12 ' A' ' 55' ' ' ILE . 11.3 p -73.82 -39.3 64.16 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-N 121.3 1.864 . . . . 0.0 110.946 -176.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.0 t -64.22 -47.83 78.2 Favored 'General case' 0 N--CA 1.412 -2.344 0 O-C-N 124.017 0.823 . . . . 0.0 109.659 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.4 tp -68.75 -44.37 73.9 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.765 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.712 ' CE3' HD12 ' A' ' 78' ' ' LEU . 48.8 m0 -66.2 -74.02 0.12 Allowed 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 118.952 -0.547 . . . . 0.0 111.708 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.339 0.0 OUTLIER -70.83 -19.29 62.68 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 118.044 -1.462 . . . . 0.0 111.884 -172.601 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.03 -48.91 65.57 Favored Glycine 0 C--N 1.356 1.646 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 172.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.6 p -70.0 -29.63 66.75 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 117.442 0.621 . . . . 0.0 110.25 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.77 HD13 ' HG2' ' A' ' 53' ' ' ARG . 22.8 mt -61.07 -32.49 72.13 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.003 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.633 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 80.5 t80 -92.11 -27.38 17.78 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.873 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -67.89 -30.67 70.08 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 120.629 0.252 . . . . 0.0 111.004 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.69 -0.01 56.24 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.6 t30 47.17 53.87 10.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.136 1.774 . . . . 0.0 112.006 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -65.58 0.69 1.5 Allowed 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.9 t70 59.3 70.87 0.61 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.305 1.042 . . . . 0.0 111.365 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.541 ' CG2' ' HD2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -146.92 175.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.919 -172.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.432 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 26.7 tt0 -131.04 115.92 17.09 Favored 'General case' 0 C--O 1.194 -1.828 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.77 ' HG2' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -130.41 140.77 50.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -172.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.777 ' H ' HG12 ' A' ' 62' ' ' ILE . 24.4 m-85 -134.02 152.06 51.69 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.853 HG12 HG22 ' A' ' 37' ' ' THR . 19.9 mt -92.65 97.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 167.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 m -99.1 -22.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.84 169.03 40.81 Favored Glycine 0 CA--C 1.482 -1.975 0 C-N-CA 118.192 -1.956 . . . . 0.0 113.78 175.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.445 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 36.9 m -65.04 120.4 12.57 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.0 OUTLIER 78.79 14.76 1.19 Allowed 'General case' 0 C--N 1.371 1.541 0 CA-C-O 122.658 1.218 . . . . 0.0 108.823 -178.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.638 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 4.1 tpp85 -143.84 117.49 9.23 Favored 'General case' 0 CA--C 1.557 1.236 0 O-C-N 121.419 -0.8 . . . . 0.0 111.266 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.96 166.44 20.06 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -175.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.777 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -138.77 155.23 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.461 -2.464 0 C-N-CA 118.174 -1.41 . . . . 0.0 109.699 172.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.528 ' CE2' ' HB1' ' A' ' 71' ' ' ALA . 6.0 p90 -134.97 106.37 6.8 Favored 'General case' 0 N--CA 1.417 -2.093 0 O-C-N 126.335 2.272 . . . . 0.0 107.307 163.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.669 ' SD ' ' HB3' ' A' ' 19' ' ' MET . 20.2 ttt -92.15 110.22 21.6 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.45 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.777 HD21 ' HB3' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -75.12 132.38 41.18 Favored 'General case' 0 C--O 1.254 1.313 0 O-C-N 125.895 1.997 . . . . 0.0 110.952 -175.672 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.318 2.1 tmt_? -108.41 -54.95 2.44 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -41.24 -34.16 0.45 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.09 -31.1 7.97 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 117.723 -2.18 . . . . 0.0 115.079 -173.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.9 m -158.66 60.17 0.43 Allowed 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -171.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.45 ' OH ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -152.81 21.38 0.6 Allowed 'General case' 0 C--O 1.218 -0.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.174 178.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.528 ' HB1' ' CE2' ' A' ' 63' ' ' PHE . . . -103.19 -29.27 11.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -168.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.567 ' HZ2' HD23 ' A' ' 18' ' ' LEU 0.512 8.1 m0 -87.18 -9.93 53.95 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 116.317 -2.153 . . . . 0.0 113.828 -171.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.556 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 35.0 tt0 -73.42 -43.12 61.1 Favored 'General case' 0 C--O 1.279 2.653 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 166.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.566 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 61.0 mt -50.77 -47.0 29.36 Favored 'Isoleucine or valine' 0 C--O 1.278 2.578 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.801 173.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.587 ' HG3' HG21 ' A' ' 87' ' ' VAL . 44.8 tttm -56.11 -50.61 70.58 Favored 'General case' 0 C--N 1.375 1.688 0 C-N-CA 125.807 1.643 . . . . 0.0 110.269 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -61.86 -25.64 67.65 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.566 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 23.1 m-85 -73.76 -61.14 1.94 Allowed 'General case' 0 CA--C 1.48 -1.726 0 C-N-CA 118.382 -1.327 . . . . 0.0 108.35 -175.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.712 HD12 ' CE3' ' A' ' 40' ' ' TRP . 1.9 pt? -66.52 -32.71 74.23 Favored 'General case' 0 C--O 1.297 3.583 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.001 -173.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.789 HG13 ' HB2' ' A' ' 84' ' ' CYS . 54.9 t -77.3 -21.55 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.414 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.6 m -103.54 6.76 37.56 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.209 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.605 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . 6.2 tp-100 -77.3 -46.18 23.85 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.455 2.3 p30 -165.26 -94.55 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 171.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -84.7 136.52 33.69 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 117.935 -1.506 . . . . 0.0 111.899 -174.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.789 ' HB2' HG13 ' A' ' 79' ' ' VAL . 7.9 p -152.66 150.84 29.9 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.403 -170.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.06 -41.15 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.853 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 7.6 tp10 -153.81 137.59 16.17 Favored 'General case' 0 C--O 1.21 -1.013 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.35 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.587 HG21 ' HG3' ' A' ' 75' ' ' LYS . 48.7 t -131.68 94.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.332 0.8 OUTLIER -98.19 126.32 43.61 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-O 123.603 1.668 . . . . 0.0 113.006 176.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.871 ' HA ' ' HG3' ' A' ' 20' ' ' MET . 3.0 mp . . . . . 1 N--CA 1.374 -4.274 0 CA-C-N 111.223 -2.717 . . . . 0.0 106.16 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -85.44 130.76 34.51 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.337 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.804 HD11 ' HH2' ' A' ' 72' ' ' TRP . 94.4 mt -130.91 123.84 29.82 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 22.0 ptm -84.54 107.5 16.81 Favored 'General case' 0 C--N 1.265 -3.079 0 C-N-CA 118.57 -1.252 . . . . 0.0 108.31 170.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.799 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 32.1 ttm -87.91 104.44 16.61 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 118.135 -1.426 . . . . 0.0 110.187 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -91.6 112.41 24.32 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.576 1.95 . . . . 0.0 106.298 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 p -129.04 132.69 67.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -168.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.995 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 70.9 m -80.39 128.38 33.5 Favored 'General case' 0 CA--C 1.595 2.69 0 C-N-CA 125.429 1.492 . . . . 0.0 109.267 173.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.4 p -110.93 138.34 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.606 3.113 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 1.042 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 85.7 p 52.64 -74.94 0.01 OUTLIER 'General case' 0 C--N 1.368 1.401 0 C-N-CA 126.481 1.913 . . . . 0.0 115.936 -169.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.68 -14.38 2.22 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -171.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -96.61 120.46 62.01 Favored Pre-proline 0 N--CA 1.42 -1.969 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.579 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 74.4 Cg_endo -73.71 41.66 0.64 Allowed 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 123.49 2.793 . . . . 0.0 112.485 -175.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.6 p -110.52 170.39 8.12 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.522 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.1 tp10 -81.47 -15.44 55.03 Favored 'General case' 0 C--O 1.17 -3.099 0 CA-C-N 119.934 1.243 . . . . 0.0 109.793 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.759 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 1.3 tmtt? -48.92 -63.6 1.05 Allowed 'General case' 0 C--O 1.269 2.122 0 C-N-CA 125.19 1.396 . . . . 0.0 114.534 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 1.042 ' HG2' ' HB3' ' A' ' 25' ' ' SER . 4.6 tp10 -67.76 -45.16 75.68 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -172.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 15.5 m -45.2 -58.56 3.17 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 112.071 -2.331 . . . . 0.0 109.689 172.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.759 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 10.8 pt-20 -58.38 -50.86 72.14 Favored 'General case' 0 C--O 1.26 1.61 0 C-N-CA 123.788 0.835 . . . . 0.0 112.751 -172.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.852 ' HG3' HG13 ' A' ' 36' ' ' ILE . 5.9 pt-20 -66.86 -47.67 71.2 Favored 'General case' 0 C--O 1.269 2.082 0 C-N-CA 117.959 -1.496 . . . . 0.0 109.626 -175.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.852 HG13 ' HG3' ' A' ' 35' ' ' GLU . 9.4 mt -76.05 -34.72 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.378 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.145 -172.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 40' ' ' TRP . 44.7 p -68.61 -33.61 74.35 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 118.658 0.663 . . . . 0.0 110.82 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 m -63.16 -45.18 93.08 Favored 'General case' 0 C--O 1.258 1.53 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.57 -38.76 92.34 Favored 'General case' 0 C--N 1.378 1.805 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.761 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 14.1 m0 -65.67 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.248 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.643 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.384 0.0 OUTLIER -70.83 -14.26 62.34 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 117.992 -1.483 . . . . 0.0 112.357 -169.08 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.29 -53.04 38.8 Favored Glycine 0 C--N 1.366 2.243 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.566 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 80.5 p -72.32 -30.28 64.61 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.314 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.799 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 21.5 mt -62.44 -29.5 70.56 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.471 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.604 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 21.3 t80 -92.09 -30.86 15.77 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.566 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 24.7 t-20 -66.47 -34.83 78.81 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.153 0.581 . . . . 0.0 112.03 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.85 -1.29 57.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 56.25 56.41 5.83 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.194 1.398 . . . . 0.0 111.781 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -89.55 155.0 19.56 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.589 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 23.6 t70 -91.45 76.46 5.87 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 120.576 1.535 . . . . 0.0 110.252 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.525 HG22 ' HD2' ' A' ' 53' ' ' ARG . 2.5 m -139.5 167.19 20.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.565 -172.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.521 ' HB3' ' HB3' ' A' ' 64' ' ' MET . 6.3 tt0 -120.9 122.13 39.56 Favored 'General case' 0 C--O 1.189 -2.115 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.799 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.72 128.29 36.59 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -177.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.814 ' H ' HG12 ' A' ' 62' ' ' ILE . 52.0 t80 -135.6 146.64 48.13 Favored 'General case' 0 C--N 1.272 -2.762 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.886 -167.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.3 mt -93.0 96.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 171.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.55 -34.64 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.53 -166.86 39.34 Favored Glycine 0 CA--C 1.479 -2.166 0 C-N-CA 118.721 -1.704 . . . . 0.0 113.8 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 49.7 m -69.95 123.63 22.0 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.579 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 5.1 t70 79.4 -1.99 2.19 Favored 'General case' 0 C--O 1.215 -0.752 0 O-C-N 124.542 1.152 . . . . 0.0 109.405 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -126.28 117.56 23.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.408 0.623 . . . . 0.0 111.92 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.83 165.19 25.57 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.814 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -143.74 153.64 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.663 0 C-N-CA 118.231 -1.388 . . . . 0.0 109.639 173.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.448 ' HA ' ' HG3' ' A' ' 53' ' ' ARG 0.28 10.0 p90 -131.9 104.19 6.73 Favored 'General case' 0 N--CA 1.402 -2.875 0 O-C-N 126.558 2.411 . . . . 0.0 107.155 161.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.521 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . 23.9 ttt -90.28 109.96 21.04 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.809 -176.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.716 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.265 3.9 mp -76.59 145.13 39.15 Favored 'General case' 0 CA--C 1.457 -2.634 0 C-N-CA 126.085 1.754 . . . . 0.0 110.892 -175.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.589 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.329 61.6 ttt180 -119.52 -58.42 1.91 Allowed 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 174.141 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.557 ' C ' ' H ' ' A' ' 69' ' ' SER . 10.4 t70 -70.67 8.55 0.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.87 -24.78 0.02 OUTLIER Glycine 0 CA--C 1.559 2.837 0 CA-C-N 120.126 1.33 . . . . 0.0 116.244 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.557 ' H ' ' C ' ' A' ' 67' ' ' ASP . 6.3 m -87.05 15.71 5.77 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -169.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -164.23 135.21 4.37 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.718 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.791 ' HA ' HD11 ' A' ' 74' ' ' ILE . . . 156.37 -31.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 127.019 2.128 . . . . 0.0 111.708 172.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.804 ' HH2' HD11 ' A' ' 18' ' ' LEU 0.272 13.7 m-90 -74.53 -30.86 61.94 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-O 121.722 0.772 . . . . 0.0 111.873 -174.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.413 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 36.8 tt0 -68.8 -37.51 79.3 Favored 'General case' 0 C--O 1.265 1.915 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.791 HD11 ' HA ' ' A' ' 71' ' ' ALA . 12.7 mt -61.62 -44.21 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.557 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.516 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.751 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.44 -27.9 64.62 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.822 -178.066 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.74 -48.71 79.46 Favored 'General case' 0 C--O 1.247 0.963 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.954 171.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.52 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 18.9 m-85 -55.64 -45.66 77.58 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.157 0.98 . . . . 0.0 109.923 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.751 ' HG ' ' HA ' ' A' ' 75' ' ' LYS 0.27 4.3 pp -63.96 -47.46 80.34 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.54 ' N ' HD11 ' A' ' 78' ' ' LEU 0.355 4.4 m -77.04 -1.8 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 116.63 -2.028 . . . . 0.0 112.685 176.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -85.57 -20.03 30.19 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.005 166.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -80.93 -17.53 50.22 Favored 'General case' 0 C--N 1.367 1.357 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 171.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.258 23.2 t70 88.99 -50.61 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 112.489 -2.141 . . . . 0.0 114.527 168.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.735 ' HB3' ' HB3' ' A' ' 25' ' ' SER . 33.3 mmt180 -84.79 76.6 10.21 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 78' ' ' LEU . 61.3 m -154.91 37.62 0.41 Allowed 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 123.073 1.416 . . . . 0.0 110.406 -168.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -32.16 -45.92 0.11 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 131.009 3.723 . . . . 0.0 120.274 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.995 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 30.6 tt0 -146.71 123.58 11.3 Favored 'General case' 0 C--O 1.198 -1.629 0 C-N-CA 117.244 -1.782 . . . . 0.0 113.906 -164.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.595 ' HB ' HD12 ' A' ' 89' ' ' LEU . 16.3 m -113.55 131.69 64.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.441 ' C ' HD11 ' A' ' 89' ' ' LEU 0.265 16.7 p -117.77 120.84 39.16 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 122.917 1.341 . . . . 0.0 110.095 165.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.799 ' HG ' ' HG3' ' A' ' 20' ' ' MET . 5.1 mp . . . . . 0 C--N 1.262 -3.239 0 CA-C-N 112.708 -2.042 . . . . 0.0 106.638 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 20.3 tptm . . . . . 0 C--O 1.225 -0.207 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.8 t -72.0 133.61 45.42 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.131 0.491 . . . . 0.0 109.854 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 1.042 HD22 ' HA ' ' A' ' 89' ' ' LEU . 13.3 tp -134.04 133.93 41.8 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.178 -177.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.7 mtp -83.56 100.27 10.69 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 104.47 -2.418 . . . . 0.0 104.47 164.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.507 ' HB2' HD23 ' A' ' 18' ' ' LEU . 53.7 ttp -86.45 119.97 27.29 Favored 'General case' 0 CA--C 1.475 -1.911 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.804 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.584 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 49.8 t80 -97.96 124.6 42.49 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.868 -1.969 . . . . 0.0 106.896 -174.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -129.37 125.9 62.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -173.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.997 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 86.8 m -77.05 120.61 22.39 Favored 'General case' 0 CA--C 1.587 2.4 0 C-N-CA 125.409 1.483 . . . . 0.0 110.891 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.596 HG22 HD11 ' A' ' 36' ' ' ILE . 10.3 p -114.48 125.09 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 170.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.87 13.05 4.01 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 115.73 -2.388 . . . . 0.0 113.54 -163.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.11 -37.91 93.48 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 119.198 -1.477 . . . . 0.0 109.895 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 1.096 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 23.6 t-20 -117.13 106.73 46.77 Favored Pre-proline 0 N--CA 1.423 -1.824 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -72.94 30.32 0.29 Allowed 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 123.569 2.846 . . . . 0.0 113.251 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -143.4 -171.16 3.44 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.409 ' O ' ' HB ' ' A' ' 33' ' ' THR . 33.2 tt0 -82.29 -7.05 59.62 Favored 'General case' 0 C--O 1.206 -1.199 0 CA-C-N 118.802 0.728 . . . . 0.0 112.537 -171.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 2.4 tmpt? -60.91 -45.59 94.02 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 118.235 0.47 . . . . 0.0 110.369 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 1.096 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.5 tp10 -67.59 -49.55 62.57 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 86.9 m -44.49 -52.13 8.19 Favored 'General case' 0 C--O 1.196 -1.738 0 C-N-CA 124.989 1.316 . . . . 0.0 112.409 172.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.3 pt-20 -67.84 -51.51 47.62 Favored 'General case' 0 C--O 1.253 1.273 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -59.02 -47.06 86.58 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.929 1.347 . . . . 0.0 108.071 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.822 HD12 ' HG3' ' A' ' 32' ' ' GLU . 10.1 mt -69.85 -40.61 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.58 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.804 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.871 HG23 HG12 ' A' ' 55' ' ' ILE . 12.9 p -69.61 -37.69 76.95 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 120.54 1.518 . . . . 0.0 111.047 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 p -64.75 -57.86 7.81 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 123.864 0.727 . . . . 0.0 109.668 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.1 tp -66.11 -43.21 87.88 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.731 ' CD2' HG21 ' A' ' 36' ' ' ILE . 44.0 m0 -69.59 -69.12 0.36 Allowed 'General case' 0 C--O 1.197 -1.706 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.901 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.843 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.421 0.0 OUTLIER -68.97 -20.05 64.17 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 117.554 -1.659 . . . . 0.0 112.669 -171.827 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.46 -50.42 59.51 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 170.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 46' ' ' ASN . 65.3 p -69.64 -25.39 63.91 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.082 -0.658 . . . . 0.0 110.644 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.843 ' HG ' ' HA ' ' A' ' 41' ' ' GLN . 20.1 mt -62.07 -31.15 71.54 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 174.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -77.45 -44.13 30.06 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.383 0.611 . . . . 0.0 110.479 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.441 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 84.8 m-20 -63.61 -30.59 71.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -172.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.18 2.52 54.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.15 0.5 . . . . 0.0 110.33 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 55.05 62.32 2.56 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.336 1.455 . . . . 0.0 111.826 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -98.54 152.12 19.91 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 120.664 -1.272 . . . . 0.0 108.211 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -87.26 82.56 7.58 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 120.343 1.429 . . . . 0.0 110.288 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.967 HG11 ' HA ' ' A' ' 65' ' ' LEU . 2.1 m -147.75 165.63 5.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.607 -174.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.499 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 1.9 mp0 -131.25 124.4 30.46 Favored 'General case' 0 C--O 1.194 -1.859 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 171.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.839 ' HG3' ' HA ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -124.56 138.99 54.28 Favored 'General case' 0 C--N 1.287 -2.133 0 O-C-N 121.47 -0.769 . . . . 0.0 109.259 -172.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.819 ' H ' HG12 ' A' ' 62' ' ' ILE . 21.0 t80 -134.93 151.4 50.83 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.781 -1.167 . . . . 0.0 113.294 -167.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.871 HG12 HG23 ' A' ' 37' ' ' THR . 48.9 mt -83.66 123.32 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 39.2 t -101.74 -38.85 6.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.94 -163.32 30.44 Favored Glycine 0 CA--C 1.481 -2.043 0 C-N-CA 119.329 -1.415 . . . . 0.0 113.12 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 m -52.96 119.1 4.25 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.943 0.897 . . . . 0.0 109.534 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER 73.59 13.9 4.35 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 121.896 0.855 . . . . 0.0 111.729 175.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.584 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -146.55 125.86 13.09 Favored 'General case' 0 CA--C 1.572 1.803 0 O-C-N 120.763 -1.211 . . . . 0.0 112.016 -177.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.98 163.5 32.81 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.819 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -137.55 156.24 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.178 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.652 173.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.875 ' HE2' HG22 ' A' ' 74' ' ' ILE . 1.1 m-30 -125.96 101.04 6.63 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 126.674 2.483 . . . . 0.0 104.926 167.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 26.5 ttt -83.97 100.34 10.98 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 117.816 -1.554 . . . . 0.0 108.305 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 1.046 HD13 ' HB3' ' A' ' 71' ' ' ALA . 2.6 pt? -97.28 148.3 23.26 Favored 'General case' 0 CA--C 1.45 -2.895 0 CA-C-O 122.484 1.135 . . . . 0.0 112.714 -175.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.358 16.0 ttp180 -109.06 -54.86 2.48 Favored 'General case' 1 C--N 1.24 -4.165 0 CA-C-N 113.066 -1.879 . . . . 0.0 115.6 -173.402 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.11 -8.67 0.5 Allowed 'General case' 0 CA--C 1.594 2.67 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 174.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.44 -31.09 2.98 Favored Glycine 0 C--N 1.359 1.835 0 O-C-N 120.049 -1.657 . . . . 0.0 113.533 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.4 p -81.4 -69.49 0.61 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -174.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.675 ' HE1' ' HB2' ' A' ' 65' ' ' LEU 0.297 0.2 OUTLIER -46.36 -28.98 1.49 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 120.687 3.588 . . . . 0.0 120.687 -162.632 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 1.046 ' HB3' HD13 ' A' ' 65' ' ' LEU . . . -64.14 -35.76 81.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 116.555 2.058 . . . . 0.0 116.555 -166.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.697 ' HH2' HD21 ' A' ' 18' ' ' LEU 0.323 27.2 m-90 -83.36 -19.72 35.6 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.417 -1.313 . . . . 0.0 113.481 -173.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -74.55 -35.14 63.09 Favored 'General case' 0 C--O 1.28 2.693 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 170.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.875 HG22 ' HE2' ' A' ' 63' ' ' PHE . 22.6 mt -65.0 -35.1 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.823 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.873 ' HG3' HG12 ' A' ' 87' ' ' VAL . 12.5 tmtt? -67.58 -33.18 74.49 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.761 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -58.46 -47.34 84.32 Favored 'General case' 0 C--O 1.263 1.769 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.113 170.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.561 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 5.7 m-30 -52.0 -47.06 65.12 Favored 'General case' 0 N--CA 1.513 2.709 0 CA-C-O 122.152 0.977 . . . . 0.0 109.64 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.675 ' HG ' ' HA ' ' A' ' 75' ' ' LYS . 30.9 mt -53.62 -63.6 1.1 Allowed 'General case' 0 CA--C 1.471 -2.093 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.423 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.6 m -69.04 -11.0 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 C-N-CA 119.553 -0.859 . . . . 0.0 112.537 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.7 m -94.44 -10.49 32.26 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.967 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.443 ' NE2' ' HB3' ' A' ' 77' ' ' PHE . 45.5 mt-30 -124.81 -28.68 3.48 Favored 'General case' 0 C--N 1.38 1.908 0 C-N-CA 116.137 -2.225 . . . . 0.0 112.112 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.622 ' HB2' ' HZ2' ' A' ' 40' ' ' TRP . 11.8 m-20 -133.17 167.56 20.13 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.19 63.07 6.99 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.176 1.353 . . . . 0.0 112.838 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 40.5 t -82.43 176.71 9.21 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.683 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -167.73 -39.42 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -169.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.997 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 32.1 tt0 -147.55 121.85 9.61 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.612 -167.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.873 HG12 ' HG3' ' A' ' 75' ' ' LYS . 28.4 m -118.96 129.34 75.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.242 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.8 p -115.99 120.27 38.6 Favored 'General case' 0 C--O 1.281 2.714 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 1.042 ' HA ' HD22 ' A' ' 18' ' ' LEU 0.302 7.1 tp . . . . . 0 CA--C 1.577 1.994 0 CA-C-N 112.341 -2.209 . . . . 0.0 107.815 171.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.53 HG23 ' HA ' ' A' ' 66' ' ' ARG . 90.7 m -70.28 117.0 11.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 173.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.99 HD22 ' HA ' ' A' ' 89' ' ' LEU . 9.9 tp -133.59 140.39 47.11 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.903 -168.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.499 ' HG2' ' SD ' ' A' ' 64' ' ' MET . 81.3 mtp -83.01 100.63 10.58 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 162.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.638 ' HB3' HD23 ' A' ' 18' ' ' LEU . 2.1 ppp? -87.08 137.42 32.36 Favored 'General case' 0 C--O 1.259 1.605 0 C-N-CA 115.915 -2.314 . . . . 0.0 108.588 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -107.14 126.53 52.5 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.064 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.443 HG13 ' HB1' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -116.21 124.85 72.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.886 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 1.021 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 17.6 m -98.6 135.04 40.69 Favored 'General case' 0 CA--C 1.582 2.205 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 36' ' ' ILE . 12.6 p -132.17 119.88 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.609 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 t -124.32 -1.98 8.09 Favored 'General case' 0 C--O 1.239 0.52 0 O-C-N 119.327 -2.108 . . . . 0.0 112.84 -165.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.91 -32.08 78.48 Favored Glycine 0 CA--C 1.506 -0.505 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.629 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.727 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 24.9 t-20 -117.14 106.74 46.76 Favored Pre-proline 0 N--CA 1.4 -2.939 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -85.75 32.02 0.47 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.7 p -135.53 -160.51 1.06 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.417 ' O ' ' HB ' ' A' ' 33' ' ' THR . 3.7 tp10 -84.44 -7.22 59.36 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -177.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 2.2 tmpt? -65.5 -49.8 67.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -172.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.755 ' HG2' ' HB2' ' A' ' 83' ' ' ARG . 16.4 tp10 -72.74 -35.5 67.53 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 117.663 -1.615 . . . . 0.0 108.129 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.55 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 84.3 m -49.61 -52.92 27.08 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.07 172.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.9 pt-20 -70.01 -37.86 75.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -62.42 -55.11 30.94 Favored 'General case' 0 C--O 1.209 -1.053 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.763 HG23 ' CE3' ' A' ' 40' ' ' TRP . 95.9 mt -58.13 -49.92 79.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.062 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.902 HG22 HG12 ' A' ' 55' ' ' ILE . 36.0 p -65.04 -56.81 10.87 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.522 -176.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 m -65.22 -48.43 73.35 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.452 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.2 mt -75.09 -52.93 9.82 Favored 'General case' 0 C--O 1.252 1.19 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.763 ' CE3' HG23 ' A' ' 36' ' ' ILE . 6.5 m0 -72.5 -60.69 2.11 Favored 'General case' 0 C--O 1.157 -3.767 0 CA-C-O 117.198 -1.382 . . . . 0.0 109.062 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.884 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.44 0.0 OUTLIER -64.4 -24.68 67.72 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-N 121.066 1.757 . . . . 0.0 112.893 -173.706 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.67 -47.48 90.17 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.845 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 54.5 p -77.62 -19.96 54.66 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 122.306 -0.526 . . . . 0.0 111.861 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.884 ' HG ' ' HA ' ' A' ' 41' ' ' GLN . 23.9 mt -65.05 -34.02 77.43 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.427 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 90.1 t80 -85.69 -33.61 21.49 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.854 173.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.845 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 15.2 t-20 -61.0 -39.21 88.83 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.44 6.48 33.73 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 122.0 -0.437 . . . . 0.0 110.585 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 58.9 41.24 21.57 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.914 0.886 . . . . 0.0 112.226 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.414 ' O ' HG11 ' A' ' 51' ' ' VAL . 18.3 m-85 -73.57 10.89 0.93 Allowed 'General case' 0 CA--C 1.582 2.178 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 45.32 70.34 0.36 Allowed 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 125.61 1.564 . . . . 0.0 112.253 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.912 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.2 m -147.13 176.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.289 -169.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.489 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 20.8 mt-30 -134.33 120.26 19.67 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.72 ' HD3' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -126.23 141.42 51.93 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -171.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.63 ' N ' HG12 ' A' ' 62' ' ' ILE . 39.8 m-85 -133.29 151.96 51.91 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -165.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.902 HG12 HG22 ' A' ' 37' ' ' THR . 19.5 mt -88.33 114.12 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 167.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.979 HG22 ' HB3' ' A' ' 60' ' ' ARG . 8.9 m -113.81 -21.6 5.35 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.726 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.347 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.21 171.16 36.14 Favored Glycine 0 C--O 1.209 -1.422 0 C-N-CA 117.666 -2.207 . . . . 0.0 114.759 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.55 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 42.3 m -66.38 118.5 10.13 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.529 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 0.3 OUTLIER 85.04 5.08 0.55 Allowed 'General case' 0 C--N 1.37 1.463 0 O-C-N 124.203 0.94 . . . . 0.0 110.229 -173.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.979 ' HB3' HG22 ' A' ' 56' ' ' VAL . 2.8 mpt_? -135.18 132.5 38.04 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB1' HG13 ' A' ' 22' ' ' VAL . . . -143.09 166.12 25.53 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.83 1.252 . . . . 0.0 108.178 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.63 HG12 ' N ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER -145.66 157.98 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.855 168.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.637 ' CE2' ' HB ' ' A' ' 74' ' ' ILE 0.385 11.8 p90 -134.08 104.01 6.04 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 125.575 1.797 . . . . 0.0 110.45 162.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.499 ' SD ' ' HG2' ' A' ' 19' ' ' MET . 24.1 ttt -84.59 110.86 19.03 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.015 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 1.064 HD12 ' HB3' ' A' ' 71' ' ' ALA . 2.1 pt? -102.11 148.09 25.82 Favored 'General case' 0 CA--C 1.486 -1.517 0 O-C-N 124.309 1.006 . . . . 0.0 113.013 -173.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.53 ' HA ' HG23 ' A' ' 17' ' ' THR 0.266 31.3 tpt180 -113.53 -62.18 1.63 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.271 -1.786 . . . . 0.0 115.44 -172.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -47.1 -17.65 0.06 Allowed 'General case' 0 CA--C 1.59 2.502 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.07 -16.18 17.69 Favored Glycine 0 C--N 1.358 1.78 0 O-C-N 120.727 -1.233 . . . . 0.0 114.498 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -118.97 33.37 5.68 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -167.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.671 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -156.86 2.58 0.13 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 117.913 2.561 . . . . 0.0 117.913 -174.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 1.064 ' HB3' HD12 ' A' ' 65' ' ' LEU . . . -79.1 -28.22 42.98 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 120.124 1.329 . . . . 0.0 113.6 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.668 ' HH2' HD21 ' A' ' 18' ' ' LEU 0.475 28.0 m-90 -88.21 -12.44 43.81 Favored 'General case' 0 N--CA 1.41 -2.468 0 C-N-CA 117.31 -1.756 . . . . 0.0 113.992 -173.336 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 1.6 mp0 -75.35 -29.1 59.83 Favored 'General case' 0 C--O 1.274 2.388 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.658 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 85.6 mt -68.61 -32.85 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.062 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 174.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.801 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -59.01 -43.87 91.61 Favored 'General case' 0 C--O 1.285 2.943 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 22.9 t70 -50.28 -50.03 51.61 Favored 'General case' 0 C--O 1.26 1.607 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.19 172.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.658 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 53.6 m-85 -55.96 -43.61 77.7 Favored 'General case' 0 C--O 1.186 -2.279 0 C-N-CA 118.752 -1.179 . . . . 0.0 112.223 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.801 ' HG ' ' HA ' ' A' ' 75' ' ' LYS 0.28 4.9 mt -49.48 -60.38 2.9 Favored 'General case' 0 C--O 1.294 3.422 0 CA-C-O 123.258 1.504 . . . . 0.0 109.899 -178.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.687 HG11 ' CB ' ' A' ' 84' ' ' CYS . 24.1 m -75.15 -7.83 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 111.774 -2.466 . . . . 0.0 111.463 -171.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.0 m -104.83 -5.6 21.03 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.174 172.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.577 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 29.0 mm-40 -85.08 -56.47 3.54 Favored 'General case' 0 CA--C 1.47 -2.096 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.361 28.3 t70 -179.57 -84.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.755 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 24.5 mmt-85 -87.38 144.29 26.83 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.315 1.416 . . . . 0.0 109.202 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.687 ' CB ' HG11 ' A' ' 79' ' ' VAL . 8.6 p -159.23 147.83 18.05 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.37 -44.51 0.05 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 1.021 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 40.5 tt0 -140.17 118.77 12.3 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.054 -1.058 . . . . 0.0 110.528 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.2 p -113.09 102.62 14.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.731 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.9 p -119.82 124.75 46.88 Favored 'General case' 0 C--O 1.26 1.632 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.99 ' HA ' HD22 ' A' ' 18' ' ' LEU 0.268 5.1 tp . . . . . 0 CA--C 1.584 2.285 0 CA-C-N 113.624 -1.625 . . . . 0.0 106.87 171.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.579 ' HD2' ' HB2' ' A' ' 18' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.7 m -80.79 110.63 16.49 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.649 HD22 ' HZ2' ' A' ' 72' ' ' TRP . 60.2 tp -134.28 118.42 17.52 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.47 -174.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.845 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 26.4 ptt? -83.61 104.83 14.05 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 117.213 -1.795 . . . . 0.0 106.481 165.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.58 ' HG3' ' HE1' ' A' ' 72' ' ' TRP . 14.2 tmm? -87.88 139.73 30.22 Favored 'General case' 0 C--O 1.268 2.053 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.47 -172.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -106.43 126.43 52.24 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 125.056 1.472 . . . . 0.0 110.085 -167.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.82 137.75 56.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.161 -174.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 1.024 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 54.2 m -107.72 131.31 54.57 Favored 'General case' 0 CA--C 1.628 3.95 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.222 170.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.699 HG11 ' HG2' ' A' ' 32' ' ' GLU . 80.5 t -115.36 94.26 3.02 Favored 'Isoleucine or valine' 0 C--N 1.405 2.998 0 C-N-CA 128.471 2.709 . . . . 0.0 106.598 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.73 35.99 4.53 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-N 122.098 2.226 . . . . 0.0 112.923 -174.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.54 ' HA3' ' HB2' ' A' ' 83' ' ' ARG . . . -59.87 -35.53 87.07 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 168.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.738 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -111.36 148.56 39.03 Favored Pre-proline 0 N--CA 1.42 -1.957 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 167.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -92.64 43.18 0.31 Allowed 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 121.642 1.561 . . . . 0.0 110.851 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -130.77 -146.25 0.3 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.5 -173.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.598 ' HG3' ' HA ' ' A' ' 58' ' ' SER . 30.2 tt0 -125.58 17.98 8.11 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 170.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.741 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 8.2 tmtt? -92.98 -37.93 11.94 Favored 'General case' 0 C--O 1.256 1.429 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.738 ' HB3' ' HB2' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -65.8 -44.15 86.54 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 175.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 84.8 m -49.38 -62.4 1.57 Allowed 'General case' 0 C--O 1.187 -2.199 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.211 169.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.741 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 11.7 pt-20 -51.64 -54.87 23.28 Favored 'General case' 0 C--O 1.26 1.641 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -174.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.853 ' HG3' HG13 ' A' ' 36' ' ' ILE . 11.9 pt-20 -65.23 -49.72 68.61 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.727 0.775 . . . . 0.0 109.445 -174.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.853 HG13 ' HG3' ' A' ' 35' ' ' GLU . 56.9 mt -71.55 -43.5 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.027 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.202 -172.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.4 p -66.79 -37.35 84.39 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 118.177 0.444 . . . . 0.0 111.254 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.6 m -67.55 -38.93 84.88 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.994 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 tp -67.55 -35.63 79.43 Favored 'General case' 0 C--N 1.365 1.268 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.65 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 11.9 m0 -68.85 -77.53 0.08 Allowed 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.953 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.635 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.351 0.0 OUTLIER -66.43 -20.89 66.18 Favored 'General case' 0 C--O 1.248 0.987 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.958 -171.571 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.87 -55.29 31.22 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.939 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 47.8 t -70.84 -26.93 63.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 116.708 0.254 . . . . 0.0 111.026 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.78 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 32.8 mt -61.03 -35.51 77.07 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 70.0 t80 -90.99 -27.29 18.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.939 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 21.8 t-20 -65.26 -33.59 76.36 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.485 0.714 . . . . 0.0 111.92 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.19 1.88 55.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.063 0.459 . . . . 0.0 109.855 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 53.91 66.13 1.32 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.521 1.529 . . . . 0.0 112.037 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -99.48 159.93 14.66 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -95.32 86.48 4.54 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 121.014 1.733 . . . . 0.0 109.801 -177.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.864 HG13 ' HA ' ' A' ' 65' ' ' LEU . 1.4 m -146.66 163.46 8.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.969 -174.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 13.5 mt-30 -128.59 115.83 18.69 Favored 'General case' 0 C--O 1.194 -1.839 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.78 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -121.41 139.33 53.59 Favored 'General case' 0 C--N 1.28 -2.451 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.663 -168.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.648 ' H ' HG12 ' A' ' 62' ' ' ILE . 83.0 m-85 -133.58 151.72 51.76 Favored 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -170.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.7 mt -94.09 96.3 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 167.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 60' ' ' ARG . 4.3 m -92.02 -24.48 5.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.97 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.03 173.61 40.89 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 117.016 -2.516 . . . . 0.0 114.158 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.598 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 30.8 t -70.32 115.78 9.91 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 24' ' ' VAL 0.268 0.6 OUTLIER 73.18 17.16 4.09 Favored 'General case' 0 C--O 1.207 -1.168 0 C-N-CA 125.8 1.64 . . . . 0.0 109.152 -178.607 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HB3' HG22 ' A' ' 56' ' ' VAL . 9.1 mpt_? -131.88 132.12 43.35 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.075 0.95 . . . . 0.0 112.518 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.45 166.3 24.18 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.491 1.116 . . . . 0.0 109.145 -173.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.741 HD11 ' HB2' ' A' ' 19' ' ' MET . 1.0 OUTLIER -143.77 157.28 16.25 Favored 'Isoleucine or valine' 0 C--O 1.275 2.442 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.808 172.103 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.774 ' HZ ' HD22 ' A' ' 78' ' ' LEU . 2.2 m-30 -125.96 111.47 14.8 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 166.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.845 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 22.1 ttt -84.44 93.68 8.35 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 118.384 -1.326 . . . . 0.0 109.9 173.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.906 ' HG ' ' HB1' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -98.65 146.93 25.34 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 124.805 1.242 . . . . 0.0 114.316 -174.103 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.464 7.6 ppt_? -117.28 -54.48 2.39 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -47.79 -19.71 0.24 Allowed 'General case' 0 CA--C 1.584 2.275 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.4 10.32 7.5 Favored Glycine 0 C--N 1.374 2.654 0 CA-C-N 120.101 1.319 . . . . 0.0 115.252 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.3 m -128.23 40.01 3.74 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 118.359 1.08 . . . . 0.0 111.439 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.614 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -170.59 -7.28 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.864 0 O-C-N 121.769 -0.582 . . . . 0.0 111.487 -172.353 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.906 ' HB1' ' HG ' ' A' ' 65' ' ' LEU . . . -80.21 -42.84 22.53 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -166.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.649 ' HZ2' HD22 ' A' ' 18' ' ' LEU 0.311 9.2 m0 -92.75 -9.97 38.68 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 123.461 1.601 . . . . 0.0 110.44 -170.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.76 -38.65 73.48 Favored 'General case' 0 C--O 1.298 3.64 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 166.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.666 HG21 ' CE2' ' A' ' 63' ' ' PHE . 42.8 mt -59.14 -38.32 73.53 Favored 'Isoleucine or valine' 0 C--N 1.389 2.301 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.831 ' HG3' HG21 ' A' ' 87' ' ' VAL . 12.6 tmtt? -58.0 -43.69 86.79 Favored 'General case' 0 C--O 1.288 3.126 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.582 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.92 -43.34 86.19 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.863 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -62.32 -31.83 72.49 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.416 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.785 ' HG ' ' HA ' ' A' ' 75' ' ' LYS . 55.6 mt -53.14 -58.83 5.67 Favored 'General case' 0 C--O 1.285 2.964 0 CA-C-O 122.87 1.319 . . . . 0.0 110.192 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.632 HG23 ' HB3' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -76.74 -13.4 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.875 -173.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.7 m -91.63 -7.54 49.76 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.756 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.543 ' NE2' HG12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -84.3 -50.98 7.35 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.408 11.9 t70 -152.58 -97.36 0.05 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.518 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.54 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 75.2 mtm180 -140.26 92.16 2.51 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 120.22 1.373 . . . . 0.0 111.626 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.632 ' HB3' HG23 ' A' ' 79' ' ' VAL . 2.3 t -93.88 161.42 14.32 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.611 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.68 -25.47 0.37 Allowed 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -167.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 1.024 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 34.6 tt0 -145.13 125.27 13.69 Favored 'General case' 0 CA--C 1.479 -1.765 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.366 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.831 HG21 ' HG3' ' A' ' 75' ' ' LYS . 14.0 p -128.07 103.9 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.9 0 CA-C-O 122.203 1.002 . . . . 0.0 109.685 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 m -100.89 109.36 21.31 Favored 'General case' 1 C--O 1.312 4.359 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.404 -175.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.693 ' CD1' HG23 ' A' ' 87' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.356 0.866 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? . . . . . 0 N--CA 1.425 -1.692 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -91.86 124.99 36.39 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.838 ' HB3' HD11 ' A' ' 89' ' ' LEU . 32.1 mt -130.86 118.51 20.86 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.162 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.484 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 24.9 ptm -84.14 111.55 19.44 Favored 'General case' 0 C--N 1.267 -2.982 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.235 171.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.764 ' HG2' HD12 ' A' ' 89' ' ' LEU . 11.3 mtt -84.2 103.19 13.19 Favored 'General case' 0 CA--C 1.46 -2.508 0 C-N-CA 118.499 -1.28 . . . . 0.0 109.38 171.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -89.52 98.07 11.56 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 175.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -104.39 122.9 57.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.309 -170.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.954 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 93.2 m -81.11 134.87 35.73 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 174.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 59' ' ' ASP . 1.6 p -113.43 152.29 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.273 0 CA-C-N 120.721 1.601 . . . . 0.0 107.878 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.642 ' OG ' ' HB2' ' A' ' 85' ' ' ALA . 70.8 m -87.41 160.81 18.19 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 120.815 1.643 . . . . 0.0 107.283 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.797 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 78.39 72.24 1.18 Allowed Glycine 0 N--CA 1.414 -2.774 0 C-N-CA 118.313 -1.899 . . . . 0.0 111.088 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.484 ' OD1' ' HD3' ' A' ' 31' ' ' LYS . 16.7 t-20 -87.87 101.71 2.79 Favored Pre-proline 0 C--O 1.243 0.758 0 CA-C-N 118.262 1.031 . . . . 0.0 109.485 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.797 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 84.1 Cg_endo -118.79 -30.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.486 0 N-CA-C 116.659 1.754 . . . . 0.0 116.659 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.741 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 1.1 p -132.95 -99.47 0.28 Allowed 'General case' 1 N--CA 1.554 4.728 0 C-N-CA 113.73 -3.188 . . . . 0.0 116.339 -164.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . 4.2 tp10 -100.38 7.61 44.16 Favored 'General case' 0 N--CA 1.399 -3.024 1 N-CA-C 97.741 -4.911 . . . . 0.0 97.741 156.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.741 ' HG3' ' H ' ' A' ' 29' ' ' THR 0.435 0.2 OUTLIER 82.0 -175.16 0.04 OUTLIER 'General case' 1 N--CA 1.298 -8.066 1 C-N-CA 132.181 4.192 . . . . 0.0 116.226 170.356 . . . . . . . . 6 4 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.742 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 9.3 tp10 -61.13 -13.9 20.79 Favored 'General case' 2 N--CA 1.363 -4.817 0 CA-C-N 111.776 -2.465 . . . . 0.0 106.965 173.021 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.467 ' H ' ' C ' ' A' ' 31' ' ' LYS . 54.4 m -67.81 -48.57 65.87 Favored 'General case' 0 N--CA 1.411 -2.378 0 C-N-CA 125.021 1.328 . . . . 0.0 108.457 171.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 3.7 pt-20 -57.7 -48.85 78.38 Favored 'General case' 0 C--O 1.27 2.158 0 CA-C-O 120.78 0.324 . . . . 0.0 110.203 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -56.78 -56.49 20.84 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 123.496 1.617 . . . . 0.0 110.59 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.742 ' HB ' ' O ' ' A' ' 32' ' ' GLU . 13.9 mt -70.54 -30.0 40.8 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.255 0 CA-C-N 112.03 -2.35 . . . . 0.0 112.96 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.742 HG21 HG12 ' A' ' 55' ' ' ILE . 8.1 p -71.82 -44.86 63.19 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 117.948 -1.501 . . . . 0.0 110.055 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.7 p -60.3 -59.67 5.04 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.188 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.3 tp -64.95 -49.72 69.24 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.863 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 37.0 m0 -74.75 -60.84 2.1 Favored 'General case' 0 C--O 1.168 -3.224 0 CA-C-O 117.763 -1.113 . . . . 0.0 110.152 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.682 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.382 0.0 OUTLIER -66.26 -22.31 66.31 Favored 'General case' 0 C--O 1.253 1.248 0 C-N-CA 117.372 -1.731 . . . . 0.0 111.803 -171.721 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.39 -55.83 26.89 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.583 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 37.8 p -67.66 -29.32 68.58 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 116.999 0.399 . . . . 0.0 111.707 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.808 HD11 ' HG2' ' A' ' 53' ' ' ARG . 20.6 mt -60.86 -35.34 76.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.241 0.616 . . . . 0.0 109.871 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.617 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 87.5 t80 -91.32 -27.01 18.66 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.222 175.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.583 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.2 t-20 -66.96 -28.88 68.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.859 0.361 . . . . 0.0 111.253 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.23 -3.49 50.64 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.567 0.699 . . . . 0.0 109.8 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.1 t30 55.88 43.93 26.71 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.267 1.427 . . . . 0.0 112.726 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.482 ' HB3' ' HE2' ' A' ' 70' ' ' TYR . 23.1 m-85 -66.78 5.85 0.57 Allowed 'General case' 0 CA--C 1.597 2.777 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.7 t70 57.2 70.81 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 125.314 1.446 . . . . 0.0 111.713 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.529 ' CG2' ' HD2' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -147.75 171.02 3.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 113.439 -1.71 . . . . 0.0 109.822 -175.168 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.641 ' HG2' ' HB3' ' A' ' 64' ' ' MET . 0.0 OUTLIER -132.54 126.73 33.52 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.67 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.808 ' HG2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -131.9 134.52 45.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -169.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.763 ' H ' HG12 ' A' ' 62' ' ' ILE . 80.9 m-85 -134.89 152.62 51.9 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -165.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.742 HG12 HG21 ' A' ' 37' ' ' THR . 39.2 mt -89.62 95.11 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 166.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.03 -31.43 4.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.752 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.2 63.25 0.22 Allowed Glycine 0 N--CA 1.403 -3.503 0 C-N-CA 116.391 -2.814 . . . . 0.0 116.717 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.663 ' HB3' ' HE3' ' A' ' 31' ' ' LYS 0.313 13.8 m 21.04 88.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 125.488 1.346 . . . . 0.0 112.586 162.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.636 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER 110.0 -16.18 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 128.011 2.525 . . . . 0.0 106.766 -173.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -125.57 134.61 51.9 Favored 'General case' 0 CA--C 1.578 2.019 0 C-N-CA 126.163 1.785 . . . . 0.0 109.816 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.484 ' O ' HG12 ' A' ' 22' ' ' VAL . . . -135.9 169.38 17.67 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.119 1.367 . . . . 0.0 108.141 -171.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.763 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER -141.96 155.9 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.054 0 CA-C-N 121.34 1.882 . . . . 0.0 111.634 173.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.636 ' CE2' ' HB ' ' A' ' 74' ' ' ILE 0.289 8.2 p90 -132.64 103.9 6.37 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 126.603 2.439 . . . . 0.0 108.254 161.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.641 ' HB3' ' HG2' ' A' ' 52' ' ' GLN . 27.0 ttt -91.22 108.84 20.15 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.311 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.744 ' HG ' ' HB3' ' A' ' 71' ' ' ALA 0.26 6.5 mp -66.85 144.84 56.04 Favored 'General case' 0 CA--C 1.472 -2.048 0 C-N-CA 127.97 2.508 . . . . 0.0 112.961 -177.732 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.4 33.7 ttp180 -122.35 -53.67 1.91 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 168.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.41 7.39 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.39 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.3 -31.94 0.09 OUTLIER Glycine 0 CA--C 1.569 3.434 0 N-CA-C 116.55 1.38 . . . . 0.0 116.55 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 70' ' ' TYR . 31.8 t -135.31 87.22 2.31 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 117.787 -1.101 . . . . 0.0 112.832 -170.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.482 ' HE2' ' HB3' ' A' ' 49' ' ' TYR . 0.1 OUTLIER 174.32 -0.69 0.0 OUTLIER 'General case' 0 C--N 1.409 3.184 0 CA-C-N 120.204 1.365 . . . . 0.0 113.241 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.744 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . . . -88.22 -29.9 20.12 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -169.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.83 ' HZ2' ' HG ' ' A' ' 89' ' ' LEU . 28.1 m-90 -78.99 -15.12 58.7 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.133 -0.979 . . . . 0.0 110.341 -176.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.42 -44.15 79.46 Favored 'General case' 0 C--O 1.266 1.944 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 167.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.651 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.0 mt -59.67 -38.56 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.138 175.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.694 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 13.4 tmtt? -65.05 -37.97 89.33 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.529 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.95 -44.89 95.81 Favored 'General case' 0 C--O 1.262 1.72 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.328 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.651 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 12.0 m-85 -57.28 -48.06 79.87 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.773 0.797 . . . . 0.0 109.05 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.863 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 4.2 pp -63.13 -41.88 99.4 Favored 'General case' 0 C--O 1.293 3.345 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 1.059 HG12 ' HB2' ' A' ' 84' ' ' CYS . 32.6 m -76.29 -11.74 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 CA-C-O 121.838 0.828 . . . . 0.0 109.559 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.2 m -104.06 0.49 29.85 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.939 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.73 ' HG2' ' HE1' ' A' ' 40' ' ' TRP . 8.5 tp-100 -85.2 -53.5 5.21 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.341 1.9 p30 -176.64 -94.04 0.0 OUTLIER 'General case' 0 C--O 1.243 0.74 0 O-C-N 125.235 1.584 . . . . 0.0 113.939 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.579 ' HD2' ' HA3' ' A' ' 26' ' ' GLY 0.291 48.2 mtm180 -93.3 131.62 38.26 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 118.328 -1.349 . . . . 0.0 112.243 -177.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 1.059 ' HB2' HG12 ' A' ' 79' ' ' VAL . 4.5 p -154.78 154.51 32.92 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.612 -168.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.642 ' HB2' ' OG ' ' A' ' 25' ' ' SER . . . -159.56 -49.92 0.06 Allowed 'General case' 0 C--N 1.351 0.645 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -174.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.954 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 38.2 tt0 -154.52 127.11 8.02 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 119.517 1.053 . . . . 0.0 112.149 -172.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.8 m -111.36 103.79 16.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.274 23.4 p -102.9 136.49 42.62 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 117.991 -1.483 . . . . 0.0 112.497 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.838 HD11 ' HB3' ' A' ' 18' ' ' LEU . 4.6 mm? . . . . . 0 N--CA 1.409 -2.491 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -167.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.1 tptt . . . . . 0 C--O 1.241 0.638 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -71.62 120.91 17.88 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.623 ' HB3' HD21 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -127.91 115.23 18.25 Favored 'General case' 0 C--O 1.197 -1.667 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -171.052 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.3 ttt -86.58 105.21 16.69 Favored 'General case' 0 C--N 1.281 -2.383 0 O-C-N 121.694 -0.629 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.638 ' HE2' HD11 ' A' ' 65' ' ' LEU . 12.4 ttm -97.65 116.82 30.6 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 117.28 -1.768 . . . . 0.0 112.671 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -100.76 116.55 32.91 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 112.637 -2.074 . . . . 0.0 106.328 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.75 125.89 65.94 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 CA-C-O 121.457 0.646 . . . . 0.0 111.663 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.792 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 88.3 m -84.55 131.17 34.66 Favored 'General case' 0 CA--C 1.595 2.693 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.035 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.0 p -131.29 137.64 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.579 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.43 23.1 t -109.23 -96.62 0.39 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 122.858 2.572 . . . . 0.0 114.277 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.554 ' HA3' ' HG3' ' A' ' 83' ' ' ARG . . . 55.48 -67.14 0.01 OUTLIER Glycine 0 C--N 1.352 1.438 0 CA-C-N 119.654 1.116 . . . . 0.0 113.017 -168.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -118.56 137.49 24.86 Favored Pre-proline 0 N--CA 1.417 -2.1 0 CA-C-N 117.71 0.755 . . . . 0.0 109.323 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.75 40.45 0.91 Allowed 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 122.621 2.214 . . . . 0.0 107.577 170.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.0 m -140.08 143.31 36.25 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 -165.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' HB ' ' A' ' 33' ' ' THR . 32.7 tt0 -68.2 -7.57 31.36 Favored 'General case' 0 C--N 1.371 1.538 0 CA-C-N 120.538 1.517 . . . . 0.0 111.22 -177.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.475 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 1.9 tmpt? -52.52 -40.43 62.44 Favored 'General case' 0 C--O 1.257 1.484 0 CA-C-O 121.321 0.581 . . . . 0.0 109.941 174.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.737 ' HG3' HD13 ' A' ' 36' ' ' ILE . 3.4 tp10 -69.23 -56.64 7.0 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 57.3 m -39.84 -47.77 2.18 Favored 'General case' 0 C--O 1.189 -2.111 0 C-N-CA 125.697 1.599 . . . . 0.0 111.897 171.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.4 pt-20 -70.99 -53.46 14.74 Favored 'General case' 0 C--O 1.253 1.275 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.65 -36.1 82.69 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.102 -1.439 . . . . 0.0 109.292 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.737 HD13 ' HG3' ' A' ' 32' ' ' GLU . 2.7 mt -68.0 -41.3 84.44 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.379 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.405 176.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.883 HG23 HG12 ' A' ' 55' ' ' ILE . 11.7 p -69.78 -40.09 76.25 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 120.299 1.409 . . . . 0.0 111.115 -176.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 p -64.72 -50.87 65.24 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 124.111 0.882 . . . . 0.0 110.039 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 mt -61.84 -49.42 76.36 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.048 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.618 ' CZ2' ' HB2' ' A' ' 78' ' ' LEU . 45.1 m0 -61.23 -71.97 0.13 Allowed 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 1.037 ' HB3' HH11 ' A' ' 53' ' ' ARG 0.314 0.0 OUTLIER -70.27 -18.65 63.13 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 117.521 -1.672 . . . . 0.0 112.078 -176.752 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.9 -48.44 80.78 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.412 173.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.441 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 54.3 p -79.01 -34.73 43.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 122.763 -0.257 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.811 HD13 ' CD ' ' A' ' 53' ' ' ARG . 11.4 mt -62.28 -33.17 74.13 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.894 0.378 . . . . 0.0 110.637 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -86.65 -30.07 22.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.408 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 9.2 t30 -66.17 -36.2 82.46 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.82 4.37 37.39 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.908 -0.495 . . . . 0.0 109.954 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.1 t30 58.57 47.9 12.65 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.471 1.108 . . . . 0.0 112.379 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -68.08 -13.13 61.96 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.567 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 26.5 t0 62.12 78.21 0.3 Allowed 'General case' 0 C--N 1.353 0.734 0 CA-C-O 122.755 1.264 . . . . 0.0 109.58 -176.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 m -140.84 177.38 3.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.13 -170.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -139.17 131.07 27.7 Favored 'General case' 0 C--O 1.177 -2.739 0 N-CA-C 104.001 -2.592 . . . . 0.0 104.001 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 1.037 HH11 ' HB3' ' A' ' 41' ' ' GLN . 23.2 mtp-105 -138.06 145.92 42.34 Favored 'General case' 0 C--N 1.273 -2.725 0 O-C-N 121.442 -0.786 . . . . 0.0 109.044 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.769 ' H ' HG12 ' A' ' 62' ' ' ILE . 15.1 t80 -134.67 151.2 50.85 Favored 'General case' 0 C--O 1.259 1.566 0 C-N-CA 118.028 -1.469 . . . . 0.0 113.3 -168.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.883 HG12 HG23 ' A' ' 37' ' ' THR . 58.0 mt -93.77 107.07 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 89.7 t -94.59 -48.16 13.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.484 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.35 177.95 40.49 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 117.553 -2.26 . . . . 0.0 114.962 -174.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.643 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 4.8 p -72.71 44.03 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 127.138 2.175 . . . . 0.0 114.192 -176.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.643 ' HB3' ' O ' ' A' ' 58' ' ' SER . 2.5 p-10 148.58 6.18 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 125.73 1.612 . . . . 0.0 107.377 -169.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.505 ' HB3' ' HB ' ' A' ' 56' ' ' VAL . 7.2 mpt_? -127.9 133.34 49.28 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 123.959 0.904 . . . . 0.0 110.583 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.59 161.51 38.32 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.769 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -138.16 156.38 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.454 -2.725 0 C-N-CA 118.014 -1.474 . . . . 0.0 110.883 171.382 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.805 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 5.8 p90 -128.77 113.82 15.81 Favored 'General case' 0 N--CA 1.413 -2.287 0 O-C-N 126.88 2.612 . . . . 0.0 106.776 161.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.7 ttt -97.13 118.1 32.8 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 122.017 0.913 . . . . 0.0 111.413 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.638 HD11 ' HE2' ' A' ' 20' ' ' MET . 5.8 mp -73.4 145.88 45.52 Favored 'General case' 0 CA--C 1.47 -2.124 0 CA-C-N 112.189 -2.278 . . . . 0.0 111.54 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.567 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.362 58.8 ttt180 -118.2 -62.13 1.58 Allowed 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 176.098 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 69' ' ' SER . 9.4 t70 -71.9 17.59 0.09 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 120.267 1.394 . . . . 0.0 112.924 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.37 -32.71 0.02 OUTLIER Glycine 0 CA--C 1.551 2.34 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 -169.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 67' ' ' ASP . 14.8 m -93.67 20.4 7.52 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -166.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.468 ' O ' ' HD1' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -148.25 125.44 11.48 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.597 -0.69 . . . . 0.0 111.069 178.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.566 ' HB1' ' HG ' ' A' ' 65' ' ' LEU . . . 171.91 -30.95 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 124.178 0.924 . . . . 0.0 112.227 176.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.495 ' NE1' ' HE1' ' A' ' 20' ' ' MET 0.428 5.3 m-90 -89.02 -28.3 20.27 Favored 'General case' 0 C--O 1.267 2.022 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -165.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.564 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 38.9 tt0 -72.43 -39.16 68.09 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 170.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 71' ' ' ALA . 30.5 mt -51.63 -48.86 36.15 Favored 'Isoleucine or valine' 0 C--O 1.286 3.024 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.9 173.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.597 ' O ' HG21 ' A' ' 79' ' ' VAL . 21.4 pttp -67.07 -37.85 84.72 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.75 -46.53 74.34 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.202 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.564 ' CZ ' ' HG2' ' A' ' 73' ' ' GLU . 18.0 m-85 -60.96 -59.23 5.71 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.922 0.868 . . . . 0.0 109.646 -175.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.618 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.1 pp -63.33 -40.42 97.26 Favored 'General case' 0 C--O 1.266 1.932 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -171.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.659 ' HB ' ' CB ' ' A' ' 84' ' ' CYS 0.265 27.6 m -80.36 -12.88 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 118.343 -1.343 . . . . 0.0 111.622 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.8 m -97.3 -0.05 47.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -87.99 -54.54 4.18 Favored 'General case' 0 CA--C 1.475 -1.942 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.472 38.0 t70 -137.71 -92.99 0.21 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 175.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.554 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 18.8 mmt180 -99.14 153.28 19.03 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 120.96 1.709 . . . . 0.0 110.955 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.659 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 24.8 p -152.07 154.97 37.0 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.251 -173.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.44 -51.16 0.02 OUTLIER 'General case' 0 C--N 1.355 0.84 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.792 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 36.9 tt0 -153.84 116.91 4.52 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.776 -173.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.96 101.68 12.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.258 23.5 p -105.19 120.62 41.98 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 123.1 1.429 . . . . 0.0 114.758 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 1.2 mp . . . . . 0 C--N 1.282 -2.359 0 CA-C-N 112.155 -2.293 . . . . 0.0 106.527 177.438 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tptt . . . . . 0 N--CA 1.444 -0.732 0 N-CA-C 111.362 0.134 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -78.65 123.21 26.89 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.65 ' CD1' HD12 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -133.18 103.15 5.86 Favored 'General case' 0 C--O 1.191 -2.001 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -174.171 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.659 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 9.4 ptp -84.1 116.92 23.13 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.891 -1.13 . . . . 0.0 110.891 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.762 ' HG2' HD13 ' A' ' 89' ' ' LEU . 93.1 mtp -86.7 99.28 11.65 Favored 'General case' 0 CA--C 1.487 -1.466 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.246 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.457 ' CZ ' ' HD2' ' A' ' 60' ' ' ARG . 12.3 t80 -89.04 106.05 18.18 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 61' ' ' ALA . 9.1 p -126.28 125.91 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.923 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.039 -165.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 1.048 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 31.4 m -92.88 142.31 27.46 Favored 'General case' 0 C--O 1.276 2.477 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.596 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.755 HG21 ' HA ' ' A' ' 83' ' ' ARG . 7.5 p -131.03 128.52 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 103.681 -2.711 . . . . 0.0 103.681 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.61 20.79 1.04 Allowed 'General case' 0 C--O 1.245 0.864 0 CA-C-N 122.478 2.399 . . . . 0.0 112.347 -171.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.64 -31.83 73.88 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 106.821 -2.511 . . . . 0.0 106.821 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.9 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 24.8 t-20 -118.46 104.58 47.48 Favored Pre-proline 0 N--CA 1.405 -2.711 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.54 32.23 0.45 Allowed 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.736 2.291 . . . . 0.0 112.395 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.427 ' HB ' ' H ' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -146.81 -161.24 1.28 Allowed 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.628 -173.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.7 tp10 -76.69 -18.29 58.62 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 5.0 tmtt? -64.56 -52.42 57.71 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.9 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.4 tp10 -71.01 -35.44 72.03 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 117.777 -1.569 . . . . 0.0 107.643 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 54.5 m -49.6 -57.52 6.99 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.029 172.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 15.2 pt-20 -65.98 -40.25 91.06 Favored 'General case' 0 C--O 1.255 1.371 0 C-N-CA 122.792 0.437 . . . . 0.0 111.784 -176.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -51.69 -63.0 1.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.694 HG21 ' CE3' ' A' ' 40' ' ' TRP . 35.4 mt -67.21 -44.46 87.66 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 112.384 -2.189 . . . . 0.0 112.957 -175.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.759 ' HB ' HG12 ' A' ' 55' ' ' ILE . 32.4 p -65.35 -53.49 42.87 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.547 -0.861 . . . . 0.0 112.011 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.9 t -70.55 -46.87 62.73 Favored 'General case' 0 C--O 1.257 1.46 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.429 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.73 -43.13 66.39 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.759 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.694 ' CE3' HG21 ' A' ' 36' ' ' ILE . 37.9 m0 -73.29 -61.75 1.71 Allowed 'General case' 0 C--O 1.167 -3.262 0 CA-C-O 117.486 -1.245 . . . . 0.0 109.65 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.715 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.377 0.0 OUTLIER -63.47 -25.69 68.38 Favored 'General case' 0 C--O 1.253 1.278 0 C-N-CA 117.871 -1.532 . . . . 0.0 112.608 -172.166 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.94 -50.92 59.47 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 171.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.75 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 58.7 p -74.06 -25.29 59.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.344 0.572 . . . . 0.0 111.404 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.728 HD11 ' HG2' ' A' ' 53' ' ' ARG . 32.5 mt -62.62 -33.51 75.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 176.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 89.9 t80 -87.97 -32.8 18.68 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.45 173.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.75 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 6.9 t30 -62.36 -36.96 83.87 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.11 3.21 52.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.277 0.561 . . . . 0.0 110.017 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.7 t30 53.24 51.89 14.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.226 1.41 . . . . 0.0 112.568 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -64.73 -7.02 9.25 Favored 'General case' 0 CA--C 1.595 2.69 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.0 t70 61.04 67.88 0.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.141 1.377 . . . . 0.0 110.037 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.745 HG23 ' HD2' ' A' ' 53' ' ' ARG . 2.6 m -147.92 175.42 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.249 -171.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.548 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 17.5 mt-30 -130.96 125.18 32.72 Favored 'General case' 0 C--O 1.189 -2.131 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 177.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.745 ' HD2' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -134.5 136.6 43.25 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -172.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.765 ' H ' HG12 ' A' ' 62' ' ' ILE . 47.9 t80 -135.03 150.49 50.31 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 118.187 -1.405 . . . . 0.0 113.579 -166.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.759 HG12 ' HB ' ' A' ' 37' ' ' THR . 19.1 mt -93.23 96.36 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 171.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -80.01 -33.85 14.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.81 -178.87 40.38 Favored Glycine 0 CA--C 1.484 -1.905 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.245 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -60.24 121.01 10.9 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.258 0.0 OUTLIER 79.3 8.67 1.77 Allowed 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 121.937 0.875 . . . . 0.0 111.379 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.457 ' HD2' ' CZ ' ' A' ' 21' ' ' PHE . 1.3 tpp180 -137.56 118.92 14.69 Favored 'General case' 0 CA--C 1.573 1.858 0 O-C-N 121.45 -0.781 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.492 ' O ' HG12 ' A' ' 22' ' ' VAL . . . -137.07 162.1 34.27 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -175.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.765 HG12 ' H ' ' A' ' 54' ' ' PHE . 2.5 pt -142.49 157.13 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 C-N-CA 117.422 -1.711 . . . . 0.0 110.337 170.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.632 ' CE2' ' HB ' ' A' ' 74' ' ' ILE 0.296 9.0 p90 -133.02 101.33 5.18 Favored 'General case' 0 N--CA 1.426 -1.672 0 O-C-N 126.264 2.227 . . . . 0.0 108.394 161.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.659 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 25.0 ttt -87.17 113.88 23.3 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.73 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.728 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.315 2.3 mp -80.66 148.22 30.31 Favored 'General case' 0 CA--C 1.442 -3.173 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.287 -178.092 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -117.54 163.12 16.9 Favored 'General case' 0 C--N 1.252 -3.637 0 N-CA-C 104.513 -2.403 . . . . 0.0 104.513 169.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 76.98 -36.22 0.25 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.17 -29.13 7.87 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 119.895 -1.145 . . . . 0.0 114.16 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.9 m -96.07 32.95 1.81 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -167.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 41.9 p90 -178.43 137.07 0.16 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 117.029 -1.463 . . . . 0.0 109.744 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.728 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 164.0 -35.45 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.128 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 171.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.671 ' HZ2' ' HG ' ' A' ' 89' ' ' LEU 0.298 22.0 m-90 -80.36 -9.76 59.75 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 120.376 -1.453 . . . . 0.0 111.684 -172.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.14 -35.62 69.14 Favored 'General case' 0 C--O 1.299 3.684 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.632 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 67.3 mt -62.53 -39.35 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 174.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.679 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 12.4 tmtt? -61.53 -37.23 83.01 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.729 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.83 -48.15 81.86 Favored 'General case' 0 C--O 1.261 1.691 0 C-N-CA 119.619 -0.833 . . . . 0.0 110.138 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -57.48 -45.14 85.19 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.366 1.079 . . . . 0.0 110.11 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.679 ' HG ' ' HA ' ' A' ' 75' ' ' LYS 0.271 4.2 pp -61.06 -48.77 80.18 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -179.167 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.677 HG11 HD11 ' A' ' 78' ' ' LEU . 23.7 m -75.18 -6.87 9.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 117.458 -1.697 . . . . 0.0 112.22 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -96.59 -5.9 38.07 Favored 'General case' 0 N--CA 1.403 -2.792 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.721 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -100.75 -58.12 1.96 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.6 t70 164.16 173.11 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.484 1 N-CA-C 99.532 -4.247 . . . . 0.0 99.532 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.755 ' HA ' HG21 ' A' ' 24' ' ' VAL . 0.0 OUTLIER 74.23 89.75 0.09 Allowed 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -163.547 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.593 ' HA ' HG12 ' A' ' 79' ' ' VAL . 12.6 p -153.69 56.84 0.74 Allowed 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.787 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.77 -62.68 1.11 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 1.048 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 33.2 tt0 -134.44 125.28 27.13 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 120.65 1.568 . . . . 0.0 110.202 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.8 t -117.66 111.41 34.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.44 ' O ' HD23 ' A' ' 89' ' ' LEU . 38.8 p -124.95 129.19 49.86 Favored 'General case' 0 C--O 1.277 2.509 0 C-N-CA 118.751 -1.179 . . . . 0.0 112.726 174.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.762 HD13 ' HG2' ' A' ' 20' ' ' MET . 4.4 mm? . . . . . 0 N--CA 1.412 -2.35 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.985 -175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.0 tptt . . . . . 0 N--CA 1.431 -1.417 0 CA-C-O 121.063 0.458 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.6 m -67.15 123.13 19.42 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.48 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.594 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -122.76 121.23 35.82 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 -176.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.472 ' HB3' ' HG3' ' A' ' 64' ' ' MET . 14.9 ptt? -109.05 133.74 52.59 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.371 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.518 ' SD ' ' HA ' ' A' ' 89' ' ' LEU . 2.9 mpp? -108.86 118.93 38.07 Favored 'General case' 0 CA--C 1.46 -2.511 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.672 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -103.94 128.78 51.46 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 171.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.44 124.13 69.01 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.542 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.629 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.965 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 95.8 m -75.43 124.88 27.92 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 173.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.486 HG22 HD11 ' A' ' 36' ' ' ILE . 1.9 p -128.45 124.35 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.361 0 CA-C-N 120.319 1.418 . . . . 0.0 111.568 -169.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.937 ' HB2' ' HB2' ' A' ' 83' ' ' ARG . 33.0 t 70.68 -50.15 0.67 Allowed 'General case' 0 C--N 1.363 1.176 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 167.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.24 23.5 9.62 Favored Glycine 0 N--CA 1.415 -2.715 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.31 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 28' ' ' PRO 0.251 9.2 p30 -116.65 111.08 41.72 Favored Pre-proline 0 N--CA 1.417 -2.101 0 C-N-CA 117.609 -1.636 . . . . 0.0 112.205 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.779 ' HA ' ' HB3' ' A' ' 58' ' ' SER . 12.6 Cg_exo -74.19 37.17 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.805 2.337 . . . . 0.0 109.598 176.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.461 ' H ' ' C ' ' A' ' 27' ' ' ASN . 13.2 m -88.62 52.7 2.5 Favored 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.239 -170.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.726 ' O ' ' HG3' ' A' ' 30' ' ' GLU . 7.6 tp10 66.1 19.92 11.17 Favored 'General case' 0 C--N 1.414 3.377 0 CA-C-O 126.803 3.192 . . . . 0.0 103.328 -162.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.838 ' HD2' ' HA ' ' A' ' 58' ' ' SER 0.517 0.0 OUTLIER 62.42 144.8 0.02 OUTLIER 'General case' 2 N--CA 1.259 -10.019 0 CA-C-O 127.461 3.505 . . . . 0.0 114.104 -178.934 . . . . . . . . 5 4 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.864 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -66.98 -10.44 49.58 Favored 'General case' 2 N--CA 1.348 -5.543 0 CA-C-N 110.191 -3.186 . . . . 0.0 105.01 169.214 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.644 ' HB ' ' HB2' ' A' ' 31' ' ' LYS . 94.3 m -69.18 -35.12 75.94 Favored 'General case' 1 N--CA 1.359 -4.976 0 C-N-CA 127.921 2.488 . . . . 0.0 108.463 174.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.608 ' HG3' ' N ' ' A' ' 35' ' ' GLU . 3.9 pt-20 -74.19 -40.77 62.28 Favored 'General case' 0 C--N 1.389 2.319 0 CA-C-N 121.487 1.949 . . . . 0.0 106.941 177.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.608 ' N ' ' HG3' ' A' ' 34' ' ' GLU . 9.7 tp10 -59.4 -56.69 18.78 Favored 'General case' 0 C--O 1.279 2.634 0 CA-C-O 124.087 1.899 . . . . 0.0 108.576 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.864 ' HB ' ' O ' ' A' ' 32' ' ' GLU . 1.1 mt -70.3 -25.17 26.73 Favored 'Isoleucine or valine' 0 C--O 1.163 -3.455 0 CA-C-N 111.74 -2.482 . . . . 0.0 112.305 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.527 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 6.7 p -74.04 -41.9 61.09 Favored 'General case' 0 CA--C 1.464 -2.328 0 CA-C-N 121.697 2.044 . . . . 0.0 109.466 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 m -60.18 -51.62 68.8 Favored 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.858 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.5 tp -72.32 -49.68 32.59 Favored 'General case' 0 C--O 1.25 1.123 0 C-N-CA 118.038 -1.465 . . . . 0.0 111.434 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.673 ' CZ2' ' HB2' ' A' ' 78' ' ' LEU . 51.0 m0 -69.27 -67.99 0.44 Allowed 'General case' 0 C--O 1.189 -2.106 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.409 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.591 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.36 0.0 OUTLIER -69.9 -20.36 63.37 Favored 'General case' 0 C--O 1.254 1.303 0 C-N-CA 118.516 -1.273 . . . . 0.0 112.075 -170.865 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.32 -53.36 45.03 Favored Glycine 0 C--N 1.365 2.18 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.66 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 36.7 p -69.83 -29.77 67.11 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.53 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.861 HD11 ' HG2' ' A' ' 53' ' ' ARG . 25.5 mt -59.64 -35.01 73.54 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.691 0.397 . . . . 0.0 110.547 177.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.555 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 82.3 t80 -91.08 -27.37 18.63 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.66 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 8.7 t30 -64.79 -34.89 79.41 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.692 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.24 0.53 57.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.865 0.365 . . . . 0.0 110.491 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.3 t30 53.24 57.79 5.9 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.967 1.307 . . . . 0.0 112.46 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -73.8 -0.21 15.1 Favored 'General case' 0 CA--C 1.597 2.763 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 171.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.5 t70 62.05 67.78 0.72 Allowed 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 124.402 1.081 . . . . 0.0 110.792 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.652 HG23 ' HD2' ' A' ' 53' ' ' ARG . 6.7 m -147.36 174.83 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.502 -172.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.587 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 1.9 mp0 -131.51 131.68 43.62 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 172.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.861 ' HG2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -129.74 129.85 44.68 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -174.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.795 ' H ' HG12 ' A' ' 62' ' ' ILE . 29.2 t80 -133.93 152.36 51.83 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 119.095 -1.042 . . . . 0.0 113.112 -159.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.588 HG22 HG21 ' A' ' 33' ' ' THR . 75.3 mt -88.17 107.32 17.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.877 175.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.753 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 97.1 t -81.47 -40.97 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.025 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.56 -171.34 43.63 Favored Glycine 0 CA--C 1.469 -2.825 0 C-N-CA 118.629 -1.748 . . . . 0.0 113.46 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.838 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 6.6 m -62.0 118.26 7.04 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 118.057 -0.973 . . . . 0.0 108.742 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.607 ' HB3' ' O ' ' A' ' 58' ' ' SER . 2.4 t70 80.89 11.16 0.91 Allowed 'General case' 0 N--CA 1.408 -2.566 0 CA-C-O 122.545 1.164 . . . . 0.0 109.228 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.753 ' HB3' ' HB ' ' A' ' 56' ' ' VAL . 11.4 mpt_? -137.1 116.08 12.36 Favored 'General case' 0 CA--C 1.562 1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 112.149 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.62 163.1 22.68 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.129 0.972 . . . . 0.0 108.728 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.795 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.7 OUTLIER -139.52 158.08 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.223 0 C-N-CA 118.223 -1.391 . . . . 0.0 111.128 173.118 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.475 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 2.3 p90 -129.08 106.75 9.07 Favored 'General case' 0 N--CA 1.419 -2.009 0 O-C-N 126.485 2.365 . . . . 0.0 106.917 164.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.472 ' HG3' ' HB3' ' A' ' 19' ' ' MET . 23.1 ttt -94.99 117.04 29.48 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.273 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.74 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.484 0.0 OUTLIER -114.34 147.73 38.68 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -177.339 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.354 36.3 ttp180 -104.57 -62.6 1.31 Allowed 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -164.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -55.92 -8.08 0.39 Allowed 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.83 15.98 29.49 Favored Glycine 0 C--N 1.369 2.375 0 CA-C-N 120.194 1.361 . . . . 0.0 115.09 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.9 p -116.66 22.19 12.89 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 118.39 1.095 . . . . 0.0 113.597 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.3 p90 177.8 145.79 0.12 Allowed 'General case' 0 C--O 1.245 0.823 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -167.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.74 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 160.48 -28.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 125.166 1.541 . . . . 0.0 111.92 171.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.436 ' O ' ' HG3' ' A' ' 75' ' ' LYS 0.522 7.1 m0 -89.48 -16.4 30.88 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 117.071 -1.852 . . . . 0.0 115.176 -169.196 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.92 -36.38 80.07 Favored 'General case' 0 C--O 1.257 1.457 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 165.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.532 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 57.2 mt -53.89 -50.13 54.76 Favored 'Isoleucine or valine' 0 C--O 1.29 3.204 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.795 174.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.609 ' O ' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -63.42 -36.11 82.65 Favored 'General case' 0 C--N 1.373 1.612 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.243 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.79 -47.07 83.6 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.84 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.532 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 13.9 m-85 -58.18 -60.25 4.04 Favored 'General case' 0 C--N 1.365 1.245 0 CA-C-O 122.35 1.071 . . . . 0.0 109.198 -175.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.673 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.6 pp -62.29 -38.46 89.44 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.641 ' HB ' ' CB ' ' A' ' 84' ' ' CYS . 34.0 m -80.09 -9.75 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 118.203 -1.399 . . . . 0.0 111.431 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.0 m -105.8 3.29 28.62 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -107.3 -45.95 3.99 Favored 'General case' 0 CA--C 1.473 -2.014 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.269 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.78 -160.79 0.86 Allowed 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.937 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 24.2 mmt180 -80.35 159.67 25.68 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 120.127 1.33 . . . . 0.0 110.123 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.641 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 26.7 p -136.59 146.1 45.69 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.256 -172.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.27 -53.43 0.13 Allowed 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.965 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.5 tt0 -153.72 118.82 5.08 Favored 'General case' 0 C--O 1.195 -1.809 0 CA-C-N 119.806 1.184 . . . . 0.0 110.68 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.9 t -113.14 101.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.324 17.4 p -108.64 132.69 53.65 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 123.387 1.565 . . . . 0.0 114.489 177.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.518 ' HA ' ' SD ' ' A' ' 20' ' ' MET . 3.7 mp . . . . . 0 C--N 1.263 -3.18 0 CA-C-N 110.807 -2.906 . . . . 0.0 108.093 -174.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.2 tptt . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 20.8 p -108.21 110.02 21.54 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.426 0.69 . . . . 0.0 109.474 173.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.916 HD21 ' HH2' ' A' ' 72' ' ' TRP . 30.8 tp -135.0 124.51 24.97 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -171.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.658 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.1 ptp -85.39 109.26 18.3 Favored 'General case' 0 C--O 1.207 -1.148 0 O-C-N 121.47 -0.769 . . . . 0.0 111.487 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.636 ' HE1' ' HB3' ' A' ' 65' ' ' LEU . 4.5 mpp? -84.36 128.94 34.87 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.517 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 59.6 t80 -111.05 109.06 18.99 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 125.502 1.751 . . . . 0.0 108.46 -169.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.05 128.79 75.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 114.76 1.392 . . . . 0.0 114.76 -169.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.966 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 49.5 m -87.41 141.41 28.65 Favored 'General case' 0 CA--C 1.595 2.708 0 C-N-CA 127.322 2.249 . . . . 0.0 109.006 176.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' A' ' 83' ' ' ARG . 35.9 t -132.0 97.33 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.014 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -166.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.507 ' OG ' ' HB3' ' A' ' 83' ' ' ARG 0.324 60.8 m 62.3 -30.07 0.08 Allowed 'General case' 0 C--N 1.389 2.293 0 N-CA-C 119.085 2.995 . . . . 0.0 119.085 170.229 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 123.76 1.5 8.97 Favored Glycine 0 N--CA 1.426 -2.018 0 C-N-CA 118.39 -1.862 . . . . 0.0 115.269 175.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.3 t-20 -79.65 104.66 2.51 Favored Pre-proline 0 C--O 1.22 -0.452 0 CA-C-N 119.04 1.42 . . . . 0.0 107.862 173.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 82.2 Cg_endo -91.52 33.71 0.29 Allowed 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 123.348 2.699 . . . . 0.0 109.532 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 m -129.53 155.19 46.18 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -69.94 3.37 2.7 Favored 'General case' 0 C--O 1.182 -2.455 0 CA-C-N 121.741 2.064 . . . . 0.0 111.824 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.606 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 1.8 tmtt? -60.0 -55.48 33.44 Favored 'General case' 0 C--O 1.275 2.43 0 CA-C-O 121.947 0.88 . . . . 0.0 111.228 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.734 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 1.7 tp10 -65.2 -52.3 55.64 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -176.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 93.1 m -42.89 -52.76 4.99 Favored 'General case' 0 C--O 1.187 -2.213 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.765 172.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 11.9 pt-20 -62.4 -55.47 27.6 Favored 'General case' 0 C--O 1.263 1.811 0 CA-C-N 118.689 0.677 . . . . 0.0 112.071 -175.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 34' ' ' GLU . 9.3 tp10 -58.93 -53.84 53.89 Favored 'General case' 0 C--O 1.254 1.311 0 CA-C-O 122.972 1.368 . . . . 0.0 108.235 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.734 ' HB ' ' O ' ' A' ' 32' ' ' GLU . 5.3 mt -64.24 -40.95 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.368 0 CA-C-N 112.527 -2.124 . . . . 0.0 113.331 -176.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.844 HG23 HG12 ' A' ' 55' ' ' ILE . 21.5 p -70.47 -37.7 74.31 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 120.214 1.37 . . . . 0.0 110.048 -177.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.4 m -63.45 -46.29 86.96 Favored 'General case' 0 N--CA 1.417 -2.08 0 O-C-N 123.966 0.791 . . . . 0.0 109.417 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.2 tp -73.03 -43.83 61.57 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.97 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.847 ' CE3' HD13 ' A' ' 78' ' ' LEU . 48.1 m0 -66.89 -70.24 0.26 Allowed 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 119.353 -0.356 . . . . 0.0 111.067 -177.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.652 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.294 0.0 OUTLIER -73.06 -19.26 61.21 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.832 -173.222 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.32 -50.89 59.03 Favored Glycine 0 C--N 1.357 1.726 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 172.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.462 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 60.9 p -69.64 -28.95 66.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.466 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.941 HD11 ' HG2' ' A' ' 53' ' ' ARG . 15.5 mt -62.49 -32.89 73.86 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.743 176.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.53 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 83.5 t80 -87.11 -31.56 20.38 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.057 0.456 . . . . 0.0 109.872 176.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 25.8 t-20 -67.21 -30.26 70.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.126 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.2 4.81 44.33 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 122.3 -0.25 . . . . 0.0 111.106 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.2 t30 56.92 47.14 18.32 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.048 0.939 . . . . 0.0 112.687 174.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.51 151.62 19.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.539 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 28.6 t70 -92.98 95.52 9.53 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 121.751 2.069 . . . . 0.0 109.115 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.68 HG11 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -146.84 162.75 8.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.009 -173.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.424 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 2.2 mp0 -126.38 121.34 32.22 Favored 'General case' 0 C--O 1.199 -1.574 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 174.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.941 ' HG2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -127.9 136.99 52.13 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.29 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.688 ' N ' HG12 ' A' ' 62' ' ' ILE . 46.3 m-85 -133.3 152.63 51.94 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -163.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.844 HG12 HG23 ' A' ' 37' ' ' THR . 46.8 mt -91.53 96.89 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 169.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.2 m -102.67 -20.56 5.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.753 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.37 174.98 47.4 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 117.728 -2.177 . . . . 0.0 114.066 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 51.0 m -75.05 117.98 17.49 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.511 ' HB3' ' O ' ' A' ' 58' ' ' SER . 5.4 t70 80.02 7.69 1.61 Allowed 'General case' 0 C--N 1.365 1.26 0 O-C-N 124.272 0.982 . . . . 0.0 108.835 -174.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.517 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 1.5 tpp180 -130.37 117.46 19.76 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.669 -176.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.09 163.11 29.2 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.688 HG12 ' N ' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -135.86 157.38 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.38 0 C-N-CA 117.739 -1.585 . . . . 0.0 110.106 174.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.55 ' CE2' ' HB ' ' A' ' 74' ' ' ILE . 2.4 p90 -134.61 106.97 7.24 Favored 'General case' 0 N--CA 1.428 -1.567 0 O-C-N 126.192 2.183 . . . . 0.0 107.923 162.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.658 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 23.6 ttt -90.23 116.37 28.16 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 119.039 -0.505 . . . . 0.0 109.975 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.694 HD22 ' H ' ' A' ' 18' ' ' LEU . 1.1 pt? -90.75 144.49 25.67 Favored 'General case' 0 C--O 1.259 1.594 0 O-C-N 124.972 1.42 . . . . 0.0 112.202 -174.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.539 ' HB3' ' O ' ' A' ' 50' ' ' ASP 0.285 2.7 tmt_? -118.09 -53.32 2.37 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 125.575 1.797 . . . . 0.0 114.666 177.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.56 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 32.6 t70 -43.96 -19.87 0.02 OUTLIER 'General case' 0 CA--C 1.586 2.334 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.71 -25.55 4.53 Favored Glycine 0 C--N 1.358 1.788 0 CA-C-N 120.322 1.419 . . . . 0.0 115.384 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.8 m -137.2 49.02 2.04 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -170.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.56 ' CE1' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -156.17 -0.48 0.14 Allowed 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.37 -0.831 . . . . 0.0 113.158 -176.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.563 ' CB ' HD12 ' A' ' 65' ' ' LEU . . . -86.11 -39.18 16.99 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 -169.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.916 ' HH2' HD21 ' A' ' 18' ' ' LEU 0.428 28.8 m-90 -80.95 -14.1 58.27 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 116.511 -2.076 . . . . 0.0 112.126 -171.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -71.88 -36.92 70.22 Favored 'General case' 0 C--O 1.279 2.653 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 166.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.65 ' O ' HD21 ' A' ' 78' ' ' LEU . 73.7 mt -57.58 -42.83 82.08 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.985 ' HG3' HG22 ' A' ' 87' ' ' VAL . 22.5 ttpp -51.87 -52.37 50.14 Favored 'General case' 0 C--N 1.374 1.644 0 C-N-CA 125.067 1.347 . . . . 0.0 109.441 177.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.07 -34.92 70.65 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.801 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.646 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 14.9 m-85 -74.02 -57.65 3.83 Favored 'General case' 0 CA--C 1.466 -2.287 0 C-N-CA 118.522 -1.271 . . . . 0.0 107.907 -169.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.847 HD13 ' CE3' ' A' ' 40' ' ' TRP . 1.8 pt? -68.51 -35.57 77.66 Favored 'General case' 0 N--CA 1.4 -2.966 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.731 -169.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 75' ' ' LYS 0.286 23.1 m -78.2 -19.99 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 116.594 -2.042 . . . . 0.0 110.67 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.9 m -95.22 5.61 51.29 Favored 'General case' 0 N--CA 1.411 -2.401 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.96 169.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.506 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . 7.5 tp-100 -89.03 -41.9 12.06 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -176.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.543 ' OD2' ' HG2' ' A' ' 83' ' ' ARG 0.386 17.7 t70 -140.35 -85.77 0.21 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.543 ' HG2' ' OD2' ' A' ' 82' ' ' ASP . 21.4 mmt180 -110.35 165.39 11.81 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.96 1.709 . . . . 0.0 109.836 176.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 79' ' ' VAL . 24.6 p -159.89 148.22 17.18 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.08 -54.31 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.862 1.265 . . . . 0.0 112.193 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.966 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 40.4 tt0 -154.96 123.15 5.9 Favored 'General case' 0 C--O 1.207 -1.173 0 C-N-CA 119.63 -0.828 . . . . 0.0 113.163 -169.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.985 HG22 ' HG3' ' A' ' 75' ' ' LYS . 62.0 t -112.0 104.51 17.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 173.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.589 ' O ' HD22 ' A' ' 89' ' ' LEU . 10.0 p -113.44 148.36 36.05 Favored 'General case' 0 C--O 1.266 1.954 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.742 ' CD1' ' HG ' ' A' ' 18' ' ' LEU 0.864 0.9 OUTLIER . . . . . 0 N--CA 1.44 -0.944 1 N-CA-C 122.567 4.284 . . . . 0.0 122.567 -177.612 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.2 tptt . . . . . 0 N--CA 1.438 -1.047 0 CA-C-O 120.677 0.275 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.735 HG21 ' HA ' ' A' ' 66' ' ' ARG . 19.3 p -72.33 135.65 45.97 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.428 174.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.742 HD11 ' HE2' ' A' ' 20' ' ' MET . 0.3 OUTLIER -134.24 116.6 15.5 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.447 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.2 ptm -94.63 119.1 32.75 Favored 'General case' 0 C--N 1.287 -2.125 0 O-C-N 121.623 -0.673 . . . . 0.0 109.195 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 1.095 ' HE3' HD23 ' A' ' 89' ' ' LEU . 1.3 pmm? -121.8 133.41 54.9 Favored 'General case' 0 C--O 1.281 2.753 0 C-N-CA 118.008 -1.477 . . . . 0.0 113.621 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -96.34 119.33 34.63 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.609 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -121.44 131.22 73.58 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.787 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.338 -176.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 1.055 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 97.1 m -99.46 151.88 20.62 Favored 'General case' 1 CA--C 1.648 4.748 0 C-N-CA 130.669 3.588 . . . . 0.0 112.31 -178.355 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.821 ' HB ' ' HG2' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -121.49 155.97 25.51 Favored 'Isoleucine or valine' 0 C--N 1.405 2.996 0 C-N-CA 126.246 1.818 . . . . 0.0 108.007 -168.415 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.697 ' OG ' ' HB3' ' A' ' 85' ' ' ALA . 54.2 m -108.18 168.92 8.95 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-N 120.628 1.558 . . . . 0.0 107.37 171.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.01 -88.5 0.47 Allowed Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 119.651 1.114 . . . . 0.0 112.198 174.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -115.78 113.04 42.47 Favored Pre-proline 0 N--CA 1.417 -2.076 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.75 30.27 0.32 Allowed 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 123.84 3.027 . . . . 0.0 112.982 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.515 ' OG1' ' HD2' ' A' ' 31' ' ' LYS . 70.2 p -128.41 -163.78 1.31 Allowed 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.523 ' HA ' ' HG1' ' A' ' 33' ' ' THR . 37.9 tt0 -84.24 1.8 42.98 Favored 'General case' 0 N--CA 1.421 -1.907 0 O-C-N 121.382 -0.824 . . . . 0.0 111.49 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.596 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -69.66 -44.93 69.54 Favored 'General case' 0 C--O 1.281 2.717 0 O-C-N 120.987 -1.071 . . . . 0.0 112.181 -177.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.686 ' HG3' HD11 ' A' ' 36' ' ' ILE . 3.2 tp10 -69.99 -44.08 70.12 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.71 ' HA ' HH21 ' A' ' 60' ' ' ARG . 20.1 m -44.02 -63.67 0.82 Allowed 'General case' 0 C--O 1.183 -2.422 0 CA-C-N 112.616 -2.083 . . . . 0.0 111.338 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 13.1 pt-20 -58.2 -52.82 63.98 Favored 'General case' 0 C--O 1.255 1.354 0 O-C-N 124.419 1.075 . . . . 0.0 113.125 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.642 ' HG3' HD12 ' A' ' 36' ' ' ILE . 8.8 pt-20 -66.41 -44.29 83.4 Favored 'General case' 0 C--O 1.27 2.151 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.699 -176.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.686 HD11 ' HG3' ' A' ' 32' ' ' GLU . 1.3 mp -66.43 -44.1 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.795 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.473 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.799 HG22 HG12 ' A' ' 55' ' ' ILE . 33.4 p -68.09 -39.79 82.77 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 120.039 1.291 . . . . 0.0 111.618 -175.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.3 p -60.98 -54.0 50.33 Favored 'General case' 0 C--O 1.262 1.719 0 O-C-N 124.276 0.985 . . . . 0.0 109.6 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.09 -44.21 96.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.411 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.619 ' CZ3' HD13 ' A' ' 78' ' ' LEU . 42.0 m0 -64.7 -74.99 0.09 Allowed 'General case' 0 C--O 1.205 -1.244 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.796 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.365 0.0 OUTLIER -70.68 -18.17 62.83 Favored 'General case' 0 C--O 1.255 1.349 0 C-N-CA 118.457 -1.297 . . . . 0.0 112.409 -172.185 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.9 -49.81 65.31 Favored Glycine 0 N--CA 1.432 -1.619 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 171.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.43 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 75.9 p -71.76 -26.83 62.61 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.333 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.796 ' HG ' ' HA ' ' A' ' 41' ' ' GLN . 28.7 mt -59.65 -37.88 79.91 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.702 176.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.483 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 86.6 t80 -86.26 -33.33 20.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.481 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 7.5 t30 -65.11 -34.66 78.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.07 9.1 20.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.926 0.393 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 59.88 35.49 21.81 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.709 1.203 . . . . 0.0 113.652 172.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.503 ' O ' HG13 ' A' ' 51' ' ' VAL . 13.7 m-85 -78.05 25.23 0.22 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 25.67 76.65 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.678 0 C-N-CA 126.811 2.045 . . . . 0.0 113.671 -177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.936 HG11 ' HA ' ' A' ' 65' ' ' LEU . 1.5 m -146.5 175.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.134 -173.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.495 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -134.33 120.9 20.47 Favored 'General case' 0 C--O 1.194 -1.853 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.739 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.75 131.16 35.19 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -169.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.736 ' H ' HG12 ' A' ' 62' ' ' ILE . 36.4 t80 -136.59 148.62 47.61 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 118.835 -1.146 . . . . 0.0 113.901 -164.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.799 HG12 HG22 ' A' ' 37' ' ' THR . 71.5 mt -80.39 123.28 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 170.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.21 -29.2 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.15 152.83 20.1 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.835 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 49.5 m -85.08 82.27 8.5 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.032 0.444 . . . . 0.0 110.505 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.495 ' HB2' HG13 ' A' ' 24' ' ' VAL . 0.3 OUTLIER 158.81 -32.35 0.0 OUTLIER 'General case' 0 N--CA 1.384 -3.742 0 N-CA-C 101.467 -3.531 . . . . 0.0 101.467 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.821 ' HG2' ' HB ' ' A' ' 24' ' ' VAL 0.457 1.1 mmp_? -145.41 -179.64 6.79 Favored 'General case' 0 C--N 1.391 2.41 1 N-CA-C 124.954 5.168 . . . . 0.0 124.954 -167.91 . . . . . . . . 4 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.468 ' N ' ' HD3' ' A' ' 60' ' ' ARG . . . -152.6 172.44 16.6 Favored 'General case' 0 C--N 1.382 2.002 0 CA-C-N 112.526 -2.125 . . . . 0.0 111.449 -160.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.736 HG12 ' H ' ' A' ' 54' ' ' PHE . 13.7 pt -123.12 158.55 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.439 -3.307 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.52 ' CE2' ' HB ' ' A' ' 74' ' ' ILE 0.288 4.0 p90 -123.21 121.15 35.2 Favored 'General case' 0 N--CA 1.401 -2.893 0 O-C-N 126.447 2.342 . . . . 0.0 105.742 160.45 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.458 ' HB3' ' O ' ' A' ' 52' ' ' GLN . 1.3 tmt? -105.6 117.48 34.13 Favored 'General case' 0 C--N 1.273 -2.752 0 O-C-N 120.98 -1.075 . . . . 0.0 109.528 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 1.125 HD11 ' HB3' ' A' ' 71' ' ' ALA . 2.4 pt? -104.53 148.31 26.62 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.735 ' HA ' HG21 ' A' ' 17' ' ' THR 0.28 45.7 ttm105 -112.88 -55.47 2.52 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.605 -2.543 . . . . 0.0 115.291 -174.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -44.86 -21.11 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.659 0 CA-C-N 120.6 1.545 . . . . 0.0 115.019 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.64 -31.93 3.79 Favored Glycine 0 N--CA 1.426 -1.968 0 O-C-N 120.907 -1.121 . . . . 0.0 113.965 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 m -121.03 69.43 0.89 Allowed 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -166.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.914 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -179.82 2.14 0.01 OUTLIER 'General case' 0 C--N 1.381 1.965 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 179.376 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 1.125 ' HB3' HD11 ' A' ' 65' ' ' LEU . . . -85.18 -34.94 21.97 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -171.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.573 ' CE2' HD21 ' A' ' 89' ' ' LEU . 13.8 m-90 -72.4 -28.39 62.95 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-O 122.287 1.041 . . . . 0.0 110.343 -175.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.415 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 44.1 tt0 -69.03 -43.29 75.03 Favored 'General case' 0 C--O 1.258 1.552 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.55 171.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.52 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 84.2 mt -56.66 -42.15 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.109 0 CA-C-O 121.695 0.76 . . . . 0.0 109.787 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.671 ' HE2' ' HB ' ' A' ' 87' ' ' VAL . 52.7 tttm -56.49 -51.43 68.52 Favored 'General case' 0 C--O 1.282 2.802 0 C-N-CA 124.79 1.236 . . . . 0.0 109.707 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -55.15 -47.37 75.22 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.555 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 11.4 m-85 -53.55 -59.44 4.59 Favored 'General case' 0 C--N 1.366 1.292 0 O-C-N 123.872 0.733 . . . . 0.0 109.353 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.619 HD13 ' CZ3' ' A' ' 40' ' ' TRP . 16.4 mt -52.89 -53.37 50.15 Favored 'General case' 0 C--O 1.3 3.732 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -172.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.516 ' HB ' ' CB ' ' A' ' 84' ' ' CYS 0.308 27.8 m -75.8 -9.38 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.198 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.873 -177.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.2 m -100.23 2.32 42.68 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.599 166.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 69.9 mm-40 -91.04 -40.89 11.38 Favored 'General case' 0 CA--C 1.439 -3.309 0 C-N-CA 118.909 -1.117 . . . . 0.0 109.519 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.412 35.6 t70 -155.91 -90.72 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.543 ' HB2' HG23 ' A' ' 24' ' ' VAL . 31.8 mmt180 -102.09 144.24 30.91 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 120.747 1.612 . . . . 0.0 110.559 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.516 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 10.6 p -140.59 135.64 31.98 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.697 ' HB3' ' OG ' ' A' ' 25' ' ' SER . . . -149.85 -51.67 0.15 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 1.055 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 32.9 tt0 -154.75 116.52 4.14 Favored 'General case' 0 C--O 1.181 -2.517 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.538 -173.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.671 ' HB ' ' HE2' ' A' ' 75' ' ' LYS . 14.2 t -111.4 102.21 13.64 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.7 p -109.84 125.19 52.5 Favored 'General case' 0 CA--C 1.473 -1.994 0 C-N-CA 117.619 -1.632 . . . . 0.0 112.023 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 1.095 HD23 ' HE3' ' A' ' 20' ' ' MET . 4.1 mp . . . . . 1 N--CA 1.371 -4.41 0 CA-C-N 112.257 -2.247 . . . . 0.0 107.667 -176.02 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.0 tptt . . . . . 0 C--O 1.205 -1.26 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.444 HG23 ' HE2' ' A' ' 64' ' ' MET . 93.0 m -65.46 117.93 8.68 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.867 ' HG ' ' HH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -126.65 111.91 14.86 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.58 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 21.9 ptm -94.9 114.97 26.88 Favored 'General case' 0 C--N 1.277 -2.558 0 O-C-N 121.112 -0.992 . . . . 0.0 109.401 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.69 ' HE2' HD21 ' A' ' 89' ' ' LEU . 29.8 ttm -97.66 119.21 35.83 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.107 -176.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.429 ' HA ' HG21 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -107.02 119.17 38.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.022 1.729 . . . . 0.0 106.758 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.556 HG22 HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -127.54 128.53 69.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -175.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.908 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 48.8 m -85.97 142.39 28.83 Favored 'General case' 0 CA--C 1.6 2.892 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.382 176.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 83' ' ' ARG 0.283 42.0 t -132.27 140.51 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 C-N-CA 125.414 1.486 . . . . 0.0 108.687 -170.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.526 20.8 t -109.55 -110.34 0.33 Allowed 'General case' 0 C--N 1.369 1.45 0 CA-C-N 122.957 2.617 . . . . 0.0 113.523 168.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.571 ' HA3' ' HG3' ' A' ' 83' ' ' ARG . . . 63.05 -72.34 0.03 OUTLIER Glycine 0 CA--C 1.543 1.827 0 CA-C-N 120.802 1.637 . . . . 0.0 112.402 -173.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.782 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 55.4 t30 -116.76 132.44 23.39 Favored Pre-proline 0 N--CA 1.416 -2.143 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 176.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -91.75 41.76 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.557 1.505 . . . . 0.0 113.298 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.5 p -125.18 -129.73 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 117.828 -1.549 . . . . 0.0 111.141 -173.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.534 ' O ' ' HB ' ' A' ' 33' ' ' THR . 31.2 tt0 -133.76 11.83 4.02 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 171.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 8.9 tmtt? -86.13 -36.95 19.26 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 122.231 1.015 . . . . 0.0 108.337 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.788 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -65.98 -46.07 79.37 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 175.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 58.8 m -45.28 -54.35 7.19 Favored 'General case' 0 C--O 1.193 -1.87 0 C-N-CA 125.696 1.598 . . . . 0.0 111.655 170.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 12.9 pt-20 -63.6 -49.72 72.23 Favored 'General case' 0 C--O 1.257 1.46 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -59.14 -55.66 32.09 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.749 1.261 . . . . 0.0 108.265 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.788 ' HB ' ' O ' ' A' ' 32' ' ' GLU . 3.1 mt -62.41 -42.81 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.123 0 CA-C-N 112.997 -1.911 . . . . 0.0 112.529 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.799 HG21 HG12 ' A' ' 55' ' ' ILE . 17.9 p -70.98 -39.56 72.41 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 120.819 1.645 . . . . 0.0 111.703 -176.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.8 p -63.27 -52.5 61.8 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.922 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.7 tp -63.7 -45.56 89.45 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.089 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.798 ' CE3' HD12 ' A' ' 78' ' ' LEU . 45.3 m0 -63.26 -74.52 0.09 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 119.364 -0.351 . . . . 0.0 111.52 -178.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.734 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.311 0.0 OUTLIER -71.06 -19.87 62.43 Favored 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.896 -1.122 . . . . 0.0 112.501 -172.279 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.45 -51.53 53.72 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 173.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.3 p -68.7 -30.92 69.68 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.261 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.768 HD13 ' HG2' ' A' ' 53' ' ' ARG . 33.5 mt -58.66 -37.16 75.37 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.319 177.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.67 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 64.1 t80 -85.64 -32.56 21.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.873 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.41 -37.4 86.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.4 2.03 51.63 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.123 0.487 . . . . 0.0 110.626 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.3 t30 58.99 51.8 6.9 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.951 1.3 . . . . 0.0 112.116 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -84.34 37.09 0.61 Allowed 'General case' 0 CA--C 1.558 1.258 0 O-C-N 120.903 -1.123 . . . . 0.0 113.473 175.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.2 t70 27.1 71.02 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 C-N-CA 126.397 1.879 . . . . 0.0 114.087 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.735 HG22 ' HD2' ' A' ' 53' ' ' ARG . 1.3 m -147.66 169.57 3.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.329 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.5 ' O ' ' HB3' ' A' ' 64' ' ' MET . 0.5 OUTLIER -122.12 126.26 47.98 Favored 'General case' 0 C--O 1.189 -2.107 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 175.03 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.768 ' HG2' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -133.29 135.8 45.09 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -173.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.669 ' H ' HG12 ' A' ' 62' ' ' ILE . 44.5 t80 -135.4 151.55 50.57 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 119.245 -0.982 . . . . 0.0 113.208 -164.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.799 HG12 HG21 ' A' ' 37' ' ' THR . 43.2 mt -87.01 96.86 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 172.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 m -89.51 -32.28 5.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -163.3 167.68 37.68 Favored Glycine 0 CA--C 1.489 -1.573 0 C-N-CA 117.402 -2.333 . . . . 0.0 114.663 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -70.69 104.12 2.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 0.1 OUTLIER 91.99 18.73 0.03 OUTLIER 'General case' 0 C--N 1.36 1.027 0 C-N-CA 128.378 2.671 . . . . 0.0 110.101 -177.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.702 ' HG2' ' HA ' ' A' ' 23' ' ' THR . 17.8 mtm180 -146.07 132.0 19.17 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.53 165.36 25.07 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.251 -173.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.669 HG12 ' H ' ' A' ' 54' ' ' PHE . 6.0 pt -140.64 158.8 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.414 0 C-N-CA 118.283 -1.367 . . . . 0.0 110.634 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.57 ' CE2' ' HB ' ' A' ' 74' ' ' ILE . 1.1 p90 -133.81 106.72 7.47 Favored 'General case' 0 N--CA 1.423 -1.785 0 O-C-N 126.31 2.256 . . . . 0.0 108.065 162.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.58 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 1.2 tmt? -83.8 112.75 20.38 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 113.022 -1.899 . . . . 0.0 107.66 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.867 HD13 ' HB1' ' A' ' 71' ' ' ALA 0.329 2.3 pt? -109.26 147.73 32.15 Favored 'General case' 0 CA--C 1.468 -2.207 0 CA-C-O 123.487 1.613 . . . . 0.0 114.988 -177.183 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 66' ' ' ARG . 40.2 ttm180 -100.82 -53.14 3.13 Favored 'General case' 0 C--N 1.252 -3.673 0 CA-C-N 110.365 -3.107 . . . . 0.0 112.539 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . 0.43 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 16.1 t70 -39.8 -24.85 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 114.725 1.379 . . . . 0.0 114.725 165.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.67 -34.19 0.71 Allowed Glycine 0 C--O 1.202 -1.901 0 C-N-CA 123.842 0.734 . . . . 0.0 114.761 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 15.2 p -96.96 -49.1 5.16 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 119.493 3.145 . . . . 0.0 119.493 -173.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.441 ' CD1' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -65.46 10.14 0.1 Allowed 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -172.21 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.867 ' HB1' HD13 ' A' ' 65' ' ' LEU . . . -84.71 -23.14 29.47 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 121.156 -0.965 . . . . 0.0 113.15 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.867 ' HH2' ' HG ' ' A' ' 18' ' ' LEU . 5.8 m-90 -67.63 -41.14 84.36 Favored 'General case' 0 C--O 1.277 2.547 0 CA-C-O 121.857 0.837 . . . . 0.0 111.035 -176.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.559 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 42.9 tt0 -67.21 -44.82 78.59 Favored 'General case' 0 C--O 1.295 3.461 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.625 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 90.5 mt -51.32 -49.75 29.9 Favored 'Isoleucine or valine' 0 C--O 1.281 2.762 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.719 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 78' ' ' LEU . 21.2 pttp -63.57 -40.03 95.91 Favored 'General case' 0 C--N 1.383 2.063 0 CA-C-O 121.586 0.708 . . . . 0.0 110.522 -174.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.59 -34.41 72.7 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.496 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.625 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 21.6 m-85 -69.68 -69.61 0.33 Allowed 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -172.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.798 HD12 ' CE3' ' A' ' 40' ' ' TRP . 2.4 pt? -64.33 -34.71 78.78 Favored 'General case' 0 C--O 1.272 2.246 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.704 -167.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.627 ' O ' ' HB3' ' A' ' 84' ' ' CYS . 34.6 t -83.63 -25.05 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 C-N-CA 117.903 -1.519 . . . . 0.0 109.304 -172.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.8 m -96.16 7.84 45.39 Favored 'General case' 0 N--CA 1.407 -2.615 0 C-N-CA 117.673 -1.611 . . . . 0.0 108.562 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.745 HE21 ' HA ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -91.12 -52.63 4.73 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.094 -178.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.453 ' OD1' ' HG2' ' A' ' 83' ' ' ARG 0.388 9.2 t70 -110.9 -95.13 0.43 Allowed 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.045 -1.062 . . . . 0.0 112.192 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.571 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 52.9 mmt-85 -112.98 152.86 28.91 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 121.425 1.921 . . . . 0.0 111.49 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.627 ' HB3' ' O ' ' A' ' 79' ' ' VAL . 13.0 p -138.03 160.67 38.75 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.011 -172.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.79 -54.39 0.02 OUTLIER 'General case' 0 C--N 1.379 1.865 0 C-N-CA 124.133 0.973 . . . . 0.0 113.001 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.908 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 34.8 tt0 -155.66 131.01 9.55 Favored 'General case' 0 C--O 1.208 -1.119 0 O-C-N 121.874 -0.516 . . . . 0.0 110.946 -170.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.461 HG13 ' HB ' ' A' ' 22' ' ' VAL . 16.0 m -115.01 115.28 49.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.222 172.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.494 ' C ' HD11 ' A' ' 89' ' ' LEU 0.28 32.2 p -112.28 123.91 51.3 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 123.207 1.479 . . . . 0.0 112.022 172.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.69 HD21 ' HE2' ' A' ' 20' ' ' MET . 6.0 mp . . . . . 0 N--CA 1.39 -3.44 0 CA-C-N 113.091 -1.868 . . . . 0.0 110.271 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.2 tptt . . . . . 0 N--CA 1.437 -1.123 0 CA-C-O 120.57 0.224 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 p -117.33 121.46 41.2 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.72 HD12 ' HB3' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -134.59 108.14 7.89 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -173.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.1 ptm -84.1 100.95 11.45 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.542 ' HE3' ' HG ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -88.79 138.69 31.18 Favored 'General case' 0 C--O 1.25 1.123 0 C-N-CA 117.029 -1.868 . . . . 0.0 111.043 -171.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -109.52 113.45 26.25 Favored 'General case' 0 C--O 1.267 2.013 0 O-C-N 125.245 1.59 . . . . 0.0 108.723 -174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -117.44 123.86 72.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.77 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 1.069 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 92.3 m -98.12 133.99 41.8 Favored 'General case' 0 CA--C 1.608 3.197 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.138 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.872 HG11 HD12 ' A' ' 36' ' ' ILE . 91.1 t -130.95 101.47 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.409 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 2.6 t -118.92 7.05 11.41 Favored 'General case' 0 C--N 1.361 1.108 0 CA-C-N 122.286 2.312 . . . . 0.0 114.042 -166.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.45 -46.21 52.87 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 174.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 1.054 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 16.4 t-20 -115.21 104.11 53.93 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 167.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 2.7 Cg_endo -82.23 24.52 0.71 Allowed 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 123.52 2.813 . . . . 0.0 113.351 -173.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.435 ' C ' ' HB3' ' A' ' 58' ' ' SER . 6.9 p -125.12 -162.51 1.11 Allowed 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.295 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -73.61 -29.22 62.25 Favored 'General case' 0 C--O 1.194 -1.844 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -59.56 -48.09 83.03 Favored 'General case' 0 C--O 1.263 1.768 0 CA-C-N 119.167 0.894 . . . . 0.0 112.726 -171.133 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 1.054 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 2.8 tp10 -64.01 -49.36 72.74 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.5 m -52.1 -46.06 65.12 Favored 'General case' 0 C--O 1.192 -1.93 0 CA-C-N 113.445 -1.707 . . . . 0.0 111.351 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.58 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 16.3 pt-20 -75.99 -31.32 58.92 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -75.55 -47.36 27.11 Favored 'General case' 0 C--O 1.279 2.651 0 N-CA-C 101.238 -3.616 . . . . 0.0 101.238 -174.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.872 HD12 HG11 ' A' ' 24' ' ' VAL 1.532 1.5 pp -57.19 -57.31 10.47 Favored 'Isoleucine or valine' 1 N--CA 1.309 -7.487 0 N-CA-C 120.917 3.673 . . . . 0.0 120.917 175.159 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.521 ' HA ' ' HB2' ' A' ' 40' ' ' TRP . 39.6 p -67.84 -31.42 71.24 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 t -64.85 -46.54 81.45 Favored 'General case' 0 N--CA 1.424 -1.737 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.074 176.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.7 mt -67.76 -46.29 72.46 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.901 178.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.724 ' HB3' ' NH1' ' A' ' 53' ' ' ARG . 37.8 m0 -57.3 -67.72 0.3 Allowed 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.943 -1.481 . . . . 0.0 114.837 -175.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.443 ' O ' ' HD1' ' A' ' 45' ' ' PHE 0.331 0.0 OUTLIER -78.9 -17.5 55.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 117.102 -1.839 . . . . 0.0 110.677 -176.513 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.95 -59.43 9.38 Favored Glycine 0 CA--C 1.472 -2.596 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 170.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.3 m -74.79 -36.85 62.49 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-N 113.245 -1.478 . . . . 0.0 112.496 -175.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 1.005 HD12 ' HD2' ' A' ' 53' ' ' ARG . 12.7 mt -61.1 -33.54 73.52 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.209 178.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.496 ' HZ ' ' HA ' ' A' ' 52' ' ' GLN . 53.0 m-85 -87.11 -32.18 20.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.348 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -70.19 -29.98 66.98 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.12 8.4 15.67 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.079 0.466 . . . . 0.0 110.898 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 t30 67.38 52.21 0.83 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.176 1.391 . . . . 0.0 113.538 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -100.59 154.34 18.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.35 -1.469 . . . . 0.0 107.852 170.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.518 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 30.2 t70 -92.54 83.62 4.95 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 120.02 1.282 . . . . 0.0 109.407 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.77 174.36 12.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.205 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.496 ' HA ' ' HZ ' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -134.22 140.2 46.32 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 169.359 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 1.005 ' HD2' HD12 ' A' ' 44' ' ' LEU . 35.7 mtp180 -142.91 139.55 30.82 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 118.958 0.799 . . . . 0.0 109.735 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.638 ' H ' HG12 ' A' ' 62' ' ' ILE . 50.1 m-85 -132.33 151.38 51.87 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.044 -1.462 . . . . 0.0 114.099 -169.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 57.8 mt -99.19 96.41 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 170.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 60' ' ' ARG . 4.7 m -98.16 -23.14 4.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.048 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.94 161.57 35.39 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 118.524 -1.798 . . . . 0.0 112.159 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.435 ' HB3' ' C ' ' A' ' 29' ' ' THR . 51.1 m -75.64 106.48 7.23 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.49 ' O ' ' HD2' ' A' ' 60' ' ' ARG 0.271 0.0 OUTLIER 98.42 5.04 0.02 OUTLIER 'General case' 0 C--N 1.366 1.283 0 C-N-CA 127.0 2.12 . . . . 0.0 110.188 -174.167 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 59' ' ' ASP . 5.8 mpt_? -134.11 123.04 23.77 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.95 0.9 . . . . 0.0 112.131 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.09 168.18 17.16 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.638 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -141.16 153.24 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.45 -2.878 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.954 172.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.95 ' HA ' ' HG2' ' A' ' 53' ' ' ARG 0.27 31.2 p90 -129.45 108.62 10.41 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 127.114 2.759 . . . . 0.0 108.665 163.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.442 ' HB3' ' HB2' ' A' ' 52' ' ' GLN . 26.5 ttt -92.42 119.75 32.25 Favored 'General case' 0 C--O 1.27 2.158 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -81.65 122.06 27.14 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 128.956 2.902 . . . . 0.0 110.161 178.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.518 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.253 23.6 ttt180 -105.44 -49.5 3.42 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 172.091 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -75.87 50.88 0.6 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.079 1.309 . . . . 0.0 112.777 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.411 ' C ' ' HG ' ' A' ' 69' ' ' SER . . . 58.58 -34.66 0.02 OUTLIER Glycine 0 CA--C 1.55 2.233 0 N-CA-C 120.991 3.157 . . . . 0.0 120.991 173.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.411 ' HG ' ' C ' ' A' ' 68' ' ' GLY . 62.0 m -163.07 51.65 0.17 Allowed 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 120.189 1.995 . . . . 0.0 116.384 -171.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.463 ' HE1' ' HA ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -122.01 13.83 10.6 Favored 'General case' 0 C--O 1.213 -0.849 0 O-C-N 120.286 -1.508 . . . . 0.0 112.306 177.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.765 ' HA ' HD11 ' A' ' 74' ' ' ILE . . . -102.14 -12.94 17.69 Favored 'General case' 0 C--O 1.197 -1.661 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -169.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.655 ' CE3' HD12 ' A' ' 89' ' ' LEU . 8.5 m95 -84.85 -31.0 24.02 Favored 'General case' 0 C--N 1.27 -2.872 0 O-C-N 120.536 -1.353 . . . . 0.0 109.102 -166.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -75.11 -33.81 61.64 Favored 'General case' 0 C--O 1.257 1.464 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.765 HD11 ' HA ' ' A' ' 71' ' ' ALA . 54.2 mt -59.01 -39.73 79.01 Favored 'Isoleucine or valine' 0 C--O 1.264 1.855 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.004 175.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.904 ' HD2' HD11 ' A' ' 89' ' ' LEU . 32.9 tttm -57.05 -53.21 60.62 Favored 'General case' 0 C--O 1.275 2.447 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.267 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -55.08 -46.94 75.49 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.821 1.326 . . . . 0.0 112.284 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.458 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 13.0 m-85 -56.74 -55.91 28.13 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.559 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.643 HD22 ' NE1' ' A' ' 40' ' ' TRP . 9.5 mt -58.53 -48.55 80.48 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 75' ' ' LYS 0.281 18.3 m -78.99 -6.26 9.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 116.558 -2.057 . . . . 0.0 113.136 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.0 m -106.68 4.02 27.37 Favored 'General case' 0 N--CA 1.423 -1.777 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.698 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -118.45 -25.02 6.62 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 117.374 -1.731 . . . . 0.0 111.149 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -139.73 -164.1 1.62 Allowed 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.728 ' HB3' HG12 ' A' ' 24' ' ' VAL . 23.2 tpp180 -60.56 136.15 57.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 118.858 0.754 . . . . 0.0 111.009 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.419 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 18.2 p -130.57 146.21 52.04 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -174.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.29 -38.62 0.09 Allowed 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 122.71 0.404 . . . . 0.0 111.157 170.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 1.069 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 39.9 tt0 -153.24 129.0 10.13 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.745 -176.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.16 92.68 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.3 p -116.78 111.34 19.61 Favored 'General case' 0 C--O 1.257 1.487 0 CA-C-O 121.926 0.869 . . . . 0.0 110.816 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.904 HD11 ' HD2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.408 -2.539 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.9 tptp . . . . . 0 N--CA 1.437 -1.086 0 CA-C-O 120.796 0.332 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.9 p -65.59 114.49 4.96 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.381 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.73 ' HB3' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -128.02 108.21 10.48 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.424 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 25.1 ptm -93.6 108.8 20.47 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.845 ' HB2' ' HA ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -106.93 143.09 35.52 Favored 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 116.703 -1.999 . . . . 0.0 112.742 -173.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.431 ' CE2' ' HD3' ' A' ' 60' ' ' ARG . 1.1 t80 -114.91 114.72 25.85 Favored 'General case' 0 C--O 1.26 1.609 0 C-N-CA 128.079 2.552 . . . . 0.0 109.863 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.737 HG23 ' SD ' ' A' ' 20' ' ' MET . 3.6 t -104.0 131.65 52.25 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.33 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 1.05 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 97.7 m -99.83 129.76 45.96 Favored 'General case' 0 CA--C 1.594 2.635 0 O-C-N 124.529 1.143 . . . . 0.0 108.375 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.673 HG12 ' HB2' ' A' ' 83' ' ' ARG 0.295 93.5 t -122.38 101.82 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 C-N-CA 127.029 2.132 . . . . 0.0 106.8 -171.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -115.08 -1.01 13.14 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 122.471 2.396 . . . . 0.0 115.105 -168.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.692 ' HA3' ' HD2' ' A' ' 83' ' ' ARG . . . -56.51 -48.17 78.36 Favored Glycine 0 N--CA 1.474 1.226 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.46 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 4.9 t30 -115.75 116.67 40.67 Favored Pre-proline 0 N--CA 1.401 -2.878 0 N-CA-C 100.447 -3.909 . . . . 0.0 100.447 169.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -106.18 34.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.306 2.004 . . . . 0.0 111.305 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.445 ' C ' ' H ' ' A' ' 31' ' ' LYS . 2.9 m -129.5 54.5 1.82 Allowed 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 118.116 -1.434 . . . . 0.0 114.849 -168.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.468 ' O ' ' HB ' ' A' ' 33' ' ' THR . 35.9 mt-10 59.92 -21.13 0.03 OUTLIER 'General case' 0 C--N 1.377 1.796 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 178.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HD3' ' C ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -69.68 -41.93 74.79 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.669 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 1.2 pm0 -68.31 -41.62 80.59 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 90.9 m -48.19 -53.08 18.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.15 0.98 . . . . 0.0 110.517 174.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 12.5 pt-20 -69.6 -49.12 57.06 Favored 'General case' 0 C--O 1.259 1.558 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -49.73 -60.0 3.29 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.232 1.413 . . . . 0.0 107.836 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.813 HG21 ' CE3' ' A' ' 40' ' ' TRP . 22.3 mt -64.76 -44.56 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.035 0 CA-C-N 112.135 -2.302 . . . . 0.0 113.01 -175.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.913 HG22 HG12 ' A' ' 55' ' ' ILE . 22.4 p -66.83 -48.86 67.6 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 117.87 -1.532 . . . . 0.0 111.826 -176.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.0 p -63.29 -57.2 11.2 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.592 0.557 . . . . 0.0 111.463 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.3 tp -67.18 -39.35 86.39 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.813 ' CE3' HG21 ' A' ' 36' ' ' ILE . 46.1 m0 -79.96 -48.6 13.12 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -174.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.454 ' O ' ' HD1' ' A' ' 45' ' ' PHE 0.286 0.0 OUTLIER -72.61 -23.42 60.94 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 116.686 -2.006 . . . . 0.0 109.857 178.828 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.59 -51.44 57.59 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 173.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.503 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 10.5 p -66.75 -38.95 87.64 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 1.035 HD11 ' HD2' ' A' ' 53' ' ' ARG . 19.3 mt -60.17 -35.57 75.65 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 177.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.454 ' HD1' ' O ' ' A' ' 41' ' ' GLN . 35.1 m-85 -85.81 -25.22 26.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.242 0.544 . . . . 0.0 110.521 176.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.503 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.4 t-20 -68.39 -31.84 71.48 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.372 0.669 . . . . 0.0 111.681 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.45 2.66 49.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.241 0.543 . . . . 0.0 110.307 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.7 t30 57.16 60.7 2.84 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.028 1.331 . . . . 0.0 114.238 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -100.32 167.82 10.17 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 166.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -97.8 100.8 12.18 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 120.22 1.373 . . . . 0.0 108.348 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 m -146.13 176.92 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.243 -171.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.493 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 22.9 mt-30 -140.58 145.5 36.81 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 173.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 1.035 ' HD2' HD11 ' A' ' 44' ' ' LEU . 21.6 mtp180 -143.53 144.14 31.84 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 118.943 0.792 . . . . 0.0 111.233 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.658 ' H ' HG12 ' A' ' 62' ' ' ILE . 80.7 m-85 -133.68 151.75 51.72 Favored 'General case' 0 C--O 1.261 1.661 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -170.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.913 HG12 HG22 ' A' ' 37' ' ' THR . 17.4 mt -92.56 102.86 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 167.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.574 HG21 ' HD2' ' A' ' 60' ' ' ARG . 6.9 m -112.51 -27.41 2.77 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.784 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.95 161.38 31.89 Favored Glycine 0 N--CA 1.419 -2.492 0 C-N-CA 118.158 -1.972 . . . . 0.0 113.681 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 m -64.4 125.17 23.79 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 p30 68.22 21.61 8.47 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 125.106 1.362 . . . . 0.0 109.556 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.574 ' HD2' HG21 ' A' ' 56' ' ' VAL . 1.1 tmm_? -153.6 119.77 5.44 Favored 'General case' 0 CA--C 1.583 2.215 0 CA-C-O 122.278 1.037 . . . . 0.0 113.327 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.29 168.75 13.08 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.527 1.131 . . . . 0.0 109.066 -171.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.658 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -134.6 156.79 40.7 Favored 'Isoleucine or valine' 0 C--O 1.283 2.861 0 C-N-CA 117.474 -1.69 . . . . 0.0 110.993 175.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.982 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 49.0 p90 -123.24 109.82 14.44 Favored 'General case' 0 N--CA 1.422 -1.845 0 O-C-N 127.507 3.005 . . . . 0.0 107.309 163.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.549 ' HB2' ' CD1' ' A' ' 62' ' ' ILE . 23.7 ttt -95.87 110.81 22.93 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.303 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.851 ' HG ' ' HB1' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -113.3 147.42 37.64 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -171.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.284 30.6 ttm180 -111.78 -58.51 2.11 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -176.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -44.46 -19.99 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.22 -9.13 3.32 Favored Glycine 0 C--N 1.358 1.767 0 CA-C-N 119.717 1.144 . . . . 0.0 114.903 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -117.05 32.46 6.15 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.301 1.051 . . . . 0.0 113.696 -168.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -166.68 12.98 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.606 -171.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.851 ' HB1' ' HG ' ' A' ' 65' ' ' LEU . . . -97.22 -37.77 9.95 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -166.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.627 ' CE2' HD21 ' A' ' 89' ' ' LEU . 9.0 m-90 -76.0 -27.53 57.45 Favored 'General case' 0 C--O 1.273 2.331 0 O-C-N 120.895 -1.128 . . . . 0.0 110.636 -174.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -63.62 -35.22 79.79 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 113.835 -1.529 . . . . 0.0 107.722 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.8 HD13 ' HA ' ' A' ' 71' ' ' ALA . 26.3 mt -67.58 -45.2 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.154 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -57.71 -41.69 82.25 Favored 'General case' 0 C--O 1.283 2.851 0 CA-C-O 121.907 0.861 . . . . 0.0 109.387 -174.022 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.492 ' N ' ' HD2' ' A' ' 75' ' ' LYS . 17.1 t70 -61.46 -50.01 74.51 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 112.826 -1.988 . . . . 0.0 111.649 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.421 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 14.8 m-85 -62.09 -48.3 80.82 Favored 'General case' 0 C--O 1.197 -1.696 0 C-N-CA 118.47 -1.292 . . . . 0.0 110.383 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.805 HD11 ' CE3' ' A' ' 40' ' ' TRP . 4.3 mt -55.57 -54.5 43.3 Favored 'General case' 0 C--O 1.296 3.504 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.678 ' O ' ' HB3' ' A' ' 84' ' ' CYS 0.354 30.0 m -72.62 -19.1 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 C-N-CA 115.935 -2.306 . . . . 0.0 112.574 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.3 m -85.96 -4.3 59.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.148 171.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 21.7 mm-40 -90.43 -32.27 16.48 Favored 'General case' 0 CA--C 1.453 -2.78 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.073 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.505 ' OD2' ' HG2' ' A' ' 83' ' ' ARG 0.44 21.7 t70 -147.31 -94.58 0.09 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 116.913 -1.915 . . . . 0.0 114.628 -178.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.692 ' HD2' ' HA3' ' A' ' 26' ' ' GLY . 10.8 mmt180 -105.38 126.74 52.46 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 121.191 1.814 . . . . 0.0 109.264 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 0.678 ' HB3' ' O ' ' A' ' 79' ' ' VAL . 22.2 p -111.46 97.09 6.5 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -176.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.75 -42.37 2.42 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 1.05 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 37.2 tt0 -153.61 125.2 7.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 118.034 -1.466 . . . . 0.0 112.781 -174.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.503 HG23 ' HD3' ' A' ' 75' ' ' LYS . 2.9 m -112.75 93.44 2.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 p -105.44 99.4 9.01 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 118.413 -1.315 . . . . 0.0 112.208 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.845 ' HA ' ' HB2' ' A' ' 20' ' ' MET . 5.4 mp . . . . . 0 N--CA 1.384 -3.73 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.545 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.6 tptt . . . . . 0 N--CA 1.438 -1.042 0 CA-C-O 120.497 0.189 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 6.3 m -85.58 111.36 19.97 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.822 ' HB3' HD22 ' A' ' 65' ' ' LEU . 21.8 tp -133.2 116.02 15.71 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -174.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.67 ' HB3' ' HE3' ' A' ' 64' ' ' MET . 19.6 ptm -83.56 103.13 12.64 Favored 'General case' 0 C--O 1.207 -1.171 0 O-C-N 121.502 -0.749 . . . . 0.0 112.792 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . 0.658 ' HE3' ' HB2' ' A' ' 71' ' ' ALA . 12.3 mtm -84.56 126.01 32.94 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -174.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -108.8 115.0 29.25 Favored 'General case' 0 N--CA 1.432 -1.34 0 O-C-N 125.618 1.824 . . . . 0.0 108.606 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.25 125.52 72.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.485 -176.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.806 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 30.2 m -90.85 110.62 21.84 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 113.638 -1.619 . . . . 0.0 107.365 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.701 HG11 ' HA ' ' A' ' 84' ' ' CYS . 75.5 t -103.77 92.55 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.341 0 CA-C-N 120.373 1.442 . . . . 0.0 109.145 -176.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 m -93.38 96.5 9.98 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 120.755 1.616 . . . . 0.0 110.292 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.21 -50.08 0.02 OUTLIER Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 44.9 t-20 -116.47 106.12 49.16 Favored Pre-proline 0 CA--C 1.493 -1.212 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 175.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 27' ' ' ASN . 16.2 Cg_exo -68.58 42.44 0.27 Allowed 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 123.93 3.086 . . . . 0.0 114.111 -171.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.6 p -147.0 -176.5 5.23 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.464 ' O ' ' HB ' ' A' ' 33' ' ' THR . 48.8 mt-10 -85.81 10.32 14.06 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 118.831 0.741 . . . . 0.0 110.225 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.544 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -77.74 -34.43 52.55 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.565 ' HG2' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -71.26 -40.84 70.73 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.318 -0.953 . . . . 0.0 108.493 177.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.525 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 29.0 m -49.87 -55.63 13.58 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 125.866 1.666 . . . . 0.0 110.807 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.544 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.1 pt-20 -67.5 -43.95 79.66 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.867 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -50.71 -62.56 1.53 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 123.075 1.416 . . . . 0.0 107.474 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.845 HG21 ' CE3' ' A' ' 40' ' ' TRP . 25.0 mt -61.71 -44.38 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 112.067 -2.333 . . . . 0.0 112.981 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.879 HG22 HG12 ' A' ' 55' ' ' ILE . 25.1 p -68.28 -52.93 28.2 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.913 -175.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.4 p -62.79 -56.68 15.3 Favored 'General case' 0 C--O 1.256 1.432 0 O-C-N 123.618 0.574 . . . . 0.0 111.621 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.87 -49.6 74.22 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.845 ' CE3' HG21 ' A' ' 36' ' ' ILE . 50.8 m0 -75.14 -47.25 29.44 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -173.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.298 0.0 OUTLIER -73.98 -19.47 60.64 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 116.608 -2.037 . . . . 0.0 109.816 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.99 -52.87 49.61 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 170.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.522 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 9.6 p -69.73 -34.51 73.96 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 117.099 0.449 . . . . 0.0 112.01 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 1.035 HD12 ' HD2' ' A' ' 53' ' ' ARG . 9.2 mt -61.06 -35.28 76.53 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -87.99 -22.31 24.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.358 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 16.1 t-20 -65.53 -34.22 77.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.653 0.263 . . . . 0.0 110.984 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.99 5.05 27.13 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.411 0.624 . . . . 0.0 109.863 175.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 t30 51.77 45.4 28.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.342 1.857 . . . . 0.0 113.673 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -80.09 165.87 22.07 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -98.25 94.53 6.83 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 120.359 1.436 . . . . 0.0 108.656 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 m -135.12 173.09 14.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.592 -171.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -138.43 123.93 19.56 Favored 'General case' 0 C--O 1.196 -1.721 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 1.045 ' HG2' ' HA ' ' A' ' 63' ' ' PHE . 16.8 mtp180 -120.43 142.03 49.6 Favored 'General case' 0 C--N 1.268 -2.947 0 O-C-N 121.235 -0.915 . . . . 0.0 110.998 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.639 ' H ' HG12 ' A' ' 62' ' ' ILE . 41.1 m-85 -129.57 152.14 49.41 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -170.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.879 HG12 HG22 ' A' ' 37' ' ' THR . 29.8 mt -94.8 109.44 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' A' ' 60' ' ' ARG . 3.7 m -112.07 -16.19 9.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -175.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 161.97 177.12 34.75 Favored Glycine 0 CA--C 1.482 -2.022 0 C-N-CA 117.477 -2.297 . . . . 0.0 114.262 169.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.525 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 37.6 t -66.14 116.65 7.44 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.557 ' C ' ' HD2' ' A' ' 60' ' ' ARG . 0.2 OUTLIER 85.98 9.39 0.28 Allowed 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 125.41 1.484 . . . . 0.0 109.058 -178.378 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.632 ' HB3' HG21 ' A' ' 56' ' ' VAL . 3.8 mpt_? -138.68 124.26 19.57 Favored 'General case' 0 C--O 1.255 1.387 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.89 162.24 32.97 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.639 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -137.56 154.45 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.044 0 C-N-CA 117.969 -1.493 . . . . 0.0 111.545 174.08 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 1.045 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -126.65 112.65 15.71 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.223 2.827 . . . . 0.0 107.76 162.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.67 ' HE3' ' HB3' ' A' ' 19' ' ' MET . 43.4 ttm -95.42 125.55 40.11 Favored 'General case' 0 C--O 1.258 1.544 0 O-C-N 121.332 -0.855 . . . . 0.0 109.805 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.822 HD22 ' HB3' ' A' ' 18' ' ' LEU . 1.2 pt? -102.2 144.62 30.51 Favored 'General case' 0 CA--C 1.494 -1.182 0 O-C-N 124.622 1.201 . . . . 0.0 110.669 -176.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.292 5.5 tmm_? -119.73 -49.22 2.34 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -46.78 -23.44 0.43 Allowed 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 171.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.42 -31.93 4.65 Favored Glycine 0 C--N 1.36 1.864 0 CA-C-N 120.231 1.378 . . . . 0.0 113.8 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.2 m -128.34 45.42 2.77 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -166.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -153.02 2.25 0.29 Allowed 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.239 -0.913 . . . . 0.0 112.562 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.717 ' HA ' HD11 ' A' ' 74' ' ' ILE . . . -94.52 -34.41 12.69 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 119.077 2.991 . . . . 0.0 119.077 -170.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TRP . . . . . 0.796 ' HD1' ' HD3' ' A' ' 75' ' ' LYS 0.512 9.3 m-90 -81.42 -16.81 50.99 Favored 'General case' 0 C--O 1.263 1.781 0 C-N-CA 116.494 -2.083 . . . . 0.0 114.85 -167.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -73.56 -29.73 62.61 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 168.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.717 HD11 ' HA ' ' A' ' 71' ' ' ALA . 74.9 mt -61.23 -42.13 92.27 Favored 'Isoleucine or valine' 0 C--O 1.258 1.54 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.869 173.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.846 ' HB2' HG21 ' A' ' 87' ' ' VAL . 53.1 pttt -61.32 -41.45 97.04 Favored 'General case' 0 C--N 1.378 1.842 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.386 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.45 -52.02 65.0 Favored 'General case' 0 C--O 1.271 2.204 0 O-C-N 124.29 0.994 . . . . 0.0 110.582 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.477 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 8.0 m-85 -54.62 -47.54 73.32 Favored 'General case' 0 C--O 1.205 -1.288 0 O-C-N 123.553 0.533 . . . . 0.0 110.114 -178.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . 0.703 HD11 ' CZ3' ' A' ' 40' ' ' TRP . 10.3 mt -63.59 -51.58 64.69 Favored 'General case' 0 C--O 1.287 3.039 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -175.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 1.026 ' HA ' ' HB2' ' A' ' 84' ' ' CYS . 29.5 m -71.38 -6.6 7.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.547 0.689 . . . . 0.0 112.268 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 m -110.35 1.0 18.18 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.246 170.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 5.5 tp-100 -88.18 -36.99 16.5 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -177.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.486 10.5 t70 -142.37 -96.84 0.12 Allowed 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 117.954 2.575 . . . . 0.0 117.954 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -146.77 40.66 1.09 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' CYS . . . . . 1.026 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 55.5 m -79.45 12.03 2.68 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 111.158 -2.746 . . . . 0.0 115.669 -165.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . 0.314 . . 29.66 -58.99 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 173.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.806 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 6.2 tp10 -145.46 132.07 19.88 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 119.882 1.219 . . . . 0.0 111.676 -169.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.846 HG21 ' HB2' ' A' ' 75' ' ' LYS . 47.2 t -114.09 106.26 20.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 173.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.475 ' O ' HD23 ' A' ' 89' ' ' LEU . 14.3 p -118.98 146.98 44.55 Favored 'General case' 0 C--O 1.293 3.352 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.684 ' CD1' ' HG ' ' A' ' 18' ' ' LEU 0.758 2.7 mt . . . . . 0 N--CA 1.441 -0.879 0 N-CA-C 121.152 3.76 . . . . 0.0 121.152 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 0.14 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.27 -13.37 37.64 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.26 2.64 . . . . 0.0 113.161 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.46 16.25 59.45 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.078 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.425 ' HE2' ' OE2' ' A' ' 6' ' ' GLU . 26.1 pttm -73.27 134.2 80.34 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.65 ' HG3' ' HA3' ' A' ' 96' ' ' GLY . 12.3 Cg_exo -70.11 95.18 0.57 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.226 1.951 . . . . 0.0 112.599 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.616 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 25.5 mm-40 -81.75 -22.83 37.02 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.78 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.5 p -53.64 -56.95 12.75 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.966 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 pt -66.0 -41.75 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.609 HD13 ' HA ' ' A' ' 69' ' ' SER . 1.4 pt? -73.25 -37.35 66.37 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 117.852 -1.539 . . . . 0.0 111.553 -175.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.616 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -79.29 -27.02 42.23 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 118.116 -1.434 . . . . 0.0 112.17 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.417 ' N ' ' HD2' ' A' ' 10' ' ' LYS . 16.3 tpt -77.57 -33.12 54.09 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.091 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -81.56 -46.77 13.97 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.793 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.2 pttp 45.93 -166.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 125.592 1.557 . . . . 0.0 113.838 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.8 tptt 64.81 23.96 12.74 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.793 0.837 . . . . 0.0 110.747 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.66 64.36 4.29 Favored Glycine 0 CA--C 1.558 2.763 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.375 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -82.82 123.49 29.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 119.496 1.648 . . . . 0.0 109.355 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 8.0 m -67.44 116.77 8.55 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.679 ' O ' HD13 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -120.52 116.9 26.3 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.524 -2.399 . . . . 0.0 104.524 -177.72 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 24.5 ptm -89.32 133.96 34.26 Favored 'General case' 0 C--N 1.28 -2.435 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.271 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.477 ' HE1' ' NE1' ' A' ' 72' ' ' TRP . 8.0 ttm -123.58 121.71 36.3 Favored 'General case' 0 N--CA 1.405 -2.715 0 C-N-CA 116.246 -2.181 . . . . 0.0 112.944 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -94.54 126.16 39.64 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.226 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 61' ' ' ALA . 0.2 OUTLIER -120.83 130.55 74.49 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-O 121.191 0.52 . . . . 0.0 110.071 -178.013 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 1.095 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 78.1 m -95.66 132.04 41.25 Favored 'General case' 0 N--CA 1.397 -3.093 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 172.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 1.078 HG23 ' HB2' ' A' ' 82' ' ' ASP . 2.5 p -131.41 127.83 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.077 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -172.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.537 ' HB3' ' OD2' ' A' ' 59' ' ' ASP . 15.5 p -142.69 33.01 1.43 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 121.726 2.057 . . . . 0.0 115.356 -170.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.65 -34.76 90.8 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 171.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.529 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 22.3 m-80 -118.13 122.69 30.13 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 171.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.67 28.89 0.41 Allowed 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.763 2.308 . . . . 0.0 112.792 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.0 p -137.78 -157.13 0.75 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.447 ' O ' ' HB ' ' A' ' 33' ' ' THR . 39.9 mt-10 -87.99 5.2 41.95 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-O 119.263 -0.398 . . . . 0.0 111.384 175.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.6 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 5.7 tmtt? -70.92 -38.77 72.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.361 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 27' ' ' ASN . 6.2 tp10 -74.25 -41.04 61.93 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 178.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 96.5 m -44.6 -59.37 2.5 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.181 170.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.6 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.2 pt-20 -61.43 -45.7 93.2 Favored 'General case' 0 C--O 1.25 1.107 0 C-N-CA 122.935 0.494 . . . . 0.0 112.082 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -52.91 -59.03 5.03 Favored 'General case' 0 C--O 1.254 1.317 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.739 HG23 ' CE3' ' A' ' 40' ' ' TRP . 2.0 mp -67.17 -46.18 84.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.53 -1.213 . . . . 0.0 113.352 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.737 HG22 HG12 ' A' ' 55' ' ' ILE . 31.0 p -62.24 -52.61 63.05 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.1 m -70.82 -44.63 66.15 Favored 'General case' 0 C--O 1.26 1.646 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.973 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.0 tp -71.21 -43.55 67.14 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.431 -176.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.739 ' CE3' HG23 ' A' ' 36' ' ' ILE . 43.8 m0 -76.07 -60.34 2.37 Favored 'General case' 0 C--O 1.161 -3.594 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.057 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.663 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.404 0.0 OUTLIER -65.71 -22.23 66.6 Favored 'General case' 0 C--O 1.255 1.356 0 C-N-CA 117.017 -1.873 . . . . 0.0 112.044 -173.078 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.86 -54.13 39.5 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.658 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 27.8 p -70.38 -27.3 64.21 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 117.257 0.528 . . . . 0.0 111.976 177.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.791 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 17.5 mt -61.51 -31.79 71.8 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.301 0.64 . . . . 0.0 109.351 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.435 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 72.8 t80 -92.68 -28.33 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.355 174.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.658 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 10.2 t30 -68.43 -28.88 67.45 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.047 0.451 . . . . 0.0 111.564 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.4 12.12 19.42 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.373 0.606 . . . . 0.0 109.726 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.0 p30 48.25 48.7 18.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.888 1.675 . . . . 0.0 114.74 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -91.45 159.58 15.88 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.62 88.81 3.71 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 120.606 1.548 . . . . 0.0 109.83 -176.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 1.014 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.7 m -146.79 169.83 4.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.559 -169.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.504 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 17.3 mt-30 -131.86 123.7 28.04 Favored 'General case' 0 C--O 1.2 -1.516 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 176.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.791 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -130.62 135.4 47.84 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.503 -173.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.687 ' H ' HG12 ' A' ' 62' ' ' ILE . 56.0 m-85 -133.83 153.19 51.91 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -165.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.737 HG12 HG22 ' A' ' 37' ' ' THR . 22.9 mt -87.24 108.23 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 168.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.717 HG23 ' HB3' ' A' ' 60' ' ' ARG . 15.6 m -113.28 -11.73 11.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.711 -175.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.14 176.95 41.33 Favored Glycine 0 CA--C 1.504 -0.631 0 C-N-CA 117.163 -2.446 . . . . 0.0 115.362 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 m -68.36 110.78 4.26 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.537 ' OD2' ' HB3' ' A' ' 25' ' ' SER 0.257 0.0 OUTLIER 78.37 17.46 1.14 Allowed 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 122.947 1.356 . . . . 0.0 109.938 -178.45 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.717 ' HB3' HG23 ' A' ' 56' ' ' VAL . 7.3 mpt_? -133.18 127.44 33.84 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.173 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.475 ' O ' HG12 ' A' ' 22' ' ' VAL . . . -137.25 165.81 25.27 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.687 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.6 pt -144.53 157.81 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.336 0 C-N-CA 117.962 -1.495 . . . . 0.0 110.62 168.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.597 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -132.1 105.89 7.65 Favored 'General case' 0 N--CA 1.414 -2.233 0 O-C-N 126.595 2.434 . . . . 0.0 105.979 164.509 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.405 ' HB2' HD12 ' A' ' 62' ' ' ILE . 25.1 ttt -92.19 103.97 16.39 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 1.046 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.277 0.0 OUTLIER -96.06 146.32 24.74 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -171.834 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.491 ' C ' ' HD3' ' A' ' 66' ' ' ARG 0.354 1.1 tmt_? -120.98 -59.09 1.76 Allowed 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -46.18 -9.25 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 117.996 2.591 . . . . 0.0 117.996 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.87 28.96 64.07 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 119.793 1.179 . . . . 0.0 113.668 -174.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.609 ' HA ' HD13 ' A' ' 9' ' ' LEU . 19.8 p -149.34 43.43 0.94 Allowed 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.609 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -173.49 -3.85 0.01 OUTLIER 'General case' 0 C--N 1.378 1.818 0 N-CA-C 117.732 2.494 . . . . 0.0 117.732 -176.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 1.046 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -74.31 -35.41 63.68 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -168.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.477 ' NE1' ' HE1' ' A' ' 20' ' ' MET 0.478 5.4 m-90 -88.23 -11.24 47.23 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -169.048 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.84 -38.71 70.08 Favored 'General case' 0 C--O 1.262 1.719 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 167.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.609 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 25.5 mt -64.7 -36.93 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.277 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.809 ' HE2' HG13 ' A' ' 87' ' ' VAL . 55.2 tttm -58.14 -42.58 86.16 Favored 'General case' 0 C--O 1.291 3.275 0 CA-C-O 122.081 0.943 . . . . 0.0 110.617 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -58.42 -46.98 85.41 Favored 'General case' 0 C--O 1.264 1.867 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.288 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.609 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 11.0 m-85 -55.96 -43.99 78.06 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.264 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.634 ' HG ' ' HA ' ' A' ' 75' ' ' LYS . 11.5 mt -50.09 -64.61 0.76 Allowed 'General case' 0 CA--C 1.446 -3.05 0 O-C-N 123.835 0.71 . . . . 0.0 109.719 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . 0.303 25.7 m -77.24 -5.49 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 C-N-CA 118.113 -1.435 . . . . 0.0 114.42 -171.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m -86.35 -22.33 26.74 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.758 167.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -117.26 -35.19 4.11 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 1.078 ' HB2' HG23 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -80.28 24.95 0.41 Allowed 'General case' 0 N--CA 1.516 2.875 0 CA-C-N 119.811 1.187 . . . . 0.0 111.52 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 73.46 -81.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -155.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.422 ' HA ' ' OD1' ' A' ' 82' ' ' ASP . 11.5 p 159.6 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.595 1.558 . . . . 0.0 112.305 171.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . 0.363 . . -109.31 -78.86 0.59 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 119.122 3.008 . . . . 0.0 119.122 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 1.095 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 33.8 tt0 -148.41 126.56 12.13 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 121.089 1.768 . . . . 0.0 112.993 -165.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.809 HG13 ' HE2' ' A' ' 75' ' ' LYS . 2.5 p -111.38 123.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.782 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.414 ' O ' ' HG3' ' A' ' 20' ' ' MET 0.258 25.9 p -123.39 110.5 15.22 Favored 'General case' 0 C--O 1.264 1.834 0 CA-C-O 122.702 1.239 . . . . 0.0 113.042 171.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.53 HD12 HG22 ' A' ' 87' ' ' VAL . 1.7 mp -76.11 155.7 34.46 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.687 -2.052 . . . . 0.0 107.117 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.489 ' H ' HD11 ' A' ' 18' ' ' LEU . 23.8 tt0 -86.64 151.71 23.19 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 171.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 118.49 -172.9 14.66 Favored Glycine 0 CA--C 1.568 3.387 0 CA-C-O 118.724 -1.042 . . . . 0.0 111.846 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -112.48 126.24 55.1 Favored 'General case' 0 C--N 1.367 1.349 0 CA-C-N 120.968 2.384 . . . . 0.0 109.988 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . 0.267 24.0 ptm 55.84 95.07 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.716 1.606 . . . . 0.0 114.265 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -95.0 119.21 66.22 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.95 26.56 0.54 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 123.176 2.584 . . . . 0.0 113.8 -175.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.65 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . -146.79 62.22 0.45 Allowed Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 118.707 -0.664 . . . . 0.0 110.038 179.842 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.299 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.29 -54.05 0.55 Allowed 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 123.025 2.483 . . . . 0.0 112.74 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.16 -58.39 5.04 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -115.67 140.25 25.82 Favored Pre-proline 0 N--CA 1.429 -1.515 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 171.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.416 ' HB2' ' HB2' ' A' ' 72' ' ' TRP . 64.8 Cg_endo -75.43 165.79 29.97 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.556 1.504 . . . . 0.0 114.199 -172.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.551 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 41.1 mt-10 83.56 10.69 0.48 Allowed 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 126.585 1.954 . . . . 0.0 112.06 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.5 p -61.9 -44.96 95.72 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.718 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.468 HG23 HD11 ' A' ' 8' ' ' ILE . 5.9 pt -64.45 -38.07 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.381 0 CA-C-O 122.427 1.108 . . . . 0.0 110.862 -178.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.7 tp -72.1 -47.64 49.83 Favored 'General case' 0 N--CA 1.384 -3.774 0 CA-C-N 112.915 -1.948 . . . . 0.0 111.377 -172.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.551 ' HG2' ' O ' ' A' ' 6' ' ' GLU . 22.4 pttp -86.9 -9.51 55.54 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.205 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 49.8 ttm -79.5 -34.54 41.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 172.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.4 m -82.71 -51.35 7.79 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.308 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt 173.38 149.12 0.07 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -89.38 -175.88 4.88 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 48.0 40.69 20.57 Favored Glycine 0 CA--C 1.557 2.713 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.954 -171.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -117.08 131.87 56.82 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 119.058 1.429 . . . . 0.0 108.838 -176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.697 HG23 ' HE2' ' A' ' 64' ' ' MET . 90.2 m -68.44 121.46 16.38 Favored 'General case' 0 N--CA 1.411 -2.403 0 O-C-N 124.114 0.884 . . . . 0.0 109.34 176.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.717 HD13 ' SD ' ' A' ' 20' ' ' MET . 0.2 OUTLIER -133.56 116.49 15.98 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 176.052 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.515 ' HE3' ' HD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -113.57 140.99 47.71 Favored 'General case' 0 C--N 1.274 -2.708 0 O-C-N 120.921 -1.112 . . . . 0.0 109.306 179.059 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.717 ' SD ' HD13 ' A' ' 18' ' ' LEU . 2.9 mpp? -118.69 127.43 53.56 Favored 'General case' 0 CA--C 1.447 -3.006 0 C-N-CA 120.334 -0.547 . . . . 0.0 111.33 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.515 ' HD2' ' HE3' ' A' ' 19' ' ' MET 0.293 30.4 p90 -98.87 123.42 43.12 Favored 'General case' 0 N--CA 1.413 -2.317 0 C-N-CA 117.354 -1.739 . . . . 0.0 106.729 168.05 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.49 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.9 p -114.89 122.15 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 CA-C-N 114.647 -1.16 . . . . 0.0 113.815 -167.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 1.062 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 24.4 m -75.32 135.76 40.88 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 171.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.48 HG23 ' CD1' ' A' ' 36' ' ' ILE . 7.9 p -121.52 127.7 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.681 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -162.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.653 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 29.5 t 71.26 -48.78 0.68 Allowed 'General case' 0 C--N 1.374 1.663 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 164.057 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.11 -16.74 6.76 Favored Glycine 0 N--CA 1.421 -2.319 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -173.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.42 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.0 t-20 -72.39 110.22 7.61 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -85.7 23.65 0.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.89 2.393 . . . . 0.0 113.015 -172.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -123.32 -170.91 2.2 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -91.61 9.41 32.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.58 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 3.9 tmtt? -67.52 -54.7 17.78 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.252 0.548 . . . . 0.0 110.395 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.653 ' HG2' ' HB3' ' A' ' 25' ' ' SER . 3.4 tp10 -69.0 -40.14 78.91 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -175.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -46.8 -56.29 6.5 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.668 171.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 15.4 pt-20 -62.78 -49.06 76.47 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 122.585 0.354 . . . . 0.0 111.628 -175.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -48.62 -58.48 4.65 Favored 'General case' 0 C--O 1.254 1.32 0 C-N-CA 125.656 1.583 . . . . 0.0 108.335 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.685 HG22 ' CE3' ' A' ' 40' ' ' TRP . 43.6 mt -72.24 -43.34 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 CA-C-N 111.647 -2.524 . . . . 0.0 113.617 -173.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.857 HG22 HG12 ' A' ' 55' ' ' ILE . 22.7 p -63.76 -48.77 75.64 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.241 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.5 p -63.69 -62.98 1.3 Allowed 'General case' 0 C--O 1.263 1.766 0 O-C-N 123.323 0.39 . . . . 0.0 110.774 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.14 -46.7 86.01 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.685 ' CE3' HG22 ' A' ' 36' ' ' ILE . 29.4 m0 -74.89 -59.67 2.63 Favored 'General case' 0 C--O 1.165 -3.38 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.612 -176.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.724 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.375 0.0 OUTLIER -64.58 -25.56 68.02 Favored 'General case' 0 C--O 1.252 1.222 0 C-N-CA 117.214 -1.794 . . . . 0.0 112.027 -172.199 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.19 -53.71 42.47 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.518 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 35.5 p -70.89 -28.51 64.6 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 116.881 0.34 . . . . 0.0 111.732 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.993 HD13 ' HG2' ' A' ' 53' ' ' ARG . 18.2 mt -61.18 -35.13 76.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.276 0.631 . . . . 0.0 109.378 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.615 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 60.9 t80 -87.59 -30.14 20.72 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.913 177.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.2 t-20 -69.02 -27.71 65.92 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.134 0.492 . . . . 0.0 111.481 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.11 1.03 52.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.994 0.426 . . . . 0.0 110.557 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 60.34 35.06 20.69 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.686 1.194 . . . . 0.0 112.266 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -65.56 -2.35 3.36 Favored 'General case' 0 CA--C 1.611 3.31 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 59.7 71.74 0.56 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.396 1.478 . . . . 0.0 111.108 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.547 HG21 ' HD2' ' A' ' 53' ' ' ARG . 6.4 m -147.66 176.21 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.725 -170.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.619 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 12.8 mt-30 -135.96 133.35 37.49 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 174.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.993 ' HG2' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.36 135.42 37.0 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -174.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.746 ' H ' HG12 ' A' ' 62' ' ' ILE . 36.7 t80 -134.36 151.57 51.3 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 117.797 -1.561 . . . . 0.0 113.737 -163.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.857 HG12 HG22 ' A' ' 37' ' ' THR . 25.7 mt -89.5 96.13 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 170.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 60' ' ' ARG . 7.4 p -94.61 -25.43 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-O 120.605 0.241 . . . . 0.0 110.912 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.67 173.52 45.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 118.667 -1.73 . . . . 0.0 114.706 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.528 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 21.0 m -70.57 117.94 12.74 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.528 ' HB3' ' O ' ' A' ' 58' ' ' SER . 14.2 t70 82.47 9.98 0.7 Allowed 'General case' 0 C--O 1.188 -2.139 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.646 ' HB3' HG13 ' A' ' 56' ' ' VAL . 5.5 mpt_? -138.78 117.84 12.56 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 122.247 1.022 . . . . 0.0 113.525 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.59 168.44 12.62 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 125.046 1.339 . . . . 0.0 107.445 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.746 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.5 pt -138.06 157.43 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.256 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.072 171.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -130.82 102.96 6.3 Favored 'General case' 0 N--CA 1.422 -1.841 0 O-C-N 126.807 2.567 . . . . 0.0 107.929 166.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.697 ' HE2' HG23 ' A' ' 17' ' ' THR . 1.0 OUTLIER -87.98 117.29 26.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.802 ' HG ' ' HB3' ' A' ' 71' ' ' ALA 0.429 0.0 OUTLIER -121.03 148.46 44.1 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.646 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.324 26.3 ttp180 -112.64 -57.2 2.31 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -169.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.546 ' HB2' ' CE1' ' A' ' 70' ' ' TYR . 1.7 m-20 -50.23 -13.85 0.13 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 175.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.15 29.11 62.21 Favored Glycine 0 C--N 1.36 1.887 0 CA-C-N 120.475 1.488 . . . . 0.0 115.702 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.5 m -151.99 44.34 0.73 Allowed 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 118.733 1.266 . . . . 0.0 112.949 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 67' ' ' ASP . 14.8 p90 178.99 16.75 0.0 OUTLIER 'General case' 0 C--N 1.365 1.279 0 CA-C-N 119.075 0.852 . . . . 0.0 111.97 -169.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.802 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . . . -100.11 -33.96 10.25 Favored 'General case' 0 C--O 1.267 1.995 0 CA-C-O 122.372 1.082 . . . . 0.0 113.867 -170.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.546 ' CE3' ' HA ' ' A' ' 6' ' ' GLU 0.496 13.0 m0 -89.19 -9.62 50.14 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 116.88 -1.928 . . . . 0.0 112.447 -172.317 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -73.04 -26.66 61.38 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.356 164.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.623 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.0 mt -64.89 -38.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.37 1.462 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 171.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.611 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 29.1 ttpp -57.7 -41.46 81.76 Favored 'General case' 1 C--O 1.317 4.607 0 CA-C-O 122.831 1.301 . . . . 0.0 110.829 175.422 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -57.72 -44.95 86.31 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 118.881 -1.128 . . . . 0.0 110.47 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.78 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 17.1 m-85 -62.13 -27.7 69.12 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.543 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.611 ' HG ' ' HA ' ' A' ' 75' ' ' LYS . 39.8 mt -56.19 -59.32 5.1 Favored 'General case' 0 C--O 1.275 2.446 0 CA-C-O 122.082 0.944 . . . . 0.0 109.199 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.656 HG13 ' SG ' ' A' ' 84' ' ' CYS 0.277 1.2 m -77.04 -4.43 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 C-N-CA 117.467 -1.693 . . . . 0.0 113.134 178.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.78 ' HB3' ' HA ' ' A' ' 77' ' ' PHE . 9.9 t -88.65 -14.32 37.68 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.41 171.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.569 ' HG3' ' NE1' ' A' ' 40' ' ' TRP . 78.3 mm-40 -90.44 -43.42 10.29 Favored 'General case' 0 C--N 1.38 1.892 0 C-N-CA 117.328 -1.749 . . . . 0.0 109.182 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.378 29.3 t70 -176.23 -82.52 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.662 1.226 . . . . 0.0 113.181 173.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -127.27 147.67 50.23 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 120.649 1.568 . . . . 0.0 109.399 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.656 ' SG ' HG13 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -133.51 164.49 27.04 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 178.23 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.37 -51.12 0.15 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 1.062 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.1 tt0 -143.19 121.22 12.09 Favored 'General case' 0 CA--C 1.496 -1.13 0 O-C-N 120.757 -1.214 . . . . 0.0 112.103 -172.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.6 m -111.83 121.69 64.78 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.871 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.475 ' O ' ' HA ' ' A' ' 20' ' ' MET 0.293 22.3 p -106.36 114.41 28.52 Favored 'General case' 0 N--CA 1.406 -2.675 0 C-N-CA 117.348 -1.741 . . . . 0.0 109.656 165.044 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.554 ' HB2' ' CZ ' ' A' ' 94' ' ' TYR . 1.5 mm? -79.59 144.72 33.58 Favored 'General case' 0 N--CA 1.407 -2.603 0 CA-C-N 110.858 -2.883 . . . . 0.0 108.138 -175.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.439 ' HB3' ' H ' ' A' ' 19' ' ' MET . 40.0 tt0 -86.82 177.62 7.24 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.49 -174.96 44.49 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -102.75 110.7 22.71 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 120.497 2.148 . . . . 0.0 105.653 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 49.5 ttm 60.93 46.4 8.56 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -172.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.599 ' HA ' ' HD3' ' A' ' 97' ' ' LYS . 89.6 t80 -55.84 -42.97 98.86 Favored Pre-proline 0 CA--C 1.559 1.297 0 CA-C-N 114.304 -1.316 . . . . 0.0 114.11 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 94' ' ' TYR . 9.4 Cg_endo -55.1 -19.16 19.53 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.342 2.028 . . . . 0.0 113.578 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -102.77 11.18 56.17 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.002 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.599 ' HD3' ' HA ' ' A' ' 94' ' ' TYR . 28.3 mtpp . . . . . 0 C--O 1.255 1.391 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.438 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.581 ' HG2' ' HE2' ' A' ' 16' ' ' LYS . 31.2 Cg_exo -63.78 -41.14 25.49 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.445 2.097 . . . . 0.0 110.573 175.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.58 -56.24 1.65 Allowed Glycine 0 CA--C 1.532 1.133 0 CA-C-N 115.33 -0.85 . . . . 0.0 114.599 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 22.7 pttm -62.75 136.93 96.54 Favored Pre-proline 0 C--O 1.239 0.548 0 CA-C-N 118.362 1.081 . . . . 0.0 111.566 -175.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 92' ' ' GLN . 22.0 Cg_exo -69.25 114.63 3.69 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.5 2.133 . . . . 0.0 110.631 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.66 67.32 0.71 Allowed 'General case' 0 C--O 1.271 2.203 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.412 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 m 65.54 46.24 2.53 Favored 'General case' 0 C--N 1.38 1.893 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.9 tp 49.94 54.05 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.392 2.435 0 C-N-CA 124.802 1.241 . . . . 0.0 109.523 -174.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.291 1.8 pp 46.95 60.21 3.53 Favored 'General case' 0 C--N 1.409 3.155 0 CA-C-O 122.849 1.309 . . . . 0.0 112.158 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . 0.306 18.6 ptpt 52.63 68.24 0.86 Allowed 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.311 -2.222 . . . . 0.0 113.415 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.539 ' O ' ' HB ' ' A' ' 12' ' ' THR . 50.0 ttm 79.98 -24.24 0.21 Allowed 'General case' 0 C--O 1.243 0.758 0 CA-C-N 113.974 -1.467 . . . . 0.0 114.112 173.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.539 ' HB ' ' O ' ' A' ' 11' ' ' MET . 15.0 t 147.93 8.06 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.367 0.667 . . . . 0.0 112.027 -170.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.687 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 7.1 tmtt? -154.35 100.24 2.27 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 117.036 -1.866 . . . . 0.0 112.731 -172.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -151.09 -97.79 0.06 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 170.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.5 71.32 0.1 OUTLIER Glycine 0 CA--C 1.56 2.893 0 CA-C-O 118.48 -1.178 . . . . 0.0 114.378 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.772 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 0.7 OUTLIER -129.57 153.93 47.56 Favored 'General case' 0 C--N 1.364 1.239 0 CA-C-N 120.007 1.904 . . . . 0.0 108.559 178.539 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.8 m -83.96 125.44 32.05 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 174.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.8 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -133.22 112.76 11.96 Favored 'General case' 0 C--O 1.19 -2.055 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.483 -175.143 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 27.4 ptm -84.04 127.62 34.01 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 119.444 -0.902 . . . . 0.0 108.762 174.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.611 ' HE3' HD13 ' A' ' 89' ' ' LEU . 27.3 ttm -101.06 107.91 19.48 Favored 'General case' 0 N--CA 1.424 -1.739 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.947 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -94.1 114.39 26.53 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.5 p -127.15 125.65 66.62 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -169.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 1.045 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 18.8 m -84.71 142.07 30.12 Favored 'General case' 0 CA--C 1.588 2.419 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.608 174.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.567 HG22 HD12 ' A' ' 36' ' ' ILE . 8.5 p -125.82 129.39 72.51 Favored 'Isoleucine or valine' 0 C--N 1.378 1.829 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.84 29.49 1.89 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 115.385 -2.526 . . . . 0.0 114.104 -166.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.44 -34.45 25.68 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 1.018 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 13.9 t-20 -116.95 121.64 32.39 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -85.43 27.28 0.61 Allowed 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 123.087 2.525 . . . . 0.0 114.067 -173.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 22.4 p -144.9 -160.74 1.17 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -174.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.472 ' HA ' ' HB ' ' A' ' 33' ' ' THR . 40.4 tt0 -89.12 1.76 55.14 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.017 -177.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.482 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 5.9 tmtt? -68.08 -50.46 54.88 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.896 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 1.018 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.7 tp10 -70.82 -42.37 70.34 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 118.575 -1.25 . . . . 0.0 107.703 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.472 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 59.9 m -42.49 -51.58 4.99 Favored 'General case' 0 C--O 1.199 -1.591 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.557 171.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 13.7 pt-20 -71.89 -48.37 46.15 Favored 'General case' 0 C--O 1.252 1.22 0 O-C-N 121.781 -0.574 . . . . 0.0 112.476 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -47.69 -57.77 5.12 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.522 1.529 . . . . 0.0 107.501 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.72 HG21 ' CD2' ' A' ' 40' ' ' TRP . 14.7 mt -69.14 -43.95 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 CA-C-N 111.452 -2.613 . . . . 0.0 113.551 -176.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.53 ' HB ' HG12 ' A' ' 55' ' ' ILE . 19.8 p -67.5 -42.08 83.44 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 120.533 1.515 . . . . 0.0 111.315 -174.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.0 p -66.05 -55.64 15.61 Favored 'General case' 0 N--CA 1.425 -1.691 0 O-C-N 123.974 0.796 . . . . 0.0 110.138 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 tp -60.75 -46.17 91.47 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.76 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 44.0 m0 -68.67 -69.97 0.3 Allowed 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.36 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.74 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.321 0.0 OUTLIER -69.31 -21.86 63.83 Favored 'General case' 0 C--O 1.255 1.377 0 C-N-CA 117.918 -1.513 . . . . 0.0 111.968 -171.462 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.11 -51.47 54.95 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 p -68.19 -32.66 73.05 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 117.191 0.495 . . . . 0.0 110.545 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.877 HD12 ' HG2' ' A' ' 53' ' ' ARG . 33.4 mt -60.53 -33.15 72.23 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.005 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.627 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 78.0 t80 -91.08 -30.13 16.92 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.991 175.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -66.06 -32.77 74.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.68 1.89 53.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.25 0.548 . . . . 0.0 109.802 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 t30 49.37 60.49 3.73 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 125.65 1.58 . . . . 0.0 112.763 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -74.02 12.63 0.67 Allowed 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 50.22 67.26 0.94 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.901 1.28 . . . . 0.0 112.517 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.596 HG22 ' HD2' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -146.88 174.23 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.245 -177.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.46 ' HB3' ' HB3' ' A' ' 64' ' ' MET . 7.9 tt0 -131.1 117.97 19.85 Favored 'General case' 0 C--O 1.191 -1.986 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.877 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -128.17 141.17 51.55 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.213 -170.261 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.761 ' H ' HG12 ' A' ' 62' ' ' ILE . 16.8 m-85 -133.72 151.96 51.76 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -168.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.53 HG12 ' HB ' ' A' ' 37' ' ' THR . 21.5 mt -93.03 96.64 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 167.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.57 HG21 ' HB3' ' A' ' 60' ' ' ARG . 8.2 m -91.1 -31.25 4.95 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.535 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.33 173.73 45.68 Favored Glycine 0 CA--C 1.49 -1.493 0 C-N-CA 117.028 -2.51 . . . . 0.0 114.191 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.506 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 33.2 m -66.71 118.95 10.98 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.506 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER 85.25 9.08 0.36 Allowed 'General case' 0 C--N 1.363 1.173 0 CA-C-O 122.138 0.97 . . . . 0.0 109.129 -178.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.57 ' HB3' HG21 ' A' ' 56' ' ' VAL . 8.1 mpt_? -140.21 131.63 26.88 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.13 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.05 165.92 26.05 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.761 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -143.51 157.23 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.99 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.914 170.355 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.592 ' CE2' ' HB2' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -135.65 104.81 5.92 Favored 'General case' 0 N--CA 1.428 -1.552 0 O-C-N 126.196 2.185 . . . . 0.0 107.321 162.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.55 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 26.7 ttt -87.2 116.66 25.43 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.164 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.625 ' HG ' ' HB1' ' A' ' 71' ' ' ALA . 3.8 mp -82.88 145.55 29.37 Favored 'General case' 0 C--O 1.256 1.415 0 C-N-CA 126.077 1.751 . . . . 0.0 112.288 -175.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.298 72.3 ttt180 -110.15 -61.77 1.61 Allowed 'General case' 0 CA--C 1.587 2.395 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 175.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -57.03 -10.95 1.28 Allowed 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.772 ' HA3' ' H ' ' A' ' 16' ' ' LYS . . . 56.61 26.71 53.45 Favored Glycine 0 C--N 1.36 1.89 0 CA-C-N 119.491 1.041 . . . . 0.0 114.501 -173.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.687 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 18.0 m -143.06 38.93 1.45 Allowed 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -179.56 -176.18 0.37 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -167.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.625 ' HB1' ' HG ' ' A' ' 65' ' ' LEU . . . 98.06 -30.89 0.02 OUTLIER 'General case' 0 C--N 1.376 1.718 0 C-N-CA 126.574 1.95 . . . . 0.0 115.016 173.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.676 ' HH2' ' HG ' ' A' ' 18' ' ' LEU 0.294 17.5 m-90 -71.32 -30.17 65.89 Favored 'General case' 0 C--O 1.277 2.502 0 CA-C-O 121.794 0.807 . . . . 0.0 111.803 -177.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -66.16 -40.13 90.29 Favored 'General case' 0 C--O 1.266 1.963 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.45 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.563 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 23.3 mt -54.98 -45.83 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.05 175.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.713 ' HE3' HG23 ' A' ' 87' ' ' VAL . 12.5 tmtt? -58.8 -42.88 90.14 Favored 'General case' 0 C--O 1.266 1.954 0 CA-C-O 121.372 0.606 . . . . 0.0 110.242 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.3 -42.96 96.6 Favored 'General case' 0 C--O 1.277 2.529 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.636 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.563 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 14.5 m-85 -55.85 -45.45 78.44 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.722 HD12 ' CZ3' ' A' ' 40' ' ' TRP . 20.1 mt -58.84 -46.82 86.8 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.673 HG22 ' HB3' ' A' ' 84' ' ' CYS . 2.1 t -70.29 -20.44 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.826 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.8 t -90.55 -8.16 50.97 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -88.04 -38.39 15.5 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.317 6.6 t70 -155.02 -104.35 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.727 176.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.401 ' HD2' ' HA ' ' A' ' 83' ' ' ARG . 23.5 tpt180 -143.32 84.35 1.81 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 121.115 1.78 . . . . 0.0 112.406 176.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.673 ' HB3' HG22 ' A' ' 79' ' ' VAL . 6.0 t -86.27 160.74 19.06 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.82 -40.33 0.09 Allowed 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -167.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 1.045 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 45.3 tt0 -126.49 116.67 21.47 Favored 'General case' 0 CA--C 1.47 -2.101 0 C-N-CA 118.187 -1.405 . . . . 0.0 109.719 -172.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.954 HG12 HD22 ' A' ' 89' ' ' LEU . 24.2 t -110.35 98.26 6.82 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.797 -175.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.572 ' C ' HD21 ' A' ' 89' ' ' LEU . 38.6 p -111.08 142.73 42.85 Favored 'General case' 0 C--O 1.261 1.692 0 CA-C-O 121.657 0.742 . . . . 0.0 111.251 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.954 HD22 HG12 ' A' ' 87' ' ' VAL . 2.9 mm? -126.67 154.69 43.73 Favored 'General case' 0 N--CA 1.405 -2.704 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.967 -166.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -80.9 157.99 25.44 Favored 'General case' 0 C--N 1.252 -3.667 0 CA-C-N 112.699 -2.046 . . . . 0.0 109.583 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.7 153.21 5.87 Favored Glycine 0 N--CA 1.412 -2.924 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.506 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 13.9 mm100 -87.49 123.48 32.45 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 120.796 2.298 . . . . 0.0 107.651 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 50.4 ttp 82.81 4.89 0.97 Allowed 'General case' 0 CA--C 1.544 0.734 0 O-C-N 125.034 1.459 . . . . 0.0 109.535 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.68 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -83.51 112.7 41.58 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 174.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -94.48 175.3 1.24 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.071 2.514 . . . . 0.0 112.999 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.67 -30.44 3.26 Favored Glycine 0 C--N 1.312 -0.789 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.278 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? . . . . . 0 N--CA 1.432 -1.358 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.305 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.329 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.12 -47.09 11.01 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.984 2.456 . . . . 0.0 112.032 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.41 51.35 2.72 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 21.2 ptmt -61.51 131.85 92.73 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 116.944 0.372 . . . . 0.0 111.826 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 7.8 Cg_exo -77.33 -152.87 0.04 OUTLIER 'Trans proline' 0 C--O 1.242 0.706 0 C-N-CA 123.722 2.948 . . . . 0.0 111.656 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.651 ' HA ' ' HE3' ' A' ' 72' ' ' TRP . 54.2 mt-10 82.92 8.65 0.7 Allowed 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 126.163 1.785 . . . . 0.0 108.86 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.2 p -63.86 -35.91 82.18 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.806 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.432 ' H ' HG12 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -53.81 -50.58 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.93 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.29 0.6 OUTLIER -88.34 -30.57 19.46 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -171.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -82.53 -17.19 45.88 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.383 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.7 tpp -100.95 -37.23 8.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.843 176.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -111.68 -25.88 9.29 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -164.8 110.24 0.95 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.235 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -77.56 -6.98 55.59 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.393 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 67' ' ' ASP . . . -123.33 61.61 0.57 Allowed Glycine 0 CA--C 1.55 2.234 0 CA-C-O 119.256 -0.747 . . . . 0.0 113.169 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.665 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 27.0 tptp -123.02 112.9 18.34 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 119.571 1.686 . . . . 0.0 111.776 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.8 m -65.81 125.5 25.55 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.814 HD12 ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -124.74 109.03 12.61 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.371 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.609 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 22.3 ptm -96.6 102.98 14.86 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.723 ' HE1' HD11 ' A' ' 18' ' ' LEU . 7.4 ptp -114.75 135.14 54.5 Favored 'General case' 0 C--O 1.272 2.271 0 C-N-CA 116.789 -1.965 . . . . 0.0 112.83 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.563 ' HA ' HG22 ' A' ' 62' ' ' ILE . 3.6 t80 -97.46 118.52 34.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.85 2.46 . . . . 0.0 107.71 -173.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.63 124.42 70.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.825 ' HA ' ' HG3' ' A' ' 60' ' ' ARG . 83.4 m -88.81 121.32 31.05 Favored 'General case' 0 CA--C 1.605 3.06 0 C-N-CA 125.923 1.689 . . . . 0.0 112.275 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.69 HG12 ' HB2' ' A' ' 83' ' ' ARG 0.305 56.4 t -111.01 130.54 64.26 Favored 'Isoleucine or valine' 0 C--N 1.378 1.813 0 C-N-CA 127.668 2.387 . . . . 0.0 104.714 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.5 m -121.92 -5.86 9.03 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-N 122.658 2.481 . . . . 0.0 115.998 -169.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.31 -44.72 21.14 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 121.452 -0.404 . . . . 0.0 112.817 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.542 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 4.7 m-20 -106.07 154.16 39.75 Favored Pre-proline 0 CA--C 1.514 -0.436 0 CA-C-N 117.757 0.779 . . . . 0.0 109.271 172.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -111.12 40.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 123.883 3.056 . . . . 0.0 110.882 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.3 p -131.89 -105.08 0.26 Allowed 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.647 -0.658 . . . . 0.0 112.72 -168.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.718 ' HA ' ' O ' ' A' ' 58' ' ' SER . 30.0 tt0 -167.19 15.74 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.907 2.083 . . . . 0.0 106.669 170.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 9.5 tmtt? -86.78 -31.68 20.77 Favored 'General case' 0 C--O 1.259 1.556 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.359 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.949 ' HG3' HD11 ' A' ' 36' ' ' ILE . 7.1 tp10 -73.32 -44.69 58.5 Favored 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 104.303 -2.481 . . . . 0.0 104.303 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.856 ' OG1' ' HA ' ' A' ' 59' ' ' ASP . 59.6 m -44.2 -51.14 8.42 Favored 'General case' 0 C--O 1.179 -2.64 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.391 167.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.7 pt-20 -63.39 -52.33 62.09 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 119.631 1.105 . . . . 0.0 112.42 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -53.6 -60.03 3.83 Favored 'General case' 0 C--O 1.263 1.798 0 CA-C-O 123.315 1.531 . . . . 0.0 107.978 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.949 HD11 ' HG3' ' A' ' 32' ' ' GLU . 1.3 mt -60.43 -45.03 97.37 Favored 'Isoleucine or valine' 0 C--O 1.163 -3.464 0 CA-C-N 112.095 -2.32 . . . . 0.0 112.745 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.749 HG21 HG12 ' A' ' 55' ' ' ILE . 19.2 p -68.76 -34.53 75.73 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-N 121.071 1.76 . . . . 0.0 110.869 -176.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.4 m -63.06 -51.13 67.88 Favored 'General case' 0 N--CA 1.407 -2.588 0 C-N-CA 119.551 -0.859 . . . . 0.0 109.819 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.5 mp -71.71 -43.06 66.59 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.366 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.69 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 43.4 m0 -62.44 -76.58 0.06 Allowed 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 123.757 0.661 . . . . 0.0 111.251 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.645 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.323 0.0 OUTLIER -71.74 -19.66 62.01 Favored 'General case' 0 C--O 1.254 1.337 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.976 -172.386 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.58 -51.82 55.1 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.741 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 32.0 t -72.47 -25.29 61.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.797 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 31.1 mt -62.78 -34.37 77.11 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.81 0.338 . . . . 0.0 110.242 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.556 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 70.8 t80 -91.24 -24.43 19.89 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.926 175.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.741 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 8.1 t30 -67.24 -31.62 72.1 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.698 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.22 5.08 48.79 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.271 0.558 . . . . 0.0 109.583 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.5 t30 46.67 55.39 7.74 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.516 1.927 . . . . 0.0 112.905 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -67.51 1.6 2.25 Favored 'General case' 0 CA--C 1.594 2.661 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t70 56.58 69.48 0.74 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.188 1.395 . . . . 0.0 110.951 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.859 HG21 ' HD2' ' A' ' 53' ' ' ARG . 6.7 m -147.44 176.06 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.629 -172.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.538 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 25.7 tt0 -133.78 126.23 30.19 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.859 ' HD2' HG21 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -134.69 140.78 46.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 108.784 -170.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.669 ' H ' HG12 ' A' ' 62' ' ' ILE . 38.1 m-85 -133.8 153.15 51.93 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 -166.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.749 HG12 HG21 ' A' ' 37' ' ' THR . 76.6 mt -86.42 112.42 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 166.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.8 m -130.12 -26.68 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -171.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.765 ' HA3' ' HB2' ' A' ' 60' ' ' ARG . . . -138.41 174.83 21.79 Favored Glycine 0 CA--C 1.48 -2.127 0 C-N-CA 118.643 -1.741 . . . . 0.0 112.058 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.718 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 5.2 m -39.02 -71.1 0.09 Allowed 'General case' 0 C--N 1.367 1.364 0 O-C-N 125.654 1.444 . . . . 0.0 109.417 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.856 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 21.4 m-20 -126.64 65.55 1.26 Allowed 'General case' 1 N--CA 1.363 -4.775 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 168.72 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.825 ' HG3' ' HA ' ' A' ' 23' ' ' THR . 4.1 mpt_? -134.18 137.0 44.14 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 112.896 -1.956 . . . . 0.0 108.823 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.56 169.59 17.06 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.669 HG12 ' H ' ' A' ' 54' ' ' PHE . 9.8 pt -136.56 157.64 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.065 0 C-N-CA 118.472 -1.291 . . . . 0.0 109.553 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.498 ' HZ ' ' HB2' ' A' ' 75' ' ' LYS 0.28 6.7 p90 -125.81 109.38 12.47 Favored 'General case' 0 N--CA 1.408 -2.55 0 O-C-N 126.394 2.309 . . . . 0.0 107.909 164.159 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.542 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 21.4 ttt -100.04 104.5 16.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.416 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.898 ' HG ' ' HB1' ' A' ' 71' ' ' ALA 0.34 0.0 OUTLIER -99.75 147.15 25.75 Favored 'General case' 0 CA--C 1.462 -2.405 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.041 -178.962 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.367 20.8 ttp180 -105.13 -68.61 0.85 Allowed 'General case' 0 C--N 1.264 -3.147 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -164.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.881 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 37.4 t70 -44.48 -24.51 0.19 Allowed 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.665 ' HA3' ' H ' ' A' ' 16' ' ' LYS . . . 69.78 12.29 67.36 Favored Glycine 0 C--N 1.366 2.196 0 CA-C-N 120.224 1.374 . . . . 0.0 115.996 -175.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.4 t -121.38 32.53 5.87 Favored 'General case' 0 CA--C 1.563 1.463 0 CA-C-N 118.649 1.224 . . . . 0.0 111.905 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.881 ' HE1' ' HB3' ' A' ' 67' ' ' ASP . 45.0 p90 175.13 137.96 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -174.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.898 ' HB1' ' HG ' ' A' ' 65' ' ' LEU . . . 169.27 -33.3 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.881 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.677 ' CZ2' HD12 ' A' ' 89' ' ' LEU 0.622 10.5 m0 -82.5 -11.73 58.28 Favored 'General case' 0 C--O 1.263 1.778 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 -168.359 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.459 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 43.6 tt0 -74.08 -36.82 64.32 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 170.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.464 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 63.9 mt -55.11 -46.29 77.44 Favored 'Isoleucine or valine' 0 C--O 1.278 2.565 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.514 ' HB2' ' HD1' ' A' ' 72' ' ' TRP . 13.9 tmtt? -56.73 -48.97 76.58 Favored 'General case' 0 C--O 1.282 2.793 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.124 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.31 -47.39 83.84 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.211 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 15.8 m-85 -52.59 -53.75 42.37 Favored 'General case' 0 C--N 1.371 1.54 0 O-C-N 123.73 0.644 . . . . 0.0 109.661 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.629 HD21 ' CD2' ' A' ' 40' ' ' TRP . 14.0 mt -60.46 -55.06 38.03 Favored 'General case' 0 C--O 1.302 3.816 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.476 HG21 ' O ' ' A' ' 75' ' ' LYS 0.308 27.4 m -78.29 -5.7 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 C-N-CA 117.986 -1.486 . . . . 0.0 113.217 -174.175 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.7 m -108.47 5.1 24.94 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.726 165.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.431 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 7.9 tp-100 -82.26 -45.1 15.46 Favored 'General case' 0 CA--C 1.456 -2.643 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.391 4.6 p30 -163.72 -94.14 0.02 OUTLIER 'General case' 0 C--O 1.245 0.863 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 175.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.69 ' HB2' HG12 ' A' ' 24' ' ' VAL . 21.2 mmt180 -91.22 129.77 37.17 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.406 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 11.8 p -150.71 152.17 33.51 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.677 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.79 -36.71 0.1 Allowed 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 123.301 0.64 . . . . 0.0 110.316 170.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.714 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 41.2 tt0 -154.29 129.95 10.0 Favored 'General case' 0 C--O 1.207 -1.135 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.647 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.491 HG11 ' CD2' ' A' ' 89' ' ' LEU . 58.6 t -117.4 98.32 6.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 171.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.484 HG21 ' HD3' ' A' ' 97' ' ' LYS . 16.9 p -100.01 136.14 40.38 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 122.708 1.242 . . . . 0.0 111.848 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.814 ' HB3' HD12 ' A' ' 18' ' ' LEU . 6.8 mt -108.08 155.3 20.54 Favored 'General case' 0 N--CA 1.398 -3.053 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.078 -168.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 19' ' ' MET . 1.9 tm-20 -82.15 144.9 30.42 Favored 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.424 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -179.88 170.2 41.33 Favored Glycine 0 C--N 1.276 -2.75 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -81.72 109.26 15.97 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 121.353 2.577 . . . . 0.0 105.999 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 56.6 ttp 53.92 55.69 8.06 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -173.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.479 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 40.4 t80 -58.38 125.63 76.22 Favored Pre-proline 0 C--O 1.248 1.008 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.565 -176.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.98 102.66 1.63 Allowed 'Trans proline' 0 C--O 1.249 1.035 0 C-N-CA 122.733 2.289 . . . . 0.0 111.329 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 166.27 -11.17 0.07 OUTLIER Glycine 0 C--N 1.301 -1.407 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.822 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.484 ' HD3' HG21 ' A' ' 88' ' ' THR . 51.1 tptt . . . . . 0 N--CA 1.428 -1.541 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.622 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.74 -29.19 19.55 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.292 1.995 . . . . 0.0 112.591 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 85.3 -1.74 88.42 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.45 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -114.34 146.67 36.32 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' A' ' 93' ' ' MET . 32.3 Cg_exo -62.08 119.38 6.47 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.022 1.815 . . . . 0.0 110.012 175.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -78.34 10.87 2.72 Favored 'General case' 0 C--O 1.27 2.178 0 C-N-CA 123.151 0.581 . . . . 0.0 111.627 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.3 m 62.07 46.92 6.07 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.459 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.423 ' C ' ' HG ' ' A' ' 9' ' ' LEU . 5.5 tt 46.97 54.1 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.394 2.511 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.776 ' HB3' ' HB3' ' A' ' 16' ' ' LYS 0.317 3.3 pp 57.15 68.56 0.84 Allowed 'General case' 0 C--N 1.379 1.884 0 CA-C-O 122.965 1.364 . . . . 0.0 113.237 178.401 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.523 ' HG3' ' HB2' ' A' ' 13' ' ' LYS 0.293 18.7 ptpt 51.26 61.58 3.16 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.476 -1.693 . . . . 0.0 115.086 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 49.4 ttm 67.53 37.51 3.38 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.584 0.753 . . . . 0.0 110.543 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 m 71.34 36.66 1.3 Allowed 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.427 0.632 . . . . 0.0 110.803 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.523 ' HB2' ' HG3' ' A' ' 10' ' ' LYS . 56.8 mtpt -91.74 -98.44 0.12 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.04 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -155.42 -172.28 4.1 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 118.053 0.388 . . . . 0.0 110.429 -175.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.32 -51.53 1.4 Allowed Glycine 0 C--N 1.356 1.644 0 N-CA-C 115.24 0.856 . . . . 0.0 115.24 172.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.776 ' HB3' ' HB3' ' A' ' 9' ' ' LEU . 49.6 tptt -83.78 135.93 34.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 118.215 1.007 . . . . 0.0 111.54 -176.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.597 HG21 ' HD2' ' A' ' 66' ' ' ARG . 30.3 m -69.73 115.16 8.65 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 1.072 HD13 ' HB3' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -110.96 102.9 11.34 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.853 1.311 . . . . 0.0 108.365 -176.433 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.743 ' H ' ' HB2' ' A' ' 90' ' ' GLU . 6.2 ttt -84.84 119.62 25.53 Favored 'General case' 0 C--N 1.27 -2.859 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.737 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.777 ' HE3' HD23 ' A' ' 89' ' ' LEU . 26.0 ttm -110.46 110.04 20.64 Favored 'General case' 0 N--CA 1.415 -2.215 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.077 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -91.77 115.93 28.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -128.72 130.69 68.82 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -169.806 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 1.114 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 18.3 m -84.9 143.63 28.89 Favored 'General case' 0 CA--C 1.604 3.034 0 O-C-N 124.77 1.294 . . . . 0.0 110.946 174.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.405 HG22 HD11 ' A' ' 36' ' ' ILE 0.288 6.9 t -126.74 135.48 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.66 0 C-N-CA 130.069 3.348 . . . . 0.0 104.326 -176.287 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -117.13 -21.26 8.92 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-N 122.921 2.601 . . . . 0.0 117.062 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.05 -45.19 62.66 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.021 0.828 . . . . 0.0 114.217 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.86 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.5 t-20 -116.18 116.82 39.56 Favored Pre-proline 0 N--CA 1.433 -1.313 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -88.36 30.84 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.901 2.401 . . . . 0.0 113.147 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 p -139.1 -174.84 3.96 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.53 ' O ' ' HB ' ' A' ' 33' ' ' THR . 32.7 tt0 -77.27 0.37 22.31 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.573 0.624 . . . . 0.0 111.727 -173.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.408 ' C ' ' HD3' ' A' ' 31' ' ' LYS . 6.7 tmtt? -68.26 -43.35 78.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 122.049 -0.407 . . . . 0.0 110.601 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.86 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.7 OUTLIER -71.29 -39.32 71.58 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 118.086 -1.445 . . . . 0.0 108.314 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 61.1 m -45.04 -54.21 6.91 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 124.407 1.083 . . . . 0.0 111.482 172.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.63 -43.02 70.1 Favored 'General case' 0 C--O 1.265 1.882 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -52.72 -55.32 23.55 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.675 HG23 ' CE3' ' A' ' 40' ' ' TRP . 27.3 mt -62.59 -35.68 71.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.549 0 CA-C-N 112.574 -2.103 . . . . 0.0 112.932 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.2 m -61.77 -55.18 32.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.399 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.506 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 34.2 m -65.54 -48.51 72.19 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.592 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.0 -57.22 8.27 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.112 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.675 ' CE3' HG23 ' A' ' 36' ' ' ILE . 36.4 m0 -69.22 -74.03 0.14 Allowed 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.248 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.765 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.405 0.0 OUTLIER -72.05 -15.74 62.03 Favored 'General case' 0 C--O 1.253 1.28 0 C-N-CA 116.957 -1.897 . . . . 0.0 112.773 -168.01 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 38' ' ' SER . . . -67.23 -51.3 39.15 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 171.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.448 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 39.9 t -70.32 -27.47 64.39 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.775 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 16.2 mt -64.2 -28.71 69.93 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.038 0.447 . . . . 0.0 110.075 177.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.543 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 75.9 t80 -94.31 -28.44 15.57 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.108 0.48 . . . . 0.0 110.43 174.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.448 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 20.8 t-20 -72.79 -29.73 63.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -176.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.96 11.94 19.01 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.5 44.62 9.95 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.751 1.62 . . . . 0.0 114.158 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -82.3 151.41 26.76 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.92 87.62 7.36 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.726 1.603 . . . . 0.0 110.503 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.845 HG12 ' HA ' ' A' ' 65' ' ' LEU . 3.1 m -147.89 175.53 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.955 -173.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.519 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 26.8 tt0 -140.02 123.29 16.92 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.775 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -136.07 135.89 39.74 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -170.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.761 ' H ' HG12 ' A' ' 62' ' ' ILE . 16.7 m-85 -134.46 153.99 51.63 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -165.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.502 HG22 HD13 ' A' ' 55' ' ' ILE . 80.2 mt -80.03 124.75 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 165.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.98 -15.46 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 120.83 0.348 . . . . 0.0 110.739 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.506 ' HA3' ' HG2' ' A' ' 60' ' ' ARG . . . -166.32 163.64 37.03 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 118.051 -2.023 . . . . 0.0 113.905 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 37.3 m -77.91 45.85 0.54 Allowed 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 124.668 1.187 . . . . 0.0 111.579 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.497 ' HB3' ' O ' ' A' ' 58' ' ' SER . 3.1 p-10 158.63 14.92 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.745 0 C-N-CA 126.904 2.082 . . . . 0.0 106.496 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.506 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -149.02 147.76 28.93 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-O 121.669 0.747 . . . . 0.0 112.344 177.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.45 169.88 16.84 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 125.736 1.614 . . . . 0.0 106.874 -172.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.761 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.7 pt -136.19 157.82 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.778 0 C-N-CA 118.377 -1.329 . . . . 0.0 109.559 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.562 ' CE2' ' HB1' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -134.33 109.23 8.67 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 126.434 2.334 . . . . 0.0 106.362 162.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.573 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 23.3 ttt -97.83 108.96 21.79 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.347 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.986 HD13 ' HB3' ' A' ' 71' ' ' ALA 0.306 2.3 pt? -98.47 147.94 24.23 Favored 'General case' 0 CA--C 1.464 -2.359 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -176.127 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.597 ' HD2' HG21 ' A' ' 17' ' ' THR 0.26 12.6 mmm180 -100.28 -53.41 3.13 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 111.578 -2.555 . . . . 0.0 113.576 -174.017 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -45.47 -27.46 0.72 Allowed 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.95 -31.31 5.37 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 119.663 1.12 . . . . 0.0 111.936 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.261 40.6 t -98.17 -61.61 1.36 Allowed 'General case' 0 CA--C 1.588 2.43 0 N-CA-C 118.29 2.7 . . . . 0.0 118.29 -175.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.406 ' CD1' HD11 ' A' ' 65' ' ' LEU . 0.1 OUTLIER -64.42 34.46 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 -168.62 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.986 ' HB3' HD13 ' A' ' 65' ' ' LEU . . . -103.16 -22.47 13.74 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.768 ' HH2' ' HG ' ' A' ' 18' ' ' LEU 0.504 13.6 m-90 -82.16 -28.93 31.84 Favored 'General case' 0 C--O 1.284 2.921 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -170.259 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.15 -27.57 63.64 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.65 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.8 mt -62.22 -39.97 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.756 ' HA ' HD11 ' A' ' 78' ' ' LEU . 26.2 ttpp -58.54 -43.3 89.21 Favored 'General case' 0 C--O 1.288 3.089 0 CA-C-O 121.445 0.641 . . . . 0.0 110.595 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.41 -45.96 80.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.209 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.65 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 10.0 m-85 -60.38 -39.71 88.22 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.321 -177.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.756 HD11 ' HA ' ' A' ' 75' ' ' LYS 0.275 21.5 mt -52.46 -59.74 4.07 Favored 'General case' 0 CA--C 1.45 -2.877 0 C-N-CA 123.077 0.551 . . . . 0.0 110.205 177.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.688 HG22 ' HB3' ' A' ' 84' ' ' CYS . 1.6 t -77.94 -9.26 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.684 -172.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.2 t -92.83 -12.24 31.62 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.615 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -107.15 -39.11 5.81 Favored 'General case' 0 CA--C 1.473 -1.989 0 C-N-CA 117.799 -1.56 . . . . 0.0 108.637 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -141.43 -169.45 2.87 Favored 'General case' 0 N--CA 1.389 -3.488 0 CA-C-N 113.419 -1.719 . . . . 0.0 107.06 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -108.32 76.92 1.06 Allowed 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 119.905 1.23 . . . . 0.0 110.645 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.688 ' HB3' HG22 ' A' ' 79' ' ' VAL . 3.8 t -70.49 157.53 37.68 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 113.518 -1.673 . . . . 0.0 109.645 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.75 -35.59 0.09 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 1.114 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.4 tt0 -135.51 125.22 25.38 Favored 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.42 -171.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.413 ' HB ' HD21 ' A' ' 89' ' ' LEU . 18.7 m -123.26 113.12 36.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.42 ' C ' HD22 ' A' ' 89' ' ' LEU . 3.4 p -107.31 128.27 54.29 Favored 'General case' 0 CA--C 1.477 -1.831 0 CA-C-O 122.36 1.076 . . . . 0.0 109.841 168.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 1.072 ' HB3' HD13 ' A' ' 18' ' ' LEU . 3.3 mt -109.41 158.6 17.77 Favored 'General case' 0 C--N 1.259 -3.366 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.731 -168.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.743 ' HB2' ' H ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -78.38 146.92 34.34 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 123.733 0.645 . . . . 0.0 109.754 -172.006 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.04 101.99 2.47 Favored Glycine 0 N--CA 1.408 -3.214 0 N-CA-C 107.234 -2.346 . . . . 0.0 107.234 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -59.4 110.88 1.19 Allowed 'General case' 0 C--N 1.378 1.815 0 CA-C-N 121.031 2.416 . . . . 0.0 108.667 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.402 ' O ' ' HA ' ' A' ' 5' ' ' PRO . 55.2 ttm 58.46 69.17 0.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 124.43 1.081 . . . . 0.0 108.664 -170.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.693 ' CE2' HD13 ' A' ' 89' ' ' LEU . 11.7 p90 -71.12 -38.65 7.24 Favored Pre-proline 0 CA--C 1.568 1.663 0 CA-C-N 113.78 -1.554 . . . . 0.0 114.645 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.46 ' HD3' ' CG ' ' A' ' 94' ' ' TYR . 42.9 Cg_endo -102.0 -173.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.118 1.879 . . . . 0.0 111.537 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.38 -4.74 28.21 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.97 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.562 ' C ' ' HE3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.556 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.403 ' HA2' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 CA--C 1.506 -0.493 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.403 ' HD3' ' HA2' ' A' ' 1' ' ' GLY . 27.0 Cg_exo -64.08 -22.64 67.65 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.464 2.776 . . . . 0.0 113.129 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.89 ' HA3' ' HA ' ' A' ' 95' ' ' PRO . . . -126.02 31.12 4.17 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -107.84 154.64 40.89 Favored Pre-proline 0 C--O 1.255 1.351 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -177.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -44.74 146.17 2.43 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.545 2.83 . . . . 0.0 113.254 178.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.493 ' HA ' ' HG ' ' A' ' 9' ' ' LEU . 25.2 mm-40 73.09 -46.42 0.65 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.08 1.352 . . . . 0.0 113.016 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.9 m -69.52 -29.47 67.08 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 121.181 -0.949 . . . . 0.0 109.851 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.633 HG13 ' CZ3' ' A' ' 72' ' ' TRP . 0.6 OUTLIER -71.33 -38.76 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.095 176.532 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.896 HD22 ' HA ' ' A' ' 69' ' ' SER . 3.4 pp -79.48 -11.08 59.91 Favored 'General case' 0 C--O 1.2 -1.532 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.937 178.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -92.95 -23.96 18.56 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.397 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.0 ttt -78.51 -31.18 47.51 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.382 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -98.46 -19.35 17.73 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.018 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 75.72 169.28 0.27 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.885 1.274 . . . . 0.0 111.885 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.597 ' HE2' ' HB2' ' A' ' 69' ' ' SER . 37.9 ttmt -75.84 142.64 42.15 Favored 'General case' 0 CA--C 1.577 1.999 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.543 ' H ' ' HA3' ' A' ' 68' ' ' GLY . . . 134.22 -54.38 0.76 Allowed Glycine 0 CA--C 1.556 2.621 0 C-N-CA 118.185 -1.96 . . . . 0.0 115.697 -175.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -67.07 133.59 50.17 Favored 'General case' 0 C--N 1.364 1.198 0 CA-C-N 120.222 2.011 . . . . 0.0 112.488 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -78.61 124.27 27.99 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.777 ' HB3' HD21 ' A' ' 65' ' ' LEU . 25.6 tp -131.2 115.4 16.3 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.008 -174.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.669 ' HB3' ' SD ' ' A' ' 64' ' ' MET . 20.0 ptm -84.31 105.99 15.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.602 0.715 . . . . 0.0 112.282 176.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.871 ' HG3' ' HA ' ' A' ' 89' ' ' LEU . 3.6 mpp? -86.29 125.22 33.44 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.554 0.692 . . . . 0.0 112.261 176.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.638 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 47.2 t80 -106.06 112.92 26.17 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 127.246 2.218 . . . . 0.0 106.116 -176.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.78 130.36 74.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -168.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.853 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 89.5 m -93.05 131.14 38.32 Favored 'General case' 0 CA--C 1.611 3.295 0 C-N-CA 126.151 1.781 . . . . 0.0 111.883 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.42 HG11 ' HG2' ' A' ' 32' ' ' GLU . 71.6 t -132.14 113.44 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.358 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.129 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -105.77 -18.98 13.89 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 122.01 2.187 . . . . 0.0 115.185 -164.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -39.17 -49.08 2.78 Favored Glycine 0 N--CA 1.487 2.035 0 O-C-N 123.419 0.449 . . . . 0.0 113.612 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 1.117 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 26.9 t-20 -115.86 104.74 52.35 Favored Pre-proline 0 N--CA 1.421 -1.881 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.14 33.74 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 123.888 3.059 . . . . 0.0 112.71 -174.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -148.43 -165.27 2.23 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 33' ' ' THR . 39.6 tt0 -81.05 -18.47 46.57 Favored 'General case' 0 C--O 1.19 -2.039 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -173.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.478 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 3.4 tmtt? -58.96 -41.25 87.03 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-N 119.032 0.833 . . . . 0.0 111.491 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 1.117 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 5.9 tp10 -66.42 -61.49 1.97 Allowed 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 31.5 m -34.35 -50.25 0.41 Allowed 'General case' 0 C--O 1.19 -2.073 0 C-N-CA 127.158 2.183 . . . . 0.0 113.026 172.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 12.8 pt-20 -71.99 -49.66 35.26 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 118.124 0.42 . . . . 0.0 112.031 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -54.24 -54.15 43.89 Favored 'General case' 0 C--O 1.263 1.801 0 CA-C-O 123.045 1.402 . . . . 0.0 107.296 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.998 HD11 ' HG3' ' A' ' 32' ' ' GLU . 1.5 mt -66.83 -38.99 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.584 0 CA-C-N 111.622 -2.536 . . . . 0.0 113.541 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.853 HG22 HG12 ' A' ' 55' ' ' ILE . 11.3 p -73.82 -39.3 64.16 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-N 121.3 1.864 . . . . 0.0 110.946 -176.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.0 t -64.22 -47.83 78.2 Favored 'General case' 0 N--CA 1.412 -2.344 0 O-C-N 124.017 0.823 . . . . 0.0 109.659 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.4 tp -68.75 -44.37 73.9 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.765 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.712 ' CE3' HD12 ' A' ' 78' ' ' LEU . 48.8 m0 -66.2 -74.02 0.12 Allowed 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 118.952 -0.547 . . . . 0.0 111.708 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.63 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.339 0.0 OUTLIER -70.83 -19.29 62.68 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 118.044 -1.462 . . . . 0.0 111.884 -172.601 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.03 -48.91 65.57 Favored Glycine 0 C--N 1.356 1.646 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 172.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.6 p -70.0 -29.63 66.75 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 117.442 0.621 . . . . 0.0 110.25 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.77 HD13 ' HG2' ' A' ' 53' ' ' ARG . 22.8 mt -61.07 -32.49 72.13 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.003 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.633 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 80.5 t80 -92.11 -27.38 17.78 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.873 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -67.89 -30.67 70.08 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 120.629 0.252 . . . . 0.0 111.004 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.69 -0.01 56.24 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.6 t30 47.17 53.87 10.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.136 1.774 . . . . 0.0 112.006 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -65.58 0.69 1.5 Allowed 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.9 t70 59.3 70.87 0.61 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.305 1.042 . . . . 0.0 111.365 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.541 ' CG2' ' HD2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -146.92 175.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.919 -172.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.432 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 26.7 tt0 -131.04 115.92 17.09 Favored 'General case' 0 C--O 1.194 -1.828 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.77 ' HG2' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -130.41 140.77 50.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -172.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.777 ' H ' HG12 ' A' ' 62' ' ' ILE . 24.4 m-85 -134.02 152.06 51.69 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.853 HG12 HG22 ' A' ' 37' ' ' THR . 19.9 mt -92.65 97.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 167.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 m -99.1 -22.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.84 169.03 40.81 Favored Glycine 0 CA--C 1.482 -1.975 0 C-N-CA 118.192 -1.956 . . . . 0.0 113.78 175.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.445 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 36.9 m -65.04 120.4 12.57 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.0 OUTLIER 78.79 14.76 1.19 Allowed 'General case' 0 C--N 1.371 1.541 0 CA-C-O 122.658 1.218 . . . . 0.0 108.823 -178.613 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.638 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 4.1 tpp85 -143.84 117.49 9.23 Favored 'General case' 0 CA--C 1.557 1.236 0 O-C-N 121.419 -0.8 . . . . 0.0 111.266 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.96 166.44 20.06 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -175.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.777 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -138.77 155.23 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.461 -2.464 0 C-N-CA 118.174 -1.41 . . . . 0.0 109.699 172.785 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.528 ' CE2' ' HB1' ' A' ' 71' ' ' ALA . 6.0 p90 -134.97 106.37 6.8 Favored 'General case' 0 N--CA 1.417 -2.093 0 O-C-N 126.335 2.272 . . . . 0.0 107.307 163.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.669 ' SD ' ' HB3' ' A' ' 19' ' ' MET . 20.2 ttt -92.15 110.22 21.6 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.45 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.777 HD21 ' HB3' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -75.12 132.38 41.18 Favored 'General case' 0 C--O 1.254 1.313 0 O-C-N 125.895 1.997 . . . . 0.0 110.952 -175.672 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.318 2.1 tmt_? -108.41 -54.95 2.44 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -41.24 -34.16 0.45 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.543 ' HA3' ' H ' ' A' ' 15' ' ' GLY . . . 109.09 -31.1 7.97 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 117.723 -2.18 . . . . 0.0 115.079 -173.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.896 ' HA ' HD22 ' A' ' 9' ' ' LEU . 56.9 m -158.66 60.17 0.43 Allowed 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -171.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.45 ' OH ' HG11 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -152.81 21.38 0.6 Allowed 'General case' 0 C--O 1.218 -0.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.174 178.602 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.528 ' HB1' ' CE2' ' A' ' 63' ' ' PHE . . . -103.19 -29.27 11.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -168.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.633 ' CZ3' HG13 ' A' ' 8' ' ' ILE 0.512 8.1 m0 -87.18 -9.93 53.95 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 116.317 -2.153 . . . . 0.0 113.828 -171.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.556 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 35.0 tt0 -73.42 -43.12 61.1 Favored 'General case' 0 C--O 1.279 2.653 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 166.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.566 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 61.0 mt -50.77 -47.0 29.36 Favored 'Isoleucine or valine' 0 C--O 1.278 2.578 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.801 173.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.587 ' HG3' HG21 ' A' ' 87' ' ' VAL . 44.8 tttm -56.11 -50.61 70.58 Favored 'General case' 0 C--N 1.375 1.688 0 C-N-CA 125.807 1.643 . . . . 0.0 110.269 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -61.86 -25.64 67.65 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.566 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 23.1 m-85 -73.76 -61.14 1.94 Allowed 'General case' 0 CA--C 1.48 -1.726 0 C-N-CA 118.382 -1.327 . . . . 0.0 108.35 -175.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.712 HD12 ' CE3' ' A' ' 40' ' ' TRP . 1.9 pt? -66.52 -32.71 74.23 Favored 'General case' 0 C--O 1.297 3.583 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.001 -173.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.789 HG13 ' HB2' ' A' ' 84' ' ' CYS . 54.9 t -77.3 -21.55 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.414 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.6 m -103.54 6.76 37.56 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.209 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.605 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . 6.2 tp-100 -77.3 -46.18 23.85 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.455 2.3 p30 -165.26 -94.55 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 171.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? -84.7 136.52 33.69 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 117.935 -1.506 . . . . 0.0 111.899 -174.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.789 ' HB2' HG13 ' A' ' 79' ' ' VAL . 7.9 p -152.66 150.84 29.9 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.403 -170.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.06 -41.15 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.853 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 7.6 tp10 -153.81 137.59 16.17 Favored 'General case' 0 C--O 1.21 -1.013 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.35 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.587 HG21 ' HG3' ' A' ' 75' ' ' LYS . 48.7 t -131.68 94.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.332 0.8 OUTLIER -98.19 126.32 43.61 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-O 123.603 1.668 . . . . 0.0 113.006 176.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.871 ' HA ' ' HG3' ' A' ' 20' ' ' MET . 3.0 mp -75.88 155.34 35.35 Favored 'General case' 1 N--CA 1.374 -4.274 0 CA-C-N 111.223 -2.717 . . . . 0.0 106.16 178.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.738 ' HB3' HD12 ' A' ' 18' ' ' LEU . 11.8 tp10 -81.67 159.8 23.88 Favored 'General case' 0 C--N 1.266 -3.022 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.91 57.05 3.34 Favored Glycine 0 N--CA 1.422 -2.238 0 CA-C-O 118.569 -1.129 . . . . 0.0 112.265 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.499 ' HA ' ' OE1' ' A' ' 92' ' ' GLN . 9.9 mm-40 -52.83 110.15 0.49 Allowed 'General case' 0 C--N 1.368 1.386 0 CA-C-N 118.784 1.292 . . . . 0.0 111.65 176.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 27.7 ttt 165.41 -25.48 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.737 -2.029 . . . . 0.0 106.222 -172.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.534 ' CD1' ' HD3' ' A' ' 95' ' ' PRO 0.295 23.5 p90 -50.57 -39.26 49.61 Favored Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 116.885 2.179 . . . . 0.0 116.885 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.89 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -78.37 -18.09 12.63 Favored 'Trans proline' 0 C--N 1.377 2.04 0 CA-C-N 121.968 1.739 . . . . 0.0 111.301 177.674 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 122.44 -133.48 9.25 Favored Glycine 0 N--CA 1.406 -3.347 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -173.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt . . . . . 0 C--N 1.293 -1.862 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.962 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.882 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -64.09 -23.02 67.42 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.964 2.442 . . . . 0.0 112.276 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.09 35.86 3.23 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 19.5 pttp -71.49 139.37 83.93 Favored Pre-proline 0 C--O 1.238 0.49 0 C-N-CA 123.777 0.831 . . . . 0.0 110.492 177.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.568 ' C ' ' H ' ' A' ' 7' ' ' SER . 5.7 Cg_exo -76.33 -158.64 0.08 OUTLIER 'Trans proline' 0 C--O 1.251 1.165 0 C-N-CA 122.622 2.215 . . . . 0.0 112.935 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 71.72 -39.15 0.44 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.565 1.546 . . . . 0.0 107.259 -160.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.568 ' H ' ' C ' ' A' ' 5' ' ' PRO . 8.8 t -76.58 170.95 15.46 Favored 'General case' 0 N--CA 1.383 -3.78 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 173.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 1.063 HG23 ' HA ' ' A' ' 11' ' ' MET 0.297 8.7 tp 30.47 42.06 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.269 2.126 0 CA-C-O 121.886 0.851 . . . . 0.0 110.716 -157.31 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.829 HD13 ' HA ' ' A' ' 13' ' ' LYS . 1.7 pp 52.02 69.38 0.68 Allowed 'General case' 0 C--N 1.412 3.292 0 CA-C-O 122.925 1.345 . . . . 0.0 111.906 171.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 9' ' ' LEU 0.277 22.6 ptmt 61.9 28.21 17.19 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.611 -2.086 . . . . 0.0 112.098 -175.575 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 1.063 ' HA ' HG23 ' A' ' 8' ' ' ILE . 53.2 ttm 56.32 26.79 10.99 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.441 1.096 . . . . 0.0 110.251 -178.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.414 ' HG1' ' C ' ' A' ' 11' ' ' MET . 24.3 m -161.97 -65.67 0.05 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.949 -1.094 . . . . 0.0 112.088 -172.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.829 ' HA ' HD13 ' A' ' 9' ' ' LEU . 40.6 ttmt 174.94 116.24 0.02 OUTLIER 'General case' 0 C--N 1.352 0.705 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -171.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.681 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 65.8 pttt -166.46 168.63 14.64 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 67' ' ' ASP . . . -67.79 43.94 0.28 Allowed Glycine 0 CA--C 1.546 1.971 0 N-CA-C 116.291 1.277 . . . . 0.0 116.291 -176.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 9' ' ' LEU . 17.0 tppt? -83.47 133.77 34.88 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 118.76 1.28 . . . . 0.0 109.401 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -85.44 130.76 34.51 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.337 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.804 HD11 ' HH2' ' A' ' 72' ' ' TRP . 94.4 mt -130.91 123.84 29.82 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.409 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 22.0 ptm -84.54 107.5 16.81 Favored 'General case' 0 C--N 1.265 -3.079 0 C-N-CA 118.57 -1.252 . . . . 0.0 108.31 170.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.799 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 32.1 ttm -87.91 104.44 16.61 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 118.135 -1.426 . . . . 0.0 110.187 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -91.6 112.41 24.32 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.576 1.95 . . . . 0.0 106.298 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 p -129.04 132.69 67.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -168.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.995 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 70.9 m -80.39 128.38 33.5 Favored 'General case' 0 CA--C 1.595 2.69 0 C-N-CA 125.429 1.492 . . . . 0.0 109.267 173.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.4 p -110.93 138.34 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.606 3.113 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 1.042 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 85.7 p 52.64 -74.94 0.01 OUTLIER 'General case' 0 C--N 1.368 1.401 0 C-N-CA 126.481 1.913 . . . . 0.0 115.936 -169.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.68 -14.38 2.22 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -171.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -96.61 120.46 62.01 Favored Pre-proline 0 N--CA 1.42 -1.969 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.579 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 74.4 Cg_endo -73.71 41.66 0.64 Allowed 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 123.49 2.793 . . . . 0.0 112.485 -175.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.6 p -110.52 170.39 8.12 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.522 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.1 tp10 -81.47 -15.44 55.03 Favored 'General case' 0 C--O 1.17 -3.099 0 CA-C-N 119.934 1.243 . . . . 0.0 109.793 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.759 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 1.3 tmtt? -48.92 -63.6 1.05 Allowed 'General case' 0 C--O 1.269 2.122 0 C-N-CA 125.19 1.396 . . . . 0.0 114.534 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 1.042 ' HG2' ' HB3' ' A' ' 25' ' ' SER . 4.6 tp10 -67.76 -45.16 75.68 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -172.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 15.5 m -45.2 -58.56 3.17 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 112.071 -2.331 . . . . 0.0 109.689 172.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.759 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 10.8 pt-20 -58.38 -50.86 72.14 Favored 'General case' 0 C--O 1.26 1.61 0 C-N-CA 123.788 0.835 . . . . 0.0 112.751 -172.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.852 ' HG3' HG13 ' A' ' 36' ' ' ILE . 5.9 pt-20 -66.86 -47.67 71.2 Favored 'General case' 0 C--O 1.269 2.082 0 C-N-CA 117.959 -1.496 . . . . 0.0 109.626 -175.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.852 HG13 ' HG3' ' A' ' 35' ' ' GLU . 9.4 mt -76.05 -34.72 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.378 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.145 -172.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.488 ' HA ' ' HB2' ' A' ' 40' ' ' TRP . 44.7 p -68.61 -33.61 74.35 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 118.658 0.663 . . . . 0.0 110.82 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 m -63.16 -45.18 93.08 Favored 'General case' 0 C--O 1.258 1.53 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.57 -38.76 92.34 Favored 'General case' 0 C--N 1.378 1.805 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.761 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 14.1 m0 -65.67 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.248 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.643 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.384 0.0 OUTLIER -70.83 -14.26 62.34 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 117.992 -1.483 . . . . 0.0 112.357 -169.08 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.29 -53.04 38.8 Favored Glycine 0 C--N 1.366 2.243 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.566 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 80.5 p -72.32 -30.28 64.61 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.314 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.799 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 21.5 mt -62.44 -29.5 70.56 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.471 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.604 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 21.3 t80 -92.09 -30.86 15.77 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.566 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 24.7 t-20 -66.47 -34.83 78.81 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.153 0.581 . . . . 0.0 112.03 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.85 -1.29 57.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 56.25 56.41 5.83 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.194 1.398 . . . . 0.0 111.781 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -89.55 155.0 19.56 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.589 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 23.6 t70 -91.45 76.46 5.87 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 120.576 1.535 . . . . 0.0 110.252 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.525 HG22 ' HD2' ' A' ' 53' ' ' ARG . 2.5 m -139.5 167.19 20.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.565 -172.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.521 ' HB3' ' HB3' ' A' ' 64' ' ' MET . 6.3 tt0 -120.9 122.13 39.56 Favored 'General case' 0 C--O 1.189 -2.115 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.799 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.72 128.29 36.59 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -177.18 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.814 ' H ' HG12 ' A' ' 62' ' ' ILE . 52.0 t80 -135.6 146.64 48.13 Favored 'General case' 0 C--N 1.272 -2.762 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.886 -167.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.3 mt -93.0 96.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 171.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.55 -34.64 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.53 -166.86 39.34 Favored Glycine 0 CA--C 1.479 -2.166 0 C-N-CA 118.721 -1.704 . . . . 0.0 113.8 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 49.7 m -69.95 123.63 22.0 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.579 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 5.1 t70 79.4 -1.99 2.19 Favored 'General case' 0 C--O 1.215 -0.752 0 O-C-N 124.542 1.152 . . . . 0.0 109.405 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -126.28 117.56 23.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.408 0.623 . . . . 0.0 111.92 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.83 165.19 25.57 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.814 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -143.74 153.64 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.663 0 C-N-CA 118.231 -1.388 . . . . 0.0 109.639 173.03 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.448 ' HA ' ' HG3' ' A' ' 53' ' ' ARG 0.28 10.0 p90 -131.9 104.19 6.73 Favored 'General case' 0 N--CA 1.402 -2.875 0 O-C-N 126.558 2.411 . . . . 0.0 107.155 161.341 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.521 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . 23.9 ttt -90.28 109.96 21.04 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.809 -176.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.716 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.265 3.9 mp -76.59 145.13 39.15 Favored 'General case' 0 CA--C 1.457 -2.634 0 C-N-CA 126.085 1.754 . . . . 0.0 110.892 -175.642 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.589 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.329 61.6 ttt180 -119.52 -58.42 1.91 Allowed 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 174.141 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.557 ' C ' ' H ' ' A' ' 69' ' ' SER . 10.4 t70 -70.67 8.55 0.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.681 ' HA3' ' O ' ' A' ' 14' ' ' LYS . . . 58.87 -24.78 0.02 OUTLIER Glycine 0 CA--C 1.559 2.837 0 CA-C-N 120.126 1.33 . . . . 0.0 116.244 -169.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.557 ' H ' ' C ' ' A' ' 67' ' ' ASP . 6.3 m -87.05 15.71 5.77 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -169.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -164.23 135.21 4.37 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.718 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.791 ' HA ' HD11 ' A' ' 74' ' ' ILE . . . 156.37 -31.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 127.019 2.128 . . . . 0.0 111.708 172.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.804 ' HH2' HD11 ' A' ' 18' ' ' LEU 0.272 13.7 m-90 -74.53 -30.86 61.94 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-O 121.722 0.772 . . . . 0.0 111.873 -174.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.413 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 36.8 tt0 -68.8 -37.51 79.3 Favored 'General case' 0 C--O 1.265 1.915 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.791 HD11 ' HA ' ' A' ' 71' ' ' ALA . 12.7 mt -61.62 -44.21 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.557 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.516 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.751 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.44 -27.9 64.62 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.822 -178.066 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.74 -48.71 79.46 Favored 'General case' 0 C--O 1.247 0.963 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.954 171.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.52 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 18.9 m-85 -55.64 -45.66 77.58 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.157 0.98 . . . . 0.0 109.923 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.751 ' HG ' ' HA ' ' A' ' 75' ' ' LYS 0.27 4.3 pp -63.96 -47.46 80.34 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.786 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.54 ' N ' HD11 ' A' ' 78' ' ' LEU 0.355 4.4 m -77.04 -1.8 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 116.63 -2.028 . . . . 0.0 112.685 176.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -85.57 -20.03 30.19 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.005 166.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -80.93 -17.53 50.22 Favored 'General case' 0 C--N 1.367 1.357 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 171.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.258 23.2 t70 88.99 -50.61 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 112.489 -2.141 . . . . 0.0 114.527 168.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.735 ' HB3' ' HB3' ' A' ' 25' ' ' SER . 33.3 mmt180 -84.79 76.6 10.21 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.46 ' SG ' ' HB2' ' A' ' 78' ' ' LEU . 61.3 m -154.91 37.62 0.41 Allowed 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 123.073 1.416 . . . . 0.0 110.406 -168.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -32.16 -45.92 0.11 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 131.009 3.723 . . . . 0.0 120.274 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.995 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 30.6 tt0 -146.71 123.58 11.3 Favored 'General case' 0 C--O 1.198 -1.629 0 C-N-CA 117.244 -1.782 . . . . 0.0 113.906 -164.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.595 ' HB ' HD12 ' A' ' 89' ' ' LEU . 16.3 m -113.55 131.69 64.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.441 ' C ' HD11 ' A' ' 89' ' ' LEU 0.265 16.7 p -117.77 120.84 39.16 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 122.917 1.341 . . . . 0.0 110.095 165.099 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.799 ' HG ' ' HG3' ' A' ' 20' ' ' MET . 5.1 mp -103.37 157.19 17.2 Favored 'General case' 0 C--N 1.262 -3.239 0 CA-C-N 112.708 -2.042 . . . . 0.0 106.638 -173.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.641 ' HB3' HD22 ' A' ' 18' ' ' LEU . 7.5 tt0 -78.18 146.55 34.94 Favored 'General case' 0 C--N 1.256 -3.463 0 CA-C-O 121.909 0.861 . . . . 0.0 111.98 -162.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 133.23 163.92 10.65 Favored Glycine 0 N--CA 1.416 -2.693 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -108.05 109.08 20.44 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 120.961 2.381 . . . . 0.0 106.717 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.19 73.04 0.39 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 -170.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.674 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 3.4 p90 -101.7 149.18 36.22 Favored Pre-proline 0 C--N 1.297 -1.705 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.093 -172.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.403 ' HD2' ' OG ' ' A' ' 7' ' ' SER . 88.3 Cg_endo -84.7 151.79 11.51 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.191 1.927 . . . . 0.0 110.271 172.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.09 93.91 0.11 Allowed Glycine 0 C--N 1.297 -1.623 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 124.384 1.074 . . . . 0.0 110.88 -174.794 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.452 ' N ' ' HB2' ' A' ' 6' ' ' GLU . . . . . . . . 0 CA--C 1.493 -1.312 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.64 -13.45 37.2 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.574 2.183 . . . . 0.0 113.676 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.3 -35.35 0.58 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.233 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -100.16 140.12 21.24 Favored Pre-proline 0 C--O 1.246 0.903 0 O-C-N 122.461 -0.435 . . . . 0.0 110.991 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.591 ' HB3' ' HB2' ' A' ' 97' ' ' LYS . 35.1 Cg_exo -62.89 130.66 30.02 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.887 2.391 . . . . 0.0 109.428 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HB2' ' N ' ' A' ' 1' ' ' GLY . 25.7 tt0 -107.99 11.13 28.1 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.302 -173.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.3 m 61.81 53.37 3.17 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.282 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.431 ' O ' HD13 ' A' ' 9' ' ' LEU . 5.8 tp 51.43 56.33 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.397 2.672 0 C-N-CA 124.076 0.95 . . . . 0.0 109.164 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 8' ' ' ILE 0.362 2.0 pp 51.63 65.31 1.53 Allowed 'General case' 0 C--N 1.391 2.41 0 CA-C-O 123.156 1.455 . . . . 0.0 114.125 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . 0.287 60.8 pttt 49.19 68.09 0.77 Allowed 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 112.615 -2.084 . . . . 0.0 114.297 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 84.0 mtp 65.8 30.59 10.01 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.466 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.557 HG22 ' HE3' ' A' ' 72' ' ' TRP . 12.1 m 77.2 38.03 0.24 Allowed 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.706 0.802 . . . . 0.0 112.645 172.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -153.52 98.28 2.22 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.899 -0.501 . . . . 0.0 110.656 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.404 ' CB ' ' HB2' ' A' ' 9' ' ' LEU . 78.2 tttt -148.71 16.37 0.99 Allowed 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.397 0.618 . . . . 0.0 110.975 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 53.66 51.6 47.51 Favored Glycine 0 CA--C 1.563 3.042 0 N-CA-C 118.006 1.962 . . . . 0.0 118.006 175.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 20.3 tptm -128.55 133.31 48.35 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 120.443 2.122 . . . . 0.0 109.348 175.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.8 t -72.0 133.61 45.42 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.131 0.491 . . . . 0.0 109.854 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 1.042 HD22 ' HA ' ' A' ' 89' ' ' LEU . 13.3 tp -134.04 133.93 41.8 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.178 -177.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 86.7 mtp -83.56 100.27 10.69 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 104.47 -2.418 . . . . 0.0 104.47 164.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.507 ' HB2' HD23 ' A' ' 18' ' ' LEU . 53.7 ttp -86.45 119.97 27.29 Favored 'General case' 0 CA--C 1.475 -1.911 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.804 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.584 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 49.8 t80 -97.96 124.6 42.49 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.868 -1.969 . . . . 0.0 106.896 -174.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -129.37 125.9 62.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -173.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.997 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 86.8 m -77.05 120.61 22.39 Favored 'General case' 0 CA--C 1.587 2.4 0 C-N-CA 125.409 1.483 . . . . 0.0 110.891 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.596 HG22 HD11 ' A' ' 36' ' ' ILE . 10.3 p -114.48 125.09 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 170.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.87 13.05 4.01 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 115.73 -2.388 . . . . 0.0 113.54 -163.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.11 -37.91 93.48 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 119.198 -1.477 . . . . 0.0 109.895 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 1.096 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 23.6 t-20 -117.13 106.73 46.77 Favored Pre-proline 0 N--CA 1.423 -1.824 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -72.94 30.32 0.29 Allowed 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 123.569 2.846 . . . . 0.0 113.251 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -143.4 -171.16 3.44 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.409 ' O ' ' HB ' ' A' ' 33' ' ' THR . 33.2 tt0 -82.29 -7.05 59.62 Favored 'General case' 0 C--O 1.206 -1.199 0 CA-C-N 118.802 0.728 . . . . 0.0 112.537 -171.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.506 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 2.4 tmpt? -60.91 -45.59 94.02 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 118.235 0.47 . . . . 0.0 110.369 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 1.096 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.5 tp10 -67.59 -49.55 62.57 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.409 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 86.9 m -44.49 -52.13 8.19 Favored 'General case' 0 C--O 1.196 -1.738 0 C-N-CA 124.989 1.316 . . . . 0.0 112.409 172.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.3 pt-20 -67.84 -51.51 47.62 Favored 'General case' 0 C--O 1.253 1.273 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -59.02 -47.06 86.58 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.929 1.347 . . . . 0.0 108.071 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.822 HD12 ' HG3' ' A' ' 32' ' ' GLU . 10.1 mt -69.85 -40.61 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.58 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.804 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.871 HG23 HG12 ' A' ' 55' ' ' ILE . 12.9 p -69.61 -37.69 76.95 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 120.54 1.518 . . . . 0.0 111.047 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 p -64.75 -57.86 7.81 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 123.864 0.727 . . . . 0.0 109.668 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.1 tp -66.11 -43.21 87.88 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.731 ' CD2' HG21 ' A' ' 36' ' ' ILE . 44.0 m0 -69.59 -69.12 0.36 Allowed 'General case' 0 C--O 1.197 -1.706 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.901 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.843 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.421 0.0 OUTLIER -68.97 -20.05 64.17 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 117.554 -1.659 . . . . 0.0 112.669 -171.827 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.46 -50.42 59.51 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 170.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.441 ' HA ' ' HB2' ' A' ' 46' ' ' ASN . 65.3 p -69.64 -25.39 63.91 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.082 -0.658 . . . . 0.0 110.644 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.843 ' HG ' ' HA ' ' A' ' 41' ' ' GLN . 20.1 mt -62.07 -31.15 71.54 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 174.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -77.45 -44.13 30.06 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.383 0.611 . . . . 0.0 110.479 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.441 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 84.8 m-20 -63.61 -30.59 71.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -172.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.18 2.52 54.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.15 0.5 . . . . 0.0 110.33 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 55.05 62.32 2.56 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.336 1.455 . . . . 0.0 111.826 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -98.54 152.12 19.91 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 120.664 -1.272 . . . . 0.0 108.211 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -87.26 82.56 7.58 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 120.343 1.429 . . . . 0.0 110.288 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.967 HG11 ' HA ' ' A' ' 65' ' ' LEU . 2.1 m -147.75 165.63 5.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.607 -174.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.499 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 1.9 mp0 -131.25 124.4 30.46 Favored 'General case' 0 C--O 1.194 -1.859 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 171.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.839 ' HG3' ' HA ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -124.56 138.99 54.28 Favored 'General case' 0 C--N 1.287 -2.133 0 O-C-N 121.47 -0.769 . . . . 0.0 109.259 -172.488 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.819 ' H ' HG12 ' A' ' 62' ' ' ILE . 21.0 t80 -134.93 151.4 50.83 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.781 -1.167 . . . . 0.0 113.294 -167.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.871 HG12 HG23 ' A' ' 37' ' ' THR . 48.9 mt -83.66 123.32 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.429 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 39.2 t -101.74 -38.85 6.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.94 -163.32 30.44 Favored Glycine 0 CA--C 1.481 -2.043 0 C-N-CA 119.329 -1.415 . . . . 0.0 113.12 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 m -52.96 119.1 4.25 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.943 0.897 . . . . 0.0 109.534 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.418 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER 73.59 13.9 4.35 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 121.896 0.855 . . . . 0.0 111.729 175.1 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.584 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -146.55 125.86 13.09 Favored 'General case' 0 CA--C 1.572 1.803 0 O-C-N 120.763 -1.211 . . . . 0.0 112.016 -177.719 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.98 163.5 32.81 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.819 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -137.55 156.24 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.178 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.652 173.72 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.875 ' HE2' HG22 ' A' ' 74' ' ' ILE . 1.1 m-30 -125.96 101.04 6.63 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 126.674 2.483 . . . . 0.0 104.926 167.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 26.5 ttt -83.97 100.34 10.98 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 117.816 -1.554 . . . . 0.0 108.305 176.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 1.046 HD13 ' HB3' ' A' ' 71' ' ' ALA . 2.6 pt? -97.28 148.3 23.26 Favored 'General case' 0 CA--C 1.45 -2.895 0 CA-C-O 122.484 1.135 . . . . 0.0 112.714 -175.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.358 16.0 ttp180 -109.06 -54.86 2.48 Favored 'General case' 1 C--N 1.24 -4.165 0 CA-C-N 113.066 -1.879 . . . . 0.0 115.6 -173.402 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.11 -8.67 0.5 Allowed 'General case' 0 CA--C 1.594 2.67 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 174.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.44 -31.09 2.98 Favored Glycine 0 C--N 1.359 1.835 0 O-C-N 120.049 -1.657 . . . . 0.0 113.533 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 12' ' ' THR . 36.4 p -81.4 -69.49 0.61 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -174.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.675 ' HE1' ' HB2' ' A' ' 65' ' ' LEU 0.297 0.2 OUTLIER -46.36 -28.98 1.49 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 120.687 3.588 . . . . 0.0 120.687 -162.632 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 1.046 ' HB3' HD13 ' A' ' 65' ' ' LEU . . . -64.14 -35.76 81.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 116.555 2.058 . . . . 0.0 116.555 -166.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.697 ' HH2' HD21 ' A' ' 18' ' ' LEU 0.323 27.2 m-90 -83.36 -19.72 35.6 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.417 -1.313 . . . . 0.0 113.481 -173.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -74.55 -35.14 63.09 Favored 'General case' 0 C--O 1.28 2.693 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 170.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.875 HG22 ' HE2' ' A' ' 63' ' ' PHE . 22.6 mt -65.0 -35.1 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.823 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.873 ' HG3' HG12 ' A' ' 87' ' ' VAL . 12.5 tmtt? -67.58 -33.18 74.49 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.761 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -58.46 -47.34 84.32 Favored 'General case' 0 C--O 1.263 1.769 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.113 170.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.561 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 5.7 m-30 -52.0 -47.06 65.12 Favored 'General case' 0 N--CA 1.513 2.709 0 CA-C-O 122.152 0.977 . . . . 0.0 109.64 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.675 ' HG ' ' HA ' ' A' ' 75' ' ' LYS . 30.9 mt -53.62 -63.6 1.1 Allowed 'General case' 0 CA--C 1.471 -2.093 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.423 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.6 m -69.04 -11.0 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 C-N-CA 119.553 -0.859 . . . . 0.0 112.537 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.7 m -94.44 -10.49 32.26 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.967 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.443 ' NE2' ' HB3' ' A' ' 77' ' ' PHE . 45.5 mt-30 -124.81 -28.68 3.48 Favored 'General case' 0 C--N 1.38 1.908 0 C-N-CA 116.137 -2.225 . . . . 0.0 112.112 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.622 ' HB2' ' HZ2' ' A' ' 40' ' ' TRP . 11.8 m-20 -133.17 167.56 20.13 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.19 63.07 6.99 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.176 1.353 . . . . 0.0 112.838 -174.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 40.5 t -82.43 176.71 9.21 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.683 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -167.73 -39.42 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -169.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.997 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 32.1 tt0 -147.55 121.85 9.61 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.612 -167.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.873 HG12 ' HG3' ' A' ' 75' ' ' LYS . 28.4 m -118.96 129.34 75.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.242 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.471 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 7.8 p -115.99 120.27 38.6 Favored 'General case' 0 C--O 1.281 2.714 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 1.042 ' HA ' HD22 ' A' ' 18' ' ' LEU 0.302 7.1 tp -79.39 91.68 5.11 Favored 'General case' 0 CA--C 1.577 1.994 0 CA-C-N 112.341 -2.209 . . . . 0.0 107.815 171.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.695 ' N ' HD11 ' A' ' 18' ' ' LEU . 2.4 tm-20 -80.65 123.96 28.6 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 126.953 2.101 . . . . 0.0 113.434 -166.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.72 -20.69 33.84 Favored Glycine 0 C--N 1.314 -0.648 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.519 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -95.81 111.66 23.58 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 176.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.1 tpt -69.85 101.77 1.81 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.77 0.795 . . . . 0.0 110.464 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.471 ' OH ' ' HA ' ' A' ' 88' ' ' THR . 28.7 p90 -117.64 119.8 33.74 Favored Pre-proline 0 N--CA 1.389 -3.518 0 CA-C-N 114.375 -1.284 . . . . 0.0 107.951 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -97.39 94.76 0.07 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.277 0 C-N-CA 122.386 2.057 . . . . 0.0 112.583 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.53 -82.04 1.66 Allowed Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 120.499 -0.857 . . . . 0.0 113.014 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 5' ' ' PRO . 12.3 mptt . . . . . 0 C--N 1.306 -1.323 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.46 -175.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.415 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -88.41 -8.72 5.3 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.262 1.975 . . . . 0.0 111.822 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.37 -36.79 2.21 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.795 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 21.3 ptmt -98.39 132.99 23.24 Favored Pre-proline 0 C--N 1.312 -1.035 0 O-C-N 122.098 -0.648 . . . . 0.0 110.799 -178.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 3.0 Cg_exo -81.07 122.45 4.25 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.495 2.13 . . . . 0.0 109.878 176.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -106.92 14.87 26.04 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.736 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 m 63.2 38.93 10.17 Favored 'General case' 0 C--N 1.347 0.463 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.869 HG23 ' HA ' ' A' ' 11' ' ' MET 0.277 11.3 tt 51.51 52.16 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.282 2.784 0 CA-C-O 122.572 1.177 . . . . 0.0 109.761 -172.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 8' ' ' ILE 0.314 1.9 pp 52.57 61.4 3.21 Favored 'General case' 0 C--N 1.4 2.79 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.821 177.131 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.579 ' HG2' ' HG2' ' A' ' 13' ' ' LYS . 14.8 ptmm? 54.28 35.01 21.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.109 -1.86 . . . . 0.0 111.693 -175.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.869 ' HA ' HG23 ' A' ' 8' ' ' ILE . 45.4 ttm 65.89 14.3 9.5 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.973 1.709 . . . . 0.0 110.743 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.9 m -170.02 -53.98 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.522 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 -163.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.773 ' HG3' ' H ' ' A' ' 14' ' ' LYS 0.334 20.4 ptmt -39.67 -95.71 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 119.76 3.245 . . . . 0.0 119.76 -160.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.773 ' H ' ' HG3' ' A' ' 13' ' ' LYS . 86.4 tttt -168.16 147.86 4.72 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -167.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.92 -79.81 0.11 Allowed Glycine 0 CA--C 1.552 2.351 0 C-N-CA 117.754 -2.165 . . . . 0.0 116.169 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.687 ' HD2' ' HB2' ' A' ' 92' ' ' GLN . 33.1 ttpt -115.33 135.07 54.53 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 120.227 2.013 . . . . 0.0 113.924 -169.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.53 HG23 ' HA ' ' A' ' 66' ' ' ARG . 90.7 m -70.28 117.0 11.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 173.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.99 HD22 ' HA ' ' A' ' 89' ' ' LEU . 9.9 tp -133.59 140.39 47.11 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.903 -168.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.499 ' HG2' ' SD ' ' A' ' 64' ' ' MET . 81.3 mtp -83.01 100.63 10.58 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 162.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.638 ' HB3' HD23 ' A' ' 18' ' ' LEU . 2.1 ppp? -87.08 137.42 32.36 Favored 'General case' 0 C--O 1.259 1.605 0 C-N-CA 115.915 -2.314 . . . . 0.0 108.588 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -107.14 126.53 52.5 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.064 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.443 HG13 ' HB1' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -116.21 124.85 72.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.886 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 1.021 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 17.6 m -98.6 135.04 40.69 Favored 'General case' 0 CA--C 1.582 2.205 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 36' ' ' ILE . 12.6 p -132.17 119.88 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.609 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 t -124.32 -1.98 8.09 Favored 'General case' 0 C--O 1.239 0.52 0 O-C-N 119.327 -2.108 . . . . 0.0 112.84 -165.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.91 -32.08 78.48 Favored Glycine 0 CA--C 1.506 -0.505 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.629 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.727 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 24.9 t-20 -117.14 106.74 46.76 Favored Pre-proline 0 N--CA 1.4 -2.939 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -85.75 32.02 0.47 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.7 p -135.53 -160.51 1.06 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.417 ' O ' ' HB ' ' A' ' 33' ' ' THR . 3.7 tp10 -84.44 -7.22 59.36 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -177.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 2.2 tmpt? -65.5 -49.8 67.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -172.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.755 ' HG2' ' HB2' ' A' ' 83' ' ' ARG . 16.4 tp10 -72.74 -35.5 67.53 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 117.663 -1.615 . . . . 0.0 108.129 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.55 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 84.3 m -49.61 -52.92 27.08 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.07 172.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.9 pt-20 -70.01 -37.86 75.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -62.42 -55.11 30.94 Favored 'General case' 0 C--O 1.209 -1.053 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.763 HG23 ' CE3' ' A' ' 40' ' ' TRP . 95.9 mt -58.13 -49.92 79.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.062 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.902 HG22 HG12 ' A' ' 55' ' ' ILE . 36.0 p -65.04 -56.81 10.87 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.522 -176.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 m -65.22 -48.43 73.35 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.452 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.2 mt -75.09 -52.93 9.82 Favored 'General case' 0 C--O 1.252 1.19 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.763 ' CE3' HG23 ' A' ' 36' ' ' ILE . 6.5 m0 -72.5 -60.69 2.11 Favored 'General case' 0 C--O 1.157 -3.767 0 CA-C-O 117.198 -1.382 . . . . 0.0 109.062 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.884 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.44 0.0 OUTLIER -64.4 -24.68 67.72 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-N 121.066 1.757 . . . . 0.0 112.893 -173.706 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.67 -47.48 90.17 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.845 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 54.5 p -77.62 -19.96 54.66 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 122.306 -0.526 . . . . 0.0 111.861 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.884 ' HG ' ' HA ' ' A' ' 41' ' ' GLN . 23.9 mt -65.05 -34.02 77.43 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.427 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 90.1 t80 -85.69 -33.61 21.49 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.854 173.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.845 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 15.2 t-20 -61.0 -39.21 88.83 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.44 6.48 33.73 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 122.0 -0.437 . . . . 0.0 110.585 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 58.9 41.24 21.57 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.914 0.886 . . . . 0.0 112.226 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.414 ' O ' HG11 ' A' ' 51' ' ' VAL . 18.3 m-85 -73.57 10.89 0.93 Allowed 'General case' 0 CA--C 1.582 2.178 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 45.32 70.34 0.36 Allowed 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 125.61 1.564 . . . . 0.0 112.253 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.912 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.2 m -147.13 176.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.289 -169.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.489 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 20.8 mt-30 -134.33 120.26 19.67 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.72 ' HD3' ' N ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -126.23 141.42 51.93 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -171.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.63 ' N ' HG12 ' A' ' 62' ' ' ILE . 39.8 m-85 -133.29 151.96 51.91 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -165.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.902 HG12 HG22 ' A' ' 37' ' ' THR . 19.5 mt -88.33 114.12 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 167.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.979 HG22 ' HB3' ' A' ' 60' ' ' ARG . 8.9 m -113.81 -21.6 5.35 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.726 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.347 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.21 171.16 36.14 Favored Glycine 0 C--O 1.209 -1.422 0 C-N-CA 117.666 -2.207 . . . . 0.0 114.759 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.55 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 42.3 m -66.38 118.5 10.13 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.529 ' O ' ' HD2' ' A' ' 60' ' ' ARG . 0.3 OUTLIER 85.04 5.08 0.55 Allowed 'General case' 0 C--N 1.37 1.463 0 O-C-N 124.203 0.94 . . . . 0.0 110.229 -173.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.979 ' HB3' HG22 ' A' ' 56' ' ' VAL . 2.8 mpt_? -135.18 132.5 38.04 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.443 ' HB1' HG13 ' A' ' 22' ' ' VAL . . . -143.09 166.12 25.53 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.83 1.252 . . . . 0.0 108.178 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.63 HG12 ' N ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER -145.66 157.98 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.855 168.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.637 ' CE2' ' HB ' ' A' ' 74' ' ' ILE 0.385 11.8 p90 -134.08 104.01 6.04 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 125.575 1.797 . . . . 0.0 110.45 162.594 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.499 ' SD ' ' HG2' ' A' ' 19' ' ' MET . 24.1 ttt -84.59 110.86 19.03 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.015 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 1.064 HD12 ' HB3' ' A' ' 71' ' ' ALA . 2.1 pt? -102.11 148.09 25.82 Favored 'General case' 0 CA--C 1.486 -1.517 0 O-C-N 124.309 1.006 . . . . 0.0 113.013 -173.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.53 ' HA ' HG23 ' A' ' 17' ' ' THR 0.266 31.3 tpt180 -113.53 -62.18 1.63 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.271 -1.786 . . . . 0.0 115.44 -172.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -47.1 -17.65 0.06 Allowed 'General case' 0 CA--C 1.59 2.502 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.07 -16.18 17.69 Favored Glycine 0 C--N 1.358 1.78 0 O-C-N 120.727 -1.233 . . . . 0.0 114.498 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.465 ' OG ' ' HG3' ' A' ' 14' ' ' LYS . 1.2 m -118.97 33.37 5.68 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -167.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.671 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -156.86 2.58 0.13 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 117.913 2.561 . . . . 0.0 117.913 -174.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 1.064 ' HB3' HD12 ' A' ' 65' ' ' LEU . . . -79.1 -28.22 42.98 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 120.124 1.329 . . . . 0.0 113.6 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.668 ' HH2' HD21 ' A' ' 18' ' ' LEU 0.475 28.0 m-90 -88.21 -12.44 43.81 Favored 'General case' 0 N--CA 1.41 -2.468 0 C-N-CA 117.31 -1.756 . . . . 0.0 113.992 -173.336 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.501 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 1.6 mp0 -75.35 -29.1 59.83 Favored 'General case' 0 C--O 1.274 2.388 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.658 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 85.6 mt -68.61 -32.85 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.062 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 174.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.801 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -59.01 -43.87 91.61 Favored 'General case' 0 C--O 1.285 2.943 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.501 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 22.9 t70 -50.28 -50.03 51.61 Favored 'General case' 0 C--O 1.26 1.607 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.19 172.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.658 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 53.6 m-85 -55.96 -43.61 77.7 Favored 'General case' 0 C--O 1.186 -2.279 0 C-N-CA 118.752 -1.179 . . . . 0.0 112.223 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.801 ' HG ' ' HA ' ' A' ' 75' ' ' LYS 0.28 4.9 mt -49.48 -60.38 2.9 Favored 'General case' 0 C--O 1.294 3.422 0 CA-C-O 123.258 1.504 . . . . 0.0 109.899 -178.484 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.687 HG11 ' CB ' ' A' ' 84' ' ' CYS . 24.1 m -75.15 -7.83 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 111.774 -2.466 . . . . 0.0 111.463 -171.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.0 m -104.83 -5.6 21.03 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.174 172.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.577 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 29.0 mm-40 -85.08 -56.47 3.54 Favored 'General case' 0 CA--C 1.47 -2.096 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.361 28.3 t70 -179.57 -84.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.755 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 24.5 mmt-85 -87.38 144.29 26.83 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.315 1.416 . . . . 0.0 109.202 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.687 ' CB ' HG11 ' A' ' 79' ' ' VAL . 8.6 p -159.23 147.83 18.05 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.37 -44.51 0.05 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 1.021 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 40.5 tt0 -140.17 118.77 12.3 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.054 -1.058 . . . . 0.0 110.528 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.2 p -113.09 102.62 14.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.731 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.531 HG23 ' HH ' ' A' ' 94' ' ' TYR . 6.9 p -119.82 124.75 46.88 Favored 'General case' 0 C--O 1.26 1.632 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.99 ' HA ' HD22 ' A' ' 18' ' ' LEU 0.268 5.1 tp -75.74 89.98 2.85 Favored 'General case' 0 CA--C 1.584 2.285 0 CA-C-N 113.624 -1.625 . . . . 0.0 106.87 171.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.495 ' N ' HD13 ' A' ' 18' ' ' LEU . 7.7 tp10 -107.17 151.77 24.97 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -160.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 100.2 -64.01 0.62 Allowed Glycine 0 C--N 1.305 -1.144 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.687 ' HB2' ' HD2' ' A' ' 16' ' ' LYS . 48.9 mt-30 -111.43 109.87 20.04 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 169.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 16.7 mmt -75.65 173.7 10.72 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -169.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.531 ' HH ' HG23 ' A' ' 88' ' ' THR . 18.4 p90 -129.52 122.24 20.69 Favored Pre-proline 0 C--N 1.284 -2.264 0 CA-C-N 113.505 -1.68 . . . . 0.0 107.086 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.49 105.11 1.01 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.376 2.051 . . . . 0.0 110.194 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.42 -96.64 1.76 Allowed Glycine 0 N--CA 1.41 -3.068 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.001 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? . . . . . 0 C--N 1.295 -1.775 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 176.487 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.773 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.536 ' HB2' ' HG3' ' A' ' 4' ' ' LYS . 12.5 Cg_exo -69.5 -39.26 7.23 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.199 1.933 . . . . 0.0 111.4 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.79 14.24 75.97 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.536 ' HG3' ' HB2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -66.96 140.51 96.13 Favored Pre-proline 0 C--N 1.317 -0.815 0 C-N-CA 123.424 0.69 . . . . 0.0 111.81 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -61.41 105.32 0.34 Allowed 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 122.327 2.018 . . . . 0.0 111.569 179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.44 ' HB3' ' HA ' ' A' ' 9' ' ' LEU . 4.6 tp10 -129.23 18.06 5.99 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.2 m 55.87 72.2 0.51 Allowed 'General case' 0 CA--C 1.575 1.917 0 C-N-CA 123.941 0.896 . . . . 0.0 110.326 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 1.003 HG22 ' HA ' ' A' ' 11' ' ' MET 0.279 12.8 tt 50.38 40.67 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.415 3.428 0 CA-C-O 122.99 1.376 . . . . 0.0 109.702 -175.68 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.594 HD11 ' O ' ' A' ' 9' ' ' LEU 0.28 3.5 pp 49.89 73.99 0.23 Allowed 'General case' 0 C--N 1.394 2.541 0 CA-C-N 112.957 -1.929 . . . . 0.0 111.843 175.858 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.67 ' HB3' ' HZ2' ' A' ' 10' ' ' LYS 0.252 0.5 OUTLIER 53.72 33.53 16.97 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.719 -1.582 . . . . 0.0 112.026 -176.51 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 1.003 ' HA ' HG22 ' A' ' 8' ' ' ILE . 25.7 mmt 61.9 14.95 6.74 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 125.114 1.366 . . . . 0.0 112.295 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.443 ' HG1' ' C ' ' A' ' 11' ' ' MET . 93.7 m -175.87 -45.32 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -165.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -136.25 153.2 51.27 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -166.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 14' ' ' LYS 0.965 72.6 mmtt 129.2 -79.59 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 1 N-CA-C 121.895 4.035 . . . . 0.0 121.895 173.793 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.24 81.01 0.05 OUTLIER Glycine 0 CA--C 1.553 2.41 0 C-N-CA 115.98 -3.009 . . . . 0.0 118.248 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.579 ' HD2' ' HB2' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -130.59 143.29 50.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 120.841 2.321 . . . . 0.0 107.614 168.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.7 m -80.79 110.63 16.49 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.649 HD22 ' HZ2' ' A' ' 72' ' ' TRP . 60.2 tp -134.28 118.42 17.52 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.47 -174.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.845 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 26.4 ptt? -83.61 104.83 14.05 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 117.213 -1.795 . . . . 0.0 106.481 165.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.58 ' HG3' ' HE1' ' A' ' 72' ' ' TRP . 14.2 tmm? -87.88 139.73 30.22 Favored 'General case' 0 C--O 1.268 2.053 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.47 -172.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -106.43 126.43 52.24 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 125.056 1.472 . . . . 0.0 110.085 -167.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.82 137.75 56.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.161 -174.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 1.024 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 54.2 m -107.72 131.31 54.57 Favored 'General case' 0 CA--C 1.628 3.95 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.222 170.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.699 HG11 ' HG2' ' A' ' 32' ' ' GLU . 80.5 t -115.36 94.26 3.02 Favored 'Isoleucine or valine' 0 C--N 1.405 2.998 0 C-N-CA 128.471 2.709 . . . . 0.0 106.598 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.73 35.99 4.53 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-N 122.098 2.226 . . . . 0.0 112.923 -174.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.54 ' HA3' ' HB2' ' A' ' 83' ' ' ARG . . . -59.87 -35.53 87.07 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 168.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.738 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -111.36 148.56 39.03 Favored Pre-proline 0 N--CA 1.42 -1.957 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 167.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -92.64 43.18 0.31 Allowed 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 121.642 1.561 . . . . 0.0 110.851 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -130.77 -146.25 0.3 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.5 -173.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.598 ' HG3' ' HA ' ' A' ' 58' ' ' SER . 30.2 tt0 -125.58 17.98 8.11 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 170.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.741 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 8.2 tmtt? -92.98 -37.93 11.94 Favored 'General case' 0 C--O 1.256 1.429 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.738 ' HB3' ' HB2' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -65.8 -44.15 86.54 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 175.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 84.8 m -49.38 -62.4 1.57 Allowed 'General case' 0 C--O 1.187 -2.199 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.211 169.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.741 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 11.7 pt-20 -51.64 -54.87 23.28 Favored 'General case' 0 C--O 1.26 1.641 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -174.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.853 ' HG3' HG13 ' A' ' 36' ' ' ILE . 11.9 pt-20 -65.23 -49.72 68.61 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.727 0.775 . . . . 0.0 109.445 -174.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.853 HG13 ' HG3' ' A' ' 35' ' ' GLU . 56.9 mt -71.55 -43.5 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.027 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.202 -172.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.4 p -66.79 -37.35 84.39 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 118.177 0.444 . . . . 0.0 111.254 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.6 m -67.55 -38.93 84.88 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.994 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 tp -67.55 -35.63 79.43 Favored 'General case' 0 C--N 1.365 1.268 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.65 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 11.9 m0 -68.85 -77.53 0.08 Allowed 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.953 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.635 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.351 0.0 OUTLIER -66.43 -20.89 66.18 Favored 'General case' 0 C--O 1.248 0.987 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.958 -171.571 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.87 -55.29 31.22 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.939 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 47.8 t -70.84 -26.93 63.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 116.708 0.254 . . . . 0.0 111.026 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.78 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 32.8 mt -61.03 -35.51 77.07 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 70.0 t80 -90.99 -27.29 18.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.939 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 21.8 t-20 -65.26 -33.59 76.36 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.485 0.714 . . . . 0.0 111.92 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.19 1.88 55.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.063 0.459 . . . . 0.0 109.855 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 53.91 66.13 1.32 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.521 1.529 . . . . 0.0 112.037 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -99.48 159.93 14.66 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -95.32 86.48 4.54 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 121.014 1.733 . . . . 0.0 109.801 -177.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.864 HG13 ' HA ' ' A' ' 65' ' ' LEU . 1.4 m -146.66 163.46 8.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.969 -174.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.544 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 13.5 mt-30 -128.59 115.83 18.69 Favored 'General case' 0 C--O 1.194 -1.839 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.78 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -121.41 139.33 53.59 Favored 'General case' 0 C--N 1.28 -2.451 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.663 -168.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.648 ' H ' HG12 ' A' ' 62' ' ' ILE . 83.0 m-85 -133.58 151.72 51.76 Favored 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -170.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.7 mt -94.09 96.3 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 167.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.466 HG22 ' HB3' ' A' ' 60' ' ' ARG . 4.3 m -92.02 -24.48 5.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.97 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.03 173.61 40.89 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 117.016 -2.516 . . . . 0.0 114.158 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.598 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 30.8 t -70.32 115.78 9.91 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 24' ' ' VAL 0.268 0.6 OUTLIER 73.18 17.16 4.09 Favored 'General case' 0 C--O 1.207 -1.168 0 C-N-CA 125.8 1.64 . . . . 0.0 109.152 -178.607 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HB3' HG22 ' A' ' 56' ' ' VAL . 9.1 mpt_? -131.88 132.12 43.35 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.075 0.95 . . . . 0.0 112.518 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.45 166.3 24.18 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.491 1.116 . . . . 0.0 109.145 -173.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.741 HD11 ' HB2' ' A' ' 19' ' ' MET . 1.0 OUTLIER -143.77 157.28 16.25 Favored 'Isoleucine or valine' 0 C--O 1.275 2.442 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.808 172.103 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.774 ' HZ ' HD22 ' A' ' 78' ' ' LEU . 2.2 m-30 -125.96 111.47 14.8 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 166.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.845 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 22.1 ttt -84.44 93.68 8.35 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 118.384 -1.326 . . . . 0.0 109.9 173.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.906 ' HG ' ' HB1' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -98.65 146.93 25.34 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 124.805 1.242 . . . . 0.0 114.316 -174.103 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.464 7.6 ppt_? -117.28 -54.48 2.39 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -47.79 -19.71 0.24 Allowed 'General case' 0 CA--C 1.584 2.275 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.4 10.32 7.5 Favored Glycine 0 C--N 1.374 2.654 0 CA-C-N 120.101 1.319 . . . . 0.0 115.252 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.3 m -128.23 40.01 3.74 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 118.359 1.08 . . . . 0.0 111.439 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.614 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -170.59 -7.28 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.864 0 O-C-N 121.769 -0.582 . . . . 0.0 111.487 -172.353 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.906 ' HB1' ' HG ' ' A' ' 65' ' ' LEU . . . -80.21 -42.84 22.53 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -166.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.649 ' HZ2' HD22 ' A' ' 18' ' ' LEU 0.311 9.2 m0 -92.75 -9.97 38.68 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 123.461 1.601 . . . . 0.0 110.44 -170.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.76 -38.65 73.48 Favored 'General case' 0 C--O 1.298 3.64 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 166.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.666 HG21 ' CE2' ' A' ' 63' ' ' PHE . 42.8 mt -59.14 -38.32 73.53 Favored 'Isoleucine or valine' 0 C--N 1.389 2.301 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.831 ' HG3' HG21 ' A' ' 87' ' ' VAL . 12.6 tmtt? -58.0 -43.69 86.79 Favored 'General case' 0 C--O 1.288 3.126 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.582 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.92 -43.34 86.19 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.863 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -62.32 -31.83 72.49 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.416 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.785 ' HG ' ' HA ' ' A' ' 75' ' ' LYS . 55.6 mt -53.14 -58.83 5.67 Favored 'General case' 0 C--O 1.285 2.964 0 CA-C-O 122.87 1.319 . . . . 0.0 110.192 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.632 HG23 ' HB3' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -76.74 -13.4 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.875 -173.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.7 m -91.63 -7.54 49.76 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.756 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.543 ' NE2' HG12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -84.3 -50.98 7.35 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.408 11.9 t70 -152.58 -97.36 0.05 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.518 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.54 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 75.2 mtm180 -140.26 92.16 2.51 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 120.22 1.373 . . . . 0.0 111.626 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.632 ' HB3' HG23 ' A' ' 79' ' ' VAL . 2.3 t -93.88 161.42 14.32 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.611 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.68 -25.47 0.37 Allowed 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -167.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 1.024 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 34.6 tt0 -145.13 125.27 13.69 Favored 'General case' 0 CA--C 1.479 -1.765 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.366 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.831 HG21 ' HG3' ' A' ' 75' ' ' LYS . 14.0 p -128.07 103.9 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.9 0 CA-C-O 122.203 1.002 . . . . 0.0 109.685 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 m -100.89 109.36 21.31 Favored 'General case' 1 C--O 1.312 4.359 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.404 -175.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.936 ' HA ' ' HE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -139.51 146.59 40.15 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.547 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.734 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 52.6 mm-40 -146.68 135.43 22.23 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 127.966 2.507 . . . . 0.0 105.667 171.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.696 ' HA3' ' HA ' ' A' ' 8' ' ' ILE . . . -94.21 -13.08 55.37 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 119.048 -1.549 . . . . 0.0 110.098 175.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -110.45 115.64 30.0 Favored 'General case' 0 N--CA 1.426 -1.636 0 O-C-N 122.679 -0.307 . . . . 0.0 110.322 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 59.5 ttp 57.89 75.47 0.38 Allowed 'General case' 0 C--O 1.244 0.777 0 O-C-N 124.62 1.2 . . . . 0.0 111.339 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.936 ' HE2' ' HA ' ' A' ' 89' ' ' LEU . 2.2 t80 -172.6 102.65 0.34 Allowed Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.458 ' O ' ' HG2' ' A' ' 19' ' ' MET . 2.7 Cg_exo -81.32 -32.85 0.83 Allowed 'Trans proline' 0 CA--C 1.504 -0.986 0 C-N-CA 122.763 2.309 . . . . 0.0 110.929 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.49 -142.93 10.42 Favored Glycine 1 N--CA 1.395 -4.076 0 N-CA-C 106.299 -2.721 . . . . 0.0 106.299 -173.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.8 mttm . . . . . 0 C--N 1.279 -2.474 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.153 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.617 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.81 -47.22 19.23 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.098 2.532 . . . . 0.0 112.878 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 133.06 -37.12 2.05 Favored Glycine 0 C--N 1.314 -0.663 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -114.62 140.65 25.56 Favored Pre-proline 0 N--CA 1.433 -1.292 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 174.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -95.96 38.01 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.399 0 C-N-CA 122.855 2.37 . . . . 0.0 116.073 -172.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.461 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 41.3 mt-10 -112.13 -37.77 4.95 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.798 177.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.3 m -61.56 -30.67 70.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 pt -60.71 -47.67 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 120.902 0.382 . . . . 0.0 110.829 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.267 3.1 pp -85.22 -13.94 48.35 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.461 ' HE3' ' HB3' ' A' ' 6' ' ' GLU . 93.6 mttt -93.79 -20.5 20.03 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.689 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.7 ttm -90.75 -32.27 16.21 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.414 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.751 HG23 ' HB2' ' A' ' 16' ' ' LYS . 3.8 m -94.2 -40.25 10.11 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.655 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 69' ' ' SER 0.307 68.6 mttm 81.55 -88.79 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 176.327 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 67' ' ' ASP . 24.0 ttmm -130.58 -27.98 2.1 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.873 -1.131 . . . . 0.0 112.83 -173.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.09 47.0 3.1 Favored Glycine 0 C--N 1.286 -2.23 0 C-N-CA 119.532 -1.318 . . . . 0.0 115.255 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.751 ' HB2' HG23 ' A' ' 12' ' ' THR . 16.8 tppt? -129.07 120.93 26.79 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 118.686 1.243 . . . . 0.0 109.376 173.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -91.86 124.99 36.39 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.838 ' HB3' HD11 ' A' ' 89' ' ' LEU . 32.1 mt -130.86 118.51 20.86 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.162 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.484 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 24.9 ptm -84.14 111.55 19.44 Favored 'General case' 0 C--N 1.267 -2.982 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.235 171.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.764 ' HG2' HD12 ' A' ' 89' ' ' LEU . 11.3 mtt -84.2 103.19 13.19 Favored 'General case' 0 CA--C 1.46 -2.508 0 C-N-CA 118.499 -1.28 . . . . 0.0 109.38 171.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -89.52 98.07 11.56 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 175.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -104.39 122.9 57.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.309 -170.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.954 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 93.2 m -81.11 134.87 35.73 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 174.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 59' ' ' ASP . 1.6 p -113.43 152.29 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.273 0 CA-C-N 120.721 1.601 . . . . 0.0 107.878 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.642 ' OG ' ' HB2' ' A' ' 85' ' ' ALA . 70.8 m -87.41 160.81 18.19 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 120.815 1.643 . . . . 0.0 107.283 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.797 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 78.39 72.24 1.18 Allowed Glycine 0 N--CA 1.414 -2.774 0 C-N-CA 118.313 -1.899 . . . . 0.0 111.088 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.484 ' OD1' ' HD3' ' A' ' 31' ' ' LYS . 16.7 t-20 -87.87 101.71 2.79 Favored Pre-proline 0 C--O 1.243 0.758 0 CA-C-N 118.262 1.031 . . . . 0.0 109.485 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.797 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 84.1 Cg_endo -118.79 -30.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.486 0 N-CA-C 116.659 1.754 . . . . 0.0 116.659 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.741 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 1.1 p -132.95 -99.47 0.28 Allowed 'General case' 1 N--CA 1.554 4.728 0 C-N-CA 113.73 -3.188 . . . . 0.0 116.339 -164.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . 4.2 tp10 -100.38 7.61 44.16 Favored 'General case' 0 N--CA 1.399 -3.024 1 N-CA-C 97.741 -4.911 . . . . 0.0 97.741 156.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.741 ' HG3' ' H ' ' A' ' 29' ' ' THR 0.435 0.2 OUTLIER 82.0 -175.16 0.04 OUTLIER 'General case' 1 N--CA 1.298 -8.066 1 C-N-CA 132.181 4.192 . . . . 0.0 116.226 170.356 . . . . . . . . 6 4 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.742 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 9.3 tp10 -61.13 -13.9 20.79 Favored 'General case' 2 N--CA 1.363 -4.817 0 CA-C-N 111.776 -2.465 . . . . 0.0 106.965 173.021 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.467 ' H ' ' C ' ' A' ' 31' ' ' LYS . 54.4 m -67.81 -48.57 65.87 Favored 'General case' 0 N--CA 1.411 -2.378 0 C-N-CA 125.021 1.328 . . . . 0.0 108.457 171.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.72 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 3.7 pt-20 -57.7 -48.85 78.38 Favored 'General case' 0 C--O 1.27 2.158 0 CA-C-O 120.78 0.324 . . . . 0.0 110.203 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -56.78 -56.49 20.84 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 123.496 1.617 . . . . 0.0 110.59 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.742 ' HB ' ' O ' ' A' ' 32' ' ' GLU . 13.9 mt -70.54 -30.0 40.8 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.255 0 CA-C-N 112.03 -2.35 . . . . 0.0 112.96 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.742 HG21 HG12 ' A' ' 55' ' ' ILE . 8.1 p -71.82 -44.86 63.19 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 117.948 -1.501 . . . . 0.0 110.055 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.7 p -60.3 -59.67 5.04 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.188 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.3 tp -64.95 -49.72 69.24 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.863 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 37.0 m0 -74.75 -60.84 2.1 Favored 'General case' 0 C--O 1.168 -3.224 0 CA-C-O 117.763 -1.113 . . . . 0.0 110.152 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.682 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.382 0.0 OUTLIER -66.26 -22.31 66.31 Favored 'General case' 0 C--O 1.253 1.248 0 C-N-CA 117.372 -1.731 . . . . 0.0 111.803 -171.721 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.39 -55.83 26.89 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.583 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 37.8 p -67.66 -29.32 68.58 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 116.999 0.399 . . . . 0.0 111.707 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.808 HD11 ' HG2' ' A' ' 53' ' ' ARG . 20.6 mt -60.86 -35.34 76.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.241 0.616 . . . . 0.0 109.871 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.617 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 87.5 t80 -91.32 -27.01 18.66 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.222 175.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.583 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.2 t-20 -66.96 -28.88 68.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.859 0.361 . . . . 0.0 111.253 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.23 -3.49 50.64 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.567 0.699 . . . . 0.0 109.8 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.1 t30 55.88 43.93 26.71 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.267 1.427 . . . . 0.0 112.726 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.482 ' HB3' ' HE2' ' A' ' 70' ' ' TYR . 23.1 m-85 -66.78 5.85 0.57 Allowed 'General case' 0 CA--C 1.597 2.777 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.7 t70 57.2 70.81 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 125.314 1.446 . . . . 0.0 111.713 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.529 ' CG2' ' HD2' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -147.75 171.02 3.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 113.439 -1.71 . . . . 0.0 109.822 -175.168 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.641 ' HG2' ' HB3' ' A' ' 64' ' ' MET . 0.0 OUTLIER -132.54 126.73 33.52 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.67 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.808 ' HG2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -131.9 134.52 45.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -169.718 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.763 ' H ' HG12 ' A' ' 62' ' ' ILE . 80.9 m-85 -134.89 152.62 51.9 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -165.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.742 HG12 HG21 ' A' ' 37' ' ' THR . 39.2 mt -89.62 95.11 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 166.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.03 -31.43 4.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.752 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.2 63.25 0.22 Allowed Glycine 0 N--CA 1.403 -3.503 0 C-N-CA 116.391 -2.814 . . . . 0.0 116.717 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.663 ' HB3' ' HE3' ' A' ' 31' ' ' LYS 0.313 13.8 m 21.04 88.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 125.488 1.346 . . . . 0.0 112.586 162.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.636 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER 110.0 -16.18 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 128.011 2.525 . . . . 0.0 106.766 -173.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -125.57 134.61 51.9 Favored 'General case' 0 CA--C 1.578 2.019 0 C-N-CA 126.163 1.785 . . . . 0.0 109.816 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.484 ' O ' HG12 ' A' ' 22' ' ' VAL . . . -135.9 169.38 17.67 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.119 1.367 . . . . 0.0 108.141 -171.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.763 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER -141.96 155.9 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.054 0 CA-C-N 121.34 1.882 . . . . 0.0 111.634 173.736 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.636 ' CE2' ' HB ' ' A' ' 74' ' ' ILE 0.289 8.2 p90 -132.64 103.9 6.37 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 126.603 2.439 . . . . 0.0 108.254 161.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.641 ' HB3' ' HG2' ' A' ' 52' ' ' GLN . 27.0 ttt -91.22 108.84 20.15 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.311 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.744 ' HG ' ' HB3' ' A' ' 71' ' ' ALA 0.26 6.5 mp -66.85 144.84 56.04 Favored 'General case' 0 CA--C 1.472 -2.048 0 C-N-CA 127.97 2.508 . . . . 0.0 112.961 -177.732 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.4 33.7 ttp180 -122.35 -53.67 1.91 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 168.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 15.0 t70 -54.41 7.39 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.39 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 177.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.3 -31.94 0.09 OUTLIER Glycine 0 CA--C 1.569 3.434 0 N-CA-C 116.55 1.38 . . . . 0.0 116.55 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 31.8 t -135.31 87.22 2.31 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 117.787 -1.101 . . . . 0.0 112.832 -170.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.482 ' HE2' ' HB3' ' A' ' 49' ' ' TYR . 0.1 OUTLIER 174.32 -0.69 0.0 OUTLIER 'General case' 0 C--N 1.409 3.184 0 CA-C-N 120.204 1.365 . . . . 0.0 113.241 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.744 ' HB3' ' HG ' ' A' ' 65' ' ' LEU . . . -88.22 -29.9 20.12 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -169.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.83 ' HZ2' ' HG ' ' A' ' 89' ' ' LEU . 28.1 m-90 -78.99 -15.12 58.7 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.133 -0.979 . . . . 0.0 110.341 -176.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.42 -44.15 79.46 Favored 'General case' 0 C--O 1.266 1.944 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 167.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.651 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.0 mt -59.67 -38.56 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.138 175.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.694 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 13.4 tmtt? -65.05 -37.97 89.33 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.529 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.95 -44.89 95.81 Favored 'General case' 0 C--O 1.262 1.72 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.328 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.651 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 12.0 m-85 -57.28 -48.06 79.87 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.773 0.797 . . . . 0.0 109.05 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.863 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 4.2 pp -63.13 -41.88 99.4 Favored 'General case' 0 C--O 1.293 3.345 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 1.059 HG12 ' HB2' ' A' ' 84' ' ' CYS . 32.6 m -76.29 -11.74 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 CA-C-O 121.838 0.828 . . . . 0.0 109.559 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.2 m -104.06 0.49 29.85 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.939 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.73 ' HG2' ' HE1' ' A' ' 40' ' ' TRP . 8.5 tp-100 -85.2 -53.5 5.21 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.341 1.9 p30 -176.64 -94.04 0.0 OUTLIER 'General case' 0 C--O 1.243 0.74 0 O-C-N 125.235 1.584 . . . . 0.0 113.939 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.579 ' HD2' ' HA3' ' A' ' 26' ' ' GLY 0.291 48.2 mtm180 -93.3 131.62 38.26 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 118.328 -1.349 . . . . 0.0 112.243 -177.179 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 1.059 ' HB2' HG12 ' A' ' 79' ' ' VAL . 4.5 p -154.78 154.51 32.92 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.612 -168.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.642 ' HB2' ' OG ' ' A' ' 25' ' ' SER . . . -159.56 -49.92 0.06 Allowed 'General case' 0 C--N 1.351 0.645 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -174.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.954 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 38.2 tt0 -154.52 127.11 8.02 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 119.517 1.053 . . . . 0.0 112.149 -172.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 12.8 m -111.36 103.79 16.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.274 23.4 p -102.9 136.49 42.62 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 117.991 -1.483 . . . . 0.0 112.497 177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.838 HD11 ' HB3' ' A' ' 18' ' ' LEU . 4.6 mm? -116.73 157.4 25.54 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -167.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.578 ' HB3' HD22 ' A' ' 18' ' ' LEU 0.265 0.1 OUTLIER -79.31 164.24 24.25 Favored 'General case' 0 C--N 1.252 -3.661 0 CA-C-N 110.866 -2.879 . . . . 0.0 109.084 -175.102 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.27 84.35 1.61 Allowed Glycine 0 N--CA 1.415 -2.76 0 CA-C-O 117.816 -1.547 . . . . 0.0 110.799 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -57.87 109.13 0.67 Allowed 'General case' 0 C--N 1.372 1.58 0 CA-C-N 120.048 1.924 . . . . 0.0 107.597 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.454 ' SD ' ' HD2' ' A' ' 97' ' ' LYS . 15.1 tpt 155.92 -41.65 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 -169.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.647 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . 81.1 t80 -49.21 -59.07 7.12 Favored Pre-proline 0 CA--C 1.563 1.47 0 C-N-CA 126.001 1.72 . . . . 0.0 113.767 -177.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.647 ' HD3' ' HB3' ' A' ' 94' ' ' TYR . 11.6 Cg_endo -91.92 10.88 2.47 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.853 1.702 . . . . 0.0 112.589 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -108.39 -47.66 0.91 Allowed Glycine 0 N--CA 1.427 -1.909 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.415 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.454 ' HD2' ' SD ' ' A' ' 93' ' ' MET . 96.2 mttt . . . . . 0 C--N 1.308 -1.228 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.848 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.23 -173.51 1.88 Allowed 'Trans proline' 0 CA--C 1.554 1.503 0 C-N-CA 121.847 1.698 . . . . 0.0 109.724 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.67 28.79 3.84 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.155 -1.497 . . . . 0.0 110.725 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 36.8 ttmt -96.93 144.85 28.57 Favored Pre-proline 0 N--CA 1.434 -1.266 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.526 ' HB3' HD23 ' A' ' 89' ' ' LEU . 5.2 Cg_exo -77.22 -148.74 0.03 OUTLIER 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 123.128 2.552 . . . . 0.0 111.362 176.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.482 ' H ' HD13 ' A' ' 8' ' ' ILE . 44.0 mt-10 74.23 -8.21 1.5 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.134 1.374 . . . . 0.0 113.82 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -61.27 -21.72 64.18 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.825 0.821 . . . . 0.0 109.65 177.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.606 HD11 ' H ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -57.66 -57.19 11.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 124.881 1.272 . . . . 0.0 110.77 173.844 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.675 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 3.9 pp -77.52 -18.67 56.8 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.724 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 7' ' ' SER . 68.4 mttm -79.95 -22.39 42.69 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.534 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.0 ttt -97.43 -29.49 13.46 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.787 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.432 HG21 ' HD3' ' A' ' 16' ' ' LYS . 20.9 m -84.18 -64.28 1.19 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.831 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 175.34 -73.36 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.64 0.776 . . . . 0.0 109.752 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.675 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 87.5 tttt 179.7 -71.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.807 0.443 . . . . 0.0 110.037 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.18 56.09 1.49 Allowed Glycine 0 CA--C 1.546 1.973 0 C-N-CA 124.032 0.825 . . . . 0.0 114.523 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.432 ' HD3' HG21 ' A' ' 12' ' ' THR . 57.1 tptt -95.55 133.42 39.59 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 118.842 1.321 . . . . 0.0 109.651 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -71.62 120.91 17.88 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.623 ' HB3' HD21 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -127.91 115.23 18.25 Favored 'General case' 0 C--O 1.197 -1.667 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -171.052 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.54 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 22.3 ttt -86.58 105.21 16.69 Favored 'General case' 0 C--N 1.281 -2.383 0 O-C-N 121.694 -0.629 . . . . 0.0 110.272 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.638 ' HE2' HD11 ' A' ' 65' ' ' LEU . 12.4 ttm -97.65 116.82 30.6 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 117.28 -1.768 . . . . 0.0 112.671 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -100.76 116.55 32.91 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 112.637 -2.074 . . . . 0.0 106.328 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.75 125.89 65.94 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 CA-C-O 121.457 0.646 . . . . 0.0 111.663 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.792 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 88.3 m -84.55 131.17 34.66 Favored 'General case' 0 CA--C 1.595 2.693 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.035 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.0 p -131.29 137.64 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.579 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.43 23.1 t -109.23 -96.62 0.39 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 122.858 2.572 . . . . 0.0 114.277 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.554 ' HA3' ' HG3' ' A' ' 83' ' ' ARG . . . 55.48 -67.14 0.01 OUTLIER Glycine 0 C--N 1.352 1.438 0 CA-C-N 119.654 1.116 . . . . 0.0 113.017 -168.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -118.56 137.49 24.86 Favored Pre-proline 0 N--CA 1.417 -2.1 0 CA-C-N 117.71 0.755 . . . . 0.0 109.323 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.75 40.45 0.91 Allowed 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 122.621 2.214 . . . . 0.0 107.577 170.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.0 m -140.08 143.31 36.25 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 -165.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.455 ' O ' ' HB ' ' A' ' 33' ' ' THR . 32.7 tt0 -68.2 -7.57 31.36 Favored 'General case' 0 C--N 1.371 1.538 0 CA-C-N 120.538 1.517 . . . . 0.0 111.22 -177.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.475 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 1.9 tmpt? -52.52 -40.43 62.44 Favored 'General case' 0 C--O 1.257 1.484 0 CA-C-O 121.321 0.581 . . . . 0.0 109.941 174.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.737 ' HG3' HD13 ' A' ' 36' ' ' ILE . 3.4 tp10 -69.23 -56.64 7.0 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 57.3 m -39.84 -47.77 2.18 Favored 'General case' 0 C--O 1.189 -2.111 0 C-N-CA 125.697 1.599 . . . . 0.0 111.897 171.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.475 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.4 pt-20 -70.99 -53.46 14.74 Favored 'General case' 0 C--O 1.253 1.275 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.65 -36.1 82.69 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.102 -1.439 . . . . 0.0 109.292 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.737 HD13 ' HG3' ' A' ' 32' ' ' GLU . 2.7 mt -68.0 -41.3 84.44 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.379 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.405 176.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.883 HG23 HG12 ' A' ' 55' ' ' ILE . 11.7 p -69.78 -40.09 76.25 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 120.299 1.409 . . . . 0.0 111.115 -176.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 p -64.72 -50.87 65.24 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 124.111 0.882 . . . . 0.0 110.039 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 mt -61.84 -49.42 76.36 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.048 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.618 ' CZ2' ' HB2' ' A' ' 78' ' ' LEU . 45.1 m0 -61.23 -71.97 0.13 Allowed 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 1.037 ' HB3' HH11 ' A' ' 53' ' ' ARG 0.314 0.0 OUTLIER -70.27 -18.65 63.13 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 117.521 -1.672 . . . . 0.0 112.078 -176.752 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.9 -48.44 80.78 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.412 173.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.441 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 54.3 p -79.01 -34.73 43.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 122.763 -0.257 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.811 HD13 ' CD ' ' A' ' 53' ' ' ARG . 11.4 mt -62.28 -33.17 74.13 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.894 0.378 . . . . 0.0 110.637 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -86.65 -30.07 22.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.408 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 9.2 t30 -66.17 -36.2 82.46 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.82 4.37 37.39 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.908 -0.495 . . . . 0.0 109.954 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.1 t30 58.57 47.9 12.65 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.471 1.108 . . . . 0.0 112.379 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -68.08 -13.13 61.96 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.567 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 26.5 t0 62.12 78.21 0.3 Allowed 'General case' 0 C--N 1.353 0.734 0 CA-C-O 122.755 1.264 . . . . 0.0 109.58 -176.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 m -140.84 177.38 3.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.13 -170.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -139.17 131.07 27.7 Favored 'General case' 0 C--O 1.177 -2.739 0 N-CA-C 104.001 -2.592 . . . . 0.0 104.001 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 1.037 HH11 ' HB3' ' A' ' 41' ' ' GLN . 23.2 mtp-105 -138.06 145.92 42.34 Favored 'General case' 0 C--N 1.273 -2.725 0 O-C-N 121.442 -0.786 . . . . 0.0 109.044 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.769 ' H ' HG12 ' A' ' 62' ' ' ILE . 15.1 t80 -134.67 151.2 50.85 Favored 'General case' 0 C--O 1.259 1.566 0 C-N-CA 118.028 -1.469 . . . . 0.0 113.3 -168.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.883 HG12 HG23 ' A' ' 37' ' ' THR . 58.0 mt -93.77 107.07 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.505 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 89.7 t -94.59 -48.16 13.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.484 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.35 177.95 40.49 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 117.553 -2.26 . . . . 0.0 114.962 -174.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.643 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 4.8 p -72.71 44.03 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 127.138 2.175 . . . . 0.0 114.192 -176.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.643 ' HB3' ' O ' ' A' ' 58' ' ' SER . 2.5 p-10 148.58 6.18 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 125.73 1.612 . . . . 0.0 107.377 -169.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.505 ' HB3' ' HB ' ' A' ' 56' ' ' VAL . 7.2 mpt_? -127.9 133.34 49.28 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 123.959 0.904 . . . . 0.0 110.583 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.59 161.51 38.32 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.769 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -138.16 156.38 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.454 -2.725 0 C-N-CA 118.014 -1.474 . . . . 0.0 110.883 171.382 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.805 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 5.8 p90 -128.77 113.82 15.81 Favored 'General case' 0 N--CA 1.413 -2.287 0 O-C-N 126.88 2.612 . . . . 0.0 106.776 161.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.7 ttt -97.13 118.1 32.8 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 122.017 0.913 . . . . 0.0 111.413 -178.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.638 HD11 ' HE2' ' A' ' 20' ' ' MET . 5.8 mp -73.4 145.88 45.52 Favored 'General case' 0 CA--C 1.47 -2.124 0 CA-C-N 112.189 -2.278 . . . . 0.0 111.54 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.567 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.362 58.8 ttt180 -118.2 -62.13 1.58 Allowed 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 176.098 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.493 ' C ' ' H ' ' A' ' 69' ' ' SER . 9.4 t70 -71.9 17.59 0.09 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 120.267 1.394 . . . . 0.0 112.924 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.638 ' HA3' ' O ' ' A' ' 14' ' ' LYS . . . 58.37 -32.71 0.02 OUTLIER Glycine 0 CA--C 1.551 2.34 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 -169.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.493 ' H ' ' C ' ' A' ' 67' ' ' ASP . 14.8 m -93.67 20.4 7.52 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -166.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.468 ' O ' ' HD1' ' A' ' 70' ' ' TYR . 0.6 OUTLIER -148.25 125.44 11.48 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.597 -0.69 . . . . 0.0 111.069 178.361 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.566 ' HB1' ' HG ' ' A' ' 65' ' ' LEU . . . 171.91 -30.95 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 124.178 0.924 . . . . 0.0 112.227 176.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.495 ' NE1' ' HE1' ' A' ' 20' ' ' MET 0.428 5.3 m-90 -89.02 -28.3 20.27 Favored 'General case' 0 C--O 1.267 2.022 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -165.859 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.564 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 38.9 tt0 -72.43 -39.16 68.09 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 170.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 71' ' ' ALA . 30.5 mt -51.63 -48.86 36.15 Favored 'Isoleucine or valine' 0 C--O 1.286 3.024 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.9 173.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.597 ' O ' HG21 ' A' ' 79' ' ' VAL . 21.4 pttp -67.07 -37.85 84.72 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.75 -46.53 74.34 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.202 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.564 ' CZ ' ' HG2' ' A' ' 73' ' ' GLU . 18.0 m-85 -60.96 -59.23 5.71 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.922 0.868 . . . . 0.0 109.646 -175.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.618 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.1 pp -63.33 -40.42 97.26 Favored 'General case' 0 C--O 1.266 1.932 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -171.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.659 ' HB ' ' CB ' ' A' ' 84' ' ' CYS 0.265 27.6 m -80.36 -12.88 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 118.343 -1.343 . . . . 0.0 111.622 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.8 m -97.3 -0.05 47.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -87.99 -54.54 4.18 Favored 'General case' 0 CA--C 1.475 -1.942 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.472 38.0 t70 -137.71 -92.99 0.21 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 175.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.554 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 18.8 mmt180 -99.14 153.28 19.03 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 120.96 1.709 . . . . 0.0 110.955 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.659 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 24.8 p -152.07 154.97 37.0 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.251 -173.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.44 -51.16 0.02 OUTLIER 'General case' 0 C--N 1.355 0.84 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.792 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 36.9 tt0 -153.84 116.91 4.52 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.776 -173.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.96 101.68 12.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.258 23.5 p -105.19 120.62 41.98 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 123.1 1.429 . . . . 0.0 114.758 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.528 HD21 HD12 ' A' ' 8' ' ' ILE . 1.2 mp -75.25 156.78 35.35 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 112.155 -2.293 . . . . 0.0 106.527 177.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 19' ' ' MET . 40.5 tt0 -95.29 159.69 14.89 Favored 'General case' 0 C--N 1.278 -2.514 0 C-N-CA 124.031 0.932 . . . . 0.0 108.992 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.59 68.93 1.49 Allowed Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.325 -1.264 . . . . 0.0 111.728 173.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.483 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 98.2 mt-30 -50.07 108.96 0.25 Allowed 'General case' 0 C--N 1.374 1.645 0 CA-C-N 118.541 1.171 . . . . 0.0 113.568 -173.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.443 ' O ' ' HB2' ' A' ' 7' ' ' SER . 60.1 mtt -158.03 17.48 0.24 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 127.354 2.262 . . . . 0.0 106.533 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.483 ' CE2' ' HA ' ' A' ' 92' ' ' GLN . 7.5 p90 -123.3 92.22 49.13 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.356 -171.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -93.12 -3.7 3.27 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 122.398 2.065 . . . . 0.0 112.012 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.22 80.31 1.06 Allowed Glycine 0 N--CA 1.423 -2.196 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt . . . . . 0 C--N 1.298 -1.642 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.512 -177.879 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.551 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.53 3.23 7.7 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.254 2.636 . . . . 0.0 112.844 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.12 -36.48 93.0 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -88.34 140.19 30.29 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.86 33.7 0.24 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.22 2.613 . . . . 0.0 115.559 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.556 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . 34.2 mm-40 -72.05 -20.96 61.6 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 101.75 -3.426 . . . . 0.0 101.75 156.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.7 m 73.49 167.19 0.3 Allowed 'General case' 1 N--CA 1.37 -4.449 0 CA-C-N 112.809 -1.996 . . . . 0.0 109.768 167.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.2 mt -46.24 -25.23 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.644 0.735 . . . . 0.0 112.324 174.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.916 ' HB3' ' HA ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -73.63 -58.75 3.09 Favored 'General case' 0 N--CA 1.421 -1.886 0 C-N-CA 124.268 1.027 . . . . 0.0 109.974 -173.197 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' A' ' 6' ' ' GLU . 94.6 mttt -76.21 -22.88 54.72 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.095 -1.042 . . . . 0.0 109.778 -175.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.9 tpt -70.61 -42.88 70.37 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.657 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.5 m -145.85 -33.09 0.34 Allowed 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -173.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.537 ' HB2' ' HA ' ' A' ' 9' ' ' LEU . 72.8 mmtt -104.22 87.85 2.85 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -166.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.502 ' HD3' ' HA ' ' A' ' 10' ' ' LYS . 3.5 mmmp? -110.23 -19.69 12.92 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.327 174.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.74 60.87 0.51 Allowed Glycine 0 CA--C 1.55 2.265 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.57 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -131.2 134.53 46.56 Favored 'General case' 0 C--N 1.365 1.253 0 CA-C-N 120.157 1.978 . . . . 0.0 111.362 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -78.65 123.21 26.89 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.65 ' CD1' HD12 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -133.18 103.15 5.86 Favored 'General case' 0 C--O 1.191 -2.001 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -174.171 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.659 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 9.4 ptp -84.1 116.92 23.13 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.891 -1.13 . . . . 0.0 110.891 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.762 ' HG2' HD13 ' A' ' 89' ' ' LEU . 93.1 mtp -86.7 99.28 11.65 Favored 'General case' 0 CA--C 1.487 -1.466 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.246 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.457 ' CZ ' ' HD2' ' A' ' 60' ' ' ARG . 12.3 t80 -89.04 106.05 18.18 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 61' ' ' ALA . 9.1 p -126.28 125.91 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.923 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.039 -165.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 1.048 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 31.4 m -92.88 142.31 27.46 Favored 'General case' 0 C--O 1.276 2.477 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.596 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.755 HG21 ' HA ' ' A' ' 83' ' ' ARG . 7.5 p -131.03 128.52 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 103.681 -2.711 . . . . 0.0 103.681 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.61 20.79 1.04 Allowed 'General case' 0 C--O 1.245 0.864 0 CA-C-N 122.478 2.399 . . . . 0.0 112.347 -171.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.64 -31.83 73.88 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 106.821 -2.511 . . . . 0.0 106.821 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.9 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 24.8 t-20 -118.46 104.58 47.48 Favored Pre-proline 0 N--CA 1.405 -2.711 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.54 32.23 0.45 Allowed 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.736 2.291 . . . . 0.0 112.395 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.427 ' HB ' ' H ' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -146.81 -161.24 1.28 Allowed 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.628 -173.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.483 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.7 tp10 -76.69 -18.29 58.62 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.505 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 5.0 tmtt? -64.56 -52.42 57.71 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.9 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.4 tp10 -71.01 -35.44 72.03 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 117.777 -1.569 . . . . 0.0 107.643 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.483 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 54.5 m -49.6 -57.52 6.99 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.029 172.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 15.2 pt-20 -65.98 -40.25 91.06 Favored 'General case' 0 C--O 1.255 1.371 0 C-N-CA 122.792 0.437 . . . . 0.0 111.784 -176.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -51.69 -63.0 1.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.694 HG21 ' CE3' ' A' ' 40' ' ' TRP . 35.4 mt -67.21 -44.46 87.66 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 112.384 -2.189 . . . . 0.0 112.957 -175.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.759 ' HB ' HG12 ' A' ' 55' ' ' ILE . 32.4 p -65.35 -53.49 42.87 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.547 -0.861 . . . . 0.0 112.011 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.9 t -70.55 -46.87 62.73 Favored 'General case' 0 C--O 1.257 1.46 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.429 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.73 -43.13 66.39 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.759 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.694 ' CE3' HG21 ' A' ' 36' ' ' ILE . 37.9 m0 -73.29 -61.75 1.71 Allowed 'General case' 0 C--O 1.167 -3.262 0 CA-C-O 117.486 -1.245 . . . . 0.0 109.65 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.715 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.377 0.0 OUTLIER -63.47 -25.69 68.38 Favored 'General case' 0 C--O 1.253 1.278 0 C-N-CA 117.871 -1.532 . . . . 0.0 112.608 -172.166 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.94 -50.92 59.47 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 171.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.75 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 58.7 p -74.06 -25.29 59.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.344 0.572 . . . . 0.0 111.404 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.728 HD11 ' HG2' ' A' ' 53' ' ' ARG . 32.5 mt -62.62 -33.51 75.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 176.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.501 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 89.9 t80 -87.97 -32.8 18.68 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.45 173.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.75 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 6.9 t30 -62.36 -36.96 83.87 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.11 3.21 52.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.277 0.561 . . . . 0.0 110.017 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.7 t30 53.24 51.89 14.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.226 1.41 . . . . 0.0 112.568 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -64.73 -7.02 9.25 Favored 'General case' 0 CA--C 1.595 2.69 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.0 t70 61.04 67.88 0.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.141 1.377 . . . . 0.0 110.037 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.745 HG23 ' HD2' ' A' ' 53' ' ' ARG . 2.6 m -147.92 175.42 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.249 -171.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.548 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 17.5 mt-30 -130.96 125.18 32.72 Favored 'General case' 0 C--O 1.189 -2.131 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 177.731 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.745 ' HD2' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -134.5 136.6 43.25 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -172.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.765 ' H ' HG12 ' A' ' 62' ' ' ILE . 47.9 t80 -135.03 150.49 50.31 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 118.187 -1.405 . . . . 0.0 113.579 -166.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.759 HG12 ' HB ' ' A' ' 37' ' ' THR . 19.1 mt -93.23 96.36 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 171.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -80.01 -33.85 14.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.81 -178.87 40.38 Favored Glycine 0 CA--C 1.484 -1.905 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.245 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -60.24 121.01 10.9 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.258 0.0 OUTLIER 79.3 8.67 1.77 Allowed 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 121.937 0.875 . . . . 0.0 111.379 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.457 ' HD2' ' CZ ' ' A' ' 21' ' ' PHE . 1.3 tpp180 -137.56 118.92 14.69 Favored 'General case' 0 CA--C 1.573 1.858 0 O-C-N 121.45 -0.781 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.492 ' O ' HG12 ' A' ' 22' ' ' VAL . . . -137.07 162.1 34.27 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -175.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.765 HG12 ' H ' ' A' ' 54' ' ' PHE . 2.5 pt -142.49 157.13 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 C-N-CA 117.422 -1.711 . . . . 0.0 110.337 170.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.632 ' CE2' ' HB ' ' A' ' 74' ' ' ILE 0.296 9.0 p90 -133.02 101.33 5.18 Favored 'General case' 0 N--CA 1.426 -1.672 0 O-C-N 126.264 2.227 . . . . 0.0 108.394 161.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.659 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 25.0 ttt -87.17 113.88 23.3 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.73 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.728 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.315 2.3 mp -80.66 148.22 30.31 Favored 'General case' 0 CA--C 1.442 -3.173 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.287 -178.092 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -117.54 163.12 16.9 Favored 'General case' 0 C--N 1.252 -3.637 0 N-CA-C 104.513 -2.403 . . . . 0.0 104.513 169.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 76.98 -36.22 0.25 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.17 -29.13 7.87 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 119.895 -1.145 . . . . 0.0 114.16 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.916 ' HA ' ' HB3' ' A' ' 9' ' ' LEU . 38.9 m -96.07 32.95 1.81 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -167.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 41.9 p90 -178.43 137.07 0.16 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 117.029 -1.463 . . . . 0.0 109.744 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.728 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 164.0 -35.45 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.128 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 171.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.671 ' HZ2' ' HG ' ' A' ' 89' ' ' LEU 0.298 22.0 m-90 -80.36 -9.76 59.75 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 120.376 -1.453 . . . . 0.0 111.684 -172.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.14 -35.62 69.14 Favored 'General case' 0 C--O 1.299 3.684 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.632 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 67.3 mt -62.53 -39.35 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 174.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.679 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 12.4 tmtt? -61.53 -37.23 83.01 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.729 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.83 -48.15 81.86 Favored 'General case' 0 C--O 1.261 1.691 0 C-N-CA 119.619 -0.833 . . . . 0.0 110.138 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -57.48 -45.14 85.19 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.366 1.079 . . . . 0.0 110.11 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.679 ' HG ' ' HA ' ' A' ' 75' ' ' LYS 0.271 4.2 pp -61.06 -48.77 80.18 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -179.167 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.677 HG11 HD11 ' A' ' 78' ' ' LEU . 23.7 m -75.18 -6.87 9.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 117.458 -1.697 . . . . 0.0 112.22 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -96.59 -5.9 38.07 Favored 'General case' 0 N--CA 1.403 -2.792 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.721 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -100.75 -58.12 1.96 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.6 t70 164.16 173.11 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.484 1 N-CA-C 99.532 -4.247 . . . . 0.0 99.532 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.755 ' HA ' HG21 ' A' ' 24' ' ' VAL . 0.0 OUTLIER 74.23 89.75 0.09 Allowed 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -163.547 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.593 ' HA ' HG12 ' A' ' 79' ' ' VAL . 12.6 p -153.69 56.84 0.74 Allowed 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.787 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.77 -62.68 1.11 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 1.048 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 33.2 tt0 -134.44 125.28 27.13 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 120.65 1.568 . . . . 0.0 110.202 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.8 t -117.66 111.41 34.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.44 ' O ' HD23 ' A' ' 89' ' ' LEU . 38.8 p -124.95 129.19 49.86 Favored 'General case' 0 C--O 1.277 2.509 0 C-N-CA 118.751 -1.179 . . . . 0.0 112.726 174.096 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.762 HD13 ' HG2' ' A' ' 20' ' ' MET . 4.4 mm? -129.84 155.8 45.41 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.985 -175.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -81.53 157.48 24.79 Favored 'General case' 0 C--N 1.245 -3.956 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.88 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 134.38 173.4 13.13 Favored Glycine 0 CA--C 1.548 2.15 0 CA-C-O 118.48 -1.178 . . . . 0.0 110.999 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -95.11 132.62 39.83 Favored 'General case' 0 C--N 1.363 1.159 0 CA-C-N 120.25 2.025 . . . . 0.0 109.06 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.8 tpt 54.54 56.67 6.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.187 0.994 . . . . 0.0 109.805 -176.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.748 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 83.7 t80 -80.95 -49.69 1.04 Allowed Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.448 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.467 ' HD2' ' N ' ' A' ' 94' ' ' TYR . 22.7 Cg_endo -59.84 140.2 91.99 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.2 1.933 . . . . 0.0 112.331 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.22 -71.71 0.27 Allowed Glycine 0 N--CA 1.417 -2.61 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.444 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 118.104 -0.95 . . . . 0.0 108.734 177.82 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.52 -8.14 13.7 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.613 2.209 . . . . 0.0 113.09 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 137.07 -43.11 1.25 Allowed Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 62.9 pttt -114.32 129.73 24.61 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 6.2 Cg_exo -76.49 165.17 29.54 Favored 'Trans proline' 0 C--O 1.248 1.002 0 C-N-CA 122.906 2.404 . . . . 0.0 112.903 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.613 ' HA ' ' CE3' ' A' ' 72' ' ' TRP . 92.2 mt-10 66.68 10.37 7.41 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.438 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.4 p -66.93 -34.55 78.01 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.684 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.612 ' CG2' ' HA ' ' A' ' 97' ' ' LYS . 1.5 pt -59.45 -49.67 82.73 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.899 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.479 ' HG ' ' CZ3' ' A' ' 72' ' ' TRP 0.364 1.3 pp -81.68 -31.24 32.32 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt -86.57 -21.88 26.6 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.928 -171.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.2 ttt -99.5 -36.23 9.62 Favored 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.635 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.6 m -88.9 -50.25 6.31 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 118.55 -1.26 . . . . 0.0 112.944 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.88 113.29 0.49 Allowed 'General case' 0 C--O 1.253 1.284 0 CA-C-N 119.131 0.878 . . . . 0.0 113.173 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.537 ' HD2' ' HB3' ' A' ' 69' ' ' SER . 53.7 mtmt -94.34 -176.3 3.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 174.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.13 -36.86 1.3 Allowed Glycine 0 CA--C 1.546 1.993 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.95 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -68.35 121.9 17.25 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 117.604 0.702 . . . . 0.0 110.237 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.6 m -67.15 123.13 19.42 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.48 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.663 HD12 ' H ' ' A' ' 90' ' ' GLU . 0.4 OUTLIER -122.76 121.23 35.82 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 -176.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.472 ' HB3' ' HG3' ' A' ' 64' ' ' MET . 14.9 ptt? -109.05 133.74 52.59 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.371 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.518 ' SD ' ' HA ' ' A' ' 89' ' ' LEU . 2.9 mpp? -108.86 118.93 38.07 Favored 'General case' 0 CA--C 1.46 -2.511 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.672 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -103.94 128.78 51.46 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 171.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.44 124.13 69.01 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.542 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.629 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.965 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 95.8 m -75.43 124.88 27.92 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 173.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.486 HG22 HD11 ' A' ' 36' ' ' ILE . 1.9 p -128.45 124.35 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.361 0 CA-C-N 120.319 1.418 . . . . 0.0 111.568 -169.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.937 ' HB2' ' HB2' ' A' ' 83' ' ' ARG . 33.0 t 70.68 -50.15 0.67 Allowed 'General case' 0 C--N 1.363 1.176 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 167.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.24 23.5 9.62 Favored Glycine 0 N--CA 1.415 -2.715 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.31 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 28' ' ' PRO 0.251 9.2 p30 -116.65 111.08 41.72 Favored Pre-proline 0 N--CA 1.417 -2.101 0 C-N-CA 117.609 -1.636 . . . . 0.0 112.205 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.779 ' HA ' ' HB3' ' A' ' 58' ' ' SER . 12.6 Cg_exo -74.19 37.17 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.805 2.337 . . . . 0.0 109.598 176.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.461 ' H ' ' C ' ' A' ' 27' ' ' ASN . 13.2 m -88.62 52.7 2.5 Favored 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.239 -170.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.726 ' O ' ' HG3' ' A' ' 30' ' ' GLU . 7.6 tp10 66.1 19.92 11.17 Favored 'General case' 0 C--N 1.414 3.377 0 CA-C-O 126.803 3.192 . . . . 0.0 103.328 -162.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.838 ' HD2' ' HA ' ' A' ' 58' ' ' SER 0.517 0.0 OUTLIER 62.42 144.8 0.02 OUTLIER 'General case' 2 N--CA 1.259 -10.019 0 CA-C-O 127.461 3.505 . . . . 0.0 114.104 -178.934 . . . . . . . . 5 4 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.864 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -66.98 -10.44 49.58 Favored 'General case' 2 N--CA 1.348 -5.543 0 CA-C-N 110.191 -3.186 . . . . 0.0 105.01 169.214 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.644 ' HB ' ' HB2' ' A' ' 31' ' ' LYS . 94.3 m -69.18 -35.12 75.94 Favored 'General case' 1 N--CA 1.359 -4.976 0 C-N-CA 127.921 2.488 . . . . 0.0 108.463 174.572 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.608 ' HG3' ' N ' ' A' ' 35' ' ' GLU . 3.9 pt-20 -74.19 -40.77 62.28 Favored 'General case' 0 C--N 1.389 2.319 0 CA-C-N 121.487 1.949 . . . . 0.0 106.941 177.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.608 ' N ' ' HG3' ' A' ' 34' ' ' GLU . 9.7 tp10 -59.4 -56.69 18.78 Favored 'General case' 0 C--O 1.279 2.634 0 CA-C-O 124.087 1.899 . . . . 0.0 108.576 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.864 ' HB ' ' O ' ' A' ' 32' ' ' GLU . 1.1 mt -70.3 -25.17 26.73 Favored 'Isoleucine or valine' 0 C--O 1.163 -3.455 0 CA-C-N 111.74 -2.482 . . . . 0.0 112.305 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.527 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 6.7 p -74.04 -41.9 61.09 Favored 'General case' 0 CA--C 1.464 -2.328 0 CA-C-N 121.697 2.044 . . . . 0.0 109.466 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 m -60.18 -51.62 68.8 Favored 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.858 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.5 tp -72.32 -49.68 32.59 Favored 'General case' 0 C--O 1.25 1.123 0 C-N-CA 118.038 -1.465 . . . . 0.0 111.434 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.673 ' CZ2' ' HB2' ' A' ' 78' ' ' LEU . 51.0 m0 -69.27 -67.99 0.44 Allowed 'General case' 0 C--O 1.189 -2.106 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.409 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.591 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.36 0.0 OUTLIER -69.9 -20.36 63.37 Favored 'General case' 0 C--O 1.254 1.303 0 C-N-CA 118.516 -1.273 . . . . 0.0 112.075 -170.865 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.32 -53.36 45.03 Favored Glycine 0 C--N 1.365 2.18 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.66 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 36.7 p -69.83 -29.77 67.11 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.53 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.861 HD11 ' HG2' ' A' ' 53' ' ' ARG . 25.5 mt -59.64 -35.01 73.54 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.691 0.397 . . . . 0.0 110.547 177.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.555 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 82.3 t80 -91.08 -27.37 18.63 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.66 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 8.7 t30 -64.79 -34.89 79.41 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.692 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.24 0.53 57.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.865 0.365 . . . . 0.0 110.491 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.3 t30 53.24 57.79 5.9 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.967 1.307 . . . . 0.0 112.46 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -73.8 -0.21 15.1 Favored 'General case' 0 CA--C 1.597 2.763 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 171.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.5 t70 62.05 67.78 0.72 Allowed 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 124.402 1.081 . . . . 0.0 110.792 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.652 HG23 ' HD2' ' A' ' 53' ' ' ARG . 6.7 m -147.36 174.83 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.502 -172.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.587 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 1.9 mp0 -131.51 131.68 43.62 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 172.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.861 ' HG2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -129.74 129.85 44.68 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -174.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.795 ' H ' HG12 ' A' ' 62' ' ' ILE . 29.2 t80 -133.93 152.36 51.83 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 119.095 -1.042 . . . . 0.0 113.112 -159.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.588 HG22 HG21 ' A' ' 33' ' ' THR . 75.3 mt -88.17 107.32 17.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.877 175.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.753 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 97.1 t -81.47 -40.97 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.025 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.56 -171.34 43.63 Favored Glycine 0 CA--C 1.469 -2.825 0 C-N-CA 118.629 -1.748 . . . . 0.0 113.46 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.838 ' HA ' ' HD2' ' A' ' 31' ' ' LYS . 6.6 m -62.0 118.26 7.04 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 118.057 -0.973 . . . . 0.0 108.742 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.607 ' HB3' ' O ' ' A' ' 58' ' ' SER . 2.4 t70 80.89 11.16 0.91 Allowed 'General case' 0 N--CA 1.408 -2.566 0 CA-C-O 122.545 1.164 . . . . 0.0 109.228 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.753 ' HB3' ' HB ' ' A' ' 56' ' ' VAL . 11.4 mpt_? -137.1 116.08 12.36 Favored 'General case' 0 CA--C 1.562 1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 112.149 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.62 163.1 22.68 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.129 0.972 . . . . 0.0 108.728 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.795 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.7 OUTLIER -139.52 158.08 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.223 0 C-N-CA 118.223 -1.391 . . . . 0.0 111.128 173.118 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.475 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 2.3 p90 -129.08 106.75 9.07 Favored 'General case' 0 N--CA 1.419 -2.009 0 O-C-N 126.485 2.365 . . . . 0.0 106.917 164.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.472 ' HG3' ' HB3' ' A' ' 19' ' ' MET . 23.1 ttt -94.99 117.04 29.48 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.273 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.74 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.484 0.0 OUTLIER -114.34 147.73 38.68 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -177.339 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.354 36.3 ttp180 -104.57 -62.6 1.31 Allowed 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -164.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -55.92 -8.08 0.39 Allowed 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.401 ' O ' HD12 ' A' ' 9' ' ' LEU . . . 58.83 15.98 29.49 Favored Glycine 0 C--N 1.369 2.375 0 CA-C-N 120.194 1.361 . . . . 0.0 115.09 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.537 ' HB3' ' HD2' ' A' ' 14' ' ' LYS . 15.9 p -116.66 22.19 12.89 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 118.39 1.095 . . . . 0.0 113.597 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 2.3 p90 177.8 145.79 0.12 Allowed 'General case' 0 C--O 1.245 0.823 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -167.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.74 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 160.48 -28.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 125.166 1.541 . . . . 0.0 111.92 171.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.613 ' CE3' ' HA ' ' A' ' 6' ' ' GLU 0.522 7.1 m0 -89.48 -16.4 30.88 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 117.071 -1.852 . . . . 0.0 115.176 -169.196 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.92 -36.38 80.07 Favored 'General case' 0 C--O 1.257 1.457 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 165.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.532 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 57.2 mt -53.89 -50.13 54.76 Favored 'Isoleucine or valine' 0 C--O 1.29 3.204 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.795 174.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.609 ' O ' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -63.42 -36.11 82.65 Favored 'General case' 0 C--N 1.373 1.612 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.243 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.79 -47.07 83.6 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.84 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.532 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 13.9 m-85 -58.18 -60.25 4.04 Favored 'General case' 0 C--N 1.365 1.245 0 CA-C-O 122.35 1.071 . . . . 0.0 109.198 -175.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.673 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.6 pp -62.29 -38.46 89.44 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.641 ' HB ' ' CB ' ' A' ' 84' ' ' CYS . 34.0 m -80.09 -9.75 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 118.203 -1.399 . . . . 0.0 111.431 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.0 m -105.8 3.29 28.62 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -107.3 -45.95 3.99 Favored 'General case' 0 CA--C 1.473 -2.014 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.269 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.78 -160.79 0.86 Allowed 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.937 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 24.2 mmt180 -80.35 159.67 25.68 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 120.127 1.33 . . . . 0.0 110.123 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.641 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 26.7 p -136.59 146.1 45.69 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.256 -172.2 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.27 -53.43 0.13 Allowed 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.965 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.5 tt0 -153.72 118.82 5.08 Favored 'General case' 0 C--O 1.195 -1.809 0 CA-C-N 119.806 1.184 . . . . 0.0 110.68 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.9 t -113.14 101.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.324 17.4 p -108.64 132.69 53.65 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 123.387 1.565 . . . . 0.0 114.489 177.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.518 ' HA ' ' SD ' ' A' ' 20' ' ' MET . 3.7 mp -88.31 156.75 19.01 Favored 'General case' 0 C--N 1.263 -3.18 0 CA-C-N 110.807 -2.906 . . . . 0.0 108.093 -174.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.663 ' H ' HD12 ' A' ' 18' ' ' LEU . 10.6 tp10 -80.82 155.3 26.69 Favored 'General case' 0 C--N 1.272 -2.785 0 O-C-N 121.429 -0.795 . . . . 0.0 108.93 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.67 53.01 17.77 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.586 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -65.9 107.43 1.84 Allowed 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 118.116 0.958 . . . . 0.0 112.148 -176.312 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 23.4 mmt -169.08 30.54 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 128.479 2.712 . . . . 0.0 105.031 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.586 ' CE2' ' HA ' ' A' ' 92' ' ' GLN . 2.5 p90 -111.37 100.64 48.26 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.509 -173.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -96.34 25.73 0.27 Allowed 'Trans proline' 0 C--O 1.249 1.068 0 C-N-CA 123.598 2.866 . . . . 0.0 110.575 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 127.05 -62.88 0.61 Allowed Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -174.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.694 ' HB3' ' HZ1' ' A' ' 97' ' ' LYS . 6.6 ttpm? . . . . . 0 C--N 1.314 -0.958 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.256 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.4 -1.76 9.53 Favored 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 123.429 2.753 . . . . 0.0 113.702 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.94 -37.03 74.13 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 121.35 -0.452 . . . . 0.0 112.594 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 21.6 pttp -101.19 133.67 20.81 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 117.219 0.51 . . . . 0.0 110.219 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.631 ' C ' ' H ' ' A' ' 7' ' ' SER . 4.9 Cg_exo -80.55 -165.82 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.144 2.562 . . . . 0.0 112.846 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 18.4 mt-10 72.66 -27.94 0.19 Allowed 'General case' 0 N--CA 1.518 2.946 0 C-N-CA 127.355 2.262 . . . . 0.0 107.35 -164.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.631 ' H ' ' C ' ' A' ' 5' ' ' PRO . 26.1 t -80.5 -176.07 5.52 Favored 'General case' 1 N--CA 1.357 -5.084 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 173.47 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.508 ' O ' HD11 ' A' ' 9' ' ' LEU . 10.0 tp 38.11 45.22 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 123.977 0.911 . . . . 0.0 109.433 -164.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 1.011 HD13 ' HG2' ' A' ' 13' ' ' LYS 0.394 1.8 pp 64.37 67.67 0.57 Allowed 'General case' 0 C--N 1.389 2.3 0 CA-C-O 123.46 1.6 . . . . 0.0 113.959 171.658 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.491 ' HE3' ' HB3' ' A' ' 13' ' ' LYS 0.36 0.0 OUTLIER 54.27 43.49 30.46 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 111.978 -2.374 . . . . 0.0 113.093 -179.516 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.729 ' HA ' ' HE3' ' A' ' 11' ' ' MET . 1.7 tpt 65.25 57.45 0.93 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.21 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.821 HG23 ' HA ' ' A' ' 69' ' ' SER . 24.3 m 68.38 55.43 0.51 Allowed 'General case' 0 CA--C 1.596 2.715 0 O-C-N 122.127 -0.358 . . . . 0.0 111.879 170.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.011 ' HG2' HD13 ' A' ' 9' ' ' LEU . 21.8 ptmt -46.77 125.24 7.02 Favored 'General case' 0 C--N 1.387 2.213 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -76.02 -14.41 60.22 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.083 0.953 . . . . 0.0 112.752 -171.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.3 44.49 1.48 Allowed Glycine 0 C--N 1.285 -2.265 0 C-N-CA 119.547 -1.311 . . . . 0.0 113.609 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -130.41 133.57 46.46 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 119.027 1.414 . . . . 0.0 112.632 -176.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 20.8 p -108.21 110.02 21.54 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.426 0.69 . . . . 0.0 109.474 173.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.916 HD21 ' HH2' ' A' ' 72' ' ' TRP . 30.8 tp -135.0 124.51 24.97 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -171.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.658 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.1 ptp -85.39 109.26 18.3 Favored 'General case' 0 C--O 1.207 -1.148 0 O-C-N 121.47 -0.769 . . . . 0.0 111.487 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.636 ' HE1' ' HB3' ' A' ' 65' ' ' LEU . 4.5 mpp? -84.36 128.94 34.87 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.517 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 59.6 t80 -111.05 109.06 18.99 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 125.502 1.751 . . . . 0.0 108.46 -169.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.05 128.79 75.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 114.76 1.392 . . . . 0.0 114.76 -169.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.966 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 49.5 m -87.41 141.41 28.65 Favored 'General case' 0 CA--C 1.595 2.708 0 C-N-CA 127.322 2.249 . . . . 0.0 109.006 176.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.528 HG11 ' HB2' ' A' ' 83' ' ' ARG . 35.9 t -132.0 97.33 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.014 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -166.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.507 ' OG ' ' HB3' ' A' ' 83' ' ' ARG 0.324 60.8 m 62.3 -30.07 0.08 Allowed 'General case' 0 C--N 1.389 2.293 0 N-CA-C 119.085 2.995 . . . . 0.0 119.085 170.229 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 123.76 1.5 8.97 Favored Glycine 0 N--CA 1.426 -2.018 0 C-N-CA 118.39 -1.862 . . . . 0.0 115.269 175.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.567 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.3 t-20 -79.65 104.66 2.51 Favored Pre-proline 0 C--O 1.22 -0.452 0 CA-C-N 119.04 1.42 . . . . 0.0 107.862 173.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 82.2 Cg_endo -91.52 33.71 0.29 Allowed 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 123.348 2.699 . . . . 0.0 109.532 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 m -129.53 155.19 46.18 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -69.94 3.37 2.7 Favored 'General case' 0 C--O 1.182 -2.455 0 CA-C-N 121.741 2.064 . . . . 0.0 111.824 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.606 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 1.8 tmtt? -60.0 -55.48 33.44 Favored 'General case' 0 C--O 1.275 2.43 0 CA-C-O 121.947 0.88 . . . . 0.0 111.228 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.734 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 1.7 tp10 -65.2 -52.3 55.64 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -176.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.485 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 93.1 m -42.89 -52.76 4.99 Favored 'General case' 0 C--O 1.187 -2.213 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.765 172.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 11.9 pt-20 -62.4 -55.47 27.6 Favored 'General case' 0 C--O 1.263 1.811 0 CA-C-N 118.689 0.677 . . . . 0.0 112.071 -175.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 34' ' ' GLU . 9.3 tp10 -58.93 -53.84 53.89 Favored 'General case' 0 C--O 1.254 1.311 0 CA-C-O 122.972 1.368 . . . . 0.0 108.235 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.734 ' HB ' ' O ' ' A' ' 32' ' ' GLU . 5.3 mt -64.24 -40.95 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.368 0 CA-C-N 112.527 -2.124 . . . . 0.0 113.331 -176.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.844 HG23 HG12 ' A' ' 55' ' ' ILE . 21.5 p -70.47 -37.7 74.31 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 120.214 1.37 . . . . 0.0 110.048 -177.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.4 m -63.45 -46.29 86.96 Favored 'General case' 0 N--CA 1.417 -2.08 0 O-C-N 123.966 0.791 . . . . 0.0 109.417 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.2 tp -73.03 -43.83 61.57 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.97 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.847 ' CE3' HD13 ' A' ' 78' ' ' LEU . 48.1 m0 -66.89 -70.24 0.26 Allowed 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 119.353 -0.356 . . . . 0.0 111.067 -177.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.652 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.294 0.0 OUTLIER -73.06 -19.26 61.21 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.832 -173.222 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.32 -50.89 59.03 Favored Glycine 0 C--N 1.357 1.726 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 172.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.462 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 60.9 p -69.64 -28.95 66.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.466 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.941 HD11 ' HG2' ' A' ' 53' ' ' ARG . 15.5 mt -62.49 -32.89 73.86 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.743 176.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.53 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 83.5 t80 -87.11 -31.56 20.38 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.057 0.456 . . . . 0.0 109.872 176.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 25.8 t-20 -67.21 -30.26 70.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.126 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.2 4.81 44.33 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 122.3 -0.25 . . . . 0.0 111.106 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.2 t30 56.92 47.14 18.32 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.048 0.939 . . . . 0.0 112.687 174.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.51 151.62 19.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.539 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 28.6 t70 -92.98 95.52 9.53 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 121.751 2.069 . . . . 0.0 109.115 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.68 HG11 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -146.84 162.75 8.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.009 -173.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.424 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 2.2 mp0 -126.38 121.34 32.22 Favored 'General case' 0 C--O 1.199 -1.574 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 174.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.941 ' HG2' HD11 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -127.9 136.99 52.13 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.29 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.688 ' N ' HG12 ' A' ' 62' ' ' ILE . 46.3 m-85 -133.3 152.63 51.94 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -163.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.844 HG12 HG23 ' A' ' 37' ' ' THR . 46.8 mt -91.53 96.89 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 169.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.2 m -102.67 -20.56 5.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.753 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.37 174.98 47.4 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 117.728 -2.177 . . . . 0.0 114.066 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 51.0 m -75.05 117.98 17.49 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.511 ' HB3' ' O ' ' A' ' 58' ' ' SER . 5.4 t70 80.02 7.69 1.61 Allowed 'General case' 0 C--N 1.365 1.26 0 O-C-N 124.272 0.982 . . . . 0.0 108.835 -174.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.517 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 1.5 tpp180 -130.37 117.46 19.76 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.669 -176.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.09 163.11 29.2 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.688 HG12 ' N ' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -135.86 157.38 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.38 0 C-N-CA 117.739 -1.585 . . . . 0.0 110.106 174.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.55 ' CE2' ' HB ' ' A' ' 74' ' ' ILE . 2.4 p90 -134.61 106.97 7.24 Favored 'General case' 0 N--CA 1.428 -1.567 0 O-C-N 126.192 2.183 . . . . 0.0 107.923 162.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.658 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 23.6 ttt -90.23 116.37 28.16 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 119.039 -0.505 . . . . 0.0 109.975 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.694 HD22 ' H ' ' A' ' 18' ' ' LEU . 1.1 pt? -90.75 144.49 25.67 Favored 'General case' 0 C--O 1.259 1.594 0 O-C-N 124.972 1.42 . . . . 0.0 112.202 -174.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.539 ' HB3' ' O ' ' A' ' 50' ' ' ASP 0.285 2.7 tmt_? -118.09 -53.32 2.37 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 125.575 1.797 . . . . 0.0 114.666 177.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.56 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 32.6 t70 -43.96 -19.87 0.02 OUTLIER 'General case' 0 CA--C 1.586 2.334 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.71 -25.55 4.53 Favored Glycine 0 C--N 1.358 1.788 0 CA-C-N 120.322 1.419 . . . . 0.0 115.384 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.821 ' HA ' HG23 ' A' ' 12' ' ' THR . 68.8 m -137.2 49.02 2.04 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -170.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.56 ' CE1' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -156.17 -0.48 0.14 Allowed 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.37 -0.831 . . . . 0.0 113.158 -176.877 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.563 ' CB ' HD12 ' A' ' 65' ' ' LEU . . . -86.11 -39.18 16.99 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 -169.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.916 ' HH2' HD21 ' A' ' 18' ' ' LEU 0.428 28.8 m-90 -80.95 -14.1 58.27 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 116.511 -2.076 . . . . 0.0 112.126 -171.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -71.88 -36.92 70.22 Favored 'General case' 0 C--O 1.279 2.653 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 166.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.65 ' O ' HD21 ' A' ' 78' ' ' LEU . 73.7 mt -57.58 -42.83 82.08 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.985 ' HG3' HG22 ' A' ' 87' ' ' VAL . 22.5 ttpp -51.87 -52.37 50.14 Favored 'General case' 0 C--N 1.374 1.644 0 C-N-CA 125.067 1.347 . . . . 0.0 109.441 177.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.07 -34.92 70.65 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.801 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.646 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 14.9 m-85 -74.02 -57.65 3.83 Favored 'General case' 0 CA--C 1.466 -2.287 0 C-N-CA 118.522 -1.271 . . . . 0.0 107.907 -169.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.847 HD13 ' CE3' ' A' ' 40' ' ' TRP . 1.8 pt? -68.51 -35.57 77.66 Favored 'General case' 0 N--CA 1.4 -2.966 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.731 -169.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 75' ' ' LYS 0.286 23.1 m -78.2 -19.99 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 116.594 -2.042 . . . . 0.0 110.67 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.9 m -95.22 5.61 51.29 Favored 'General case' 0 N--CA 1.411 -2.401 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.96 169.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.506 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . 7.5 tp-100 -89.03 -41.9 12.06 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -176.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.543 ' OD2' ' HG2' ' A' ' 83' ' ' ARG 0.386 17.7 t70 -140.35 -85.77 0.21 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.543 ' HG2' ' OD2' ' A' ' 82' ' ' ASP . 21.4 mmt180 -110.35 165.39 11.81 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.96 1.709 . . . . 0.0 109.836 176.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 79' ' ' VAL . 24.6 p -159.89 148.22 17.18 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.08 -54.31 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.862 1.265 . . . . 0.0 112.193 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.966 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 40.4 tt0 -154.96 123.15 5.9 Favored 'General case' 0 C--O 1.207 -1.173 0 C-N-CA 119.63 -0.828 . . . . 0.0 113.163 -169.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.985 HG22 ' HG3' ' A' ' 75' ' ' LYS . 62.0 t -112.0 104.51 17.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 173.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.589 ' O ' HD22 ' A' ' 89' ' ' LEU . 10.0 p -113.44 148.36 36.05 Favored 'General case' 0 C--O 1.266 1.954 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.742 ' CD1' ' HG ' ' A' ' 18' ' ' LEU 0.864 0.9 OUTLIER -137.63 156.68 47.79 Favored 'General case' 0 N--CA 1.44 -0.944 1 N-CA-C 122.567 4.284 . . . . 0.0 122.567 -177.612 . . . . . . . . 5 4 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.67 ' H ' HD23 ' A' ' 89' ' ' LEU 0.254 27.7 tt0 -81.63 160.08 23.86 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 110.652 -2.976 . . . . 0.0 110.026 -177.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 128.29 152.51 7.82 Favored Glycine 0 CA--C 1.545 1.957 0 CA-C-O 117.759 -1.579 . . . . 0.0 109.4 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -79.11 113.47 17.26 Favored 'General case' 0 C--N 1.366 1.289 0 CA-C-N 120.946 2.373 . . . . 0.0 107.054 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 52.7 ttm 67.35 84.36 0.15 Allowed 'General case' 0 C--N 1.316 -0.882 0 O-C-N 124.648 1.217 . . . . 0.0 109.971 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 73.9 t80 -105.28 106.43 55.83 Favored Pre-proline 0 C--N 1.299 -1.608 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.234 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -96.19 10.64 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.309 2.672 . . . . 0.0 113.749 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.64 37.49 3.42 Favored Glycine 0 C--O 1.241 0.592 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.1 tttt . . . . . 0 C--O 1.259 1.559 0 C-N-CA 123.583 0.753 . . . . 0.0 110.163 -175.0 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.466 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.77 -25.28 14.73 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.828 2.352 . . . . 0.0 113.394 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.45 -37.97 1.26 Allowed Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 20.2 pttp -110.37 121.42 41.48 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 173.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 5.4 Cg_exo -81.52 110.52 2.2 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.278 2.652 . . . . 0.0 112.457 -174.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.34 -26.73 4.59 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.787 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.0 m -62.69 -20.83 65.25 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.171 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.807 HG23 HD13 ' A' ' 9' ' ' LEU . 3.9 tp -47.69 -66.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.317 172.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.807 HD13 HG23 ' A' ' 8' ' ' ILE . 3.1 mp -84.96 -32.8 22.84 Favored 'General case' 0 CA--C 1.48 -1.737 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.109 -176.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -68.18 -15.8 63.73 Favored 'General case' 0 N--CA 1.433 -1.323 0 O-C-N 123.871 0.732 . . . . 0.0 112.333 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.2 ttt -112.45 -34.42 5.87 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.207 173.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.1 m -89.85 -55.6 3.57 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.519 ' HD3' ' O ' ' A' ' 14' ' ' LYS . 12.1 tmtt? 173.37 116.46 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -172.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.795 ' HA ' ' HB3' ' A' ' 9' ' ' LEU . 34.5 mtmm -82.61 169.9 15.75 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.22 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.29 55.44 12.67 Favored Glycine 0 CA--C 1.559 2.824 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.116 -173.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.514 ' HB2' ' HD2' ' A' ' 13' ' ' LYS . 54.2 tptt -128.28 122.93 32.82 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 119.345 1.573 . . . . 0.0 111.004 -177.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.735 HG21 ' HA ' ' A' ' 66' ' ' ARG . 19.3 p -72.33 135.65 45.97 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.428 174.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.742 HD11 ' HE2' ' A' ' 20' ' ' MET . 0.3 OUTLIER -134.24 116.6 15.5 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.447 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.2 ptm -94.63 119.1 32.75 Favored 'General case' 0 C--N 1.287 -2.125 0 O-C-N 121.623 -0.673 . . . . 0.0 109.195 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 1.095 ' HE3' HD23 ' A' ' 89' ' ' LEU . 1.3 pmm? -121.8 133.41 54.9 Favored 'General case' 0 C--O 1.281 2.753 0 C-N-CA 118.008 -1.477 . . . . 0.0 113.621 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -96.34 119.33 34.63 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.609 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -121.44 131.22 73.58 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.787 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.338 -176.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 1.055 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 97.1 m -99.46 151.88 20.62 Favored 'General case' 1 CA--C 1.648 4.748 0 C-N-CA 130.669 3.588 . . . . 0.0 112.31 -178.355 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.821 ' HB ' ' HG2' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -121.49 155.97 25.51 Favored 'Isoleucine or valine' 0 C--N 1.405 2.996 0 C-N-CA 126.246 1.818 . . . . 0.0 108.007 -168.415 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.697 ' OG ' ' HB3' ' A' ' 85' ' ' ALA . 54.2 m -108.18 168.92 8.95 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-N 120.628 1.558 . . . . 0.0 107.37 171.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.01 -88.5 0.47 Allowed Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 119.651 1.114 . . . . 0.0 112.198 174.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -115.78 113.04 42.47 Favored Pre-proline 0 N--CA 1.417 -2.076 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.75 30.27 0.32 Allowed 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 123.84 3.027 . . . . 0.0 112.982 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.515 ' OG1' ' HD2' ' A' ' 31' ' ' LYS . 70.2 p -128.41 -163.78 1.31 Allowed 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.523 ' HA ' ' HG1' ' A' ' 33' ' ' THR . 37.9 tt0 -84.24 1.8 42.98 Favored 'General case' 0 N--CA 1.421 -1.907 0 O-C-N 121.382 -0.824 . . . . 0.0 111.49 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.596 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -69.66 -44.93 69.54 Favored 'General case' 0 C--O 1.281 2.717 0 O-C-N 120.987 -1.071 . . . . 0.0 112.181 -177.857 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.686 ' HG3' HD11 ' A' ' 36' ' ' ILE . 3.2 tp10 -69.99 -44.08 70.12 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.71 ' HA ' HH21 ' A' ' 60' ' ' ARG . 20.1 m -44.02 -63.67 0.82 Allowed 'General case' 0 C--O 1.183 -2.422 0 CA-C-N 112.616 -2.083 . . . . 0.0 111.338 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.596 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 13.1 pt-20 -58.2 -52.82 63.98 Favored 'General case' 0 C--O 1.255 1.354 0 O-C-N 124.419 1.075 . . . . 0.0 113.125 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.642 ' HG3' HD12 ' A' ' 36' ' ' ILE . 8.8 pt-20 -66.41 -44.29 83.4 Favored 'General case' 0 C--O 1.27 2.151 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.699 -176.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.686 HD11 ' HG3' ' A' ' 32' ' ' GLU . 1.3 mp -66.43 -44.1 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.795 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.473 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.799 HG22 HG12 ' A' ' 55' ' ' ILE . 33.4 p -68.09 -39.79 82.77 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 120.039 1.291 . . . . 0.0 111.618 -175.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.3 p -60.98 -54.0 50.33 Favored 'General case' 0 C--O 1.262 1.719 0 O-C-N 124.276 0.985 . . . . 0.0 109.6 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.09 -44.21 96.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.411 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.619 ' CZ3' HD13 ' A' ' 78' ' ' LEU . 42.0 m0 -64.7 -74.99 0.09 Allowed 'General case' 0 C--O 1.205 -1.244 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.796 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.365 0.0 OUTLIER -70.68 -18.17 62.83 Favored 'General case' 0 C--O 1.255 1.349 0 C-N-CA 118.457 -1.297 . . . . 0.0 112.409 -172.185 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.9 -49.81 65.31 Favored Glycine 0 N--CA 1.432 -1.619 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 171.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.43 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 75.9 p -71.76 -26.83 62.61 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.333 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.796 ' HG ' ' HA ' ' A' ' 41' ' ' GLN . 28.7 mt -59.65 -37.88 79.91 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.702 176.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.483 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 86.6 t80 -86.26 -33.33 20.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.481 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 7.5 t30 -65.11 -34.66 78.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.07 9.1 20.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.926 0.393 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 59.88 35.49 21.81 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.709 1.203 . . . . 0.0 113.652 172.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.503 ' O ' HG13 ' A' ' 51' ' ' VAL . 13.7 m-85 -78.05 25.23 0.22 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 25.67 76.65 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.678 0 C-N-CA 126.811 2.045 . . . . 0.0 113.671 -177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.936 HG11 ' HA ' ' A' ' 65' ' ' LEU . 1.5 m -146.5 175.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.134 -173.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.495 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -134.33 120.9 20.47 Favored 'General case' 0 C--O 1.194 -1.853 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.739 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.75 131.16 35.19 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -169.737 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.736 ' H ' HG12 ' A' ' 62' ' ' ILE . 36.4 t80 -136.59 148.62 47.61 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 118.835 -1.146 . . . . 0.0 113.901 -164.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.799 HG12 HG22 ' A' ' 37' ' ' THR . 71.5 mt -80.39 123.28 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 170.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.21 -29.2 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.15 152.83 20.1 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.835 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 49.5 m -85.08 82.27 8.5 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.032 0.444 . . . . 0.0 110.505 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.495 ' HB2' HG13 ' A' ' 24' ' ' VAL . 0.3 OUTLIER 158.81 -32.35 0.0 OUTLIER 'General case' 0 N--CA 1.384 -3.742 0 N-CA-C 101.467 -3.531 . . . . 0.0 101.467 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.821 ' HG2' ' HB ' ' A' ' 24' ' ' VAL 0.457 1.1 mmp_? -145.41 -179.64 6.79 Favored 'General case' 0 C--N 1.391 2.41 1 N-CA-C 124.954 5.168 . . . . 0.0 124.954 -167.91 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.468 ' N ' ' HD3' ' A' ' 60' ' ' ARG . . . -152.6 172.44 16.6 Favored 'General case' 0 C--N 1.382 2.002 0 CA-C-N 112.526 -2.125 . . . . 0.0 111.449 -160.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.736 HG12 ' H ' ' A' ' 54' ' ' PHE . 13.7 pt -123.12 158.55 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.439 -3.307 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.52 ' CE2' ' HB ' ' A' ' 74' ' ' ILE 0.288 4.0 p90 -123.21 121.15 35.2 Favored 'General case' 0 N--CA 1.401 -2.893 0 O-C-N 126.447 2.342 . . . . 0.0 105.742 160.45 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.458 ' HB3' ' O ' ' A' ' 52' ' ' GLN . 1.3 tmt? -105.6 117.48 34.13 Favored 'General case' 0 C--N 1.273 -2.752 0 O-C-N 120.98 -1.075 . . . . 0.0 109.528 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 1.125 HD11 ' HB3' ' A' ' 71' ' ' ALA . 2.4 pt? -104.53 148.31 26.62 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.735 ' HA ' HG21 ' A' ' 17' ' ' THR 0.28 45.7 ttm105 -112.88 -55.47 2.52 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.605 -2.543 . . . . 0.0 115.291 -174.474 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -44.86 -21.11 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.659 0 CA-C-N 120.6 1.545 . . . . 0.0 115.019 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.413 ' O ' HD22 ' A' ' 9' ' ' LEU . . . 85.64 -31.93 3.79 Favored Glycine 0 N--CA 1.426 -1.968 0 O-C-N 120.907 -1.121 . . . . 0.0 113.965 -175.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 m -121.03 69.43 0.89 Allowed 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -166.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.914 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -179.82 2.14 0.01 OUTLIER 'General case' 0 C--N 1.381 1.965 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 179.376 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 1.125 ' HB3' HD11 ' A' ' 65' ' ' LEU . . . -85.18 -34.94 21.97 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -171.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.573 ' CE2' HD21 ' A' ' 89' ' ' LEU . 13.8 m-90 -72.4 -28.39 62.95 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-O 122.287 1.041 . . . . 0.0 110.343 -175.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.415 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 44.1 tt0 -69.03 -43.29 75.03 Favored 'General case' 0 C--O 1.258 1.552 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.55 171.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.52 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 84.2 mt -56.66 -42.15 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.109 0 CA-C-O 121.695 0.76 . . . . 0.0 109.787 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.671 ' HE2' ' HB ' ' A' ' 87' ' ' VAL . 52.7 tttm -56.49 -51.43 68.52 Favored 'General case' 0 C--O 1.282 2.802 0 C-N-CA 124.79 1.236 . . . . 0.0 109.707 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -55.15 -47.37 75.22 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.555 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 11.4 m-85 -53.55 -59.44 4.59 Favored 'General case' 0 C--N 1.366 1.292 0 O-C-N 123.872 0.733 . . . . 0.0 109.353 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.619 HD13 ' CZ3' ' A' ' 40' ' ' TRP . 16.4 mt -52.89 -53.37 50.15 Favored 'General case' 0 C--O 1.3 3.732 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -172.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.516 ' HB ' ' CB ' ' A' ' 84' ' ' CYS 0.308 27.8 m -75.8 -9.38 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.198 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.873 -177.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.2 m -100.23 2.32 42.68 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.599 166.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 69.9 mm-40 -91.04 -40.89 11.38 Favored 'General case' 0 CA--C 1.439 -3.309 0 C-N-CA 118.909 -1.117 . . . . 0.0 109.519 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.412 35.6 t70 -155.91 -90.72 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.543 ' HB2' HG23 ' A' ' 24' ' ' VAL . 31.8 mmt180 -102.09 144.24 30.91 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 120.747 1.612 . . . . 0.0 110.559 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.516 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 10.6 p -140.59 135.64 31.98 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.697 ' HB3' ' OG ' ' A' ' 25' ' ' SER . . . -149.85 -51.67 0.15 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 1.055 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 32.9 tt0 -154.75 116.52 4.14 Favored 'General case' 0 C--O 1.181 -2.517 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.538 -173.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.671 ' HB ' ' HE2' ' A' ' 75' ' ' LYS . 14.2 t -111.4 102.21 13.64 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.7 p -109.84 125.19 52.5 Favored 'General case' 0 CA--C 1.473 -1.994 0 C-N-CA 117.619 -1.632 . . . . 0.0 112.023 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 1.095 HD23 ' HE3' ' A' ' 20' ' ' MET . 4.1 mp -106.72 154.14 21.39 Favored 'General case' 1 N--CA 1.371 -4.41 0 CA-C-N 112.257 -2.247 . . . . 0.0 107.667 -176.02 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.29 163.03 23.23 Favored 'General case' 0 C--N 1.261 -3.272 0 C-N-CA 124.792 1.237 . . . . 0.0 109.695 -175.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.87 172.36 22.54 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -88.24 109.0 19.58 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 121.169 2.484 . . . . 0.0 106.714 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 27.2 ttt 54.98 75.91 0.28 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.392 1.057 . . . . 0.0 108.213 -171.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.603 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 54.7 t80 -80.77 117.67 69.0 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.467 -175.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 94' ' ' TYR . 40.0 Cg_endo -103.37 162.14 0.25 Allowed 'Trans proline' 0 CA--C 1.553 1.475 0 C-N-CA 123.679 2.919 . . . . 0.0 112.237 173.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.55 79.99 1.33 Allowed Glycine 0 C--N 1.313 -0.726 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.288 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.622 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.418 ' HA3' ' SD ' ' A' ' 93' ' ' MET . . . . . . . . 0 CA--C 1.505 -0.542 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -70.87 -25.5 23.38 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.71 2.274 . . . . 0.0 112.909 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.74 28.16 69.57 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -75.75 137.72 70.09 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.406 ' CB ' ' HE3' ' A' ' 11' ' ' MET . 67.0 Cg_endo -78.98 40.81 0.98 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.437 2.758 . . . . 0.0 114.034 -171.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 47.7 mt-10 -82.03 -14.74 55.48 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 158.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.0 m -58.21 158.37 7.17 Favored 'General case' 0 CA--C 1.589 2.467 0 CA-C-N 112.415 -2.175 . . . . 0.0 105.772 167.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.89 HG21 ' HA ' ' A' ' 11' ' ' MET 0.296 8.8 tp 40.56 46.79 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.285 2.959 0 C-N-CA 124.577 1.151 . . . . 0.0 111.462 -167.306 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.789 HD11 ' HA ' ' A' ' 13' ' ' LYS 0.276 1.6 pp 51.43 63.05 2.4 Favored 'General case' 0 C--N 1.399 2.754 0 CA-C-O 122.717 1.246 . . . . 0.0 112.635 171.409 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.604 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER 61.93 32.63 17.79 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 112.367 -2.197 . . . . 0.0 111.885 -177.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.89 ' HA ' HG21 ' A' ' 8' ' ' ILE . 56.1 ttm 58.72 24.19 11.94 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.743 -177.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.4 m -158.92 -67.26 0.08 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.208 -1.557 . . . . 0.0 114.245 -170.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.789 ' HA ' HD11 ' A' ' 9' ' ' LEU . 59.8 tttp -179.52 124.81 0.08 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.069 0.395 . . . . 0.0 110.313 -174.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -151.12 179.59 8.15 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.04 52.17 0.86 Allowed Glycine 0 CA--C 1.536 1.36 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -89.07 135.76 33.38 Favored 'General case' 0 C--O 1.205 -1.26 0 CA-C-N 117.726 0.763 . . . . 0.0 109.84 -174.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.444 HG23 ' HE2' ' A' ' 64' ' ' MET . 93.0 m -65.46 117.93 8.68 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.867 ' HG ' ' HH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -126.65 111.91 14.86 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.58 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 21.9 ptm -94.9 114.97 26.88 Favored 'General case' 0 C--N 1.277 -2.558 0 O-C-N 121.112 -0.992 . . . . 0.0 109.401 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.69 ' HE2' HD21 ' A' ' 89' ' ' LEU . 29.8 ttm -97.66 119.21 35.83 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.107 -176.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.429 ' HA ' HG21 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -107.02 119.17 38.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.022 1.729 . . . . 0.0 106.758 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.556 HG22 HG22 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -127.54 128.53 69.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -175.505 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.908 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 48.8 m -85.97 142.39 28.83 Favored 'General case' 0 CA--C 1.6 2.892 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.382 176.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.409 HG13 ' HB2' ' A' ' 83' ' ' ARG 0.283 42.0 t -132.27 140.51 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 C-N-CA 125.414 1.486 . . . . 0.0 108.687 -170.778 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.526 20.8 t -109.55 -110.34 0.33 Allowed 'General case' 0 C--N 1.369 1.45 0 CA-C-N 122.957 2.617 . . . . 0.0 113.523 168.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.571 ' HA3' ' HG3' ' A' ' 83' ' ' ARG . . . 63.05 -72.34 0.03 OUTLIER Glycine 0 CA--C 1.543 1.827 0 CA-C-N 120.802 1.637 . . . . 0.0 112.402 -173.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.782 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 55.4 t30 -116.76 132.44 23.39 Favored Pre-proline 0 N--CA 1.416 -2.143 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 176.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -91.75 41.76 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.557 1.505 . . . . 0.0 113.298 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.5 p -125.18 -129.73 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 117.828 -1.549 . . . . 0.0 111.141 -173.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.534 ' O ' ' HB ' ' A' ' 33' ' ' THR . 31.2 tt0 -133.76 11.83 4.02 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 171.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 8.9 tmtt? -86.13 -36.95 19.26 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 122.231 1.015 . . . . 0.0 108.337 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.788 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -65.98 -46.07 79.37 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 175.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.534 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 58.8 m -45.28 -54.35 7.19 Favored 'General case' 0 C--O 1.193 -1.87 0 C-N-CA 125.696 1.598 . . . . 0.0 111.655 170.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 12.9 pt-20 -63.6 -49.72 72.23 Favored 'General case' 0 C--O 1.257 1.46 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -59.14 -55.66 32.09 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.749 1.261 . . . . 0.0 108.265 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.788 ' HB ' ' O ' ' A' ' 32' ' ' GLU . 3.1 mt -62.41 -42.81 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.123 0 CA-C-N 112.997 -1.911 . . . . 0.0 112.529 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.799 HG21 HG12 ' A' ' 55' ' ' ILE . 17.9 p -70.98 -39.56 72.41 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 120.819 1.645 . . . . 0.0 111.703 -176.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.8 p -63.27 -52.5 61.8 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.922 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.7 tp -63.7 -45.56 89.45 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.089 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.798 ' CE3' HD12 ' A' ' 78' ' ' LEU . 45.3 m0 -63.26 -74.52 0.09 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 119.364 -0.351 . . . . 0.0 111.52 -178.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.734 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.311 0.0 OUTLIER -71.06 -19.87 62.43 Favored 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.896 -1.122 . . . . 0.0 112.501 -172.279 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.45 -51.53 53.72 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 173.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.3 p -68.7 -30.92 69.68 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.261 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.768 HD13 ' HG2' ' A' ' 53' ' ' ARG . 33.5 mt -58.66 -37.16 75.37 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.319 177.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.67 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 64.1 t80 -85.64 -32.56 21.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.873 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.41 -37.4 86.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.4 2.03 51.63 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.123 0.487 . . . . 0.0 110.626 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.3 t30 58.99 51.8 6.9 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.951 1.3 . . . . 0.0 112.116 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -84.34 37.09 0.61 Allowed 'General case' 0 CA--C 1.558 1.258 0 O-C-N 120.903 -1.123 . . . . 0.0 113.473 175.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.2 t70 27.1 71.02 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 C-N-CA 126.397 1.879 . . . . 0.0 114.087 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.735 HG22 ' HD2' ' A' ' 53' ' ' ARG . 1.3 m -147.66 169.57 3.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.329 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.5 ' O ' ' HB3' ' A' ' 64' ' ' MET . 0.5 OUTLIER -122.12 126.26 47.98 Favored 'General case' 0 C--O 1.189 -2.107 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 175.03 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.768 ' HG2' HD13 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -133.29 135.8 45.09 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -173.377 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.669 ' H ' HG12 ' A' ' 62' ' ' ILE . 44.5 t80 -135.4 151.55 50.57 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 119.245 -0.982 . . . . 0.0 113.208 -164.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.799 HG12 HG21 ' A' ' 37' ' ' THR . 43.2 mt -87.01 96.86 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 172.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 m -89.51 -32.28 5.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -163.3 167.68 37.68 Favored Glycine 0 CA--C 1.489 -1.573 0 C-N-CA 117.402 -2.333 . . . . 0.0 114.663 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -70.69 104.12 2.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 0.1 OUTLIER 91.99 18.73 0.03 OUTLIER 'General case' 0 C--N 1.36 1.027 0 C-N-CA 128.378 2.671 . . . . 0.0 110.101 -177.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.702 ' HG2' ' HA ' ' A' ' 23' ' ' THR . 17.8 mtm180 -146.07 132.0 19.17 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.53 165.36 25.07 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.251 -173.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.669 HG12 ' H ' ' A' ' 54' ' ' PHE . 6.0 pt -140.64 158.8 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.414 0 C-N-CA 118.283 -1.367 . . . . 0.0 110.634 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.57 ' CE2' ' HB ' ' A' ' 74' ' ' ILE . 1.1 p90 -133.81 106.72 7.47 Favored 'General case' 0 N--CA 1.423 -1.785 0 O-C-N 126.31 2.256 . . . . 0.0 108.065 162.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.58 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 1.2 tmt? -83.8 112.75 20.38 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 113.022 -1.899 . . . . 0.0 107.66 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.867 HD13 ' HB1' ' A' ' 71' ' ' ALA 0.329 2.3 pt? -109.26 147.73 32.15 Favored 'General case' 0 CA--C 1.468 -2.207 0 CA-C-O 123.487 1.613 . . . . 0.0 114.988 -177.183 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 66' ' ' ARG . 40.2 ttm180 -100.82 -53.14 3.13 Favored 'General case' 0 C--N 1.252 -3.673 0 CA-C-N 110.365 -3.107 . . . . 0.0 112.539 -174.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.43 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 16.1 t70 -39.8 -24.85 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 114.725 1.379 . . . . 0.0 114.725 165.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.67 -34.19 0.71 Allowed Glycine 0 C--O 1.202 -1.901 0 C-N-CA 123.842 0.734 . . . . 0.0 114.761 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 15.2 p -96.96 -49.1 5.16 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 119.493 3.145 . . . . 0.0 119.493 -173.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.441 ' CD1' HD11 ' A' ' 65' ' ' LEU . 0.0 OUTLIER -65.46 10.14 0.1 Allowed 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -172.21 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.867 ' HB1' HD13 ' A' ' 65' ' ' LEU . . . -84.71 -23.14 29.47 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 121.156 -0.965 . . . . 0.0 113.15 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.867 ' HH2' ' HG ' ' A' ' 18' ' ' LEU . 5.8 m-90 -67.63 -41.14 84.36 Favored 'General case' 0 C--O 1.277 2.547 0 CA-C-O 121.857 0.837 . . . . 0.0 111.035 -176.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.559 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 42.9 tt0 -67.21 -44.82 78.59 Favored 'General case' 0 C--O 1.295 3.461 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.625 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 90.5 mt -51.32 -49.75 29.9 Favored 'Isoleucine or valine' 0 C--O 1.281 2.762 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.719 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.529 ' HA ' ' CD2' ' A' ' 78' ' ' LEU . 21.2 pttp -63.57 -40.03 95.91 Favored 'General case' 0 C--N 1.383 2.063 0 CA-C-O 121.586 0.708 . . . . 0.0 110.522 -174.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.59 -34.41 72.7 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.496 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.625 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 21.6 m-85 -69.68 -69.61 0.33 Allowed 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -172.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.798 HD12 ' CE3' ' A' ' 40' ' ' TRP . 2.4 pt? -64.33 -34.71 78.78 Favored 'General case' 0 C--O 1.272 2.246 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.704 -167.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.627 ' O ' ' HB3' ' A' ' 84' ' ' CYS . 34.6 t -83.63 -25.05 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 C-N-CA 117.903 -1.519 . . . . 0.0 109.304 -172.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.8 m -96.16 7.84 45.39 Favored 'General case' 0 N--CA 1.407 -2.615 0 C-N-CA 117.673 -1.611 . . . . 0.0 108.562 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.745 HE21 ' HA ' ' A' ' 81' ' ' GLN . 0.0 OUTLIER -91.12 -52.63 4.73 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.094 -178.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.453 ' OD1' ' HG2' ' A' ' 83' ' ' ARG 0.388 9.2 t70 -110.9 -95.13 0.43 Allowed 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.045 -1.062 . . . . 0.0 112.192 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.571 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 52.9 mmt-85 -112.98 152.86 28.91 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 121.425 1.921 . . . . 0.0 111.49 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.627 ' HB3' ' O ' ' A' ' 79' ' ' VAL . 13.0 p -138.03 160.67 38.75 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.011 -172.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.79 -54.39 0.02 OUTLIER 'General case' 0 C--N 1.379 1.865 0 C-N-CA 124.133 0.973 . . . . 0.0 113.001 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.908 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 34.8 tt0 -155.66 131.01 9.55 Favored 'General case' 0 C--O 1.208 -1.119 0 O-C-N 121.874 -0.516 . . . . 0.0 110.946 -170.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.461 HG13 ' HB ' ' A' ' 22' ' ' VAL . 16.0 m -115.01 115.28 49.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.222 172.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.494 ' C ' HD11 ' A' ' 89' ' ' LEU 0.28 32.2 p -112.28 123.91 51.3 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 123.207 1.479 . . . . 0.0 112.022 172.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.69 HD21 ' HE2' ' A' ' 20' ' ' MET . 6.0 mp -113.19 156.48 23.17 Favored 'General case' 0 N--CA 1.39 -3.44 0 CA-C-N 113.091 -1.868 . . . . 0.0 110.271 -170.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.569 ' HB3' HD13 ' A' ' 18' ' ' LEU . 9.1 tp10 -81.06 167.9 19.24 Favored 'General case' 0 C--N 1.257 -3.415 0 C-N-CA 125.615 1.566 . . . . 0.0 111.607 -174.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 146.66 171.11 15.64 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -87.22 109.17 19.3 Favored 'General case' 0 C--N 1.364 1.215 0 CA-C-N 121.777 2.788 . . . . 0.0 107.667 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.418 ' SD ' ' HA3' ' A' ' 1' ' ' GLY . 47.4 ttm 54.18 77.7 0.18 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.037 0.922 . . . . 0.0 109.737 -171.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.66 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 26.9 t80 -83.65 114.25 52.43 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.741 -175.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 94' ' ' TYR . 4.2 Cg_endo -89.87 -21.11 1.07 Allowed 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.879 2.386 . . . . 0.0 111.988 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.499 ' HA2' ' CZ ' ' A' ' 94' ' ' TYR . . . 133.37 -131.49 6.11 Favored Glycine 0 N--CA 1.411 -3.003 0 N-CA-C 107.714 -2.155 . . . . 0.0 107.714 -173.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? . . . . . 0 C--N 1.281 -2.391 0 CA-C-O 117.011 -1.471 . . . . 0.0 109.211 178.771 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.705 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.84 -25.73 23.29 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.716 2.277 . . . . 0.0 112.314 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.09 29.11 9.82 Favored Glycine 0 C--O 1.243 0.668 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.475 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 21.6 ptmt -66.14 136.99 95.55 Favored Pre-proline 0 C--O 1.254 1.311 0 C-N-CA 123.17 0.588 . . . . 0.0 110.129 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 31.6 Cg_exo -62.41 150.02 88.78 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.519 2.146 . . . . 0.0 113.368 -177.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.629 ' HA ' HD21 ' A' ' 9' ' ' LEU 0.251 42.9 mt-10 73.79 -39.41 0.43 Allowed 'General case' 0 C--O 1.244 0.786 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 176.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.511 ' HA ' ' HG3' ' A' ' 10' ' ' LYS . 66.2 m -63.94 -36.39 83.78 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.448 ' H ' HG12 ' A' ' 8' ' ' ILE 0.265 0.4 OUTLIER -70.05 -38.71 75.92 Favored 'Isoleucine or valine' 0 C--O 1.255 1.351 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -178.39 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.629 HD21 ' HA ' ' A' ' 6' ' ' GLU . 2.4 pt? -79.21 -29.31 42.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 118.316 -1.353 . . . . 0.0 111.273 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.511 ' HG3' ' HA ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -74.77 -21.21 59.45 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 118.771 -1.171 . . . . 0.0 110.158 175.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 ttt -76.96 -44.23 32.1 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.089 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.611 HG23 ' HD3' ' A' ' 16' ' ' LYS . 18.1 m -97.69 -10.36 25.13 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 119.221 -0.991 . . . . 0.0 113.386 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 52.34 -155.52 0.17 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 125.15 1.38 . . . . 0.0 112.92 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.753 ' HA ' ' HA3' ' A' ' 68' ' ' GLY . 37.3 ttpt -67.65 -11.05 57.36 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.676 0.75 . . . . 0.0 111.332 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.31 40.45 2.84 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.761 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.611 ' HD3' HG23 ' A' ' 12' ' ' THR . 58.2 tptt -129.97 143.77 50.97 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 117.775 0.788 . . . . 0.0 110.633 -175.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 p -117.33 121.46 41.2 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.72 HD12 ' HB3' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -134.59 108.14 7.89 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -173.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.1 ptm -84.1 100.95 11.45 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.542 ' HE3' ' HG ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -88.79 138.69 31.18 Favored 'General case' 0 C--O 1.25 1.123 0 C-N-CA 117.029 -1.868 . . . . 0.0 111.043 -171.533 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -109.52 113.45 26.25 Favored 'General case' 0 C--O 1.267 2.013 0 O-C-N 125.245 1.59 . . . . 0.0 108.723 -174.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -117.44 123.86 72.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.77 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 1.069 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 92.3 m -98.12 133.99 41.8 Favored 'General case' 0 CA--C 1.608 3.197 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.138 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.872 HG11 HD12 ' A' ' 36' ' ' ILE . 91.1 t -130.95 101.47 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.409 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 2.6 t -118.92 7.05 11.41 Favored 'General case' 0 C--N 1.361 1.108 0 CA-C-N 122.286 2.312 . . . . 0.0 114.042 -166.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.45 -46.21 52.87 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 174.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 1.054 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 16.4 t-20 -115.21 104.11 53.93 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 167.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.423 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 2.7 Cg_endo -82.23 24.52 0.71 Allowed 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 123.52 2.813 . . . . 0.0 113.351 -173.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.435 ' C ' ' HB3' ' A' ' 58' ' ' SER . 6.9 p -125.12 -162.51 1.11 Allowed 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.295 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -73.61 -29.22 62.25 Favored 'General case' 0 C--O 1.194 -1.844 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.58 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -59.56 -48.09 83.03 Favored 'General case' 0 C--O 1.263 1.768 0 CA-C-N 119.167 0.894 . . . . 0.0 112.726 -171.133 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 1.054 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 2.8 tp10 -64.01 -49.36 72.74 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.5 m -52.1 -46.06 65.12 Favored 'General case' 0 C--O 1.192 -1.93 0 CA-C-N 113.445 -1.707 . . . . 0.0 111.351 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.58 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 16.3 pt-20 -75.99 -31.32 58.92 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -75.55 -47.36 27.11 Favored 'General case' 0 C--O 1.279 2.651 0 N-CA-C 101.238 -3.616 . . . . 0.0 101.238 -174.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.872 HD12 HG11 ' A' ' 24' ' ' VAL 1.532 1.5 pp -57.19 -57.31 10.47 Favored 'Isoleucine or valine' 1 N--CA 1.309 -7.487 0 N-CA-C 120.917 3.673 . . . . 0.0 120.917 175.159 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.521 ' HA ' ' HB2' ' A' ' 40' ' ' TRP . 39.6 p -67.84 -31.42 71.24 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 t -64.85 -46.54 81.45 Favored 'General case' 0 N--CA 1.424 -1.737 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.074 176.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.7 mt -67.76 -46.29 72.46 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.901 178.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.724 ' HB3' ' NH1' ' A' ' 53' ' ' ARG . 37.8 m0 -57.3 -67.72 0.3 Allowed 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.943 -1.481 . . . . 0.0 114.837 -175.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.443 ' O ' ' HD1' ' A' ' 45' ' ' PHE 0.331 0.0 OUTLIER -78.9 -17.5 55.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 117.102 -1.839 . . . . 0.0 110.677 -176.513 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.95 -59.43 9.38 Favored Glycine 0 CA--C 1.472 -2.596 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 170.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.3 m -74.79 -36.85 62.49 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-N 113.245 -1.478 . . . . 0.0 112.496 -175.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 1.005 HD12 ' HD2' ' A' ' 53' ' ' ARG . 12.7 mt -61.1 -33.54 73.52 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.209 178.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.496 ' HZ ' ' HA ' ' A' ' 52' ' ' GLN . 53.0 m-85 -87.11 -32.18 20.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.348 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -70.19 -29.98 66.98 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.12 8.4 15.67 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.079 0.466 . . . . 0.0 110.898 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 t30 67.38 52.21 0.83 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.176 1.391 . . . . 0.0 113.538 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -100.59 154.34 18.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.35 -1.469 . . . . 0.0 107.852 170.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.518 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 30.2 t70 -92.54 83.62 4.95 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 120.02 1.282 . . . . 0.0 109.407 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.77 174.36 12.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.205 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.496 ' HA ' ' HZ ' ' A' ' 45' ' ' PHE . 0.9 OUTLIER -134.22 140.2 46.32 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 169.359 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 1.005 ' HD2' HD12 ' A' ' 44' ' ' LEU . 35.7 mtp180 -142.91 139.55 30.82 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 118.958 0.799 . . . . 0.0 109.735 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.638 ' H ' HG12 ' A' ' 62' ' ' ILE . 50.1 m-85 -132.33 151.38 51.87 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.044 -1.462 . . . . 0.0 114.099 -169.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 57.8 mt -99.19 96.41 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 170.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.46 HG22 ' HB3' ' A' ' 60' ' ' ARG . 4.7 m -98.16 -23.14 4.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.048 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.94 161.57 35.39 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 118.524 -1.798 . . . . 0.0 112.159 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.435 ' HB3' ' C ' ' A' ' 29' ' ' THR . 51.1 m -75.64 106.48 7.23 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.49 ' O ' ' HD2' ' A' ' 60' ' ' ARG 0.271 0.0 OUTLIER 98.42 5.04 0.02 OUTLIER 'General case' 0 C--N 1.366 1.283 0 C-N-CA 127.0 2.12 . . . . 0.0 110.188 -174.167 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.49 ' HD2' ' O ' ' A' ' 59' ' ' ASP . 5.8 mpt_? -134.11 123.04 23.77 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.95 0.9 . . . . 0.0 112.131 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.09 168.18 17.16 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.638 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -141.16 153.24 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.45 -2.878 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.954 172.291 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.95 ' HA ' ' HG2' ' A' ' 53' ' ' ARG 0.27 31.2 p90 -129.45 108.62 10.41 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 127.114 2.759 . . . . 0.0 108.665 163.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.442 ' HB3' ' HB2' ' A' ' 52' ' ' GLN . 26.5 ttt -92.42 119.75 32.25 Favored 'General case' 0 C--O 1.27 2.158 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.555 HD23 ' HB3' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -81.65 122.06 27.14 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 128.956 2.902 . . . . 0.0 110.161 178.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.518 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.253 23.6 ttt180 -105.44 -49.5 3.42 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 172.091 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -75.87 50.88 0.6 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.079 1.309 . . . . 0.0 112.777 179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.753 ' HA3' ' HA ' ' A' ' 14' ' ' LYS . . . 58.58 -34.66 0.02 OUTLIER Glycine 0 CA--C 1.55 2.233 0 N-CA-C 120.991 3.157 . . . . 0.0 120.991 173.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 9' ' ' LEU . 62.0 m -163.07 51.65 0.17 Allowed 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 120.189 1.995 . . . . 0.0 116.384 -171.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.463 ' HE1' ' HA ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -122.01 13.83 10.6 Favored 'General case' 0 C--O 1.213 -0.849 0 O-C-N 120.286 -1.508 . . . . 0.0 112.306 177.861 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.765 ' HA ' HD11 ' A' ' 74' ' ' ILE . . . -102.14 -12.94 17.69 Favored 'General case' 0 C--O 1.197 -1.661 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -169.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.655 ' CE3' HD12 ' A' ' 89' ' ' LEU . 8.5 m95 -84.85 -31.0 24.02 Favored 'General case' 0 C--N 1.27 -2.872 0 O-C-N 120.536 -1.353 . . . . 0.0 109.102 -166.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -75.11 -33.81 61.64 Favored 'General case' 0 C--O 1.257 1.464 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.765 HD11 ' HA ' ' A' ' 71' ' ' ALA . 54.2 mt -59.01 -39.73 79.01 Favored 'Isoleucine or valine' 0 C--O 1.264 1.855 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.004 175.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.904 ' HD2' HD11 ' A' ' 89' ' ' LEU . 32.9 tttm -57.05 -53.21 60.62 Favored 'General case' 0 C--O 1.275 2.447 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.267 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -55.08 -46.94 75.49 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.821 1.326 . . . . 0.0 112.284 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.458 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 13.0 m-85 -56.74 -55.91 28.13 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.559 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.643 HD22 ' NE1' ' A' ' 40' ' ' TRP . 9.5 mt -58.53 -48.55 80.48 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.505 HG22 ' O ' ' A' ' 75' ' ' LYS 0.281 18.3 m -78.99 -6.26 9.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 116.558 -2.057 . . . . 0.0 113.136 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.0 m -106.68 4.02 27.37 Favored 'General case' 0 N--CA 1.423 -1.777 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.698 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -118.45 -25.02 6.62 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 117.374 -1.731 . . . . 0.0 111.149 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -139.73 -164.1 1.62 Allowed 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.728 ' HB3' HG12 ' A' ' 24' ' ' VAL . 23.2 tpp180 -60.56 136.15 57.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 118.858 0.754 . . . . 0.0 111.009 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.419 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 18.2 p -130.57 146.21 52.04 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -174.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.29 -38.62 0.09 Allowed 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 122.71 0.404 . . . . 0.0 111.157 170.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 1.069 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 39.9 tt0 -153.24 129.0 10.13 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.745 -176.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.16 92.68 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.3 p -116.78 111.34 19.61 Favored 'General case' 0 C--O 1.257 1.487 0 CA-C-O 121.926 0.869 . . . . 0.0 110.816 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.904 HD11 ' HD2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -103.47 89.27 3.32 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.384 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.931 ' HB3' ' HB3' ' A' ' 94' ' ' TYR . 10.3 tp10 -149.56 172.63 14.7 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 163.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.11 -55.75 2.86 Favored Glycine 0 N--CA 1.415 -2.755 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.435 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -113.02 158.61 20.08 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 118.496 1.148 . . . . 0.0 111.16 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.0 tpt 71.12 -71.14 0.14 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.429 1.492 . . . . 0.0 113.182 174.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.931 ' HB3' ' HB3' ' A' ' 90' ' ' GLU . 14.2 t80 -49.39 -46.99 78.13 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 124.614 1.166 . . . . 0.0 112.471 -176.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.594 ' HG3' ' O ' ' A' ' 90' ' ' GLU . 4.3 Cg_endo -102.46 19.5 0.2 Allowed 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 121.978 1.785 . . . . 0.0 113.743 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.68 55.16 0.24 Allowed Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 119.674 -1.25 . . . . 0.0 111.836 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 C--N 1.293 -1.863 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.515 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.277 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.818 ' HD2' ' HB2' ' A' ' 7' ' ' SER . 4.7 Cg_exo -78.77 -163.88 0.25 Allowed 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.481 2.787 . . . . 0.0 111.904 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.02 -41.28 4.09 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.227 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.518 ' HD2' ' HG2' ' A' ' 6' ' ' GLU . 30.3 ttmt -86.15 138.33 34.67 Favored Pre-proline 0 N--CA 1.44 -0.931 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -80.36 40.87 1.03 Allowed 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.126 2.551 . . . . 0.0 112.789 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.518 ' HG2' ' HD2' ' A' ' 4' ' ' LYS . 10.0 pt-20 -85.47 -4.26 59.11 Favored 'General case' 0 C--O 1.247 0.96 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 160.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.818 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 85.2 p -75.76 174.2 10.14 Favored 'General case' 1 N--CA 1.375 -4.221 0 CA-C-N 111.87 -2.423 . . . . 0.0 106.676 -175.617 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.413 HD11 ' HA ' ' A' ' 8' ' ' ILE 0.264 8.7 tp 31.95 49.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 C-N-CA 126.256 1.822 . . . . 0.0 111.617 -164.457 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 9' ' ' LEU 0.348 2.9 pp 55.82 64.77 1.63 Allowed 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 122.971 1.367 . . . . 0.0 114.516 174.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt 63.39 47.78 3.79 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.531 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.0 mtt 67.58 34.11 4.73 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 123.598 0.561 . . . . 0.0 110.201 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.817 HG22 ' HA ' ' A' ' 69' ' ' SER . 6.1 m 74.44 25.26 1.67 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.893 1.277 . . . . 0.0 110.362 177.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -137.37 92.3 2.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.213 -0.929 . . . . 0.0 113.013 -174.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HG2' ' HB2' ' A' ' 9' ' ' LEU . 17.6 ptpt -155.69 -6.05 0.12 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.483 173.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.04 69.62 1.24 Allowed Glycine 0 CA--C 1.559 2.837 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.342 -175.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -125.79 133.02 52.17 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 119.822 1.811 . . . . 0.0 111.251 -174.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.9 p -65.59 114.49 4.96 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.381 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.73 ' HB3' HD21 ' A' ' 65' ' ' LEU . 0.2 OUTLIER -128.02 108.21 10.48 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.465 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 25.1 ptm -93.6 108.8 20.47 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.845 ' HB2' ' HA ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -106.93 143.09 35.52 Favored 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 116.703 -1.999 . . . . 0.0 112.742 -173.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.431 ' CE2' ' HD3' ' A' ' 60' ' ' ARG . 1.1 t80 -114.91 114.72 25.85 Favored 'General case' 0 C--O 1.26 1.609 0 C-N-CA 128.079 2.552 . . . . 0.0 109.863 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.737 HG23 ' SD ' ' A' ' 20' ' ' MET . 3.6 t -104.0 131.65 52.25 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.33 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 1.05 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 97.7 m -99.83 129.76 45.96 Favored 'General case' 0 CA--C 1.594 2.635 0 O-C-N 124.529 1.143 . . . . 0.0 108.375 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.673 HG12 ' HB2' ' A' ' 83' ' ' ARG 0.295 93.5 t -122.38 101.82 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 C-N-CA 127.029 2.132 . . . . 0.0 106.8 -171.426 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -115.08 -1.01 13.14 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 122.471 2.396 . . . . 0.0 115.105 -168.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.692 ' HA3' ' HD2' ' A' ' 83' ' ' ARG . . . -56.51 -48.17 78.36 Favored Glycine 0 N--CA 1.474 1.226 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.46 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 4.9 t30 -115.75 116.67 40.67 Favored Pre-proline 0 N--CA 1.401 -2.878 0 N-CA-C 100.447 -3.909 . . . . 0.0 100.447 169.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -106.18 34.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.306 2.004 . . . . 0.0 111.305 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.445 ' C ' ' H ' ' A' ' 31' ' ' LYS . 2.9 m -129.5 54.5 1.82 Allowed 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 118.116 -1.434 . . . . 0.0 114.849 -168.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.468 ' O ' ' HB ' ' A' ' 33' ' ' THR . 35.9 mt-10 59.92 -21.13 0.03 OUTLIER 'General case' 0 C--N 1.377 1.796 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 178.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HD3' ' C ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -69.68 -41.93 74.79 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.669 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 1.2 pm0 -68.31 -41.62 80.59 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 90.9 m -48.19 -53.08 18.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.15 0.98 . . . . 0.0 110.517 174.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 12.5 pt-20 -69.6 -49.12 57.06 Favored 'General case' 0 C--O 1.259 1.558 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -49.73 -60.0 3.29 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.232 1.413 . . . . 0.0 107.836 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.813 HG21 ' CE3' ' A' ' 40' ' ' TRP . 22.3 mt -64.76 -44.56 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.035 0 CA-C-N 112.135 -2.302 . . . . 0.0 113.01 -175.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.913 HG22 HG12 ' A' ' 55' ' ' ILE . 22.4 p -66.83 -48.86 67.6 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 117.87 -1.532 . . . . 0.0 111.826 -176.094 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.0 p -63.29 -57.2 11.2 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.592 0.557 . . . . 0.0 111.463 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.3 tp -67.18 -39.35 86.39 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.813 ' CE3' HG21 ' A' ' 36' ' ' ILE . 46.1 m0 -79.96 -48.6 13.12 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -174.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.454 ' O ' ' HD1' ' A' ' 45' ' ' PHE 0.286 0.0 OUTLIER -72.61 -23.42 60.94 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 116.686 -2.006 . . . . 0.0 109.857 178.828 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.59 -51.44 57.59 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 173.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.503 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 10.5 p -66.75 -38.95 87.64 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 1.035 HD11 ' HD2' ' A' ' 53' ' ' ARG . 19.3 mt -60.17 -35.57 75.65 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 177.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.454 ' HD1' ' O ' ' A' ' 41' ' ' GLN . 35.1 m-85 -85.81 -25.22 26.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.242 0.544 . . . . 0.0 110.521 176.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.503 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.4 t-20 -68.39 -31.84 71.48 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.372 0.669 . . . . 0.0 111.681 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.45 2.66 49.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.241 0.543 . . . . 0.0 110.307 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.7 t30 57.16 60.7 2.84 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.028 1.331 . . . . 0.0 114.238 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -100.32 167.82 10.17 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 166.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -97.8 100.8 12.18 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 120.22 1.373 . . . . 0.0 108.348 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 m -146.13 176.92 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.243 -171.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.493 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 22.9 mt-30 -140.58 145.5 36.81 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 173.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 1.035 ' HD2' HD11 ' A' ' 44' ' ' LEU . 21.6 mtp180 -143.53 144.14 31.84 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 118.943 0.792 . . . . 0.0 111.233 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.658 ' H ' HG12 ' A' ' 62' ' ' ILE . 80.7 m-85 -133.68 151.75 51.72 Favored 'General case' 0 C--O 1.261 1.661 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -170.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.913 HG12 HG22 ' A' ' 37' ' ' THR . 17.4 mt -92.56 102.86 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 167.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.574 HG21 ' HD2' ' A' ' 60' ' ' ARG . 6.9 m -112.51 -27.41 2.77 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.784 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.95 161.38 31.89 Favored Glycine 0 N--CA 1.419 -2.492 0 C-N-CA 118.158 -1.972 . . . . 0.0 113.681 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 m -64.4 125.17 23.79 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.599 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 p30 68.22 21.61 8.47 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 125.106 1.362 . . . . 0.0 109.556 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.574 ' HD2' HG21 ' A' ' 56' ' ' VAL . 1.1 tmm_? -153.6 119.77 5.44 Favored 'General case' 0 CA--C 1.583 2.215 0 CA-C-O 122.278 1.037 . . . . 0.0 113.327 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.29 168.75 13.08 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.527 1.131 . . . . 0.0 109.066 -171.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.658 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.2 OUTLIER -134.6 156.79 40.7 Favored 'Isoleucine or valine' 0 C--O 1.283 2.861 0 C-N-CA 117.474 -1.69 . . . . 0.0 110.993 175.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.982 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 49.0 p90 -123.24 109.82 14.44 Favored 'General case' 0 N--CA 1.422 -1.845 0 O-C-N 127.507 3.005 . . . . 0.0 107.309 163.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.549 ' HB2' ' CD1' ' A' ' 62' ' ' ILE . 23.7 ttt -95.87 110.81 22.93 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.303 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.851 ' HG ' ' HB1' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -113.3 147.42 37.64 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -171.818 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.284 30.6 ttm180 -111.78 -58.51 2.11 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -176.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -44.46 -19.99 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.22 -9.13 3.32 Favored Glycine 0 C--N 1.358 1.767 0 CA-C-N 119.717 1.144 . . . . 0.0 114.903 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.817 ' HA ' HG22 ' A' ' 12' ' ' THR . 1.3 m -117.05 32.46 6.15 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.301 1.051 . . . . 0.0 113.696 -168.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -166.68 12.98 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.606 -171.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.851 ' HB1' ' HG ' ' A' ' 65' ' ' LEU . . . -97.22 -37.77 9.95 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -166.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.627 ' CE2' HD21 ' A' ' 89' ' ' LEU . 9.0 m-90 -76.0 -27.53 57.45 Favored 'General case' 0 C--O 1.273 2.331 0 O-C-N 120.895 -1.128 . . . . 0.0 110.636 -174.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -63.62 -35.22 79.79 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 113.835 -1.529 . . . . 0.0 107.722 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.8 HD13 ' HA ' ' A' ' 71' ' ' ALA . 26.3 mt -67.58 -45.2 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.154 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -57.71 -41.69 82.25 Favored 'General case' 0 C--O 1.283 2.851 0 CA-C-O 121.907 0.861 . . . . 0.0 109.387 -174.022 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.492 ' N ' ' HD2' ' A' ' 75' ' ' LYS . 17.1 t70 -61.46 -50.01 74.51 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 112.826 -1.988 . . . . 0.0 111.649 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.421 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 14.8 m-85 -62.09 -48.3 80.82 Favored 'General case' 0 C--O 1.197 -1.696 0 C-N-CA 118.47 -1.292 . . . . 0.0 110.383 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.805 HD11 ' CE3' ' A' ' 40' ' ' TRP . 4.3 mt -55.57 -54.5 43.3 Favored 'General case' 0 C--O 1.296 3.504 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.678 ' O ' ' HB3' ' A' ' 84' ' ' CYS 0.354 30.0 m -72.62 -19.1 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 C-N-CA 115.935 -2.306 . . . . 0.0 112.574 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.3 m -85.96 -4.3 59.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.148 171.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 21.7 mm-40 -90.43 -32.27 16.48 Favored 'General case' 0 CA--C 1.453 -2.78 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.073 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.505 ' OD2' ' HG2' ' A' ' 83' ' ' ARG 0.44 21.7 t70 -147.31 -94.58 0.09 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 116.913 -1.915 . . . . 0.0 114.628 -178.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.692 ' HD2' ' HA3' ' A' ' 26' ' ' GLY . 10.8 mmt180 -105.38 126.74 52.46 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 121.191 1.814 . . . . 0.0 109.264 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 0.678 ' HB3' ' O ' ' A' ' 79' ' ' VAL . 22.2 p -111.46 97.09 6.5 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -176.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.75 -42.37 2.42 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 1.05 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 37.2 tt0 -153.61 125.2 7.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 118.034 -1.466 . . . . 0.0 112.781 -174.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.503 HG23 ' HD3' ' A' ' 75' ' ' LYS . 2.9 m -112.75 93.44 2.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 p -105.44 99.4 9.01 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 118.413 -1.315 . . . . 0.0 112.208 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.845 ' HA ' ' HB2' ' A' ' 20' ' ' MET . 5.4 mp -78.43 156.27 29.5 Favored 'General case' 0 N--CA 1.384 -3.73 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.545 176.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.543 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 2.8 tm-20 -77.62 140.59 39.65 Favored 'General case' 0 C--N 1.276 -2.602 0 C-N-CA 123.546 0.738 . . . . 0.0 109.326 -166.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.69 ' HA3' ' HB3' ' A' ' 94' ' ' TYR . . . 134.59 91.9 0.41 Allowed Glycine 0 N--CA 1.404 -3.461 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -56.88 109.74 0.69 Allowed 'General case' 0 C--N 1.373 1.627 0 CA-C-N 120.771 2.285 . . . . 0.0 108.895 174.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' MET . . . . . 0.509 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 14.4 tpt 61.54 72.84 0.5 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.827 -168.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.69 ' HB3' ' HA3' ' A' ' 91' ' ' GLY . 6.5 p90 -101.73 96.27 6.31 Favored Pre-proline 0 N--CA 1.444 -0.768 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.509 ' HD3' ' O ' ' A' ' 93' ' ' MET . 88.4 Cg_endo -95.2 8.54 1.89 Allowed 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.228 1.952 . . . . 0.0 111.43 -177.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.59 -37.07 3.06 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.021 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.5 pttt . . . . . 0 N--CA 1.436 -1.151 0 C-N-CA 122.418 0.287 . . . . 0.0 110.452 179.028 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.517 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.07 -19.5 26.82 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 123.958 3.105 . . . . 0.0 114.159 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.2 -25.36 75.73 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.605 -0.331 . . . . 0.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.449 ' HG2' ' HG3' ' A' ' 6' ' ' GLU . 61.2 tttp -85.11 133.1 43.58 Favored Pre-proline 0 N--CA 1.435 -1.178 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.384 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 6.6 Cg_endo -82.05 57.31 6.19 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.508 2.805 . . . . 0.0 113.279 -175.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.449 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 35.8 mt-10 -81.89 -13.74 57.15 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 102.5 -3.148 . . . . 0.0 102.5 159.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.45 ' HB2' HD23 ' A' ' 9' ' ' LEU . 49.2 m 65.89 163.77 0.17 Allowed 'General case' 0 N--CA 1.382 -3.853 0 CA-C-N 110.675 -2.966 . . . . 0.0 109.952 171.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.8 pt -43.83 -25.33 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 173.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.45 HD23 ' HB2' ' A' ' 7' ' ' SER . 2.5 pt? -78.51 -57.82 3.57 Favored 'General case' 0 C--O 1.195 -1.782 0 C-N-CA 119.249 -0.981 . . . . 0.0 111.069 -174.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -78.0 -14.94 59.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 118.285 -1.366 . . . . 0.0 111.399 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.6 ttm -82.76 -36.97 25.23 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.03 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.8 m -130.85 -24.09 2.45 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 118.594 -1.242 . . . . 0.0 113.953 -176.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HD2' ' HB3' ' A' ' 16' ' ' LYS . 47.6 mmtm -102.15 97.36 7.68 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.115 -0.991 . . . . 0.0 110.94 -175.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.602 ' HB2' ' HZ3' ' A' ' 14' ' ' LYS . 10.2 mtmp? -109.47 -23.24 11.62 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.082 0.467 . . . . 0.0 110.79 -178.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.85 64.1 0.31 Allowed Glycine 0 CA--C 1.553 2.426 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.764 174.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.41 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 52.6 tptt -130.36 134.08 46.89 Favored 'General case' 0 C--N 1.363 1.192 0 CA-C-N 119.741 1.771 . . . . 0.0 110.758 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.534 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 6.3 m -85.58 111.36 19.97 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.822 ' HB3' HD22 ' A' ' 65' ' ' LEU . 21.8 tp -133.2 116.02 15.71 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -174.185 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.67 ' HB3' ' HE3' ' A' ' 64' ' ' MET . 19.6 ptm -83.56 103.13 12.64 Favored 'General case' 0 C--O 1.207 -1.171 0 O-C-N 121.502 -0.749 . . . . 0.0 112.792 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . 0.658 ' HE3' ' HB2' ' A' ' 71' ' ' ALA . 12.3 mtm -84.56 126.01 32.94 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -174.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -108.8 115.0 29.25 Favored 'General case' 0 N--CA 1.432 -1.34 0 O-C-N 125.618 1.824 . . . . 0.0 108.606 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -115.25 125.52 72.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.485 -176.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.806 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 30.2 m -90.85 110.62 21.84 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 113.638 -1.619 . . . . 0.0 107.365 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.701 HG11 ' HA ' ' A' ' 84' ' ' CYS . 75.5 t -103.77 92.55 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.341 0 CA-C-N 120.373 1.442 . . . . 0.0 109.145 -176.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 m -93.38 96.5 9.98 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 120.755 1.616 . . . . 0.0 110.292 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.21 -50.08 0.02 OUTLIER Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 44.9 t-20 -116.47 106.12 49.16 Favored Pre-proline 0 CA--C 1.493 -1.212 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 175.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 27' ' ' ASN . 16.2 Cg_exo -68.58 42.44 0.27 Allowed 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 123.93 3.086 . . . . 0.0 114.111 -171.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.6 p -147.0 -176.5 5.23 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.464 ' O ' ' HB ' ' A' ' 33' ' ' THR . 48.8 mt-10 -85.81 10.32 14.06 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 118.831 0.741 . . . . 0.0 110.225 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.544 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -77.74 -34.43 52.55 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.565 ' HG2' HD13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -71.26 -40.84 70.73 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.318 -0.953 . . . . 0.0 108.493 177.593 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.525 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 29.0 m -49.87 -55.63 13.58 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 125.866 1.666 . . . . 0.0 110.807 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.544 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.1 pt-20 -67.5 -43.95 79.66 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.867 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -50.71 -62.56 1.53 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 123.075 1.416 . . . . 0.0 107.474 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.845 HG21 ' CE3' ' A' ' 40' ' ' TRP . 25.0 mt -61.71 -44.38 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 112.067 -2.333 . . . . 0.0 112.981 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.879 HG22 HG12 ' A' ' 55' ' ' ILE . 25.1 p -68.28 -52.93 28.2 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.913 -175.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.4 p -62.79 -56.68 15.3 Favored 'General case' 0 C--O 1.256 1.432 0 O-C-N 123.618 0.574 . . . . 0.0 111.621 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.87 -49.6 74.22 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.845 ' CE3' HG21 ' A' ' 36' ' ' ILE . 50.8 m0 -75.14 -47.25 29.44 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -173.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.298 0.0 OUTLIER -73.98 -19.47 60.64 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 116.608 -2.037 . . . . 0.0 109.816 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.99 -52.87 49.61 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 170.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.522 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 9.6 p -69.73 -34.51 73.96 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 117.099 0.449 . . . . 0.0 112.01 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 1.035 HD12 ' HD2' ' A' ' 53' ' ' ARG . 9.2 mt -61.06 -35.28 76.53 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -87.99 -22.31 24.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.358 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 16.1 t-20 -65.53 -34.22 77.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.653 0.263 . . . . 0.0 110.984 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.99 5.05 27.13 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.411 0.624 . . . . 0.0 109.863 175.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 t30 51.77 45.4 28.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.342 1.857 . . . . 0.0 113.673 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -80.09 165.87 22.07 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -98.25 94.53 6.83 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 120.359 1.436 . . . . 0.0 108.656 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 m -135.12 173.09 14.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.592 -171.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -138.43 123.93 19.56 Favored 'General case' 0 C--O 1.196 -1.721 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 1.045 ' HG2' ' HA ' ' A' ' 63' ' ' PHE . 16.8 mtp180 -120.43 142.03 49.6 Favored 'General case' 0 C--N 1.268 -2.947 0 O-C-N 121.235 -0.915 . . . . 0.0 110.998 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.639 ' H ' HG12 ' A' ' 62' ' ' ILE . 41.1 m-85 -129.57 152.14 49.41 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -170.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.879 HG12 HG22 ' A' ' 37' ' ' THR . 29.8 mt -94.8 109.44 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' A' ' 60' ' ' ARG . 3.7 m -112.07 -16.19 9.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -175.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 161.97 177.12 34.75 Favored Glycine 0 CA--C 1.482 -2.022 0 C-N-CA 117.477 -2.297 . . . . 0.0 114.262 169.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.525 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 37.6 t -66.14 116.65 7.44 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.557 ' C ' ' HD2' ' A' ' 60' ' ' ARG . 0.2 OUTLIER 85.98 9.39 0.28 Allowed 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 125.41 1.484 . . . . 0.0 109.058 -178.378 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.632 ' HB3' HG21 ' A' ' 56' ' ' VAL . 3.8 mpt_? -138.68 124.26 19.57 Favored 'General case' 0 C--O 1.255 1.387 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.89 162.24 32.97 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.639 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -137.56 154.45 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.044 0 C-N-CA 117.969 -1.493 . . . . 0.0 111.545 174.08 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 1.045 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -126.65 112.65 15.71 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.223 2.827 . . . . 0.0 107.76 162.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.67 ' HE3' ' HB3' ' A' ' 19' ' ' MET . 43.4 ttm -95.42 125.55 40.11 Favored 'General case' 0 C--O 1.258 1.544 0 O-C-N 121.332 -0.855 . . . . 0.0 109.805 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.822 HD22 ' HB3' ' A' ' 18' ' ' LEU . 1.2 pt? -102.2 144.62 30.51 Favored 'General case' 0 CA--C 1.494 -1.182 0 O-C-N 124.622 1.201 . . . . 0.0 110.669 -176.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.292 5.5 tmm_? -119.73 -49.22 2.34 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -46.78 -23.44 0.43 Allowed 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 171.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.42 -31.93 4.65 Favored Glycine 0 C--N 1.36 1.864 0 CA-C-N 120.231 1.378 . . . . 0.0 113.8 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.2 m -128.34 45.42 2.77 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -166.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -153.02 2.25 0.29 Allowed 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.239 -0.913 . . . . 0.0 112.562 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.717 ' HA ' HD11 ' A' ' 74' ' ' ILE . . . -94.52 -34.41 12.69 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 119.077 2.991 . . . . 0.0 119.077 -170.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TRP . . . . . 0.796 ' HD1' ' HD3' ' A' ' 75' ' ' LYS 0.512 9.3 m-90 -81.42 -16.81 50.99 Favored 'General case' 0 C--O 1.263 1.781 0 C-N-CA 116.494 -2.083 . . . . 0.0 114.85 -167.712 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -73.56 -29.73 62.61 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 168.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.717 HD11 ' HA ' ' A' ' 71' ' ' ALA . 74.9 mt -61.23 -42.13 92.27 Favored 'Isoleucine or valine' 0 C--O 1.258 1.54 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.869 173.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.846 ' HB2' HG21 ' A' ' 87' ' ' VAL . 53.1 pttt -61.32 -41.45 97.04 Favored 'General case' 0 C--N 1.378 1.842 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.386 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.45 -52.02 65.0 Favored 'General case' 0 C--O 1.271 2.204 0 O-C-N 124.29 0.994 . . . . 0.0 110.582 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.477 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 8.0 m-85 -54.62 -47.54 73.32 Favored 'General case' 0 C--O 1.205 -1.288 0 O-C-N 123.553 0.533 . . . . 0.0 110.114 -178.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.703 HD11 ' CZ3' ' A' ' 40' ' ' TRP . 10.3 mt -63.59 -51.58 64.69 Favored 'General case' 0 C--O 1.287 3.039 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -175.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 1.026 ' HA ' ' HB2' ' A' ' 84' ' ' CYS . 29.5 m -71.38 -6.6 7.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.547 0.689 . . . . 0.0 112.268 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 m -110.35 1.0 18.18 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.246 170.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 5.5 tp-100 -88.18 -36.99 16.5 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -177.167 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.486 10.5 t70 -142.37 -96.84 0.12 Allowed 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 117.954 2.575 . . . . 0.0 117.954 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -146.77 40.66 1.09 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' CYS . . . . . 1.026 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 55.5 m -79.45 12.03 2.68 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 111.158 -2.746 . . . . 0.0 115.669 -165.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . 0.314 . . 29.66 -58.99 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 173.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.806 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 6.2 tp10 -145.46 132.07 19.88 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 119.882 1.219 . . . . 0.0 111.676 -169.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.846 HG21 ' HB2' ' A' ' 75' ' ' LYS . 47.2 t -114.09 106.26 20.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 173.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.475 ' O ' HD23 ' A' ' 89' ' ' LEU . 14.3 p -118.98 146.98 44.55 Favored 'General case' 0 C--O 1.293 3.352 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.684 ' CD1' ' HG ' ' A' ' 18' ' ' LEU 0.758 2.7 mt -138.2 157.56 46.04 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 121.152 3.76 . . . . 0.0 121.152 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.537 ' H ' HD21 ' A' ' 89' ' ' LEU 0.318 27.3 tt0 -79.99 155.65 27.55 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 110.586 -3.006 . . . . 0.0 109.16 -176.147 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 124.47 -179.64 16.07 Favored Glycine 0 CA--C 1.549 2.173 0 CA-C-O 118.748 -1.029 . . . . 0.0 111.336 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -111.09 138.81 47.06 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 119.648 1.724 . . . . 0.0 107.214 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 25.5 ttt 61.05 33.16 19.71 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.453 1.121 . . . . 0.0 109.236 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.64 ' HH ' ' HB2' ' A' ' 89' ' ' LEU . 83.0 t80 -66.67 -52.28 35.24 Favored Pre-proline 0 CA--C 1.57 1.738 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.831 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.14 -178.95 4.68 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 121.42 1.413 . . . . 0.0 111.229 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.63 81.16 0.96 Allowed Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? . . . . . 0 C--N 1.303 -1.456 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.478 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.4 tptp . . . . . 0 N--CA 1.432 -1.343 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 8.0 m -67.44 116.77 8.55 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.69 ' O ' HD13 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -120.52 116.9 26.3 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.524 -2.399 . . . . 0.0 104.524 -177.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.44 ' HA ' ' HG3' ' A' ' 64' ' ' MET . 24.5 ptm -89.32 133.96 34.26 Favored 'General case' 0 C--N 1.28 -2.435 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.271 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.438 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 8.0 ttm -123.58 121.71 36.3 Favored 'General case' 0 N--CA 1.405 -2.715 0 C-N-CA 116.246 -2.181 . . . . 0.0 112.944 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -94.54 126.16 39.64 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.226 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 61' ' ' ALA . 0.2 OUTLIER -120.83 130.55 74.49 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-O 121.191 0.52 . . . . 0.0 110.071 -178.013 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.091 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 78.1 m -95.66 132.04 41.25 Favored 'General case' 0 N--CA 1.397 -3.093 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 172.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 1.026 HG23 ' HB2' ' A' ' 82' ' ' ASP . 2.5 p -131.41 127.83 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.077 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -172.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.549 ' HB3' ' OD2' ' A' ' 59' ' ' ASP . 15.5 p -142.69 33.01 1.43 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 121.726 2.057 . . . . 0.0 115.356 -170.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.65 -34.76 90.8 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 171.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 22.3 m-80 -118.13 122.69 30.13 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 171.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.67 28.89 0.41 Allowed 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.763 2.308 . . . . 0.0 112.792 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.0 p -137.78 -157.13 0.75 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.462 ' O ' ' HB ' ' A' ' 33' ' ' THR . 39.9 mt-10 -87.99 5.2 41.95 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-O 119.263 -0.398 . . . . 0.0 111.384 175.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.582 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 5.7 tmtt? -70.92 -38.77 72.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.361 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.606 ' HG3' HD13 ' A' ' 36' ' ' ILE . 6.2 tp10 -74.25 -41.04 61.93 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 96.5 m -44.6 -59.37 2.5 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.181 170.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.582 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.2 pt-20 -61.43 -45.7 93.2 Favored 'General case' 0 C--O 1.25 1.107 0 C-N-CA 122.935 0.494 . . . . 0.0 112.082 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -52.91 -59.03 5.03 Favored 'General case' 0 C--O 1.254 1.317 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.728 HG23 ' CE3' ' A' ' 40' ' ' TRP . 2.0 mp -67.17 -46.18 84.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.53 -1.213 . . . . 0.0 113.352 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.687 HG21 HG12 ' A' ' 55' ' ' ILE . 31.0 p -62.24 -52.61 63.05 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.1 m -70.82 -44.63 66.15 Favored 'General case' 0 C--O 1.26 1.646 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.973 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.0 tp -71.21 -43.55 67.14 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.431 -176.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.728 ' CE3' HG23 ' A' ' 36' ' ' ILE . 43.8 m0 -76.07 -60.34 2.37 Favored 'General case' 0 C--O 1.161 -3.594 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.057 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.606 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.404 0.0 OUTLIER -65.71 -22.23 66.6 Favored 'General case' 0 C--O 1.255 1.356 0 C-N-CA 117.017 -1.873 . . . . 0.0 112.044 -173.078 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.86 -54.13 39.5 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 27.8 p -70.38 -27.3 64.21 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 117.257 0.528 . . . . 0.0 111.976 177.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.805 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 17.5 mt -61.51 -31.79 71.8 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.301 0.64 . . . . 0.0 109.351 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 72.8 t80 -92.68 -28.33 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.355 174.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.676 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 10.2 t30 -68.43 -28.88 67.45 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.047 0.451 . . . . 0.0 111.564 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.4 12.12 19.42 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.373 0.606 . . . . 0.0 109.726 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.0 p30 48.25 48.7 18.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.888 1.675 . . . . 0.0 114.74 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -91.45 159.58 15.88 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.62 88.81 3.71 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 120.606 1.548 . . . . 0.0 109.83 -176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.002 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.7 m -146.79 169.83 4.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.559 -169.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.444 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 89.7 mt-30 -131.86 123.7 28.04 Favored 'General case' 0 C--O 1.2 -1.516 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 176.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.805 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -130.62 135.4 47.84 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.503 -173.209 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.732 ' H ' HG12 ' A' ' 62' ' ' ILE . 56.0 m-85 -133.83 153.19 51.91 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -165.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.687 HG12 HG21 ' A' ' 37' ' ' THR . 22.9 mt -87.24 108.23 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 168.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.72 HG23 ' HB3' ' A' ' 60' ' ' ARG . 15.6 m -113.28 -11.73 11.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.711 -175.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.14 176.95 41.33 Favored Glycine 0 CA--C 1.504 -0.631 0 C-N-CA 117.163 -2.446 . . . . 0.0 115.362 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 m -68.36 110.78 4.26 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.549 ' OD2' ' HB3' ' A' ' 25' ' ' SER 0.257 0.0 OUTLIER 78.37 17.46 1.14 Allowed 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 122.947 1.356 . . . . 0.0 109.938 -178.45 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.72 ' HB3' HG23 ' A' ' 56' ' ' VAL . 7.3 mpt_? -133.18 127.44 33.84 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.173 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.413 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -137.25 165.81 25.27 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.732 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.6 pt -144.53 157.81 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.336 0 C-N-CA 117.962 -1.495 . . . . 0.0 110.62 168.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.734 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -132.1 105.89 7.65 Favored 'General case' 0 N--CA 1.414 -2.233 0 O-C-N 126.595 2.434 . . . . 0.0 105.979 164.509 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.44 ' HG3' ' HA ' ' A' ' 19' ' ' MET . 25.1 ttt -92.19 103.97 16.39 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.002 ' HA ' HG12 ' A' ' 51' ' ' VAL 0.277 0.0 OUTLIER -96.06 146.32 24.74 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -171.834 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 17' ' ' THR 0.354 1.1 tmt_? -120.98 -59.09 1.76 Allowed 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -46.18 -9.25 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 117.996 2.591 . . . . 0.0 117.996 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.87 28.96 64.07 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 119.793 1.179 . . . . 0.0 113.668 -174.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.8 p -149.34 43.43 0.94 Allowed 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.613 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -173.49 -3.85 0.01 OUTLIER 'General case' 0 C--N 1.378 1.818 0 N-CA-C 117.732 2.494 . . . . 0.0 117.732 -176.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 1.0 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -74.31 -35.41 63.68 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -168.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.413 ' NE1' ' HE1' ' A' ' 20' ' ' MET 0.478 5.4 m-90 -88.23 -11.24 47.23 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -169.048 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.84 -38.71 70.08 Favored 'General case' 0 C--O 1.262 1.719 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 167.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.624 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 25.5 mt -64.7 -36.93 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.277 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.83 ' HE2' HG11 ' A' ' 87' ' ' VAL . 55.2 tttm -58.14 -42.58 86.16 Favored 'General case' 0 C--O 1.291 3.275 0 CA-C-O 122.081 0.943 . . . . 0.0 110.617 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -58.42 -46.98 85.41 Favored 'General case' 0 C--O 1.264 1.867 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.288 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.624 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 11.0 m-85 -55.96 -43.99 78.06 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.264 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.635 ' HG ' ' HA ' ' A' ' 75' ' ' LYS . 11.5 mt -50.09 -64.61 0.76 Allowed 'General case' 0 CA--C 1.446 -3.05 0 O-C-N 123.835 0.71 . . . . 0.0 109.719 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . 0.303 25.7 m -77.24 -5.49 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 C-N-CA 118.113 -1.435 . . . . 0.0 114.42 -171.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m -86.35 -22.33 26.74 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.758 167.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -117.26 -35.19 4.11 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 1.026 ' HB2' HG23 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -80.28 24.95 0.41 Allowed 'General case' 0 N--CA 1.516 2.875 0 CA-C-N 119.811 1.187 . . . . 0.0 111.52 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 73.46 -81.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -155.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.431 ' HA ' ' OD1' ' A' ' 82' ' ' ASP . 11.5 p 159.6 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.595 1.558 . . . . 0.0 112.305 171.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . 0.363 . . -109.31 -78.86 0.59 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 119.122 3.008 . . . . 0.0 119.122 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.091 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 33.8 tt0 -148.41 126.56 12.13 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 121.089 1.768 . . . . 0.0 112.993 -165.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.83 HG11 ' HE2' ' A' ' 75' ' ' LYS . 2.5 p -111.38 123.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.782 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 20' ' ' MET 0.258 25.9 p -123.39 110.5 15.22 Favored 'General case' 0 C--O 1.264 1.834 0 CA-C-O 122.702 1.239 . . . . 0.0 113.042 171.102 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.508 HD12 HG22 ' A' ' 87' ' ' VAL . 1.7 mp . . . . . 0 C--N 1.291 -1.945 0 CA-C-N 112.687 -2.052 . . . . 0.0 107.117 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.1 tptp . . . . . 0 N--CA 1.428 -1.537 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.2 m -68.44 121.46 16.38 Favored 'General case' 0 N--CA 1.411 -2.403 0 O-C-N 124.114 0.884 . . . . 0.0 109.34 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.703 HD12 ' SD ' ' A' ' 20' ' ' MET . 0.2 OUTLIER -133.56 116.49 15.98 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 176.052 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.406 ' HB2' ' HA ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -113.57 140.99 47.71 Favored 'General case' 0 C--N 1.274 -2.708 0 O-C-N 120.921 -1.112 . . . . 0.0 109.306 179.059 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.703 ' SD ' HD12 ' A' ' 18' ' ' LEU . 2.9 mpp? -118.69 127.43 53.56 Favored 'General case' 0 CA--C 1.447 -3.006 0 C-N-CA 120.334 -0.547 . . . . 0.0 111.33 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . 0.293 30.4 p90 -98.87 123.42 43.12 Favored 'General case' 0 N--CA 1.413 -2.317 0 C-N-CA 117.354 -1.739 . . . . 0.0 106.729 168.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.9 p -114.89 122.15 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 CA-C-N 114.647 -1.16 . . . . 0.0 113.815 -167.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.036 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 24.4 m -75.32 135.76 40.88 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 171.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.611 HG21 HD13 ' A' ' 36' ' ' ILE . 7.9 p -121.52 127.7 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.681 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -162.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.642 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 29.5 t 71.26 -48.78 0.68 Allowed 'General case' 0 C--N 1.374 1.663 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 164.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.11 -16.74 6.76 Favored Glycine 0 N--CA 1.421 -2.319 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -173.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.0 t-20 -72.39 110.22 7.61 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -85.7 23.65 0.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.89 2.393 . . . . 0.0 113.015 -172.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -123.32 -170.91 2.2 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -91.61 9.41 32.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.555 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 3.9 tmtt? -67.52 -54.7 17.78 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.252 0.548 . . . . 0.0 110.395 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.719 ' HG3' HD12 ' A' ' 36' ' ' ILE . 3.4 tp10 -69.0 -40.14 78.91 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -175.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -46.8 -56.29 6.5 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.668 171.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 15.4 pt-20 -62.78 -49.06 76.47 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 122.585 0.354 . . . . 0.0 111.628 -175.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -48.62 -58.48 4.65 Favored 'General case' 0 C--O 1.254 1.32 0 C-N-CA 125.656 1.583 . . . . 0.0 108.335 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.719 HD12 ' HG3' ' A' ' 32' ' ' GLU . 43.6 mt -72.24 -43.34 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 CA-C-N 111.647 -2.524 . . . . 0.0 113.617 -173.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.823 HG21 HG12 ' A' ' 55' ' ' ILE . 22.7 p -63.76 -48.77 75.64 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.241 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.5 p -63.69 -62.98 1.3 Allowed 'General case' 0 C--O 1.263 1.766 0 O-C-N 123.323 0.39 . . . . 0.0 110.774 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.14 -46.7 86.01 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.682 ' CE3' HG23 ' A' ' 36' ' ' ILE . 29.4 m0 -74.89 -59.67 2.63 Favored 'General case' 0 C--O 1.165 -3.38 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.612 -176.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.807 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.375 0.0 OUTLIER -64.58 -25.56 68.02 Favored 'General case' 0 C--O 1.252 1.222 0 C-N-CA 117.214 -1.794 . . . . 0.0 112.027 -172.199 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.19 -53.71 42.47 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.527 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 35.5 p -70.89 -28.51 64.6 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 116.881 0.34 . . . . 0.0 111.732 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.965 HD12 ' HG2' ' A' ' 53' ' ' ARG . 18.2 mt -61.18 -35.13 76.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.276 0.631 . . . . 0.0 109.378 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.631 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 60.9 t80 -87.59 -30.14 20.72 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.913 177.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.2 t-20 -69.02 -27.71 65.92 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.134 0.492 . . . . 0.0 111.481 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.11 1.03 52.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.994 0.426 . . . . 0.0 110.557 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 60.34 35.06 20.69 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.686 1.194 . . . . 0.0 112.266 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -65.56 -2.35 3.36 Favored 'General case' 0 CA--C 1.611 3.31 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 59.7 71.74 0.56 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.396 1.478 . . . . 0.0 111.108 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' A' ' 65' ' ' LEU . 6.4 m -147.66 176.21 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.725 -170.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.574 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 74.7 mt-30 -135.96 133.35 37.49 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 174.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.965 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.36 135.42 37.0 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -174.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.783 ' H ' HG12 ' A' ' 62' ' ' ILE . 36.7 t80 -134.36 151.57 51.3 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 117.797 -1.561 . . . . 0.0 113.737 -163.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.823 HG12 HG21 ' A' ' 37' ' ' THR . 25.7 mt -89.5 96.13 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 170.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.664 HG13 ' HB3' ' A' ' 60' ' ' ARG . 7.4 p -94.61 -25.43 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-O 120.605 0.241 . . . . 0.0 110.912 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.67 173.52 45.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 118.667 -1.73 . . . . 0.0 114.706 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.527 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 21.0 m -70.57 117.94 12.74 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.65 ' O ' ' HA ' ' A' ' 23' ' ' THR . 14.2 t70 82.47 9.98 0.7 Allowed 'General case' 0 C--O 1.188 -2.139 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.664 ' HB3' HG13 ' A' ' 56' ' ' VAL . 5.5 mpt_? -138.78 117.84 12.56 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 122.247 1.022 . . . . 0.0 113.525 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.59 168.44 12.62 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 125.046 1.339 . . . . 0.0 107.445 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.783 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.5 pt -138.06 157.43 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.256 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.072 171.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.451 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -130.82 102.96 6.3 Favored 'General case' 0 N--CA 1.422 -1.841 0 O-C-N 126.807 2.567 . . . . 0.0 107.929 166.156 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.471 ' HB3' ' O ' ' A' ' 52' ' ' GLN . 1.0 OUTLIER -87.98 117.29 26.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.544 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.769 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.429 0.0 OUTLIER -121.03 148.46 44.1 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.646 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.324 26.3 ttp180 -112.64 -57.2 2.31 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -169.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.564 ' HB2' ' CE1' ' A' ' 70' ' ' TYR . 1.7 m-20 -50.23 -13.85 0.13 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 175.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.15 29.11 62.21 Favored Glycine 0 C--N 1.36 1.887 0 CA-C-N 120.475 1.488 . . . . 0.0 115.702 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.402 ' H ' ' HD1' ' A' ' 70' ' ' TYR . 32.5 m -151.99 44.34 0.73 Allowed 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 118.733 1.266 . . . . 0.0 112.949 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 67' ' ' ASP . 14.8 p90 178.99 16.75 0.0 OUTLIER 'General case' 0 C--N 1.365 1.279 0 CA-C-N 119.075 0.852 . . . . 0.0 111.97 -169.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.769 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -100.11 -33.96 10.25 Favored 'General case' 0 C--O 1.267 1.995 0 CA-C-O 122.372 1.082 . . . . 0.0 113.867 -170.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.476 ' O ' ' HB3' ' A' ' 75' ' ' LYS 0.496 13.0 m0 -89.19 -9.62 50.14 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 116.88 -1.928 . . . . 0.0 112.447 -172.317 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -73.04 -26.66 61.38 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.356 164.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.615 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.0 mt -64.89 -38.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.37 1.462 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 171.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 78' ' ' LEU . 29.1 ttpp -57.7 -41.46 81.76 Favored 'General case' 1 C--O 1.317 4.607 0 CA-C-O 122.831 1.301 . . . . 0.0 110.829 175.422 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -57.72 -44.95 86.31 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 118.881 -1.128 . . . . 0.0 110.47 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.748 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 17.1 m-85 -62.13 -27.7 69.12 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.543 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.598 ' CD1' ' HA ' ' A' ' 75' ' ' LYS . 39.8 mt -56.19 -59.32 5.1 Favored 'General case' 0 C--O 1.275 2.446 0 CA-C-O 122.082 0.944 . . . . 0.0 109.199 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.684 HG13 ' SG ' ' A' ' 84' ' ' CYS 0.277 1.2 m -77.04 -4.43 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 C-N-CA 117.467 -1.693 . . . . 0.0 113.134 178.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.748 ' HB3' ' HA ' ' A' ' 77' ' ' PHE . 9.9 t -88.65 -14.32 37.68 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.41 171.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.567 ' HG3' ' NE1' ' A' ' 40' ' ' TRP . 78.3 mm-40 -90.44 -43.42 10.29 Favored 'General case' 0 C--N 1.38 1.892 0 C-N-CA 117.328 -1.749 . . . . 0.0 109.182 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.378 29.3 t70 -176.23 -82.52 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.662 1.226 . . . . 0.0 113.181 173.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -127.27 147.67 50.23 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 120.649 1.568 . . . . 0.0 109.399 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.684 ' SG ' HG13 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -133.51 164.49 27.04 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 178.23 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.37 -51.12 0.15 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.036 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.1 tt0 -143.19 121.22 12.09 Favored 'General case' 0 CA--C 1.496 -1.13 0 O-C-N 120.757 -1.214 . . . . 0.0 112.103 -172.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.6 m -111.83 121.69 64.78 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.871 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' MET 0.293 22.3 p -106.36 114.41 28.52 Favored 'General case' 0 N--CA 1.406 -2.675 0 C-N-CA 117.348 -1.741 . . . . 0.0 109.656 165.044 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.545 HD13 ' CG ' ' A' ' 20' ' ' MET . 1.5 mm? . . . . . 0 N--CA 1.407 -2.603 0 CA-C-N 110.858 -2.883 . . . . 0.0 108.138 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.515 -0.394 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.8 m -83.96 125.44 32.05 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 174.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.814 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -133.22 112.76 11.96 Favored 'General case' 0 C--O 1.19 -2.055 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.483 -175.143 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 27.4 ptm -84.04 127.62 34.01 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 119.444 -0.902 . . . . 0.0 108.762 174.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.514 ' HG3' ' CD1' ' A' ' 89' ' ' LEU . 27.3 ttm -101.06 107.91 19.48 Favored 'General case' 0 N--CA 1.424 -1.739 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.947 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -94.1 114.39 26.53 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.5 p -127.15 125.65 66.62 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -169.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.101 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 18.8 m -84.71 142.07 30.12 Favored 'General case' 0 CA--C 1.588 2.419 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.608 174.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.66 HG21 HD13 ' A' ' 36' ' ' ILE . 8.5 p -125.82 129.39 72.51 Favored 'Isoleucine or valine' 0 C--N 1.378 1.829 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.84 29.49 1.89 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 115.385 -2.526 . . . . 0.0 114.104 -166.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.44 -34.45 25.68 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 1.022 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 13.9 t-20 -116.95 121.64 32.39 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -85.43 27.28 0.61 Allowed 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 123.087 2.525 . . . . 0.0 114.067 -173.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.427 ' HB ' ' H ' ' A' ' 30' ' ' GLU . 22.4 p -144.9 -160.74 1.17 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -174.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.489 ' HA ' ' HB ' ' A' ' 33' ' ' THR . 40.4 tt0 -89.12 1.76 55.14 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.017 -177.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 5.9 tmtt? -68.08 -50.46 54.88 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.896 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 1.022 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.7 tp10 -70.82 -42.37 70.34 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 118.575 -1.25 . . . . 0.0 107.703 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 59.9 m -42.49 -51.58 4.99 Favored 'General case' 0 C--O 1.199 -1.591 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.557 171.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 13.7 pt-20 -71.89 -48.37 46.15 Favored 'General case' 0 C--O 1.252 1.22 0 O-C-N 121.781 -0.574 . . . . 0.0 112.476 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -47.69 -57.77 5.12 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.522 1.529 . . . . 0.0 107.501 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.758 HG23 ' CD2' ' A' ' 40' ' ' TRP . 14.7 mt -69.14 -43.95 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 CA-C-N 111.452 -2.613 . . . . 0.0 113.551 -176.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.595 HG21 HG23 ' A' ' 55' ' ' ILE . 19.8 p -67.5 -42.08 83.44 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 120.533 1.515 . . . . 0.0 111.315 -174.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.0 p -66.05 -55.64 15.61 Favored 'General case' 0 N--CA 1.425 -1.691 0 O-C-N 123.974 0.796 . . . . 0.0 110.138 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 tp -60.75 -46.17 91.47 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.787 ' CZ3' HD13 ' A' ' 78' ' ' LEU . 44.0 m0 -68.67 -69.97 0.3 Allowed 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.36 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.843 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.321 0.0 OUTLIER -69.31 -21.86 63.83 Favored 'General case' 0 C--O 1.255 1.377 0 C-N-CA 117.918 -1.513 . . . . 0.0 111.968 -171.462 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.11 -51.47 54.95 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 p -68.19 -32.66 73.05 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 117.191 0.495 . . . . 0.0 110.545 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.817 HD12 ' HG2' ' A' ' 53' ' ' ARG . 33.4 mt -60.53 -33.15 72.23 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.005 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.65 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 78.0 t80 -91.08 -30.13 16.92 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.991 175.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -66.06 -32.77 74.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.68 1.89 53.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.25 0.548 . . . . 0.0 109.802 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 t30 49.37 60.49 3.73 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 125.65 1.58 . . . . 0.0 112.763 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -74.02 12.63 0.67 Allowed 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 50.22 67.26 0.94 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.901 1.28 . . . . 0.0 112.517 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.616 HG23 ' HD2' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -146.88 174.23 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.245 -177.572 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.474 ' HB3' ' HB3' ' A' ' 64' ' ' MET . 7.9 tt0 -131.1 117.97 19.85 Favored 'General case' 0 C--O 1.191 -1.986 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.843 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -128.17 141.17 51.55 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.213 -170.261 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.79 ' H ' HG12 ' A' ' 62' ' ' ILE . 16.8 m-85 -133.72 151.96 51.76 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -168.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.595 HG23 HG21 ' A' ' 37' ' ' THR . 21.5 mt -93.03 96.64 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 167.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 60' ' ' ARG . 8.2 m -91.1 -31.25 4.95 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.535 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.33 173.73 45.68 Favored Glycine 0 CA--C 1.49 -1.493 0 C-N-CA 117.028 -2.51 . . . . 0.0 114.191 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 33.2 m -66.71 118.95 10.98 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER 85.25 9.08 0.36 Allowed 'General case' 0 C--N 1.363 1.173 0 CA-C-O 122.138 0.97 . . . . 0.0 109.129 -178.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.541 ' HB3' HG23 ' A' ' 56' ' ' VAL . 8.1 mpt_? -140.21 131.63 26.88 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.13 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.05 165.92 26.05 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.79 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -143.51 157.23 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.99 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.914 170.355 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.597 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -135.65 104.81 5.92 Favored 'General case' 0 N--CA 1.428 -1.552 0 O-C-N 126.196 2.185 . . . . 0.0 107.321 162.406 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 26.7 ttt -87.2 116.66 25.43 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.164 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.588 ' HA ' HG12 ' A' ' 51' ' ' VAL . 3.8 mp -82.88 145.55 29.37 Favored 'General case' 0 C--O 1.256 1.415 0 C-N-CA 126.077 1.751 . . . . 0.0 112.288 -175.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.298 72.3 ttt180 -110.15 -61.77 1.61 Allowed 'General case' 0 CA--C 1.587 2.395 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 175.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -57.03 -10.95 1.28 Allowed 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 56.61 26.71 53.45 Favored Glycine 0 C--N 1.36 1.89 0 CA-C-N 119.491 1.041 . . . . 0.0 114.501 -173.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.0 m -143.06 38.93 1.45 Allowed 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -179.56 -176.18 0.37 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -167.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.573 ' HB1' ' CE2' ' A' ' 63' ' ' PHE . . . 98.06 -30.89 0.02 OUTLIER 'General case' 0 C--N 1.376 1.718 0 C-N-CA 126.574 1.95 . . . . 0.0 115.016 173.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.689 ' HH2' ' HG ' ' A' ' 18' ' ' LEU 0.294 17.5 m-90 -71.32 -30.17 65.89 Favored 'General case' 0 C--O 1.277 2.502 0 CA-C-O 121.794 0.807 . . . . 0.0 111.803 -177.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -66.16 -40.13 90.29 Favored 'General case' 0 C--O 1.266 1.963 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.45 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.569 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 23.3 mt -54.98 -45.83 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.05 175.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.737 ' HE3' HG21 ' A' ' 87' ' ' VAL . 12.5 tmtt? -58.8 -42.88 90.14 Favored 'General case' 0 C--O 1.266 1.954 0 CA-C-O 121.372 0.606 . . . . 0.0 110.242 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.3 -42.96 96.6 Favored 'General case' 0 C--O 1.277 2.529 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.636 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 14.5 m-85 -55.85 -45.45 78.44 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.787 HD13 ' CZ3' ' A' ' 40' ' ' TRP . 20.1 mt -58.84 -46.82 86.8 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.789 HG22 ' HB3' ' A' ' 84' ' ' CYS . 2.1 t -70.29 -20.44 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.826 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.8 t -90.55 -8.16 50.97 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -88.04 -38.39 15.5 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.317 6.6 t70 -155.02 -104.35 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.727 176.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 83' ' ' ARG . 23.5 tpt180 -143.32 84.35 1.81 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 121.115 1.78 . . . . 0.0 112.406 176.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.789 ' HB3' HG22 ' A' ' 79' ' ' VAL . 6.0 t -86.27 160.74 19.06 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.82 -40.33 0.09 Allowed 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -167.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.101 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 45.3 tt0 -126.49 116.67 21.47 Favored 'General case' 0 CA--C 1.47 -2.101 0 C-N-CA 118.187 -1.405 . . . . 0.0 109.719 -172.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.835 HG12 HD21 ' A' ' 89' ' ' LEU . 24.2 t -110.35 98.26 6.82 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.797 -175.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.56 ' C ' HD22 ' A' ' 89' ' ' LEU . 38.6 p -111.08 142.73 42.85 Favored 'General case' 0 C--O 1.261 1.692 0 CA-C-O 121.657 0.742 . . . . 0.0 111.251 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.835 HD21 HG12 ' A' ' 87' ' ' VAL . 2.9 mm? . . . . . 0 N--CA 1.405 -2.704 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.967 -166.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.506 ' N ' ' HA3' ' A' ' 68' ' ' GLY . 27.0 tptp . . . . . 0 CA--C 1.532 0.274 0 CA-C-O 120.947 0.404 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.8 m -65.81 125.5 25.55 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.801 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -124.74 109.03 12.61 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.371 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.591 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 22.3 ptm -96.6 102.98 14.86 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.678 ' HE3' HD11 ' A' ' 65' ' ' LEU . 7.4 ptp -114.75 135.14 54.5 Favored 'General case' 0 C--O 1.272 2.271 0 C-N-CA 116.789 -1.965 . . . . 0.0 112.83 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.542 ' HA ' HG22 ' A' ' 62' ' ' ILE . 3.6 t80 -97.46 118.52 34.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.85 2.46 . . . . 0.0 107.71 -173.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.63 124.42 70.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.801 ' HA ' ' HG3' ' A' ' 60' ' ' ARG . 83.4 m -88.81 121.32 31.05 Favored 'General case' 0 CA--C 1.605 3.06 0 C-N-CA 125.923 1.689 . . . . 0.0 112.275 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.681 HG13 ' HB2' ' A' ' 83' ' ' ARG 0.305 56.4 t -111.01 130.54 64.26 Favored 'Isoleucine or valine' 0 C--N 1.378 1.813 0 C-N-CA 127.668 2.387 . . . . 0.0 104.714 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.5 m -121.92 -5.86 9.03 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-N 122.658 2.481 . . . . 0.0 115.998 -169.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.31 -44.72 21.14 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 121.452 -0.404 . . . . 0.0 112.817 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.557 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 1.0 OUTLIER -106.07 154.16 39.75 Favored Pre-proline 0 CA--C 1.514 -0.436 0 CA-C-N 117.757 0.779 . . . . 0.0 109.271 172.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -111.12 40.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 123.883 3.056 . . . . 0.0 110.882 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.3 p -131.89 -105.08 0.26 Allowed 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.647 -0.658 . . . . 0.0 112.72 -168.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.753 ' HA ' ' O ' ' A' ' 58' ' ' SER . 30.0 tt0 -167.19 15.74 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.907 2.083 . . . . 0.0 106.669 170.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 9.5 tmtt? -86.78 -31.68 20.77 Favored 'General case' 0 C--O 1.259 1.556 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.359 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 1.003 ' HG3' HD12 ' A' ' 36' ' ' ILE . 7.1 tp10 -73.32 -44.69 58.5 Favored 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 104.303 -2.481 . . . . 0.0 104.303 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.814 ' OG1' ' HA ' ' A' ' 59' ' ' ASP . 59.6 m -44.2 -51.14 8.42 Favored 'General case' 0 C--O 1.179 -2.64 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.391 167.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.591 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.7 pt-20 -63.39 -52.33 62.09 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 119.631 1.105 . . . . 0.0 112.42 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -53.6 -60.03 3.83 Favored 'General case' 0 C--O 1.263 1.798 0 CA-C-O 123.315 1.531 . . . . 0.0 107.978 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.003 HD12 ' HG3' ' A' ' 32' ' ' GLU . 1.3 mt -60.43 -45.03 97.37 Favored 'Isoleucine or valine' 0 C--O 1.163 -3.464 0 CA-C-N 112.095 -2.32 . . . . 0.0 112.745 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.854 HG21 HG12 ' A' ' 55' ' ' ILE . 19.2 p -68.76 -34.53 75.73 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-N 121.071 1.76 . . . . 0.0 110.869 -176.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.4 m -63.06 -51.13 67.88 Favored 'General case' 0 N--CA 1.407 -2.588 0 C-N-CA 119.551 -0.859 . . . . 0.0 109.819 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.5 mp -71.71 -43.06 66.59 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.366 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.693 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 43.4 m0 -62.44 -76.58 0.06 Allowed 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 123.757 0.661 . . . . 0.0 111.251 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.634 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.323 0.0 OUTLIER -71.74 -19.66 62.01 Favored 'General case' 0 C--O 1.254 1.337 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.976 -172.386 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.58 -51.82 55.1 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.751 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 32.0 t -72.47 -25.29 61.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.816 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 31.1 mt -62.78 -34.37 77.11 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.81 0.338 . . . . 0.0 110.242 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.568 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 70.8 t80 -91.24 -24.43 19.89 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.926 175.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.751 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 8.1 t30 -67.24 -31.62 72.1 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.698 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.22 5.08 48.79 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.271 0.558 . . . . 0.0 109.583 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.5 t30 46.67 55.39 7.74 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.516 1.927 . . . . 0.0 112.905 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -67.51 1.6 2.25 Favored 'General case' 0 CA--C 1.594 2.661 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t70 56.58 69.48 0.74 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.188 1.395 . . . . 0.0 110.951 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.86 HG12 ' HA ' ' A' ' 65' ' ' LEU . 6.7 m -147.44 176.06 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.629 -172.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.535 ' O ' ' HB3' ' A' ' 64' ' ' MET . 37.2 tt0 -133.78 126.23 30.19 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.816 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -134.69 140.78 46.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 108.784 -170.666 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.71 ' H ' HG12 ' A' ' 62' ' ' ILE . 38.1 m-85 -133.8 153.15 51.93 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 -166.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.854 HG12 HG21 ' A' ' 37' ' ' THR . 76.6 mt -86.42 112.42 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 166.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.8 m -130.12 -26.68 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -171.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.77 ' HA3' ' HB2' ' A' ' 60' ' ' ARG . . . -138.41 174.83 21.79 Favored Glycine 0 CA--C 1.48 -2.127 0 C-N-CA 118.643 -1.741 . . . . 0.0 112.058 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.753 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 5.2 m -39.02 -71.1 0.09 Allowed 'General case' 0 C--N 1.367 1.364 0 O-C-N 125.654 1.444 . . . . 0.0 109.417 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.814 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 21.4 m-20 -126.64 65.55 1.26 Allowed 'General case' 1 N--CA 1.363 -4.775 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 168.72 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.801 ' HG3' ' HA ' ' A' ' 23' ' ' THR . 4.1 mpt_? -134.18 137.0 44.14 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 112.896 -1.956 . . . . 0.0 108.823 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.56 169.59 17.06 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.71 HG12 ' H ' ' A' ' 54' ' ' PHE . 9.8 pt -136.56 157.64 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.065 0 C-N-CA 118.472 -1.291 . . . . 0.0 109.553 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.504 ' HZ ' ' HB2' ' A' ' 75' ' ' LYS 0.28 6.7 p90 -125.81 109.38 12.47 Favored 'General case' 0 N--CA 1.408 -2.55 0 O-C-N 126.394 2.309 . . . . 0.0 107.909 164.159 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.591 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 21.4 ttt -100.04 104.5 16.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.416 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.931 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.34 0.0 OUTLIER -99.75 147.15 25.75 Favored 'General case' 0 CA--C 1.462 -2.405 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.041 -178.962 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.367 20.8 ttp180 -105.13 -68.61 0.85 Allowed 'General case' 0 C--N 1.264 -3.147 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -164.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.937 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 37.4 t70 -44.48 -24.51 0.19 Allowed 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.506 ' HA3' ' N ' ' A' ' 16' ' ' LYS . . . 69.78 12.29 67.36 Favored Glycine 0 C--N 1.366 2.196 0 CA-C-N 120.224 1.374 . . . . 0.0 115.996 -175.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.4 t -121.38 32.53 5.87 Favored 'General case' 0 CA--C 1.563 1.463 0 CA-C-N 118.649 1.224 . . . . 0.0 111.905 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.937 ' HE1' ' HB3' ' A' ' 67' ' ' ASP . 45.0 p90 175.13 137.96 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -174.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.931 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 169.27 -33.3 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.881 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.687 ' CZ2' HD13 ' A' ' 89' ' ' LEU 0.622 10.5 m0 -82.5 -11.73 58.28 Favored 'General case' 0 C--O 1.263 1.778 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 -168.359 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 43.6 tt0 -74.08 -36.82 64.32 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 170.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 63.9 mt -55.11 -46.29 77.44 Favored 'Isoleucine or valine' 0 C--O 1.278 2.565 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB2' ' HD1' ' A' ' 72' ' ' TRP . 13.9 tmtt? -56.73 -48.97 76.58 Favored 'General case' 0 C--O 1.282 2.793 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.124 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.31 -47.39 83.84 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.211 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.468 ' CZ ' ' HG2' ' A' ' 73' ' ' GLU . 15.8 m-85 -52.59 -53.75 42.37 Favored 'General case' 0 C--N 1.371 1.54 0 O-C-N 123.73 0.644 . . . . 0.0 109.661 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.684 HD13 ' CE3' ' A' ' 40' ' ' TRP . 14.0 mt -60.46 -55.06 38.03 Favored 'General case' 0 C--O 1.302 3.816 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 75' ' ' LYS 0.308 27.4 m -78.29 -5.7 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 C-N-CA 117.986 -1.486 . . . . 0.0 113.217 -174.175 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.7 m -108.47 5.1 24.94 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.726 165.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 47.4 tp60 -82.26 -45.1 15.46 Favored 'General case' 0 CA--C 1.456 -2.643 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.391 4.6 p30 -163.72 -94.14 0.02 OUTLIER 'General case' 0 C--O 1.245 0.863 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 175.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.681 ' HB2' HG13 ' A' ' 24' ' ' VAL . 21.2 mmt180 -91.22 129.77 37.17 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.406 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 11.8 p -150.71 152.17 33.51 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.677 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.79 -36.71 0.1 Allowed 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 123.301 0.64 . . . . 0.0 110.316 170.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.687 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 41.2 tt0 -154.29 129.95 10.0 Favored 'General case' 0 C--O 1.207 -1.135 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.647 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.509 HG12 ' CD2' ' A' ' 89' ' ' LEU . 58.6 t -117.4 98.32 6.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 171.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.406 ' C ' HD23 ' A' ' 89' ' ' LEU . 16.9 p -100.01 136.14 40.38 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 122.708 1.242 . . . . 0.0 111.848 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.801 ' HB3' HD11 ' A' ' 18' ' ' LEU . 6.8 mt . . . . . 0 N--CA 1.398 -3.053 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.078 -168.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' A' ' 17' ' ' THR . 49.6 tptt . . . . . 0 N--CA 1.437 -1.085 0 CA-C-O 120.919 0.39 . . . . 0.0 111.54 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.617 HG23 ' HD2' ' A' ' 66' ' ' ARG . 30.3 m -69.73 115.16 8.65 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.032 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -110.96 102.9 11.34 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.853 1.311 . . . . 0.0 108.365 -176.433 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.594 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 6.2 ttt -84.84 119.62 25.53 Favored 'General case' 0 C--N 1.27 -2.859 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.737 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.509 ' HB2' ' HE2' ' A' ' 20' ' ' MET . 26.0 ttm -110.46 110.04 20.64 Favored 'General case' 0 N--CA 1.415 -2.215 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.077 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -91.77 115.93 28.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -128.72 130.69 68.82 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -169.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.073 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 18.3 m -84.9 143.63 28.89 Favored 'General case' 0 CA--C 1.604 3.034 0 O-C-N 124.77 1.294 . . . . 0.0 110.946 174.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.527 HG21 HD13 ' A' ' 36' ' ' ILE 0.288 6.9 t -126.74 135.48 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.66 0 C-N-CA 130.069 3.348 . . . . 0.0 104.326 -176.287 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -117.13 -21.26 8.92 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-N 122.921 2.601 . . . . 0.0 117.062 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.05 -45.19 62.66 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.021 0.828 . . . . 0.0 114.217 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.859 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.5 t-20 -116.18 116.82 39.56 Favored Pre-proline 0 N--CA 1.433 -1.313 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -88.36 30.84 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.901 2.401 . . . . 0.0 113.147 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 p -139.1 -174.84 3.96 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.531 ' O ' ' HB ' ' A' ' 33' ' ' THR . 32.7 tt0 -77.27 0.37 22.31 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.573 0.624 . . . . 0.0 111.727 -173.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -68.26 -43.35 78.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 122.049 -0.407 . . . . 0.0 110.601 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.859 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.7 OUTLIER -71.29 -39.32 71.58 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 118.086 -1.445 . . . . 0.0 108.314 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 61.1 m -45.04 -54.21 6.91 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 124.407 1.083 . . . . 0.0 111.482 172.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.63 -43.02 70.1 Favored 'General case' 0 C--O 1.265 1.882 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -52.72 -55.32 23.55 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.644 HG23 ' CE3' ' A' ' 40' ' ' TRP . 27.3 mt -62.59 -35.68 71.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.549 0 CA-C-N 112.574 -2.103 . . . . 0.0 112.932 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.2 m -61.77 -55.18 32.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.399 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.452 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 34.2 m -65.54 -48.51 72.19 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.592 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.0 -57.22 8.27 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.112 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.682 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 36.4 m0 -69.22 -74.03 0.14 Allowed 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.248 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.675 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.405 0.0 OUTLIER -72.05 -15.74 62.03 Favored 'General case' 0 C--O 1.253 1.28 0 C-N-CA 116.957 -1.897 . . . . 0.0 112.773 -168.01 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 38' ' ' SER . . . -67.23 -51.3 39.15 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 171.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 39.9 t -70.32 -27.47 64.39 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.795 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 16.2 mt -64.2 -28.71 69.93 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.038 0.447 . . . . 0.0 110.075 177.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.562 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 75.9 t80 -94.31 -28.44 15.57 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.108 0.48 . . . . 0.0 110.43 174.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 20.8 t-20 -72.79 -29.73 63.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.96 11.94 19.01 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.5 44.62 9.95 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.751 1.62 . . . . 0.0 114.158 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -82.3 151.41 26.76 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.92 87.62 7.36 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.726 1.603 . . . . 0.0 110.503 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.866 HG12 ' HA ' ' A' ' 65' ' ' LEU . 3.1 m -147.89 175.53 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.955 -173.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.448 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 26.8 tt0 -140.02 123.29 16.92 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.795 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -136.07 135.89 39.74 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -170.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.815 ' H ' HG12 ' A' ' 62' ' ' ILE . 16.7 m-85 -134.46 153.99 51.63 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -165.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 80.2 mt -80.03 124.75 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 165.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.98 -15.46 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 120.83 0.348 . . . . 0.0 110.739 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.524 ' HA3' ' HG2' ' A' ' 60' ' ' ARG . . . -166.32 163.64 37.03 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 118.051 -2.023 . . . . 0.0 113.905 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.478 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 37.3 m -77.91 45.85 0.54 Allowed 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 124.668 1.187 . . . . 0.0 111.579 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 58' ' ' SER . 3.1 p-10 158.63 14.92 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.745 0 C-N-CA 126.904 2.082 . . . . 0.0 106.496 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.524 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -149.02 147.76 28.93 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-O 121.669 0.747 . . . . 0.0 112.344 177.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.45 169.88 16.84 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 125.736 1.614 . . . . 0.0 106.874 -172.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.815 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.7 pt -136.19 157.82 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.778 0 C-N-CA 118.377 -1.329 . . . . 0.0 109.559 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.557 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -134.33 109.23 8.67 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 126.434 2.334 . . . . 0.0 106.362 162.411 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.594 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 23.3 ttt -97.83 108.96 21.79 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.347 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.919 HD13 ' HB2' ' A' ' 71' ' ' ALA 0.306 2.3 pt? -98.47 147.94 24.23 Favored 'General case' 0 CA--C 1.464 -2.359 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -176.127 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.617 ' HD2' HG23 ' A' ' 17' ' ' THR 0.26 12.6 mmm180 -100.28 -53.41 3.13 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 111.578 -2.555 . . . . 0.0 113.576 -174.017 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -45.47 -27.46 0.72 Allowed 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.95 -31.31 5.37 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 119.663 1.12 . . . . 0.0 111.936 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.261 40.6 t -98.17 -61.61 1.36 Allowed 'General case' 0 CA--C 1.588 2.43 0 N-CA-C 118.29 2.7 . . . . 0.0 118.29 -175.227 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.479 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -64.42 34.46 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 -168.62 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.919 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -103.16 -22.47 13.74 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.772 ' HH2' ' HG ' ' A' ' 18' ' ' LEU 0.504 13.6 m-90 -82.16 -28.93 31.84 Favored 'General case' 0 C--O 1.284 2.921 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -170.259 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.15 -27.57 63.64 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.655 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.8 mt -62.22 -39.97 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.759 ' HA ' ' CD1' ' A' ' 78' ' ' LEU . 26.2 ttpp -58.54 -43.3 89.21 Favored 'General case' 0 C--O 1.288 3.089 0 CA-C-O 121.445 0.641 . . . . 0.0 110.595 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.41 -45.96 80.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.209 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.655 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 10.0 m-85 -60.38 -39.71 88.22 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.321 -177.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.759 ' CD1' ' HA ' ' A' ' 75' ' ' LYS 0.275 21.5 mt -52.46 -59.74 4.07 Favored 'General case' 0 CA--C 1.45 -2.877 0 C-N-CA 123.077 0.551 . . . . 0.0 110.205 177.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.825 HG22 ' HB3' ' A' ' 84' ' ' CYS . 1.6 t -77.94 -9.26 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.684 -172.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.2 t -92.83 -12.24 31.62 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.615 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -107.15 -39.11 5.81 Favored 'General case' 0 CA--C 1.473 -1.989 0 C-N-CA 117.799 -1.56 . . . . 0.0 108.637 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -141.43 -169.45 2.87 Favored 'General case' 0 N--CA 1.389 -3.488 0 CA-C-N 113.419 -1.719 . . . . 0.0 107.06 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -108.32 76.92 1.06 Allowed 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 119.905 1.23 . . . . 0.0 110.645 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.825 ' HB3' HG22 ' A' ' 79' ' ' VAL . 3.8 t -70.49 157.53 37.68 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 113.518 -1.673 . . . . 0.0 109.645 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.75 -35.59 0.09 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.073 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.4 tt0 -135.51 125.22 25.38 Favored 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.42 -171.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.438 ' HB ' HD21 ' A' ' 89' ' ' LEU . 18.7 m -123.26 113.12 36.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.42 ' C ' HD23 ' A' ' 89' ' ' LEU . 3.4 p -107.31 128.27 54.29 Favored 'General case' 0 CA--C 1.477 -1.831 0 CA-C-O 122.36 1.076 . . . . 0.0 109.841 168.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.032 ' HB3' HD11 ' A' ' 18' ' ' LEU . 3.3 mt . . . . . 0 C--N 1.259 -3.366 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.731 -168.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? . . . . . 0 CA--C 1.549 0.916 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -78.61 124.27 27.99 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.813 ' HB3' HD22 ' A' ' 65' ' ' LEU . 25.6 tp -131.2 115.4 16.3 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.008 -174.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.678 ' HB3' ' SD ' ' A' ' 64' ' ' MET . 20.0 ptm -84.31 105.99 15.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.602 0.715 . . . . 0.0 112.282 176.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.831 ' HG3' ' HA ' ' A' ' 89' ' ' LEU . 3.6 mpp? -86.29 125.22 33.44 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.554 0.692 . . . . 0.0 112.261 176.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.635 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 47.2 t80 -106.06 112.92 26.17 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 127.246 2.218 . . . . 0.0 106.116 -176.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.78 130.36 74.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -168.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.848 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 89.5 m -93.05 131.14 38.32 Favored 'General case' 0 CA--C 1.611 3.295 0 C-N-CA 126.151 1.781 . . . . 0.0 111.883 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.6 t -132.14 113.44 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.358 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -105.77 -18.98 13.89 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 122.01 2.187 . . . . 0.0 115.185 -164.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.45 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . -39.17 -49.08 2.78 Favored Glycine 0 N--CA 1.487 2.035 0 O-C-N 123.419 0.449 . . . . 0.0 113.612 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 1.08 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 26.9 t-20 -115.86 104.74 52.35 Favored Pre-proline 0 N--CA 1.421 -1.881 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.14 33.74 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 123.888 3.059 . . . . 0.0 112.71 -174.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -148.43 -165.27 2.23 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.475 ' O ' ' HB ' ' A' ' 33' ' ' THR . 39.6 tt0 -81.05 -18.47 46.57 Favored 'General case' 0 C--O 1.19 -2.039 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -173.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.46 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 3.4 tmtt? -58.96 -41.25 87.03 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-N 119.032 0.833 . . . . 0.0 111.491 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 1.08 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 5.9 tp10 -66.42 -61.49 1.97 Allowed 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 31.5 m -34.35 -50.25 0.41 Allowed 'General case' 0 C--O 1.19 -2.073 0 C-N-CA 127.158 2.183 . . . . 0.0 113.026 172.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.8 pt-20 -71.99 -49.66 35.26 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 118.124 0.42 . . . . 0.0 112.031 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -54.24 -54.15 43.89 Favored 'General case' 0 C--O 1.263 1.801 0 CA-C-O 123.045 1.402 . . . . 0.0 107.296 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.041 HD12 ' HG3' ' A' ' 32' ' ' GLU . 1.5 mt -66.83 -38.99 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.584 0 CA-C-N 111.622 -2.536 . . . . 0.0 113.541 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.744 HG21 HG12 ' A' ' 55' ' ' ILE . 11.3 p -73.82 -39.3 64.16 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-N 121.3 1.864 . . . . 0.0 110.946 -176.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.0 t -64.22 -47.83 78.2 Favored 'General case' 0 N--CA 1.412 -2.344 0 O-C-N 124.017 0.823 . . . . 0.0 109.659 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.4 tp -68.75 -44.37 73.9 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.765 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.827 ' CE3' HD12 ' A' ' 78' ' ' LEU . 48.8 m0 -66.2 -74.02 0.12 Allowed 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 118.952 -0.547 . . . . 0.0 111.708 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.693 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.339 0.0 OUTLIER -70.83 -19.29 62.68 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 118.044 -1.462 . . . . 0.0 111.884 -172.601 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.03 -48.91 65.57 Favored Glycine 0 C--N 1.356 1.646 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 172.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.6 p -70.0 -29.63 66.75 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 117.442 0.621 . . . . 0.0 110.25 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.743 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 22.8 mt -61.07 -32.49 72.13 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.003 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.651 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 80.5 t80 -92.11 -27.38 17.78 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.873 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -67.89 -30.67 70.08 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 120.629 0.252 . . . . 0.0 111.004 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.69 -0.01 56.24 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.6 t30 47.17 53.87 10.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.136 1.774 . . . . 0.0 112.006 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -65.58 0.69 1.5 Allowed 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.9 t70 59.3 70.87 0.61 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.305 1.042 . . . . 0.0 111.365 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.54 ' CG2' ' HD2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -146.92 175.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.919 -172.936 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -131.04 115.92 17.09 Favored 'General case' 0 C--O 1.194 -1.828 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.743 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -130.41 140.77 50.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -172.279 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.812 ' H ' HG12 ' A' ' 62' ' ' ILE . 24.4 m-85 -134.02 152.06 51.69 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.744 HG12 HG21 ' A' ' 37' ' ' THR . 19.9 mt -92.65 97.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 167.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 m -99.1 -22.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.84 169.03 40.81 Favored Glycine 0 CA--C 1.482 -1.975 0 C-N-CA 118.192 -1.956 . . . . 0.0 113.78 175.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.468 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 36.9 m -65.04 120.4 12.57 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.0 OUTLIER 78.79 14.76 1.19 Allowed 'General case' 0 C--N 1.371 1.541 0 CA-C-O 122.658 1.218 . . . . 0.0 108.823 -178.613 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.635 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 4.1 tpp85 -143.84 117.49 9.23 Favored 'General case' 0 CA--C 1.557 1.236 0 O-C-N 121.419 -0.8 . . . . 0.0 111.266 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.96 166.44 20.06 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -175.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.812 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -138.77 155.23 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.461 -2.464 0 C-N-CA 118.174 -1.41 . . . . 0.0 109.699 172.785 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.521 ' CE2' ' HB1' ' A' ' 71' ' ' ALA . 6.0 p90 -134.97 106.37 6.8 Favored 'General case' 0 N--CA 1.417 -2.093 0 O-C-N 126.335 2.272 . . . . 0.0 107.307 163.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.678 ' SD ' ' HB3' ' A' ' 19' ' ' MET . 20.2 ttt -92.15 110.22 21.6 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.45 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.813 HD22 ' HB3' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -75.12 132.38 41.18 Favored 'General case' 0 C--O 1.254 1.313 0 O-C-N 125.895 1.997 . . . . 0.0 110.952 -175.672 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.318 2.1 tmt_? -108.41 -54.95 2.44 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -41.24 -34.16 0.45 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.09 -31.1 7.97 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 117.723 -2.18 . . . . 0.0 115.079 -173.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.9 m -158.66 60.17 0.43 Allowed 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -171.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.457 ' OH ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -152.81 21.38 0.6 Allowed 'General case' 0 C--O 1.218 -0.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.174 178.602 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.603 ' O ' ' HB ' ' A' ' 74' ' ' ILE . . . -103.19 -29.27 11.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -168.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.538 ' HZ2' HD23 ' A' ' 18' ' ' LEU 0.512 8.1 m0 -87.18 -9.93 53.95 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 116.317 -2.153 . . . . 0.0 113.828 -171.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.566 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 35.0 tt0 -73.42 -43.12 61.1 Favored 'General case' 0 C--O 1.279 2.653 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 166.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 61.0 mt -50.77 -47.0 29.36 Favored 'Isoleucine or valine' 0 C--O 1.278 2.578 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.801 173.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.613 ' HG3' HG21 ' A' ' 87' ' ' VAL . 44.8 tttm -56.11 -50.61 70.58 Favored 'General case' 0 C--N 1.375 1.688 0 C-N-CA 125.807 1.643 . . . . 0.0 110.269 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -61.86 -25.64 67.65 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.566 ' CZ ' ' HG2' ' A' ' 73' ' ' GLU . 23.1 m-85 -73.76 -61.14 1.94 Allowed 'General case' 0 CA--C 1.48 -1.726 0 C-N-CA 118.382 -1.327 . . . . 0.0 108.35 -175.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.827 HD12 ' CE3' ' A' ' 40' ' ' TRP . 1.9 pt? -66.52 -32.71 74.23 Favored 'General case' 0 C--O 1.297 3.583 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.001 -173.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.837 HG13 ' HB2' ' A' ' 84' ' ' CYS . 54.9 t -77.3 -21.55 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.414 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.6 m -103.54 6.76 37.56 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.209 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.625 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . 6.2 tp-100 -77.3 -46.18 23.85 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.455 2.3 p30 -165.26 -94.55 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 171.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG2' ' HA3' ' A' ' 26' ' ' GLY . 4.7 mpt_? -84.7 136.52 33.69 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 117.935 -1.506 . . . . 0.0 111.899 -174.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.837 ' HB2' HG13 ' A' ' 79' ' ' VAL . 7.9 p -152.66 150.84 29.9 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.403 -170.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.06 -41.15 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.848 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 7.6 tp10 -153.81 137.59 16.17 Favored 'General case' 0 C--O 1.21 -1.013 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.35 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.613 HG21 ' HG3' ' A' ' 75' ' ' LYS . 48.7 t -131.68 94.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.332 0.8 OUTLIER -98.19 126.32 43.61 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-O 123.603 1.668 . . . . 0.0 113.006 176.356 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.831 ' HA ' ' HG3' ' A' ' 20' ' ' MET . 3.0 mp . . . . . 1 N--CA 1.374 -4.274 0 CA-C-N 111.223 -2.717 . . . . 0.0 106.16 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -85.44 130.76 34.51 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.337 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.691 HD12 ' HH2' ' A' ' 72' ' ' TRP . 94.4 mt -130.91 123.84 29.82 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.422 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 22.0 ptm -84.54 107.5 16.81 Favored 'General case' 0 C--N 1.265 -3.079 0 C-N-CA 118.57 -1.252 . . . . 0.0 108.31 170.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.723 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 32.1 ttm -87.91 104.44 16.61 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 118.135 -1.426 . . . . 0.0 110.187 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -91.6 112.41 24.32 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.576 1.95 . . . . 0.0 106.298 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 p -129.04 132.69 67.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -168.001 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.993 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 70.9 m -80.39 128.38 33.5 Favored 'General case' 0 CA--C 1.595 2.69 0 C-N-CA 125.429 1.492 . . . . 0.0 109.267 173.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.4 p -110.93 138.34 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.606 3.113 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.991 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 85.7 p 52.64 -74.94 0.01 OUTLIER 'General case' 0 C--N 1.368 1.401 0 C-N-CA 126.481 1.913 . . . . 0.0 115.936 -169.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.68 -14.38 2.22 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -171.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -96.61 120.46 62.01 Favored Pre-proline 0 N--CA 1.42 -1.969 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.631 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 74.4 Cg_endo -73.71 41.66 0.64 Allowed 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 123.49 2.793 . . . . 0.0 112.485 -175.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.6 p -110.52 170.39 8.12 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.52 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.1 tp10 -81.47 -15.44 55.03 Favored 'General case' 0 C--O 1.17 -3.099 0 CA-C-N 119.934 1.243 . . . . 0.0 109.793 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.757 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 1.3 tmtt? -48.92 -63.6 1.05 Allowed 'General case' 0 C--O 1.269 2.122 0 C-N-CA 125.19 1.396 . . . . 0.0 114.534 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.991 ' HG2' ' HB3' ' A' ' 25' ' ' SER . 4.6 tp10 -67.76 -45.16 75.68 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -172.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 15.5 m -45.2 -58.56 3.17 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 112.071 -2.331 . . . . 0.0 109.689 172.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.757 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 10.8 pt-20 -58.38 -50.86 72.14 Favored 'General case' 0 C--O 1.26 1.61 0 C-N-CA 123.788 0.835 . . . . 0.0 112.751 -172.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.87 ' HG3' HG13 ' A' ' 36' ' ' ILE . 5.9 pt-20 -66.86 -47.67 71.2 Favored 'General case' 0 C--O 1.269 2.082 0 C-N-CA 117.959 -1.496 . . . . 0.0 109.626 -175.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.87 HG13 ' HG3' ' A' ' 35' ' ' GLU . 9.4 mt -76.05 -34.72 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.378 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.145 -172.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' A' ' 40' ' ' TRP . 44.7 p -68.61 -33.61 74.35 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 118.658 0.663 . . . . 0.0 110.82 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 m -63.16 -45.18 93.08 Favored 'General case' 0 C--O 1.258 1.53 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.57 -38.76 92.34 Favored 'General case' 0 C--N 1.378 1.805 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.769 ' HE1' ' HB3' ' A' ' 78' ' ' LEU . 14.1 m0 -65.67 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.248 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.697 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.384 0.0 OUTLIER -70.83 -14.26 62.34 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 117.992 -1.483 . . . . 0.0 112.357 -169.08 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.29 -53.04 38.8 Favored Glycine 0 C--N 1.366 2.243 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.549 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 80.5 p -72.32 -30.28 64.61 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.314 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.811 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 21.5 mt -62.44 -29.5 70.56 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.471 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.598 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 21.3 t80 -92.09 -30.86 15.77 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 24.7 t-20 -66.47 -34.83 78.81 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.153 0.581 . . . . 0.0 112.03 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.85 -1.29 57.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 56.25 56.41 5.83 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.194 1.398 . . . . 0.0 111.781 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -89.55 155.0 19.56 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.6 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 23.6 t70 -91.45 76.46 5.87 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 120.576 1.535 . . . . 0.0 110.252 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.5 m -139.5 167.19 20.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.565 -172.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 64' ' ' MET . 37.9 tt0 -120.9 122.13 39.56 Favored 'General case' 0 C--O 1.189 -2.115 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.811 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.72 128.29 36.59 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -177.18 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.907 ' H ' HG12 ' A' ' 62' ' ' ILE . 52.0 t80 -135.6 146.64 48.13 Favored 'General case' 0 C--N 1.272 -2.762 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.886 -167.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.3 mt -93.0 96.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 171.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.55 -34.64 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.53 -166.86 39.34 Favored Glycine 0 CA--C 1.479 -2.166 0 C-N-CA 118.721 -1.704 . . . . 0.0 113.8 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 49.7 m -69.95 123.63 22.0 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.631 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 5.1 t70 79.4 -1.99 2.19 Favored 'General case' 0 C--O 1.215 -0.752 0 O-C-N 124.542 1.152 . . . . 0.0 109.405 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -126.28 117.56 23.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.408 0.623 . . . . 0.0 111.92 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.83 165.19 25.57 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.907 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -143.74 153.64 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.663 0 C-N-CA 118.231 -1.388 . . . . 0.0 109.639 173.03 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.606 ' HA ' ' HG3' ' A' ' 53' ' ' ARG 0.28 10.0 p90 -131.9 104.19 6.73 Favored 'General case' 0 N--CA 1.402 -2.875 0 O-C-N 126.558 2.411 . . . . 0.0 107.155 161.341 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.532 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . 23.9 ttt -90.28 109.96 21.04 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.809 -176.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.683 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.265 3.9 mp -76.59 145.13 39.15 Favored 'General case' 0 CA--C 1.457 -2.634 0 C-N-CA 126.085 1.754 . . . . 0.0 110.892 -175.642 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.6 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.329 61.6 ttt180 -119.52 -58.42 1.91 Allowed 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 174.141 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 69' ' ' SER . 10.4 t70 -70.67 8.55 0.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.87 -24.78 0.02 OUTLIER Glycine 0 CA--C 1.559 2.837 0 CA-C-N 120.126 1.33 . . . . 0.0 116.244 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 67' ' ' ASP . 6.3 m -87.05 15.71 5.77 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -169.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -164.23 135.21 4.37 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.718 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.811 ' HA ' HD12 ' A' ' 74' ' ' ILE . . . 156.37 -31.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 127.019 2.128 . . . . 0.0 111.708 172.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.699 ' CZ2' HD23 ' A' ' 89' ' ' LEU 0.272 13.7 m-90 -74.53 -30.86 61.94 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-O 121.722 0.772 . . . . 0.0 111.873 -174.356 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 36.8 tt0 -68.8 -37.51 79.3 Favored 'General case' 0 C--O 1.265 1.915 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.811 HD12 ' HA ' ' A' ' 71' ' ' ALA . 12.7 mt -61.62 -44.21 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.557 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.516 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.713 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.44 -27.9 64.62 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.822 -178.066 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.74 -48.71 79.46 Favored 'General case' 0 C--O 1.247 0.963 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.954 171.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.527 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 18.9 m-85 -55.64 -45.66 77.58 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.157 0.98 . . . . 0.0 109.923 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.769 ' HB3' ' HE1' ' A' ' 40' ' ' TRP 0.27 4.3 pp -63.96 -47.46 80.34 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.786 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.516 ' N ' HD12 ' A' ' 78' ' ' LEU 0.355 4.4 m -77.04 -1.8 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 116.63 -2.028 . . . . 0.0 112.685 176.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -85.57 -20.03 30.19 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.005 166.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.421 ' HG2' HG23 ' A' ' 36' ' ' ILE . 59.3 tp60 -80.93 -17.53 50.22 Favored 'General case' 0 C--N 1.367 1.357 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 171.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.258 23.2 t70 88.99 -50.61 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 112.489 -2.141 . . . . 0.0 114.527 168.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.794 ' HB3' ' HB3' ' A' ' 25' ' ' SER . 33.3 mmt180 -84.79 76.6 10.21 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.658 ' HB3' HD13 ' A' ' 78' ' ' LEU . 61.3 m -154.91 37.62 0.41 Allowed 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 123.073 1.416 . . . . 0.0 110.406 -168.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -32.16 -45.92 0.11 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 131.009 3.723 . . . . 0.0 120.274 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.993 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 30.6 tt0 -146.71 123.58 11.3 Favored 'General case' 0 C--O 1.198 -1.629 0 C-N-CA 117.244 -1.782 . . . . 0.0 113.906 -164.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.625 ' HB ' HD11 ' A' ' 89' ' ' LEU . 16.3 m -113.55 131.69 64.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.447 ' C ' HD12 ' A' ' 89' ' ' LEU 0.265 16.7 p -117.77 120.84 39.16 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 122.917 1.341 . . . . 0.0 110.095 165.099 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.723 ' HG ' ' HG3' ' A' ' 20' ' ' MET . 5.1 mp . . . . . 0 C--N 1.262 -3.239 0 CA-C-N 112.708 -2.042 . . . . 0.0 106.638 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 20.3 tptm . . . . . 0 C--O 1.225 -0.207 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.8 t -72.0 133.61 45.42 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.131 0.491 . . . . 0.0 109.854 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.933 HD21 ' HA ' ' A' ' 89' ' ' LEU . 13.3 tp -134.04 133.93 41.8 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.178 -177.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 86.7 mtp -83.56 100.27 10.69 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 104.47 -2.418 . . . . 0.0 104.47 164.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.556 ' CE ' ' HB1' ' A' ' 71' ' ' ALA . 53.7 ttp -86.45 119.97 27.29 Favored 'General case' 0 CA--C 1.475 -1.911 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.804 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 49.8 t80 -97.96 124.6 42.49 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.868 -1.969 . . . . 0.0 106.896 -174.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -129.37 125.9 62.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -173.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.051 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 86.8 m -77.05 120.61 22.39 Favored 'General case' 0 CA--C 1.587 2.4 0 C-N-CA 125.409 1.483 . . . . 0.0 110.891 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.659 HG21 HD13 ' A' ' 36' ' ' ILE . 10.3 p -114.48 125.09 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 170.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.87 13.05 4.01 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 115.73 -2.388 . . . . 0.0 113.54 -163.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.11 -37.91 93.48 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 119.198 -1.477 . . . . 0.0 109.895 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 1.127 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 23.6 t-20 -117.13 106.73 46.77 Favored Pre-proline 0 N--CA 1.423 -1.824 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -72.94 30.32 0.29 Allowed 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 123.569 2.846 . . . . 0.0 113.251 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -143.4 -171.16 3.44 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.411 ' O ' ' HB ' ' A' ' 33' ' ' THR . 33.2 tt0 -82.29 -7.05 59.62 Favored 'General case' 0 C--O 1.206 -1.199 0 CA-C-N 118.802 0.728 . . . . 0.0 112.537 -171.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.515 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 2.4 tmpt? -60.91 -45.59 94.02 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 118.235 0.47 . . . . 0.0 110.369 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 1.127 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.5 tp10 -67.59 -49.55 62.57 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 86.9 m -44.49 -52.13 8.19 Favored 'General case' 0 C--O 1.196 -1.738 0 C-N-CA 124.989 1.316 . . . . 0.0 112.409 172.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.515 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.3 pt-20 -67.84 -51.51 47.62 Favored 'General case' 0 C--O 1.253 1.273 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -59.02 -47.06 86.58 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.929 1.347 . . . . 0.0 108.071 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.895 HD12 ' HG3' ' A' ' 32' ' ' GLU . 10.1 mt -69.85 -40.61 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.58 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.804 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.876 HG21 HG12 ' A' ' 55' ' ' ILE . 12.9 p -69.61 -37.69 76.95 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 120.54 1.518 . . . . 0.0 111.047 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 p -64.75 -57.86 7.81 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 123.864 0.727 . . . . 0.0 109.668 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.1 tp -66.11 -43.21 87.88 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.745 ' HZ2' ' HB2' ' A' ' 82' ' ' ASP . 44.0 m0 -69.59 -69.12 0.36 Allowed 'General case' 0 C--O 1.197 -1.706 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.901 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.791 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.421 0.0 OUTLIER -68.97 -20.05 64.17 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 117.554 -1.659 . . . . 0.0 112.669 -171.827 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.46 -50.42 59.51 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 170.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.44 ' HA ' ' HB2' ' A' ' 46' ' ' ASN . 65.3 p -69.64 -25.39 63.91 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.082 -0.658 . . . . 0.0 110.644 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.791 ' HG ' ' HA ' ' A' ' 41' ' ' GLN . 20.1 mt -62.07 -31.15 71.54 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 174.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -77.45 -44.13 30.06 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.383 0.611 . . . . 0.0 110.479 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 84.8 m-20 -63.61 -30.59 71.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -172.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.18 2.52 54.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.15 0.5 . . . . 0.0 110.33 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 55.05 62.32 2.56 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.336 1.455 . . . . 0.0 111.826 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -98.54 152.12 19.91 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 120.664 -1.272 . . . . 0.0 108.211 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -87.26 82.56 7.58 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 120.343 1.429 . . . . 0.0 110.288 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 1.031 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.1 m -147.75 165.63 5.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.607 -174.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.444 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 1.9 mp0 -131.25 124.4 30.46 Favored 'General case' 0 C--O 1.194 -1.859 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 171.576 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.836 ' HG3' ' HA ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -124.56 138.99 54.28 Favored 'General case' 0 C--N 1.287 -2.133 0 O-C-N 121.47 -0.769 . . . . 0.0 109.259 -172.488 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.871 ' H ' HG12 ' A' ' 62' ' ' ILE . 21.0 t80 -134.93 151.4 50.83 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.781 -1.167 . . . . 0.0 113.294 -167.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.876 HG12 HG21 ' A' ' 37' ' ' THR . 48.9 mt -83.66 123.32 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 39.2 t -101.74 -38.85 6.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.94 -163.32 30.44 Favored Glycine 0 CA--C 1.481 -2.043 0 C-N-CA 119.329 -1.415 . . . . 0.0 113.12 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 m -52.96 119.1 4.25 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.943 0.897 . . . . 0.0 109.534 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER 73.59 13.9 4.35 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 121.896 0.855 . . . . 0.0 111.729 175.1 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.598 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -146.55 125.86 13.09 Favored 'General case' 0 CA--C 1.572 1.803 0 O-C-N 120.763 -1.211 . . . . 0.0 112.016 -177.719 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.98 163.5 32.81 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.871 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -137.55 156.24 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.178 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.652 173.72 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.836 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 1.1 m-30 -125.96 101.04 6.63 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 126.674 2.483 . . . . 0.0 104.926 167.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 26.5 ttt -83.97 100.34 10.98 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 117.816 -1.554 . . . . 0.0 108.305 176.115 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.031 ' HA ' HG12 ' A' ' 51' ' ' VAL . 2.6 pt? -97.28 148.3 23.26 Favored 'General case' 0 CA--C 1.45 -2.895 0 CA-C-O 122.484 1.135 . . . . 0.0 112.714 -175.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.358 16.0 ttp180 -109.06 -54.86 2.48 Favored 'General case' 1 C--N 1.24 -4.165 0 CA-C-N 113.066 -1.879 . . . . 0.0 115.6 -173.402 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.11 -8.67 0.5 Allowed 'General case' 0 CA--C 1.594 2.67 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 174.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.44 -31.09 2.98 Favored Glycine 0 C--N 1.359 1.835 0 O-C-N 120.049 -1.657 . . . . 0.0 113.533 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.4 p -81.4 -69.49 0.61 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -174.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.688 ' CE1' ' HB2' ' A' ' 65' ' ' LEU 0.297 0.2 OUTLIER -46.36 -28.98 1.49 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 120.687 3.588 . . . . 0.0 120.687 -162.632 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.867 ' HA ' HD12 ' A' ' 74' ' ' ILE . . . -64.14 -35.76 81.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 116.555 2.058 . . . . 0.0 116.555 -166.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.651 ' CZ2' ' HB2' ' A' ' 89' ' ' LEU 0.323 27.2 m-90 -83.36 -19.72 35.6 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.417 -1.313 . . . . 0.0 113.481 -173.237 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -74.55 -35.14 63.09 Favored 'General case' 0 C--O 1.28 2.693 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 170.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 71' ' ' ALA . 22.6 mt -65.0 -35.1 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.823 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.846 ' HG3' HG11 ' A' ' 87' ' ' VAL . 12.5 tmtt? -67.58 -33.18 74.49 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.761 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -58.46 -47.34 84.32 Favored 'General case' 0 C--O 1.263 1.769 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.113 170.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.578 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 5.7 m-30 -52.0 -47.06 65.12 Favored 'General case' 0 N--CA 1.513 2.709 0 CA-C-O 122.152 0.977 . . . . 0.0 109.64 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.674 ' CD1' ' HA ' ' A' ' 75' ' ' LYS . 30.9 mt -53.62 -63.6 1.1 Allowed 'General case' 0 CA--C 1.471 -2.093 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.423 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.6 m -69.04 -11.0 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 C-N-CA 119.553 -0.859 . . . . 0.0 112.537 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.7 m -94.44 -10.49 32.26 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.967 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -124.81 -28.68 3.48 Favored 'General case' 0 C--N 1.38 1.908 0 C-N-CA 116.137 -2.225 . . . . 0.0 112.112 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.745 ' HB2' ' HZ2' ' A' ' 40' ' ' TRP . 11.8 m-20 -133.17 167.56 20.13 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -83.19 63.07 6.99 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.176 1.353 . . . . 0.0 112.838 -174.648 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 40.5 t -82.43 176.71 9.21 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.683 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -167.73 -39.42 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -169.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.051 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 32.1 tt0 -147.55 121.85 9.61 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.612 -167.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.846 HG11 ' HG3' ' A' ' 75' ' ' LYS . 28.4 m -118.96 129.34 75.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.242 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.8 p -115.99 120.27 38.6 Favored 'General case' 0 C--O 1.281 2.714 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.933 ' HA ' HD21 ' A' ' 18' ' ' LEU 0.302 7.1 tp . . . . . 0 CA--C 1.577 1.994 0 CA-C-N 112.341 -2.209 . . . . 0.0 107.815 171.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.454 ' HE3' HD11 ' A' ' 89' ' ' LEU . 33.1 ttpt . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.552 HG23 ' HA ' ' A' ' 66' ' ' ARG . 90.7 m -70.28 117.0 11.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 173.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 1.089 HD21 ' HA ' ' A' ' 89' ' ' LEU . 9.9 tp -133.59 140.39 47.11 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.903 -168.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.518 ' HG2' ' SD ' ' A' ' 64' ' ' MET . 81.3 mtp -83.01 100.63 10.58 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 162.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.644 ' HB3' HD23 ' A' ' 18' ' ' LEU . 2.1 ppp? -87.08 137.42 32.36 Favored 'General case' 0 C--O 1.259 1.605 0 C-N-CA 115.915 -2.314 . . . . 0.0 108.588 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -107.14 126.53 52.5 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.064 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.694 HG13 ' HB3' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -116.21 124.85 72.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.886 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.014 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 17.6 m -98.6 135.04 40.69 Favored 'General case' 0 CA--C 1.582 2.205 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.688 HG21 HD11 ' A' ' 36' ' ' ILE . 12.6 p -132.17 119.88 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.609 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 t -124.32 -1.98 8.09 Favored 'General case' 0 C--O 1.239 0.52 0 O-C-N 119.327 -2.108 . . . . 0.0 112.84 -165.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.91 -32.08 78.48 Favored Glycine 0 CA--C 1.506 -0.505 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.629 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.75 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 24.9 t-20 -117.14 106.74 46.76 Favored Pre-proline 0 N--CA 1.4 -2.939 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -85.75 32.02 0.47 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.7 p -135.53 -160.51 1.06 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.419 ' O ' ' HB ' ' A' ' 33' ' ' THR . 3.7 tp10 -84.44 -7.22 59.36 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -177.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 2.2 tmpt? -65.5 -49.8 67.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -172.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.75 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 16.4 tp10 -72.74 -35.5 67.53 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 117.663 -1.615 . . . . 0.0 108.129 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.547 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 84.3 m -49.61 -52.92 27.08 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.07 172.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.9 pt-20 -70.01 -37.86 75.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -62.42 -55.11 30.94 Favored 'General case' 0 C--O 1.209 -1.053 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.757 HG23 ' CE3' ' A' ' 40' ' ' TRP . 95.9 mt -58.13 -49.92 79.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.062 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.897 HG21 HG12 ' A' ' 55' ' ' ILE . 36.0 p -65.04 -56.81 10.87 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.522 -176.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 m -65.22 -48.43 73.35 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.452 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.2 mt -75.09 -52.93 9.82 Favored 'General case' 0 C--O 1.252 1.19 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.757 ' CE3' HG23 ' A' ' 36' ' ' ILE . 6.5 m0 -72.5 -60.69 2.11 Favored 'General case' 0 C--O 1.157 -3.767 0 CA-C-O 117.198 -1.382 . . . . 0.0 109.062 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.79 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.44 0.0 OUTLIER -64.4 -24.68 67.72 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-N 121.066 1.757 . . . . 0.0 112.893 -173.706 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.67 -47.48 90.17 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.87 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 54.5 p -77.62 -19.96 54.66 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 122.306 -0.526 . . . . 0.0 111.861 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.79 ' HG ' ' HA ' ' A' ' 41' ' ' GLN . 23.9 mt -65.05 -34.02 77.43 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.46 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 90.1 t80 -85.69 -33.61 21.49 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.854 173.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.87 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 15.2 t-20 -61.0 -39.21 88.83 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.44 6.48 33.73 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 122.0 -0.437 . . . . 0.0 110.585 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 58.9 41.24 21.57 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.914 0.886 . . . . 0.0 112.226 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.428 ' O ' HG13 ' A' ' 51' ' ' VAL . 18.3 m-85 -73.57 10.89 0.93 Allowed 'General case' 0 CA--C 1.582 2.178 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 45.32 70.34 0.36 Allowed 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 125.61 1.564 . . . . 0.0 112.253 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.933 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.2 m -147.13 176.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.289 -169.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.41 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 96.1 mt-30 -134.33 120.26 19.67 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.73 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -126.23 141.42 51.93 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -171.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.636 ' H ' HG12 ' A' ' 62' ' ' ILE . 39.8 m-85 -133.29 151.96 51.91 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -165.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.897 HG12 HG21 ' A' ' 37' ' ' THR . 19.5 mt -88.33 114.12 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 167.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.967 HG23 ' HB3' ' A' ' 60' ' ' ARG . 8.9 m -113.81 -21.6 5.35 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.726 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.347 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.21 171.16 36.14 Favored Glycine 0 C--O 1.209 -1.422 0 C-N-CA 117.666 -2.207 . . . . 0.0 114.759 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.547 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 42.3 m -66.38 118.5 10.13 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER 85.04 5.08 0.55 Allowed 'General case' 0 C--N 1.37 1.463 0 O-C-N 124.203 0.94 . . . . 0.0 110.229 -173.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.967 ' HB3' HG23 ' A' ' 56' ' ' VAL . 2.8 mpt_? -135.18 132.5 38.04 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.694 ' HB3' HG13 ' A' ' 22' ' ' VAL . . . -143.09 166.12 25.53 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.83 1.252 . . . . 0.0 108.178 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.636 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER -145.66 157.98 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.855 168.515 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.628 ' O ' ' HG3' ' A' ' 20' ' ' MET 0.385 11.8 p90 -134.08 104.01 6.04 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 125.575 1.797 . . . . 0.0 110.45 162.594 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.518 ' SD ' ' HG2' ' A' ' 19' ' ' MET . 24.1 ttt -84.59 110.86 19.03 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.015 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.942 HD13 ' HB2' ' A' ' 71' ' ' ALA . 2.1 pt? -102.11 148.09 25.82 Favored 'General case' 0 CA--C 1.486 -1.517 0 O-C-N 124.309 1.006 . . . . 0.0 113.013 -173.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.552 ' HA ' HG23 ' A' ' 17' ' ' THR 0.266 31.3 tpt180 -113.53 -62.18 1.63 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.271 -1.786 . . . . 0.0 115.44 -172.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -47.1 -17.65 0.06 Allowed 'General case' 0 CA--C 1.59 2.502 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.07 -16.18 17.69 Favored Glycine 0 C--N 1.358 1.78 0 O-C-N 120.727 -1.233 . . . . 0.0 114.498 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -118.97 33.37 5.68 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -167.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.669 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -156.86 2.58 0.13 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 117.913 2.561 . . . . 0.0 117.913 -174.527 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.942 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -79.1 -28.22 42.98 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 120.124 1.329 . . . . 0.0 113.6 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.613 ' CZ2' ' HB2' ' A' ' 89' ' ' LEU 0.475 28.0 m-90 -88.21 -12.44 43.81 Favored 'General case' 0 N--CA 1.41 -2.468 0 C-N-CA 117.31 -1.756 . . . . 0.0 113.992 -173.336 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 1.6 mp0 -75.35 -29.1 59.83 Favored 'General case' 0 C--O 1.274 2.388 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.699 ' HA ' ' HD2' ' A' ' 77' ' ' PHE . 85.6 mt -68.61 -32.85 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.062 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 174.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.807 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -59.01 -43.87 91.61 Favored 'General case' 0 C--O 1.285 2.943 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 22.9 t70 -50.28 -50.03 51.61 Favored 'General case' 0 C--O 1.26 1.607 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.19 172.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.699 ' HD2' ' HA ' ' A' ' 74' ' ' ILE . 53.6 m-85 -55.96 -43.61 77.7 Favored 'General case' 0 C--O 1.186 -2.279 0 C-N-CA 118.752 -1.179 . . . . 0.0 112.223 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.807 ' HG ' ' HA ' ' A' ' 75' ' ' LYS 0.28 4.9 mt -49.48 -60.38 2.9 Favored 'General case' 0 C--O 1.294 3.422 0 CA-C-O 123.258 1.504 . . . . 0.0 109.899 -178.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.681 HG12 ' CB ' ' A' ' 84' ' ' CYS . 24.1 m -75.15 -7.83 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 111.774 -2.466 . . . . 0.0 111.463 -171.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.0 m -104.83 -5.6 21.03 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.174 172.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 29.0 mm-40 -85.08 -56.47 3.54 Favored 'General case' 0 CA--C 1.47 -2.096 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.361 28.3 t70 -179.57 -84.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.733 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 24.5 mmt-85 -87.38 144.29 26.83 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.315 1.416 . . . . 0.0 109.202 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.681 ' CB ' HG12 ' A' ' 79' ' ' VAL . 8.6 p -159.23 147.83 18.05 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.37 -44.51 0.05 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.014 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 40.5 tt0 -140.17 118.77 12.3 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.054 -1.058 . . . . 0.0 110.528 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.411 HG21 ' HG3' ' A' ' 75' ' ' LYS . 2.2 p -113.09 102.62 14.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.731 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.9 p -119.82 124.75 46.88 Favored 'General case' 0 C--O 1.26 1.632 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.089 ' HA ' HD21 ' A' ' 18' ' ' LEU 0.268 5.1 tp . . . . . 0 CA--C 1.584 2.285 0 CA-C-N 113.624 -1.625 . . . . 0.0 106.87 171.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.603 ' HD2' ' HB2' ' A' ' 18' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.7 m -80.79 110.63 16.49 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.671 HD23 ' HZ2' ' A' ' 72' ' ' TRP . 60.2 tp -134.28 118.42 17.52 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.47 -174.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.922 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 26.4 ptt? -83.61 104.83 14.05 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 117.213 -1.795 . . . . 0.0 106.481 165.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.576 ' HG3' ' HE1' ' A' ' 72' ' ' TRP . 14.2 tmm? -87.88 139.73 30.22 Favored 'General case' 0 C--O 1.268 2.053 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.47 -172.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -106.43 126.43 52.24 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 125.056 1.472 . . . . 0.0 110.085 -167.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.82 137.75 56.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.161 -174.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.044 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 54.2 m -107.72 131.31 54.57 Favored 'General case' 0 CA--C 1.628 3.95 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.222 170.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.57 HG12 ' HG2' ' A' ' 32' ' ' GLU . 80.5 t -115.36 94.26 3.02 Favored 'Isoleucine or valine' 0 C--N 1.405 2.998 0 C-N-CA 128.471 2.709 . . . . 0.0 106.598 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.73 35.99 4.53 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-N 122.098 2.226 . . . . 0.0 112.923 -174.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.573 ' HA3' ' HB2' ' A' ' 83' ' ' ARG . . . -59.87 -35.53 87.07 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 168.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.741 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 4.1 m-20 -111.36 148.56 39.03 Favored Pre-proline 0 N--CA 1.42 -1.957 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 167.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -92.64 43.18 0.31 Allowed 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 121.642 1.561 . . . . 0.0 110.851 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -130.77 -146.25 0.3 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.5 -173.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.593 ' HG3' ' HA ' ' A' ' 58' ' ' SER . 30.2 tt0 -125.58 17.98 8.11 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 170.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.769 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 8.2 tmtt? -92.98 -37.93 11.94 Favored 'General case' 0 C--O 1.256 1.429 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.741 ' HB3' ' HB2' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -65.8 -44.15 86.54 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 175.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 84.8 m -49.38 -62.4 1.57 Allowed 'General case' 0 C--O 1.187 -2.199 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.211 169.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.769 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 11.7 pt-20 -51.64 -54.87 23.28 Favored 'General case' 0 C--O 1.26 1.641 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -174.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.872 ' HG3' HG13 ' A' ' 36' ' ' ILE . 11.9 pt-20 -65.23 -49.72 68.61 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.727 0.775 . . . . 0.0 109.445 -174.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.872 HG13 ' HG3' ' A' ' 35' ' ' GLU . 56.9 mt -71.55 -43.5 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.027 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.202 -172.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.4 p -66.79 -37.35 84.39 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 118.177 0.444 . . . . 0.0 111.254 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.6 m -67.55 -38.93 84.88 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.994 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 tp -67.55 -35.63 79.43 Favored 'General case' 0 C--N 1.365 1.268 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.657 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 11.9 m0 -68.85 -77.53 0.08 Allowed 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.953 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.677 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.351 0.0 OUTLIER -66.43 -20.89 66.18 Favored 'General case' 0 C--O 1.248 0.987 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.958 -171.571 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.87 -55.29 31.22 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.93 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 47.8 t -70.84 -26.93 63.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 116.708 0.254 . . . . 0.0 111.026 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.792 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 32.8 mt -61.03 -35.51 77.07 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.523 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 70.0 t80 -90.99 -27.29 18.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.93 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 21.8 t-20 -65.26 -33.59 76.36 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.485 0.714 . . . . 0.0 111.92 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.19 1.88 55.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.063 0.459 . . . . 0.0 109.855 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 53.91 66.13 1.32 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.521 1.529 . . . . 0.0 112.037 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -99.48 159.93 14.66 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -95.32 86.48 4.54 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 121.014 1.733 . . . . 0.0 109.801 -177.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.902 HG12 ' HA ' ' A' ' 65' ' ' LEU . 1.4 m -146.66 163.46 8.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.969 -174.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.55 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 13.5 mt-30 -128.59 115.83 18.69 Favored 'General case' 0 C--O 1.194 -1.839 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.792 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -121.41 139.33 53.59 Favored 'General case' 0 C--N 1.28 -2.451 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.663 -168.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.658 ' H ' HG12 ' A' ' 62' ' ' ILE . 83.0 m-85 -133.58 151.72 51.76 Favored 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -170.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.7 mt -94.09 96.3 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 167.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 60' ' ' ARG . 4.3 m -92.02 -24.48 5.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.97 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.03 173.61 40.89 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 117.016 -2.516 . . . . 0.0 114.158 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.593 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 30.8 t -70.32 115.78 9.91 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 24' ' ' VAL 0.268 0.6 OUTLIER 73.18 17.16 4.09 Favored 'General case' 0 C--O 1.207 -1.168 0 C-N-CA 125.8 1.64 . . . . 0.0 109.152 -178.607 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.47 ' HB3' HG23 ' A' ' 56' ' ' VAL . 9.1 mpt_? -131.88 132.12 43.35 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.075 0.95 . . . . 0.0 112.518 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.45 166.3 24.18 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.491 1.116 . . . . 0.0 109.145 -173.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.768 HD12 ' HB2' ' A' ' 19' ' ' MET . 1.0 OUTLIER -143.77 157.28 16.25 Favored 'Isoleucine or valine' 0 C--O 1.275 2.442 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.808 172.103 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.756 ' HZ ' HD21 ' A' ' 78' ' ' LEU . 2.2 m-30 -125.96 111.47 14.8 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 166.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.922 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 22.1 ttt -84.44 93.68 8.35 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 118.384 -1.326 . . . . 0.0 109.9 173.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.938 ' HG ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -98.65 146.93 25.34 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 124.805 1.242 . . . . 0.0 114.316 -174.103 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.464 7.6 ppt_? -117.28 -54.48 2.39 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -47.79 -19.71 0.24 Allowed 'General case' 0 CA--C 1.584 2.275 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.4 10.32 7.5 Favored Glycine 0 C--N 1.374 2.654 0 CA-C-N 120.101 1.319 . . . . 0.0 115.252 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.3 m -128.23 40.01 3.74 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 118.359 1.08 . . . . 0.0 111.439 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.635 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -170.59 -7.28 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.864 0 O-C-N 121.769 -0.582 . . . . 0.0 111.487 -172.353 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.938 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -80.21 -42.84 22.53 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -166.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.671 ' HZ2' HD23 ' A' ' 18' ' ' LEU 0.311 9.2 m0 -92.75 -9.97 38.68 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 123.461 1.601 . . . . 0.0 110.44 -170.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.76 -38.65 73.48 Favored 'General case' 0 C--O 1.298 3.64 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 166.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 70' ' ' TYR . 42.8 mt -59.14 -38.32 73.53 Favored 'Isoleucine or valine' 0 C--N 1.389 2.301 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.855 ' HG3' HG21 ' A' ' 87' ' ' VAL . 12.6 tmtt? -58.0 -43.69 86.79 Favored 'General case' 0 C--O 1.288 3.126 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.582 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.92 -43.34 86.19 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.863 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -62.32 -31.83 72.49 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.416 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.779 ' HG ' ' HA ' ' A' ' 75' ' ' LYS . 55.6 mt -53.14 -58.83 5.67 Favored 'General case' 0 C--O 1.285 2.964 0 CA-C-O 122.87 1.319 . . . . 0.0 110.192 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.737 HG22 ' HB3' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -76.74 -13.4 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.875 -173.552 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.7 m -91.63 -7.54 49.76 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.756 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.1 tm0? -84.3 -50.98 7.35 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.408 11.9 t70 -152.58 -97.36 0.05 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.518 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.573 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 75.2 mtm180 -140.26 92.16 2.51 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 120.22 1.373 . . . . 0.0 111.626 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.737 ' HB3' HG22 ' A' ' 79' ' ' VAL . 2.3 t -93.88 161.42 14.32 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.611 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.68 -25.47 0.37 Allowed 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -167.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.044 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 34.6 tt0 -145.13 125.27 13.69 Favored 'General case' 0 CA--C 1.479 -1.765 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.366 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.855 HG21 ' HG3' ' A' ' 75' ' ' LYS . 14.0 p -128.07 103.9 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.9 0 CA-C-O 122.203 1.002 . . . . 0.0 109.685 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 m -100.89 109.36 21.31 Favored 'General case' 1 C--O 1.312 4.359 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.404 -175.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.699 ' CD1' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.356 0.866 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? . . . . . 0 N--CA 1.425 -1.692 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -91.86 124.99 36.39 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.833 ' HB3' HD12 ' A' ' 89' ' ' LEU . 32.1 mt -130.86 118.51 20.86 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.162 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 24.9 ptm -84.14 111.55 19.44 Favored 'General case' 0 C--N 1.267 -2.982 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.235 171.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.848 ' HG2' HD11 ' A' ' 89' ' ' LEU . 11.3 mtt -84.2 103.19 13.19 Favored 'General case' 0 CA--C 1.46 -2.508 0 C-N-CA 118.499 -1.28 . . . . 0.0 109.38 171.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -89.52 98.07 11.56 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 175.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.418 ' HB ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -104.39 122.9 57.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.309 -170.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.983 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 93.2 m -81.11 134.87 35.73 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 174.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 32' ' ' GLU . 1.6 p -113.43 152.29 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.273 0 CA-C-N 120.721 1.601 . . . . 0.0 107.878 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.659 ' OG ' ' HB2' ' A' ' 85' ' ' ALA . 70.8 m -87.41 160.81 18.19 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 120.815 1.643 . . . . 0.0 107.283 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.798 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 78.39 72.24 1.18 Allowed Glycine 0 N--CA 1.414 -2.774 0 C-N-CA 118.313 -1.899 . . . . 0.0 111.088 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.487 ' OD1' ' HD3' ' A' ' 31' ' ' LYS . 16.7 t-20 -87.87 101.71 2.79 Favored Pre-proline 0 C--O 1.243 0.758 0 CA-C-N 118.262 1.031 . . . . 0.0 109.485 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.798 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 84.1 Cg_endo -118.79 -30.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.486 0 N-CA-C 116.659 1.754 . . . . 0.0 116.659 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.745 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 1.1 p -132.95 -99.47 0.28 Allowed 'General case' 1 N--CA 1.554 4.728 0 C-N-CA 113.73 -3.188 . . . . 0.0 116.339 -164.187 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.796 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . 4.2 tp10 -100.38 7.61 44.16 Favored 'General case' 0 N--CA 1.399 -3.024 1 N-CA-C 97.741 -4.911 . . . . 0.0 97.741 156.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.785 ' HA ' ' HD2' ' A' ' 28' ' ' PRO 0.435 0.2 OUTLIER 82.0 -175.16 0.04 OUTLIER 'General case' 1 N--CA 1.298 -8.066 1 C-N-CA 132.181 4.192 . . . . 0.0 116.226 170.356 . . . . . . . . 6 4 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.784 ' HG3' HD12 ' A' ' 36' ' ' ILE . 9.3 tp10 -61.13 -13.9 20.79 Favored 'General case' 2 N--CA 1.363 -4.817 0 CA-C-N 111.776 -2.465 . . . . 0.0 106.965 173.021 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 54.4 m -67.81 -48.57 65.87 Favored 'General case' 0 N--CA 1.411 -2.378 0 C-N-CA 125.021 1.328 . . . . 0.0 108.457 171.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.796 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 3.7 pt-20 -57.7 -48.85 78.38 Favored 'General case' 0 C--O 1.27 2.158 0 CA-C-O 120.78 0.324 . . . . 0.0 110.203 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -56.78 -56.49 20.84 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 123.496 1.617 . . . . 0.0 110.59 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.784 HD12 ' HG3' ' A' ' 32' ' ' GLU . 13.9 mt -70.54 -30.0 40.8 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.255 0 CA-C-N 112.03 -2.35 . . . . 0.0 112.96 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.814 HG21 HG12 ' A' ' 55' ' ' ILE . 8.1 p -71.82 -44.86 63.19 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 117.948 -1.501 . . . . 0.0 110.055 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.7 p -60.3 -59.67 5.04 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.188 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.3 tp -64.95 -49.72 69.24 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.882 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 37.0 m0 -74.75 -60.84 2.1 Favored 'General case' 0 C--O 1.168 -3.224 0 CA-C-O 117.763 -1.113 . . . . 0.0 110.152 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.757 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.382 0.0 OUTLIER -66.26 -22.31 66.31 Favored 'General case' 0 C--O 1.253 1.248 0 C-N-CA 117.372 -1.731 . . . . 0.0 111.803 -171.721 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.39 -55.83 26.89 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.588 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 37.8 p -67.66 -29.32 68.58 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 116.999 0.399 . . . . 0.0 111.707 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.837 HD12 ' HG2' ' A' ' 53' ' ' ARG . 20.6 mt -60.86 -35.34 76.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.241 0.616 . . . . 0.0 109.871 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.636 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 87.5 t80 -91.32 -27.01 18.66 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.222 175.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.588 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.2 t-20 -66.96 -28.88 68.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.859 0.361 . . . . 0.0 111.253 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.23 -3.49 50.64 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.567 0.699 . . . . 0.0 109.8 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.1 t30 55.88 43.93 26.71 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.267 1.427 . . . . 0.0 112.726 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.521 ' HB3' ' HE2' ' A' ' 70' ' ' TYR . 23.1 m-85 -66.78 5.85 0.57 Allowed 'General case' 0 CA--C 1.597 2.777 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.7 t70 57.2 70.81 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 125.314 1.446 . . . . 0.0 111.713 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.531 ' CG2' ' HD2' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -147.75 171.02 3.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 113.439 -1.71 . . . . 0.0 109.822 -175.168 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.655 ' HG2' ' HB3' ' A' ' 64' ' ' MET . 0.0 OUTLIER -132.54 126.73 33.52 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.67 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.837 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -131.9 134.52 45.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -169.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.806 ' H ' HG12 ' A' ' 62' ' ' ILE . 80.9 m-85 -134.89 152.62 51.9 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -165.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.814 HG12 HG21 ' A' ' 37' ' ' THR . 39.2 mt -89.62 95.11 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 166.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.03 -31.43 4.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.752 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.2 63.25 0.22 Allowed Glycine 0 N--CA 1.403 -3.503 0 C-N-CA 116.391 -2.814 . . . . 0.0 116.717 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.676 ' HB3' ' HE3' ' A' ' 31' ' ' LYS 0.313 13.8 m 21.04 88.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 125.488 1.346 . . . . 0.0 112.586 162.187 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.633 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER 110.0 -16.18 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 128.011 2.525 . . . . 0.0 106.766 -173.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -125.57 134.61 51.9 Favored 'General case' 0 CA--C 1.578 2.019 0 C-N-CA 126.163 1.785 . . . . 0.0 109.816 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.9 169.38 17.67 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.119 1.367 . . . . 0.0 108.141 -171.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.806 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER -141.96 155.9 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.054 0 CA-C-N 121.34 1.882 . . . . 0.0 111.634 173.736 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.559 ' HA ' ' HG3' ' A' ' 53' ' ' ARG 0.289 8.2 p90 -132.64 103.9 6.37 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 126.603 2.439 . . . . 0.0 108.254 161.64 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.655 ' HB3' ' HG2' ' A' ' 52' ' ' GLN . 27.0 ttt -91.22 108.84 20.15 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.311 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.758 HD22 HD12 ' A' ' 18' ' ' LEU 0.26 6.5 mp -66.85 144.84 56.04 Favored 'General case' 0 CA--C 1.472 -2.048 0 C-N-CA 127.97 2.508 . . . . 0.0 112.961 -177.732 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.4 33.7 ttp180 -122.35 -53.67 1.91 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 168.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.41 7.39 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.39 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.3 -31.94 0.09 OUTLIER Glycine 0 CA--C 1.569 3.434 0 N-CA-C 116.55 1.38 . . . . 0.0 116.55 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 70' ' ' TYR . 31.8 t -135.31 87.22 2.31 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 117.787 -1.101 . . . . 0.0 112.832 -170.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.521 ' HE2' ' HB3' ' A' ' 49' ' ' TYR . 0.1 OUTLIER 174.32 -0.69 0.0 OUTLIER 'General case' 0 C--N 1.409 3.184 0 CA-C-N 120.204 1.365 . . . . 0.0 113.241 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.733 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -88.22 -29.9 20.12 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -169.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.773 ' HZ2' ' HG ' ' A' ' 89' ' ' LEU . 28.1 m-90 -78.99 -15.12 58.7 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.133 -0.979 . . . . 0.0 110.341 -176.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.42 -44.15 79.46 Favored 'General case' 0 C--O 1.266 1.944 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 167.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.659 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.0 mt -59.67 -38.56 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.138 175.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.621 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 13.4 tmtt? -65.05 -37.97 89.33 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.529 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.95 -44.89 95.81 Favored 'General case' 0 C--O 1.262 1.72 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.328 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.659 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 12.0 m-85 -57.28 -48.06 79.87 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.773 0.797 . . . . 0.0 109.05 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.882 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 4.2 pp -63.13 -41.88 99.4 Favored 'General case' 0 C--O 1.293 3.345 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.996 HG12 ' HB2' ' A' ' 84' ' ' CYS . 32.6 m -76.29 -11.74 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 CA-C-O 121.838 0.828 . . . . 0.0 109.559 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.2 m -104.06 0.49 29.85 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.939 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.783 ' HG2' ' HE1' ' A' ' 40' ' ' TRP . 60.8 tp60 -85.2 -53.5 5.21 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.341 1.9 p30 -176.64 -94.04 0.0 OUTLIER 'General case' 0 C--O 1.243 0.74 0 O-C-N 125.235 1.584 . . . . 0.0 113.939 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.588 ' HD2' ' HA3' ' A' ' 26' ' ' GLY 0.291 48.2 mtm180 -93.3 131.62 38.26 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 118.328 -1.349 . . . . 0.0 112.243 -177.179 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.996 ' HB2' HG12 ' A' ' 79' ' ' VAL . 4.5 p -154.78 154.51 32.92 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.612 -168.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.659 ' HB2' ' OG ' ' A' ' 25' ' ' SER . . . -159.56 -49.92 0.06 Allowed 'General case' 0 C--N 1.351 0.645 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -174.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.983 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 38.2 tt0 -154.52 127.11 8.02 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 119.517 1.053 . . . . 0.0 112.149 -172.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.418 HG12 ' HB ' ' A' ' 22' ' ' VAL . 12.8 m -111.36 103.79 16.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 173.726 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.437 ' C ' HD22 ' A' ' 89' ' ' LEU 0.274 23.4 p -102.9 136.49 42.62 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 117.991 -1.483 . . . . 0.0 112.497 177.366 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.848 HD11 ' HG2' ' A' ' 20' ' ' MET . 4.6 mm? . . . . . 0 N--CA 1.409 -2.491 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -167.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.1 tptt . . . . . 0 C--O 1.241 0.638 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -71.62 120.91 17.88 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.627 ' HB3' HD22 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -127.91 115.23 18.25 Favored 'General case' 0 C--O 1.197 -1.667 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -171.052 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.3 ttt -86.58 105.21 16.69 Favored 'General case' 0 C--N 1.281 -2.383 0 O-C-N 121.694 -0.629 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.674 ' HE3' HD11 ' A' ' 65' ' ' LEU . 12.4 ttm -97.65 116.82 30.6 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 117.28 -1.768 . . . . 0.0 112.671 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -100.76 116.55 32.91 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 112.637 -2.074 . . . . 0.0 106.328 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.75 125.89 65.94 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 CA-C-O 121.457 0.646 . . . . 0.0 111.663 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.784 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 88.3 m -84.55 131.17 34.66 Favored 'General case' 0 CA--C 1.595 2.693 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.035 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.404 HG21 HD13 ' A' ' 36' ' ' ILE . 2.0 p -131.29 137.64 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.579 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.43 23.1 t -109.23 -96.62 0.39 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 122.858 2.572 . . . . 0.0 114.277 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.608 ' HA3' ' HG3' ' A' ' 83' ' ' ARG . . . 55.48 -67.14 0.01 OUTLIER Glycine 0 C--N 1.352 1.438 0 CA-C-N 119.654 1.116 . . . . 0.0 113.017 -168.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -118.56 137.49 24.86 Favored Pre-proline 0 N--CA 1.417 -2.1 0 CA-C-N 117.71 0.755 . . . . 0.0 109.323 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.75 40.45 0.91 Allowed 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 122.621 2.214 . . . . 0.0 107.577 170.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.0 m -140.08 143.31 36.25 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 -165.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.457 ' O ' ' HB ' ' A' ' 33' ' ' THR . 32.7 tt0 -68.2 -7.57 31.36 Favored 'General case' 0 C--N 1.371 1.538 0 CA-C-N 120.538 1.517 . . . . 0.0 111.22 -177.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 1.9 tmpt? -52.52 -40.43 62.44 Favored 'General case' 0 C--O 1.257 1.484 0 CA-C-O 121.321 0.581 . . . . 0.0 109.941 174.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.799 ' HG3' HD12 ' A' ' 36' ' ' ILE . 3.4 tp10 -69.23 -56.64 7.0 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 57.3 m -39.84 -47.77 2.18 Favored 'General case' 0 C--O 1.189 -2.111 0 C-N-CA 125.697 1.599 . . . . 0.0 111.897 171.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.4 pt-20 -70.99 -53.46 14.74 Favored 'General case' 0 C--O 1.253 1.275 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.65 -36.1 82.69 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.102 -1.439 . . . . 0.0 109.292 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.799 HD12 ' HG3' ' A' ' 32' ' ' GLU . 2.7 mt -68.0 -41.3 84.44 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.379 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.405 176.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.898 HG21 HG12 ' A' ' 55' ' ' ILE . 11.7 p -69.78 -40.09 76.25 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 120.299 1.409 . . . . 0.0 111.115 -176.493 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 p -64.72 -50.87 65.24 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 124.111 0.882 . . . . 0.0 110.039 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 mt -61.84 -49.42 76.36 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.048 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.629 ' CZ2' ' HB2' ' A' ' 78' ' ' LEU . 45.1 m0 -61.23 -71.97 0.13 Allowed 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 1.012 ' HB3' HH11 ' A' ' 53' ' ' ARG 0.314 0.0 OUTLIER -70.27 -18.65 63.13 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 117.521 -1.672 . . . . 0.0 112.078 -176.752 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.9 -48.44 80.78 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.412 173.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 54.3 p -79.01 -34.73 43.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 122.763 -0.257 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.984 HD12 ' HD2' ' A' ' 53' ' ' ARG . 11.4 mt -62.28 -33.17 74.13 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.894 0.378 . . . . 0.0 110.637 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -86.65 -30.07 22.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.408 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 9.2 t30 -66.17 -36.2 82.46 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.82 4.37 37.39 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.908 -0.495 . . . . 0.0 109.954 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.1 t30 58.57 47.9 12.65 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.471 1.108 . . . . 0.0 112.379 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -68.08 -13.13 61.96 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.578 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 26.5 t0 62.12 78.21 0.3 Allowed 'General case' 0 C--N 1.353 0.734 0 CA-C-O 122.755 1.264 . . . . 0.0 109.58 -176.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 m -140.84 177.38 3.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.13 -170.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -139.17 131.07 27.7 Favored 'General case' 0 C--O 1.177 -2.739 0 N-CA-C 104.001 -2.592 . . . . 0.0 104.001 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 1.012 HH11 ' HB3' ' A' ' 41' ' ' GLN . 23.2 mtp-105 -138.06 145.92 42.34 Favored 'General case' 0 C--N 1.273 -2.725 0 O-C-N 121.442 -0.786 . . . . 0.0 109.044 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.825 ' H ' HG12 ' A' ' 62' ' ' ILE . 15.1 t80 -134.67 151.2 50.85 Favored 'General case' 0 C--O 1.259 1.566 0 C-N-CA 118.028 -1.469 . . . . 0.0 113.3 -168.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.898 HG12 HG21 ' A' ' 37' ' ' THR . 58.0 mt -93.77 107.07 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 89.7 t -94.59 -48.16 13.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.484 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.35 177.95 40.49 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 117.553 -2.26 . . . . 0.0 114.962 -174.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.569 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 4.8 p -72.71 44.03 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 127.138 2.175 . . . . 0.0 114.192 -176.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' A' ' 58' ' ' SER . 2.5 p-10 148.58 6.18 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 125.73 1.612 . . . . 0.0 107.377 -169.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.515 ' HB3' ' HB ' ' A' ' 56' ' ' VAL . 7.2 mpt_? -127.9 133.34 49.28 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 123.959 0.904 . . . . 0.0 110.583 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.59 161.51 38.32 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.825 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -138.16 156.38 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.454 -2.725 0 C-N-CA 118.014 -1.474 . . . . 0.0 110.883 171.382 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.952 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 5.8 p90 -128.77 113.82 15.81 Favored 'General case' 0 N--CA 1.413 -2.287 0 O-C-N 126.88 2.612 . . . . 0.0 106.776 161.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.409 ' HB2' ' CD1' ' A' ' 62' ' ' ILE . 20.7 ttt -97.13 118.1 32.8 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 122.017 0.913 . . . . 0.0 111.413 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.674 HD11 ' HE3' ' A' ' 20' ' ' MET . 5.8 mp -73.4 145.88 45.52 Favored 'General case' 0 CA--C 1.47 -2.124 0 CA-C-N 112.189 -2.278 . . . . 0.0 111.54 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.578 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.362 58.8 ttt180 -118.2 -62.13 1.58 Allowed 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 176.098 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 69' ' ' SER . 9.4 t70 -71.9 17.59 0.09 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 120.267 1.394 . . . . 0.0 112.924 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.37 -32.71 0.02 OUTLIER Glycine 0 CA--C 1.551 2.34 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 -169.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.436 ' H ' ' C ' ' A' ' 67' ' ' ASP . 14.8 m -93.67 20.4 7.52 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -166.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.489 ' HE1' ' H ' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -148.25 125.44 11.48 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.597 -0.69 . . . . 0.0 111.069 178.361 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.555 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 171.91 -30.95 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 124.178 0.924 . . . . 0.0 112.227 176.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.59 ' NE1' ' HE1' ' A' ' 20' ' ' MET 0.428 5.3 m-90 -89.02 -28.3 20.27 Favored 'General case' 0 C--O 1.267 2.022 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -165.859 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 38.9 tt0 -72.43 -39.16 68.09 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 170.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 71' ' ' ALA . 30.5 mt -51.63 -48.86 36.15 Favored 'Isoleucine or valine' 0 C--O 1.286 3.024 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.9 173.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.608 ' O ' HG22 ' A' ' 79' ' ' VAL . 21.4 pttp -67.07 -37.85 84.72 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.75 -46.53 74.34 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.202 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.572 ' CZ ' ' HG2' ' A' ' 73' ' ' GLU . 18.0 m-85 -60.96 -59.23 5.71 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.922 0.868 . . . . 0.0 109.646 -175.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.629 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.1 pp -63.33 -40.42 97.26 Favored 'General case' 0 C--O 1.266 1.932 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -171.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.647 ' HB ' ' CB ' ' A' ' 84' ' ' CYS 0.265 27.6 m -80.36 -12.88 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 118.343 -1.343 . . . . 0.0 111.622 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.8 m -97.3 -0.05 47.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -87.99 -54.54 4.18 Favored 'General case' 0 CA--C 1.475 -1.942 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.472 38.0 t70 -137.71 -92.99 0.21 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 175.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.608 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 18.8 mmt180 -99.14 153.28 19.03 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 120.96 1.709 . . . . 0.0 110.955 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.647 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 24.8 p -152.07 154.97 37.0 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.251 -173.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.44 -51.16 0.02 OUTLIER 'General case' 0 C--N 1.355 0.84 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.784 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 36.9 tt0 -153.84 116.91 4.52 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.776 -173.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.96 101.68 12.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.258 23.5 p -105.19 120.62 41.98 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 123.1 1.429 . . . . 0.0 114.758 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.426 ' N ' HD12 ' A' ' 89' ' ' LEU . 1.2 mp . . . . . 0 C--N 1.282 -2.359 0 CA-C-N 112.155 -2.293 . . . . 0.0 106.527 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tptt . . . . . 0 N--CA 1.444 -0.732 0 N-CA-C 111.362 0.134 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -78.65 123.21 26.89 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.661 ' CD1' HD12 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -133.18 103.15 5.86 Favored 'General case' 0 C--O 1.191 -2.001 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -174.171 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.678 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 9.4 ptp -84.1 116.92 23.13 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.891 -1.13 . . . . 0.0 110.891 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.878 ' HG2' HD11 ' A' ' 89' ' ' LEU . 93.1 mtp -86.7 99.28 11.65 Favored 'General case' 0 CA--C 1.487 -1.466 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.246 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.458 ' CZ ' ' HD2' ' A' ' 60' ' ' ARG . 12.3 t80 -89.04 106.05 18.18 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.451 HG22 ' NE ' ' A' ' 83' ' ' ARG . 9.1 p -126.28 125.91 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.923 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.039 -165.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.073 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 31.4 m -92.88 142.31 27.46 Favored 'General case' 0 C--O 1.276 2.477 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.596 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.915 HG23 ' HA ' ' A' ' 83' ' ' ARG . 7.5 p -131.03 128.52 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 103.681 -2.711 . . . . 0.0 103.681 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.61 20.79 1.04 Allowed 'General case' 0 C--O 1.245 0.864 0 CA-C-N 122.478 2.399 . . . . 0.0 112.347 -171.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.64 -31.83 73.88 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 106.821 -2.511 . . . . 0.0 106.821 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.93 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 24.8 t-20 -118.46 104.58 47.48 Favored Pre-proline 0 N--CA 1.405 -2.711 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.54 32.23 0.45 Allowed 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.736 2.291 . . . . 0.0 112.395 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.41 ' HB ' ' H ' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -146.81 -161.24 1.28 Allowed 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.628 -173.379 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.7 tp10 -76.69 -18.29 58.62 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 5.0 tmtt? -64.56 -52.42 57.71 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.93 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.4 tp10 -71.01 -35.44 72.03 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 117.777 -1.569 . . . . 0.0 107.643 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 54.5 m -49.6 -57.52 6.99 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.029 172.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 15.2 pt-20 -65.98 -40.25 91.06 Favored 'General case' 0 C--O 1.255 1.371 0 C-N-CA 122.792 0.437 . . . . 0.0 111.784 -176.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -51.69 -63.0 1.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.695 HG23 ' CE3' ' A' ' 40' ' ' TRP . 35.4 mt -67.21 -44.46 87.66 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 112.384 -2.189 . . . . 0.0 112.957 -175.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.773 ' HB ' HG12 ' A' ' 55' ' ' ILE . 32.4 p -65.35 -53.49 42.87 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.547 -0.861 . . . . 0.0 112.011 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.9 t -70.55 -46.87 62.73 Favored 'General case' 0 C--O 1.257 1.46 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.429 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.73 -43.13 66.39 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.759 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.695 ' CE3' HG23 ' A' ' 36' ' ' ILE . 37.9 m0 -73.29 -61.75 1.71 Allowed 'General case' 0 C--O 1.167 -3.262 0 CA-C-O 117.486 -1.245 . . . . 0.0 109.65 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.828 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.377 0.0 OUTLIER -63.47 -25.69 68.38 Favored 'General case' 0 C--O 1.253 1.278 0 C-N-CA 117.871 -1.532 . . . . 0.0 112.608 -172.166 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.94 -50.92 59.47 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 171.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.741 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 58.7 p -74.06 -25.29 59.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.344 0.572 . . . . 0.0 111.404 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.782 HD12 ' HG2' ' A' ' 53' ' ' ARG . 32.5 mt -62.62 -33.51 75.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 176.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.536 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 89.9 t80 -87.97 -32.8 18.68 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.45 173.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.741 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 6.9 t30 -62.36 -36.96 83.87 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.11 3.21 52.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.277 0.561 . . . . 0.0 110.017 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.7 t30 53.24 51.89 14.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.226 1.41 . . . . 0.0 112.568 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -64.73 -7.02 9.25 Favored 'General case' 0 CA--C 1.595 2.69 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.0 t70 61.04 67.88 0.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.141 1.377 . . . . 0.0 110.037 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.669 HG23 ' HD2' ' A' ' 53' ' ' ARG . 2.6 m -147.92 175.42 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.249 -171.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.481 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 17.5 mt-30 -130.96 125.18 32.72 Favored 'General case' 0 C--O 1.189 -2.131 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 177.731 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.828 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -134.5 136.6 43.25 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -172.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.814 ' H ' HG12 ' A' ' 62' ' ' ILE . 47.9 t80 -135.03 150.49 50.31 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 118.187 -1.405 . . . . 0.0 113.579 -166.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.773 HG12 ' HB ' ' A' ' 37' ' ' THR . 19.1 mt -93.23 96.36 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 171.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -80.01 -33.85 14.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.81 -178.87 40.38 Favored Glycine 0 CA--C 1.484 -1.905 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.245 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -60.24 121.01 10.9 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.258 0.0 OUTLIER 79.3 8.67 1.77 Allowed 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 121.937 0.875 . . . . 0.0 111.379 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.458 ' HD2' ' CZ ' ' A' ' 21' ' ' PHE . 1.3 tpp180 -137.56 118.92 14.69 Favored 'General case' 0 CA--C 1.573 1.858 0 O-C-N 121.45 -0.781 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.07 162.1 34.27 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -175.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.814 HG12 ' H ' ' A' ' 54' ' ' PHE . 2.5 pt -142.49 157.13 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 C-N-CA 117.422 -1.711 . . . . 0.0 110.337 170.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.526 ' CE2' ' HB ' ' A' ' 74' ' ' ILE 0.296 9.0 p90 -133.02 101.33 5.18 Favored 'General case' 0 N--CA 1.426 -1.672 0 O-C-N 126.264 2.227 . . . . 0.0 108.394 161.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.678 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 25.0 ttt -87.17 113.88 23.3 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.73 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.687 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.315 2.3 mp -80.66 148.22 30.31 Favored 'General case' 0 CA--C 1.442 -3.173 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.287 -178.092 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -117.54 163.12 16.9 Favored 'General case' 0 C--N 1.252 -3.637 0 N-CA-C 104.513 -2.403 . . . . 0.0 104.513 169.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 76.98 -36.22 0.25 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.17 -29.13 7.87 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 119.895 -1.145 . . . . 0.0 114.16 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.9 m -96.07 32.95 1.81 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -167.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 41.9 p90 -178.43 137.07 0.16 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 117.029 -1.463 . . . . 0.0 109.744 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.687 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 164.0 -35.45 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.128 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 171.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.685 ' HZ2' ' HG ' ' A' ' 89' ' ' LEU 0.298 22.0 m-90 -80.36 -9.76 59.75 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 120.376 -1.453 . . . . 0.0 111.684 -172.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.14 -35.62 69.14 Favored 'General case' 0 C--O 1.299 3.684 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.526 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 67.3 mt -62.53 -39.35 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 174.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.659 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 12.4 tmtt? -61.53 -37.23 83.01 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.729 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.83 -48.15 81.86 Favored 'General case' 0 C--O 1.261 1.691 0 C-N-CA 119.619 -0.833 . . . . 0.0 110.138 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -57.48 -45.14 85.19 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.366 1.079 . . . . 0.0 110.11 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.714 HD12 HG13 ' A' ' 79' ' ' VAL 0.271 4.2 pp -61.06 -48.77 80.18 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -179.167 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.714 HG13 HD12 ' A' ' 78' ' ' LEU . 23.7 m -75.18 -6.87 9.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 117.458 -1.697 . . . . 0.0 112.22 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -96.59 -5.9 38.07 Favored 'General case' 0 N--CA 1.403 -2.792 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.721 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -100.75 -58.12 1.96 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.6 t70 164.16 173.11 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.484 1 N-CA-C 99.532 -4.247 . . . . 0.0 99.532 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.915 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER 74.23 89.75 0.09 Allowed 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -163.547 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.692 ' HA ' HG12 ' A' ' 79' ' ' VAL . 12.6 p -153.69 56.84 0.74 Allowed 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.787 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.77 -62.68 1.11 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.073 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 33.2 tt0 -134.44 125.28 27.13 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 120.65 1.568 . . . . 0.0 110.202 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.8 t -117.66 111.41 34.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.489 ' O ' HD22 ' A' ' 89' ' ' LEU . 38.8 p -124.95 129.19 49.86 Favored 'General case' 0 C--O 1.277 2.509 0 C-N-CA 118.751 -1.179 . . . . 0.0 112.726 174.096 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.878 HD11 ' HG2' ' A' ' 20' ' ' MET . 4.4 mm? . . . . . 0 N--CA 1.412 -2.35 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.985 -175.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.0 tptt . . . . . 0 N--CA 1.431 -1.417 0 CA-C-O 121.063 0.458 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.6 m -67.15 123.13 19.42 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.48 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.598 ' O ' HD22 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -122.76 121.23 35.82 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 -176.13 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.478 ' HB3' ' HG3' ' A' ' 64' ' ' MET . 14.9 ptt? -109.05 133.74 52.59 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.371 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.545 ' SD ' ' HA ' ' A' ' 89' ' ' LEU . 2.9 mpp? -108.86 118.93 38.07 Favored 'General case' 0 CA--C 1.46 -2.511 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.672 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -103.94 128.78 51.46 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 171.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.44 124.13 69.01 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.542 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.629 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.975 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 95.8 m -75.43 124.88 27.92 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 173.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.523 HG21 HD13 ' A' ' 36' ' ' ILE . 1.9 p -128.45 124.35 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.361 0 CA-C-N 120.319 1.418 . . . . 0.0 111.568 -169.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.941 ' HB2' ' HB2' ' A' ' 83' ' ' ARG . 33.0 t 70.68 -50.15 0.67 Allowed 'General case' 0 C--N 1.363 1.176 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 167.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.24 23.5 9.62 Favored Glycine 0 N--CA 1.415 -2.715 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.31 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.497 ' ND2' ' HB3' ' A' ' 32' ' ' GLU 0.251 9.2 p30 -116.65 111.08 41.72 Favored Pre-proline 0 N--CA 1.417 -2.101 0 C-N-CA 117.609 -1.636 . . . . 0.0 112.205 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.727 ' HA ' ' HB3' ' A' ' 58' ' ' SER . 12.6 Cg_exo -74.19 37.17 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.805 2.337 . . . . 0.0 109.598 176.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.2 m -88.62 52.7 2.5 Favored 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.239 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.603 ' O ' ' HG3' ' A' ' 30' ' ' GLU . 7.6 tp10 66.1 19.92 11.17 Favored 'General case' 0 C--N 1.414 3.377 0 CA-C-O 126.803 3.192 . . . . 0.0 103.328 -162.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.789 ' HB3' ' HA ' ' A' ' 58' ' ' SER 0.517 0.0 OUTLIER 62.42 144.8 0.02 OUTLIER 'General case' 2 N--CA 1.259 -10.019 0 CA-C-O 127.461 3.505 . . . . 0.0 114.104 -178.934 . . . . . . . . 5 4 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.896 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -66.98 -10.44 49.58 Favored 'General case' 2 N--CA 1.348 -5.543 0 CA-C-N 110.191 -3.186 . . . . 0.0 105.01 169.214 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.636 ' H ' ' HB2' ' A' ' 31' ' ' LYS . 94.3 m -69.18 -35.12 75.94 Favored 'General case' 1 N--CA 1.359 -4.976 0 C-N-CA 127.921 2.488 . . . . 0.0 108.463 174.572 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.604 ' HG3' ' N ' ' A' ' 35' ' ' GLU . 3.9 pt-20 -74.19 -40.77 62.28 Favored 'General case' 0 C--N 1.389 2.319 0 CA-C-N 121.487 1.949 . . . . 0.0 106.941 177.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.604 ' N ' ' HG3' ' A' ' 34' ' ' GLU . 9.7 tp10 -59.4 -56.69 18.78 Favored 'General case' 0 C--O 1.279 2.634 0 CA-C-O 124.087 1.899 . . . . 0.0 108.576 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.896 ' HB ' ' O ' ' A' ' 32' ' ' GLU . 1.1 mt -70.3 -25.17 26.73 Favored 'Isoleucine or valine' 0 C--O 1.163 -3.455 0 CA-C-N 111.74 -2.482 . . . . 0.0 112.305 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.537 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 6.7 p -74.04 -41.9 61.09 Favored 'General case' 0 CA--C 1.464 -2.328 0 CA-C-N 121.697 2.044 . . . . 0.0 109.466 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 m -60.18 -51.62 68.8 Favored 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.858 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.5 tp -72.32 -49.68 32.59 Favored 'General case' 0 C--O 1.25 1.123 0 C-N-CA 118.038 -1.465 . . . . 0.0 111.434 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.689 ' CZ2' ' HB2' ' A' ' 78' ' ' LEU . 51.0 m0 -69.27 -67.99 0.44 Allowed 'General case' 0 C--O 1.189 -2.106 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.409 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.555 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.36 0.0 OUTLIER -69.9 -20.36 63.37 Favored 'General case' 0 C--O 1.254 1.303 0 C-N-CA 118.516 -1.273 . . . . 0.0 112.075 -170.865 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.32 -53.36 45.03 Favored Glycine 0 C--N 1.365 2.18 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.653 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 36.7 p -69.83 -29.77 67.11 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.53 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.887 HD12 ' HG2' ' A' ' 53' ' ' ARG . 25.5 mt -59.64 -35.01 73.54 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.691 0.397 . . . . 0.0 110.547 177.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.57 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 82.3 t80 -91.08 -27.37 18.63 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.653 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 8.7 t30 -64.79 -34.89 79.41 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.692 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.24 0.53 57.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.865 0.365 . . . . 0.0 110.491 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.3 t30 53.24 57.79 5.9 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.967 1.307 . . . . 0.0 112.46 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.46 ' HB3' ' HE2' ' A' ' 70' ' ' TYR . 37.8 m-85 -73.8 -0.21 15.1 Favored 'General case' 0 CA--C 1.597 2.763 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.5 t70 62.05 67.78 0.72 Allowed 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 124.402 1.081 . . . . 0.0 110.792 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.628 HG12 ' HA ' ' A' ' 65' ' ' LEU . 6.7 m -147.36 174.83 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.502 -172.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.531 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 28.6 mp0 -131.51 131.68 43.62 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 172.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.887 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -129.74 129.85 44.68 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -174.863 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.864 ' H ' HG12 ' A' ' 62' ' ' ILE . 29.2 t80 -133.93 152.36 51.83 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 119.095 -1.042 . . . . 0.0 113.112 -159.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.587 HG23 HG21 ' A' ' 33' ' ' THR . 75.3 mt -88.17 107.32 17.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.877 175.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.756 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 97.1 t -81.47 -40.97 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.025 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.56 -171.34 43.63 Favored Glycine 0 CA--C 1.469 -2.825 0 C-N-CA 118.629 -1.748 . . . . 0.0 113.46 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.789 ' HA ' ' HB3' ' A' ' 31' ' ' LYS . 6.6 m -62.0 118.26 7.04 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 118.057 -0.973 . . . . 0.0 108.742 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' A' ' 58' ' ' SER . 2.4 t70 80.89 11.16 0.91 Allowed 'General case' 0 N--CA 1.408 -2.566 0 CA-C-O 122.545 1.164 . . . . 0.0 109.228 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.756 ' HB3' ' HB ' ' A' ' 56' ' ' VAL . 11.4 mpt_? -137.1 116.08 12.36 Favored 'General case' 0 CA--C 1.562 1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 112.149 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.62 163.1 22.68 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.129 0.972 . . . . 0.0 108.728 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.864 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.7 OUTLIER -139.52 158.08 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.223 0 C-N-CA 118.223 -1.391 . . . . 0.0 111.128 173.118 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.629 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 2.3 p90 -129.08 106.75 9.07 Favored 'General case' 0 N--CA 1.419 -2.009 0 O-C-N 126.485 2.365 . . . . 0.0 106.917 164.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.478 ' HG3' ' HB3' ' A' ' 19' ' ' MET . 23.1 ttt -94.99 117.04 29.48 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.273 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.727 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.484 0.0 OUTLIER -114.34 147.73 38.68 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -177.339 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.354 36.3 ttp180 -104.57 -62.6 1.31 Allowed 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -164.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -55.92 -8.08 0.39 Allowed 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.83 15.98 29.49 Favored Glycine 0 C--N 1.369 2.375 0 CA-C-N 120.194 1.361 . . . . 0.0 115.09 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.9 p -116.66 22.19 12.89 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 118.39 1.095 . . . . 0.0 113.597 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.46 ' HE2' ' HB3' ' A' ' 49' ' ' TYR . 2.3 p90 177.8 145.79 0.12 Allowed 'General case' 0 C--O 1.245 0.823 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -167.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.727 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 160.48 -28.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 125.166 1.541 . . . . 0.0 111.92 171.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.489 ' HA ' ' HG3' ' A' ' 75' ' ' LYS 0.522 7.1 m0 -89.48 -16.4 30.88 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 117.071 -1.852 . . . . 0.0 115.176 -169.196 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.92 -36.38 80.07 Favored 'General case' 0 C--O 1.257 1.457 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 165.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 57.2 mt -53.89 -50.13 54.76 Favored 'Isoleucine or valine' 0 C--O 1.29 3.204 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.795 174.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.618 ' O ' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -63.42 -36.11 82.65 Favored 'General case' 0 C--N 1.373 1.612 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.243 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.79 -47.07 83.6 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.84 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 13.9 m-85 -58.18 -60.25 4.04 Favored 'General case' 0 C--N 1.365 1.245 0 CA-C-O 122.35 1.071 . . . . 0.0 109.198 -175.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.689 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.6 pp -62.29 -38.46 89.44 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 75' ' ' LYS . 34.0 m -80.09 -9.75 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 118.203 -1.399 . . . . 0.0 111.431 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.0 m -105.8 3.29 28.62 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -107.3 -45.95 3.99 Favored 'General case' 0 CA--C 1.473 -2.014 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.269 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.78 -160.79 0.86 Allowed 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.941 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 24.2 mmt180 -80.35 159.67 25.68 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 120.127 1.33 . . . . 0.0 110.123 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.611 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 26.7 p -136.59 146.1 45.69 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.256 -172.2 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.27 -53.43 0.13 Allowed 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.975 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.5 tt0 -153.72 118.82 5.08 Favored 'General case' 0 C--O 1.195 -1.809 0 CA-C-N 119.806 1.184 . . . . 0.0 110.68 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.9 t -113.14 101.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.324 17.4 p -108.64 132.69 53.65 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 123.387 1.565 . . . . 0.0 114.489 177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.545 ' HA ' ' SD ' ' A' ' 20' ' ' MET . 3.7 mp . . . . . 0 C--N 1.263 -3.18 0 CA-C-N 110.807 -2.906 . . . . 0.0 108.093 -174.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.482 ' HE3' ' HB2' ' A' ' 18' ' ' LEU . 55.2 tptt . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 20.8 p -108.21 110.02 21.54 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.426 0.69 . . . . 0.0 109.474 173.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.925 HD23 ' HH2' ' A' ' 72' ' ' TRP . 30.8 tp -135.0 124.51 24.97 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -171.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.703 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.1 ptp -85.39 109.26 18.3 Favored 'General case' 0 C--O 1.207 -1.148 0 O-C-N 121.47 -0.769 . . . . 0.0 111.487 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.626 ' HA ' ' CG ' ' A' ' 89' ' ' LEU . 4.5 mpp? -84.36 128.94 34.87 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.526 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 59.6 t80 -111.05 109.06 18.99 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 125.502 1.751 . . . . 0.0 108.46 -169.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.05 128.79 75.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 114.76 1.392 . . . . 0.0 114.76 -169.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.974 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 49.5 m -87.41 141.41 28.65 Favored 'General case' 0 CA--C 1.595 2.708 0 C-N-CA 127.322 2.249 . . . . 0.0 109.006 176.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 83' ' ' ARG . 35.9 t -132.0 97.33 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.014 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -166.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 83' ' ' ARG 0.324 60.8 m 62.3 -30.07 0.08 Allowed 'General case' 0 C--N 1.389 2.293 0 N-CA-C 119.085 2.995 . . . . 0.0 119.085 170.229 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.474 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 123.76 1.5 8.97 Favored Glycine 0 N--CA 1.426 -2.018 0 C-N-CA 118.39 -1.862 . . . . 0.0 115.269 175.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.575 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.3 t-20 -79.65 104.66 2.51 Favored Pre-proline 0 C--O 1.22 -0.452 0 CA-C-N 119.04 1.42 . . . . 0.0 107.862 173.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 82.2 Cg_endo -91.52 33.71 0.29 Allowed 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 123.348 2.699 . . . . 0.0 109.532 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 m -129.53 155.19 46.18 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -69.94 3.37 2.7 Favored 'General case' 0 C--O 1.182 -2.455 0 CA-C-N 121.741 2.064 . . . . 0.0 111.824 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.565 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 1.8 tmtt? -60.0 -55.48 33.44 Favored 'General case' 0 C--O 1.275 2.43 0 CA-C-O 121.947 0.88 . . . . 0.0 111.228 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.812 ' HG3' HD12 ' A' ' 36' ' ' ILE . 1.7 tp10 -65.2 -52.3 55.64 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -176.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 93.1 m -42.89 -52.76 4.99 Favored 'General case' 0 C--O 1.187 -2.213 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.765 172.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 11.9 pt-20 -62.4 -55.47 27.6 Favored 'General case' 0 C--O 1.263 1.811 0 CA-C-N 118.689 0.677 . . . . 0.0 112.071 -175.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' A' ' 34' ' ' GLU . 9.3 tp10 -58.93 -53.84 53.89 Favored 'General case' 0 C--O 1.254 1.311 0 CA-C-O 122.972 1.368 . . . . 0.0 108.235 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.812 HD12 ' HG3' ' A' ' 32' ' ' GLU . 5.3 mt -64.24 -40.95 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.368 0 CA-C-N 112.527 -2.124 . . . . 0.0 113.331 -176.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.888 HG21 HG12 ' A' ' 55' ' ' ILE . 21.5 p -70.47 -37.7 74.31 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 120.214 1.37 . . . . 0.0 110.048 -177.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.4 m -63.45 -46.29 86.96 Favored 'General case' 0 N--CA 1.417 -2.08 0 O-C-N 123.966 0.791 . . . . 0.0 109.417 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.2 tp -73.03 -43.83 61.57 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.97 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.734 ' CE3' HD12 ' A' ' 78' ' ' LEU . 48.1 m0 -66.89 -70.24 0.26 Allowed 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 119.353 -0.356 . . . . 0.0 111.067 -177.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.713 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.294 0.0 OUTLIER -73.06 -19.26 61.21 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.832 -173.222 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.32 -50.89 59.03 Favored Glycine 0 C--N 1.357 1.726 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 172.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 60.9 p -69.64 -28.95 66.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.466 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.936 HD12 ' HG2' ' A' ' 53' ' ' ARG . 15.5 mt -62.49 -32.89 73.86 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.743 176.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.554 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 83.5 t80 -87.11 -31.56 20.38 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.057 0.456 . . . . 0.0 109.872 176.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 25.8 t-20 -67.21 -30.26 70.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.126 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.2 4.81 44.33 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 122.3 -0.25 . . . . 0.0 111.106 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.2 t30 56.92 47.14 18.32 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.048 0.939 . . . . 0.0 112.687 174.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.51 151.62 19.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.54 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 28.6 t70 -92.98 95.52 9.53 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 121.751 2.069 . . . . 0.0 109.115 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.706 HG12 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -146.84 162.75 8.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.009 -173.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HB3' ' HE1' ' A' ' 54' ' ' PHE . 28.4 mp0 -126.38 121.34 32.22 Favored 'General case' 0 C--O 1.199 -1.574 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 174.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.936 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -127.9 136.99 52.13 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.29 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.708 ' H ' HG12 ' A' ' 62' ' ' ILE . 46.3 m-85 -133.3 152.63 51.94 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -163.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.888 HG12 HG21 ' A' ' 37' ' ' THR . 46.8 mt -91.53 96.89 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 169.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.2 m -102.67 -20.56 5.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.753 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.37 174.98 47.4 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 117.728 -2.177 . . . . 0.0 114.066 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 51.0 m -75.05 117.98 17.49 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 23' ' ' THR . 5.4 t70 80.02 7.69 1.61 Allowed 'General case' 0 C--N 1.365 1.26 0 O-C-N 124.272 0.982 . . . . 0.0 108.835 -174.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.526 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 1.5 tpp180 -130.37 117.46 19.76 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.669 -176.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.09 163.11 29.2 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.708 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -135.86 157.38 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.38 0 C-N-CA 117.739 -1.585 . . . . 0.0 110.106 174.366 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.609 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 2.4 p90 -134.61 106.97 7.24 Favored 'General case' 0 N--CA 1.428 -1.567 0 O-C-N 126.192 2.183 . . . . 0.0 107.923 162.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.703 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 23.6 ttt -90.23 116.37 28.16 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 119.039 -0.505 . . . . 0.0 109.975 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.79 HD23 ' H ' ' A' ' 18' ' ' LEU . 1.1 pt? -90.75 144.49 25.67 Favored 'General case' 0 C--O 1.259 1.594 0 O-C-N 124.972 1.42 . . . . 0.0 112.202 -174.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.544 ' HA ' HG22 ' A' ' 17' ' ' THR 0.285 2.7 tmt_? -118.09 -53.32 2.37 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 125.575 1.797 . . . . 0.0 114.666 177.596 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.573 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 32.6 t70 -43.96 -19.87 0.02 OUTLIER 'General case' 0 CA--C 1.586 2.334 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.71 -25.55 4.53 Favored Glycine 0 C--N 1.358 1.788 0 CA-C-N 120.322 1.419 . . . . 0.0 115.384 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.8 m -137.2 49.02 2.04 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -170.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.573 ' CE1' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -156.17 -0.48 0.14 Allowed 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.37 -0.831 . . . . 0.0 113.158 -176.877 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.545 ' CB ' HD13 ' A' ' 65' ' ' LEU . . . -86.11 -39.18 16.99 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 -169.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.925 ' HH2' HD23 ' A' ' 18' ' ' LEU 0.428 28.8 m-90 -80.95 -14.1 58.27 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 116.511 -2.076 . . . . 0.0 112.126 -171.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -71.88 -36.92 70.22 Favored 'General case' 0 C--O 1.279 2.653 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 166.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.629 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 73.7 mt -57.58 -42.83 82.08 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.991 ' HG3' HG21 ' A' ' 87' ' ' VAL . 22.5 ttpp -51.87 -52.37 50.14 Favored 'General case' 0 C--N 1.374 1.644 0 C-N-CA 125.067 1.347 . . . . 0.0 109.441 177.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.07 -34.92 70.65 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.801 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.629 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 14.9 m-85 -74.02 -57.65 3.83 Favored 'General case' 0 CA--C 1.466 -2.287 0 C-N-CA 118.522 -1.271 . . . . 0.0 107.907 -169.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.734 HD12 ' CE3' ' A' ' 40' ' ' TRP . 1.8 pt? -68.51 -35.57 77.66 Favored 'General case' 0 N--CA 1.4 -2.966 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.731 -169.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 75' ' ' LYS 0.286 23.1 m -78.2 -19.99 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 116.594 -2.042 . . . . 0.0 110.67 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.9 m -95.22 5.61 51.29 Favored 'General case' 0 N--CA 1.411 -2.401 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.96 169.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.522 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . 49.7 tp60 -89.03 -41.9 12.06 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -176.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.553 ' OD2' ' HG2' ' A' ' 83' ' ' ARG 0.386 17.7 t70 -140.35 -85.77 0.21 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.553 ' HB2' HG13 ' A' ' 24' ' ' VAL . 21.4 mmt180 -110.35 165.39 11.81 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.96 1.709 . . . . 0.0 109.836 176.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.563 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 24.6 p -159.89 148.22 17.18 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.08 -54.31 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.862 1.265 . . . . 0.0 112.193 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.974 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 40.4 tt0 -154.96 123.15 5.9 Favored 'General case' 0 C--O 1.207 -1.173 0 C-N-CA 119.63 -0.828 . . . . 0.0 113.163 -169.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.991 HG21 ' HG3' ' A' ' 75' ' ' LYS . 62.0 t -112.0 104.51 17.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 173.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.525 ' O ' HD23 ' A' ' 89' ' ' LEU . 10.0 p -113.44 148.36 36.05 Favored 'General case' 0 C--O 1.266 1.954 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.74 ' CD1' ' HG ' ' A' ' 18' ' ' LEU 0.864 0.9 OUTLIER . . . . . 0 N--CA 1.44 -0.944 1 N-CA-C 122.567 4.284 . . . . 0.0 122.567 -177.612 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.2 tptt . . . . . 0 N--CA 1.438 -1.047 0 CA-C-O 120.677 0.275 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.774 HG22 ' HA ' ' A' ' 66' ' ' ARG . 19.3 p -72.33 135.65 45.97 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.428 174.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.622 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -134.24 116.6 15.5 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.447 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.2 ptm -94.63 119.1 32.75 Favored 'General case' 0 C--N 1.287 -2.125 0 O-C-N 121.623 -0.673 . . . . 0.0 109.195 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.915 ' HE2' HD23 ' A' ' 89' ' ' LEU . 1.3 pmm? -121.8 133.41 54.9 Favored 'General case' 0 C--O 1.281 2.753 0 C-N-CA 118.008 -1.477 . . . . 0.0 113.621 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -96.34 119.33 34.63 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.599 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -121.44 131.22 73.58 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.787 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.338 -176.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.077 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 97.1 m -99.46 151.88 20.62 Favored 'General case' 1 CA--C 1.648 4.748 0 C-N-CA 130.669 3.588 . . . . 0.0 112.31 -178.355 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.839 ' HB ' ' HG2' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -121.49 155.97 25.51 Favored 'Isoleucine or valine' 0 C--N 1.405 2.996 0 C-N-CA 126.246 1.818 . . . . 0.0 108.007 -168.415 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.672 ' OG ' ' HB2' ' A' ' 85' ' ' ALA . 54.2 m -108.18 168.92 8.95 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-N 120.628 1.558 . . . . 0.0 107.37 171.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.01 -88.5 0.47 Allowed Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 119.651 1.114 . . . . 0.0 112.198 174.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -115.78 113.04 42.47 Favored Pre-proline 0 N--CA 1.417 -2.076 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.75 30.27 0.32 Allowed 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 123.84 3.027 . . . . 0.0 112.982 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.538 ' OG1' ' HD2' ' A' ' 31' ' ' LYS . 70.2 p -128.41 -163.78 1.31 Allowed 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 33' ' ' THR . 37.9 tt0 -84.24 1.8 42.98 Favored 'General case' 0 N--CA 1.421 -1.907 0 O-C-N 121.382 -0.824 . . . . 0.0 111.49 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.552 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -69.66 -44.93 69.54 Favored 'General case' 0 C--O 1.281 2.717 0 O-C-N 120.987 -1.071 . . . . 0.0 112.181 -177.857 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.776 ' HG3' HD13 ' A' ' 36' ' ' ILE . 3.2 tp10 -69.99 -44.08 70.12 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.753 ' HA ' HH21 ' A' ' 60' ' ' ARG . 20.1 m -44.02 -63.67 0.82 Allowed 'General case' 0 C--O 1.183 -2.422 0 CA-C-N 112.616 -2.083 . . . . 0.0 111.338 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 13.1 pt-20 -58.2 -52.82 63.98 Favored 'General case' 0 C--O 1.255 1.354 0 O-C-N 124.419 1.075 . . . . 0.0 113.125 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.701 ' HG3' HD12 ' A' ' 36' ' ' ILE . 8.8 pt-20 -66.41 -44.29 83.4 Favored 'General case' 0 C--O 1.27 2.151 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.699 -176.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.776 HD13 ' HG3' ' A' ' 32' ' ' GLU . 1.3 mp -66.43 -44.1 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.795 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.473 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.779 HG21 HG12 ' A' ' 55' ' ' ILE . 33.4 p -68.09 -39.79 82.77 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 120.039 1.291 . . . . 0.0 111.618 -175.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.3 p -60.98 -54.0 50.33 Favored 'General case' 0 C--O 1.262 1.719 0 O-C-N 124.276 0.985 . . . . 0.0 109.6 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.09 -44.21 96.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.411 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.644 ' CE3' HD13 ' A' ' 78' ' ' LEU . 42.0 m0 -64.7 -74.99 0.09 Allowed 'General case' 0 C--O 1.205 -1.244 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.722 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.365 0.0 OUTLIER -70.68 -18.17 62.83 Favored 'General case' 0 C--O 1.255 1.349 0 C-N-CA 118.457 -1.297 . . . . 0.0 112.409 -172.185 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.9 -49.81 65.31 Favored Glycine 0 N--CA 1.432 -1.619 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 171.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 75.9 p -71.76 -26.83 62.61 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.333 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.761 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 28.7 mt -59.65 -37.88 79.91 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.702 176.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.51 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 86.6 t80 -86.26 -33.33 20.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.481 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 7.5 t30 -65.11 -34.66 78.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.07 9.1 20.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.926 0.393 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 59.88 35.49 21.81 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.709 1.203 . . . . 0.0 113.652 172.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . 0.497 ' O ' HG13 ' A' ' 51' ' ' VAL . 13.7 m-85 -78.05 25.23 0.22 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 25.67 76.65 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.678 0 C-N-CA 126.811 2.045 . . . . 0.0 113.671 -177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.989 HG12 ' HA ' ' A' ' 65' ' ' LEU . 1.5 m -146.5 175.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.134 -173.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 64' ' ' MET . 11.3 tm0? -134.33 120.9 20.47 Favored 'General case' 0 C--O 1.194 -1.853 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.761 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.75 131.16 35.19 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -169.737 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.814 ' H ' HG12 ' A' ' 62' ' ' ILE . 36.4 t80 -136.59 148.62 47.61 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 118.835 -1.146 . . . . 0.0 113.901 -164.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.779 HG12 HG21 ' A' ' 37' ' ' THR . 71.5 mt -80.39 123.28 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 170.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.21 -29.2 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.15 152.83 20.1 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.835 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 49.5 m -85.08 82.27 8.5 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.032 0.444 . . . . 0.0 110.505 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.477 ' HB2' HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER 158.81 -32.35 0.0 OUTLIER 'General case' 0 N--CA 1.384 -3.742 0 N-CA-C 101.467 -3.531 . . . . 0.0 101.467 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.839 ' HG2' ' HB ' ' A' ' 24' ' ' VAL 0.457 1.1 mmp_? -145.41 -179.64 6.79 Favored 'General case' 0 C--N 1.391 2.41 1 N-CA-C 124.954 5.168 . . . . 0.0 124.954 -167.91 . . . . . . . . 4 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 60' ' ' ARG . . . -152.6 172.44 16.6 Favored 'General case' 0 C--N 1.382 2.002 0 CA-C-N 112.526 -2.125 . . . . 0.0 111.449 -160.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.814 HG12 ' H ' ' A' ' 54' ' ' PHE . 13.7 pt -123.12 158.55 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.439 -3.307 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.466 ' O ' ' SD ' ' A' ' 20' ' ' MET 0.288 4.0 p90 -123.21 121.15 35.2 Favored 'General case' 0 N--CA 1.401 -2.893 0 O-C-N 126.447 2.342 . . . . 0.0 105.742 160.45 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 52' ' ' GLN . 1.3 tmt? -105.6 117.48 34.13 Favored 'General case' 0 C--N 1.273 -2.752 0 O-C-N 120.98 -1.075 . . . . 0.0 109.528 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.989 ' HA ' HG12 ' A' ' 51' ' ' VAL . 2.4 pt? -104.53 148.31 26.62 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.774 ' HA ' HG22 ' A' ' 17' ' ' THR 0.28 45.7 ttm105 -112.88 -55.47 2.52 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.605 -2.543 . . . . 0.0 115.291 -174.474 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -44.86 -21.11 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.659 0 CA-C-N 120.6 1.545 . . . . 0.0 115.019 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.64 -31.93 3.79 Favored Glycine 0 N--CA 1.426 -1.968 0 O-C-N 120.907 -1.121 . . . . 0.0 113.965 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 m -121.03 69.43 0.89 Allowed 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -166.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.956 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -179.82 2.14 0.01 OUTLIER 'General case' 0 C--N 1.381 1.965 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 179.376 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.938 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -85.18 -34.94 21.97 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -171.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.602 ' CE2' HD22 ' A' ' 89' ' ' LEU . 13.8 m-90 -72.4 -28.39 62.95 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-O 122.287 1.041 . . . . 0.0 110.343 -175.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.422 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 44.1 tt0 -69.03 -43.29 75.03 Favored 'General case' 0 C--O 1.258 1.552 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.55 171.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.502 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 84.2 mt -56.66 -42.15 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.109 0 CA-C-O 121.695 0.76 . . . . 0.0 109.787 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.688 ' HE2' ' HB ' ' A' ' 87' ' ' VAL . 52.7 tttm -56.49 -51.43 68.52 Favored 'General case' 0 C--O 1.282 2.802 0 C-N-CA 124.79 1.236 . . . . 0.0 109.707 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -55.15 -47.37 75.22 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.561 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 11.4 m-85 -53.55 -59.44 4.59 Favored 'General case' 0 C--N 1.366 1.292 0 O-C-N 123.872 0.733 . . . . 0.0 109.353 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.644 HD13 ' CE3' ' A' ' 40' ' ' TRP . 16.4 mt -52.89 -53.37 50.15 Favored 'General case' 0 C--O 1.3 3.732 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -172.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.478 ' HB ' ' CB ' ' A' ' 84' ' ' CYS 0.308 27.8 m -75.8 -9.38 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.198 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.873 -177.494 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.2 m -100.23 2.32 42.68 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.599 166.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 69.9 mm-40 -91.04 -40.89 11.38 Favored 'General case' 0 CA--C 1.439 -3.309 0 C-N-CA 118.909 -1.117 . . . . 0.0 109.519 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.412 35.6 t70 -155.91 -90.72 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.621 ' HB2' HG22 ' A' ' 24' ' ' VAL . 31.8 mmt180 -102.09 144.24 30.91 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 120.747 1.612 . . . . 0.0 110.559 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.478 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 10.6 p -140.59 135.64 31.98 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.672 ' HB2' ' OG ' ' A' ' 25' ' ' SER . . . -149.85 -51.67 0.15 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.077 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 32.9 tt0 -154.75 116.52 4.14 Favored 'General case' 0 C--O 1.181 -2.517 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.538 -173.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.688 ' HB ' ' HE2' ' A' ' 75' ' ' LYS . 14.2 t -111.4 102.21 13.64 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.7 p -109.84 125.19 52.5 Favored 'General case' 0 CA--C 1.473 -1.994 0 C-N-CA 117.619 -1.632 . . . . 0.0 112.023 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.915 HD23 ' HE2' ' A' ' 20' ' ' MET . 4.1 mp . . . . . 1 N--CA 1.371 -4.41 0 CA-C-N 112.257 -2.247 . . . . 0.0 107.667 -176.02 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.0 tptt . . . . . 0 C--O 1.205 -1.26 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 93.0 m -65.46 117.93 8.68 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.937 ' HG ' ' HH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -126.65 111.91 14.86 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.627 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 21.9 ptm -94.9 114.97 26.88 Favored 'General case' 0 C--N 1.277 -2.558 0 O-C-N 121.112 -0.992 . . . . 0.0 109.401 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.564 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 29.8 ttm -97.66 119.21 35.83 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.107 -176.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.436 ' HA ' HG22 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -107.02 119.17 38.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.022 1.729 . . . . 0.0 106.758 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.677 HG21 HG21 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -127.54 128.53 69.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -175.505 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.888 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 48.8 m -85.97 142.39 28.83 Favored 'General case' 0 CA--C 1.6 2.892 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.382 176.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 83' ' ' ARG 0.283 42.0 t -132.27 140.51 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 C-N-CA 125.414 1.486 . . . . 0.0 108.687 -170.778 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.526 20.8 t -109.55 -110.34 0.33 Allowed 'General case' 0 C--N 1.369 1.45 0 CA-C-N 122.957 2.617 . . . . 0.0 113.523 168.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.641 ' HA3' ' HG3' ' A' ' 83' ' ' ARG . . . 63.05 -72.34 0.03 OUTLIER Glycine 0 CA--C 1.543 1.827 0 CA-C-N 120.802 1.637 . . . . 0.0 112.402 -173.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.774 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 55.4 t30 -116.76 132.44 23.39 Favored Pre-proline 0 N--CA 1.416 -2.143 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 176.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -91.75 41.76 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.557 1.505 . . . . 0.0 113.298 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.5 p -125.18 -129.73 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 117.828 -1.549 . . . . 0.0 111.141 -173.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.543 ' O ' ' HB ' ' A' ' 33' ' ' THR . 31.2 tt0 -133.76 11.83 4.02 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 171.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.554 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 8.9 tmtt? -86.13 -36.95 19.26 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 122.231 1.015 . . . . 0.0 108.337 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.793 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -65.98 -46.07 79.37 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 175.249 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.543 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 58.8 m -45.28 -54.35 7.19 Favored 'General case' 0 C--O 1.193 -1.87 0 C-N-CA 125.696 1.598 . . . . 0.0 111.655 170.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.554 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.9 pt-20 -63.6 -49.72 72.23 Favored 'General case' 0 C--O 1.257 1.46 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -59.14 -55.66 32.09 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.749 1.261 . . . . 0.0 108.265 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.793 ' HB ' ' O ' ' A' ' 32' ' ' GLU . 3.1 mt -62.41 -42.81 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.123 0 CA-C-N 112.997 -1.911 . . . . 0.0 112.529 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.736 HG21 HG12 ' A' ' 55' ' ' ILE . 17.9 p -70.98 -39.56 72.41 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 120.819 1.645 . . . . 0.0 111.703 -176.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.8 p -63.27 -52.5 61.8 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.922 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.7 tp -63.7 -45.56 89.45 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.089 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.812 ' CD2' HD12 ' A' ' 78' ' ' LEU . 45.3 m0 -63.26 -74.52 0.09 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 119.364 -0.351 . . . . 0.0 111.52 -178.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.81 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.311 0.0 OUTLIER -71.06 -19.87 62.43 Favored 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.896 -1.122 . . . . 0.0 112.501 -172.279 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.45 -51.53 53.72 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 173.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.3 p -68.7 -30.92 69.68 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.261 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.774 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 33.5 mt -58.66 -37.16 75.37 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.319 177.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.689 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 64.1 t80 -85.64 -32.56 21.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.873 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.41 -37.4 86.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.4 2.03 51.63 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.123 0.487 . . . . 0.0 110.626 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.3 t30 58.99 51.8 6.9 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.951 1.3 . . . . 0.0 112.116 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -84.34 37.09 0.61 Allowed 'General case' 0 CA--C 1.558 1.258 0 O-C-N 120.903 -1.123 . . . . 0.0 113.473 175.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.2 t70 27.1 71.02 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 C-N-CA 126.397 1.879 . . . . 0.0 114.087 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 65' ' ' LEU . 1.3 m -147.66 169.57 3.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.329 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.501 ' O ' ' HB3' ' A' ' 64' ' ' MET . 0.5 OUTLIER -122.12 126.26 47.98 Favored 'General case' 0 C--O 1.189 -2.107 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 175.03 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.81 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -133.29 135.8 45.09 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -173.377 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.736 ' H ' HG12 ' A' ' 62' ' ' ILE . 44.5 t80 -135.4 151.55 50.57 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 119.245 -0.982 . . . . 0.0 113.208 -164.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.736 HG12 HG21 ' A' ' 37' ' ' THR . 43.2 mt -87.01 96.86 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 172.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 m -89.51 -32.28 5.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -163.3 167.68 37.68 Favored Glycine 0 CA--C 1.489 -1.573 0 C-N-CA 117.402 -2.333 . . . . 0.0 114.663 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -70.69 104.12 2.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 0.1 OUTLIER 91.99 18.73 0.03 OUTLIER 'General case' 0 C--N 1.36 1.027 0 C-N-CA 128.378 2.671 . . . . 0.0 110.101 -177.73 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.564 ' CG ' ' HA ' ' A' ' 23' ' ' THR . 17.8 mtm180 -146.07 132.0 19.17 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.53 165.36 25.07 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.251 -173.243 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.736 HG12 ' H ' ' A' ' 54' ' ' PHE . 6.0 pt -140.64 158.8 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.414 0 C-N-CA 118.283 -1.367 . . . . 0.0 110.634 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.501 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 1.1 p90 -133.81 106.72 7.47 Favored 'General case' 0 N--CA 1.423 -1.785 0 O-C-N 126.31 2.256 . . . . 0.0 108.065 162.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.627 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 1.2 tmt? -83.8 112.75 20.38 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 113.022 -1.899 . . . . 0.0 107.66 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.86 HD13 ' HB2' ' A' ' 71' ' ' ALA 0.329 2.3 pt? -109.26 147.73 32.15 Favored 'General case' 0 CA--C 1.468 -2.207 0 CA-C-O 123.487 1.613 . . . . 0.0 114.988 -177.183 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -100.82 -53.14 3.13 Favored 'General case' 0 C--N 1.252 -3.673 0 CA-C-N 110.365 -3.107 . . . . 0.0 112.539 -174.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.435 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 16.1 t70 -39.8 -24.85 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 114.725 1.379 . . . . 0.0 114.725 165.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.67 -34.19 0.71 Allowed Glycine 0 C--O 1.202 -1.901 0 C-N-CA 123.842 0.734 . . . . 0.0 114.761 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 15.2 p -96.96 -49.1 5.16 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 119.493 3.145 . . . . 0.0 119.493 -173.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.435 ' CE1' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -65.46 10.14 0.1 Allowed 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -172.21 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.86 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -84.71 -23.14 29.47 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 121.156 -0.965 . . . . 0.0 113.15 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.937 ' HH2' ' HG ' ' A' ' 18' ' ' LEU . 5.8 m-90 -67.63 -41.14 84.36 Favored 'General case' 0 C--O 1.277 2.547 0 CA-C-O 121.857 0.837 . . . . 0.0 111.035 -176.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 42.9 tt0 -67.21 -44.82 78.59 Favored 'General case' 0 C--O 1.295 3.461 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.616 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 90.5 mt -51.32 -49.75 29.9 Favored 'Isoleucine or valine' 0 C--O 1.281 2.762 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.719 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.533 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 21.2 pttp -63.57 -40.03 95.91 Favored 'General case' 0 C--N 1.383 2.063 0 CA-C-O 121.586 0.708 . . . . 0.0 110.522 -174.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.59 -34.41 72.7 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.496 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.616 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 21.6 m-85 -69.68 -69.61 0.33 Allowed 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -172.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.812 HD12 ' CD2' ' A' ' 40' ' ' TRP . 2.4 pt? -64.33 -34.71 78.78 Favored 'General case' 0 C--O 1.272 2.246 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.704 -167.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.677 HG21 HG21 ' A' ' 22' ' ' VAL . 34.6 t -83.63 -25.05 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 C-N-CA 117.903 -1.519 . . . . 0.0 109.304 -172.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.8 m -96.16 7.84 45.39 Favored 'General case' 0 N--CA 1.407 -2.615 0 C-N-CA 117.673 -1.611 . . . . 0.0 108.562 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -91.12 -52.63 4.73 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.094 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.451 ' OD1' ' HG2' ' A' ' 83' ' ' ARG 0.388 9.2 t70 -110.9 -95.13 0.43 Allowed 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.045 -1.062 . . . . 0.0 112.192 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.641 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 52.9 mmt-85 -112.98 152.86 28.91 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 121.425 1.921 . . . . 0.0 111.49 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.632 ' HB3' ' O ' ' A' ' 79' ' ' VAL . 13.0 p -138.03 160.67 38.75 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.011 -172.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.79 -54.39 0.02 OUTLIER 'General case' 0 C--N 1.379 1.865 0 C-N-CA 124.133 0.973 . . . . 0.0 113.001 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.888 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 34.8 tt0 -155.66 131.01 9.55 Favored 'General case' 0 C--O 1.208 -1.119 0 O-C-N 121.874 -0.516 . . . . 0.0 110.946 -170.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' A' ' 22' ' ' VAL . 16.0 m -115.01 115.28 49.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.222 172.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.495 ' C ' HD12 ' A' ' 89' ' ' LEU 0.28 32.2 p -112.28 123.91 51.3 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 123.207 1.479 . . . . 0.0 112.022 172.878 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.608 ' HB3' HD11 ' A' ' 18' ' ' LEU . 6.0 mp . . . . . 0 N--CA 1.39 -3.44 0 CA-C-N 113.091 -1.868 . . . . 0.0 110.271 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.2 tptt . . . . . 0 N--CA 1.437 -1.123 0 CA-C-O 120.57 0.224 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 p -117.33 121.46 41.2 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.742 HD11 ' C ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -134.59 108.14 7.89 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -173.553 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.1 ptm -84.1 100.95 11.45 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.548 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 0.3 OUTLIER -88.79 138.69 31.18 Favored 'General case' 0 C--O 1.25 1.123 0 C-N-CA 117.029 -1.868 . . . . 0.0 111.043 -171.533 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -109.52 113.45 26.25 Favored 'General case' 0 C--O 1.267 2.013 0 O-C-N 125.245 1.59 . . . . 0.0 108.723 -174.121 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -117.44 123.86 72.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.77 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.083 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 92.3 m -98.12 133.99 41.8 Favored 'General case' 0 CA--C 1.608 3.197 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.138 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.883 HG11 HD11 ' A' ' 36' ' ' ILE . 91.1 t -130.95 101.47 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.401 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 2.6 t -118.92 7.05 11.41 Favored 'General case' 0 C--N 1.361 1.108 0 CA-C-N 122.286 2.312 . . . . 0.0 114.042 -166.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.45 -46.21 52.87 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 174.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 1.076 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 16.4 t-20 -115.21 104.11 53.93 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 167.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 2.7 Cg_endo -82.23 24.52 0.71 Allowed 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 123.52 2.813 . . . . 0.0 113.351 -173.469 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.455 ' C ' ' HB3' ' A' ' 58' ' ' SER . 6.9 p -125.12 -162.51 1.11 Allowed 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.295 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -73.61 -29.22 62.25 Favored 'General case' 0 C--O 1.194 -1.844 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.617 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -59.56 -48.09 83.03 Favored 'General case' 0 C--O 1.263 1.768 0 CA-C-N 119.167 0.894 . . . . 0.0 112.726 -171.133 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 1.076 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 2.8 tp10 -64.01 -49.36 72.74 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.5 m -52.1 -46.06 65.12 Favored 'General case' 0 C--O 1.192 -1.93 0 CA-C-N 113.445 -1.707 . . . . 0.0 111.351 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.617 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 16.3 pt-20 -75.99 -31.32 58.92 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -75.55 -47.36 27.11 Favored 'General case' 0 C--O 1.279 2.651 0 N-CA-C 101.238 -3.616 . . . . 0.0 101.238 -174.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.883 HD11 HG11 ' A' ' 24' ' ' VAL 1.532 1.5 pp -57.19 -57.31 10.47 Favored 'Isoleucine or valine' 1 N--CA 1.309 -7.487 0 N-CA-C 120.917 3.673 . . . . 0.0 120.917 175.159 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.545 ' HA ' ' HB2' ' A' ' 40' ' ' TRP . 39.6 p -67.84 -31.42 71.24 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 t -64.85 -46.54 81.45 Favored 'General case' 0 N--CA 1.424 -1.737 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.074 176.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.7 mt -67.76 -46.29 72.46 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.901 178.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.729 ' HB3' ' NH1' ' A' ' 53' ' ' ARG . 37.8 m0 -57.3 -67.72 0.3 Allowed 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.943 -1.481 . . . . 0.0 114.837 -175.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.441 ' O ' ' HD1' ' A' ' 45' ' ' PHE 0.331 0.0 OUTLIER -78.9 -17.5 55.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 117.102 -1.839 . . . . 0.0 110.677 -176.513 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.95 -59.43 9.38 Favored Glycine 0 CA--C 1.472 -2.596 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 170.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.3 m -74.79 -36.85 62.49 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-N 113.245 -1.478 . . . . 0.0 112.496 -175.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.955 HD12 ' HD2' ' A' ' 53' ' ' ARG . 12.7 mt -61.1 -33.54 73.52 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.209 178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.441 ' HD1' ' O ' ' A' ' 41' ' ' GLN . 53.0 m-85 -87.11 -32.18 20.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.348 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -70.19 -29.98 66.98 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.12 8.4 15.67 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.079 0.466 . . . . 0.0 110.898 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 t30 67.38 52.21 0.83 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.176 1.391 . . . . 0.0 113.538 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -100.59 154.34 18.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.35 -1.469 . . . . 0.0 107.852 170.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.519 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 30.2 t70 -92.54 83.62 4.95 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 120.02 1.282 . . . . 0.0 109.407 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.77 174.36 12.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.205 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 1.0 OUTLIER -134.22 140.2 46.32 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 169.359 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 1.012 ' HG2' ' HA ' ' A' ' 63' ' ' PHE . 35.7 mtp180 -142.91 139.55 30.82 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 118.958 0.799 . . . . 0.0 109.735 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.671 ' H ' HG12 ' A' ' 62' ' ' ILE . 50.1 m-85 -132.33 151.38 51.87 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.044 -1.462 . . . . 0.0 114.099 -169.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 57.8 mt -99.19 96.41 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 170.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 60' ' ' ARG . 4.7 m -98.16 -23.14 4.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.048 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.94 161.57 35.39 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 118.524 -1.798 . . . . 0.0 112.159 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.455 ' HB3' ' C ' ' A' ' 29' ' ' THR . 51.1 m -75.64 106.48 7.23 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.498 ' O ' ' HD2' ' A' ' 60' ' ' ARG 0.271 0.0 OUTLIER 98.42 5.04 0.02 OUTLIER 'General case' 0 C--N 1.366 1.283 0 C-N-CA 127.0 2.12 . . . . 0.0 110.188 -174.167 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.498 ' HD2' ' O ' ' A' ' 59' ' ' ASP . 5.8 mpt_? -134.11 123.04 23.77 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.95 0.9 . . . . 0.0 112.131 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.09 168.18 17.16 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.671 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -141.16 153.24 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.45 -2.878 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.954 172.291 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.012 ' HA ' ' HG2' ' A' ' 53' ' ' ARG 0.27 31.2 p90 -129.45 108.62 10.41 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 127.114 2.759 . . . . 0.0 108.665 163.807 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.464 ' HB3' ' HB2' ' A' ' 52' ' ' GLN . 26.5 ttt -92.42 119.75 32.25 Favored 'General case' 0 C--O 1.27 2.158 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.643 HD22 ' CB ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -81.65 122.06 27.14 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 128.956 2.902 . . . . 0.0 110.161 178.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.519 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.253 23.6 ttt180 -105.44 -49.5 3.42 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 172.091 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASP . . . . . 0.445 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 25.9 t70 -75.87 50.88 0.6 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.079 1.309 . . . . 0.0 112.777 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.58 -34.66 0.02 OUTLIER Glycine 0 CA--C 1.55 2.233 0 N-CA-C 120.991 3.157 . . . . 0.0 120.991 173.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 62.0 m -163.07 51.65 0.17 Allowed 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 120.189 1.995 . . . . 0.0 116.384 -171.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.499 ' HE1' ' HA ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -122.01 13.83 10.6 Favored 'General case' 0 C--O 1.213 -0.849 0 O-C-N 120.286 -1.508 . . . . 0.0 112.306 177.861 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.928 ' HA ' HD12 ' A' ' 74' ' ' ILE . . . -102.14 -12.94 17.69 Favored 'General case' 0 C--O 1.197 -1.661 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -169.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.575 ' CE3' HD13 ' A' ' 89' ' ' LEU . 8.5 m95 -84.85 -31.0 24.02 Favored 'General case' 0 C--N 1.27 -2.872 0 O-C-N 120.536 -1.353 . . . . 0.0 109.102 -166.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 77' ' ' PHE . 18.5 tp10 -75.11 -33.81 61.64 Favored 'General case' 0 C--O 1.257 1.464 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.928 HD12 ' HA ' ' A' ' 71' ' ' ALA . 54.2 mt -59.01 -39.73 79.01 Favored 'Isoleucine or valine' 0 C--O 1.264 1.855 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.004 175.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.863 ' HD2' HD11 ' A' ' 89' ' ' LEU . 32.9 tttm -57.05 -53.21 60.62 Favored 'General case' 0 C--O 1.275 2.447 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.267 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -55.08 -46.94 75.49 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.821 1.326 . . . . 0.0 112.284 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.45 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 13.0 m-85 -56.74 -55.91 28.13 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.559 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.651 HD22 ' NE1' ' A' ' 40' ' ' TRP . 9.5 mt -58.53 -48.55 80.48 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 75' ' ' LYS 0.281 18.3 m -78.99 -6.26 9.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 116.558 -2.057 . . . . 0.0 113.136 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.0 m -106.68 4.02 27.37 Favored 'General case' 0 N--CA 1.423 -1.777 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.698 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -118.45 -25.02 6.62 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 117.374 -1.731 . . . . 0.0 111.149 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -139.73 -164.1 1.62 Allowed 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.711 ' HB3' HG13 ' A' ' 24' ' ' VAL . 23.2 tpp180 -60.56 136.15 57.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 118.858 0.754 . . . . 0.0 111.009 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 18.2 p -130.57 146.21 52.04 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -174.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.29 -38.62 0.09 Allowed 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 122.71 0.404 . . . . 0.0 111.157 170.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.083 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 39.9 tt0 -153.24 129.0 10.13 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.745 -176.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.16 92.68 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.3 p -116.78 111.34 19.61 Favored 'General case' 0 C--O 1.257 1.487 0 CA-C-O 121.926 0.869 . . . . 0.0 110.816 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.863 HD11 ' HD2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.408 -2.539 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.9 tptp . . . . . 0 N--CA 1.437 -1.086 0 CA-C-O 120.796 0.332 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.9 p -65.59 114.49 4.96 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.381 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.663 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -128.02 108.21 10.48 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.471 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 25.1 ptm -93.6 108.8 20.47 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.825 ' HB2' ' HA ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -106.93 143.09 35.52 Favored 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 116.703 -1.999 . . . . 0.0 112.742 -173.776 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.476 ' CE2' ' HD3' ' A' ' 60' ' ' ARG . 1.1 t80 -114.91 114.72 25.85 Favored 'General case' 0 C--O 1.26 1.609 0 C-N-CA 128.079 2.552 . . . . 0.0 109.863 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.745 HG23 ' SD ' ' A' ' 20' ' ' MET . 3.6 t -104.0 131.65 52.25 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.33 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 1.03 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 97.7 m -99.83 129.76 45.96 Favored 'General case' 0 CA--C 1.594 2.635 0 O-C-N 124.529 1.143 . . . . 0.0 108.375 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 59' ' ' ASP 0.295 93.5 t -122.38 101.82 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 C-N-CA 127.029 2.132 . . . . 0.0 106.8 -171.426 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -115.08 -1.01 13.14 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 122.471 2.396 . . . . 0.0 115.105 -168.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.749 ' HA3' ' HD2' ' A' ' 83' ' ' ARG . . . -56.51 -48.17 78.36 Favored Glycine 0 N--CA 1.474 1.226 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 4.9 t30 -115.75 116.67 40.67 Favored Pre-proline 0 N--CA 1.401 -2.878 0 N-CA-C 100.447 -3.909 . . . . 0.0 100.447 169.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -106.18 34.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.306 2.004 . . . . 0.0 111.305 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -129.5 54.5 1.82 Allowed 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 118.116 -1.434 . . . . 0.0 114.849 -168.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' ' HB ' ' A' ' 33' ' ' THR . 35.9 mt-10 59.92 -21.13 0.03 OUTLIER 'General case' 0 C--N 1.377 1.796 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 178.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HD3' ' C ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -69.68 -41.93 74.79 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.656 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 1.2 pm0 -68.31 -41.62 80.59 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 90.9 m -48.19 -53.08 18.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.15 0.98 . . . . 0.0 110.517 174.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.6 -49.12 57.06 Favored 'General case' 0 C--O 1.259 1.558 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -49.73 -60.0 3.29 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.232 1.413 . . . . 0.0 107.836 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.839 HG23 ' CE3' ' A' ' 40' ' ' TRP . 22.3 mt -64.76 -44.56 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.035 0 CA-C-N 112.135 -2.302 . . . . 0.0 113.01 -175.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.836 HG21 HG12 ' A' ' 55' ' ' ILE . 22.4 p -66.83 -48.86 67.6 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 117.87 -1.532 . . . . 0.0 111.826 -176.094 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.0 p -63.29 -57.2 11.2 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.592 0.557 . . . . 0.0 111.463 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.3 tp -67.18 -39.35 86.39 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.868 ' CE3' HD13 ' A' ' 78' ' ' LEU . 46.1 m0 -79.96 -48.6 13.12 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -174.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.453 ' O ' ' HD1' ' A' ' 45' ' ' PHE 0.286 0.0 OUTLIER -72.61 -23.42 60.94 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 116.686 -2.006 . . . . 0.0 109.857 178.828 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.59 -51.44 57.59 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 173.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 10.5 p -66.75 -38.95 87.64 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.052 HD12 ' HD2' ' A' ' 53' ' ' ARG . 19.3 mt -60.17 -35.57 75.65 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 177.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.453 ' HD1' ' O ' ' A' ' 41' ' ' GLN . 35.1 m-85 -85.81 -25.22 26.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.242 0.544 . . . . 0.0 110.521 176.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.4 t-20 -68.39 -31.84 71.48 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.372 0.669 . . . . 0.0 111.681 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.45 2.66 49.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.241 0.543 . . . . 0.0 110.307 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.7 t30 57.16 60.7 2.84 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.028 1.331 . . . . 0.0 114.238 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -100.32 167.82 10.17 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 166.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -97.8 100.8 12.18 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 120.22 1.373 . . . . 0.0 108.348 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 m -146.13 176.92 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.243 -171.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 67.0 mt-30 -140.58 145.5 36.81 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 173.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 1.052 ' HD2' HD12 ' A' ' 44' ' ' LEU . 21.6 mtp180 -143.53 144.14 31.84 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 118.943 0.792 . . . . 0.0 111.233 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.668 ' H ' HG12 ' A' ' 62' ' ' ILE . 80.7 m-85 -133.68 151.75 51.72 Favored 'General case' 0 C--O 1.261 1.661 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -170.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.836 HG12 HG21 ' A' ' 37' ' ' THR . 17.4 mt -92.56 102.86 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 167.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.714 HG23 ' HD2' ' A' ' 60' ' ' ARG . 6.9 m -112.51 -27.41 2.77 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.784 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.95 161.38 31.89 Favored Glycine 0 N--CA 1.419 -2.492 0 C-N-CA 118.158 -1.972 . . . . 0.0 113.681 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 m -64.4 125.17 23.79 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.641 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 p30 68.22 21.61 8.47 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 125.106 1.362 . . . . 0.0 109.556 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.714 ' HD2' HG23 ' A' ' 56' ' ' VAL . 1.1 tmm_? -153.6 119.77 5.44 Favored 'General case' 0 CA--C 1.583 2.215 0 CA-C-O 122.278 1.037 . . . . 0.0 113.327 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.29 168.75 13.08 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.527 1.131 . . . . 0.0 109.066 -171.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 20' ' ' MET . 0.2 OUTLIER -134.6 156.79 40.7 Favored 'Isoleucine or valine' 0 C--O 1.283 2.861 0 C-N-CA 117.474 -1.69 . . . . 0.0 110.993 175.759 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.017 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 49.0 p90 -123.24 109.82 14.44 Favored 'General case' 0 N--CA 1.422 -1.845 0 O-C-N 127.507 3.005 . . . . 0.0 107.309 163.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.642 ' HB2' HD11 ' A' ' 62' ' ' ILE . 23.7 ttt -95.87 110.81 22.93 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.303 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.843 ' HG ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -113.3 147.42 37.64 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -171.818 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.284 30.6 ttm180 -111.78 -58.51 2.11 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -176.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -44.46 -19.99 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.22 -9.13 3.32 Favored Glycine 0 C--N 1.358 1.767 0 CA-C-N 119.717 1.144 . . . . 0.0 114.903 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -117.05 32.46 6.15 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.301 1.051 . . . . 0.0 113.696 -168.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -166.68 12.98 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.606 -171.739 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.843 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -97.22 -37.77 9.95 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -166.051 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.612 ' CE2' HD22 ' A' ' 89' ' ' LEU . 9.0 m-90 -76.0 -27.53 57.45 Favored 'General case' 0 C--O 1.273 2.331 0 O-C-N 120.895 -1.128 . . . . 0.0 110.636 -174.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -63.62 -35.22 79.79 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 113.835 -1.529 . . . . 0.0 107.722 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.818 HD12 ' HA ' ' A' ' 71' ' ' ALA . 26.3 mt -67.58 -45.2 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.154 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HB2' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -57.71 -41.69 82.25 Favored 'General case' 0 C--O 1.283 2.851 0 CA-C-O 121.907 0.861 . . . . 0.0 109.387 -174.022 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.495 ' N ' ' HD2' ' A' ' 75' ' ' LYS . 17.1 t70 -61.46 -50.01 74.51 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 112.826 -1.988 . . . . 0.0 111.649 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.424 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 14.8 m-85 -62.09 -48.3 80.82 Favored 'General case' 0 C--O 1.197 -1.696 0 C-N-CA 118.47 -1.292 . . . . 0.0 110.383 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.868 HD13 ' CE3' ' A' ' 40' ' ' TRP . 4.3 mt -55.57 -54.5 43.3 Favored 'General case' 0 C--O 1.296 3.504 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.677 ' O ' ' HB3' ' A' ' 84' ' ' CYS 0.354 30.0 m -72.62 -19.1 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 C-N-CA 115.935 -2.306 . . . . 0.0 112.574 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.3 m -85.96 -4.3 59.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.148 171.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 21.7 mm-40 -90.43 -32.27 16.48 Favored 'General case' 0 CA--C 1.453 -2.78 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.073 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.507 ' OD2' ' HG2' ' A' ' 83' ' ' ARG 0.44 21.7 t70 -147.31 -94.58 0.09 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 116.913 -1.915 . . . . 0.0 114.628 -178.546 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.749 ' HD2' ' HA3' ' A' ' 26' ' ' GLY . 10.8 mmt180 -105.38 126.74 52.46 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 121.191 1.814 . . . . 0.0 109.264 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 0.677 ' HB3' ' O ' ' A' ' 79' ' ' VAL . 22.2 p -111.46 97.09 6.5 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -176.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.75 -42.37 2.42 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 1.03 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 37.2 tt0 -153.61 125.2 7.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 118.034 -1.466 . . . . 0.0 112.781 -174.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 75' ' ' LYS . 2.9 m -112.75 93.44 2.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 p -105.44 99.4 9.01 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 118.413 -1.315 . . . . 0.0 112.208 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.825 ' HA ' ' HB2' ' A' ' 20' ' ' MET . 5.4 mp . . . . . 0 N--CA 1.384 -3.73 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.545 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.6 tptt . . . . . 0 N--CA 1.438 -1.042 0 CA-C-O 120.497 0.189 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 6.3 m -85.58 111.36 19.97 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.835 ' HB3' HD21 ' A' ' 65' ' ' LEU . 21.8 tp -133.2 116.02 15.71 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -174.185 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.669 ' O ' HD21 ' A' ' 89' ' ' LEU . 19.6 ptm -83.56 103.13 12.64 Favored 'General case' 0 C--O 1.207 -1.171 0 O-C-N 121.502 -0.749 . . . . 0.0 112.792 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.623 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 12.3 mtm -84.56 126.01 32.94 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -174.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -108.8 115.0 29.25 Favored 'General case' 0 N--CA 1.432 -1.34 0 O-C-N 125.618 1.824 . . . . 0.0 108.606 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -115.25 125.52 72.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.485 -176.402 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.823 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 30.2 m -90.85 110.62 21.84 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 113.638 -1.619 . . . . 0.0 107.365 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 84' ' ' CYS . 75.5 t -103.77 92.55 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.341 0 CA-C-N 120.373 1.442 . . . . 0.0 109.145 -176.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 m -93.38 96.5 9.98 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 120.755 1.616 . . . . 0.0 110.292 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.21 -50.08 0.02 OUTLIER Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -116.47 106.12 49.16 Favored Pre-proline 0 CA--C 1.493 -1.212 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.58 42.44 0.27 Allowed 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 123.93 3.086 . . . . 0.0 114.111 -171.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.6 p -147.0 -176.5 5.23 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' HB ' ' A' ' 33' ' ' THR . 48.8 mt-10 -85.81 10.32 14.06 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 118.831 0.741 . . . . 0.0 110.225 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -77.74 -34.43 52.55 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.812 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.588 ' HG2' HD12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -71.26 -40.84 70.73 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.318 -0.953 . . . . 0.0 108.493 177.593 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 29.0 m -49.87 -55.63 13.58 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 125.866 1.666 . . . . 0.0 110.807 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.1 pt-20 -67.5 -43.95 79.66 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.867 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -50.71 -62.56 1.53 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 123.075 1.416 . . . . 0.0 107.474 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.87 HG23 ' CE3' ' A' ' 40' ' ' TRP . 25.0 mt -61.71 -44.38 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 112.067 -2.333 . . . . 0.0 112.981 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.812 HG21 HG12 ' A' ' 55' ' ' ILE . 25.1 p -68.28 -52.93 28.2 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.913 -175.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.4 p -62.79 -56.68 15.3 Favored 'General case' 0 C--O 1.256 1.432 0 O-C-N 123.618 0.574 . . . . 0.0 111.621 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.87 -49.6 74.22 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.87 ' CE3' HG23 ' A' ' 36' ' ' ILE . 50.8 m0 -75.14 -47.25 29.44 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -173.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.298 0.0 OUTLIER -73.98 -19.47 60.64 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 116.608 -2.037 . . . . 0.0 109.816 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.99 -52.87 49.61 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 170.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.521 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 9.6 p -69.73 -34.51 73.96 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 117.099 0.449 . . . . 0.0 112.01 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.986 HD12 ' HD2' ' A' ' 53' ' ' ARG . 9.2 mt -61.06 -35.28 76.53 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -87.99 -22.31 24.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.358 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 16.1 t-20 -65.53 -34.22 77.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.653 0.263 . . . . 0.0 110.984 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.99 5.05 27.13 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.411 0.624 . . . . 0.0 109.863 175.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 t30 51.77 45.4 28.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.342 1.857 . . . . 0.0 113.673 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -80.09 165.87 22.07 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -98.25 94.53 6.83 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 120.359 1.436 . . . . 0.0 108.656 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 m -135.12 173.09 14.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.592 -171.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -138.43 123.93 19.56 Favored 'General case' 0 C--O 1.196 -1.721 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 1.131 ' HG2' ' HA ' ' A' ' 63' ' ' PHE . 16.8 mtp180 -120.43 142.03 49.6 Favored 'General case' 0 C--N 1.268 -2.947 0 O-C-N 121.235 -0.915 . . . . 0.0 110.998 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.659 ' H ' HG12 ' A' ' 62' ' ' ILE . 41.1 m-85 -129.57 152.14 49.41 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -170.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.812 HG12 HG21 ' A' ' 37' ' ' THR . 29.8 mt -94.8 109.44 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.591 HG23 ' HB3' ' A' ' 60' ' ' ARG . 3.7 m -112.07 -16.19 9.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -175.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 161.97 177.12 34.75 Favored Glycine 0 CA--C 1.482 -2.022 0 C-N-CA 117.477 -2.297 . . . . 0.0 114.262 169.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.529 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 37.6 t -66.14 116.65 7.44 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.537 ' C ' ' HD2' ' A' ' 60' ' ' ARG . 0.2 OUTLIER 85.98 9.39 0.28 Allowed 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 125.41 1.484 . . . . 0.0 109.058 -178.378 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.591 ' HB3' HG23 ' A' ' 56' ' ' VAL . 3.8 mpt_? -138.68 124.26 19.57 Favored 'General case' 0 C--O 1.255 1.387 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.195 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.89 162.24 32.97 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.659 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -137.56 154.45 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.044 0 C-N-CA 117.969 -1.493 . . . . 0.0 111.545 174.08 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 1.131 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -126.65 112.65 15.71 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.223 2.827 . . . . 0.0 107.76 162.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.439 ' HB2' HD11 ' A' ' 62' ' ' ILE . 43.4 ttm -95.42 125.55 40.11 Favored 'General case' 0 C--O 1.258 1.544 0 O-C-N 121.332 -0.855 . . . . 0.0 109.805 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.835 HD21 ' HB3' ' A' ' 18' ' ' LEU . 1.2 pt? -102.2 144.62 30.51 Favored 'General case' 0 CA--C 1.494 -1.182 0 O-C-N 124.622 1.201 . . . . 0.0 110.669 -176.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.292 5.5 tmm_? -119.73 -49.22 2.34 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -46.78 -23.44 0.43 Allowed 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 171.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.42 -31.93 4.65 Favored Glycine 0 C--N 1.36 1.864 0 CA-C-N 120.231 1.378 . . . . 0.0 113.8 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.2 m -128.34 45.42 2.77 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -166.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.623 ' CE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -153.02 2.25 0.29 Allowed 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.239 -0.913 . . . . 0.0 112.562 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.728 ' HA ' HD12 ' A' ' 74' ' ' ILE . . . -94.52 -34.41 12.69 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 119.077 2.991 . . . . 0.0 119.077 -170.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TRP . . . . . 0.789 ' HD1' ' HD3' ' A' ' 75' ' ' LYS 0.512 9.3 m-90 -81.42 -16.81 50.99 Favored 'General case' 0 C--O 1.263 1.781 0 C-N-CA 116.494 -2.083 . . . . 0.0 114.85 -167.712 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -73.56 -29.73 62.61 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 168.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 71' ' ' ALA . 74.9 mt -61.23 -42.13 92.27 Favored 'Isoleucine or valine' 0 C--O 1.258 1.54 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.869 173.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.865 ' HB2' HG21 ' A' ' 87' ' ' VAL . 53.1 pttt -61.32 -41.45 97.04 Favored 'General case' 0 C--N 1.378 1.842 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.386 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.45 -52.02 65.0 Favored 'General case' 0 C--O 1.271 2.204 0 O-C-N 124.29 0.994 . . . . 0.0 110.582 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.471 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 8.0 m-85 -54.62 -47.54 73.32 Favored 'General case' 0 C--O 1.205 -1.288 0 O-C-N 123.553 0.533 . . . . 0.0 110.114 -178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . 0.79 HD13 ' CE3' ' A' ' 40' ' ' TRP . 10.3 mt -63.59 -51.58 64.69 Favored 'General case' 0 C--O 1.287 3.039 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -175.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 1.11 ' HA ' ' HB2' ' A' ' 84' ' ' CYS . 29.5 m -71.38 -6.6 7.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.547 0.689 . . . . 0.0 112.268 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 m -110.35 1.0 18.18 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.246 170.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 30.6 tp60 -88.18 -36.99 16.5 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -177.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.486 10.5 t70 -142.37 -96.84 0.12 Allowed 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 117.954 2.575 . . . . 0.0 117.954 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -146.77 40.66 1.09 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' CYS . . . . . 1.11 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 55.5 m -79.45 12.03 2.68 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 111.158 -2.746 . . . . 0.0 115.669 -165.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . 0.314 . . 29.66 -58.99 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 173.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.823 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 6.2 tp10 -145.46 132.07 19.88 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 119.882 1.219 . . . . 0.0 111.676 -169.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.865 HG21 ' HB2' ' A' ' 75' ' ' LYS . 47.2 t -114.09 106.26 20.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 173.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.433 ' O ' HD23 ' A' ' 89' ' ' LEU . 14.3 p -118.98 146.98 44.55 Favored 'General case' 0 C--O 1.293 3.352 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.72 ' CD1' ' HG ' ' A' ' 18' ' ' LEU 0.758 2.7 mt . . . . . 0 N--CA 1.441 -0.879 0 N-CA-C 121.152 3.76 . . . . 0.0 121.152 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 0.14 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.27 -13.37 37.64 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.26 2.64 . . . . 0.0 113.161 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.46 16.25 59.45 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.078 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.429 ' HE2' ' OE2' ' A' ' 6' ' ' GLU . 26.1 pttm -73.27 134.2 80.34 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.673 ' HG3' ' HA3' ' A' ' 96' ' ' GLY . 12.3 Cg_exo -70.11 95.18 0.57 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.226 1.951 . . . . 0.0 112.599 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.625 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 25.5 mm-40 -81.75 -22.83 37.02 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.78 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.434 ' HA ' ' HE2' ' A' ' 10' ' ' LYS . 5.5 p -53.64 -56.95 12.75 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.966 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 pt -66.0 -41.75 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.66 HD12 ' HA ' ' A' ' 69' ' ' SER . 1.4 pt? -73.25 -37.35 66.37 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 117.852 -1.539 . . . . 0.0 111.553 -175.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -79.29 -27.02 42.23 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 118.116 -1.434 . . . . 0.0 112.17 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.418 ' N ' ' HD2' ' A' ' 10' ' ' LYS . 16.3 tpt -77.57 -33.12 54.09 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.091 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -81.56 -46.77 13.97 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.793 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.2 pttp 45.93 -166.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 125.592 1.557 . . . . 0.0 113.838 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.8 tptt 64.81 23.96 12.74 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.793 0.837 . . . . 0.0 110.747 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.66 64.36 4.29 Favored Glycine 0 CA--C 1.558 2.763 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.375 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -82.82 123.49 29.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 119.496 1.648 . . . . 0.0 109.355 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 8.0 m -67.44 116.77 8.55 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.69 ' O ' HD13 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -120.52 116.9 26.3 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.524 -2.399 . . . . 0.0 104.524 -177.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.44 ' HA ' ' HG3' ' A' ' 64' ' ' MET . 24.5 ptm -89.32 133.96 34.26 Favored 'General case' 0 C--N 1.28 -2.435 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.271 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.438 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 8.0 ttm -123.58 121.71 36.3 Favored 'General case' 0 N--CA 1.405 -2.715 0 C-N-CA 116.246 -2.181 . . . . 0.0 112.944 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -94.54 126.16 39.64 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.226 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 61' ' ' ALA . 0.2 OUTLIER -120.83 130.55 74.49 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-O 121.191 0.52 . . . . 0.0 110.071 -178.013 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.091 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 78.1 m -95.66 132.04 41.25 Favored 'General case' 0 N--CA 1.397 -3.093 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 172.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 1.026 HG23 ' HB2' ' A' ' 82' ' ' ASP . 2.5 p -131.41 127.83 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.077 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -172.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.549 ' HB3' ' OD2' ' A' ' 59' ' ' ASP . 15.5 p -142.69 33.01 1.43 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 121.726 2.057 . . . . 0.0 115.356 -170.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.65 -34.76 90.8 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 171.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 22.3 m-80 -118.13 122.69 30.13 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 171.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.67 28.89 0.41 Allowed 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.763 2.308 . . . . 0.0 112.792 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.0 p -137.78 -157.13 0.75 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.462 ' O ' ' HB ' ' A' ' 33' ' ' THR . 39.9 mt-10 -87.99 5.2 41.95 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-O 119.263 -0.398 . . . . 0.0 111.384 175.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.582 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 5.7 tmtt? -70.92 -38.77 72.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.361 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.606 ' HG3' HD13 ' A' ' 36' ' ' ILE . 6.2 tp10 -74.25 -41.04 61.93 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 178.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 96.5 m -44.6 -59.37 2.5 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.181 170.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.582 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.2 pt-20 -61.43 -45.7 93.2 Favored 'General case' 0 C--O 1.25 1.107 0 C-N-CA 122.935 0.494 . . . . 0.0 112.082 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -52.91 -59.03 5.03 Favored 'General case' 0 C--O 1.254 1.317 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.728 HG23 ' CE3' ' A' ' 40' ' ' TRP . 2.0 mp -67.17 -46.18 84.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.53 -1.213 . . . . 0.0 113.352 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.687 HG21 HG12 ' A' ' 55' ' ' ILE . 31.0 p -62.24 -52.61 63.05 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.1 m -70.82 -44.63 66.15 Favored 'General case' 0 C--O 1.26 1.646 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.973 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.0 tp -71.21 -43.55 67.14 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.431 -176.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.728 ' CE3' HG23 ' A' ' 36' ' ' ILE . 43.8 m0 -76.07 -60.34 2.37 Favored 'General case' 0 C--O 1.161 -3.594 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.057 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.606 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.404 0.0 OUTLIER -65.71 -22.23 66.6 Favored 'General case' 0 C--O 1.255 1.356 0 C-N-CA 117.017 -1.873 . . . . 0.0 112.044 -173.078 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.86 -54.13 39.5 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 27.8 p -70.38 -27.3 64.21 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 117.257 0.528 . . . . 0.0 111.976 177.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.805 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 17.5 mt -61.51 -31.79 71.8 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.301 0.64 . . . . 0.0 109.351 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 72.8 t80 -92.68 -28.33 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.355 174.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.676 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 10.2 t30 -68.43 -28.88 67.45 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.047 0.451 . . . . 0.0 111.564 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.4 12.12 19.42 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.373 0.606 . . . . 0.0 109.726 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.0 p30 48.25 48.7 18.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.888 1.675 . . . . 0.0 114.74 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -91.45 159.58 15.88 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.62 88.81 3.71 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 120.606 1.548 . . . . 0.0 109.83 -176.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.002 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.7 m -146.79 169.83 4.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.559 -169.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.444 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 89.7 mt-30 -131.86 123.7 28.04 Favored 'General case' 0 C--O 1.2 -1.516 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 176.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.805 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -130.62 135.4 47.84 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.503 -173.209 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.732 ' H ' HG12 ' A' ' 62' ' ' ILE . 56.0 m-85 -133.83 153.19 51.91 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -165.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.687 HG12 HG21 ' A' ' 37' ' ' THR . 22.9 mt -87.24 108.23 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 168.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.72 HG23 ' HB3' ' A' ' 60' ' ' ARG . 15.6 m -113.28 -11.73 11.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.711 -175.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.14 176.95 41.33 Favored Glycine 0 CA--C 1.504 -0.631 0 C-N-CA 117.163 -2.446 . . . . 0.0 115.362 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 m -68.36 110.78 4.26 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.549 ' OD2' ' HB3' ' A' ' 25' ' ' SER 0.257 0.0 OUTLIER 78.37 17.46 1.14 Allowed 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 122.947 1.356 . . . . 0.0 109.938 -178.45 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.72 ' HB3' HG23 ' A' ' 56' ' ' VAL . 7.3 mpt_? -133.18 127.44 33.84 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.173 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.413 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -137.25 165.81 25.27 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.732 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.6 pt -144.53 157.81 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.336 0 C-N-CA 117.962 -1.495 . . . . 0.0 110.62 168.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.734 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -132.1 105.89 7.65 Favored 'General case' 0 N--CA 1.414 -2.233 0 O-C-N 126.595 2.434 . . . . 0.0 105.979 164.509 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.44 ' HG3' ' HA ' ' A' ' 19' ' ' MET . 25.1 ttt -92.19 103.97 16.39 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.002 ' HA ' HG12 ' A' ' 51' ' ' VAL 0.277 0.0 OUTLIER -96.06 146.32 24.74 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -171.834 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 17' ' ' THR 0.354 1.1 tmt_? -120.98 -59.09 1.76 Allowed 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -46.18 -9.25 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 117.996 2.591 . . . . 0.0 117.996 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.87 28.96 64.07 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 119.793 1.179 . . . . 0.0 113.668 -174.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.66 ' HA ' HD12 ' A' ' 9' ' ' LEU . 19.8 p -149.34 43.43 0.94 Allowed 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.613 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -173.49 -3.85 0.01 OUTLIER 'General case' 0 C--N 1.378 1.818 0 N-CA-C 117.732 2.494 . . . . 0.0 117.732 -176.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 1.0 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -74.31 -35.41 63.68 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -168.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.413 ' NE1' ' HE1' ' A' ' 20' ' ' MET 0.478 5.4 m-90 -88.23 -11.24 47.23 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -169.048 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.84 -38.71 70.08 Favored 'General case' 0 C--O 1.262 1.719 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 167.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.624 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 25.5 mt -64.7 -36.93 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.277 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.83 ' HE2' HG11 ' A' ' 87' ' ' VAL . 55.2 tttm -58.14 -42.58 86.16 Favored 'General case' 0 C--O 1.291 3.275 0 CA-C-O 122.081 0.943 . . . . 0.0 110.617 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -58.42 -46.98 85.41 Favored 'General case' 0 C--O 1.264 1.867 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.288 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.624 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 11.0 m-85 -55.96 -43.99 78.06 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.264 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.635 ' HG ' ' HA ' ' A' ' 75' ' ' LYS . 11.5 mt -50.09 -64.61 0.76 Allowed 'General case' 0 CA--C 1.446 -3.05 0 O-C-N 123.835 0.71 . . . . 0.0 109.719 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . 0.303 25.7 m -77.24 -5.49 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 C-N-CA 118.113 -1.435 . . . . 0.0 114.42 -171.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m -86.35 -22.33 26.74 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.758 167.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -117.26 -35.19 4.11 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 1.026 ' HB2' HG23 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -80.28 24.95 0.41 Allowed 'General case' 0 N--CA 1.516 2.875 0 CA-C-N 119.811 1.187 . . . . 0.0 111.52 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 73.46 -81.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -155.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.431 ' HA ' ' OD1' ' A' ' 82' ' ' ASP . 11.5 p 159.6 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.595 1.558 . . . . 0.0 112.305 171.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . 0.363 . . -109.31 -78.86 0.59 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 119.122 3.008 . . . . 0.0 119.122 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.091 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 33.8 tt0 -148.41 126.56 12.13 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 121.089 1.768 . . . . 0.0 112.993 -165.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.83 HG11 ' HE2' ' A' ' 75' ' ' LYS . 2.5 p -111.38 123.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.782 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 20' ' ' MET 0.258 25.9 p -123.39 110.5 15.22 Favored 'General case' 0 C--O 1.264 1.834 0 CA-C-O 122.702 1.239 . . . . 0.0 113.042 171.102 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.508 HD12 HG22 ' A' ' 87' ' ' VAL . 1.7 mp -76.11 155.7 34.46 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.687 -2.052 . . . . 0.0 107.117 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.549 ' H ' HD13 ' A' ' 18' ' ' LEU . 23.8 tt0 -86.64 151.71 23.19 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 171.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 118.49 -172.9 14.66 Favored Glycine 0 CA--C 1.568 3.387 0 CA-C-O 118.724 -1.042 . . . . 0.0 111.846 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 tp-100 -112.48 126.24 55.1 Favored 'General case' 0 C--N 1.367 1.349 0 CA-C-N 120.968 2.384 . . . . 0.0 109.988 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . 0.267 24.0 ptm 55.84 95.07 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.716 1.606 . . . . 0.0 114.265 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -95.0 119.21 66.22 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.95 26.56 0.54 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 123.176 2.584 . . . . 0.0 113.8 -175.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.673 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . -146.79 62.22 0.45 Allowed Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 118.707 -0.664 . . . . 0.0 110.038 179.842 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.299 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.29 -54.05 0.55 Allowed 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 123.025 2.483 . . . . 0.0 112.74 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.16 -58.39 5.04 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -115.67 140.25 25.82 Favored Pre-proline 0 N--CA 1.429 -1.515 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 171.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.448 ' HB2' ' HB2' ' A' ' 72' ' ' TRP . 64.8 Cg_endo -75.43 165.79 29.97 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.556 1.504 . . . . 0.0 114.199 -172.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.57 ' HA ' ' CE3' ' A' ' 72' ' ' TRP . 41.1 mt-10 83.56 10.69 0.48 Allowed 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 126.585 1.954 . . . . 0.0 112.06 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.5 p -61.9 -44.96 95.72 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.718 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.9 pt -64.45 -38.07 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.381 0 CA-C-O 122.427 1.108 . . . . 0.0 110.862 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.7 tp -72.1 -47.64 49.83 Favored 'General case' 0 N--CA 1.384 -3.774 0 CA-C-N 112.915 -1.948 . . . . 0.0 111.377 -172.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 6' ' ' GLU . 22.4 pttp -86.9 -9.51 55.54 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.205 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 49.8 ttm -79.5 -34.54 41.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 172.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.4 m -82.71 -51.35 7.79 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.308 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt 173.38 149.12 0.07 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -89.38 -175.88 4.88 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 48.0 40.69 20.57 Favored Glycine 0 CA--C 1.557 2.713 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.954 -171.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -117.08 131.87 56.82 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 119.058 1.429 . . . . 0.0 108.838 -176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.2 m -68.44 121.46 16.38 Favored 'General case' 0 N--CA 1.411 -2.403 0 O-C-N 124.114 0.884 . . . . 0.0 109.34 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.703 HD12 ' SD ' ' A' ' 20' ' ' MET . 0.2 OUTLIER -133.56 116.49 15.98 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 176.052 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.453 ' H ' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -113.57 140.99 47.71 Favored 'General case' 0 C--N 1.274 -2.708 0 O-C-N 120.921 -1.112 . . . . 0.0 109.306 179.059 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.703 ' SD ' HD12 ' A' ' 18' ' ' LEU . 2.9 mpp? -118.69 127.43 53.56 Favored 'General case' 0 CA--C 1.447 -3.006 0 C-N-CA 120.334 -0.547 . . . . 0.0 111.33 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . 0.293 30.4 p90 -98.87 123.42 43.12 Favored 'General case' 0 N--CA 1.413 -2.317 0 C-N-CA 117.354 -1.739 . . . . 0.0 106.729 168.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.9 p -114.89 122.15 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 CA-C-N 114.647 -1.16 . . . . 0.0 113.815 -167.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.036 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 24.4 m -75.32 135.76 40.88 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 171.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.611 HG21 HD13 ' A' ' 36' ' ' ILE . 7.9 p -121.52 127.7 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.681 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -162.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.642 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 29.5 t 71.26 -48.78 0.68 Allowed 'General case' 0 C--N 1.374 1.663 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 164.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.11 -16.74 6.76 Favored Glycine 0 N--CA 1.421 -2.319 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -173.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.0 t-20 -72.39 110.22 7.61 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -85.7 23.65 0.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.89 2.393 . . . . 0.0 113.015 -172.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -123.32 -170.91 2.2 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -91.61 9.41 32.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.555 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 3.9 tmtt? -67.52 -54.7 17.78 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.252 0.548 . . . . 0.0 110.395 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.719 ' HG3' HD12 ' A' ' 36' ' ' ILE . 3.4 tp10 -69.0 -40.14 78.91 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -175.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -46.8 -56.29 6.5 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.668 171.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 15.4 pt-20 -62.78 -49.06 76.47 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 122.585 0.354 . . . . 0.0 111.628 -175.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -48.62 -58.48 4.65 Favored 'General case' 0 C--O 1.254 1.32 0 C-N-CA 125.656 1.583 . . . . 0.0 108.335 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.719 HD12 ' HG3' ' A' ' 32' ' ' GLU . 43.6 mt -72.24 -43.34 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 CA-C-N 111.647 -2.524 . . . . 0.0 113.617 -173.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.823 HG21 HG12 ' A' ' 55' ' ' ILE . 22.7 p -63.76 -48.77 75.64 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.241 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.5 p -63.69 -62.98 1.3 Allowed 'General case' 0 C--O 1.263 1.766 0 O-C-N 123.323 0.39 . . . . 0.0 110.774 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.14 -46.7 86.01 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.682 ' CE3' HG23 ' A' ' 36' ' ' ILE . 29.4 m0 -74.89 -59.67 2.63 Favored 'General case' 0 C--O 1.165 -3.38 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.612 -176.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.807 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.375 0.0 OUTLIER -64.58 -25.56 68.02 Favored 'General case' 0 C--O 1.252 1.222 0 C-N-CA 117.214 -1.794 . . . . 0.0 112.027 -172.199 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.19 -53.71 42.47 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.527 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 35.5 p -70.89 -28.51 64.6 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 116.881 0.34 . . . . 0.0 111.732 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.965 HD12 ' HG2' ' A' ' 53' ' ' ARG . 18.2 mt -61.18 -35.13 76.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.276 0.631 . . . . 0.0 109.378 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.631 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 60.9 t80 -87.59 -30.14 20.72 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.913 177.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.2 t-20 -69.02 -27.71 65.92 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.134 0.492 . . . . 0.0 111.481 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.11 1.03 52.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.994 0.426 . . . . 0.0 110.557 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 60.34 35.06 20.69 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.686 1.194 . . . . 0.0 112.266 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -65.56 -2.35 3.36 Favored 'General case' 0 CA--C 1.611 3.31 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 59.7 71.74 0.56 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.396 1.478 . . . . 0.0 111.108 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' A' ' 65' ' ' LEU . 6.4 m -147.66 176.21 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.725 -170.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.574 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 74.7 mt-30 -135.96 133.35 37.49 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 174.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.965 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.36 135.42 37.0 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -174.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.783 ' H ' HG12 ' A' ' 62' ' ' ILE . 36.7 t80 -134.36 151.57 51.3 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 117.797 -1.561 . . . . 0.0 113.737 -163.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.823 HG12 HG21 ' A' ' 37' ' ' THR . 25.7 mt -89.5 96.13 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 170.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.664 HG13 ' HB3' ' A' ' 60' ' ' ARG . 7.4 p -94.61 -25.43 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-O 120.605 0.241 . . . . 0.0 110.912 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.67 173.52 45.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 118.667 -1.73 . . . . 0.0 114.706 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.527 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 21.0 m -70.57 117.94 12.74 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.65 ' O ' ' HA ' ' A' ' 23' ' ' THR . 14.2 t70 82.47 9.98 0.7 Allowed 'General case' 0 C--O 1.188 -2.139 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.664 ' HB3' HG13 ' A' ' 56' ' ' VAL . 5.5 mpt_? -138.78 117.84 12.56 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 122.247 1.022 . . . . 0.0 113.525 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.59 168.44 12.62 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 125.046 1.339 . . . . 0.0 107.445 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.783 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.5 pt -138.06 157.43 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.256 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.072 171.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.451 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -130.82 102.96 6.3 Favored 'General case' 0 N--CA 1.422 -1.841 0 O-C-N 126.807 2.567 . . . . 0.0 107.929 166.156 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.471 ' HB3' ' O ' ' A' ' 52' ' ' GLN . 1.0 OUTLIER -87.98 117.29 26.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.544 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.769 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.429 0.0 OUTLIER -121.03 148.46 44.1 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.646 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.324 26.3 ttp180 -112.64 -57.2 2.31 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -169.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.564 ' HB2' ' CE1' ' A' ' 70' ' ' TYR . 1.7 m-20 -50.23 -13.85 0.13 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 175.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.15 29.11 62.21 Favored Glycine 0 C--N 1.36 1.887 0 CA-C-N 120.475 1.488 . . . . 0.0 115.702 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.402 ' H ' ' HD1' ' A' ' 70' ' ' TYR . 32.5 m -151.99 44.34 0.73 Allowed 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 118.733 1.266 . . . . 0.0 112.949 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 67' ' ' ASP . 14.8 p90 178.99 16.75 0.0 OUTLIER 'General case' 0 C--N 1.365 1.279 0 CA-C-N 119.075 0.852 . . . . 0.0 111.97 -169.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.769 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -100.11 -33.96 10.25 Favored 'General case' 0 C--O 1.267 1.995 0 CA-C-O 122.372 1.082 . . . . 0.0 113.867 -170.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.57 ' CE3' ' HA ' ' A' ' 6' ' ' GLU 0.496 13.0 m0 -89.19 -9.62 50.14 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 116.88 -1.928 . . . . 0.0 112.447 -172.317 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -73.04 -26.66 61.38 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.356 164.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.615 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.0 mt -64.89 -38.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.37 1.462 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 171.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 78' ' ' LEU . 29.1 ttpp -57.7 -41.46 81.76 Favored 'General case' 1 C--O 1.317 4.607 0 CA-C-O 122.831 1.301 . . . . 0.0 110.829 175.422 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -57.72 -44.95 86.31 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 118.881 -1.128 . . . . 0.0 110.47 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.748 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 17.1 m-85 -62.13 -27.7 69.12 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.543 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.598 ' CD1' ' HA ' ' A' ' 75' ' ' LYS . 39.8 mt -56.19 -59.32 5.1 Favored 'General case' 0 C--O 1.275 2.446 0 CA-C-O 122.082 0.944 . . . . 0.0 109.199 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.684 HG13 ' SG ' ' A' ' 84' ' ' CYS 0.277 1.2 m -77.04 -4.43 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 C-N-CA 117.467 -1.693 . . . . 0.0 113.134 178.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.748 ' HB3' ' HA ' ' A' ' 77' ' ' PHE . 9.9 t -88.65 -14.32 37.68 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.41 171.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.567 ' HG3' ' NE1' ' A' ' 40' ' ' TRP . 78.3 mm-40 -90.44 -43.42 10.29 Favored 'General case' 0 C--N 1.38 1.892 0 C-N-CA 117.328 -1.749 . . . . 0.0 109.182 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.378 29.3 t70 -176.23 -82.52 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.662 1.226 . . . . 0.0 113.181 173.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -127.27 147.67 50.23 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 120.649 1.568 . . . . 0.0 109.399 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.684 ' SG ' HG13 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -133.51 164.49 27.04 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 178.23 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.37 -51.12 0.15 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.036 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.1 tt0 -143.19 121.22 12.09 Favored 'General case' 0 CA--C 1.496 -1.13 0 O-C-N 120.757 -1.214 . . . . 0.0 112.103 -172.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.6 m -111.83 121.69 64.78 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.871 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' MET 0.293 22.3 p -106.36 114.41 28.52 Favored 'General case' 0 N--CA 1.406 -2.675 0 C-N-CA 117.348 -1.741 . . . . 0.0 109.656 165.044 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 94' ' ' TYR . 1.5 mm? -79.59 144.72 33.58 Favored 'General case' 0 N--CA 1.407 -2.603 0 CA-C-N 110.858 -2.883 . . . . 0.0 108.138 -175.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.481 ' H ' HD13 ' A' ' 18' ' ' LEU . 40.0 tt0 -86.82 177.62 7.24 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.49 -174.96 44.49 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -102.75 110.7 22.71 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 120.497 2.148 . . . . 0.0 105.653 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 49.5 ttm 60.93 46.4 8.56 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -172.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.61 ' HA ' ' HD3' ' A' ' 97' ' ' LYS . 89.6 t80 -55.84 -42.97 98.86 Favored Pre-proline 0 CA--C 1.559 1.297 0 CA-C-N 114.304 -1.316 . . . . 0.0 114.11 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 94' ' ' TYR . 9.4 Cg_endo -55.1 -19.16 19.53 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.342 2.028 . . . . 0.0 113.578 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -102.77 11.18 56.17 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.002 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.61 ' HD3' ' HA ' ' A' ' 94' ' ' TYR . 28.3 mtpp . . . . . 0 C--O 1.255 1.391 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.438 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.59 ' HG2' ' HE2' ' A' ' 16' ' ' LYS . 31.2 Cg_exo -63.78 -41.14 25.49 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.445 2.097 . . . . 0.0 110.573 175.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.58 -56.24 1.65 Allowed Glycine 0 CA--C 1.532 1.133 0 CA-C-N 115.33 -0.85 . . . . 0.0 114.599 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 22.7 pttm -62.75 136.93 96.54 Favored Pre-proline 0 C--O 1.239 0.548 0 CA-C-N 118.362 1.081 . . . . 0.0 111.566 -175.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 92' ' ' GLN . 22.0 Cg_exo -69.25 114.63 3.69 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.5 2.133 . . . . 0.0 110.631 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.66 67.32 0.71 Allowed 'General case' 0 C--O 1.271 2.203 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.412 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 m 65.54 46.24 2.53 Favored 'General case' 0 C--N 1.38 1.893 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.421 HD11 ' CZ2' ' A' ' 72' ' ' TRP . 7.9 tp 49.94 54.05 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.392 2.435 0 C-N-CA 124.802 1.241 . . . . 0.0 109.523 -174.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.291 1.8 pp 46.95 60.21 3.53 Favored 'General case' 0 C--N 1.409 3.155 0 CA-C-O 122.849 1.309 . . . . 0.0 112.158 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . 0.306 18.6 ptpt 52.63 68.24 0.86 Allowed 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.311 -2.222 . . . . 0.0 113.415 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.576 ' O ' ' HB ' ' A' ' 12' ' ' THR . 50.0 ttm 79.98 -24.24 0.21 Allowed 'General case' 0 C--O 1.243 0.758 0 CA-C-N 113.974 -1.467 . . . . 0.0 114.112 173.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.576 ' HB ' ' O ' ' A' ' 11' ' ' MET . 15.0 t 147.93 8.06 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.367 0.667 . . . . 0.0 112.027 -170.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.678 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 7.1 tmtt? -154.35 100.24 2.27 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 117.036 -1.866 . . . . 0.0 112.731 -172.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -151.09 -97.79 0.06 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 170.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.5 71.32 0.1 OUTLIER Glycine 0 CA--C 1.56 2.893 0 CA-C-O 118.48 -1.178 . . . . 0.0 114.378 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.806 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 0.7 OUTLIER -129.57 153.93 47.56 Favored 'General case' 0 C--N 1.364 1.239 0 CA-C-N 120.007 1.904 . . . . 0.0 108.559 178.539 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.8 m -83.96 125.44 32.05 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 174.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.814 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -133.22 112.76 11.96 Favored 'General case' 0 C--O 1.19 -2.055 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.483 -175.143 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 27.4 ptm -84.04 127.62 34.01 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 119.444 -0.902 . . . . 0.0 108.762 174.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.514 ' HG3' ' CD1' ' A' ' 89' ' ' LEU . 27.3 ttm -101.06 107.91 19.48 Favored 'General case' 0 N--CA 1.424 -1.739 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.947 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -94.1 114.39 26.53 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.5 p -127.15 125.65 66.62 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -169.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.101 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 18.8 m -84.71 142.07 30.12 Favored 'General case' 0 CA--C 1.588 2.419 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.608 174.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.66 HG21 HD13 ' A' ' 36' ' ' ILE . 8.5 p -125.82 129.39 72.51 Favored 'Isoleucine or valine' 0 C--N 1.378 1.829 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.84 29.49 1.89 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 115.385 -2.526 . . . . 0.0 114.104 -166.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.44 -34.45 25.68 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 1.022 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 13.9 t-20 -116.95 121.64 32.39 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -85.43 27.28 0.61 Allowed 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 123.087 2.525 . . . . 0.0 114.067 -173.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.427 ' HB ' ' H ' ' A' ' 30' ' ' GLU . 22.4 p -144.9 -160.74 1.17 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -174.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.489 ' HA ' ' HB ' ' A' ' 33' ' ' THR . 40.4 tt0 -89.12 1.76 55.14 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.017 -177.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 5.9 tmtt? -68.08 -50.46 54.88 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.896 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 1.022 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.7 tp10 -70.82 -42.37 70.34 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 118.575 -1.25 . . . . 0.0 107.703 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 59.9 m -42.49 -51.58 4.99 Favored 'General case' 0 C--O 1.199 -1.591 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.557 171.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 13.7 pt-20 -71.89 -48.37 46.15 Favored 'General case' 0 C--O 1.252 1.22 0 O-C-N 121.781 -0.574 . . . . 0.0 112.476 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -47.69 -57.77 5.12 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.522 1.529 . . . . 0.0 107.501 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.758 HG23 ' CD2' ' A' ' 40' ' ' TRP . 14.7 mt -69.14 -43.95 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 CA-C-N 111.452 -2.613 . . . . 0.0 113.551 -176.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.595 HG21 HG23 ' A' ' 55' ' ' ILE . 19.8 p -67.5 -42.08 83.44 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 120.533 1.515 . . . . 0.0 111.315 -174.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.0 p -66.05 -55.64 15.61 Favored 'General case' 0 N--CA 1.425 -1.691 0 O-C-N 123.974 0.796 . . . . 0.0 110.138 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 tp -60.75 -46.17 91.47 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.787 ' CZ3' HD13 ' A' ' 78' ' ' LEU . 44.0 m0 -68.67 -69.97 0.3 Allowed 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.36 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.843 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.321 0.0 OUTLIER -69.31 -21.86 63.83 Favored 'General case' 0 C--O 1.255 1.377 0 C-N-CA 117.918 -1.513 . . . . 0.0 111.968 -171.462 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.11 -51.47 54.95 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 p -68.19 -32.66 73.05 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 117.191 0.495 . . . . 0.0 110.545 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.817 HD12 ' HG2' ' A' ' 53' ' ' ARG . 33.4 mt -60.53 -33.15 72.23 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.005 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.65 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 78.0 t80 -91.08 -30.13 16.92 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.991 175.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -66.06 -32.77 74.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.68 1.89 53.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.25 0.548 . . . . 0.0 109.802 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 t30 49.37 60.49 3.73 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 125.65 1.58 . . . . 0.0 112.763 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -74.02 12.63 0.67 Allowed 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 50.22 67.26 0.94 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.901 1.28 . . . . 0.0 112.517 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.616 HG23 ' HD2' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -146.88 174.23 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.245 -177.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.474 ' HB3' ' HB3' ' A' ' 64' ' ' MET . 7.9 tt0 -131.1 117.97 19.85 Favored 'General case' 0 C--O 1.191 -1.986 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.843 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -128.17 141.17 51.55 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.213 -170.261 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.79 ' H ' HG12 ' A' ' 62' ' ' ILE . 16.8 m-85 -133.72 151.96 51.76 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -168.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.595 HG23 HG21 ' A' ' 37' ' ' THR . 21.5 mt -93.03 96.64 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 167.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 60' ' ' ARG . 8.2 m -91.1 -31.25 4.95 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.535 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.33 173.73 45.68 Favored Glycine 0 CA--C 1.49 -1.493 0 C-N-CA 117.028 -2.51 . . . . 0.0 114.191 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 33.2 m -66.71 118.95 10.98 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER 85.25 9.08 0.36 Allowed 'General case' 0 C--N 1.363 1.173 0 CA-C-O 122.138 0.97 . . . . 0.0 109.129 -178.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.541 ' HB3' HG23 ' A' ' 56' ' ' VAL . 8.1 mpt_? -140.21 131.63 26.88 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.13 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.05 165.92 26.05 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.79 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -143.51 157.23 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.99 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.914 170.355 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.597 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -135.65 104.81 5.92 Favored 'General case' 0 N--CA 1.428 -1.552 0 O-C-N 126.196 2.185 . . . . 0.0 107.321 162.406 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 26.7 ttt -87.2 116.66 25.43 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.164 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.588 ' HA ' HG12 ' A' ' 51' ' ' VAL . 3.8 mp -82.88 145.55 29.37 Favored 'General case' 0 C--O 1.256 1.415 0 C-N-CA 126.077 1.751 . . . . 0.0 112.288 -175.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.298 72.3 ttt180 -110.15 -61.77 1.61 Allowed 'General case' 0 CA--C 1.587 2.395 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 175.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -57.03 -10.95 1.28 Allowed 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.806 ' HA3' ' H ' ' A' ' 16' ' ' LYS . . . 56.61 26.71 53.45 Favored Glycine 0 C--N 1.36 1.89 0 CA-C-N 119.491 1.041 . . . . 0.0 114.501 -173.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.678 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 18.0 m -143.06 38.93 1.45 Allowed 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -179.56 -176.18 0.37 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -167.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.573 ' HB1' ' CE2' ' A' ' 63' ' ' PHE . . . 98.06 -30.89 0.02 OUTLIER 'General case' 0 C--N 1.376 1.718 0 C-N-CA 126.574 1.95 . . . . 0.0 115.016 173.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.689 ' HH2' ' HG ' ' A' ' 18' ' ' LEU 0.294 17.5 m-90 -71.32 -30.17 65.89 Favored 'General case' 0 C--O 1.277 2.502 0 CA-C-O 121.794 0.807 . . . . 0.0 111.803 -177.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -66.16 -40.13 90.29 Favored 'General case' 0 C--O 1.266 1.963 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.45 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.569 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 23.3 mt -54.98 -45.83 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.05 175.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.737 ' HE3' HG21 ' A' ' 87' ' ' VAL . 12.5 tmtt? -58.8 -42.88 90.14 Favored 'General case' 0 C--O 1.266 1.954 0 CA-C-O 121.372 0.606 . . . . 0.0 110.242 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.3 -42.96 96.6 Favored 'General case' 0 C--O 1.277 2.529 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.636 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 14.5 m-85 -55.85 -45.45 78.44 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.787 HD13 ' CZ3' ' A' ' 40' ' ' TRP . 20.1 mt -58.84 -46.82 86.8 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.789 HG22 ' HB3' ' A' ' 84' ' ' CYS . 2.1 t -70.29 -20.44 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.826 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.8 t -90.55 -8.16 50.97 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -88.04 -38.39 15.5 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.317 6.6 t70 -155.02 -104.35 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.727 176.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 83' ' ' ARG . 23.5 tpt180 -143.32 84.35 1.81 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 121.115 1.78 . . . . 0.0 112.406 176.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.789 ' HB3' HG22 ' A' ' 79' ' ' VAL . 6.0 t -86.27 160.74 19.06 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.82 -40.33 0.09 Allowed 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -167.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.101 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 45.3 tt0 -126.49 116.67 21.47 Favored 'General case' 0 CA--C 1.47 -2.101 0 C-N-CA 118.187 -1.405 . . . . 0.0 109.719 -172.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.835 HG12 HD21 ' A' ' 89' ' ' LEU . 24.2 t -110.35 98.26 6.82 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.797 -175.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.56 ' C ' HD22 ' A' ' 89' ' ' LEU . 38.6 p -111.08 142.73 42.85 Favored 'General case' 0 C--O 1.261 1.692 0 CA-C-O 121.657 0.742 . . . . 0.0 111.251 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.835 HD21 HG12 ' A' ' 87' ' ' VAL . 2.9 mm? -126.67 154.69 43.73 Favored 'General case' 0 N--CA 1.405 -2.704 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.967 -166.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.429 ' H ' HD13 ' A' ' 18' ' ' LEU . 13.8 tt0 -80.9 157.99 25.44 Favored 'General case' 0 C--N 1.252 -3.667 0 CA-C-N 112.699 -2.046 . . . . 0.0 109.583 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.7 153.21 5.87 Favored Glycine 0 N--CA 1.412 -2.924 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.519 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 13.9 mm100 -87.49 123.48 32.45 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 120.796 2.298 . . . . 0.0 107.651 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 50.4 ttp 82.81 4.89 0.97 Allowed 'General case' 0 CA--C 1.544 0.734 0 O-C-N 125.034 1.459 . . . . 0.0 109.535 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.706 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -83.51 112.7 41.58 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 174.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -94.48 175.3 1.24 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.071 2.514 . . . . 0.0 112.999 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.67 -30.44 3.26 Favored Glycine 0 C--N 1.312 -0.789 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.278 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? . . . . . 0 N--CA 1.432 -1.358 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.305 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.329 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.12 -47.09 11.01 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.984 2.456 . . . . 0.0 112.032 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.41 51.35 2.72 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.508 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 21.2 ptmt -61.51 131.85 92.73 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 116.944 0.372 . . . . 0.0 111.826 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 7.8 Cg_exo -77.33 -152.87 0.04 OUTLIER 'Trans proline' 0 C--O 1.242 0.706 0 C-N-CA 123.722 2.948 . . . . 0.0 111.656 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.618 ' HA ' ' HE3' ' A' ' 72' ' ' TRP . 54.2 mt-10 82.92 8.65 0.7 Allowed 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 126.163 1.785 . . . . 0.0 108.86 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.2 p -63.86 -35.91 82.18 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.806 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.402 HG12 ' HZ3' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -53.81 -50.58 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.93 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.427 ' H ' ' HG ' ' A' ' 9' ' ' LEU 0.29 0.6 OUTLIER -88.34 -30.57 19.46 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -171.615 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -82.53 -17.19 45.88 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.383 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.7 tpp -100.95 -37.23 8.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.843 176.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -111.68 -25.88 9.29 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -164.8 110.24 0.95 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.235 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -77.56 -6.98 55.59 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.393 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 67' ' ' ASP . . . -123.33 61.61 0.57 Allowed Glycine 0 CA--C 1.55 2.234 0 CA-C-O 119.256 -0.747 . . . . 0.0 113.169 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.701 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 27.0 tptp -123.02 112.9 18.34 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 119.571 1.686 . . . . 0.0 111.776 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.8 m -65.81 125.5 25.55 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.801 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -124.74 109.03 12.61 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.371 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.619 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 22.3 ptm -96.6 102.98 14.86 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.678 ' HE3' HD11 ' A' ' 65' ' ' LEU . 7.4 ptp -114.75 135.14 54.5 Favored 'General case' 0 C--O 1.272 2.271 0 C-N-CA 116.789 -1.965 . . . . 0.0 112.83 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.542 ' HA ' HG22 ' A' ' 62' ' ' ILE . 3.6 t80 -97.46 118.52 34.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.85 2.46 . . . . 0.0 107.71 -173.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.63 124.42 70.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.801 ' HA ' ' HG3' ' A' ' 60' ' ' ARG . 83.4 m -88.81 121.32 31.05 Favored 'General case' 0 CA--C 1.605 3.06 0 C-N-CA 125.923 1.689 . . . . 0.0 112.275 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.681 HG13 ' HB2' ' A' ' 83' ' ' ARG 0.305 56.4 t -111.01 130.54 64.26 Favored 'Isoleucine or valine' 0 C--N 1.378 1.813 0 C-N-CA 127.668 2.387 . . . . 0.0 104.714 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.5 m -121.92 -5.86 9.03 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-N 122.658 2.481 . . . . 0.0 115.998 -169.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.31 -44.72 21.14 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 121.452 -0.404 . . . . 0.0 112.817 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.557 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 1.0 OUTLIER -106.07 154.16 39.75 Favored Pre-proline 0 CA--C 1.514 -0.436 0 CA-C-N 117.757 0.779 . . . . 0.0 109.271 172.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -111.12 40.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 123.883 3.056 . . . . 0.0 110.882 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.3 p -131.89 -105.08 0.26 Allowed 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.647 -0.658 . . . . 0.0 112.72 -168.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.753 ' HA ' ' O ' ' A' ' 58' ' ' SER . 30.0 tt0 -167.19 15.74 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.907 2.083 . . . . 0.0 106.669 170.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 9.5 tmtt? -86.78 -31.68 20.77 Favored 'General case' 0 C--O 1.259 1.556 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.359 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 1.003 ' HG3' HD12 ' A' ' 36' ' ' ILE . 7.1 tp10 -73.32 -44.69 58.5 Favored 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 104.303 -2.481 . . . . 0.0 104.303 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.814 ' OG1' ' HA ' ' A' ' 59' ' ' ASP . 59.6 m -44.2 -51.14 8.42 Favored 'General case' 0 C--O 1.179 -2.64 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.391 167.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.591 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.7 pt-20 -63.39 -52.33 62.09 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 119.631 1.105 . . . . 0.0 112.42 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -53.6 -60.03 3.83 Favored 'General case' 0 C--O 1.263 1.798 0 CA-C-O 123.315 1.531 . . . . 0.0 107.978 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.003 HD12 ' HG3' ' A' ' 32' ' ' GLU . 1.3 mt -60.43 -45.03 97.37 Favored 'Isoleucine or valine' 0 C--O 1.163 -3.464 0 CA-C-N 112.095 -2.32 . . . . 0.0 112.745 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.854 HG21 HG12 ' A' ' 55' ' ' ILE . 19.2 p -68.76 -34.53 75.73 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-N 121.071 1.76 . . . . 0.0 110.869 -176.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.4 m -63.06 -51.13 67.88 Favored 'General case' 0 N--CA 1.407 -2.588 0 C-N-CA 119.551 -0.859 . . . . 0.0 109.819 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.5 mp -71.71 -43.06 66.59 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.366 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.693 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 43.4 m0 -62.44 -76.58 0.06 Allowed 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 123.757 0.661 . . . . 0.0 111.251 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.634 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.323 0.0 OUTLIER -71.74 -19.66 62.01 Favored 'General case' 0 C--O 1.254 1.337 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.976 -172.386 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.58 -51.82 55.1 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.751 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 32.0 t -72.47 -25.29 61.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.816 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 31.1 mt -62.78 -34.37 77.11 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.81 0.338 . . . . 0.0 110.242 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.568 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 70.8 t80 -91.24 -24.43 19.89 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.926 175.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.751 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 8.1 t30 -67.24 -31.62 72.1 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.698 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.22 5.08 48.79 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.271 0.558 . . . . 0.0 109.583 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.5 t30 46.67 55.39 7.74 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.516 1.927 . . . . 0.0 112.905 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -67.51 1.6 2.25 Favored 'General case' 0 CA--C 1.594 2.661 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t70 56.58 69.48 0.74 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.188 1.395 . . . . 0.0 110.951 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.86 HG12 ' HA ' ' A' ' 65' ' ' LEU . 6.7 m -147.44 176.06 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.629 -172.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.535 ' O ' ' HB3' ' A' ' 64' ' ' MET . 37.2 tt0 -133.78 126.23 30.19 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.816 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -134.69 140.78 46.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 108.784 -170.666 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.71 ' H ' HG12 ' A' ' 62' ' ' ILE . 38.1 m-85 -133.8 153.15 51.93 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 -166.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.854 HG12 HG21 ' A' ' 37' ' ' THR . 76.6 mt -86.42 112.42 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 166.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.8 m -130.12 -26.68 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -171.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.77 ' HA3' ' HB2' ' A' ' 60' ' ' ARG . . . -138.41 174.83 21.79 Favored Glycine 0 CA--C 1.48 -2.127 0 C-N-CA 118.643 -1.741 . . . . 0.0 112.058 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.753 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 5.2 m -39.02 -71.1 0.09 Allowed 'General case' 0 C--N 1.367 1.364 0 O-C-N 125.654 1.444 . . . . 0.0 109.417 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.814 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 21.4 m-20 -126.64 65.55 1.26 Allowed 'General case' 1 N--CA 1.363 -4.775 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 168.72 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.801 ' HG3' ' HA ' ' A' ' 23' ' ' THR . 4.1 mpt_? -134.18 137.0 44.14 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 112.896 -1.956 . . . . 0.0 108.823 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.56 169.59 17.06 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.71 HG12 ' H ' ' A' ' 54' ' ' PHE . 9.8 pt -136.56 157.64 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.065 0 C-N-CA 118.472 -1.291 . . . . 0.0 109.553 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.504 ' HZ ' ' HB2' ' A' ' 75' ' ' LYS 0.28 6.7 p90 -125.81 109.38 12.47 Favored 'General case' 0 N--CA 1.408 -2.55 0 O-C-N 126.394 2.309 . . . . 0.0 107.909 164.159 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.591 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 21.4 ttt -100.04 104.5 16.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.416 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.931 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.34 0.0 OUTLIER -99.75 147.15 25.75 Favored 'General case' 0 CA--C 1.462 -2.405 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.041 -178.962 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.367 20.8 ttp180 -105.13 -68.61 0.85 Allowed 'General case' 0 C--N 1.264 -3.147 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -164.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.937 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 37.4 t70 -44.48 -24.51 0.19 Allowed 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.701 ' HA3' ' H ' ' A' ' 16' ' ' LYS . . . 69.78 12.29 67.36 Favored Glycine 0 C--N 1.366 2.196 0 CA-C-N 120.224 1.374 . . . . 0.0 115.996 -175.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.4 t -121.38 32.53 5.87 Favored 'General case' 0 CA--C 1.563 1.463 0 CA-C-N 118.649 1.224 . . . . 0.0 111.905 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.937 ' HE1' ' HB3' ' A' ' 67' ' ' ASP . 45.0 p90 175.13 137.96 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -174.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.931 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 169.27 -33.3 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.881 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.687 ' CZ2' HD13 ' A' ' 89' ' ' LEU 0.622 10.5 m0 -82.5 -11.73 58.28 Favored 'General case' 0 C--O 1.263 1.778 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 -168.359 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 43.6 tt0 -74.08 -36.82 64.32 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 170.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 63.9 mt -55.11 -46.29 77.44 Favored 'Isoleucine or valine' 0 C--O 1.278 2.565 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB2' ' HD1' ' A' ' 72' ' ' TRP . 13.9 tmtt? -56.73 -48.97 76.58 Favored 'General case' 0 C--O 1.282 2.793 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.124 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.31 -47.39 83.84 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.211 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.468 ' CZ ' ' HG2' ' A' ' 73' ' ' GLU . 15.8 m-85 -52.59 -53.75 42.37 Favored 'General case' 0 C--N 1.371 1.54 0 O-C-N 123.73 0.644 . . . . 0.0 109.661 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.684 HD13 ' CE3' ' A' ' 40' ' ' TRP . 14.0 mt -60.46 -55.06 38.03 Favored 'General case' 0 C--O 1.302 3.816 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 75' ' ' LYS 0.308 27.4 m -78.29 -5.7 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 C-N-CA 117.986 -1.486 . . . . 0.0 113.217 -174.175 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.7 m -108.47 5.1 24.94 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.726 165.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 47.4 tp60 -82.26 -45.1 15.46 Favored 'General case' 0 CA--C 1.456 -2.643 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.391 4.6 p30 -163.72 -94.14 0.02 OUTLIER 'General case' 0 C--O 1.245 0.863 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 175.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.681 ' HB2' HG13 ' A' ' 24' ' ' VAL . 21.2 mmt180 -91.22 129.77 37.17 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.406 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 11.8 p -150.71 152.17 33.51 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.677 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.79 -36.71 0.1 Allowed 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 123.301 0.64 . . . . 0.0 110.316 170.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.687 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 41.2 tt0 -154.29 129.95 10.0 Favored 'General case' 0 C--O 1.207 -1.135 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.647 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.509 HG12 ' CD2' ' A' ' 89' ' ' LEU . 58.6 t -117.4 98.32 6.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 171.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.497 HG21 ' HD3' ' A' ' 97' ' ' LYS . 16.9 p -100.01 136.14 40.38 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 122.708 1.242 . . . . 0.0 111.848 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.801 ' HB3' HD11 ' A' ' 18' ' ' LEU . 6.8 mt -108.08 155.3 20.54 Favored 'General case' 0 N--CA 1.398 -3.053 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.078 -168.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.619 ' HB2' ' O ' ' A' ' 19' ' ' MET . 1.9 tm-20 -82.15 144.9 30.42 Favored 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.424 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -179.88 170.2 41.33 Favored Glycine 0 C--N 1.276 -2.75 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -81.72 109.26 15.97 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 121.353 2.577 . . . . 0.0 105.999 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 56.6 ttp 53.92 55.69 8.06 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -173.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 40.4 t80 -58.38 125.63 76.22 Favored Pre-proline 0 C--O 1.248 1.008 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.565 -176.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.98 102.66 1.63 Allowed 'Trans proline' 0 C--O 1.249 1.035 0 C-N-CA 122.733 2.289 . . . . 0.0 111.329 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 166.27 -11.17 0.07 OUTLIER Glycine 0 C--N 1.301 -1.407 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.822 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.497 ' HD3' HG21 ' A' ' 88' ' ' THR . 51.1 tptt . . . . . 0 N--CA 1.428 -1.541 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.622 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.74 -29.19 19.55 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.292 1.995 . . . . 0.0 112.591 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 85.3 -1.74 88.42 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.45 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -114.34 146.67 36.32 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.08 119.38 6.47 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.022 1.815 . . . . 0.0 110.012 175.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -78.34 10.87 2.72 Favored 'General case' 0 C--O 1.27 2.178 0 C-N-CA 123.151 0.581 . . . . 0.0 111.627 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.3 m 62.07 46.92 6.07 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.459 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.42 ' C ' ' HG ' ' A' ' 9' ' ' LEU . 5.5 tt 46.97 54.1 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.394 2.511 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.824 ' HB3' ' HB3' ' A' ' 16' ' ' LYS 0.317 3.3 pp 57.15 68.56 0.84 Allowed 'General case' 0 C--N 1.379 1.884 0 CA-C-O 122.965 1.364 . . . . 0.0 113.237 178.401 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 13' ' ' LYS 0.293 18.7 ptpt 51.26 61.58 3.16 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.476 -1.693 . . . . 0.0 115.086 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 49.4 ttm 67.53 37.51 3.38 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.584 0.753 . . . . 0.0 110.543 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 m 71.34 36.66 1.3 Allowed 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.427 0.632 . . . . 0.0 110.803 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.54 ' HB2' ' HG3' ' A' ' 10' ' ' LYS . 56.8 mtpt -91.74 -98.44 0.12 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.04 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -155.42 -172.28 4.1 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 118.053 0.388 . . . . 0.0 110.429 -175.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.32 -51.53 1.4 Allowed Glycine 0 C--N 1.356 1.644 0 N-CA-C 115.24 0.856 . . . . 0.0 115.24 172.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.824 ' HB3' ' HB3' ' A' ' 9' ' ' LEU . 49.6 tptt -83.78 135.93 34.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 118.215 1.007 . . . . 0.0 111.54 -176.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.617 HG23 ' HD2' ' A' ' 66' ' ' ARG . 30.3 m -69.73 115.16 8.65 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.032 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -110.96 102.9 11.34 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.853 1.311 . . . . 0.0 108.365 -176.433 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.813 ' H ' ' HB2' ' A' ' 90' ' ' GLU . 6.2 ttt -84.84 119.62 25.53 Favored 'General case' 0 C--N 1.27 -2.859 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.737 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.509 ' HB2' ' HE2' ' A' ' 20' ' ' MET . 26.0 ttm -110.46 110.04 20.64 Favored 'General case' 0 N--CA 1.415 -2.215 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.077 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -91.77 115.93 28.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -128.72 130.69 68.82 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -169.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.073 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 18.3 m -84.9 143.63 28.89 Favored 'General case' 0 CA--C 1.604 3.034 0 O-C-N 124.77 1.294 . . . . 0.0 110.946 174.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.527 HG21 HD13 ' A' ' 36' ' ' ILE 0.288 6.9 t -126.74 135.48 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.66 0 C-N-CA 130.069 3.348 . . . . 0.0 104.326 -176.287 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -117.13 -21.26 8.92 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-N 122.921 2.601 . . . . 0.0 117.062 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.05 -45.19 62.66 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.021 0.828 . . . . 0.0 114.217 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.859 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.5 t-20 -116.18 116.82 39.56 Favored Pre-proline 0 N--CA 1.433 -1.313 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -88.36 30.84 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.901 2.401 . . . . 0.0 113.147 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 p -139.1 -174.84 3.96 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.531 ' O ' ' HB ' ' A' ' 33' ' ' THR . 32.7 tt0 -77.27 0.37 22.31 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.573 0.624 . . . . 0.0 111.727 -173.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -68.26 -43.35 78.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 122.049 -0.407 . . . . 0.0 110.601 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.859 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.7 OUTLIER -71.29 -39.32 71.58 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 118.086 -1.445 . . . . 0.0 108.314 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 61.1 m -45.04 -54.21 6.91 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 124.407 1.083 . . . . 0.0 111.482 172.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.63 -43.02 70.1 Favored 'General case' 0 C--O 1.265 1.882 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -52.72 -55.32 23.55 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.644 HG23 ' CE3' ' A' ' 40' ' ' TRP . 27.3 mt -62.59 -35.68 71.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.549 0 CA-C-N 112.574 -2.103 . . . . 0.0 112.932 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.2 m -61.77 -55.18 32.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.399 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.452 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 34.2 m -65.54 -48.51 72.19 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.592 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.0 -57.22 8.27 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.112 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.682 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 36.4 m0 -69.22 -74.03 0.14 Allowed 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.248 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.675 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.405 0.0 OUTLIER -72.05 -15.74 62.03 Favored 'General case' 0 C--O 1.253 1.28 0 C-N-CA 116.957 -1.897 . . . . 0.0 112.773 -168.01 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 38' ' ' SER . . . -67.23 -51.3 39.15 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 171.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 39.9 t -70.32 -27.47 64.39 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.795 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 16.2 mt -64.2 -28.71 69.93 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.038 0.447 . . . . 0.0 110.075 177.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.562 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 75.9 t80 -94.31 -28.44 15.57 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.108 0.48 . . . . 0.0 110.43 174.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 20.8 t-20 -72.79 -29.73 63.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -176.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.96 11.94 19.01 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.5 44.62 9.95 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.751 1.62 . . . . 0.0 114.158 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -82.3 151.41 26.76 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.92 87.62 7.36 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.726 1.603 . . . . 0.0 110.503 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.866 HG12 ' HA ' ' A' ' 65' ' ' LEU . 3.1 m -147.89 175.53 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.955 -173.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.448 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 26.8 tt0 -140.02 123.29 16.92 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.795 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -136.07 135.89 39.74 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -170.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.815 ' H ' HG12 ' A' ' 62' ' ' ILE . 16.7 m-85 -134.46 153.99 51.63 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -165.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 80.2 mt -80.03 124.75 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 165.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.98 -15.46 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 120.83 0.348 . . . . 0.0 110.739 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.524 ' HA3' ' HG2' ' A' ' 60' ' ' ARG . . . -166.32 163.64 37.03 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 118.051 -2.023 . . . . 0.0 113.905 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.478 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 37.3 m -77.91 45.85 0.54 Allowed 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 124.668 1.187 . . . . 0.0 111.579 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 58' ' ' SER . 3.1 p-10 158.63 14.92 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.745 0 C-N-CA 126.904 2.082 . . . . 0.0 106.496 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.524 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -149.02 147.76 28.93 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-O 121.669 0.747 . . . . 0.0 112.344 177.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.45 169.88 16.84 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 125.736 1.614 . . . . 0.0 106.874 -172.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.815 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.7 pt -136.19 157.82 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.778 0 C-N-CA 118.377 -1.329 . . . . 0.0 109.559 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.557 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -134.33 109.23 8.67 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 126.434 2.334 . . . . 0.0 106.362 162.411 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.594 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 23.3 ttt -97.83 108.96 21.79 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.347 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.919 HD13 ' HB2' ' A' ' 71' ' ' ALA 0.306 2.3 pt? -98.47 147.94 24.23 Favored 'General case' 0 CA--C 1.464 -2.359 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -176.127 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.617 ' HD2' HG23 ' A' ' 17' ' ' THR 0.26 12.6 mmm180 -100.28 -53.41 3.13 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 111.578 -2.555 . . . . 0.0 113.576 -174.017 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -45.47 -27.46 0.72 Allowed 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.95 -31.31 5.37 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 119.663 1.12 . . . . 0.0 111.936 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.261 40.6 t -98.17 -61.61 1.36 Allowed 'General case' 0 CA--C 1.588 2.43 0 N-CA-C 118.29 2.7 . . . . 0.0 118.29 -175.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.479 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -64.42 34.46 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 -168.62 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.919 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -103.16 -22.47 13.74 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.772 ' HH2' ' HG ' ' A' ' 18' ' ' LEU 0.504 13.6 m-90 -82.16 -28.93 31.84 Favored 'General case' 0 C--O 1.284 2.921 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -170.259 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.15 -27.57 63.64 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.655 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.8 mt -62.22 -39.97 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.759 ' HA ' ' CD1' ' A' ' 78' ' ' LEU . 26.2 ttpp -58.54 -43.3 89.21 Favored 'General case' 0 C--O 1.288 3.089 0 CA-C-O 121.445 0.641 . . . . 0.0 110.595 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.41 -45.96 80.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.209 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.655 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 10.0 m-85 -60.38 -39.71 88.22 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.321 -177.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.759 ' CD1' ' HA ' ' A' ' 75' ' ' LYS 0.275 21.5 mt -52.46 -59.74 4.07 Favored 'General case' 0 CA--C 1.45 -2.877 0 C-N-CA 123.077 0.551 . . . . 0.0 110.205 177.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.825 HG22 ' HB3' ' A' ' 84' ' ' CYS . 1.6 t -77.94 -9.26 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.684 -172.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.2 t -92.83 -12.24 31.62 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.615 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -107.15 -39.11 5.81 Favored 'General case' 0 CA--C 1.473 -1.989 0 C-N-CA 117.799 -1.56 . . . . 0.0 108.637 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -141.43 -169.45 2.87 Favored 'General case' 0 N--CA 1.389 -3.488 0 CA-C-N 113.419 -1.719 . . . . 0.0 107.06 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -108.32 76.92 1.06 Allowed 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 119.905 1.23 . . . . 0.0 110.645 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.825 ' HB3' HG22 ' A' ' 79' ' ' VAL . 3.8 t -70.49 157.53 37.68 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 113.518 -1.673 . . . . 0.0 109.645 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.75 -35.59 0.09 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.073 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.4 tt0 -135.51 125.22 25.38 Favored 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.42 -171.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.438 ' HB ' HD21 ' A' ' 89' ' ' LEU . 18.7 m -123.26 113.12 36.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.42 ' C ' HD23 ' A' ' 89' ' ' LEU . 3.4 p -107.31 128.27 54.29 Favored 'General case' 0 CA--C 1.477 -1.831 0 CA-C-O 122.36 1.076 . . . . 0.0 109.841 168.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.032 ' HB3' HD11 ' A' ' 18' ' ' LEU . 3.3 mt -109.41 158.6 17.77 Favored 'General case' 0 C--N 1.259 -3.366 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.731 -168.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.813 ' HB2' ' H ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -78.38 146.92 34.34 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 123.733 0.645 . . . . 0.0 109.754 -172.006 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.04 101.99 2.47 Favored Glycine 0 N--CA 1.408 -3.214 0 N-CA-C 107.234 -2.346 . . . . 0.0 107.234 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -59.4 110.88 1.19 Allowed 'General case' 0 C--N 1.378 1.815 0 CA-C-N 121.031 2.416 . . . . 0.0 108.667 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 55.2 ttm 58.46 69.17 0.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 124.43 1.081 . . . . 0.0 108.664 -170.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.658 ' CE2' HD12 ' A' ' 89' ' ' LEU . 11.7 p90 -71.12 -38.65 7.24 Favored Pre-proline 0 CA--C 1.568 1.663 0 CA-C-N 113.78 -1.554 . . . . 0.0 114.645 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.462 ' HD3' ' CD1' ' A' ' 94' ' ' TYR . 42.9 Cg_endo -102.0 -173.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.118 1.879 . . . . 0.0 111.537 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.38 -4.74 28.21 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.97 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.564 ' C ' ' HE3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.556 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 CA--C 1.506 -0.493 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 1' ' ' GLY . 27.0 Cg_exo -64.08 -22.64 67.65 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.464 2.776 . . . . 0.0 113.129 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.936 ' HA3' ' HA ' ' A' ' 95' ' ' PRO . . . -126.02 31.12 4.17 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.425 ' HG2' ' HD2' ' A' ' 5' ' ' PRO . 87.3 tttt -107.84 154.64 40.89 Favored Pre-proline 0 C--O 1.255 1.351 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.425 ' HD2' ' HG2' ' A' ' 4' ' ' LYS . 46.7 Cg_exo -44.74 146.17 2.43 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.545 2.83 . . . . 0.0 113.254 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HA ' ' HG ' ' A' ' 9' ' ' LEU . 25.2 mm-40 73.09 -46.42 0.65 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.08 1.352 . . . . 0.0 113.016 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.9 m -69.52 -29.47 67.08 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 121.181 -0.949 . . . . 0.0 109.851 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.604 HG13 ' CZ3' ' A' ' 72' ' ' TRP . 0.6 OUTLIER -71.33 -38.76 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.095 176.532 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.9 HD22 ' HA ' ' A' ' 69' ' ' SER . 3.4 pp -79.48 -11.08 59.91 Favored 'General case' 0 C--O 1.2 -1.532 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.937 178.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -92.95 -23.96 18.56 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.397 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.0 ttt -78.51 -31.18 47.51 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.382 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -98.46 -19.35 17.73 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.018 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 75.72 169.28 0.27 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.885 1.274 . . . . 0.0 111.885 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.624 ' HE2' ' HB2' ' A' ' 69' ' ' SER . 37.9 ttmt -75.84 142.64 42.15 Favored 'General case' 0 CA--C 1.577 1.999 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.659 ' H ' ' HA3' ' A' ' 68' ' ' GLY . . . 134.22 -54.38 0.76 Allowed Glycine 0 CA--C 1.556 2.621 0 C-N-CA 118.185 -1.96 . . . . 0.0 115.697 -175.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -67.07 133.59 50.17 Favored 'General case' 0 C--N 1.364 1.198 0 CA-C-N 120.222 2.011 . . . . 0.0 112.488 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -78.61 124.27 27.99 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.813 ' HB3' HD22 ' A' ' 65' ' ' LEU . 25.6 tp -131.2 115.4 16.3 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.008 -174.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.678 ' HB3' ' SD ' ' A' ' 64' ' ' MET . 20.0 ptm -84.31 105.99 15.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.602 0.715 . . . . 0.0 112.282 176.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.831 ' HG3' ' HA ' ' A' ' 89' ' ' LEU . 3.6 mpp? -86.29 125.22 33.44 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.554 0.692 . . . . 0.0 112.261 176.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.635 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 47.2 t80 -106.06 112.92 26.17 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 127.246 2.218 . . . . 0.0 106.116 -176.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.78 130.36 74.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -168.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.848 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 89.5 m -93.05 131.14 38.32 Favored 'General case' 0 CA--C 1.611 3.295 0 C-N-CA 126.151 1.781 . . . . 0.0 111.883 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.6 t -132.14 113.44 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.358 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -105.77 -18.98 13.89 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 122.01 2.187 . . . . 0.0 115.185 -164.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.45 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . -39.17 -49.08 2.78 Favored Glycine 0 N--CA 1.487 2.035 0 O-C-N 123.419 0.449 . . . . 0.0 113.612 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 1.08 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 26.9 t-20 -115.86 104.74 52.35 Favored Pre-proline 0 N--CA 1.421 -1.881 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.14 33.74 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 123.888 3.059 . . . . 0.0 112.71 -174.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -148.43 -165.27 2.23 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.475 ' O ' ' HB ' ' A' ' 33' ' ' THR . 39.6 tt0 -81.05 -18.47 46.57 Favored 'General case' 0 C--O 1.19 -2.039 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -173.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.46 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 3.4 tmtt? -58.96 -41.25 87.03 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-N 119.032 0.833 . . . . 0.0 111.491 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 1.08 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 5.9 tp10 -66.42 -61.49 1.97 Allowed 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 31.5 m -34.35 -50.25 0.41 Allowed 'General case' 0 C--O 1.19 -2.073 0 C-N-CA 127.158 2.183 . . . . 0.0 113.026 172.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.8 pt-20 -71.99 -49.66 35.26 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 118.124 0.42 . . . . 0.0 112.031 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -54.24 -54.15 43.89 Favored 'General case' 0 C--O 1.263 1.801 0 CA-C-O 123.045 1.402 . . . . 0.0 107.296 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.041 HD12 ' HG3' ' A' ' 32' ' ' GLU . 1.5 mt -66.83 -38.99 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.584 0 CA-C-N 111.622 -2.536 . . . . 0.0 113.541 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.744 HG21 HG12 ' A' ' 55' ' ' ILE . 11.3 p -73.82 -39.3 64.16 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-N 121.3 1.864 . . . . 0.0 110.946 -176.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.0 t -64.22 -47.83 78.2 Favored 'General case' 0 N--CA 1.412 -2.344 0 O-C-N 124.017 0.823 . . . . 0.0 109.659 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.4 tp -68.75 -44.37 73.9 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.765 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.827 ' CE3' HD12 ' A' ' 78' ' ' LEU . 48.8 m0 -66.2 -74.02 0.12 Allowed 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 118.952 -0.547 . . . . 0.0 111.708 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.693 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.339 0.0 OUTLIER -70.83 -19.29 62.68 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 118.044 -1.462 . . . . 0.0 111.884 -172.601 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.03 -48.91 65.57 Favored Glycine 0 C--N 1.356 1.646 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 172.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.6 p -70.0 -29.63 66.75 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 117.442 0.621 . . . . 0.0 110.25 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.743 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 22.8 mt -61.07 -32.49 72.13 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.003 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.651 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 80.5 t80 -92.11 -27.38 17.78 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.873 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -67.89 -30.67 70.08 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 120.629 0.252 . . . . 0.0 111.004 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.69 -0.01 56.24 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.6 t30 47.17 53.87 10.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.136 1.774 . . . . 0.0 112.006 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -65.58 0.69 1.5 Allowed 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.9 t70 59.3 70.87 0.61 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.305 1.042 . . . . 0.0 111.365 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.54 ' CG2' ' HD2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -146.92 175.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.919 -172.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -131.04 115.92 17.09 Favored 'General case' 0 C--O 1.194 -1.828 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.743 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -130.41 140.77 50.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -172.279 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.812 ' H ' HG12 ' A' ' 62' ' ' ILE . 24.4 m-85 -134.02 152.06 51.69 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.744 HG12 HG21 ' A' ' 37' ' ' THR . 19.9 mt -92.65 97.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 167.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 m -99.1 -22.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.84 169.03 40.81 Favored Glycine 0 CA--C 1.482 -1.975 0 C-N-CA 118.192 -1.956 . . . . 0.0 113.78 175.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.468 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 36.9 m -65.04 120.4 12.57 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.0 OUTLIER 78.79 14.76 1.19 Allowed 'General case' 0 C--N 1.371 1.541 0 CA-C-O 122.658 1.218 . . . . 0.0 108.823 -178.613 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.635 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 4.1 tpp85 -143.84 117.49 9.23 Favored 'General case' 0 CA--C 1.557 1.236 0 O-C-N 121.419 -0.8 . . . . 0.0 111.266 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.96 166.44 20.06 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -175.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.812 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -138.77 155.23 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.461 -2.464 0 C-N-CA 118.174 -1.41 . . . . 0.0 109.699 172.785 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.521 ' CE2' ' HB1' ' A' ' 71' ' ' ALA . 6.0 p90 -134.97 106.37 6.8 Favored 'General case' 0 N--CA 1.417 -2.093 0 O-C-N 126.335 2.272 . . . . 0.0 107.307 163.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.678 ' SD ' ' HB3' ' A' ' 19' ' ' MET . 20.2 ttt -92.15 110.22 21.6 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.45 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.813 HD22 ' HB3' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -75.12 132.38 41.18 Favored 'General case' 0 C--O 1.254 1.313 0 O-C-N 125.895 1.997 . . . . 0.0 110.952 -175.672 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.318 2.1 tmt_? -108.41 -54.95 2.44 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -41.24 -34.16 0.45 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.659 ' HA3' ' H ' ' A' ' 15' ' ' GLY . . . 109.09 -31.1 7.97 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 117.723 -2.18 . . . . 0.0 115.079 -173.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.9 ' HA ' HD22 ' A' ' 9' ' ' LEU . 56.9 m -158.66 60.17 0.43 Allowed 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -171.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.457 ' OH ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -152.81 21.38 0.6 Allowed 'General case' 0 C--O 1.218 -0.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.174 178.602 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.603 ' O ' ' HB ' ' A' ' 74' ' ' ILE . . . -103.19 -29.27 11.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -168.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.604 ' CZ3' HG13 ' A' ' 8' ' ' ILE 0.512 8.1 m0 -87.18 -9.93 53.95 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 116.317 -2.153 . . . . 0.0 113.828 -171.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.566 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 35.0 tt0 -73.42 -43.12 61.1 Favored 'General case' 0 C--O 1.279 2.653 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 166.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 61.0 mt -50.77 -47.0 29.36 Favored 'Isoleucine or valine' 0 C--O 1.278 2.578 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.801 173.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.613 ' HG3' HG21 ' A' ' 87' ' ' VAL . 44.8 tttm -56.11 -50.61 70.58 Favored 'General case' 0 C--N 1.375 1.688 0 C-N-CA 125.807 1.643 . . . . 0.0 110.269 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -61.86 -25.64 67.65 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.566 ' CZ ' ' HG2' ' A' ' 73' ' ' GLU . 23.1 m-85 -73.76 -61.14 1.94 Allowed 'General case' 0 CA--C 1.48 -1.726 0 C-N-CA 118.382 -1.327 . . . . 0.0 108.35 -175.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.827 HD12 ' CE3' ' A' ' 40' ' ' TRP . 1.9 pt? -66.52 -32.71 74.23 Favored 'General case' 0 C--O 1.297 3.583 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.001 -173.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.837 HG13 ' HB2' ' A' ' 84' ' ' CYS . 54.9 t -77.3 -21.55 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.414 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.6 m -103.54 6.76 37.56 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.209 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.625 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . 6.2 tp-100 -77.3 -46.18 23.85 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.455 2.3 p30 -165.26 -94.55 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 171.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG2' ' HA3' ' A' ' 26' ' ' GLY . 4.7 mpt_? -84.7 136.52 33.69 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 117.935 -1.506 . . . . 0.0 111.899 -174.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.837 ' HB2' HG13 ' A' ' 79' ' ' VAL . 7.9 p -152.66 150.84 29.9 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.403 -170.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.06 -41.15 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.848 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 7.6 tp10 -153.81 137.59 16.17 Favored 'General case' 0 C--O 1.21 -1.013 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.35 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.613 HG21 ' HG3' ' A' ' 75' ' ' LYS . 48.7 t -131.68 94.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.332 0.8 OUTLIER -98.19 126.32 43.61 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-O 123.603 1.668 . . . . 0.0 113.006 176.356 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.831 ' HA ' ' HG3' ' A' ' 20' ' ' MET . 3.0 mp -75.88 155.34 35.35 Favored 'General case' 1 N--CA 1.374 -4.274 0 CA-C-N 111.223 -2.717 . . . . 0.0 106.16 178.065 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.691 ' HB3' ' CD1' ' A' ' 18' ' ' LEU . 11.8 tp10 -81.67 159.8 23.88 Favored 'General case' 0 C--N 1.266 -3.022 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.91 57.05 3.34 Favored Glycine 0 N--CA 1.422 -2.238 0 CA-C-O 118.569 -1.129 . . . . 0.0 112.265 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.537 ' HA ' ' OE1' ' A' ' 92' ' ' GLN . 9.9 mm-40 -52.83 110.15 0.49 Allowed 'General case' 0 C--N 1.368 1.386 0 CA-C-N 118.784 1.292 . . . . 0.0 111.65 176.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 27.7 ttt 165.41 -25.48 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.737 -2.029 . . . . 0.0 106.222 -172.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.52 ' CD1' ' HD3' ' A' ' 95' ' ' PRO 0.295 23.5 p90 -50.57 -39.26 49.61 Favored Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 116.885 2.179 . . . . 0.0 116.885 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.936 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -78.37 -18.09 12.63 Favored 'Trans proline' 0 C--N 1.377 2.04 0 CA-C-N 121.968 1.739 . . . . 0.0 111.301 177.674 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 122.44 -133.48 9.25 Favored Glycine 0 N--CA 1.406 -3.347 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -173.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt . . . . . 0 C--N 1.293 -1.862 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.962 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.882 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -64.09 -23.02 67.42 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.964 2.442 . . . . 0.0 112.276 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.09 35.86 3.23 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 19.5 pttp -71.49 139.37 83.93 Favored Pre-proline 0 C--O 1.238 0.49 0 C-N-CA 123.777 0.831 . . . . 0.0 110.492 177.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.56 ' C ' ' H ' ' A' ' 7' ' ' SER . 5.7 Cg_exo -76.33 -158.64 0.08 OUTLIER 'Trans proline' 0 C--O 1.251 1.165 0 C-N-CA 122.622 2.215 . . . . 0.0 112.935 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 71.72 -39.15 0.44 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.565 1.546 . . . . 0.0 107.259 -160.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.56 ' H ' ' C ' ' A' ' 5' ' ' PRO . 8.8 t -76.58 170.95 15.46 Favored 'General case' 0 N--CA 1.383 -3.78 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 173.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.11 HG23 ' HA ' ' A' ' 11' ' ' MET 0.297 8.7 tp 30.47 42.06 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.269 2.126 0 CA-C-O 121.886 0.851 . . . . 0.0 110.716 -157.31 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.868 HD13 ' HA ' ' A' ' 13' ' ' LYS . 1.7 pp 52.02 69.38 0.68 Allowed 'General case' 0 C--N 1.412 3.292 0 CA-C-O 122.925 1.345 . . . . 0.0 111.906 171.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 9' ' ' LEU 0.277 22.6 ptmt 61.9 28.21 17.19 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.611 -2.086 . . . . 0.0 112.098 -175.575 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . 1.11 ' HA ' HG23 ' A' ' 8' ' ' ILE . 53.2 ttm 56.32 26.79 10.99 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.441 1.096 . . . . 0.0 110.251 -178.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -161.97 -65.67 0.05 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.949 -1.094 . . . . 0.0 112.088 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.868 ' HA ' HD13 ' A' ' 9' ' ' LEU . 40.6 ttmt 174.94 116.24 0.02 OUTLIER 'General case' 0 C--N 1.352 0.705 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -171.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.69 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 65.8 pttt -166.46 168.63 14.64 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 67' ' ' ASP . . . -67.79 43.94 0.28 Allowed Glycine 0 CA--C 1.546 1.971 0 N-CA-C 116.291 1.277 . . . . 0.0 116.291 -176.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.723 ' HB3' ' HB3' ' A' ' 9' ' ' LEU . 17.0 tppt? -83.47 133.77 34.88 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 118.76 1.28 . . . . 0.0 109.401 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -85.44 130.76 34.51 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.337 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.691 HD12 ' HH2' ' A' ' 72' ' ' TRP . 94.4 mt -130.91 123.84 29.82 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.422 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 22.0 ptm -84.54 107.5 16.81 Favored 'General case' 0 C--N 1.265 -3.079 0 C-N-CA 118.57 -1.252 . . . . 0.0 108.31 170.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.723 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 32.1 ttm -87.91 104.44 16.61 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 118.135 -1.426 . . . . 0.0 110.187 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -91.6 112.41 24.32 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.576 1.95 . . . . 0.0 106.298 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 p -129.04 132.69 67.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -168.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.993 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 70.9 m -80.39 128.38 33.5 Favored 'General case' 0 CA--C 1.595 2.69 0 C-N-CA 125.429 1.492 . . . . 0.0 109.267 173.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.4 p -110.93 138.34 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.606 3.113 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.991 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 85.7 p 52.64 -74.94 0.01 OUTLIER 'General case' 0 C--N 1.368 1.401 0 C-N-CA 126.481 1.913 . . . . 0.0 115.936 -169.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.68 -14.38 2.22 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -171.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -96.61 120.46 62.01 Favored Pre-proline 0 N--CA 1.42 -1.969 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.631 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 74.4 Cg_endo -73.71 41.66 0.64 Allowed 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 123.49 2.793 . . . . 0.0 112.485 -175.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.6 p -110.52 170.39 8.12 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.52 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.1 tp10 -81.47 -15.44 55.03 Favored 'General case' 0 C--O 1.17 -3.099 0 CA-C-N 119.934 1.243 . . . . 0.0 109.793 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.757 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 1.3 tmtt? -48.92 -63.6 1.05 Allowed 'General case' 0 C--O 1.269 2.122 0 C-N-CA 125.19 1.396 . . . . 0.0 114.534 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.991 ' HG2' ' HB3' ' A' ' 25' ' ' SER . 4.6 tp10 -67.76 -45.16 75.68 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -172.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 15.5 m -45.2 -58.56 3.17 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 112.071 -2.331 . . . . 0.0 109.689 172.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.757 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 10.8 pt-20 -58.38 -50.86 72.14 Favored 'General case' 0 C--O 1.26 1.61 0 C-N-CA 123.788 0.835 . . . . 0.0 112.751 -172.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.87 ' HG3' HG13 ' A' ' 36' ' ' ILE . 5.9 pt-20 -66.86 -47.67 71.2 Favored 'General case' 0 C--O 1.269 2.082 0 C-N-CA 117.959 -1.496 . . . . 0.0 109.626 -175.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.87 HG13 ' HG3' ' A' ' 35' ' ' GLU . 9.4 mt -76.05 -34.72 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.378 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.145 -172.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' A' ' 40' ' ' TRP . 44.7 p -68.61 -33.61 74.35 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 118.658 0.663 . . . . 0.0 110.82 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 m -63.16 -45.18 93.08 Favored 'General case' 0 C--O 1.258 1.53 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.57 -38.76 92.34 Favored 'General case' 0 C--N 1.378 1.805 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.769 ' HE1' ' HB3' ' A' ' 78' ' ' LEU . 14.1 m0 -65.67 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.248 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.697 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.384 0.0 OUTLIER -70.83 -14.26 62.34 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 117.992 -1.483 . . . . 0.0 112.357 -169.08 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.29 -53.04 38.8 Favored Glycine 0 C--N 1.366 2.243 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.549 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 80.5 p -72.32 -30.28 64.61 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.314 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.811 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 21.5 mt -62.44 -29.5 70.56 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.471 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.598 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 21.3 t80 -92.09 -30.86 15.77 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 24.7 t-20 -66.47 -34.83 78.81 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.153 0.581 . . . . 0.0 112.03 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.85 -1.29 57.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 56.25 56.41 5.83 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.194 1.398 . . . . 0.0 111.781 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -89.55 155.0 19.56 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.6 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 23.6 t70 -91.45 76.46 5.87 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 120.576 1.535 . . . . 0.0 110.252 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.5 m -139.5 167.19 20.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.565 -172.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 64' ' ' MET . 37.9 tt0 -120.9 122.13 39.56 Favored 'General case' 0 C--O 1.189 -2.115 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.811 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.72 128.29 36.59 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -177.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.907 ' H ' HG12 ' A' ' 62' ' ' ILE . 52.0 t80 -135.6 146.64 48.13 Favored 'General case' 0 C--N 1.272 -2.762 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.886 -167.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.3 mt -93.0 96.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 171.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.55 -34.64 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.53 -166.86 39.34 Favored Glycine 0 CA--C 1.479 -2.166 0 C-N-CA 118.721 -1.704 . . . . 0.0 113.8 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 49.7 m -69.95 123.63 22.0 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.631 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 5.1 t70 79.4 -1.99 2.19 Favored 'General case' 0 C--O 1.215 -0.752 0 O-C-N 124.542 1.152 . . . . 0.0 109.405 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -126.28 117.56 23.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.408 0.623 . . . . 0.0 111.92 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.83 165.19 25.57 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.907 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -143.74 153.64 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.663 0 C-N-CA 118.231 -1.388 . . . . 0.0 109.639 173.03 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.606 ' HA ' ' HG3' ' A' ' 53' ' ' ARG 0.28 10.0 p90 -131.9 104.19 6.73 Favored 'General case' 0 N--CA 1.402 -2.875 0 O-C-N 126.558 2.411 . . . . 0.0 107.155 161.341 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.532 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . 23.9 ttt -90.28 109.96 21.04 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.809 -176.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.683 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.265 3.9 mp -76.59 145.13 39.15 Favored 'General case' 0 CA--C 1.457 -2.634 0 C-N-CA 126.085 1.754 . . . . 0.0 110.892 -175.642 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.6 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.329 61.6 ttt180 -119.52 -58.42 1.91 Allowed 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 174.141 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.516 ' O ' ' HA2' ' A' ' 15' ' ' GLY . 10.4 t70 -70.67 8.55 0.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.69 ' HA3' ' O ' ' A' ' 14' ' ' LYS . . . 58.87 -24.78 0.02 OUTLIER Glycine 0 CA--C 1.559 2.837 0 CA-C-N 120.126 1.33 . . . . 0.0 116.244 -169.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 67' ' ' ASP . 6.3 m -87.05 15.71 5.77 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -169.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -164.23 135.21 4.37 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.718 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.811 ' HA ' HD12 ' A' ' 74' ' ' ILE . . . 156.37 -31.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 127.019 2.128 . . . . 0.0 111.708 172.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.699 ' CZ2' HD23 ' A' ' 89' ' ' LEU 0.272 13.7 m-90 -74.53 -30.86 61.94 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-O 121.722 0.772 . . . . 0.0 111.873 -174.356 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 36.8 tt0 -68.8 -37.51 79.3 Favored 'General case' 0 C--O 1.265 1.915 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.811 HD12 ' HA ' ' A' ' 71' ' ' ALA . 12.7 mt -61.62 -44.21 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.557 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.516 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.713 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.44 -27.9 64.62 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.822 -178.066 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.74 -48.71 79.46 Favored 'General case' 0 C--O 1.247 0.963 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.954 171.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.527 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 18.9 m-85 -55.64 -45.66 77.58 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.157 0.98 . . . . 0.0 109.923 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.769 ' HB3' ' HE1' ' A' ' 40' ' ' TRP 0.27 4.3 pp -63.96 -47.46 80.34 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.516 ' N ' HD12 ' A' ' 78' ' ' LEU 0.355 4.4 m -77.04 -1.8 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 116.63 -2.028 . . . . 0.0 112.685 176.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -85.57 -20.03 30.19 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.005 166.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.421 ' HG2' HG23 ' A' ' 36' ' ' ILE . 59.3 tp60 -80.93 -17.53 50.22 Favored 'General case' 0 C--N 1.367 1.357 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 171.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.258 23.2 t70 88.99 -50.61 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 112.489 -2.141 . . . . 0.0 114.527 168.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.794 ' HB3' ' HB3' ' A' ' 25' ' ' SER . 33.3 mmt180 -84.79 76.6 10.21 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.658 ' HB3' HD13 ' A' ' 78' ' ' LEU . 61.3 m -154.91 37.62 0.41 Allowed 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 123.073 1.416 . . . . 0.0 110.406 -168.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -32.16 -45.92 0.11 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 131.009 3.723 . . . . 0.0 120.274 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.993 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 30.6 tt0 -146.71 123.58 11.3 Favored 'General case' 0 C--O 1.198 -1.629 0 C-N-CA 117.244 -1.782 . . . . 0.0 113.906 -164.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.625 ' HB ' HD11 ' A' ' 89' ' ' LEU . 16.3 m -113.55 131.69 64.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.447 ' C ' HD12 ' A' ' 89' ' ' LEU 0.265 16.7 p -117.77 120.84 39.16 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 122.917 1.341 . . . . 0.0 110.095 165.099 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.723 ' HB2' ' CZ ' ' A' ' 94' ' ' TYR . 5.1 mp -103.37 157.19 17.2 Favored 'General case' 0 C--N 1.262 -3.239 0 CA-C-N 112.708 -2.042 . . . . 0.0 106.638 -173.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.498 ' HB3' ' CD2' ' A' ' 18' ' ' LEU . 7.5 tt0 -78.18 146.55 34.94 Favored 'General case' 0 C--N 1.256 -3.463 0 CA-C-O 121.909 0.861 . . . . 0.0 111.98 -162.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 133.23 163.92 10.65 Favored Glycine 0 N--CA 1.416 -2.693 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -108.05 109.08 20.44 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 120.961 2.381 . . . . 0.0 106.717 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.19 73.04 0.39 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 -170.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.723 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 3.4 p90 -101.7 149.18 36.22 Favored Pre-proline 0 C--N 1.297 -1.705 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.093 -172.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.42 ' HD2' ' OG ' ' A' ' 7' ' ' SER . 88.3 Cg_endo -84.7 151.79 11.51 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.191 1.927 . . . . 0.0 110.271 172.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.09 93.91 0.11 Allowed Glycine 0 C--N 1.297 -1.623 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 124.384 1.074 . . . . 0.0 110.88 -174.794 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.458 ' N ' ' HB2' ' A' ' 6' ' ' GLU . . . . . . . . 0 CA--C 1.493 -1.312 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.64 -13.45 37.2 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.574 2.183 . . . . 0.0 113.676 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.3 -35.35 0.58 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.233 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -100.16 140.12 21.24 Favored Pre-proline 0 C--O 1.246 0.903 0 O-C-N 122.461 -0.435 . . . . 0.0 110.991 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HB3' ' HB2' ' A' ' 97' ' ' LYS . 35.1 Cg_exo -62.89 130.66 30.02 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.887 2.391 . . . . 0.0 109.428 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HB2' ' N ' ' A' ' 1' ' ' GLY . 25.7 tt0 -107.99 11.13 28.1 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.302 -173.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.3 m 61.81 53.37 3.17 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.282 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.452 ' O ' HD12 ' A' ' 9' ' ' LEU . 5.8 tp 51.43 56.33 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.397 2.672 0 C-N-CA 124.076 0.95 . . . . 0.0 109.164 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 8' ' ' ILE 0.362 2.0 pp 51.63 65.31 1.53 Allowed 'General case' 0 C--N 1.391 2.41 0 CA-C-O 123.156 1.455 . . . . 0.0 114.125 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.416 ' HE2' ' HG3' ' A' ' 14' ' ' LYS 0.287 60.8 pttt 49.19 68.09 0.77 Allowed 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 112.615 -2.084 . . . . 0.0 114.297 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 84.0 mtp 65.8 30.59 10.01 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.466 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.558 HG23 ' HE3' ' A' ' 72' ' ' TRP . 12.1 m 77.2 38.03 0.24 Allowed 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.706 0.802 . . . . 0.0 112.645 172.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -153.52 98.28 2.22 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.899 -0.501 . . . . 0.0 110.656 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HG3' ' HE2' ' A' ' 10' ' ' LYS . 78.2 tttt -148.71 16.37 0.99 Allowed 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.397 0.618 . . . . 0.0 110.975 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 67' ' ' ASP . . . 53.66 51.6 47.51 Favored Glycine 0 CA--C 1.563 3.042 0 N-CA-C 118.006 1.962 . . . . 0.0 118.006 175.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 16' ' ' LYS . 20.3 tptm -128.55 133.31 48.35 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 120.443 2.122 . . . . 0.0 109.348 175.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.8 t -72.0 133.61 45.42 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.131 0.491 . . . . 0.0 109.854 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.933 HD21 ' HA ' ' A' ' 89' ' ' LEU . 13.3 tp -134.04 133.93 41.8 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.178 -177.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 86.7 mtp -83.56 100.27 10.69 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 104.47 -2.418 . . . . 0.0 104.47 164.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.556 ' CE ' ' HB1' ' A' ' 71' ' ' ALA . 53.7 ttp -86.45 119.97 27.29 Favored 'General case' 0 CA--C 1.475 -1.911 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.804 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 49.8 t80 -97.96 124.6 42.49 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.868 -1.969 . . . . 0.0 106.896 -174.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -129.37 125.9 62.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -173.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.051 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 86.8 m -77.05 120.61 22.39 Favored 'General case' 0 CA--C 1.587 2.4 0 C-N-CA 125.409 1.483 . . . . 0.0 110.891 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.659 HG21 HD13 ' A' ' 36' ' ' ILE . 10.3 p -114.48 125.09 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 170.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.87 13.05 4.01 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 115.73 -2.388 . . . . 0.0 113.54 -163.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.11 -37.91 93.48 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 119.198 -1.477 . . . . 0.0 109.895 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 1.127 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 23.6 t-20 -117.13 106.73 46.77 Favored Pre-proline 0 N--CA 1.423 -1.824 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -72.94 30.32 0.29 Allowed 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 123.569 2.846 . . . . 0.0 113.251 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -143.4 -171.16 3.44 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.411 ' O ' ' HB ' ' A' ' 33' ' ' THR . 33.2 tt0 -82.29 -7.05 59.62 Favored 'General case' 0 C--O 1.206 -1.199 0 CA-C-N 118.802 0.728 . . . . 0.0 112.537 -171.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.515 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 2.4 tmpt? -60.91 -45.59 94.02 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 118.235 0.47 . . . . 0.0 110.369 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 1.127 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.5 tp10 -67.59 -49.55 62.57 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 86.9 m -44.49 -52.13 8.19 Favored 'General case' 0 C--O 1.196 -1.738 0 C-N-CA 124.989 1.316 . . . . 0.0 112.409 172.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.515 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.3 pt-20 -67.84 -51.51 47.62 Favored 'General case' 0 C--O 1.253 1.273 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -59.02 -47.06 86.58 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.929 1.347 . . . . 0.0 108.071 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.895 HD12 ' HG3' ' A' ' 32' ' ' GLU . 10.1 mt -69.85 -40.61 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.58 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.804 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.876 HG21 HG12 ' A' ' 55' ' ' ILE . 12.9 p -69.61 -37.69 76.95 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 120.54 1.518 . . . . 0.0 111.047 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 p -64.75 -57.86 7.81 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 123.864 0.727 . . . . 0.0 109.668 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.1 tp -66.11 -43.21 87.88 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.745 ' HZ2' ' HB2' ' A' ' 82' ' ' ASP . 44.0 m0 -69.59 -69.12 0.36 Allowed 'General case' 0 C--O 1.197 -1.706 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.901 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.791 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.421 0.0 OUTLIER -68.97 -20.05 64.17 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 117.554 -1.659 . . . . 0.0 112.669 -171.827 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.46 -50.42 59.51 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 170.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.44 ' HA ' ' HB2' ' A' ' 46' ' ' ASN . 65.3 p -69.64 -25.39 63.91 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.082 -0.658 . . . . 0.0 110.644 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.791 ' HG ' ' HA ' ' A' ' 41' ' ' GLN . 20.1 mt -62.07 -31.15 71.54 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 174.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -77.45 -44.13 30.06 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.383 0.611 . . . . 0.0 110.479 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 84.8 m-20 -63.61 -30.59 71.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -172.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.18 2.52 54.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.15 0.5 . . . . 0.0 110.33 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 55.05 62.32 2.56 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.336 1.455 . . . . 0.0 111.826 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -98.54 152.12 19.91 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 120.664 -1.272 . . . . 0.0 108.211 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -87.26 82.56 7.58 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 120.343 1.429 . . . . 0.0 110.288 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 1.031 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.1 m -147.75 165.63 5.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.607 -174.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.444 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 1.9 mp0 -131.25 124.4 30.46 Favored 'General case' 0 C--O 1.194 -1.859 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 171.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.836 ' HG3' ' HA ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -124.56 138.99 54.28 Favored 'General case' 0 C--N 1.287 -2.133 0 O-C-N 121.47 -0.769 . . . . 0.0 109.259 -172.488 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.871 ' H ' HG12 ' A' ' 62' ' ' ILE . 21.0 t80 -134.93 151.4 50.83 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.781 -1.167 . . . . 0.0 113.294 -167.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.876 HG12 HG21 ' A' ' 37' ' ' THR . 48.9 mt -83.66 123.32 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 39.2 t -101.74 -38.85 6.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.94 -163.32 30.44 Favored Glycine 0 CA--C 1.481 -2.043 0 C-N-CA 119.329 -1.415 . . . . 0.0 113.12 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 m -52.96 119.1 4.25 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.943 0.897 . . . . 0.0 109.534 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER 73.59 13.9 4.35 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 121.896 0.855 . . . . 0.0 111.729 175.1 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.598 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -146.55 125.86 13.09 Favored 'General case' 0 CA--C 1.572 1.803 0 O-C-N 120.763 -1.211 . . . . 0.0 112.016 -177.719 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.98 163.5 32.81 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.871 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -137.55 156.24 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.178 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.652 173.72 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.836 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 1.1 m-30 -125.96 101.04 6.63 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 126.674 2.483 . . . . 0.0 104.926 167.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 26.5 ttt -83.97 100.34 10.98 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 117.816 -1.554 . . . . 0.0 108.305 176.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.031 ' HA ' HG12 ' A' ' 51' ' ' VAL . 2.6 pt? -97.28 148.3 23.26 Favored 'General case' 0 CA--C 1.45 -2.895 0 CA-C-O 122.484 1.135 . . . . 0.0 112.714 -175.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.358 16.0 ttp180 -109.06 -54.86 2.48 Favored 'General case' 1 C--N 1.24 -4.165 0 CA-C-N 113.066 -1.879 . . . . 0.0 115.6 -173.402 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.415 ' O ' ' HA2' ' A' ' 15' ' ' GLY . 14.8 t70 -56.11 -8.67 0.5 Allowed 'General case' 0 CA--C 1.594 2.67 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 174.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.44 -31.09 2.98 Favored Glycine 0 C--N 1.359 1.835 0 O-C-N 120.049 -1.657 . . . . 0.0 113.533 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 12' ' ' THR . 36.4 p -81.4 -69.49 0.61 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -174.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.688 ' CE1' ' HB2' ' A' ' 65' ' ' LEU 0.297 0.2 OUTLIER -46.36 -28.98 1.49 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 120.687 3.588 . . . . 0.0 120.687 -162.632 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.867 ' HA ' HD12 ' A' ' 74' ' ' ILE . . . -64.14 -35.76 81.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 116.555 2.058 . . . . 0.0 116.555 -166.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.651 ' CZ2' ' HB2' ' A' ' 89' ' ' LEU 0.323 27.2 m-90 -83.36 -19.72 35.6 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.417 -1.313 . . . . 0.0 113.481 -173.237 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -74.55 -35.14 63.09 Favored 'General case' 0 C--O 1.28 2.693 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 170.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 71' ' ' ALA . 22.6 mt -65.0 -35.1 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.823 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.846 ' HG3' HG11 ' A' ' 87' ' ' VAL . 12.5 tmtt? -67.58 -33.18 74.49 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.761 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -58.46 -47.34 84.32 Favored 'General case' 0 C--O 1.263 1.769 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.113 170.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.578 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 5.7 m-30 -52.0 -47.06 65.12 Favored 'General case' 0 N--CA 1.513 2.709 0 CA-C-O 122.152 0.977 . . . . 0.0 109.64 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.674 ' CD1' ' HA ' ' A' ' 75' ' ' LYS . 30.9 mt -53.62 -63.6 1.1 Allowed 'General case' 0 CA--C 1.471 -2.093 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.423 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.6 m -69.04 -11.0 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 C-N-CA 119.553 -0.859 . . . . 0.0 112.537 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.7 m -94.44 -10.49 32.26 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.967 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -124.81 -28.68 3.48 Favored 'General case' 0 C--N 1.38 1.908 0 C-N-CA 116.137 -2.225 . . . . 0.0 112.112 -177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.745 ' HB2' ' HZ2' ' A' ' 40' ' ' TRP . 11.8 m-20 -133.17 167.56 20.13 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -83.19 63.07 6.99 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.176 1.353 . . . . 0.0 112.838 -174.648 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 40.5 t -82.43 176.71 9.21 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.683 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -167.73 -39.42 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -169.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.051 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 32.1 tt0 -147.55 121.85 9.61 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.612 -167.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.846 HG11 ' HG3' ' A' ' 75' ' ' LYS . 28.4 m -118.96 129.34 75.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.242 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.484 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 7.8 p -115.99 120.27 38.6 Favored 'General case' 0 C--O 1.281 2.714 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.933 ' HA ' HD21 ' A' ' 18' ' ' LEU 0.302 7.1 tp -79.39 91.68 5.11 Favored 'General case' 0 CA--C 1.577 1.994 0 CA-C-N 112.341 -2.209 . . . . 0.0 107.815 171.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.781 ' N ' HD11 ' A' ' 18' ' ' LEU . 2.4 tm-20 -80.65 123.96 28.6 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 126.953 2.101 . . . . 0.0 113.434 -166.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.72 -20.69 33.84 Favored Glycine 0 C--N 1.314 -0.648 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.514 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -95.81 111.66 23.58 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 176.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.1 tpt -69.85 101.77 1.81 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.77 0.795 . . . . 0.0 110.464 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.484 ' OH ' ' HA ' ' A' ' 88' ' ' THR . 28.7 p90 -117.64 119.8 33.74 Favored Pre-proline 0 N--CA 1.389 -3.518 0 CA-C-N 114.375 -1.284 . . . . 0.0 107.951 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 94' ' ' TYR . 68.8 Cg_endo -97.39 94.76 0.07 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.277 0 C-N-CA 122.386 2.057 . . . . 0.0 112.583 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.53 -82.04 1.66 Allowed Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 120.499 -0.857 . . . . 0.0 113.014 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.613 ' HB2' ' HB3' ' A' ' 5' ' ' PRO . 12.3 mptt . . . . . 0 C--N 1.306 -1.323 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.46 -175.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.415 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -88.41 -8.72 5.3 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.262 1.975 . . . . 0.0 111.822 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.37 -36.79 2.21 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.795 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -98.39 132.99 23.24 Favored Pre-proline 0 C--N 1.312 -1.035 0 O-C-N 122.098 -0.648 . . . . 0.0 110.799 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -81.07 122.45 4.25 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.495 2.13 . . . . 0.0 109.878 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -106.92 14.87 26.04 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.736 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 m 63.2 38.93 10.17 Favored 'General case' 0 C--N 1.347 0.463 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 11' ' ' MET 0.277 11.3 tt 51.51 52.16 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.282 2.784 0 CA-C-O 122.572 1.177 . . . . 0.0 109.761 -172.126 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 8' ' ' ILE 0.314 1.9 pp 52.57 61.4 3.21 Favored 'General case' 0 C--N 1.4 2.79 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.821 177.131 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.57 ' HG2' ' HG2' ' A' ' 13' ' ' LYS . 14.8 ptmm? 54.28 35.01 21.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.109 -1.86 . . . . 0.0 111.693 -175.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.886 ' HA ' HG23 ' A' ' 8' ' ' ILE . 45.4 ttm 65.89 14.3 9.5 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.973 1.709 . . . . 0.0 110.743 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.9 m -170.02 -53.98 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.522 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 -163.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.778 ' HG3' ' H ' ' A' ' 14' ' ' LYS 0.334 20.4 ptmt -39.67 -95.71 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 119.76 3.245 . . . . 0.0 119.76 -160.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.778 ' H ' ' HG3' ' A' ' 13' ' ' LYS . 86.4 tttt -168.16 147.86 4.72 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -167.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.92 -79.81 0.11 Allowed Glycine 0 CA--C 1.552 2.351 0 C-N-CA 117.754 -2.165 . . . . 0.0 116.169 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.711 ' HD2' ' HB2' ' A' ' 92' ' ' GLN . 33.1 ttpt -115.33 135.07 54.53 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 120.227 2.013 . . . . 0.0 113.924 -169.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.552 HG23 ' HA ' ' A' ' 66' ' ' ARG . 90.7 m -70.28 117.0 11.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 173.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 1.089 HD21 ' HA ' ' A' ' 89' ' ' LEU . 9.9 tp -133.59 140.39 47.11 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.903 -168.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.518 ' HG2' ' SD ' ' A' ' 64' ' ' MET . 81.3 mtp -83.01 100.63 10.58 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 162.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.644 ' HB3' HD23 ' A' ' 18' ' ' LEU . 2.1 ppp? -87.08 137.42 32.36 Favored 'General case' 0 C--O 1.259 1.605 0 C-N-CA 115.915 -2.314 . . . . 0.0 108.588 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.471 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 31.0 t80 -107.14 126.53 52.5 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.064 -175.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.694 HG13 ' HB3' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -116.21 124.85 72.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.886 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.014 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 17.6 m -98.6 135.04 40.69 Favored 'General case' 0 CA--C 1.582 2.205 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.688 HG21 HD11 ' A' ' 36' ' ' ILE . 12.6 p -132.17 119.88 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.609 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 t -124.32 -1.98 8.09 Favored 'General case' 0 C--O 1.239 0.52 0 O-C-N 119.327 -2.108 . . . . 0.0 112.84 -165.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.91 -32.08 78.48 Favored Glycine 0 CA--C 1.506 -0.505 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.629 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.75 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 24.9 t-20 -117.14 106.74 46.76 Favored Pre-proline 0 N--CA 1.4 -2.939 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -85.75 32.02 0.47 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.7 p -135.53 -160.51 1.06 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.419 ' O ' ' HB ' ' A' ' 33' ' ' THR . 3.7 tp10 -84.44 -7.22 59.36 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -177.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 2.2 tmpt? -65.5 -49.8 67.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -172.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.75 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 16.4 tp10 -72.74 -35.5 67.53 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 117.663 -1.615 . . . . 0.0 108.129 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.547 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 84.3 m -49.61 -52.92 27.08 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.07 172.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.9 pt-20 -70.01 -37.86 75.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -62.42 -55.11 30.94 Favored 'General case' 0 C--O 1.209 -1.053 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.757 HG23 ' CE3' ' A' ' 40' ' ' TRP . 95.9 mt -58.13 -49.92 79.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.062 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.897 HG21 HG12 ' A' ' 55' ' ' ILE . 36.0 p -65.04 -56.81 10.87 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.522 -176.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 m -65.22 -48.43 73.35 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.452 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.2 mt -75.09 -52.93 9.82 Favored 'General case' 0 C--O 1.252 1.19 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.757 ' CE3' HG23 ' A' ' 36' ' ' ILE . 6.5 m0 -72.5 -60.69 2.11 Favored 'General case' 0 C--O 1.157 -3.767 0 CA-C-O 117.198 -1.382 . . . . 0.0 109.062 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.79 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.44 0.0 OUTLIER -64.4 -24.68 67.72 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-N 121.066 1.757 . . . . 0.0 112.893 -173.706 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.67 -47.48 90.17 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.87 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 54.5 p -77.62 -19.96 54.66 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 122.306 -0.526 . . . . 0.0 111.861 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.79 ' HG ' ' HA ' ' A' ' 41' ' ' GLN . 23.9 mt -65.05 -34.02 77.43 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.46 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 90.1 t80 -85.69 -33.61 21.49 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.854 173.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.87 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 15.2 t-20 -61.0 -39.21 88.83 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.44 6.48 33.73 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 122.0 -0.437 . . . . 0.0 110.585 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 58.9 41.24 21.57 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.914 0.886 . . . . 0.0 112.226 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.428 ' O ' HG13 ' A' ' 51' ' ' VAL . 18.3 m-85 -73.57 10.89 0.93 Allowed 'General case' 0 CA--C 1.582 2.178 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 45.32 70.34 0.36 Allowed 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 125.61 1.564 . . . . 0.0 112.253 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.933 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.2 m -147.13 176.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.289 -169.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.41 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 96.1 mt-30 -134.33 120.26 19.67 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.73 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -126.23 141.42 51.93 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -171.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.636 ' H ' HG12 ' A' ' 62' ' ' ILE . 39.8 m-85 -133.29 151.96 51.91 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -165.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.897 HG12 HG21 ' A' ' 37' ' ' THR . 19.5 mt -88.33 114.12 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 167.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.967 HG23 ' HB3' ' A' ' 60' ' ' ARG . 8.9 m -113.81 -21.6 5.35 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.726 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.347 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.21 171.16 36.14 Favored Glycine 0 C--O 1.209 -1.422 0 C-N-CA 117.666 -2.207 . . . . 0.0 114.759 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.547 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 42.3 m -66.38 118.5 10.13 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER 85.04 5.08 0.55 Allowed 'General case' 0 C--N 1.37 1.463 0 O-C-N 124.203 0.94 . . . . 0.0 110.229 -173.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.967 ' HB3' HG23 ' A' ' 56' ' ' VAL . 2.8 mpt_? -135.18 132.5 38.04 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.694 ' HB3' HG13 ' A' ' 22' ' ' VAL . . . -143.09 166.12 25.53 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.83 1.252 . . . . 0.0 108.178 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.636 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER -145.66 157.98 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.855 168.515 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.628 ' O ' ' HG3' ' A' ' 20' ' ' MET 0.385 11.8 p90 -134.08 104.01 6.04 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 125.575 1.797 . . . . 0.0 110.45 162.594 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.518 ' SD ' ' HG2' ' A' ' 19' ' ' MET . 24.1 ttt -84.59 110.86 19.03 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.015 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.942 HD13 ' HB2' ' A' ' 71' ' ' ALA . 2.1 pt? -102.11 148.09 25.82 Favored 'General case' 0 CA--C 1.486 -1.517 0 O-C-N 124.309 1.006 . . . . 0.0 113.013 -173.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.552 ' HA ' HG23 ' A' ' 17' ' ' THR 0.266 31.3 tpt180 -113.53 -62.18 1.63 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.271 -1.786 . . . . 0.0 115.44 -172.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -47.1 -17.65 0.06 Allowed 'General case' 0 CA--C 1.59 2.502 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.07 -16.18 17.69 Favored Glycine 0 C--N 1.358 1.78 0 O-C-N 120.727 -1.233 . . . . 0.0 114.498 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.457 ' OG ' ' HG3' ' A' ' 14' ' ' LYS . 1.2 m -118.97 33.37 5.68 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -167.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.669 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -156.86 2.58 0.13 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 117.913 2.561 . . . . 0.0 117.913 -174.527 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.942 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -79.1 -28.22 42.98 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 120.124 1.329 . . . . 0.0 113.6 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.613 ' CZ2' ' HB2' ' A' ' 89' ' ' LEU 0.475 28.0 m-90 -88.21 -12.44 43.81 Favored 'General case' 0 N--CA 1.41 -2.468 0 C-N-CA 117.31 -1.756 . . . . 0.0 113.992 -173.336 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 1.6 mp0 -75.35 -29.1 59.83 Favored 'General case' 0 C--O 1.274 2.388 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.699 ' HA ' ' HD2' ' A' ' 77' ' ' PHE . 85.6 mt -68.61 -32.85 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.062 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 174.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.807 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -59.01 -43.87 91.61 Favored 'General case' 0 C--O 1.285 2.943 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 22.9 t70 -50.28 -50.03 51.61 Favored 'General case' 0 C--O 1.26 1.607 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.19 172.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.699 ' HD2' ' HA ' ' A' ' 74' ' ' ILE . 53.6 m-85 -55.96 -43.61 77.7 Favored 'General case' 0 C--O 1.186 -2.279 0 C-N-CA 118.752 -1.179 . . . . 0.0 112.223 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.807 ' HG ' ' HA ' ' A' ' 75' ' ' LYS 0.28 4.9 mt -49.48 -60.38 2.9 Favored 'General case' 0 C--O 1.294 3.422 0 CA-C-O 123.258 1.504 . . . . 0.0 109.899 -178.484 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.681 HG12 ' CB ' ' A' ' 84' ' ' CYS . 24.1 m -75.15 -7.83 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 111.774 -2.466 . . . . 0.0 111.463 -171.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.0 m -104.83 -5.6 21.03 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.174 172.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 29.0 mm-40 -85.08 -56.47 3.54 Favored 'General case' 0 CA--C 1.47 -2.096 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.361 28.3 t70 -179.57 -84.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.733 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 24.5 mmt-85 -87.38 144.29 26.83 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.315 1.416 . . . . 0.0 109.202 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.681 ' CB ' HG12 ' A' ' 79' ' ' VAL . 8.6 p -159.23 147.83 18.05 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.37 -44.51 0.05 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.014 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 40.5 tt0 -140.17 118.77 12.3 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.054 -1.058 . . . . 0.0 110.528 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.411 HG21 ' HG3' ' A' ' 75' ' ' LYS . 2.2 p -113.09 102.62 14.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.731 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.424 HG22 ' OH ' ' A' ' 94' ' ' TYR . 6.9 p -119.82 124.75 46.88 Favored 'General case' 0 C--O 1.26 1.632 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.089 ' HA ' HD21 ' A' ' 18' ' ' LEU 0.268 5.1 tp -75.74 89.98 2.85 Favored 'General case' 0 CA--C 1.584 2.285 0 CA-C-N 113.624 -1.625 . . . . 0.0 106.87 171.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.492 ' N ' HD11 ' A' ' 18' ' ' LEU . 7.7 tp10 -107.17 151.77 24.97 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -160.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 100.2 -64.01 0.62 Allowed Glycine 0 C--N 1.305 -1.144 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.711 ' HB2' ' HD2' ' A' ' 16' ' ' LYS . 48.9 mt-30 -111.43 109.87 20.04 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 169.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 16.7 mmt -75.65 173.7 10.72 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -169.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.424 ' OH ' HG22 ' A' ' 88' ' ' THR . 18.4 p90 -129.52 122.24 20.69 Favored Pre-proline 0 C--N 1.284 -2.264 0 CA-C-N 113.505 -1.68 . . . . 0.0 107.086 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.49 105.11 1.01 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.376 2.051 . . . . 0.0 110.194 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.42 -96.64 1.76 Allowed Glycine 0 N--CA 1.41 -3.068 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.001 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? . . . . . 0 C--N 1.295 -1.775 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 176.487 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.773 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.559 ' HB2' ' HG3' ' A' ' 4' ' ' LYS . 12.5 Cg_exo -69.5 -39.26 7.23 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.199 1.933 . . . . 0.0 111.4 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.79 14.24 75.97 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.559 ' HG3' ' HB2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -66.96 140.51 96.13 Favored Pre-proline 0 C--N 1.317 -0.815 0 C-N-CA 123.424 0.69 . . . . 0.0 111.81 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 36.2 Cg_exo -61.41 105.32 0.34 Allowed 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 122.327 2.018 . . . . 0.0 111.569 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -129.23 18.06 5.99 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.2 m 55.87 72.2 0.51 Allowed 'General case' 0 CA--C 1.575 1.917 0 C-N-CA 123.941 0.896 . . . . 0.0 110.326 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 1.034 HG23 ' HA ' ' A' ' 11' ' ' MET 0.279 12.8 tt 50.38 40.67 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.415 3.428 0 CA-C-O 122.99 1.376 . . . . 0.0 109.702 -175.68 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 9' ' ' LEU 0.28 3.5 pp 49.89 73.99 0.23 Allowed 'General case' 0 C--N 1.394 2.541 0 CA-C-N 112.957 -1.929 . . . . 0.0 111.843 175.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.433 ' NZ ' ' HB3' ' A' ' 10' ' ' LYS 0.252 0.5 OUTLIER 53.72 33.53 16.97 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.719 -1.582 . . . . 0.0 112.026 -176.51 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . 1.034 ' HA ' HG23 ' A' ' 8' ' ' ILE . 25.7 mmt 61.9 14.95 6.74 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 125.114 1.366 . . . . 0.0 112.295 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -175.87 -45.32 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -165.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 68' ' ' GLY . 87.6 tttt -136.25 153.2 51.27 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -166.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.467 ' HD3' ' HA ' ' A' ' 14' ' ' LYS 0.965 72.6 mmtt 129.2 -79.59 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 1 N-CA-C 121.895 4.035 . . . . 0.0 121.895 173.793 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.24 81.01 0.05 OUTLIER Glycine 0 CA--C 1.553 2.41 0 C-N-CA 115.98 -3.009 . . . . 0.0 118.248 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.603 ' HD2' ' HB2' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -130.59 143.29 50.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 120.841 2.321 . . . . 0.0 107.614 168.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.7 m -80.79 110.63 16.49 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.671 HD23 ' HZ2' ' A' ' 72' ' ' TRP . 60.2 tp -134.28 118.42 17.52 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.47 -174.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.922 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 26.4 ptt? -83.61 104.83 14.05 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 117.213 -1.795 . . . . 0.0 106.481 165.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.576 ' HG3' ' HE1' ' A' ' 72' ' ' TRP . 14.2 tmm? -87.88 139.73 30.22 Favored 'General case' 0 C--O 1.268 2.053 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.47 -172.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -106.43 126.43 52.24 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 125.056 1.472 . . . . 0.0 110.085 -167.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.82 137.75 56.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.161 -174.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.044 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 54.2 m -107.72 131.31 54.57 Favored 'General case' 0 CA--C 1.628 3.95 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.222 170.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.57 HG12 ' HG2' ' A' ' 32' ' ' GLU . 80.5 t -115.36 94.26 3.02 Favored 'Isoleucine or valine' 0 C--N 1.405 2.998 0 C-N-CA 128.471 2.709 . . . . 0.0 106.598 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.73 35.99 4.53 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-N 122.098 2.226 . . . . 0.0 112.923 -174.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.573 ' HA3' ' HB2' ' A' ' 83' ' ' ARG . . . -59.87 -35.53 87.07 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 168.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.741 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 4.1 m-20 -111.36 148.56 39.03 Favored Pre-proline 0 N--CA 1.42 -1.957 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 167.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -92.64 43.18 0.31 Allowed 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 121.642 1.561 . . . . 0.0 110.851 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -130.77 -146.25 0.3 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.5 -173.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.593 ' HG3' ' HA ' ' A' ' 58' ' ' SER . 30.2 tt0 -125.58 17.98 8.11 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 170.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.769 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 8.2 tmtt? -92.98 -37.93 11.94 Favored 'General case' 0 C--O 1.256 1.429 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.741 ' HB3' ' HB2' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -65.8 -44.15 86.54 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 175.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 84.8 m -49.38 -62.4 1.57 Allowed 'General case' 0 C--O 1.187 -2.199 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.211 169.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.769 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 11.7 pt-20 -51.64 -54.87 23.28 Favored 'General case' 0 C--O 1.26 1.641 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -174.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.872 ' HG3' HG13 ' A' ' 36' ' ' ILE . 11.9 pt-20 -65.23 -49.72 68.61 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.727 0.775 . . . . 0.0 109.445 -174.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.872 HG13 ' HG3' ' A' ' 35' ' ' GLU . 56.9 mt -71.55 -43.5 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.027 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.202 -172.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.4 p -66.79 -37.35 84.39 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 118.177 0.444 . . . . 0.0 111.254 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.6 m -67.55 -38.93 84.88 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.994 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 tp -67.55 -35.63 79.43 Favored 'General case' 0 C--N 1.365 1.268 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.657 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 11.9 m0 -68.85 -77.53 0.08 Allowed 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.953 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.677 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.351 0.0 OUTLIER -66.43 -20.89 66.18 Favored 'General case' 0 C--O 1.248 0.987 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.958 -171.571 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.87 -55.29 31.22 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.93 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 47.8 t -70.84 -26.93 63.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 116.708 0.254 . . . . 0.0 111.026 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.792 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 32.8 mt -61.03 -35.51 77.07 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.523 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 70.0 t80 -90.99 -27.29 18.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.93 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 21.8 t-20 -65.26 -33.59 76.36 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.485 0.714 . . . . 0.0 111.92 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.19 1.88 55.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.063 0.459 . . . . 0.0 109.855 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 53.91 66.13 1.32 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.521 1.529 . . . . 0.0 112.037 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -99.48 159.93 14.66 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -95.32 86.48 4.54 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 121.014 1.733 . . . . 0.0 109.801 -177.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.902 HG12 ' HA ' ' A' ' 65' ' ' LEU . 1.4 m -146.66 163.46 8.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.969 -174.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.55 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 13.5 mt-30 -128.59 115.83 18.69 Favored 'General case' 0 C--O 1.194 -1.839 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.792 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -121.41 139.33 53.59 Favored 'General case' 0 C--N 1.28 -2.451 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.663 -168.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.658 ' H ' HG12 ' A' ' 62' ' ' ILE . 83.0 m-85 -133.58 151.72 51.76 Favored 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -170.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.7 mt -94.09 96.3 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 167.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 60' ' ' ARG . 4.3 m -92.02 -24.48 5.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.97 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.03 173.61 40.89 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 117.016 -2.516 . . . . 0.0 114.158 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.593 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 30.8 t -70.32 115.78 9.91 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 24' ' ' VAL 0.268 0.6 OUTLIER 73.18 17.16 4.09 Favored 'General case' 0 C--O 1.207 -1.168 0 C-N-CA 125.8 1.64 . . . . 0.0 109.152 -178.607 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.47 ' HB3' HG23 ' A' ' 56' ' ' VAL . 9.1 mpt_? -131.88 132.12 43.35 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.075 0.95 . . . . 0.0 112.518 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.45 166.3 24.18 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.491 1.116 . . . . 0.0 109.145 -173.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.768 HD12 ' HB2' ' A' ' 19' ' ' MET . 1.0 OUTLIER -143.77 157.28 16.25 Favored 'Isoleucine or valine' 0 C--O 1.275 2.442 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.808 172.103 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.756 ' HZ ' HD21 ' A' ' 78' ' ' LEU . 2.2 m-30 -125.96 111.47 14.8 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 166.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.922 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 22.1 ttt -84.44 93.68 8.35 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 118.384 -1.326 . . . . 0.0 109.9 173.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.938 ' HG ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -98.65 146.93 25.34 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 124.805 1.242 . . . . 0.0 114.316 -174.103 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.464 7.6 ppt_? -117.28 -54.48 2.39 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -47.79 -19.71 0.24 Allowed 'General case' 0 CA--C 1.584 2.275 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 13' ' ' LYS . . . 58.4 10.32 7.5 Favored Glycine 0 C--N 1.374 2.654 0 CA-C-N 120.101 1.319 . . . . 0.0 115.252 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.3 m -128.23 40.01 3.74 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 118.359 1.08 . . . . 0.0 111.439 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.635 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -170.59 -7.28 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.864 0 O-C-N 121.769 -0.582 . . . . 0.0 111.487 -172.353 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.938 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -80.21 -42.84 22.53 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -166.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.671 ' HZ2' HD23 ' A' ' 18' ' ' LEU 0.311 9.2 m0 -92.75 -9.97 38.68 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 123.461 1.601 . . . . 0.0 110.44 -170.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.76 -38.65 73.48 Favored 'General case' 0 C--O 1.298 3.64 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 166.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 70' ' ' TYR . 42.8 mt -59.14 -38.32 73.53 Favored 'Isoleucine or valine' 0 C--N 1.389 2.301 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.855 ' HG3' HG21 ' A' ' 87' ' ' VAL . 12.6 tmtt? -58.0 -43.69 86.79 Favored 'General case' 0 C--O 1.288 3.126 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.582 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.92 -43.34 86.19 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.863 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -62.32 -31.83 72.49 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.416 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.779 ' HG ' ' HA ' ' A' ' 75' ' ' LYS . 55.6 mt -53.14 -58.83 5.67 Favored 'General case' 0 C--O 1.285 2.964 0 CA-C-O 122.87 1.319 . . . . 0.0 110.192 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.737 HG22 ' HB3' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -76.74 -13.4 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.875 -173.552 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.7 m -91.63 -7.54 49.76 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.756 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 12.1 tm0? -84.3 -50.98 7.35 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.408 11.9 t70 -152.58 -97.36 0.05 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.518 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.573 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 75.2 mtm180 -140.26 92.16 2.51 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 120.22 1.373 . . . . 0.0 111.626 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.737 ' HB3' HG22 ' A' ' 79' ' ' VAL . 2.3 t -93.88 161.42 14.32 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.611 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.68 -25.47 0.37 Allowed 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -167.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.044 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 34.6 tt0 -145.13 125.27 13.69 Favored 'General case' 0 CA--C 1.479 -1.765 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.366 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.855 HG21 ' HG3' ' A' ' 75' ' ' LYS . 14.0 p -128.07 103.9 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.9 0 CA-C-O 122.203 1.002 . . . . 0.0 109.685 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 m -100.89 109.36 21.31 Favored 'General case' 1 C--O 1.312 4.359 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.404 -175.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.895 ' HA ' ' HE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -139.51 146.59 40.15 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.547 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.645 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 52.6 mm-40 -146.68 135.43 22.23 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 127.966 2.507 . . . . 0.0 105.667 171.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.726 ' HA3' ' HA ' ' A' ' 8' ' ' ILE . . . -94.21 -13.08 55.37 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 119.048 -1.549 . . . . 0.0 110.098 175.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -110.45 115.64 30.0 Favored 'General case' 0 N--CA 1.426 -1.636 0 O-C-N 122.679 -0.307 . . . . 0.0 110.322 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 59.5 ttp 57.89 75.47 0.38 Allowed 'General case' 0 C--O 1.244 0.777 0 O-C-N 124.62 1.2 . . . . 0.0 111.339 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.895 ' HE2' ' HA ' ' A' ' 89' ' ' LEU . 2.2 t80 -172.6 102.65 0.34 Allowed Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' A' ' 19' ' ' MET . 2.7 Cg_exo -81.32 -32.85 0.83 Allowed 'Trans proline' 0 CA--C 1.504 -0.986 0 C-N-CA 122.763 2.309 . . . . 0.0 110.929 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.49 -142.93 10.42 Favored Glycine 1 N--CA 1.395 -4.076 0 N-CA-C 106.299 -2.721 . . . . 0.0 106.299 -173.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.8 mttm . . . . . 0 C--N 1.279 -2.474 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.153 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.617 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.81 -47.22 19.23 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.098 2.532 . . . . 0.0 112.878 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 133.06 -37.12 2.05 Favored Glycine 0 C--N 1.314 -0.663 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -114.62 140.65 25.56 Favored Pre-proline 0 N--CA 1.433 -1.292 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 174.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -95.96 38.01 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.399 0 C-N-CA 122.855 2.37 . . . . 0.0 116.073 -172.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 41.3 mt-10 -112.13 -37.77 4.95 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.798 177.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.3 m -61.56 -30.67 70.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 pt -60.71 -47.67 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 120.902 0.382 . . . . 0.0 110.829 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.267 3.1 pp -85.22 -13.94 48.35 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.462 ' HE3' ' HB3' ' A' ' 6' ' ' GLU . 93.6 mttt -93.79 -20.5 20.03 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.689 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.7 ttm -90.75 -32.27 16.21 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.414 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.753 HG21 ' HB2' ' A' ' 16' ' ' LYS . 3.8 m -94.2 -40.25 10.11 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.655 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 69' ' ' SER 0.307 68.6 mttm 81.55 -88.79 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 176.327 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 67' ' ' ASP . 24.0 ttmm -130.58 -27.98 2.1 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.873 -1.131 . . . . 0.0 112.83 -173.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.09 47.0 3.1 Favored Glycine 0 C--N 1.286 -2.23 0 C-N-CA 119.532 -1.318 . . . . 0.0 115.255 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.753 ' HB2' HG21 ' A' ' 12' ' ' THR . 16.8 tppt? -129.07 120.93 26.79 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 118.686 1.243 . . . . 0.0 109.376 173.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -91.86 124.99 36.39 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.833 ' HB3' HD12 ' A' ' 89' ' ' LEU . 32.1 mt -130.86 118.51 20.86 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.162 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 24.9 ptm -84.14 111.55 19.44 Favored 'General case' 0 C--N 1.267 -2.982 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.235 171.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.848 ' HG2' HD11 ' A' ' 89' ' ' LEU . 11.3 mtt -84.2 103.19 13.19 Favored 'General case' 0 CA--C 1.46 -2.508 0 C-N-CA 118.499 -1.28 . . . . 0.0 109.38 171.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -89.52 98.07 11.56 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 175.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.418 ' HB ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -104.39 122.9 57.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.309 -170.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.983 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 93.2 m -81.11 134.87 35.73 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 174.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 32' ' ' GLU . 1.6 p -113.43 152.29 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.273 0 CA-C-N 120.721 1.601 . . . . 0.0 107.878 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.659 ' OG ' ' HB2' ' A' ' 85' ' ' ALA . 70.8 m -87.41 160.81 18.19 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 120.815 1.643 . . . . 0.0 107.283 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.798 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 78.39 72.24 1.18 Allowed Glycine 0 N--CA 1.414 -2.774 0 C-N-CA 118.313 -1.899 . . . . 0.0 111.088 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.487 ' OD1' ' HD3' ' A' ' 31' ' ' LYS . 16.7 t-20 -87.87 101.71 2.79 Favored Pre-proline 0 C--O 1.243 0.758 0 CA-C-N 118.262 1.031 . . . . 0.0 109.485 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.798 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 84.1 Cg_endo -118.79 -30.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.486 0 N-CA-C 116.659 1.754 . . . . 0.0 116.659 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.745 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 1.1 p -132.95 -99.47 0.28 Allowed 'General case' 1 N--CA 1.554 4.728 0 C-N-CA 113.73 -3.188 . . . . 0.0 116.339 -164.187 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.796 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . 4.2 tp10 -100.38 7.61 44.16 Favored 'General case' 0 N--CA 1.399 -3.024 1 N-CA-C 97.741 -4.911 . . . . 0.0 97.741 156.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.785 ' HA ' ' HD2' ' A' ' 28' ' ' PRO 0.435 0.2 OUTLIER 82.0 -175.16 0.04 OUTLIER 'General case' 1 N--CA 1.298 -8.066 1 C-N-CA 132.181 4.192 . . . . 0.0 116.226 170.356 . . . . . . . . 6 4 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.784 ' HG3' HD12 ' A' ' 36' ' ' ILE . 9.3 tp10 -61.13 -13.9 20.79 Favored 'General case' 2 N--CA 1.363 -4.817 0 CA-C-N 111.776 -2.465 . . . . 0.0 106.965 173.021 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 54.4 m -67.81 -48.57 65.87 Favored 'General case' 0 N--CA 1.411 -2.378 0 C-N-CA 125.021 1.328 . . . . 0.0 108.457 171.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.796 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 3.7 pt-20 -57.7 -48.85 78.38 Favored 'General case' 0 C--O 1.27 2.158 0 CA-C-O 120.78 0.324 . . . . 0.0 110.203 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -56.78 -56.49 20.84 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 123.496 1.617 . . . . 0.0 110.59 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.784 HD12 ' HG3' ' A' ' 32' ' ' GLU . 13.9 mt -70.54 -30.0 40.8 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.255 0 CA-C-N 112.03 -2.35 . . . . 0.0 112.96 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.814 HG21 HG12 ' A' ' 55' ' ' ILE . 8.1 p -71.82 -44.86 63.19 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 117.948 -1.501 . . . . 0.0 110.055 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.7 p -60.3 -59.67 5.04 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.188 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.3 tp -64.95 -49.72 69.24 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.882 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 37.0 m0 -74.75 -60.84 2.1 Favored 'General case' 0 C--O 1.168 -3.224 0 CA-C-O 117.763 -1.113 . . . . 0.0 110.152 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.757 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.382 0.0 OUTLIER -66.26 -22.31 66.31 Favored 'General case' 0 C--O 1.253 1.248 0 C-N-CA 117.372 -1.731 . . . . 0.0 111.803 -171.721 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.39 -55.83 26.89 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.588 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 37.8 p -67.66 -29.32 68.58 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 116.999 0.399 . . . . 0.0 111.707 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.837 HD12 ' HG2' ' A' ' 53' ' ' ARG . 20.6 mt -60.86 -35.34 76.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.241 0.616 . . . . 0.0 109.871 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.636 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 87.5 t80 -91.32 -27.01 18.66 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.222 175.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.588 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.2 t-20 -66.96 -28.88 68.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.859 0.361 . . . . 0.0 111.253 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.23 -3.49 50.64 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.567 0.699 . . . . 0.0 109.8 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.1 t30 55.88 43.93 26.71 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.267 1.427 . . . . 0.0 112.726 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.521 ' HB3' ' HE2' ' A' ' 70' ' ' TYR . 23.1 m-85 -66.78 5.85 0.57 Allowed 'General case' 0 CA--C 1.597 2.777 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.7 t70 57.2 70.81 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 125.314 1.446 . . . . 0.0 111.713 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.531 ' CG2' ' HD2' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -147.75 171.02 3.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 113.439 -1.71 . . . . 0.0 109.822 -175.168 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.655 ' HG2' ' HB3' ' A' ' 64' ' ' MET . 0.0 OUTLIER -132.54 126.73 33.52 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.67 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.837 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -131.9 134.52 45.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -169.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.806 ' H ' HG12 ' A' ' 62' ' ' ILE . 80.9 m-85 -134.89 152.62 51.9 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -165.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.814 HG12 HG21 ' A' ' 37' ' ' THR . 39.2 mt -89.62 95.11 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 166.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.03 -31.43 4.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.752 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.2 63.25 0.22 Allowed Glycine 0 N--CA 1.403 -3.503 0 C-N-CA 116.391 -2.814 . . . . 0.0 116.717 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.676 ' HB3' ' HE3' ' A' ' 31' ' ' LYS 0.313 13.8 m 21.04 88.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 125.488 1.346 . . . . 0.0 112.586 162.187 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.633 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER 110.0 -16.18 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 128.011 2.525 . . . . 0.0 106.766 -173.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -125.57 134.61 51.9 Favored 'General case' 0 CA--C 1.578 2.019 0 C-N-CA 126.163 1.785 . . . . 0.0 109.816 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.9 169.38 17.67 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.119 1.367 . . . . 0.0 108.141 -171.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.806 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER -141.96 155.9 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.054 0 CA-C-N 121.34 1.882 . . . . 0.0 111.634 173.736 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.559 ' HA ' ' HG3' ' A' ' 53' ' ' ARG 0.289 8.2 p90 -132.64 103.9 6.37 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 126.603 2.439 . . . . 0.0 108.254 161.64 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.655 ' HB3' ' HG2' ' A' ' 52' ' ' GLN . 27.0 ttt -91.22 108.84 20.15 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.311 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.758 HD22 HD12 ' A' ' 18' ' ' LEU 0.26 6.5 mp -66.85 144.84 56.04 Favored 'General case' 0 CA--C 1.472 -2.048 0 C-N-CA 127.97 2.508 . . . . 0.0 112.961 -177.732 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.4 33.7 ttp180 -122.35 -53.67 1.91 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 168.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 15.0 t70 -54.41 7.39 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.39 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 177.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.3 -31.94 0.09 OUTLIER Glycine 0 CA--C 1.569 3.434 0 N-CA-C 116.55 1.38 . . . . 0.0 116.55 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 31.8 t -135.31 87.22 2.31 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 117.787 -1.101 . . . . 0.0 112.832 -170.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.521 ' HE2' ' HB3' ' A' ' 49' ' ' TYR . 0.1 OUTLIER 174.32 -0.69 0.0 OUTLIER 'General case' 0 C--N 1.409 3.184 0 CA-C-N 120.204 1.365 . . . . 0.0 113.241 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.733 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -88.22 -29.9 20.12 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -169.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.773 ' HZ2' ' HG ' ' A' ' 89' ' ' LEU . 28.1 m-90 -78.99 -15.12 58.7 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.133 -0.979 . . . . 0.0 110.341 -176.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.42 -44.15 79.46 Favored 'General case' 0 C--O 1.266 1.944 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 167.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.659 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.0 mt -59.67 -38.56 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.138 175.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.621 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 13.4 tmtt? -65.05 -37.97 89.33 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.529 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.95 -44.89 95.81 Favored 'General case' 0 C--O 1.262 1.72 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.328 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.659 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 12.0 m-85 -57.28 -48.06 79.87 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.773 0.797 . . . . 0.0 109.05 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.882 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 4.2 pp -63.13 -41.88 99.4 Favored 'General case' 0 C--O 1.293 3.345 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.996 HG12 ' HB2' ' A' ' 84' ' ' CYS . 32.6 m -76.29 -11.74 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 CA-C-O 121.838 0.828 . . . . 0.0 109.559 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.2 m -104.06 0.49 29.85 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.939 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.783 ' HG2' ' HE1' ' A' ' 40' ' ' TRP . 60.8 tp60 -85.2 -53.5 5.21 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.341 1.9 p30 -176.64 -94.04 0.0 OUTLIER 'General case' 0 C--O 1.243 0.74 0 O-C-N 125.235 1.584 . . . . 0.0 113.939 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.588 ' HD2' ' HA3' ' A' ' 26' ' ' GLY 0.291 48.2 mtm180 -93.3 131.62 38.26 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 118.328 -1.349 . . . . 0.0 112.243 -177.179 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.996 ' HB2' HG12 ' A' ' 79' ' ' VAL . 4.5 p -154.78 154.51 32.92 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.612 -168.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.659 ' HB2' ' OG ' ' A' ' 25' ' ' SER . . . -159.56 -49.92 0.06 Allowed 'General case' 0 C--N 1.351 0.645 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -174.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.983 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 38.2 tt0 -154.52 127.11 8.02 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 119.517 1.053 . . . . 0.0 112.149 -172.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.418 HG12 ' HB ' ' A' ' 22' ' ' VAL . 12.8 m -111.36 103.79 16.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 173.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.437 ' C ' HD22 ' A' ' 89' ' ' LEU 0.274 23.4 p -102.9 136.49 42.62 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 117.991 -1.483 . . . . 0.0 112.497 177.366 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.848 HD11 ' HG2' ' A' ' 20' ' ' MET . 4.6 mm? -116.73 157.4 25.54 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -167.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.557 ' HB3' HD23 ' A' ' 18' ' ' LEU 0.265 0.1 OUTLIER -79.31 164.24 24.25 Favored 'General case' 0 C--N 1.252 -3.661 0 CA-C-N 110.866 -2.879 . . . . 0.0 109.084 -175.102 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.27 84.35 1.61 Allowed Glycine 0 N--CA 1.415 -2.76 0 CA-C-O 117.816 -1.547 . . . . 0.0 110.799 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -57.87 109.13 0.67 Allowed 'General case' 0 C--N 1.372 1.58 0 CA-C-N 120.048 1.924 . . . . 0.0 107.597 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.467 ' SD ' ' HD2' ' A' ' 97' ' ' LYS . 15.1 tpt 155.92 -41.65 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 -169.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.644 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . 81.1 t80 -49.21 -59.07 7.12 Favored Pre-proline 0 CA--C 1.563 1.47 0 C-N-CA 126.001 1.72 . . . . 0.0 113.767 -177.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.644 ' HD3' ' HB3' ' A' ' 94' ' ' TYR . 11.6 Cg_endo -91.92 10.88 2.47 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.853 1.702 . . . . 0.0 112.589 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -108.39 -47.66 0.91 Allowed Glycine 0 N--CA 1.427 -1.909 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.415 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HD2' ' SD ' ' A' ' 93' ' ' MET . 96.2 mttt . . . . . 0 C--N 1.308 -1.228 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.848 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.23 -173.51 1.88 Allowed 'Trans proline' 0 CA--C 1.554 1.503 0 C-N-CA 121.847 1.698 . . . . 0.0 109.724 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.67 28.79 3.84 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.155 -1.497 . . . . 0.0 110.725 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.485 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 36.8 ttmt -96.93 144.85 28.57 Favored Pre-proline 0 N--CA 1.434 -1.266 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HB3' HD21 ' A' ' 89' ' ' LEU . 5.2 Cg_exo -77.22 -148.74 0.03 OUTLIER 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 123.128 2.552 . . . . 0.0 111.362 176.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.525 ' H ' HD11 ' A' ' 8' ' ' ILE . 44.0 mt-10 74.23 -8.21 1.5 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.134 1.374 . . . . 0.0 113.82 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -61.27 -21.72 64.18 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.825 0.821 . . . . 0.0 109.65 177.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.662 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -57.66 -57.19 11.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 124.881 1.272 . . . . 0.0 110.77 173.844 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.688 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 3.9 pp -77.52 -18.67 56.8 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.724 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 7' ' ' SER . 68.4 mttm -79.95 -22.39 42.69 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.534 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.0 ttt -97.43 -29.49 13.46 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.787 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.435 HG21 ' HD3' ' A' ' 16' ' ' LYS . 20.9 m -84.18 -64.28 1.19 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.831 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 175.34 -73.36 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.64 0.776 . . . . 0.0 109.752 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.688 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 87.5 tttt 179.7 -71.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.807 0.443 . . . . 0.0 110.037 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.18 56.09 1.49 Allowed Glycine 0 CA--C 1.546 1.973 0 C-N-CA 124.032 0.825 . . . . 0.0 114.523 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HD3' HG21 ' A' ' 12' ' ' THR . 57.1 tptt -95.55 133.42 39.59 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 118.842 1.321 . . . . 0.0 109.651 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -71.62 120.91 17.88 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.627 ' HB3' HD22 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -127.91 115.23 18.25 Favored 'General case' 0 C--O 1.197 -1.667 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -171.052 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.53 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 22.3 ttt -86.58 105.21 16.69 Favored 'General case' 0 C--N 1.281 -2.383 0 O-C-N 121.694 -0.629 . . . . 0.0 110.272 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.674 ' HE3' HD11 ' A' ' 65' ' ' LEU . 12.4 ttm -97.65 116.82 30.6 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 117.28 -1.768 . . . . 0.0 112.671 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -100.76 116.55 32.91 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 112.637 -2.074 . . . . 0.0 106.328 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.75 125.89 65.94 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 CA-C-O 121.457 0.646 . . . . 0.0 111.663 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.784 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 88.3 m -84.55 131.17 34.66 Favored 'General case' 0 CA--C 1.595 2.693 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.035 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.404 HG21 HD13 ' A' ' 36' ' ' ILE . 2.0 p -131.29 137.64 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.579 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.43 23.1 t -109.23 -96.62 0.39 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 122.858 2.572 . . . . 0.0 114.277 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.608 ' HA3' ' HG3' ' A' ' 83' ' ' ARG . . . 55.48 -67.14 0.01 OUTLIER Glycine 0 C--N 1.352 1.438 0 CA-C-N 119.654 1.116 . . . . 0.0 113.017 -168.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -118.56 137.49 24.86 Favored Pre-proline 0 N--CA 1.417 -2.1 0 CA-C-N 117.71 0.755 . . . . 0.0 109.323 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.75 40.45 0.91 Allowed 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 122.621 2.214 . . . . 0.0 107.577 170.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.0 m -140.08 143.31 36.25 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 -165.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.457 ' O ' ' HB ' ' A' ' 33' ' ' THR . 32.7 tt0 -68.2 -7.57 31.36 Favored 'General case' 0 C--N 1.371 1.538 0 CA-C-N 120.538 1.517 . . . . 0.0 111.22 -177.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 1.9 tmpt? -52.52 -40.43 62.44 Favored 'General case' 0 C--O 1.257 1.484 0 CA-C-O 121.321 0.581 . . . . 0.0 109.941 174.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.799 ' HG3' HD12 ' A' ' 36' ' ' ILE . 3.4 tp10 -69.23 -56.64 7.0 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 57.3 m -39.84 -47.77 2.18 Favored 'General case' 0 C--O 1.189 -2.111 0 C-N-CA 125.697 1.599 . . . . 0.0 111.897 171.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.4 pt-20 -70.99 -53.46 14.74 Favored 'General case' 0 C--O 1.253 1.275 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.65 -36.1 82.69 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.102 -1.439 . . . . 0.0 109.292 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.799 HD12 ' HG3' ' A' ' 32' ' ' GLU . 2.7 mt -68.0 -41.3 84.44 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.379 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.405 176.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.898 HG21 HG12 ' A' ' 55' ' ' ILE . 11.7 p -69.78 -40.09 76.25 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 120.299 1.409 . . . . 0.0 111.115 -176.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 p -64.72 -50.87 65.24 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 124.111 0.882 . . . . 0.0 110.039 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 mt -61.84 -49.42 76.36 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.048 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.629 ' CZ2' ' HB2' ' A' ' 78' ' ' LEU . 45.1 m0 -61.23 -71.97 0.13 Allowed 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 1.012 ' HB3' HH11 ' A' ' 53' ' ' ARG 0.314 0.0 OUTLIER -70.27 -18.65 63.13 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 117.521 -1.672 . . . . 0.0 112.078 -176.752 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.9 -48.44 80.78 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.412 173.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 54.3 p -79.01 -34.73 43.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 122.763 -0.257 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.984 HD12 ' HD2' ' A' ' 53' ' ' ARG . 11.4 mt -62.28 -33.17 74.13 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.894 0.378 . . . . 0.0 110.637 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -86.65 -30.07 22.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.408 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 9.2 t30 -66.17 -36.2 82.46 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.82 4.37 37.39 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.908 -0.495 . . . . 0.0 109.954 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.1 t30 58.57 47.9 12.65 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.471 1.108 . . . . 0.0 112.379 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -68.08 -13.13 61.96 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.578 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 26.5 t0 62.12 78.21 0.3 Allowed 'General case' 0 C--N 1.353 0.734 0 CA-C-O 122.755 1.264 . . . . 0.0 109.58 -176.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 m -140.84 177.38 3.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.13 -170.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -139.17 131.07 27.7 Favored 'General case' 0 C--O 1.177 -2.739 0 N-CA-C 104.001 -2.592 . . . . 0.0 104.001 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 1.012 HH11 ' HB3' ' A' ' 41' ' ' GLN . 23.2 mtp-105 -138.06 145.92 42.34 Favored 'General case' 0 C--N 1.273 -2.725 0 O-C-N 121.442 -0.786 . . . . 0.0 109.044 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.825 ' H ' HG12 ' A' ' 62' ' ' ILE . 15.1 t80 -134.67 151.2 50.85 Favored 'General case' 0 C--O 1.259 1.566 0 C-N-CA 118.028 -1.469 . . . . 0.0 113.3 -168.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.898 HG12 HG21 ' A' ' 37' ' ' THR . 58.0 mt -93.77 107.07 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 89.7 t -94.59 -48.16 13.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.484 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.35 177.95 40.49 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 117.553 -2.26 . . . . 0.0 114.962 -174.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.569 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 4.8 p -72.71 44.03 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 127.138 2.175 . . . . 0.0 114.192 -176.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' A' ' 58' ' ' SER . 2.5 p-10 148.58 6.18 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 125.73 1.612 . . . . 0.0 107.377 -169.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.515 ' HB3' ' HB ' ' A' ' 56' ' ' VAL . 7.2 mpt_? -127.9 133.34 49.28 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 123.959 0.904 . . . . 0.0 110.583 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.59 161.51 38.32 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.825 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -138.16 156.38 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.454 -2.725 0 C-N-CA 118.014 -1.474 . . . . 0.0 110.883 171.382 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.952 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 5.8 p90 -128.77 113.82 15.81 Favored 'General case' 0 N--CA 1.413 -2.287 0 O-C-N 126.88 2.612 . . . . 0.0 106.776 161.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.409 ' HB2' ' CD1' ' A' ' 62' ' ' ILE . 20.7 ttt -97.13 118.1 32.8 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 122.017 0.913 . . . . 0.0 111.413 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.674 HD11 ' HE3' ' A' ' 20' ' ' MET . 5.8 mp -73.4 145.88 45.52 Favored 'General case' 0 CA--C 1.47 -2.124 0 CA-C-N 112.189 -2.278 . . . . 0.0 111.54 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.578 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.362 58.8 ttt180 -118.2 -62.13 1.58 Allowed 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 176.098 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 69' ' ' SER . 9.4 t70 -71.9 17.59 0.09 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 120.267 1.394 . . . . 0.0 112.924 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.644 ' HA3' ' O ' ' A' ' 14' ' ' LYS . . . 58.37 -32.71 0.02 OUTLIER Glycine 0 CA--C 1.551 2.34 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 -169.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.436 ' H ' ' C ' ' A' ' 67' ' ' ASP . 14.8 m -93.67 20.4 7.52 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -166.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.489 ' HE1' ' H ' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -148.25 125.44 11.48 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.597 -0.69 . . . . 0.0 111.069 178.361 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.555 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 171.91 -30.95 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 124.178 0.924 . . . . 0.0 112.227 176.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.59 ' NE1' ' HE1' ' A' ' 20' ' ' MET 0.428 5.3 m-90 -89.02 -28.3 20.27 Favored 'General case' 0 C--O 1.267 2.022 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -165.859 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 38.9 tt0 -72.43 -39.16 68.09 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 170.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 71' ' ' ALA . 30.5 mt -51.63 -48.86 36.15 Favored 'Isoleucine or valine' 0 C--O 1.286 3.024 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.9 173.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.608 ' O ' HG22 ' A' ' 79' ' ' VAL . 21.4 pttp -67.07 -37.85 84.72 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.75 -46.53 74.34 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.202 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.572 ' CZ ' ' HG2' ' A' ' 73' ' ' GLU . 18.0 m-85 -60.96 -59.23 5.71 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.922 0.868 . . . . 0.0 109.646 -175.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.629 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.1 pp -63.33 -40.42 97.26 Favored 'General case' 0 C--O 1.266 1.932 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -171.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.647 ' HB ' ' CB ' ' A' ' 84' ' ' CYS 0.265 27.6 m -80.36 -12.88 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 118.343 -1.343 . . . . 0.0 111.622 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.8 m -97.3 -0.05 47.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.2 tp60 -87.99 -54.54 4.18 Favored 'General case' 0 CA--C 1.475 -1.942 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.472 38.0 t70 -137.71 -92.99 0.21 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 175.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.608 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 18.8 mmt180 -99.14 153.28 19.03 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 120.96 1.709 . . . . 0.0 110.955 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.647 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 24.8 p -152.07 154.97 37.0 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.251 -173.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.44 -51.16 0.02 OUTLIER 'General case' 0 C--N 1.355 0.84 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.784 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 36.9 tt0 -153.84 116.91 4.52 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.776 -173.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.96 101.68 12.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.258 23.5 p -105.19 120.62 41.98 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 123.1 1.429 . . . . 0.0 114.758 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 5' ' ' PRO . 1.2 mp -75.25 156.78 35.35 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 112.155 -2.293 . . . . 0.0 106.527 177.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.559 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 40.5 tt0 -95.29 159.69 14.89 Favored 'General case' 0 C--N 1.278 -2.514 0 C-N-CA 124.031 0.932 . . . . 0.0 108.992 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.59 68.93 1.49 Allowed Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.325 -1.264 . . . . 0.0 111.728 173.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.492 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 98.2 mt-30 -50.07 108.96 0.25 Allowed 'General case' 0 C--N 1.374 1.645 0 CA-C-N 118.541 1.171 . . . . 0.0 113.568 -173.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.448 ' O ' ' HB2' ' A' ' 7' ' ' SER . 60.1 mtt -158.03 17.48 0.24 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 127.354 2.262 . . . . 0.0 106.533 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.492 ' CE2' ' HA ' ' A' ' 92' ' ' GLN . 7.5 p90 -123.3 92.22 49.13 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.356 -171.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -93.12 -3.7 3.27 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 122.398 2.065 . . . . 0.0 112.012 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.22 80.31 1.06 Allowed Glycine 0 N--CA 1.423 -2.196 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt . . . . . 0 C--N 1.298 -1.642 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.512 -177.879 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.551 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.53 3.23 7.7 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.254 2.636 . . . . 0.0 112.844 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.12 -36.48 93.0 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -88.34 140.19 30.29 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.86 33.7 0.24 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.22 2.613 . . . . 0.0 115.559 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.601 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . 34.2 mm-40 -72.05 -20.96 61.6 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 101.75 -3.426 . . . . 0.0 101.75 156.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.7 m 73.49 167.19 0.3 Allowed 'General case' 1 N--CA 1.37 -4.449 0 CA-C-N 112.809 -1.996 . . . . 0.0 109.768 167.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.423 HG13 ' H ' ' A' ' 8' ' ' ILE . 2.2 mt -46.24 -25.23 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.644 0.735 . . . . 0.0 112.324 174.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.031 ' HB3' ' HA ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -73.63 -58.75 3.09 Favored 'General case' 0 N--CA 1.421 -1.886 0 C-N-CA 124.268 1.027 . . . . 0.0 109.974 -173.197 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.601 ' HB2' ' HB3' ' A' ' 6' ' ' GLU . 94.6 mttt -76.21 -22.88 54.72 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.095 -1.042 . . . . 0.0 109.778 -175.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.9 tpt -70.61 -42.88 70.37 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.657 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.5 m -145.85 -33.09 0.34 Allowed 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -173.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 9' ' ' LEU . 72.8 mmtt -104.22 87.85 2.85 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -166.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.487 ' HD3' ' HA ' ' A' ' 10' ' ' LYS . 3.5 mmmp? -110.23 -19.69 12.92 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.327 174.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.74 60.87 0.51 Allowed Glycine 0 CA--C 1.55 2.265 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.57 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -131.2 134.53 46.56 Favored 'General case' 0 C--N 1.365 1.253 0 CA-C-N 120.157 1.978 . . . . 0.0 111.362 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -78.65 123.21 26.89 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.661 ' CD1' HD12 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -133.18 103.15 5.86 Favored 'General case' 0 C--O 1.191 -2.001 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -174.171 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.678 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 9.4 ptp -84.1 116.92 23.13 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.891 -1.13 . . . . 0.0 110.891 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.878 ' HG2' HD11 ' A' ' 89' ' ' LEU . 93.1 mtp -86.7 99.28 11.65 Favored 'General case' 0 CA--C 1.487 -1.466 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.246 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.458 ' CZ ' ' HD2' ' A' ' 60' ' ' ARG . 12.3 t80 -89.04 106.05 18.18 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.451 HG22 ' NE ' ' A' ' 83' ' ' ARG . 9.1 p -126.28 125.91 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.923 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.039 -165.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.073 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 31.4 m -92.88 142.31 27.46 Favored 'General case' 0 C--O 1.276 2.477 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.596 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.915 HG23 ' HA ' ' A' ' 83' ' ' ARG . 7.5 p -131.03 128.52 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 103.681 -2.711 . . . . 0.0 103.681 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.61 20.79 1.04 Allowed 'General case' 0 C--O 1.245 0.864 0 CA-C-N 122.478 2.399 . . . . 0.0 112.347 -171.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.64 -31.83 73.88 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 106.821 -2.511 . . . . 0.0 106.821 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.93 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 24.8 t-20 -118.46 104.58 47.48 Favored Pre-proline 0 N--CA 1.405 -2.711 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.54 32.23 0.45 Allowed 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.736 2.291 . . . . 0.0 112.395 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.41 ' HB ' ' H ' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -146.81 -161.24 1.28 Allowed 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.628 -173.379 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.7 tp10 -76.69 -18.29 58.62 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 5.0 tmtt? -64.56 -52.42 57.71 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.93 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.4 tp10 -71.01 -35.44 72.03 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 117.777 -1.569 . . . . 0.0 107.643 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 54.5 m -49.6 -57.52 6.99 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.029 172.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 15.2 pt-20 -65.98 -40.25 91.06 Favored 'General case' 0 C--O 1.255 1.371 0 C-N-CA 122.792 0.437 . . . . 0.0 111.784 -176.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -51.69 -63.0 1.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.695 HG23 ' CE3' ' A' ' 40' ' ' TRP . 35.4 mt -67.21 -44.46 87.66 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 112.384 -2.189 . . . . 0.0 112.957 -175.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.773 ' HB ' HG12 ' A' ' 55' ' ' ILE . 32.4 p -65.35 -53.49 42.87 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.547 -0.861 . . . . 0.0 112.011 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.9 t -70.55 -46.87 62.73 Favored 'General case' 0 C--O 1.257 1.46 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.429 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.73 -43.13 66.39 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.759 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.695 ' CE3' HG23 ' A' ' 36' ' ' ILE . 37.9 m0 -73.29 -61.75 1.71 Allowed 'General case' 0 C--O 1.167 -3.262 0 CA-C-O 117.486 -1.245 . . . . 0.0 109.65 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.828 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.377 0.0 OUTLIER -63.47 -25.69 68.38 Favored 'General case' 0 C--O 1.253 1.278 0 C-N-CA 117.871 -1.532 . . . . 0.0 112.608 -172.166 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.94 -50.92 59.47 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 171.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.741 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 58.7 p -74.06 -25.29 59.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.344 0.572 . . . . 0.0 111.404 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.782 HD12 ' HG2' ' A' ' 53' ' ' ARG . 32.5 mt -62.62 -33.51 75.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 176.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.536 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 89.9 t80 -87.97 -32.8 18.68 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.45 173.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.741 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 6.9 t30 -62.36 -36.96 83.87 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.11 3.21 52.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.277 0.561 . . . . 0.0 110.017 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.7 t30 53.24 51.89 14.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.226 1.41 . . . . 0.0 112.568 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -64.73 -7.02 9.25 Favored 'General case' 0 CA--C 1.595 2.69 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.0 t70 61.04 67.88 0.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.141 1.377 . . . . 0.0 110.037 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.669 HG23 ' HD2' ' A' ' 53' ' ' ARG . 2.6 m -147.92 175.42 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.249 -171.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.481 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 17.5 mt-30 -130.96 125.18 32.72 Favored 'General case' 0 C--O 1.189 -2.131 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 177.731 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.828 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -134.5 136.6 43.25 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -172.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.814 ' H ' HG12 ' A' ' 62' ' ' ILE . 47.9 t80 -135.03 150.49 50.31 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 118.187 -1.405 . . . . 0.0 113.579 -166.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.773 HG12 ' HB ' ' A' ' 37' ' ' THR . 19.1 mt -93.23 96.36 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 171.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -80.01 -33.85 14.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.81 -178.87 40.38 Favored Glycine 0 CA--C 1.484 -1.905 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.245 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -60.24 121.01 10.9 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.258 0.0 OUTLIER 79.3 8.67 1.77 Allowed 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 121.937 0.875 . . . . 0.0 111.379 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.458 ' HD2' ' CZ ' ' A' ' 21' ' ' PHE . 1.3 tpp180 -137.56 118.92 14.69 Favored 'General case' 0 CA--C 1.573 1.858 0 O-C-N 121.45 -0.781 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.07 162.1 34.27 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -175.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.814 HG12 ' H ' ' A' ' 54' ' ' PHE . 2.5 pt -142.49 157.13 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 C-N-CA 117.422 -1.711 . . . . 0.0 110.337 170.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.526 ' CE2' ' HB ' ' A' ' 74' ' ' ILE 0.296 9.0 p90 -133.02 101.33 5.18 Favored 'General case' 0 N--CA 1.426 -1.672 0 O-C-N 126.264 2.227 . . . . 0.0 108.394 161.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.678 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 25.0 ttt -87.17 113.88 23.3 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.73 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.687 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.315 2.3 mp -80.66 148.22 30.31 Favored 'General case' 0 CA--C 1.442 -3.173 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.287 -178.092 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -117.54 163.12 16.9 Favored 'General case' 0 C--N 1.252 -3.637 0 N-CA-C 104.513 -2.403 . . . . 0.0 104.513 169.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 76.98 -36.22 0.25 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.17 -29.13 7.87 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 119.895 -1.145 . . . . 0.0 114.16 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 1.031 ' HA ' ' HB3' ' A' ' 9' ' ' LEU . 38.9 m -96.07 32.95 1.81 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -167.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 41.9 p90 -178.43 137.07 0.16 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 117.029 -1.463 . . . . 0.0 109.744 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.687 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 164.0 -35.45 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.128 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 171.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.685 ' HZ2' ' HG ' ' A' ' 89' ' ' LEU 0.298 22.0 m-90 -80.36 -9.76 59.75 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 120.376 -1.453 . . . . 0.0 111.684 -172.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.14 -35.62 69.14 Favored 'General case' 0 C--O 1.299 3.684 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.526 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 67.3 mt -62.53 -39.35 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 174.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.659 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 12.4 tmtt? -61.53 -37.23 83.01 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.729 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.83 -48.15 81.86 Favored 'General case' 0 C--O 1.261 1.691 0 C-N-CA 119.619 -0.833 . . . . 0.0 110.138 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -57.48 -45.14 85.19 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.366 1.079 . . . . 0.0 110.11 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.714 HD12 HG13 ' A' ' 79' ' ' VAL 0.271 4.2 pp -61.06 -48.77 80.18 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -179.167 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.714 HG13 HD12 ' A' ' 78' ' ' LEU . 23.7 m -75.18 -6.87 9.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 117.458 -1.697 . . . . 0.0 112.22 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -96.59 -5.9 38.07 Favored 'General case' 0 N--CA 1.403 -2.792 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.721 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -100.75 -58.12 1.96 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.6 t70 164.16 173.11 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.484 1 N-CA-C 99.532 -4.247 . . . . 0.0 99.532 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.915 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER 74.23 89.75 0.09 Allowed 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -163.547 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.692 ' HA ' HG12 ' A' ' 79' ' ' VAL . 12.6 p -153.69 56.84 0.74 Allowed 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.787 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.77 -62.68 1.11 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.073 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 33.2 tt0 -134.44 125.28 27.13 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 120.65 1.568 . . . . 0.0 110.202 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.8 t -117.66 111.41 34.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.489 ' O ' HD22 ' A' ' 89' ' ' LEU . 38.8 p -124.95 129.19 49.86 Favored 'General case' 0 C--O 1.277 2.509 0 C-N-CA 118.751 -1.179 . . . . 0.0 112.726 174.096 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.878 HD11 ' HG2' ' A' ' 20' ' ' MET . 4.4 mm? -129.84 155.8 45.41 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.985 -175.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -81.53 157.48 24.79 Favored 'General case' 0 C--N 1.245 -3.956 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.88 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 134.38 173.4 13.13 Favored Glycine 0 CA--C 1.548 2.15 0 CA-C-O 118.48 -1.178 . . . . 0.0 110.999 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -95.11 132.62 39.83 Favored 'General case' 0 C--N 1.363 1.159 0 CA-C-N 120.25 2.025 . . . . 0.0 109.06 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.8 tpt 54.54 56.67 6.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.187 0.994 . . . . 0.0 109.805 -176.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.81 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 83.7 t80 -80.95 -49.69 1.04 Allowed Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.448 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 94' ' ' TYR . 22.7 Cg_endo -59.84 140.2 91.99 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.2 1.933 . . . . 0.0 112.331 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.22 -71.71 0.27 Allowed Glycine 0 N--CA 1.417 -2.61 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.444 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 118.104 -0.95 . . . . 0.0 108.734 177.82 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.52 -8.14 13.7 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.613 2.209 . . . . 0.0 113.09 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 137.07 -43.11 1.25 Allowed Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 62.9 pttt -114.32 129.73 24.61 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 6.2 Cg_exo -76.49 165.17 29.54 Favored 'Trans proline' 0 C--O 1.248 1.002 0 C-N-CA 122.906 2.404 . . . . 0.0 112.903 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.616 ' HA ' ' CE3' ' A' ' 72' ' ' TRP . 92.2 mt-10 66.68 10.37 7.41 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.438 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.4 p -66.93 -34.55 78.01 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.684 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.619 ' CG2' ' HA ' ' A' ' 97' ' ' LYS . 1.5 pt -59.45 -49.67 82.73 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.899 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.559 HD12 ' HG3' ' A' ' 10' ' ' LYS 0.364 1.3 pp -81.68 -31.24 32.32 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.559 ' HG3' HD12 ' A' ' 9' ' ' LEU . 54.8 mtpt -86.57 -21.88 26.6 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.928 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.2 ttt -99.5 -36.23 9.62 Favored 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.635 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.6 m -88.9 -50.25 6.31 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 118.55 -1.26 . . . . 0.0 112.944 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.88 113.29 0.49 Allowed 'General case' 0 C--O 1.253 1.284 0 CA-C-N 119.131 0.878 . . . . 0.0 113.173 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.57 ' HD2' ' HB3' ' A' ' 69' ' ' SER . 53.7 mtmt -94.34 -176.3 3.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 174.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.13 -36.86 1.3 Allowed Glycine 0 CA--C 1.546 1.993 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.95 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -68.35 121.9 17.25 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 117.604 0.702 . . . . 0.0 110.237 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.6 m -67.15 123.13 19.42 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.48 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.683 HD13 ' H ' ' A' ' 90' ' ' GLU . 0.4 OUTLIER -122.76 121.23 35.82 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 -176.13 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.478 ' HB3' ' HG3' ' A' ' 64' ' ' MET . 14.9 ptt? -109.05 133.74 52.59 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.371 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.545 ' SD ' ' HA ' ' A' ' 89' ' ' LEU . 2.9 mpp? -108.86 118.93 38.07 Favored 'General case' 0 CA--C 1.46 -2.511 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.672 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -103.94 128.78 51.46 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 171.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.44 124.13 69.01 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.542 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.629 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.975 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 95.8 m -75.43 124.88 27.92 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 173.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.523 HG21 HD13 ' A' ' 36' ' ' ILE . 1.9 p -128.45 124.35 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.361 0 CA-C-N 120.319 1.418 . . . . 0.0 111.568 -169.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.941 ' HB2' ' HB2' ' A' ' 83' ' ' ARG . 33.0 t 70.68 -50.15 0.67 Allowed 'General case' 0 C--N 1.363 1.176 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 167.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.24 23.5 9.62 Favored Glycine 0 N--CA 1.415 -2.715 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.31 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.497 ' ND2' ' HB3' ' A' ' 32' ' ' GLU 0.251 9.2 p30 -116.65 111.08 41.72 Favored Pre-proline 0 N--CA 1.417 -2.101 0 C-N-CA 117.609 -1.636 . . . . 0.0 112.205 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.727 ' HA ' ' HB3' ' A' ' 58' ' ' SER . 12.6 Cg_exo -74.19 37.17 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.805 2.337 . . . . 0.0 109.598 176.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.2 m -88.62 52.7 2.5 Favored 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.239 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.603 ' O ' ' HG3' ' A' ' 30' ' ' GLU . 7.6 tp10 66.1 19.92 11.17 Favored 'General case' 0 C--N 1.414 3.377 0 CA-C-O 126.803 3.192 . . . . 0.0 103.328 -162.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.789 ' HB3' ' HA ' ' A' ' 58' ' ' SER 0.517 0.0 OUTLIER 62.42 144.8 0.02 OUTLIER 'General case' 2 N--CA 1.259 -10.019 0 CA-C-O 127.461 3.505 . . . . 0.0 114.104 -178.934 . . . . . . . . 5 4 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.896 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -66.98 -10.44 49.58 Favored 'General case' 2 N--CA 1.348 -5.543 0 CA-C-N 110.191 -3.186 . . . . 0.0 105.01 169.214 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.636 ' H ' ' HB2' ' A' ' 31' ' ' LYS . 94.3 m -69.18 -35.12 75.94 Favored 'General case' 1 N--CA 1.359 -4.976 0 C-N-CA 127.921 2.488 . . . . 0.0 108.463 174.572 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.604 ' HG3' ' N ' ' A' ' 35' ' ' GLU . 3.9 pt-20 -74.19 -40.77 62.28 Favored 'General case' 0 C--N 1.389 2.319 0 CA-C-N 121.487 1.949 . . . . 0.0 106.941 177.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.604 ' N ' ' HG3' ' A' ' 34' ' ' GLU . 9.7 tp10 -59.4 -56.69 18.78 Favored 'General case' 0 C--O 1.279 2.634 0 CA-C-O 124.087 1.899 . . . . 0.0 108.576 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.896 ' HB ' ' O ' ' A' ' 32' ' ' GLU . 1.1 mt -70.3 -25.17 26.73 Favored 'Isoleucine or valine' 0 C--O 1.163 -3.455 0 CA-C-N 111.74 -2.482 . . . . 0.0 112.305 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.537 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 6.7 p -74.04 -41.9 61.09 Favored 'General case' 0 CA--C 1.464 -2.328 0 CA-C-N 121.697 2.044 . . . . 0.0 109.466 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 m -60.18 -51.62 68.8 Favored 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.858 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.5 tp -72.32 -49.68 32.59 Favored 'General case' 0 C--O 1.25 1.123 0 C-N-CA 118.038 -1.465 . . . . 0.0 111.434 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.689 ' CZ2' ' HB2' ' A' ' 78' ' ' LEU . 51.0 m0 -69.27 -67.99 0.44 Allowed 'General case' 0 C--O 1.189 -2.106 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.409 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.555 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.36 0.0 OUTLIER -69.9 -20.36 63.37 Favored 'General case' 0 C--O 1.254 1.303 0 C-N-CA 118.516 -1.273 . . . . 0.0 112.075 -170.865 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.32 -53.36 45.03 Favored Glycine 0 C--N 1.365 2.18 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.653 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 36.7 p -69.83 -29.77 67.11 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.53 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.887 HD12 ' HG2' ' A' ' 53' ' ' ARG . 25.5 mt -59.64 -35.01 73.54 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.691 0.397 . . . . 0.0 110.547 177.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.57 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 82.3 t80 -91.08 -27.37 18.63 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.653 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 8.7 t30 -64.79 -34.89 79.41 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.692 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.24 0.53 57.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.865 0.365 . . . . 0.0 110.491 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.3 t30 53.24 57.79 5.9 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.967 1.307 . . . . 0.0 112.46 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.46 ' HB3' ' HE2' ' A' ' 70' ' ' TYR . 37.8 m-85 -73.8 -0.21 15.1 Favored 'General case' 0 CA--C 1.597 2.763 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.5 t70 62.05 67.78 0.72 Allowed 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 124.402 1.081 . . . . 0.0 110.792 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.628 HG12 ' HA ' ' A' ' 65' ' ' LEU . 6.7 m -147.36 174.83 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.502 -172.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.531 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 28.6 mp0 -131.51 131.68 43.62 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 172.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.887 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -129.74 129.85 44.68 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -174.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.864 ' H ' HG12 ' A' ' 62' ' ' ILE . 29.2 t80 -133.93 152.36 51.83 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 119.095 -1.042 . . . . 0.0 113.112 -159.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.587 HG23 HG21 ' A' ' 33' ' ' THR . 75.3 mt -88.17 107.32 17.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.877 175.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.756 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 97.1 t -81.47 -40.97 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.025 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.56 -171.34 43.63 Favored Glycine 0 CA--C 1.469 -2.825 0 C-N-CA 118.629 -1.748 . . . . 0.0 113.46 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.789 ' HA ' ' HB3' ' A' ' 31' ' ' LYS . 6.6 m -62.0 118.26 7.04 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 118.057 -0.973 . . . . 0.0 108.742 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' A' ' 58' ' ' SER . 2.4 t70 80.89 11.16 0.91 Allowed 'General case' 0 N--CA 1.408 -2.566 0 CA-C-O 122.545 1.164 . . . . 0.0 109.228 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.756 ' HB3' ' HB ' ' A' ' 56' ' ' VAL . 11.4 mpt_? -137.1 116.08 12.36 Favored 'General case' 0 CA--C 1.562 1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 112.149 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.62 163.1 22.68 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.129 0.972 . . . . 0.0 108.728 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.864 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.7 OUTLIER -139.52 158.08 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.223 0 C-N-CA 118.223 -1.391 . . . . 0.0 111.128 173.118 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.629 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 2.3 p90 -129.08 106.75 9.07 Favored 'General case' 0 N--CA 1.419 -2.009 0 O-C-N 126.485 2.365 . . . . 0.0 106.917 164.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.478 ' HG3' ' HB3' ' A' ' 19' ' ' MET . 23.1 ttt -94.99 117.04 29.48 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.273 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.727 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.484 0.0 OUTLIER -114.34 147.73 38.68 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -177.339 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.354 36.3 ttp180 -104.57 -62.6 1.31 Allowed 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -164.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -55.92 -8.08 0.39 Allowed 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.474 ' O ' HD13 ' A' ' 9' ' ' LEU . . . 58.83 15.98 29.49 Favored Glycine 0 C--N 1.369 2.375 0 CA-C-N 120.194 1.361 . . . . 0.0 115.09 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.57 ' HB3' ' HD2' ' A' ' 14' ' ' LYS . 15.9 p -116.66 22.19 12.89 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 118.39 1.095 . . . . 0.0 113.597 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.46 ' HE2' ' HB3' ' A' ' 49' ' ' TYR . 2.3 p90 177.8 145.79 0.12 Allowed 'General case' 0 C--O 1.245 0.823 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -167.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.727 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 160.48 -28.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 125.166 1.541 . . . . 0.0 111.92 171.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.616 ' CE3' ' HA ' ' A' ' 6' ' ' GLU 0.522 7.1 m0 -89.48 -16.4 30.88 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 117.071 -1.852 . . . . 0.0 115.176 -169.196 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.92 -36.38 80.07 Favored 'General case' 0 C--O 1.257 1.457 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 165.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 57.2 mt -53.89 -50.13 54.76 Favored 'Isoleucine or valine' 0 C--O 1.29 3.204 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.795 174.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.618 ' O ' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -63.42 -36.11 82.65 Favored 'General case' 0 C--N 1.373 1.612 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.243 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.79 -47.07 83.6 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.84 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 13.9 m-85 -58.18 -60.25 4.04 Favored 'General case' 0 C--N 1.365 1.245 0 CA-C-O 122.35 1.071 . . . . 0.0 109.198 -175.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.689 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.6 pp -62.29 -38.46 89.44 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 75' ' ' LYS . 34.0 m -80.09 -9.75 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 118.203 -1.399 . . . . 0.0 111.431 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.0 m -105.8 3.29 28.62 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -107.3 -45.95 3.99 Favored 'General case' 0 CA--C 1.473 -2.014 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.269 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.78 -160.79 0.86 Allowed 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.941 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 24.2 mmt180 -80.35 159.67 25.68 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 120.127 1.33 . . . . 0.0 110.123 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.611 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 26.7 p -136.59 146.1 45.69 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.256 -172.2 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.27 -53.43 0.13 Allowed 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.975 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.5 tt0 -153.72 118.82 5.08 Favored 'General case' 0 C--O 1.195 -1.809 0 CA-C-N 119.806 1.184 . . . . 0.0 110.68 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.9 t -113.14 101.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.324 17.4 p -108.64 132.69 53.65 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 123.387 1.565 . . . . 0.0 114.489 177.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.545 ' HA ' ' SD ' ' A' ' 20' ' ' MET . 3.7 mp -88.31 156.75 19.01 Favored 'General case' 0 C--N 1.263 -3.18 0 CA-C-N 110.807 -2.906 . . . . 0.0 108.093 -174.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.683 ' H ' HD13 ' A' ' 18' ' ' LEU . 10.6 tp10 -80.82 155.3 26.69 Favored 'General case' 0 C--N 1.272 -2.785 0 O-C-N 121.429 -0.795 . . . . 0.0 108.93 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.67 53.01 17.77 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.606 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -65.9 107.43 1.84 Allowed 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 118.116 0.958 . . . . 0.0 112.148 -176.312 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 23.4 mmt -169.08 30.54 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 128.479 2.712 . . . . 0.0 105.031 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.606 ' CE2' ' HA ' ' A' ' 92' ' ' GLN . 2.5 p90 -111.37 100.64 48.26 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.509 -173.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -96.34 25.73 0.27 Allowed 'Trans proline' 0 C--O 1.249 1.068 0 C-N-CA 123.598 2.866 . . . . 0.0 110.575 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 127.05 -62.88 0.61 Allowed Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -174.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.619 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . 6.6 ttpm? . . . . . 0 C--N 1.314 -0.958 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.256 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.4 -1.76 9.53 Favored 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 123.429 2.753 . . . . 0.0 113.702 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.94 -37.03 74.13 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 121.35 -0.452 . . . . 0.0 112.594 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 21.6 pttp -101.19 133.67 20.81 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 117.219 0.51 . . . . 0.0 110.219 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.646 ' C ' ' H ' ' A' ' 7' ' ' SER . 4.9 Cg_exo -80.55 -165.82 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.144 2.562 . . . . 0.0 112.846 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 72.66 -27.94 0.19 Allowed 'General case' 0 N--CA 1.518 2.946 0 C-N-CA 127.355 2.262 . . . . 0.0 107.35 -164.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.646 ' H ' ' C ' ' A' ' 5' ' ' PRO . 26.1 t -80.5 -176.07 5.52 Favored 'General case' 1 N--CA 1.357 -5.084 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 173.47 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.537 ' O ' HD12 ' A' ' 9' ' ' LEU . 10.0 tp 38.11 45.22 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 123.977 0.911 . . . . 0.0 109.433 -164.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.026 HD13 ' HG2' ' A' ' 13' ' ' LYS 0.394 1.8 pp 64.37 67.67 0.57 Allowed 'General case' 0 C--N 1.389 2.3 0 CA-C-O 123.46 1.6 . . . . 0.0 113.959 171.658 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 13' ' ' LYS 0.36 0.0 OUTLIER 54.27 43.49 30.46 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 111.978 -2.374 . . . . 0.0 113.093 -179.516 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.617 ' SD ' ' HB3' ' A' ' 5' ' ' PRO . 1.7 tpt 65.25 57.45 0.93 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.21 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.804 HG22 ' HA ' ' A' ' 69' ' ' SER . 24.3 m 68.38 55.43 0.51 Allowed 'General case' 0 CA--C 1.596 2.715 0 O-C-N 122.127 -0.358 . . . . 0.0 111.879 170.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.026 ' HG2' HD13 ' A' ' 9' ' ' LEU . 21.8 ptmt -46.77 125.24 7.02 Favored 'General case' 0 C--N 1.387 2.213 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -76.02 -14.41 60.22 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.083 0.953 . . . . 0.0 112.752 -171.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.3 44.49 1.48 Allowed Glycine 0 C--N 1.285 -2.265 0 C-N-CA 119.547 -1.311 . . . . 0.0 113.609 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.482 ' HE3' ' HB2' ' A' ' 18' ' ' LEU . 55.2 tptt -130.41 133.57 46.46 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 119.027 1.414 . . . . 0.0 112.632 -176.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 20.8 p -108.21 110.02 21.54 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.426 0.69 . . . . 0.0 109.474 173.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.925 HD23 ' HH2' ' A' ' 72' ' ' TRP . 30.8 tp -135.0 124.51 24.97 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -171.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.703 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.1 ptp -85.39 109.26 18.3 Favored 'General case' 0 C--O 1.207 -1.148 0 O-C-N 121.47 -0.769 . . . . 0.0 111.487 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.626 ' HA ' ' CG ' ' A' ' 89' ' ' LEU . 4.5 mpp? -84.36 128.94 34.87 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.526 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 59.6 t80 -111.05 109.06 18.99 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 125.502 1.751 . . . . 0.0 108.46 -169.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.05 128.79 75.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 114.76 1.392 . . . . 0.0 114.76 -169.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.974 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 49.5 m -87.41 141.41 28.65 Favored 'General case' 0 CA--C 1.595 2.708 0 C-N-CA 127.322 2.249 . . . . 0.0 109.006 176.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 83' ' ' ARG . 35.9 t -132.0 97.33 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.014 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -166.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 83' ' ' ARG 0.324 60.8 m 62.3 -30.07 0.08 Allowed 'General case' 0 C--N 1.389 2.293 0 N-CA-C 119.085 2.995 . . . . 0.0 119.085 170.229 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.474 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 123.76 1.5 8.97 Favored Glycine 0 N--CA 1.426 -2.018 0 C-N-CA 118.39 -1.862 . . . . 0.0 115.269 175.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.575 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.3 t-20 -79.65 104.66 2.51 Favored Pre-proline 0 C--O 1.22 -0.452 0 CA-C-N 119.04 1.42 . . . . 0.0 107.862 173.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 82.2 Cg_endo -91.52 33.71 0.29 Allowed 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 123.348 2.699 . . . . 0.0 109.532 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 m -129.53 155.19 46.18 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -69.94 3.37 2.7 Favored 'General case' 0 C--O 1.182 -2.455 0 CA-C-N 121.741 2.064 . . . . 0.0 111.824 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.565 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 1.8 tmtt? -60.0 -55.48 33.44 Favored 'General case' 0 C--O 1.275 2.43 0 CA-C-O 121.947 0.88 . . . . 0.0 111.228 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.812 ' HG3' HD12 ' A' ' 36' ' ' ILE . 1.7 tp10 -65.2 -52.3 55.64 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -176.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 93.1 m -42.89 -52.76 4.99 Favored 'General case' 0 C--O 1.187 -2.213 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.765 172.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 11.9 pt-20 -62.4 -55.47 27.6 Favored 'General case' 0 C--O 1.263 1.811 0 CA-C-N 118.689 0.677 . . . . 0.0 112.071 -175.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' A' ' 34' ' ' GLU . 9.3 tp10 -58.93 -53.84 53.89 Favored 'General case' 0 C--O 1.254 1.311 0 CA-C-O 122.972 1.368 . . . . 0.0 108.235 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.812 HD12 ' HG3' ' A' ' 32' ' ' GLU . 5.3 mt -64.24 -40.95 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.368 0 CA-C-N 112.527 -2.124 . . . . 0.0 113.331 -176.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.888 HG21 HG12 ' A' ' 55' ' ' ILE . 21.5 p -70.47 -37.7 74.31 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 120.214 1.37 . . . . 0.0 110.048 -177.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.4 m -63.45 -46.29 86.96 Favored 'General case' 0 N--CA 1.417 -2.08 0 O-C-N 123.966 0.791 . . . . 0.0 109.417 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.2 tp -73.03 -43.83 61.57 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.97 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.734 ' CE3' HD12 ' A' ' 78' ' ' LEU . 48.1 m0 -66.89 -70.24 0.26 Allowed 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 119.353 -0.356 . . . . 0.0 111.067 -177.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.713 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.294 0.0 OUTLIER -73.06 -19.26 61.21 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.832 -173.222 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.32 -50.89 59.03 Favored Glycine 0 C--N 1.357 1.726 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 172.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 60.9 p -69.64 -28.95 66.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.466 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.936 HD12 ' HG2' ' A' ' 53' ' ' ARG . 15.5 mt -62.49 -32.89 73.86 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.743 176.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.554 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 83.5 t80 -87.11 -31.56 20.38 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.057 0.456 . . . . 0.0 109.872 176.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 25.8 t-20 -67.21 -30.26 70.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.126 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.2 4.81 44.33 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 122.3 -0.25 . . . . 0.0 111.106 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.2 t30 56.92 47.14 18.32 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.048 0.939 . . . . 0.0 112.687 174.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.51 151.62 19.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.54 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 28.6 t70 -92.98 95.52 9.53 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 121.751 2.069 . . . . 0.0 109.115 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.706 HG12 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -146.84 162.75 8.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.009 -173.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HB3' ' HE1' ' A' ' 54' ' ' PHE . 28.4 mp0 -126.38 121.34 32.22 Favored 'General case' 0 C--O 1.199 -1.574 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 174.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.936 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -127.9 136.99 52.13 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.29 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.708 ' H ' HG12 ' A' ' 62' ' ' ILE . 46.3 m-85 -133.3 152.63 51.94 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -163.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.888 HG12 HG21 ' A' ' 37' ' ' THR . 46.8 mt -91.53 96.89 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 169.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.2 m -102.67 -20.56 5.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.753 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.37 174.98 47.4 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 117.728 -2.177 . . . . 0.0 114.066 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 51.0 m -75.05 117.98 17.49 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 23' ' ' THR . 5.4 t70 80.02 7.69 1.61 Allowed 'General case' 0 C--N 1.365 1.26 0 O-C-N 124.272 0.982 . . . . 0.0 108.835 -174.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.526 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 1.5 tpp180 -130.37 117.46 19.76 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.669 -176.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.09 163.11 29.2 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.708 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -135.86 157.38 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.38 0 C-N-CA 117.739 -1.585 . . . . 0.0 110.106 174.366 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.609 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 2.4 p90 -134.61 106.97 7.24 Favored 'General case' 0 N--CA 1.428 -1.567 0 O-C-N 126.192 2.183 . . . . 0.0 107.923 162.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.703 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 23.6 ttt -90.23 116.37 28.16 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 119.039 -0.505 . . . . 0.0 109.975 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.79 HD23 ' H ' ' A' ' 18' ' ' LEU . 1.1 pt? -90.75 144.49 25.67 Favored 'General case' 0 C--O 1.259 1.594 0 O-C-N 124.972 1.42 . . . . 0.0 112.202 -174.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.544 ' HA ' HG22 ' A' ' 17' ' ' THR 0.285 2.7 tmt_? -118.09 -53.32 2.37 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 125.575 1.797 . . . . 0.0 114.666 177.596 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.573 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 32.6 t70 -43.96 -19.87 0.02 OUTLIER 'General case' 0 CA--C 1.586 2.334 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.71 -25.55 4.53 Favored Glycine 0 C--N 1.358 1.788 0 CA-C-N 120.322 1.419 . . . . 0.0 115.384 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.804 ' HA ' HG22 ' A' ' 12' ' ' THR . 68.8 m -137.2 49.02 2.04 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -170.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.573 ' CE1' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -156.17 -0.48 0.14 Allowed 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.37 -0.831 . . . . 0.0 113.158 -176.877 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.545 ' CB ' HD13 ' A' ' 65' ' ' LEU . . . -86.11 -39.18 16.99 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 -169.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.925 ' HH2' HD23 ' A' ' 18' ' ' LEU 0.428 28.8 m-90 -80.95 -14.1 58.27 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 116.511 -2.076 . . . . 0.0 112.126 -171.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -71.88 -36.92 70.22 Favored 'General case' 0 C--O 1.279 2.653 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 166.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.629 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 73.7 mt -57.58 -42.83 82.08 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.991 ' HG3' HG21 ' A' ' 87' ' ' VAL . 22.5 ttpp -51.87 -52.37 50.14 Favored 'General case' 0 C--N 1.374 1.644 0 C-N-CA 125.067 1.347 . . . . 0.0 109.441 177.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.07 -34.92 70.65 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.801 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.629 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 14.9 m-85 -74.02 -57.65 3.83 Favored 'General case' 0 CA--C 1.466 -2.287 0 C-N-CA 118.522 -1.271 . . . . 0.0 107.907 -169.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.734 HD12 ' CE3' ' A' ' 40' ' ' TRP . 1.8 pt? -68.51 -35.57 77.66 Favored 'General case' 0 N--CA 1.4 -2.966 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.731 -169.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 75' ' ' LYS 0.286 23.1 m -78.2 -19.99 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 116.594 -2.042 . . . . 0.0 110.67 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.9 m -95.22 5.61 51.29 Favored 'General case' 0 N--CA 1.411 -2.401 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.96 169.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.522 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . 49.7 tp60 -89.03 -41.9 12.06 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -176.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.553 ' OD2' ' HG2' ' A' ' 83' ' ' ARG 0.386 17.7 t70 -140.35 -85.77 0.21 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.553 ' HB2' HG13 ' A' ' 24' ' ' VAL . 21.4 mmt180 -110.35 165.39 11.81 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.96 1.709 . . . . 0.0 109.836 176.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.563 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 24.6 p -159.89 148.22 17.18 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.08 -54.31 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.862 1.265 . . . . 0.0 112.193 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.974 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 40.4 tt0 -154.96 123.15 5.9 Favored 'General case' 0 C--O 1.207 -1.173 0 C-N-CA 119.63 -0.828 . . . . 0.0 113.163 -169.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.991 HG21 ' HG3' ' A' ' 75' ' ' LYS . 62.0 t -112.0 104.51 17.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 173.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.525 ' O ' HD23 ' A' ' 89' ' ' LEU . 10.0 p -113.44 148.36 36.05 Favored 'General case' 0 C--O 1.266 1.954 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.74 ' CD1' ' HG ' ' A' ' 18' ' ' LEU 0.864 0.9 OUTLIER -137.63 156.68 47.79 Favored 'General case' 0 N--CA 1.44 -0.944 1 N-CA-C 122.567 4.284 . . . . 0.0 122.567 -177.612 . . . . . . . . 5 4 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.631 ' H ' HD22 ' A' ' 89' ' ' LEU 0.254 27.7 tt0 -81.63 160.08 23.86 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 110.652 -2.976 . . . . 0.0 110.026 -177.448 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 128.29 152.51 7.82 Favored Glycine 0 CA--C 1.545 1.957 0 CA-C-O 117.759 -1.579 . . . . 0.0 109.4 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -79.11 113.47 17.26 Favored 'General case' 0 C--N 1.366 1.289 0 CA-C-N 120.946 2.373 . . . . 0.0 107.054 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 52.7 ttm 67.35 84.36 0.15 Allowed 'General case' 0 C--N 1.316 -0.882 0 O-C-N 124.648 1.217 . . . . 0.0 109.971 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 73.9 t80 -105.28 106.43 55.83 Favored Pre-proline 0 C--N 1.299 -1.608 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.234 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -96.19 10.64 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.309 2.672 . . . . 0.0 113.749 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.64 37.49 3.42 Favored Glycine 0 C--O 1.241 0.592 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.1 tttt . . . . . 0 C--O 1.259 1.559 0 C-N-CA 123.583 0.753 . . . . 0.0 110.163 -175.0 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.466 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.77 -25.28 14.73 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.828 2.352 . . . . 0.0 113.394 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.45 -37.97 1.26 Allowed Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 20.2 pttp -110.37 121.42 41.48 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 173.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 5.4 Cg_exo -81.52 110.52 2.2 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.278 2.652 . . . . 0.0 112.457 -174.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.34 -26.73 4.59 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.787 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.0 m -62.69 -20.83 65.25 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.171 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.845 HG23 HD12 ' A' ' 9' ' ' LEU . 3.9 tp -47.69 -66.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.317 172.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.845 HD12 HG23 ' A' ' 8' ' ' ILE . 3.1 mp -84.96 -32.8 22.84 Favored 'General case' 0 CA--C 1.48 -1.737 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.109 -176.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -68.18 -15.8 63.73 Favored 'General case' 0 N--CA 1.433 -1.323 0 O-C-N 123.871 0.732 . . . . 0.0 112.333 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.2 ttt -112.45 -34.42 5.87 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.207 173.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.1 m -89.85 -55.6 3.57 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -176.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HD2' ' HB2' ' A' ' 16' ' ' LYS . 12.1 tmtt? 173.37 116.46 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -172.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.771 ' HA ' ' HB3' ' A' ' 9' ' ' LEU . 34.5 mtmm -82.61 169.9 15.75 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.22 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.29 55.44 12.67 Favored Glycine 0 CA--C 1.559 2.824 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.116 -173.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.541 ' HB2' ' HD2' ' A' ' 13' ' ' LYS . 54.2 tptt -128.28 122.93 32.82 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 119.345 1.573 . . . . 0.0 111.004 -177.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.774 HG22 ' HA ' ' A' ' 66' ' ' ARG . 19.3 p -72.33 135.65 45.97 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.428 174.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.622 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -134.24 116.6 15.5 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.447 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.2 ptm -94.63 119.1 32.75 Favored 'General case' 0 C--N 1.287 -2.125 0 O-C-N 121.623 -0.673 . . . . 0.0 109.195 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.915 ' HE2' HD23 ' A' ' 89' ' ' LEU . 1.3 pmm? -121.8 133.41 54.9 Favored 'General case' 0 C--O 1.281 2.753 0 C-N-CA 118.008 -1.477 . . . . 0.0 113.621 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -96.34 119.33 34.63 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.599 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -121.44 131.22 73.58 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.787 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.338 -176.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.077 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 97.1 m -99.46 151.88 20.62 Favored 'General case' 1 CA--C 1.648 4.748 0 C-N-CA 130.669 3.588 . . . . 0.0 112.31 -178.355 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.839 ' HB ' ' HG2' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -121.49 155.97 25.51 Favored 'Isoleucine or valine' 0 C--N 1.405 2.996 0 C-N-CA 126.246 1.818 . . . . 0.0 108.007 -168.415 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.672 ' OG ' ' HB2' ' A' ' 85' ' ' ALA . 54.2 m -108.18 168.92 8.95 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-N 120.628 1.558 . . . . 0.0 107.37 171.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.01 -88.5 0.47 Allowed Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 119.651 1.114 . . . . 0.0 112.198 174.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -115.78 113.04 42.47 Favored Pre-proline 0 N--CA 1.417 -2.076 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.75 30.27 0.32 Allowed 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 123.84 3.027 . . . . 0.0 112.982 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.538 ' OG1' ' HD2' ' A' ' 31' ' ' LYS . 70.2 p -128.41 -163.78 1.31 Allowed 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 33' ' ' THR . 37.9 tt0 -84.24 1.8 42.98 Favored 'General case' 0 N--CA 1.421 -1.907 0 O-C-N 121.382 -0.824 . . . . 0.0 111.49 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.552 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -69.66 -44.93 69.54 Favored 'General case' 0 C--O 1.281 2.717 0 O-C-N 120.987 -1.071 . . . . 0.0 112.181 -177.857 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.776 ' HG3' HD13 ' A' ' 36' ' ' ILE . 3.2 tp10 -69.99 -44.08 70.12 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.753 ' HA ' HH21 ' A' ' 60' ' ' ARG . 20.1 m -44.02 -63.67 0.82 Allowed 'General case' 0 C--O 1.183 -2.422 0 CA-C-N 112.616 -2.083 . . . . 0.0 111.338 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 13.1 pt-20 -58.2 -52.82 63.98 Favored 'General case' 0 C--O 1.255 1.354 0 O-C-N 124.419 1.075 . . . . 0.0 113.125 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.701 ' HG3' HD12 ' A' ' 36' ' ' ILE . 8.8 pt-20 -66.41 -44.29 83.4 Favored 'General case' 0 C--O 1.27 2.151 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.699 -176.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.776 HD13 ' HG3' ' A' ' 32' ' ' GLU . 1.3 mp -66.43 -44.1 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.795 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.473 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.779 HG21 HG12 ' A' ' 55' ' ' ILE . 33.4 p -68.09 -39.79 82.77 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 120.039 1.291 . . . . 0.0 111.618 -175.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.3 p -60.98 -54.0 50.33 Favored 'General case' 0 C--O 1.262 1.719 0 O-C-N 124.276 0.985 . . . . 0.0 109.6 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.09 -44.21 96.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.411 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.644 ' CE3' HD13 ' A' ' 78' ' ' LEU . 42.0 m0 -64.7 -74.99 0.09 Allowed 'General case' 0 C--O 1.205 -1.244 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.722 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.365 0.0 OUTLIER -70.68 -18.17 62.83 Favored 'General case' 0 C--O 1.255 1.349 0 C-N-CA 118.457 -1.297 . . . . 0.0 112.409 -172.185 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.9 -49.81 65.31 Favored Glycine 0 N--CA 1.432 -1.619 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 171.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 75.9 p -71.76 -26.83 62.61 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.333 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.761 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 28.7 mt -59.65 -37.88 79.91 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.702 176.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.51 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 86.6 t80 -86.26 -33.33 20.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.481 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 7.5 t30 -65.11 -34.66 78.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.07 9.1 20.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.926 0.393 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 59.88 35.49 21.81 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.709 1.203 . . . . 0.0 113.652 172.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . 0.497 ' O ' HG13 ' A' ' 51' ' ' VAL . 13.7 m-85 -78.05 25.23 0.22 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 25.67 76.65 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.678 0 C-N-CA 126.811 2.045 . . . . 0.0 113.671 -177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.989 HG12 ' HA ' ' A' ' 65' ' ' LEU . 1.5 m -146.5 175.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.134 -173.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 64' ' ' MET . 11.3 tm0? -134.33 120.9 20.47 Favored 'General case' 0 C--O 1.194 -1.853 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.761 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.75 131.16 35.19 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -169.737 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.814 ' H ' HG12 ' A' ' 62' ' ' ILE . 36.4 t80 -136.59 148.62 47.61 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 118.835 -1.146 . . . . 0.0 113.901 -164.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.779 HG12 HG21 ' A' ' 37' ' ' THR . 71.5 mt -80.39 123.28 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 170.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.21 -29.2 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.15 152.83 20.1 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.835 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 49.5 m -85.08 82.27 8.5 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.032 0.444 . . . . 0.0 110.505 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.477 ' HB2' HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER 158.81 -32.35 0.0 OUTLIER 'General case' 0 N--CA 1.384 -3.742 0 N-CA-C 101.467 -3.531 . . . . 0.0 101.467 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.839 ' HG2' ' HB ' ' A' ' 24' ' ' VAL 0.457 1.1 mmp_? -145.41 -179.64 6.79 Favored 'General case' 0 C--N 1.391 2.41 1 N-CA-C 124.954 5.168 . . . . 0.0 124.954 -167.91 . . . . . . . . 4 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 60' ' ' ARG . . . -152.6 172.44 16.6 Favored 'General case' 0 C--N 1.382 2.002 0 CA-C-N 112.526 -2.125 . . . . 0.0 111.449 -160.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.814 HG12 ' H ' ' A' ' 54' ' ' PHE . 13.7 pt -123.12 158.55 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.439 -3.307 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.466 ' O ' ' SD ' ' A' ' 20' ' ' MET 0.288 4.0 p90 -123.21 121.15 35.2 Favored 'General case' 0 N--CA 1.401 -2.893 0 O-C-N 126.447 2.342 . . . . 0.0 105.742 160.45 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 52' ' ' GLN . 1.3 tmt? -105.6 117.48 34.13 Favored 'General case' 0 C--N 1.273 -2.752 0 O-C-N 120.98 -1.075 . . . . 0.0 109.528 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.989 ' HA ' HG12 ' A' ' 51' ' ' VAL . 2.4 pt? -104.53 148.31 26.62 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.774 ' HA ' HG22 ' A' ' 17' ' ' THR 0.28 45.7 ttm105 -112.88 -55.47 2.52 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.605 -2.543 . . . . 0.0 115.291 -174.474 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -44.86 -21.11 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.659 0 CA-C-N 120.6 1.545 . . . . 0.0 115.019 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.416 ' O ' HD21 ' A' ' 9' ' ' LEU . . . 85.64 -31.93 3.79 Favored Glycine 0 N--CA 1.426 -1.968 0 O-C-N 120.907 -1.121 . . . . 0.0 113.965 -175.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 m -121.03 69.43 0.89 Allowed 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -166.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.956 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -179.82 2.14 0.01 OUTLIER 'General case' 0 C--N 1.381 1.965 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 179.376 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.938 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -85.18 -34.94 21.97 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -171.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.602 ' CE2' HD22 ' A' ' 89' ' ' LEU . 13.8 m-90 -72.4 -28.39 62.95 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-O 122.287 1.041 . . . . 0.0 110.343 -175.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.422 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 44.1 tt0 -69.03 -43.29 75.03 Favored 'General case' 0 C--O 1.258 1.552 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.55 171.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.502 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 84.2 mt -56.66 -42.15 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.109 0 CA-C-O 121.695 0.76 . . . . 0.0 109.787 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.688 ' HE2' ' HB ' ' A' ' 87' ' ' VAL . 52.7 tttm -56.49 -51.43 68.52 Favored 'General case' 0 C--O 1.282 2.802 0 C-N-CA 124.79 1.236 . . . . 0.0 109.707 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -55.15 -47.37 75.22 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.561 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 11.4 m-85 -53.55 -59.44 4.59 Favored 'General case' 0 C--N 1.366 1.292 0 O-C-N 123.872 0.733 . . . . 0.0 109.353 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.644 HD13 ' CE3' ' A' ' 40' ' ' TRP . 16.4 mt -52.89 -53.37 50.15 Favored 'General case' 0 C--O 1.3 3.732 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -172.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.478 ' HB ' ' CB ' ' A' ' 84' ' ' CYS 0.308 27.8 m -75.8 -9.38 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.198 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.873 -177.494 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.2 m -100.23 2.32 42.68 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.599 166.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 69.9 mm-40 -91.04 -40.89 11.38 Favored 'General case' 0 CA--C 1.439 -3.309 0 C-N-CA 118.909 -1.117 . . . . 0.0 109.519 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.412 35.6 t70 -155.91 -90.72 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.621 ' HB2' HG22 ' A' ' 24' ' ' VAL . 31.8 mmt180 -102.09 144.24 30.91 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 120.747 1.612 . . . . 0.0 110.559 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.478 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 10.6 p -140.59 135.64 31.98 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.672 ' HB2' ' OG ' ' A' ' 25' ' ' SER . . . -149.85 -51.67 0.15 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.077 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 32.9 tt0 -154.75 116.52 4.14 Favored 'General case' 0 C--O 1.181 -2.517 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.538 -173.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.688 ' HB ' ' HE2' ' A' ' 75' ' ' LYS . 14.2 t -111.4 102.21 13.64 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.7 p -109.84 125.19 52.5 Favored 'General case' 0 CA--C 1.473 -1.994 0 C-N-CA 117.619 -1.632 . . . . 0.0 112.023 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.915 HD23 ' HE2' ' A' ' 20' ' ' MET . 4.1 mp -106.72 154.14 21.39 Favored 'General case' 1 N--CA 1.371 -4.41 0 CA-C-N 112.257 -2.247 . . . . 0.0 107.667 -176.02 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.415 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -81.29 163.03 23.23 Favored 'General case' 0 C--N 1.261 -3.272 0 C-N-CA 124.792 1.237 . . . . 0.0 109.695 -175.407 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.87 172.36 22.54 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -88.24 109.0 19.58 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 121.169 2.484 . . . . 0.0 106.714 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 27.2 ttt 54.98 75.91 0.28 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.392 1.057 . . . . 0.0 108.213 -171.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 54.7 t80 -80.77 117.67 69.0 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.467 -175.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 94' ' ' TYR . 40.0 Cg_endo -103.37 162.14 0.25 Allowed 'Trans proline' 0 CA--C 1.553 1.475 0 C-N-CA 123.679 2.919 . . . . 0.0 112.237 173.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.55 79.99 1.33 Allowed Glycine 0 C--N 1.313 -0.726 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.288 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 97' ' ' LYS . 37.8 ttpt . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.416 ' HA3' ' SD ' ' A' ' 93' ' ' MET . . . . . . . . 0 CA--C 1.505 -0.542 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -70.87 -25.5 23.38 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.71 2.274 . . . . 0.0 112.909 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.74 28.16 69.57 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -75.75 137.72 70.09 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.98 40.81 0.98 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.437 2.758 . . . . 0.0 114.034 -171.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 47.7 mt-10 -82.03 -14.74 55.48 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 158.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.0 m -58.21 158.37 7.17 Favored 'General case' 0 CA--C 1.589 2.467 0 CA-C-N 112.415 -2.175 . . . . 0.0 105.772 167.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 11' ' ' MET 0.296 8.8 tp 40.56 46.79 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.285 2.959 0 C-N-CA 124.577 1.151 . . . . 0.0 111.462 -167.306 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 13' ' ' LYS 0.276 1.6 pp 51.43 63.05 2.4 Favored 'General case' 0 C--N 1.399 2.754 0 CA-C-O 122.717 1.246 . . . . 0.0 112.635 171.409 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER 61.93 32.63 17.79 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 112.367 -2.197 . . . . 0.0 111.885 -177.59 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.889 ' HA ' HG23 ' A' ' 8' ' ' ILE . 56.1 ttm 58.72 24.19 11.94 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.743 -177.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.4 m -158.92 -67.26 0.08 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.208 -1.557 . . . . 0.0 114.245 -170.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.799 ' HA ' HD13 ' A' ' 9' ' ' LEU . 59.8 tttp -179.52 124.81 0.08 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.069 0.395 . . . . 0.0 110.313 -174.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -151.12 179.59 8.15 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.04 52.17 0.86 Allowed Glycine 0 CA--C 1.536 1.36 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -89.07 135.76 33.38 Favored 'General case' 0 C--O 1.205 -1.26 0 CA-C-N 117.726 0.763 . . . . 0.0 109.84 -174.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 93.0 m -65.46 117.93 8.68 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.937 ' HG ' ' HH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -126.65 111.91 14.86 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.627 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 21.9 ptm -94.9 114.97 26.88 Favored 'General case' 0 C--N 1.277 -2.558 0 O-C-N 121.112 -0.992 . . . . 0.0 109.401 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.564 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 29.8 ttm -97.66 119.21 35.83 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.107 -176.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.436 ' HA ' HG22 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -107.02 119.17 38.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.022 1.729 . . . . 0.0 106.758 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.677 HG21 HG21 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -127.54 128.53 69.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -175.505 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.888 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 48.8 m -85.97 142.39 28.83 Favored 'General case' 0 CA--C 1.6 2.892 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.382 176.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 83' ' ' ARG 0.283 42.0 t -132.27 140.51 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 C-N-CA 125.414 1.486 . . . . 0.0 108.687 -170.778 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.526 20.8 t -109.55 -110.34 0.33 Allowed 'General case' 0 C--N 1.369 1.45 0 CA-C-N 122.957 2.617 . . . . 0.0 113.523 168.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.641 ' HA3' ' HG3' ' A' ' 83' ' ' ARG . . . 63.05 -72.34 0.03 OUTLIER Glycine 0 CA--C 1.543 1.827 0 CA-C-N 120.802 1.637 . . . . 0.0 112.402 -173.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.774 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 55.4 t30 -116.76 132.44 23.39 Favored Pre-proline 0 N--CA 1.416 -2.143 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 176.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -91.75 41.76 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.557 1.505 . . . . 0.0 113.298 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.5 p -125.18 -129.73 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 117.828 -1.549 . . . . 0.0 111.141 -173.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.543 ' O ' ' HB ' ' A' ' 33' ' ' THR . 31.2 tt0 -133.76 11.83 4.02 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 171.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.554 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 8.9 tmtt? -86.13 -36.95 19.26 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 122.231 1.015 . . . . 0.0 108.337 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.793 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -65.98 -46.07 79.37 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 175.249 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.543 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 58.8 m -45.28 -54.35 7.19 Favored 'General case' 0 C--O 1.193 -1.87 0 C-N-CA 125.696 1.598 . . . . 0.0 111.655 170.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.554 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.9 pt-20 -63.6 -49.72 72.23 Favored 'General case' 0 C--O 1.257 1.46 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -59.14 -55.66 32.09 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.749 1.261 . . . . 0.0 108.265 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.793 ' HB ' ' O ' ' A' ' 32' ' ' GLU . 3.1 mt -62.41 -42.81 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.123 0 CA-C-N 112.997 -1.911 . . . . 0.0 112.529 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.736 HG21 HG12 ' A' ' 55' ' ' ILE . 17.9 p -70.98 -39.56 72.41 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 120.819 1.645 . . . . 0.0 111.703 -176.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.8 p -63.27 -52.5 61.8 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.922 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.7 tp -63.7 -45.56 89.45 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.089 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.812 ' CD2' HD12 ' A' ' 78' ' ' LEU . 45.3 m0 -63.26 -74.52 0.09 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 119.364 -0.351 . . . . 0.0 111.52 -178.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.81 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.311 0.0 OUTLIER -71.06 -19.87 62.43 Favored 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.896 -1.122 . . . . 0.0 112.501 -172.279 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.45 -51.53 53.72 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 173.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.3 p -68.7 -30.92 69.68 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.261 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.774 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 33.5 mt -58.66 -37.16 75.37 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.319 177.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.689 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 64.1 t80 -85.64 -32.56 21.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.873 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.41 -37.4 86.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.4 2.03 51.63 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.123 0.487 . . . . 0.0 110.626 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.3 t30 58.99 51.8 6.9 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.951 1.3 . . . . 0.0 112.116 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -84.34 37.09 0.61 Allowed 'General case' 0 CA--C 1.558 1.258 0 O-C-N 120.903 -1.123 . . . . 0.0 113.473 175.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.2 t70 27.1 71.02 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 C-N-CA 126.397 1.879 . . . . 0.0 114.087 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 65' ' ' LEU . 1.3 m -147.66 169.57 3.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.329 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.501 ' O ' ' HB3' ' A' ' 64' ' ' MET . 0.5 OUTLIER -122.12 126.26 47.98 Favored 'General case' 0 C--O 1.189 -2.107 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 175.03 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.81 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -133.29 135.8 45.09 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -173.377 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.736 ' H ' HG12 ' A' ' 62' ' ' ILE . 44.5 t80 -135.4 151.55 50.57 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 119.245 -0.982 . . . . 0.0 113.208 -164.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.736 HG12 HG21 ' A' ' 37' ' ' THR . 43.2 mt -87.01 96.86 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 172.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 m -89.51 -32.28 5.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -163.3 167.68 37.68 Favored Glycine 0 CA--C 1.489 -1.573 0 C-N-CA 117.402 -2.333 . . . . 0.0 114.663 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -70.69 104.12 2.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 0.1 OUTLIER 91.99 18.73 0.03 OUTLIER 'General case' 0 C--N 1.36 1.027 0 C-N-CA 128.378 2.671 . . . . 0.0 110.101 -177.73 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.564 ' CG ' ' HA ' ' A' ' 23' ' ' THR . 17.8 mtm180 -146.07 132.0 19.17 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.53 165.36 25.07 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.251 -173.243 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.736 HG12 ' H ' ' A' ' 54' ' ' PHE . 6.0 pt -140.64 158.8 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.414 0 C-N-CA 118.283 -1.367 . . . . 0.0 110.634 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.501 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 1.1 p90 -133.81 106.72 7.47 Favored 'General case' 0 N--CA 1.423 -1.785 0 O-C-N 126.31 2.256 . . . . 0.0 108.065 162.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.627 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 1.2 tmt? -83.8 112.75 20.38 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 113.022 -1.899 . . . . 0.0 107.66 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.86 HD13 ' HB2' ' A' ' 71' ' ' ALA 0.329 2.3 pt? -109.26 147.73 32.15 Favored 'General case' 0 CA--C 1.468 -2.207 0 CA-C-O 123.487 1.613 . . . . 0.0 114.988 -177.183 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -100.82 -53.14 3.13 Favored 'General case' 0 C--N 1.252 -3.673 0 CA-C-N 110.365 -3.107 . . . . 0.0 112.539 -174.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.435 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 16.1 t70 -39.8 -24.85 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 114.725 1.379 . . . . 0.0 114.725 165.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.67 -34.19 0.71 Allowed Glycine 0 C--O 1.202 -1.901 0 C-N-CA 123.842 0.734 . . . . 0.0 114.761 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 15.2 p -96.96 -49.1 5.16 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 119.493 3.145 . . . . 0.0 119.493 -173.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.435 ' CE1' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -65.46 10.14 0.1 Allowed 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -172.21 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.86 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -84.71 -23.14 29.47 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 121.156 -0.965 . . . . 0.0 113.15 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.937 ' HH2' ' HG ' ' A' ' 18' ' ' LEU . 5.8 m-90 -67.63 -41.14 84.36 Favored 'General case' 0 C--O 1.277 2.547 0 CA-C-O 121.857 0.837 . . . . 0.0 111.035 -176.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 42.9 tt0 -67.21 -44.82 78.59 Favored 'General case' 0 C--O 1.295 3.461 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.616 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 90.5 mt -51.32 -49.75 29.9 Favored 'Isoleucine or valine' 0 C--O 1.281 2.762 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.719 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.533 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 21.2 pttp -63.57 -40.03 95.91 Favored 'General case' 0 C--N 1.383 2.063 0 CA-C-O 121.586 0.708 . . . . 0.0 110.522 -174.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.59 -34.41 72.7 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.496 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.616 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 21.6 m-85 -69.68 -69.61 0.33 Allowed 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -172.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.812 HD12 ' CD2' ' A' ' 40' ' ' TRP . 2.4 pt? -64.33 -34.71 78.78 Favored 'General case' 0 C--O 1.272 2.246 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.704 -167.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.677 HG21 HG21 ' A' ' 22' ' ' VAL . 34.6 t -83.63 -25.05 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 C-N-CA 117.903 -1.519 . . . . 0.0 109.304 -172.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.8 m -96.16 7.84 45.39 Favored 'General case' 0 N--CA 1.407 -2.615 0 C-N-CA 117.673 -1.611 . . . . 0.0 108.562 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.0 tp60 -91.12 -52.63 4.73 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.094 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.451 ' OD1' ' HG2' ' A' ' 83' ' ' ARG 0.388 9.2 t70 -110.9 -95.13 0.43 Allowed 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.045 -1.062 . . . . 0.0 112.192 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.641 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 52.9 mmt-85 -112.98 152.86 28.91 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 121.425 1.921 . . . . 0.0 111.49 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.632 ' HB3' ' O ' ' A' ' 79' ' ' VAL . 13.0 p -138.03 160.67 38.75 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.011 -172.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.79 -54.39 0.02 OUTLIER 'General case' 0 C--N 1.379 1.865 0 C-N-CA 124.133 0.973 . . . . 0.0 113.001 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.888 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 34.8 tt0 -155.66 131.01 9.55 Favored 'General case' 0 C--O 1.208 -1.119 0 O-C-N 121.874 -0.516 . . . . 0.0 110.946 -170.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' A' ' 22' ' ' VAL . 16.0 m -115.01 115.28 49.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.222 172.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.495 ' C ' HD12 ' A' ' 89' ' ' LEU 0.28 32.2 p -112.28 123.91 51.3 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 123.207 1.479 . . . . 0.0 112.022 172.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.695 ' HB2' ' CZ ' ' A' ' 94' ' ' TYR . 6.0 mp -113.19 156.48 23.17 Favored 'General case' 0 N--CA 1.39 -3.44 0 CA-C-N 113.091 -1.868 . . . . 0.0 110.271 -170.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.564 ' HB3' HD13 ' A' ' 18' ' ' LEU . 9.1 tp10 -81.06 167.9 19.24 Favored 'General case' 0 C--N 1.257 -3.415 0 C-N-CA 125.615 1.566 . . . . 0.0 111.607 -174.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 146.66 171.11 15.64 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -87.22 109.17 19.3 Favored 'General case' 0 C--N 1.364 1.215 0 CA-C-N 121.777 2.788 . . . . 0.0 107.667 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.416 ' SD ' ' HA3' ' A' ' 1' ' ' GLY . 47.4 ttm 54.18 77.7 0.18 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.037 0.922 . . . . 0.0 109.737 -171.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.695 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 26.9 t80 -83.65 114.25 52.43 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.741 -175.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 94' ' ' TYR . 4.2 Cg_endo -89.87 -21.11 1.07 Allowed 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.879 2.386 . . . . 0.0 111.988 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.503 ' HA2' ' CZ ' ' A' ' 94' ' ' TYR . . . 133.37 -131.49 6.11 Favored Glycine 0 N--CA 1.411 -3.003 0 N-CA-C 107.714 -2.155 . . . . 0.0 107.714 -173.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? . . . . . 0 C--N 1.281 -2.391 0 CA-C-O 117.011 -1.471 . . . . 0.0 109.211 178.771 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.705 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.84 -25.73 23.29 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.716 2.277 . . . . 0.0 112.314 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.09 29.11 9.82 Favored Glycine 0 C--O 1.243 0.668 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.475 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 21.6 ptmt -66.14 136.99 95.55 Favored Pre-proline 0 C--O 1.254 1.311 0 C-N-CA 123.17 0.588 . . . . 0.0 110.129 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 31.6 Cg_exo -62.41 150.02 88.78 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.519 2.146 . . . . 0.0 113.368 -177.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.683 ' HA ' HD21 ' A' ' 9' ' ' LEU 0.251 42.9 mt-10 73.79 -39.41 0.43 Allowed 'General case' 0 C--O 1.244 0.786 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 176.788 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.526 ' HA ' ' HG3' ' A' ' 10' ' ' LYS . 66.2 m -63.94 -36.39 83.78 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.265 0.4 OUTLIER -70.05 -38.71 75.92 Favored 'Isoleucine or valine' 0 C--O 1.255 1.351 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -178.39 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.683 HD21 ' HA ' ' A' ' 6' ' ' GLU . 2.4 pt? -79.21 -29.31 42.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 118.316 -1.353 . . . . 0.0 111.273 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.526 ' HG3' ' HA ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -74.77 -21.21 59.45 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 118.771 -1.171 . . . . 0.0 110.158 175.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 ttt -76.96 -44.23 32.1 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.089 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.64 HG21 ' HD3' ' A' ' 16' ' ' LYS . 18.1 m -97.69 -10.36 25.13 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 119.221 -0.991 . . . . 0.0 113.386 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 52.34 -155.52 0.17 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 125.15 1.38 . . . . 0.0 112.92 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.787 ' HA ' ' HA3' ' A' ' 68' ' ' GLY . 37.3 ttpt -67.65 -11.05 57.36 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.676 0.75 . . . . 0.0 111.332 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.31 40.45 2.84 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.761 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.64 ' HD3' HG21 ' A' ' 12' ' ' THR . 58.2 tptt -129.97 143.77 50.97 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 117.775 0.788 . . . . 0.0 110.633 -175.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 p -117.33 121.46 41.2 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.742 HD11 ' C ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -134.59 108.14 7.89 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -173.553 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.1 ptm -84.1 100.95 11.45 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.548 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 0.3 OUTLIER -88.79 138.69 31.18 Favored 'General case' 0 C--O 1.25 1.123 0 C-N-CA 117.029 -1.868 . . . . 0.0 111.043 -171.533 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -109.52 113.45 26.25 Favored 'General case' 0 C--O 1.267 2.013 0 O-C-N 125.245 1.59 . . . . 0.0 108.723 -174.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -117.44 123.86 72.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.77 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.083 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 92.3 m -98.12 133.99 41.8 Favored 'General case' 0 CA--C 1.608 3.197 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.138 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.883 HG11 HD11 ' A' ' 36' ' ' ILE . 91.1 t -130.95 101.47 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.401 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 2.6 t -118.92 7.05 11.41 Favored 'General case' 0 C--N 1.361 1.108 0 CA-C-N 122.286 2.312 . . . . 0.0 114.042 -166.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.45 -46.21 52.87 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 174.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 1.076 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 16.4 t-20 -115.21 104.11 53.93 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 167.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 2.7 Cg_endo -82.23 24.52 0.71 Allowed 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 123.52 2.813 . . . . 0.0 113.351 -173.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.455 ' C ' ' HB3' ' A' ' 58' ' ' SER . 6.9 p -125.12 -162.51 1.11 Allowed 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.295 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -73.61 -29.22 62.25 Favored 'General case' 0 C--O 1.194 -1.844 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.617 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -59.56 -48.09 83.03 Favored 'General case' 0 C--O 1.263 1.768 0 CA-C-N 119.167 0.894 . . . . 0.0 112.726 -171.133 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 1.076 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 2.8 tp10 -64.01 -49.36 72.74 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.5 m -52.1 -46.06 65.12 Favored 'General case' 0 C--O 1.192 -1.93 0 CA-C-N 113.445 -1.707 . . . . 0.0 111.351 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.617 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 16.3 pt-20 -75.99 -31.32 58.92 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -75.55 -47.36 27.11 Favored 'General case' 0 C--O 1.279 2.651 0 N-CA-C 101.238 -3.616 . . . . 0.0 101.238 -174.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.883 HD11 HG11 ' A' ' 24' ' ' VAL 1.532 1.5 pp -57.19 -57.31 10.47 Favored 'Isoleucine or valine' 1 N--CA 1.309 -7.487 0 N-CA-C 120.917 3.673 . . . . 0.0 120.917 175.159 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.545 ' HA ' ' HB2' ' A' ' 40' ' ' TRP . 39.6 p -67.84 -31.42 71.24 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 t -64.85 -46.54 81.45 Favored 'General case' 0 N--CA 1.424 -1.737 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.074 176.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.7 mt -67.76 -46.29 72.46 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.901 178.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.729 ' HB3' ' NH1' ' A' ' 53' ' ' ARG . 37.8 m0 -57.3 -67.72 0.3 Allowed 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.943 -1.481 . . . . 0.0 114.837 -175.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.441 ' O ' ' HD1' ' A' ' 45' ' ' PHE 0.331 0.0 OUTLIER -78.9 -17.5 55.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 117.102 -1.839 . . . . 0.0 110.677 -176.513 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.95 -59.43 9.38 Favored Glycine 0 CA--C 1.472 -2.596 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 170.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.3 m -74.79 -36.85 62.49 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-N 113.245 -1.478 . . . . 0.0 112.496 -175.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.955 HD12 ' HD2' ' A' ' 53' ' ' ARG . 12.7 mt -61.1 -33.54 73.52 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.209 178.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.441 ' HD1' ' O ' ' A' ' 41' ' ' GLN . 53.0 m-85 -87.11 -32.18 20.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.348 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -70.19 -29.98 66.98 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.12 8.4 15.67 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.079 0.466 . . . . 0.0 110.898 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 t30 67.38 52.21 0.83 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.176 1.391 . . . . 0.0 113.538 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -100.59 154.34 18.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.35 -1.469 . . . . 0.0 107.852 170.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.519 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 30.2 t70 -92.54 83.62 4.95 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 120.02 1.282 . . . . 0.0 109.407 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.77 174.36 12.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.205 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 1.0 OUTLIER -134.22 140.2 46.32 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 169.359 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 1.012 ' HG2' ' HA ' ' A' ' 63' ' ' PHE . 35.7 mtp180 -142.91 139.55 30.82 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 118.958 0.799 . . . . 0.0 109.735 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.671 ' H ' HG12 ' A' ' 62' ' ' ILE . 50.1 m-85 -132.33 151.38 51.87 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.044 -1.462 . . . . 0.0 114.099 -169.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 57.8 mt -99.19 96.41 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 170.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 60' ' ' ARG . 4.7 m -98.16 -23.14 4.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.048 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.94 161.57 35.39 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 118.524 -1.798 . . . . 0.0 112.159 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.455 ' HB3' ' C ' ' A' ' 29' ' ' THR . 51.1 m -75.64 106.48 7.23 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.498 ' O ' ' HD2' ' A' ' 60' ' ' ARG 0.271 0.0 OUTLIER 98.42 5.04 0.02 OUTLIER 'General case' 0 C--N 1.366 1.283 0 C-N-CA 127.0 2.12 . . . . 0.0 110.188 -174.167 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.498 ' HD2' ' O ' ' A' ' 59' ' ' ASP . 5.8 mpt_? -134.11 123.04 23.77 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.95 0.9 . . . . 0.0 112.131 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.09 168.18 17.16 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.671 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -141.16 153.24 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.45 -2.878 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.954 172.291 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.012 ' HA ' ' HG2' ' A' ' 53' ' ' ARG 0.27 31.2 p90 -129.45 108.62 10.41 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 127.114 2.759 . . . . 0.0 108.665 163.807 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.464 ' HB3' ' HB2' ' A' ' 52' ' ' GLN . 26.5 ttt -92.42 119.75 32.25 Favored 'General case' 0 C--O 1.27 2.158 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.643 HD22 ' CB ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -81.65 122.06 27.14 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 128.956 2.902 . . . . 0.0 110.161 178.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.519 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.253 23.6 ttt180 -105.44 -49.5 3.42 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 172.091 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.445 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 25.9 t70 -75.87 50.88 0.6 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.079 1.309 . . . . 0.0 112.777 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.787 ' HA3' ' HA ' ' A' ' 14' ' ' LYS . . . 58.58 -34.66 0.02 OUTLIER Glycine 0 CA--C 1.55 2.233 0 N-CA-C 120.991 3.157 . . . . 0.0 120.991 173.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.416 ' HB3' HD12 ' A' ' 9' ' ' LEU . 62.0 m -163.07 51.65 0.17 Allowed 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 120.189 1.995 . . . . 0.0 116.384 -171.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.499 ' HE1' ' HA ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -122.01 13.83 10.6 Favored 'General case' 0 C--O 1.213 -0.849 0 O-C-N 120.286 -1.508 . . . . 0.0 112.306 177.861 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.928 ' HA ' HD12 ' A' ' 74' ' ' ILE . . . -102.14 -12.94 17.69 Favored 'General case' 0 C--O 1.197 -1.661 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -169.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.661 ' CD1' HD13 ' A' ' 9' ' ' LEU . 8.5 m95 -84.85 -31.0 24.02 Favored 'General case' 0 C--N 1.27 -2.872 0 O-C-N 120.536 -1.353 . . . . 0.0 109.102 -166.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 77' ' ' PHE . 18.5 tp10 -75.11 -33.81 61.64 Favored 'General case' 0 C--O 1.257 1.464 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.928 HD12 ' HA ' ' A' ' 71' ' ' ALA . 54.2 mt -59.01 -39.73 79.01 Favored 'Isoleucine or valine' 0 C--O 1.264 1.855 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.004 175.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.863 ' HD2' HD11 ' A' ' 89' ' ' LEU . 32.9 tttm -57.05 -53.21 60.62 Favored 'General case' 0 C--O 1.275 2.447 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.267 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -55.08 -46.94 75.49 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.821 1.326 . . . . 0.0 112.284 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.45 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 13.0 m-85 -56.74 -55.91 28.13 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.559 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.651 HD22 ' NE1' ' A' ' 40' ' ' TRP . 9.5 mt -58.53 -48.55 80.48 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 75' ' ' LYS 0.281 18.3 m -78.99 -6.26 9.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 116.558 -2.057 . . . . 0.0 113.136 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.0 m -106.68 4.02 27.37 Favored 'General case' 0 N--CA 1.423 -1.777 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.698 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -118.45 -25.02 6.62 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 117.374 -1.731 . . . . 0.0 111.149 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -139.73 -164.1 1.62 Allowed 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.711 ' HB3' HG13 ' A' ' 24' ' ' VAL . 23.2 tpp180 -60.56 136.15 57.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 118.858 0.754 . . . . 0.0 111.009 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 18.2 p -130.57 146.21 52.04 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -174.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.29 -38.62 0.09 Allowed 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 122.71 0.404 . . . . 0.0 111.157 170.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.083 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 39.9 tt0 -153.24 129.0 10.13 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.745 -176.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.16 92.68 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.3 p -116.78 111.34 19.61 Favored 'General case' 0 C--O 1.257 1.487 0 CA-C-O 121.926 0.869 . . . . 0.0 110.816 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.863 HD11 ' HD2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -103.47 89.27 3.32 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.384 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.904 ' HB3' ' HB3' ' A' ' 94' ' ' TYR . 10.3 tp10 -149.56 172.63 14.7 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 163.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.11 -55.75 2.86 Favored Glycine 0 N--CA 1.415 -2.755 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.435 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -113.02 158.61 20.08 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 118.496 1.148 . . . . 0.0 111.16 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.0 tpt 71.12 -71.14 0.14 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.429 1.492 . . . . 0.0 113.182 174.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.904 ' HB3' ' HB3' ' A' ' 90' ' ' GLU . 14.2 t80 -49.39 -46.99 78.13 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 124.614 1.166 . . . . 0.0 112.471 -176.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.602 ' HG3' ' O ' ' A' ' 90' ' ' GLU . 4.3 Cg_endo -102.46 19.5 0.2 Allowed 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 121.978 1.785 . . . . 0.0 113.743 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.68 55.16 0.24 Allowed Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 119.674 -1.25 . . . . 0.0 111.836 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 C--N 1.293 -1.863 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.515 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.277 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.591 ' HD2' ' HB2' ' A' ' 7' ' ' SER . 4.7 Cg_exo -78.77 -163.88 0.25 Allowed 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.481 2.787 . . . . 0.0 111.904 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.02 -41.28 4.09 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.227 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.498 ' HD2' ' HG2' ' A' ' 6' ' ' GLU . 30.3 ttmt -86.15 138.33 34.67 Favored Pre-proline 0 N--CA 1.44 -0.931 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 5.5 Cg_endo -80.36 40.87 1.03 Allowed 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.126 2.551 . . . . 0.0 112.789 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HG2' ' HD2' ' A' ' 4' ' ' LYS . 10.0 pt-20 -85.47 -4.26 59.11 Favored 'General case' 0 C--O 1.247 0.96 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 160.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.591 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 85.2 p -75.76 174.2 10.14 Favored 'General case' 1 N--CA 1.375 -4.221 0 CA-C-N 111.87 -2.423 . . . . 0.0 106.676 -175.617 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.404 HD11 ' CD2' ' A' ' 72' ' ' TRP 0.264 8.7 tp 31.95 49.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 C-N-CA 126.256 1.822 . . . . 0.0 111.617 -164.457 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 12' ' ' THR 0.348 2.9 pp 55.82 64.77 1.63 Allowed 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 122.971 1.367 . . . . 0.0 114.516 174.45 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt 63.39 47.78 3.79 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.531 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.0 mtt 67.58 34.11 4.73 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 123.598 0.561 . . . . 0.0 110.201 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.805 HG22 ' HA ' ' A' ' 69' ' ' SER . 6.1 m 74.44 25.26 1.67 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.893 1.277 . . . . 0.0 110.362 177.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -137.37 92.3 2.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.213 -0.929 . . . . 0.0 113.013 -174.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.453 ' HG2' ' HB2' ' A' ' 9' ' ' LEU . 17.6 ptpt -155.69 -6.05 0.12 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.483 173.064 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.04 69.62 1.24 Allowed Glycine 0 CA--C 1.559 2.837 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.342 -175.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -125.79 133.02 52.17 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 119.822 1.811 . . . . 0.0 111.251 -174.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.9 p -65.59 114.49 4.96 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.381 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.663 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -128.02 108.21 10.48 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.506 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 25.1 ptm -93.6 108.8 20.47 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.825 ' HB2' ' HA ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -106.93 143.09 35.52 Favored 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 116.703 -1.999 . . . . 0.0 112.742 -173.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.476 ' CE2' ' HD3' ' A' ' 60' ' ' ARG . 1.1 t80 -114.91 114.72 25.85 Favored 'General case' 0 C--O 1.26 1.609 0 C-N-CA 128.079 2.552 . . . . 0.0 109.863 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.745 HG23 ' SD ' ' A' ' 20' ' ' MET . 3.6 t -104.0 131.65 52.25 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.33 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 1.03 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 97.7 m -99.83 129.76 45.96 Favored 'General case' 0 CA--C 1.594 2.635 0 O-C-N 124.529 1.143 . . . . 0.0 108.375 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 59' ' ' ASP 0.295 93.5 t -122.38 101.82 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 C-N-CA 127.029 2.132 . . . . 0.0 106.8 -171.426 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -115.08 -1.01 13.14 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 122.471 2.396 . . . . 0.0 115.105 -168.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.749 ' HA3' ' HD2' ' A' ' 83' ' ' ARG . . . -56.51 -48.17 78.36 Favored Glycine 0 N--CA 1.474 1.226 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 4.9 t30 -115.75 116.67 40.67 Favored Pre-proline 0 N--CA 1.401 -2.878 0 N-CA-C 100.447 -3.909 . . . . 0.0 100.447 169.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -106.18 34.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.306 2.004 . . . . 0.0 111.305 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -129.5 54.5 1.82 Allowed 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 118.116 -1.434 . . . . 0.0 114.849 -168.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' ' HB ' ' A' ' 33' ' ' THR . 35.9 mt-10 59.92 -21.13 0.03 OUTLIER 'General case' 0 C--N 1.377 1.796 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 178.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HD3' ' C ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -69.68 -41.93 74.79 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.656 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 1.2 pm0 -68.31 -41.62 80.59 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 90.9 m -48.19 -53.08 18.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.15 0.98 . . . . 0.0 110.517 174.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.6 -49.12 57.06 Favored 'General case' 0 C--O 1.259 1.558 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -49.73 -60.0 3.29 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.232 1.413 . . . . 0.0 107.836 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.839 HG23 ' CE3' ' A' ' 40' ' ' TRP . 22.3 mt -64.76 -44.56 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.035 0 CA-C-N 112.135 -2.302 . . . . 0.0 113.01 -175.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.836 HG21 HG12 ' A' ' 55' ' ' ILE . 22.4 p -66.83 -48.86 67.6 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 117.87 -1.532 . . . . 0.0 111.826 -176.094 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.0 p -63.29 -57.2 11.2 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.592 0.557 . . . . 0.0 111.463 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.3 tp -67.18 -39.35 86.39 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.868 ' CE3' HD13 ' A' ' 78' ' ' LEU . 46.1 m0 -79.96 -48.6 13.12 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -174.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.453 ' O ' ' HD1' ' A' ' 45' ' ' PHE 0.286 0.0 OUTLIER -72.61 -23.42 60.94 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 116.686 -2.006 . . . . 0.0 109.857 178.828 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.59 -51.44 57.59 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 173.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 10.5 p -66.75 -38.95 87.64 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.052 HD12 ' HD2' ' A' ' 53' ' ' ARG . 19.3 mt -60.17 -35.57 75.65 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 177.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' HD1' ' O ' ' A' ' 41' ' ' GLN . 35.1 m-85 -85.81 -25.22 26.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.242 0.544 . . . . 0.0 110.521 176.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.4 t-20 -68.39 -31.84 71.48 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.372 0.669 . . . . 0.0 111.681 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.45 2.66 49.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.241 0.543 . . . . 0.0 110.307 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.7 t30 57.16 60.7 2.84 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.028 1.331 . . . . 0.0 114.238 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -100.32 167.82 10.17 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 166.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -97.8 100.8 12.18 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 120.22 1.373 . . . . 0.0 108.348 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 m -146.13 176.92 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.243 -171.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 67.0 mt-30 -140.58 145.5 36.81 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 173.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 1.052 ' HD2' HD12 ' A' ' 44' ' ' LEU . 21.6 mtp180 -143.53 144.14 31.84 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 118.943 0.792 . . . . 0.0 111.233 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.668 ' H ' HG12 ' A' ' 62' ' ' ILE . 80.7 m-85 -133.68 151.75 51.72 Favored 'General case' 0 C--O 1.261 1.661 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -170.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.836 HG12 HG21 ' A' ' 37' ' ' THR . 17.4 mt -92.56 102.86 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 167.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.714 HG23 ' HD2' ' A' ' 60' ' ' ARG . 6.9 m -112.51 -27.41 2.77 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.784 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.95 161.38 31.89 Favored Glycine 0 N--CA 1.419 -2.492 0 C-N-CA 118.158 -1.972 . . . . 0.0 113.681 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 m -64.4 125.17 23.79 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.641 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 p30 68.22 21.61 8.47 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 125.106 1.362 . . . . 0.0 109.556 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.714 ' HD2' HG23 ' A' ' 56' ' ' VAL . 1.1 tmm_? -153.6 119.77 5.44 Favored 'General case' 0 CA--C 1.583 2.215 0 CA-C-O 122.278 1.037 . . . . 0.0 113.327 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.29 168.75 13.08 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.527 1.131 . . . . 0.0 109.066 -171.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 20' ' ' MET . 0.2 OUTLIER -134.6 156.79 40.7 Favored 'Isoleucine or valine' 0 C--O 1.283 2.861 0 C-N-CA 117.474 -1.69 . . . . 0.0 110.993 175.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.017 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 49.0 p90 -123.24 109.82 14.44 Favored 'General case' 0 N--CA 1.422 -1.845 0 O-C-N 127.507 3.005 . . . . 0.0 107.309 163.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.642 ' HB2' HD11 ' A' ' 62' ' ' ILE . 23.7 ttt -95.87 110.81 22.93 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.303 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.843 ' HG ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -113.3 147.42 37.64 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -171.818 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.284 30.6 ttm180 -111.78 -58.51 2.11 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -176.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -44.46 -19.99 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.22 -9.13 3.32 Favored Glycine 0 C--N 1.358 1.767 0 CA-C-N 119.717 1.144 . . . . 0.0 114.903 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.805 ' HA ' HG22 ' A' ' 12' ' ' THR . 1.3 m -117.05 32.46 6.15 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.301 1.051 . . . . 0.0 113.696 -168.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -166.68 12.98 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.606 -171.739 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.843 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -97.22 -37.77 9.95 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -166.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.612 ' CE2' HD22 ' A' ' 89' ' ' LEU . 9.0 m-90 -76.0 -27.53 57.45 Favored 'General case' 0 C--O 1.273 2.331 0 O-C-N 120.895 -1.128 . . . . 0.0 110.636 -174.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -63.62 -35.22 79.79 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 113.835 -1.529 . . . . 0.0 107.722 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.818 HD12 ' HA ' ' A' ' 71' ' ' ALA . 26.3 mt -67.58 -45.2 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.154 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HB2' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -57.71 -41.69 82.25 Favored 'General case' 0 C--O 1.283 2.851 0 CA-C-O 121.907 0.861 . . . . 0.0 109.387 -174.022 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.495 ' N ' ' HD2' ' A' ' 75' ' ' LYS . 17.1 t70 -61.46 -50.01 74.51 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 112.826 -1.988 . . . . 0.0 111.649 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.424 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 14.8 m-85 -62.09 -48.3 80.82 Favored 'General case' 0 C--O 1.197 -1.696 0 C-N-CA 118.47 -1.292 . . . . 0.0 110.383 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.868 HD13 ' CE3' ' A' ' 40' ' ' TRP . 4.3 mt -55.57 -54.5 43.3 Favored 'General case' 0 C--O 1.296 3.504 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.677 ' O ' ' HB3' ' A' ' 84' ' ' CYS 0.354 30.0 m -72.62 -19.1 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 C-N-CA 115.935 -2.306 . . . . 0.0 112.574 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.3 m -85.96 -4.3 59.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.148 171.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 21.7 mm-40 -90.43 -32.27 16.48 Favored 'General case' 0 CA--C 1.453 -2.78 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.073 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.507 ' OD2' ' HG2' ' A' ' 83' ' ' ARG 0.44 21.7 t70 -147.31 -94.58 0.09 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 116.913 -1.915 . . . . 0.0 114.628 -178.546 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.749 ' HD2' ' HA3' ' A' ' 26' ' ' GLY . 10.8 mmt180 -105.38 126.74 52.46 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 121.191 1.814 . . . . 0.0 109.264 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 0.677 ' HB3' ' O ' ' A' ' 79' ' ' VAL . 22.2 p -111.46 97.09 6.5 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -176.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.75 -42.37 2.42 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 1.03 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 37.2 tt0 -153.61 125.2 7.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 118.034 -1.466 . . . . 0.0 112.781 -174.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.579 HG11 ' HB2' ' A' ' 75' ' ' LYS . 2.9 m -112.75 93.44 2.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 p -105.44 99.4 9.01 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 118.413 -1.315 . . . . 0.0 112.208 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.825 ' HA ' ' HB2' ' A' ' 20' ' ' MET . 5.4 mp -78.43 156.27 29.5 Favored 'General case' 0 N--CA 1.384 -3.73 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.545 176.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.572 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 2.8 tm-20 -77.62 140.59 39.65 Favored 'General case' 0 C--N 1.276 -2.602 0 C-N-CA 123.546 0.738 . . . . 0.0 109.326 -166.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.636 ' HA3' ' HB3' ' A' ' 94' ' ' TYR . . . 134.59 91.9 0.41 Allowed Glycine 0 N--CA 1.404 -3.461 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -56.88 109.74 0.69 Allowed 'General case' 0 C--N 1.373 1.627 0 CA-C-N 120.771 2.285 . . . . 0.0 108.895 174.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' MET . . . . . 0.522 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 14.4 tpt 61.54 72.84 0.5 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.827 -168.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.636 ' HB3' ' HA3' ' A' ' 91' ' ' GLY . 6.5 p90 -101.73 96.27 6.31 Favored Pre-proline 0 N--CA 1.444 -0.768 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 93' ' ' MET . 88.4 Cg_endo -95.2 8.54 1.89 Allowed 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.228 1.952 . . . . 0.0 111.43 -177.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.59 -37.07 3.06 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.021 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.5 pttt . . . . . 0 N--CA 1.436 -1.151 0 C-N-CA 122.418 0.287 . . . . 0.0 110.452 179.028 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.517 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.07 -19.5 26.82 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 123.958 3.105 . . . . 0.0 114.159 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.2 -25.36 75.73 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.605 -0.331 . . . . 0.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.463 ' HG2' ' HG3' ' A' ' 6' ' ' GLU . 61.2 tttp -85.11 133.1 43.58 Favored Pre-proline 0 N--CA 1.435 -1.178 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.384 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 6.6 Cg_endo -82.05 57.31 6.19 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.508 2.805 . . . . 0.0 113.279 -175.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.463 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 35.8 mt-10 -81.89 -13.74 57.15 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 102.5 -3.148 . . . . 0.0 102.5 159.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.531 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 49.2 m 65.89 163.77 0.17 Allowed 'General case' 0 N--CA 1.382 -3.853 0 CA-C-N 110.675 -2.966 . . . . 0.0 109.952 171.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.8 pt -43.83 -25.33 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 173.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.531 ' CD2' ' HB2' ' A' ' 7' ' ' SER . 2.5 pt? -78.51 -57.82 3.57 Favored 'General case' 0 C--O 1.195 -1.782 0 C-N-CA 119.249 -0.981 . . . . 0.0 111.069 -174.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -78.0 -14.94 59.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 118.285 -1.366 . . . . 0.0 111.399 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.6 ttm -82.76 -36.97 25.23 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.03 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.8 m -130.85 -24.09 2.45 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 118.594 -1.242 . . . . 0.0 113.953 -176.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.441 ' HD2' ' HB3' ' A' ' 16' ' ' LYS . 47.6 mmtm -102.15 97.36 7.68 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.115 -0.991 . . . . 0.0 110.94 -175.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -109.47 -23.24 11.62 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.082 0.467 . . . . 0.0 110.79 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.85 64.1 0.31 Allowed Glycine 0 CA--C 1.553 2.426 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.764 174.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 52.6 tptt -130.36 134.08 46.89 Favored 'General case' 0 C--N 1.363 1.192 0 CA-C-N 119.741 1.771 . . . . 0.0 110.758 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 6.3 m -85.58 111.36 19.97 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.835 ' HB3' HD21 ' A' ' 65' ' ' LEU . 21.8 tp -133.2 116.02 15.71 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -174.185 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.669 ' O ' HD21 ' A' ' 89' ' ' LEU . 19.6 ptm -83.56 103.13 12.64 Favored 'General case' 0 C--O 1.207 -1.171 0 O-C-N 121.502 -0.749 . . . . 0.0 112.792 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.623 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 12.3 mtm -84.56 126.01 32.94 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -174.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -108.8 115.0 29.25 Favored 'General case' 0 N--CA 1.432 -1.34 0 O-C-N 125.618 1.824 . . . . 0.0 108.606 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -115.25 125.52 72.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.485 -176.402 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.823 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 30.2 m -90.85 110.62 21.84 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 113.638 -1.619 . . . . 0.0 107.365 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 84' ' ' CYS . 75.5 t -103.77 92.55 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.341 0 CA-C-N 120.373 1.442 . . . . 0.0 109.145 -176.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 m -93.38 96.5 9.98 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 120.755 1.616 . . . . 0.0 110.292 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.21 -50.08 0.02 OUTLIER Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -116.47 106.12 49.16 Favored Pre-proline 0 CA--C 1.493 -1.212 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.58 42.44 0.27 Allowed 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 123.93 3.086 . . . . 0.0 114.111 -171.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.6 p -147.0 -176.5 5.23 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' HB ' ' A' ' 33' ' ' THR . 48.8 mt-10 -85.81 10.32 14.06 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 118.831 0.741 . . . . 0.0 110.225 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -77.74 -34.43 52.55 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.588 ' HG2' HD12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -71.26 -40.84 70.73 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.318 -0.953 . . . . 0.0 108.493 177.593 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 29.0 m -49.87 -55.63 13.58 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 125.866 1.666 . . . . 0.0 110.807 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.1 pt-20 -67.5 -43.95 79.66 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.867 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -50.71 -62.56 1.53 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 123.075 1.416 . . . . 0.0 107.474 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.87 HG23 ' CE3' ' A' ' 40' ' ' TRP . 25.0 mt -61.71 -44.38 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 112.067 -2.333 . . . . 0.0 112.981 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.812 HG21 HG12 ' A' ' 55' ' ' ILE . 25.1 p -68.28 -52.93 28.2 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.913 -175.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.4 p -62.79 -56.68 15.3 Favored 'General case' 0 C--O 1.256 1.432 0 O-C-N 123.618 0.574 . . . . 0.0 111.621 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.87 -49.6 74.22 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.87 ' CE3' HG23 ' A' ' 36' ' ' ILE . 50.8 m0 -75.14 -47.25 29.44 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -173.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.298 0.0 OUTLIER -73.98 -19.47 60.64 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 116.608 -2.037 . . . . 0.0 109.816 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.99 -52.87 49.61 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 170.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.521 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 9.6 p -69.73 -34.51 73.96 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 117.099 0.449 . . . . 0.0 112.01 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.986 HD12 ' HD2' ' A' ' 53' ' ' ARG . 9.2 mt -61.06 -35.28 76.53 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -87.99 -22.31 24.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.358 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 16.1 t-20 -65.53 -34.22 77.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.653 0.263 . . . . 0.0 110.984 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.99 5.05 27.13 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.411 0.624 . . . . 0.0 109.863 175.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 t30 51.77 45.4 28.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.342 1.857 . . . . 0.0 113.673 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -80.09 165.87 22.07 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -98.25 94.53 6.83 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 120.359 1.436 . . . . 0.0 108.656 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 m -135.12 173.09 14.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.592 -171.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.5 mp0 -138.43 123.93 19.56 Favored 'General case' 0 C--O 1.196 -1.721 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 1.131 ' HG2' ' HA ' ' A' ' 63' ' ' PHE . 16.8 mtp180 -120.43 142.03 49.6 Favored 'General case' 0 C--N 1.268 -2.947 0 O-C-N 121.235 -0.915 . . . . 0.0 110.998 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.659 ' H ' HG12 ' A' ' 62' ' ' ILE . 41.1 m-85 -129.57 152.14 49.41 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -170.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.812 HG12 HG21 ' A' ' 37' ' ' THR . 29.8 mt -94.8 109.44 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.591 HG23 ' HB3' ' A' ' 60' ' ' ARG . 3.7 m -112.07 -16.19 9.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -175.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 161.97 177.12 34.75 Favored Glycine 0 CA--C 1.482 -2.022 0 C-N-CA 117.477 -2.297 . . . . 0.0 114.262 169.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.529 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 37.6 t -66.14 116.65 7.44 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.537 ' C ' ' HD2' ' A' ' 60' ' ' ARG . 0.2 OUTLIER 85.98 9.39 0.28 Allowed 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 125.41 1.484 . . . . 0.0 109.058 -178.378 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.591 ' HB3' HG23 ' A' ' 56' ' ' VAL . 3.8 mpt_? -138.68 124.26 19.57 Favored 'General case' 0 C--O 1.255 1.387 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.89 162.24 32.97 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.659 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -137.56 154.45 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.044 0 C-N-CA 117.969 -1.493 . . . . 0.0 111.545 174.08 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 1.131 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -126.65 112.65 15.71 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.223 2.827 . . . . 0.0 107.76 162.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.439 ' HB2' HD11 ' A' ' 62' ' ' ILE . 43.4 ttm -95.42 125.55 40.11 Favored 'General case' 0 C--O 1.258 1.544 0 O-C-N 121.332 -0.855 . . . . 0.0 109.805 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.835 HD21 ' HB3' ' A' ' 18' ' ' LEU . 1.2 pt? -102.2 144.62 30.51 Favored 'General case' 0 CA--C 1.494 -1.182 0 O-C-N 124.622 1.201 . . . . 0.0 110.669 -176.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.292 5.5 tmm_? -119.73 -49.22 2.34 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -46.78 -23.44 0.43 Allowed 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 171.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.42 -31.93 4.65 Favored Glycine 0 C--N 1.36 1.864 0 CA-C-N 120.231 1.378 . . . . 0.0 113.8 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.2 m -128.34 45.42 2.77 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -166.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.623 ' CE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -153.02 2.25 0.29 Allowed 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.239 -0.913 . . . . 0.0 112.562 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.728 ' HA ' HD12 ' A' ' 74' ' ' ILE . . . -94.52 -34.41 12.69 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 119.077 2.991 . . . . 0.0 119.077 -170.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TRP . . . . . 0.789 ' HD1' ' HD3' ' A' ' 75' ' ' LYS 0.512 9.3 m-90 -81.42 -16.81 50.99 Favored 'General case' 0 C--O 1.263 1.781 0 C-N-CA 116.494 -2.083 . . . . 0.0 114.85 -167.712 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -73.56 -29.73 62.61 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 168.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 71' ' ' ALA . 74.9 mt -61.23 -42.13 92.27 Favored 'Isoleucine or valine' 0 C--O 1.258 1.54 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.869 173.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.865 ' HB2' HG21 ' A' ' 87' ' ' VAL . 53.1 pttt -61.32 -41.45 97.04 Favored 'General case' 0 C--N 1.378 1.842 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.386 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.45 -52.02 65.0 Favored 'General case' 0 C--O 1.271 2.204 0 O-C-N 124.29 0.994 . . . . 0.0 110.582 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.471 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 8.0 m-85 -54.62 -47.54 73.32 Favored 'General case' 0 C--O 1.205 -1.288 0 O-C-N 123.553 0.533 . . . . 0.0 110.114 -178.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.79 HD13 ' CE3' ' A' ' 40' ' ' TRP . 10.3 mt -63.59 -51.58 64.69 Favored 'General case' 0 C--O 1.287 3.039 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -175.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 1.11 ' HA ' ' HB2' ' A' ' 84' ' ' CYS . 29.5 m -71.38 -6.6 7.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.547 0.689 . . . . 0.0 112.268 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 m -110.35 1.0 18.18 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.246 170.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 30.6 tp60 -88.18 -36.99 16.5 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -177.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.486 10.5 t70 -142.37 -96.84 0.12 Allowed 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 117.954 2.575 . . . . 0.0 117.954 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -146.77 40.66 1.09 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' CYS . . . . . 1.11 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 55.5 m -79.45 12.03 2.68 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 111.158 -2.746 . . . . 0.0 115.669 -165.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . 0.314 . . 29.66 -58.99 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 173.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.823 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 6.2 tp10 -145.46 132.07 19.88 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 119.882 1.219 . . . . 0.0 111.676 -169.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.865 HG21 ' HB2' ' A' ' 75' ' ' LYS . 47.2 t -114.09 106.26 20.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 173.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.433 ' O ' HD23 ' A' ' 89' ' ' LEU . 14.3 p -118.98 146.98 44.55 Favored 'General case' 0 C--O 1.293 3.352 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.72 ' CD1' ' HG ' ' A' ' 18' ' ' LEU 0.758 2.7 mt -138.2 157.56 46.04 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 121.152 3.76 . . . . 0.0 121.152 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.51 ' H ' HD22 ' A' ' 89' ' ' LEU 0.318 27.3 tt0 -79.99 155.65 27.55 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 110.586 -3.006 . . . . 0.0 109.16 -176.147 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 124.47 -179.64 16.07 Favored Glycine 0 CA--C 1.549 2.173 0 CA-C-O 118.748 -1.029 . . . . 0.0 111.336 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -111.09 138.81 47.06 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 119.648 1.724 . . . . 0.0 107.214 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 25.5 ttt 61.05 33.16 19.71 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.453 1.121 . . . . 0.0 109.236 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.631 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 83.0 t80 -66.67 -52.28 35.24 Favored Pre-proline 0 CA--C 1.57 1.738 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.831 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.14 -178.95 4.68 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 121.42 1.413 . . . . 0.0 111.229 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.63 81.16 0.96 Allowed Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? . . . . . 0 C--N 1.303 -1.456 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.478 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.4 tptp . . . . . 0 N--CA 1.432 -1.343 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 8.0 m -67.44 116.77 8.55 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.69 ' O ' HD13 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -120.52 116.9 26.3 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.524 -2.399 . . . . 0.0 104.524 -177.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.44 ' HA ' ' HG3' ' A' ' 64' ' ' MET . 24.5 ptm -89.32 133.96 34.26 Favored 'General case' 0 C--N 1.28 -2.435 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.271 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.438 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 8.0 ttm -123.58 121.71 36.3 Favored 'General case' 0 N--CA 1.405 -2.715 0 C-N-CA 116.246 -2.181 . . . . 0.0 112.944 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -94.54 126.16 39.64 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.226 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 61' ' ' ALA . 0.2 OUTLIER -120.83 130.55 74.49 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-O 121.191 0.52 . . . . 0.0 110.071 -178.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.091 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 78.1 m -95.66 132.04 41.25 Favored 'General case' 0 N--CA 1.397 -3.093 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 172.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 1.026 HG23 ' HB2' ' A' ' 82' ' ' ASP . 2.5 p -131.41 127.83 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.077 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -172.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.549 ' HB3' ' OD2' ' A' ' 59' ' ' ASP . 15.5 p -142.69 33.01 1.43 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 121.726 2.057 . . . . 0.0 115.356 -170.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.65 -34.76 90.8 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 171.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 22.3 m-80 -118.13 122.69 30.13 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 171.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.67 28.89 0.41 Allowed 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.763 2.308 . . . . 0.0 112.792 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.0 p -137.78 -157.13 0.75 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.462 ' O ' ' HB ' ' A' ' 33' ' ' THR . 39.9 mt-10 -87.99 5.2 41.95 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-O 119.263 -0.398 . . . . 0.0 111.384 175.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.582 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 5.7 tmtt? -70.92 -38.77 72.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.361 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.606 ' HG3' HD13 ' A' ' 36' ' ' ILE . 6.2 tp10 -74.25 -41.04 61.93 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 96.5 m -44.6 -59.37 2.5 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.181 170.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.582 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.2 pt-20 -61.43 -45.7 93.2 Favored 'General case' 0 C--O 1.25 1.107 0 C-N-CA 122.935 0.494 . . . . 0.0 112.082 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -52.91 -59.03 5.03 Favored 'General case' 0 C--O 1.254 1.317 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.728 HG23 ' CE3' ' A' ' 40' ' ' TRP . 2.0 mp -67.17 -46.18 84.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.53 -1.213 . . . . 0.0 113.352 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.687 HG21 HG12 ' A' ' 55' ' ' ILE . 31.0 p -62.24 -52.61 63.05 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.1 m -70.82 -44.63 66.15 Favored 'General case' 0 C--O 1.26 1.646 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.973 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.0 tp -71.21 -43.55 67.14 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.431 -176.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.728 ' CE3' HG23 ' A' ' 36' ' ' ILE . 43.8 m0 -76.07 -60.34 2.37 Favored 'General case' 0 C--O 1.161 -3.594 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.057 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.606 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.404 0.0 OUTLIER -65.71 -22.23 66.6 Favored 'General case' 0 C--O 1.255 1.356 0 C-N-CA 117.017 -1.873 . . . . 0.0 112.044 -173.078 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.86 -54.13 39.5 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 27.8 p -70.38 -27.3 64.21 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 117.257 0.528 . . . . 0.0 111.976 177.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.805 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 17.5 mt -61.51 -31.79 71.8 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.301 0.64 . . . . 0.0 109.351 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 72.8 t80 -92.68 -28.33 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.355 174.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.676 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 10.2 t30 -68.43 -28.88 67.45 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.047 0.451 . . . . 0.0 111.564 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.4 12.12 19.42 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.373 0.606 . . . . 0.0 109.726 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.0 p30 48.25 48.7 18.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.888 1.675 . . . . 0.0 114.74 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -91.45 159.58 15.88 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.62 88.81 3.71 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 120.606 1.548 . . . . 0.0 109.83 -176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.002 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.7 m -146.79 169.83 4.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.559 -169.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.444 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 17.3 mt-30 -131.86 123.7 28.04 Favored 'General case' 0 C--O 1.2 -1.516 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 176.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.805 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -130.62 135.4 47.84 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.503 -173.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.732 ' H ' HG12 ' A' ' 62' ' ' ILE . 56.0 m-85 -133.83 153.19 51.91 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -165.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.687 HG12 HG21 ' A' ' 37' ' ' THR . 22.9 mt -87.24 108.23 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 168.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.72 HG23 ' HB3' ' A' ' 60' ' ' ARG . 15.6 m -113.28 -11.73 11.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.711 -175.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.14 176.95 41.33 Favored Glycine 0 CA--C 1.504 -0.631 0 C-N-CA 117.163 -2.446 . . . . 0.0 115.362 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 m -68.36 110.78 4.26 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.549 ' OD2' ' HB3' ' A' ' 25' ' ' SER 0.257 0.0 OUTLIER 78.37 17.46 1.14 Allowed 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 122.947 1.356 . . . . 0.0 109.938 -178.45 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.72 ' HB3' HG23 ' A' ' 56' ' ' VAL . 7.3 mpt_? -133.18 127.44 33.84 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.173 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.413 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -137.25 165.81 25.27 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.732 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.6 pt -144.53 157.81 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.336 0 C-N-CA 117.962 -1.495 . . . . 0.0 110.62 168.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.734 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -132.1 105.89 7.65 Favored 'General case' 0 N--CA 1.414 -2.233 0 O-C-N 126.595 2.434 . . . . 0.0 105.979 164.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.44 ' HG3' ' HA ' ' A' ' 19' ' ' MET . 25.1 ttt -92.19 103.97 16.39 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.002 ' HA ' HG12 ' A' ' 51' ' ' VAL 0.277 0.0 OUTLIER -96.06 146.32 24.74 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -171.834 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 17' ' ' THR 0.354 1.1 tmt_? -120.98 -59.09 1.76 Allowed 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -46.18 -9.25 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 117.996 2.591 . . . . 0.0 117.996 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.87 28.96 64.07 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 119.793 1.179 . . . . 0.0 113.668 -174.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.8 p -149.34 43.43 0.94 Allowed 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.613 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -173.49 -3.85 0.01 OUTLIER 'General case' 0 C--N 1.378 1.818 0 N-CA-C 117.732 2.494 . . . . 0.0 117.732 -176.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 1.0 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -74.31 -35.41 63.68 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -168.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.413 ' NE1' ' HE1' ' A' ' 20' ' ' MET 0.478 5.4 m-90 -88.23 -11.24 47.23 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -169.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.84 -38.71 70.08 Favored 'General case' 0 C--O 1.262 1.719 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 167.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.624 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 25.5 mt -64.7 -36.93 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.277 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.83 ' HE2' HG11 ' A' ' 87' ' ' VAL . 55.2 tttm -58.14 -42.58 86.16 Favored 'General case' 0 C--O 1.291 3.275 0 CA-C-O 122.081 0.943 . . . . 0.0 110.617 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -58.42 -46.98 85.41 Favored 'General case' 0 C--O 1.264 1.867 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.288 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.624 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 11.0 m-85 -55.96 -43.99 78.06 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.264 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.635 ' HG ' ' HA ' ' A' ' 75' ' ' LYS . 11.5 mt -50.09 -64.61 0.76 Allowed 'General case' 0 CA--C 1.446 -3.05 0 O-C-N 123.835 0.71 . . . . 0.0 109.719 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . 0.303 25.7 m -77.24 -5.49 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 C-N-CA 118.113 -1.435 . . . . 0.0 114.42 -171.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m -86.35 -22.33 26.74 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.758 167.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -117.26 -35.19 4.11 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 1.026 ' HB2' HG23 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -80.28 24.95 0.41 Allowed 'General case' 0 N--CA 1.516 2.875 0 CA-C-N 119.811 1.187 . . . . 0.0 111.52 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 73.46 -81.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -155.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.431 ' HA ' ' OD1' ' A' ' 82' ' ' ASP . 11.5 p 159.6 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.595 1.558 . . . . 0.0 112.305 171.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . 0.363 . . -109.31 -78.86 0.59 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 119.122 3.008 . . . . 0.0 119.122 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.091 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 33.8 tt0 -148.41 126.56 12.13 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 121.089 1.768 . . . . 0.0 112.993 -165.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.83 HG11 ' HE2' ' A' ' 75' ' ' LYS . 2.5 p -111.38 123.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.782 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 20' ' ' MET 0.258 25.9 p -123.39 110.5 15.22 Favored 'General case' 0 C--O 1.264 1.834 0 CA-C-O 122.702 1.239 . . . . 0.0 113.042 171.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.508 HD12 HG22 ' A' ' 87' ' ' VAL . 1.7 mp . . . . . 0 C--N 1.291 -1.945 0 CA-C-N 112.687 -2.052 . . . . 0.0 107.117 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.1 tptp . . . . . 0 N--CA 1.428 -1.537 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.2 m -68.44 121.46 16.38 Favored 'General case' 0 N--CA 1.411 -2.403 0 O-C-N 124.114 0.884 . . . . 0.0 109.34 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.703 HD12 ' SD ' ' A' ' 20' ' ' MET . 0.2 OUTLIER -133.56 116.49 15.98 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 176.052 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.406 ' HB2' ' HA ' ' A' ' 64' ' ' MET . 0.0 OUTLIER -113.57 140.99 47.71 Favored 'General case' 0 C--N 1.274 -2.708 0 O-C-N 120.921 -1.112 . . . . 0.0 109.306 179.059 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.703 ' SD ' HD12 ' A' ' 18' ' ' LEU . 2.9 mpp? -118.69 127.43 53.56 Favored 'General case' 0 CA--C 1.447 -3.006 0 C-N-CA 120.334 -0.547 . . . . 0.0 111.33 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . 0.293 30.4 p90 -98.87 123.42 43.12 Favored 'General case' 0 N--CA 1.413 -2.317 0 C-N-CA 117.354 -1.739 . . . . 0.0 106.729 168.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.9 p -114.89 122.15 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 CA-C-N 114.647 -1.16 . . . . 0.0 113.815 -167.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.036 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 24.4 m -75.32 135.76 40.88 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 171.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.611 HG21 HD13 ' A' ' 36' ' ' ILE . 7.9 p -121.52 127.7 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.681 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -162.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.642 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 29.5 t 71.26 -48.78 0.68 Allowed 'General case' 0 C--N 1.374 1.663 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 164.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.11 -16.74 6.76 Favored Glycine 0 N--CA 1.421 -2.319 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -173.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.0 t-20 -72.39 110.22 7.61 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -85.7 23.65 0.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.89 2.393 . . . . 0.0 113.015 -172.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -123.32 -170.91 2.2 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -91.61 9.41 32.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.555 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 3.9 tmtt? -67.52 -54.7 17.78 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.252 0.548 . . . . 0.0 110.395 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.719 ' HG3' HD12 ' A' ' 36' ' ' ILE . 3.4 tp10 -69.0 -40.14 78.91 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -175.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -46.8 -56.29 6.5 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.668 171.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 15.4 pt-20 -62.78 -49.06 76.47 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 122.585 0.354 . . . . 0.0 111.628 -175.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -48.62 -58.48 4.65 Favored 'General case' 0 C--O 1.254 1.32 0 C-N-CA 125.656 1.583 . . . . 0.0 108.335 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.719 HD12 ' HG3' ' A' ' 32' ' ' GLU . 43.6 mt -72.24 -43.34 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 CA-C-N 111.647 -2.524 . . . . 0.0 113.617 -173.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.823 HG21 HG12 ' A' ' 55' ' ' ILE . 22.7 p -63.76 -48.77 75.64 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.241 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.5 p -63.69 -62.98 1.3 Allowed 'General case' 0 C--O 1.263 1.766 0 O-C-N 123.323 0.39 . . . . 0.0 110.774 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.14 -46.7 86.01 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.682 ' CE3' HG23 ' A' ' 36' ' ' ILE . 29.4 m0 -74.89 -59.67 2.63 Favored 'General case' 0 C--O 1.165 -3.38 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.612 -176.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.807 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.375 0.0 OUTLIER -64.58 -25.56 68.02 Favored 'General case' 0 C--O 1.252 1.222 0 C-N-CA 117.214 -1.794 . . . . 0.0 112.027 -172.199 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.19 -53.71 42.47 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.527 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 35.5 p -70.89 -28.51 64.6 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 116.881 0.34 . . . . 0.0 111.732 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.965 HD12 ' HG2' ' A' ' 53' ' ' ARG . 18.2 mt -61.18 -35.13 76.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.276 0.631 . . . . 0.0 109.378 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.631 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 60.9 t80 -87.59 -30.14 20.72 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.913 177.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.2 t-20 -69.02 -27.71 65.92 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.134 0.492 . . . . 0.0 111.481 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.11 1.03 52.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.994 0.426 . . . . 0.0 110.557 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 60.34 35.06 20.69 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.686 1.194 . . . . 0.0 112.266 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -65.56 -2.35 3.36 Favored 'General case' 0 CA--C 1.611 3.31 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 59.7 71.74 0.56 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.396 1.478 . . . . 0.0 111.108 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' A' ' 65' ' ' LEU . 6.4 m -147.66 176.21 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.725 -170.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.574 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 12.8 mt-30 -135.96 133.35 37.49 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 174.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.965 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.36 135.42 37.0 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -174.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.783 ' H ' HG12 ' A' ' 62' ' ' ILE . 36.7 t80 -134.36 151.57 51.3 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 117.797 -1.561 . . . . 0.0 113.737 -163.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.823 HG12 HG21 ' A' ' 37' ' ' THR . 25.7 mt -89.5 96.13 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 170.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.664 HG13 ' HB3' ' A' ' 60' ' ' ARG . 7.4 p -94.61 -25.43 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-O 120.605 0.241 . . . . 0.0 110.912 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.67 173.52 45.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 118.667 -1.73 . . . . 0.0 114.706 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.527 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 21.0 m -70.57 117.94 12.74 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.65 ' O ' ' HA ' ' A' ' 23' ' ' THR . 14.2 t70 82.47 9.98 0.7 Allowed 'General case' 0 C--O 1.188 -2.139 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.664 ' HB3' HG13 ' A' ' 56' ' ' VAL . 5.5 mpt_? -138.78 117.84 12.56 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 122.247 1.022 . . . . 0.0 113.525 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.59 168.44 12.62 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 125.046 1.339 . . . . 0.0 107.445 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.783 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.5 pt -138.06 157.43 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.256 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.072 171.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.451 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -130.82 102.96 6.3 Favored 'General case' 0 N--CA 1.422 -1.841 0 O-C-N 126.807 2.567 . . . . 0.0 107.929 166.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.471 ' HB3' ' O ' ' A' ' 52' ' ' GLN . 1.0 OUTLIER -87.98 117.29 26.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.769 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.429 0.0 OUTLIER -121.03 148.46 44.1 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.646 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.324 26.3 ttp180 -112.64 -57.2 2.31 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -169.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.564 ' HB2' ' CE1' ' A' ' 70' ' ' TYR . 1.7 m-20 -50.23 -13.85 0.13 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 175.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.15 29.11 62.21 Favored Glycine 0 C--N 1.36 1.887 0 CA-C-N 120.475 1.488 . . . . 0.0 115.702 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.402 ' H ' ' HD1' ' A' ' 70' ' ' TYR . 32.5 m -151.99 44.34 0.73 Allowed 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 118.733 1.266 . . . . 0.0 112.949 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 67' ' ' ASP . 14.8 p90 178.99 16.75 0.0 OUTLIER 'General case' 0 C--N 1.365 1.279 0 CA-C-N 119.075 0.852 . . . . 0.0 111.97 -169.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.769 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -100.11 -33.96 10.25 Favored 'General case' 0 C--O 1.267 1.995 0 CA-C-O 122.372 1.082 . . . . 0.0 113.867 -170.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.476 ' O ' ' HB3' ' A' ' 75' ' ' LYS 0.496 13.0 m0 -89.19 -9.62 50.14 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 116.88 -1.928 . . . . 0.0 112.447 -172.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -73.04 -26.66 61.38 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.356 164.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.615 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.0 mt -64.89 -38.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.37 1.462 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 171.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 78' ' ' LEU . 29.1 ttpp -57.7 -41.46 81.76 Favored 'General case' 1 C--O 1.317 4.607 0 CA-C-O 122.831 1.301 . . . . 0.0 110.829 175.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -57.72 -44.95 86.31 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 118.881 -1.128 . . . . 0.0 110.47 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.748 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 17.1 m-85 -62.13 -27.7 69.12 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.543 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.598 ' CD1' ' HA ' ' A' ' 75' ' ' LYS . 39.8 mt -56.19 -59.32 5.1 Favored 'General case' 0 C--O 1.275 2.446 0 CA-C-O 122.082 0.944 . . . . 0.0 109.199 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.684 HG13 ' SG ' ' A' ' 84' ' ' CYS 0.277 1.2 m -77.04 -4.43 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 C-N-CA 117.467 -1.693 . . . . 0.0 113.134 178.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.748 ' HB3' ' HA ' ' A' ' 77' ' ' PHE . 9.9 t -88.65 -14.32 37.68 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.41 171.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.567 ' HG3' ' NE1' ' A' ' 40' ' ' TRP . 78.3 mm-40 -90.44 -43.42 10.29 Favored 'General case' 0 C--N 1.38 1.892 0 C-N-CA 117.328 -1.749 . . . . 0.0 109.182 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.378 29.3 t70 -176.23 -82.52 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.662 1.226 . . . . 0.0 113.181 173.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -127.27 147.67 50.23 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 120.649 1.568 . . . . 0.0 109.399 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.684 ' SG ' HG13 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -133.51 164.49 27.04 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 178.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.37 -51.12 0.15 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.036 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.1 tt0 -143.19 121.22 12.09 Favored 'General case' 0 CA--C 1.496 -1.13 0 O-C-N 120.757 -1.214 . . . . 0.0 112.103 -172.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.6 m -111.83 121.69 64.78 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.871 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' MET 0.293 22.3 p -106.36 114.41 28.52 Favored 'General case' 0 N--CA 1.406 -2.675 0 C-N-CA 117.348 -1.741 . . . . 0.0 109.656 165.044 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.545 HD13 ' CG ' ' A' ' 20' ' ' MET . 1.5 mm? . . . . . 0 N--CA 1.407 -2.603 0 CA-C-N 110.858 -2.883 . . . . 0.0 108.138 -175.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.515 -0.394 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.8 m -83.96 125.44 32.05 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 174.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.814 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -133.22 112.76 11.96 Favored 'General case' 0 C--O 1.19 -2.055 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.483 -175.143 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 27.4 ptm -84.04 127.62 34.01 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 119.444 -0.902 . . . . 0.0 108.762 174.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.514 ' HG3' ' CD1' ' A' ' 89' ' ' LEU . 27.3 ttm -101.06 107.91 19.48 Favored 'General case' 0 N--CA 1.424 -1.739 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.947 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -94.1 114.39 26.53 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.5 p -127.15 125.65 66.62 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -169.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.101 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 18.8 m -84.71 142.07 30.12 Favored 'General case' 0 CA--C 1.588 2.419 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.608 174.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.66 HG21 HD13 ' A' ' 36' ' ' ILE . 8.5 p -125.82 129.39 72.51 Favored 'Isoleucine or valine' 0 C--N 1.378 1.829 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.84 29.49 1.89 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 115.385 -2.526 . . . . 0.0 114.104 -166.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.44 -34.45 25.68 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 1.022 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 13.9 t-20 -116.95 121.64 32.39 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -85.43 27.28 0.61 Allowed 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 123.087 2.525 . . . . 0.0 114.067 -173.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.427 ' HB ' ' H ' ' A' ' 30' ' ' GLU . 22.4 p -144.9 -160.74 1.17 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -174.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.489 ' HA ' ' HB ' ' A' ' 33' ' ' THR . 40.4 tt0 -89.12 1.76 55.14 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.017 -177.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 5.9 tmtt? -68.08 -50.46 54.88 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.896 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 1.022 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.7 tp10 -70.82 -42.37 70.34 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 118.575 -1.25 . . . . 0.0 107.703 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 59.9 m -42.49 -51.58 4.99 Favored 'General case' 0 C--O 1.199 -1.591 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.557 171.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 13.7 pt-20 -71.89 -48.37 46.15 Favored 'General case' 0 C--O 1.252 1.22 0 O-C-N 121.781 -0.574 . . . . 0.0 112.476 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -47.69 -57.77 5.12 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.522 1.529 . . . . 0.0 107.501 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.758 HG23 ' CD2' ' A' ' 40' ' ' TRP . 14.7 mt -69.14 -43.95 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 CA-C-N 111.452 -2.613 . . . . 0.0 113.551 -176.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.595 HG21 HG23 ' A' ' 55' ' ' ILE . 19.8 p -67.5 -42.08 83.44 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 120.533 1.515 . . . . 0.0 111.315 -174.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.0 p -66.05 -55.64 15.61 Favored 'General case' 0 N--CA 1.425 -1.691 0 O-C-N 123.974 0.796 . . . . 0.0 110.138 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 tp -60.75 -46.17 91.47 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.787 ' CZ3' HD13 ' A' ' 78' ' ' LEU . 44.0 m0 -68.67 -69.97 0.3 Allowed 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.36 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.843 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.321 0.0 OUTLIER -69.31 -21.86 63.83 Favored 'General case' 0 C--O 1.255 1.377 0 C-N-CA 117.918 -1.513 . . . . 0.0 111.968 -171.462 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.11 -51.47 54.95 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 p -68.19 -32.66 73.05 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 117.191 0.495 . . . . 0.0 110.545 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.817 HD12 ' HG2' ' A' ' 53' ' ' ARG . 33.4 mt -60.53 -33.15 72.23 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.005 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.65 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 78.0 t80 -91.08 -30.13 16.92 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.991 175.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -66.06 -32.77 74.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.68 1.89 53.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.25 0.548 . . . . 0.0 109.802 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 t30 49.37 60.49 3.73 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 125.65 1.58 . . . . 0.0 112.763 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -74.02 12.63 0.67 Allowed 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 50.22 67.26 0.94 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.901 1.28 . . . . 0.0 112.517 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.616 HG23 ' HD2' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -146.88 174.23 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.245 -177.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.474 ' HB3' ' HB3' ' A' ' 64' ' ' MET . 7.9 tt0 -131.1 117.97 19.85 Favored 'General case' 0 C--O 1.191 -1.986 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.843 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -128.17 141.17 51.55 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.213 -170.261 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.79 ' H ' HG12 ' A' ' 62' ' ' ILE . 16.8 m-85 -133.72 151.96 51.76 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -168.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.595 HG23 HG21 ' A' ' 37' ' ' THR . 21.5 mt -93.03 96.64 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 167.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 60' ' ' ARG . 8.2 m -91.1 -31.25 4.95 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.535 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.33 173.73 45.68 Favored Glycine 0 CA--C 1.49 -1.493 0 C-N-CA 117.028 -2.51 . . . . 0.0 114.191 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 33.2 m -66.71 118.95 10.98 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER 85.25 9.08 0.36 Allowed 'General case' 0 C--N 1.363 1.173 0 CA-C-O 122.138 0.97 . . . . 0.0 109.129 -178.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.541 ' HB3' HG23 ' A' ' 56' ' ' VAL . 8.1 mpt_? -140.21 131.63 26.88 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.13 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.05 165.92 26.05 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.79 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -143.51 157.23 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.99 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.914 170.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.597 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -135.65 104.81 5.92 Favored 'General case' 0 N--CA 1.428 -1.552 0 O-C-N 126.196 2.185 . . . . 0.0 107.321 162.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 26.7 ttt -87.2 116.66 25.43 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.164 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.588 ' HA ' HG12 ' A' ' 51' ' ' VAL . 3.8 mp -82.88 145.55 29.37 Favored 'General case' 0 C--O 1.256 1.415 0 C-N-CA 126.077 1.751 . . . . 0.0 112.288 -175.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.298 72.3 ttt180 -110.15 -61.77 1.61 Allowed 'General case' 0 CA--C 1.587 2.395 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 175.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -57.03 -10.95 1.28 Allowed 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 56.61 26.71 53.45 Favored Glycine 0 C--N 1.36 1.89 0 CA-C-N 119.491 1.041 . . . . 0.0 114.501 -173.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.0 m -143.06 38.93 1.45 Allowed 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -179.56 -176.18 0.37 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -167.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.573 ' HB1' ' CE2' ' A' ' 63' ' ' PHE . . . 98.06 -30.89 0.02 OUTLIER 'General case' 0 C--N 1.376 1.718 0 C-N-CA 126.574 1.95 . . . . 0.0 115.016 173.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.689 ' HH2' ' HG ' ' A' ' 18' ' ' LEU 0.294 17.5 m-90 -71.32 -30.17 65.89 Favored 'General case' 0 C--O 1.277 2.502 0 CA-C-O 121.794 0.807 . . . . 0.0 111.803 -177.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -66.16 -40.13 90.29 Favored 'General case' 0 C--O 1.266 1.963 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.45 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.569 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 23.3 mt -54.98 -45.83 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.05 175.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.737 ' HE3' HG21 ' A' ' 87' ' ' VAL . 12.5 tmtt? -58.8 -42.88 90.14 Favored 'General case' 0 C--O 1.266 1.954 0 CA-C-O 121.372 0.606 . . . . 0.0 110.242 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.3 -42.96 96.6 Favored 'General case' 0 C--O 1.277 2.529 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.636 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 14.5 m-85 -55.85 -45.45 78.44 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.787 HD13 ' CZ3' ' A' ' 40' ' ' TRP . 20.1 mt -58.84 -46.82 86.8 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.789 HG22 ' HB3' ' A' ' 84' ' ' CYS . 2.1 t -70.29 -20.44 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.826 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.8 t -90.55 -8.16 50.97 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -88.04 -38.39 15.5 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.317 6.6 t70 -155.02 -104.35 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.727 176.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 83' ' ' ARG . 23.5 tpt180 -143.32 84.35 1.81 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 121.115 1.78 . . . . 0.0 112.406 176.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.789 ' HB3' HG22 ' A' ' 79' ' ' VAL . 6.0 t -86.27 160.74 19.06 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.82 -40.33 0.09 Allowed 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -167.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.101 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 45.3 tt0 -126.49 116.67 21.47 Favored 'General case' 0 CA--C 1.47 -2.101 0 C-N-CA 118.187 -1.405 . . . . 0.0 109.719 -172.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.835 HG12 HD21 ' A' ' 89' ' ' LEU . 24.2 t -110.35 98.26 6.82 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.797 -175.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.56 ' C ' HD22 ' A' ' 89' ' ' LEU . 38.6 p -111.08 142.73 42.85 Favored 'General case' 0 C--O 1.261 1.692 0 CA-C-O 121.657 0.742 . . . . 0.0 111.251 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.835 HD21 HG12 ' A' ' 87' ' ' VAL . 2.9 mm? . . . . . 0 N--CA 1.405 -2.704 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.967 -166.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.506 ' N ' ' HA3' ' A' ' 68' ' ' GLY . 27.0 tptp . . . . . 0 CA--C 1.532 0.274 0 CA-C-O 120.947 0.404 . . . . 0.0 111.776 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.8 m -65.81 125.5 25.55 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.801 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -124.74 109.03 12.61 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.591 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 22.3 ptm -96.6 102.98 14.86 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.678 ' HE3' HD11 ' A' ' 65' ' ' LEU . 7.4 ptp -114.75 135.14 54.5 Favored 'General case' 0 C--O 1.272 2.271 0 C-N-CA 116.789 -1.965 . . . . 0.0 112.83 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.542 ' HA ' HG22 ' A' ' 62' ' ' ILE . 3.6 t80 -97.46 118.52 34.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.85 2.46 . . . . 0.0 107.71 -173.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.63 124.42 70.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.801 ' HA ' ' HG3' ' A' ' 60' ' ' ARG . 83.4 m -88.81 121.32 31.05 Favored 'General case' 0 CA--C 1.605 3.06 0 C-N-CA 125.923 1.689 . . . . 0.0 112.275 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.681 HG13 ' HB2' ' A' ' 83' ' ' ARG 0.305 56.4 t -111.01 130.54 64.26 Favored 'Isoleucine or valine' 0 C--N 1.378 1.813 0 C-N-CA 127.668 2.387 . . . . 0.0 104.714 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.5 m -121.92 -5.86 9.03 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-N 122.658 2.481 . . . . 0.0 115.998 -169.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.31 -44.72 21.14 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 121.452 -0.404 . . . . 0.0 112.817 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.557 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 4.7 m-20 -106.07 154.16 39.75 Favored Pre-proline 0 CA--C 1.514 -0.436 0 CA-C-N 117.757 0.779 . . . . 0.0 109.271 172.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -111.12 40.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 123.883 3.056 . . . . 0.0 110.882 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.3 p -131.89 -105.08 0.26 Allowed 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.647 -0.658 . . . . 0.0 112.72 -168.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.753 ' HA ' ' O ' ' A' ' 58' ' ' SER . 30.0 tt0 -167.19 15.74 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.907 2.083 . . . . 0.0 106.669 170.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 9.5 tmtt? -86.78 -31.68 20.77 Favored 'General case' 0 C--O 1.259 1.556 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.359 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 1.003 ' HG3' HD12 ' A' ' 36' ' ' ILE . 7.1 tp10 -73.32 -44.69 58.5 Favored 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 104.303 -2.481 . . . . 0.0 104.303 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.814 ' OG1' ' HA ' ' A' ' 59' ' ' ASP . 59.6 m -44.2 -51.14 8.42 Favored 'General case' 0 C--O 1.179 -2.64 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.391 167.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.591 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.7 pt-20 -63.39 -52.33 62.09 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 119.631 1.105 . . . . 0.0 112.42 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -53.6 -60.03 3.83 Favored 'General case' 0 C--O 1.263 1.798 0 CA-C-O 123.315 1.531 . . . . 0.0 107.978 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.003 HD12 ' HG3' ' A' ' 32' ' ' GLU . 1.3 mt -60.43 -45.03 97.37 Favored 'Isoleucine or valine' 0 C--O 1.163 -3.464 0 CA-C-N 112.095 -2.32 . . . . 0.0 112.745 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.854 HG21 HG12 ' A' ' 55' ' ' ILE . 19.2 p -68.76 -34.53 75.73 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-N 121.071 1.76 . . . . 0.0 110.869 -176.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.4 m -63.06 -51.13 67.88 Favored 'General case' 0 N--CA 1.407 -2.588 0 C-N-CA 119.551 -0.859 . . . . 0.0 109.819 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.5 mp -71.71 -43.06 66.59 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.366 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.693 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 43.4 m0 -62.44 -76.58 0.06 Allowed 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 123.757 0.661 . . . . 0.0 111.251 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.634 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.323 0.0 OUTLIER -71.74 -19.66 62.01 Favored 'General case' 0 C--O 1.254 1.337 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.976 -172.386 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.58 -51.82 55.1 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.751 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 32.0 t -72.47 -25.29 61.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.816 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 31.1 mt -62.78 -34.37 77.11 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.81 0.338 . . . . 0.0 110.242 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.568 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 70.8 t80 -91.24 -24.43 19.89 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.926 175.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.751 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 8.1 t30 -67.24 -31.62 72.1 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.698 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.22 5.08 48.79 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.271 0.558 . . . . 0.0 109.583 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.5 t30 46.67 55.39 7.74 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.516 1.927 . . . . 0.0 112.905 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -67.51 1.6 2.25 Favored 'General case' 0 CA--C 1.594 2.661 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t70 56.58 69.48 0.74 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.188 1.395 . . . . 0.0 110.951 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.86 HG12 ' HA ' ' A' ' 65' ' ' LEU . 6.7 m -147.44 176.06 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.629 -172.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.535 ' O ' ' HB3' ' A' ' 64' ' ' MET . 25.7 tt0 -133.78 126.23 30.19 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.816 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -134.69 140.78 46.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 108.784 -170.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.71 ' H ' HG12 ' A' ' 62' ' ' ILE . 38.1 m-85 -133.8 153.15 51.93 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 -166.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.854 HG12 HG21 ' A' ' 37' ' ' THR . 76.6 mt -86.42 112.42 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 166.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.8 m -130.12 -26.68 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -171.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.77 ' HA3' ' HB2' ' A' ' 60' ' ' ARG . . . -138.41 174.83 21.79 Favored Glycine 0 CA--C 1.48 -2.127 0 C-N-CA 118.643 -1.741 . . . . 0.0 112.058 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.753 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 5.2 m -39.02 -71.1 0.09 Allowed 'General case' 0 C--N 1.367 1.364 0 O-C-N 125.654 1.444 . . . . 0.0 109.417 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.814 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 21.4 m-20 -126.64 65.55 1.26 Allowed 'General case' 1 N--CA 1.363 -4.775 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 168.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.801 ' HG3' ' HA ' ' A' ' 23' ' ' THR . 4.1 mpt_? -134.18 137.0 44.14 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 112.896 -1.956 . . . . 0.0 108.823 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.56 169.59 17.06 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.71 HG12 ' H ' ' A' ' 54' ' ' PHE . 9.8 pt -136.56 157.64 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.065 0 C-N-CA 118.472 -1.291 . . . . 0.0 109.553 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.504 ' HZ ' ' HB2' ' A' ' 75' ' ' LYS 0.28 6.7 p90 -125.81 109.38 12.47 Favored 'General case' 0 N--CA 1.408 -2.55 0 O-C-N 126.394 2.309 . . . . 0.0 107.909 164.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.591 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 21.4 ttt -100.04 104.5 16.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.416 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.931 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.34 0.0 OUTLIER -99.75 147.15 25.75 Favored 'General case' 0 CA--C 1.462 -2.405 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.041 -178.962 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.367 20.8 ttp180 -105.13 -68.61 0.85 Allowed 'General case' 0 C--N 1.264 -3.147 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -164.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.937 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 37.4 t70 -44.48 -24.51 0.19 Allowed 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.506 ' HA3' ' N ' ' A' ' 16' ' ' LYS . . . 69.78 12.29 67.36 Favored Glycine 0 C--N 1.366 2.196 0 CA-C-N 120.224 1.374 . . . . 0.0 115.996 -175.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.4 t -121.38 32.53 5.87 Favored 'General case' 0 CA--C 1.563 1.463 0 CA-C-N 118.649 1.224 . . . . 0.0 111.905 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.937 ' HE1' ' HB3' ' A' ' 67' ' ' ASP . 45.0 p90 175.13 137.96 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -174.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.931 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 169.27 -33.3 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.881 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.687 ' CZ2' HD13 ' A' ' 89' ' ' LEU 0.622 10.5 m0 -82.5 -11.73 58.28 Favored 'General case' 0 C--O 1.263 1.778 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 -168.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 43.6 tt0 -74.08 -36.82 64.32 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 170.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 63.9 mt -55.11 -46.29 77.44 Favored 'Isoleucine or valine' 0 C--O 1.278 2.565 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB2' ' HD1' ' A' ' 72' ' ' TRP . 13.9 tmtt? -56.73 -48.97 76.58 Favored 'General case' 0 C--O 1.282 2.793 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.124 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.31 -47.39 83.84 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.211 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.468 ' CZ ' ' HG2' ' A' ' 73' ' ' GLU . 15.8 m-85 -52.59 -53.75 42.37 Favored 'General case' 0 C--N 1.371 1.54 0 O-C-N 123.73 0.644 . . . . 0.0 109.661 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.684 HD13 ' CE3' ' A' ' 40' ' ' TRP . 14.0 mt -60.46 -55.06 38.03 Favored 'General case' 0 C--O 1.302 3.816 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 75' ' ' LYS 0.308 27.4 m -78.29 -5.7 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 C-N-CA 117.986 -1.486 . . . . 0.0 113.217 -174.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.7 m -108.47 5.1 24.94 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.726 165.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 7.9 tp-100 -82.26 -45.1 15.46 Favored 'General case' 0 CA--C 1.456 -2.643 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.391 4.6 p30 -163.72 -94.14 0.02 OUTLIER 'General case' 0 C--O 1.245 0.863 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 175.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.681 ' HB2' HG13 ' A' ' 24' ' ' VAL . 21.2 mmt180 -91.22 129.77 37.17 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.406 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 11.8 p -150.71 152.17 33.51 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.677 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.79 -36.71 0.1 Allowed 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 123.301 0.64 . . . . 0.0 110.316 170.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.687 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 41.2 tt0 -154.29 129.95 10.0 Favored 'General case' 0 C--O 1.207 -1.135 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.647 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.509 HG12 ' CD2' ' A' ' 89' ' ' LEU . 58.6 t -117.4 98.32 6.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 171.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.406 ' C ' HD23 ' A' ' 89' ' ' LEU . 16.9 p -100.01 136.14 40.38 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 122.708 1.242 . . . . 0.0 111.848 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.801 ' HB3' HD11 ' A' ' 18' ' ' LEU . 6.8 mt . . . . . 0 N--CA 1.398 -3.053 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.078 -168.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.427 ' HE3' ' O ' ' A' ' 17' ' ' THR . 49.6 tptt . . . . . 0 N--CA 1.437 -1.085 0 CA-C-O 120.919 0.39 . . . . 0.0 111.54 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.617 HG23 ' HD2' ' A' ' 66' ' ' ARG . 30.3 m -69.73 115.16 8.65 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.032 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -110.96 102.9 11.34 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.853 1.311 . . . . 0.0 108.365 -176.433 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.594 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 6.2 ttt -84.84 119.62 25.53 Favored 'General case' 0 C--N 1.27 -2.859 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.737 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.509 ' HE2' ' HB2' ' A' ' 20' ' ' MET . 26.0 ttm -110.46 110.04 20.64 Favored 'General case' 0 N--CA 1.415 -2.215 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.077 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -91.77 115.93 28.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -128.72 130.69 68.82 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -169.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.073 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 18.3 m -84.9 143.63 28.89 Favored 'General case' 0 CA--C 1.604 3.034 0 O-C-N 124.77 1.294 . . . . 0.0 110.946 174.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.527 HG21 HD13 ' A' ' 36' ' ' ILE 0.288 6.9 t -126.74 135.48 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.66 0 C-N-CA 130.069 3.348 . . . . 0.0 104.326 -176.287 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -117.13 -21.26 8.92 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-N 122.921 2.601 . . . . 0.0 117.062 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.05 -45.19 62.66 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.021 0.828 . . . . 0.0 114.217 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.859 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.5 t-20 -116.18 116.82 39.56 Favored Pre-proline 0 N--CA 1.433 -1.313 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -88.36 30.84 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.901 2.401 . . . . 0.0 113.147 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 p -139.1 -174.84 3.96 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.531 ' O ' ' HB ' ' A' ' 33' ' ' THR . 32.7 tt0 -77.27 0.37 22.31 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.573 0.624 . . . . 0.0 111.727 -173.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -68.26 -43.35 78.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 122.049 -0.407 . . . . 0.0 110.601 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.859 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.7 OUTLIER -71.29 -39.32 71.58 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 118.086 -1.445 . . . . 0.0 108.314 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 61.1 m -45.04 -54.21 6.91 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 124.407 1.083 . . . . 0.0 111.482 172.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.63 -43.02 70.1 Favored 'General case' 0 C--O 1.265 1.882 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -52.72 -55.32 23.55 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.644 HG23 ' CE3' ' A' ' 40' ' ' TRP . 27.3 mt -62.59 -35.68 71.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.549 0 CA-C-N 112.574 -2.103 . . . . 0.0 112.932 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.2 m -61.77 -55.18 32.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.399 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.452 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 34.2 m -65.54 -48.51 72.19 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.592 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.0 -57.22 8.27 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.112 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.682 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 36.4 m0 -69.22 -74.03 0.14 Allowed 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.248 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.675 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.405 0.0 OUTLIER -72.05 -15.74 62.03 Favored 'General case' 0 C--O 1.253 1.28 0 C-N-CA 116.957 -1.897 . . . . 0.0 112.773 -168.01 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 38' ' ' SER . . . -67.23 -51.3 39.15 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 171.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 39.9 t -70.32 -27.47 64.39 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.795 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 16.2 mt -64.2 -28.71 69.93 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.038 0.447 . . . . 0.0 110.075 177.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.562 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 75.9 t80 -94.31 -28.44 15.57 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.108 0.48 . . . . 0.0 110.43 174.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 20.8 t-20 -72.79 -29.73 63.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -176.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.96 11.94 19.01 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.5 44.62 9.95 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.751 1.62 . . . . 0.0 114.158 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -82.3 151.41 26.76 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.92 87.62 7.36 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.726 1.603 . . . . 0.0 110.503 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.866 HG12 ' HA ' ' A' ' 65' ' ' LEU . 3.1 m -147.89 175.53 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.955 -173.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.448 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 26.8 tt0 -140.02 123.29 16.92 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.795 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -136.07 135.89 39.74 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -170.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.815 ' H ' HG12 ' A' ' 62' ' ' ILE . 16.7 m-85 -134.46 153.99 51.63 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -165.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 80.2 mt -80.03 124.75 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 165.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.98 -15.46 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 120.83 0.348 . . . . 0.0 110.739 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.524 ' HA3' ' HG2' ' A' ' 60' ' ' ARG . . . -166.32 163.64 37.03 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 118.051 -2.023 . . . . 0.0 113.905 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.478 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 37.3 m -77.91 45.85 0.54 Allowed 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 124.668 1.187 . . . . 0.0 111.579 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 58' ' ' SER . 3.1 p-10 158.63 14.92 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.745 0 C-N-CA 126.904 2.082 . . . . 0.0 106.496 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.524 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -149.02 147.76 28.93 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-O 121.669 0.747 . . . . 0.0 112.344 177.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.45 169.88 16.84 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 125.736 1.614 . . . . 0.0 106.874 -172.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.815 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.7 pt -136.19 157.82 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.778 0 C-N-CA 118.377 -1.329 . . . . 0.0 109.559 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.557 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -134.33 109.23 8.67 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 126.434 2.334 . . . . 0.0 106.362 162.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.594 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 23.3 ttt -97.83 108.96 21.79 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.347 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.919 HD13 ' HB2' ' A' ' 71' ' ' ALA 0.306 2.3 pt? -98.47 147.94 24.23 Favored 'General case' 0 CA--C 1.464 -2.359 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -176.127 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.617 ' HD2' HG23 ' A' ' 17' ' ' THR 0.26 12.6 mmm180 -100.28 -53.41 3.13 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 111.578 -2.555 . . . . 0.0 113.576 -174.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -45.47 -27.46 0.72 Allowed 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.95 -31.31 5.37 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 119.663 1.12 . . . . 0.0 111.936 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.261 40.6 t -98.17 -61.61 1.36 Allowed 'General case' 0 CA--C 1.588 2.43 0 N-CA-C 118.29 2.7 . . . . 0.0 118.29 -175.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.479 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -64.42 34.46 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 -168.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.919 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -103.16 -22.47 13.74 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.772 ' HH2' ' HG ' ' A' ' 18' ' ' LEU 0.504 13.6 m-90 -82.16 -28.93 31.84 Favored 'General case' 0 C--O 1.284 2.921 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -170.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.15 -27.57 63.64 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.655 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.8 mt -62.22 -39.97 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.759 ' HA ' ' CD1' ' A' ' 78' ' ' LEU . 26.2 ttpp -58.54 -43.3 89.21 Favored 'General case' 0 C--O 1.288 3.089 0 CA-C-O 121.445 0.641 . . . . 0.0 110.595 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.41 -45.96 80.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.209 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.655 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 10.0 m-85 -60.38 -39.71 88.22 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.321 -177.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.759 ' CD1' ' HA ' ' A' ' 75' ' ' LYS 0.275 21.5 mt -52.46 -59.74 4.07 Favored 'General case' 0 CA--C 1.45 -2.877 0 C-N-CA 123.077 0.551 . . . . 0.0 110.205 177.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.825 HG22 ' HB3' ' A' ' 84' ' ' CYS . 1.6 t -77.94 -9.26 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.684 -172.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.2 t -92.83 -12.24 31.62 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.615 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -107.15 -39.11 5.81 Favored 'General case' 0 CA--C 1.473 -1.989 0 C-N-CA 117.799 -1.56 . . . . 0.0 108.637 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -141.43 -169.45 2.87 Favored 'General case' 0 N--CA 1.389 -3.488 0 CA-C-N 113.419 -1.719 . . . . 0.0 107.06 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -108.32 76.92 1.06 Allowed 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 119.905 1.23 . . . . 0.0 110.645 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.825 ' HB3' HG22 ' A' ' 79' ' ' VAL . 3.8 t -70.49 157.53 37.68 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 113.518 -1.673 . . . . 0.0 109.645 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.75 -35.59 0.09 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.073 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.4 tt0 -135.51 125.22 25.38 Favored 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.42 -171.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.438 ' HB ' HD21 ' A' ' 89' ' ' LEU . 18.7 m -123.26 113.12 36.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.42 ' C ' HD23 ' A' ' 89' ' ' LEU . 3.4 p -107.31 128.27 54.29 Favored 'General case' 0 CA--C 1.477 -1.831 0 CA-C-O 122.36 1.076 . . . . 0.0 109.841 168.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.032 ' HB3' HD11 ' A' ' 18' ' ' LEU . 3.3 mt . . . . . 0 C--N 1.259 -3.366 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.731 -168.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? . . . . . 0 CA--C 1.549 0.916 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -78.61 124.27 27.99 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.813 ' HB3' HD22 ' A' ' 65' ' ' LEU . 25.6 tp -131.2 115.4 16.3 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.008 -174.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.678 ' HB3' ' SD ' ' A' ' 64' ' ' MET . 20.0 ptm -84.31 105.99 15.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.602 0.715 . . . . 0.0 112.282 176.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.831 ' HG3' ' HA ' ' A' ' 89' ' ' LEU . 3.6 mpp? -86.29 125.22 33.44 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.554 0.692 . . . . 0.0 112.261 176.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.635 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 47.2 t80 -106.06 112.92 26.17 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 127.246 2.218 . . . . 0.0 106.116 -176.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.78 130.36 74.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -168.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.848 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 89.5 m -93.05 131.14 38.32 Favored 'General case' 0 CA--C 1.611 3.295 0 C-N-CA 126.151 1.781 . . . . 0.0 111.883 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.6 t -132.14 113.44 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.358 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -105.77 -18.98 13.89 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 122.01 2.187 . . . . 0.0 115.185 -164.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.45 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . -39.17 -49.08 2.78 Favored Glycine 0 N--CA 1.487 2.035 0 O-C-N 123.419 0.449 . . . . 0.0 113.612 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 1.08 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 26.9 t-20 -115.86 104.74 52.35 Favored Pre-proline 0 N--CA 1.421 -1.881 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.14 33.74 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 123.888 3.059 . . . . 0.0 112.71 -174.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -148.43 -165.27 2.23 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.475 ' O ' ' HB ' ' A' ' 33' ' ' THR . 39.6 tt0 -81.05 -18.47 46.57 Favored 'General case' 0 C--O 1.19 -2.039 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -173.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.46 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 3.4 tmtt? -58.96 -41.25 87.03 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-N 119.032 0.833 . . . . 0.0 111.491 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 1.08 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 5.9 tp10 -66.42 -61.49 1.97 Allowed 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 31.5 m -34.35 -50.25 0.41 Allowed 'General case' 0 C--O 1.19 -2.073 0 C-N-CA 127.158 2.183 . . . . 0.0 113.026 172.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.8 pt-20 -71.99 -49.66 35.26 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 118.124 0.42 . . . . 0.0 112.031 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -54.24 -54.15 43.89 Favored 'General case' 0 C--O 1.263 1.801 0 CA-C-O 123.045 1.402 . . . . 0.0 107.296 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.041 HD12 ' HG3' ' A' ' 32' ' ' GLU . 1.5 mt -66.83 -38.99 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.584 0 CA-C-N 111.622 -2.536 . . . . 0.0 113.541 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.744 HG21 HG12 ' A' ' 55' ' ' ILE . 11.3 p -73.82 -39.3 64.16 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-N 121.3 1.864 . . . . 0.0 110.946 -176.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.0 t -64.22 -47.83 78.2 Favored 'General case' 0 N--CA 1.412 -2.344 0 O-C-N 124.017 0.823 . . . . 0.0 109.659 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.4 tp -68.75 -44.37 73.9 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.765 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.827 ' CE3' HD12 ' A' ' 78' ' ' LEU . 48.8 m0 -66.2 -74.02 0.12 Allowed 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 118.952 -0.547 . . . . 0.0 111.708 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.693 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.339 0.0 OUTLIER -70.83 -19.29 62.68 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 118.044 -1.462 . . . . 0.0 111.884 -172.601 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.03 -48.91 65.57 Favored Glycine 0 C--N 1.356 1.646 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 172.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.6 p -70.0 -29.63 66.75 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 117.442 0.621 . . . . 0.0 110.25 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.743 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 22.8 mt -61.07 -32.49 72.13 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.003 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.651 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 80.5 t80 -92.11 -27.38 17.78 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.873 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -67.89 -30.67 70.08 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 120.629 0.252 . . . . 0.0 111.004 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.69 -0.01 56.24 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.6 t30 47.17 53.87 10.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.136 1.774 . . . . 0.0 112.006 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -65.58 0.69 1.5 Allowed 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.9 t70 59.3 70.87 0.61 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.305 1.042 . . . . 0.0 111.365 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.54 ' CG2' ' HD2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -146.92 175.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.919 -172.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -131.04 115.92 17.09 Favored 'General case' 0 C--O 1.194 -1.828 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.743 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -130.41 140.77 50.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -172.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.812 ' H ' HG12 ' A' ' 62' ' ' ILE . 24.4 m-85 -134.02 152.06 51.69 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.744 HG12 HG21 ' A' ' 37' ' ' THR . 19.9 mt -92.65 97.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 167.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 m -99.1 -22.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.84 169.03 40.81 Favored Glycine 0 CA--C 1.482 -1.975 0 C-N-CA 118.192 -1.956 . . . . 0.0 113.78 175.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.468 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 36.9 m -65.04 120.4 12.57 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.0 OUTLIER 78.79 14.76 1.19 Allowed 'General case' 0 C--N 1.371 1.541 0 CA-C-O 122.658 1.218 . . . . 0.0 108.823 -178.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.635 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 4.1 tpp85 -143.84 117.49 9.23 Favored 'General case' 0 CA--C 1.557 1.236 0 O-C-N 121.419 -0.8 . . . . 0.0 111.266 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.96 166.44 20.06 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -175.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.812 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -138.77 155.23 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.461 -2.464 0 C-N-CA 118.174 -1.41 . . . . 0.0 109.699 172.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.521 ' CE2' ' HB1' ' A' ' 71' ' ' ALA . 6.0 p90 -134.97 106.37 6.8 Favored 'General case' 0 N--CA 1.417 -2.093 0 O-C-N 126.335 2.272 . . . . 0.0 107.307 163.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.678 ' SD ' ' HB3' ' A' ' 19' ' ' MET . 20.2 ttt -92.15 110.22 21.6 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.45 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.813 HD22 ' HB3' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -75.12 132.38 41.18 Favored 'General case' 0 C--O 1.254 1.313 0 O-C-N 125.895 1.997 . . . . 0.0 110.952 -175.672 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.318 2.1 tmt_? -108.41 -54.95 2.44 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -41.24 -34.16 0.45 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 109.09 -31.1 7.97 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 117.723 -2.18 . . . . 0.0 115.079 -173.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.9 m -158.66 60.17 0.43 Allowed 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -171.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.457 ' OH ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -152.81 21.38 0.6 Allowed 'General case' 0 C--O 1.218 -0.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.174 178.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.603 ' O ' ' HB ' ' A' ' 74' ' ' ILE . . . -103.19 -29.27 11.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -168.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.538 ' HZ2' HD23 ' A' ' 18' ' ' LEU 0.512 8.1 m0 -87.18 -9.93 53.95 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 116.317 -2.153 . . . . 0.0 113.828 -171.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.566 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 35.0 tt0 -73.42 -43.12 61.1 Favored 'General case' 0 C--O 1.279 2.653 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 166.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 61.0 mt -50.77 -47.0 29.36 Favored 'Isoleucine or valine' 0 C--O 1.278 2.578 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.801 173.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.613 ' HG3' HG21 ' A' ' 87' ' ' VAL . 44.8 tttm -56.11 -50.61 70.58 Favored 'General case' 0 C--N 1.375 1.688 0 C-N-CA 125.807 1.643 . . . . 0.0 110.269 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -61.86 -25.64 67.65 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.566 ' CZ ' ' HG2' ' A' ' 73' ' ' GLU . 23.1 m-85 -73.76 -61.14 1.94 Allowed 'General case' 0 CA--C 1.48 -1.726 0 C-N-CA 118.382 -1.327 . . . . 0.0 108.35 -175.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.827 HD12 ' CE3' ' A' ' 40' ' ' TRP . 1.9 pt? -66.52 -32.71 74.23 Favored 'General case' 0 C--O 1.297 3.583 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.001 -173.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.837 HG13 ' HB2' ' A' ' 84' ' ' CYS . 54.9 t -77.3 -21.55 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.414 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.6 m -103.54 6.76 37.56 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.209 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.625 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . 6.2 tp-100 -77.3 -46.18 23.85 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.455 2.3 p30 -165.26 -94.55 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 171.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG2' ' HA3' ' A' ' 26' ' ' GLY . 4.7 mpt_? -84.7 136.52 33.69 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 117.935 -1.506 . . . . 0.0 111.899 -174.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.837 ' HB2' HG13 ' A' ' 79' ' ' VAL . 7.9 p -152.66 150.84 29.9 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.403 -170.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.06 -41.15 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.848 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 7.6 tp10 -153.81 137.59 16.17 Favored 'General case' 0 C--O 1.21 -1.013 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.35 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.613 HG21 ' HG3' ' A' ' 75' ' ' LYS . 48.7 t -131.68 94.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.332 0.8 OUTLIER -98.19 126.32 43.61 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-O 123.603 1.668 . . . . 0.0 113.006 176.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.831 ' HA ' ' HG3' ' A' ' 20' ' ' MET . 3.0 mp . . . . . 1 N--CA 1.374 -4.274 0 CA-C-N 111.223 -2.717 . . . . 0.0 106.16 178.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? . . . . . 0 N--CA 1.443 -0.797 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -85.44 130.76 34.51 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.337 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.691 HD12 ' HH2' ' A' ' 72' ' ' TRP . 94.4 mt -130.91 123.84 29.82 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.422 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 22.0 ptm -84.54 107.5 16.81 Favored 'General case' 0 C--N 1.265 -3.079 0 C-N-CA 118.57 -1.252 . . . . 0.0 108.31 170.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.723 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 32.1 ttm -87.91 104.44 16.61 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 118.135 -1.426 . . . . 0.0 110.187 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -91.6 112.41 24.32 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.576 1.95 . . . . 0.0 106.298 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 p -129.04 132.69 67.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -168.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.993 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 70.9 m -80.39 128.38 33.5 Favored 'General case' 0 CA--C 1.595 2.69 0 C-N-CA 125.429 1.492 . . . . 0.0 109.267 173.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.4 p -110.93 138.34 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.606 3.113 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.991 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 85.7 p 52.64 -74.94 0.01 OUTLIER 'General case' 0 C--N 1.368 1.401 0 C-N-CA 126.481 1.913 . . . . 0.0 115.936 -169.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.68 -14.38 2.22 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -171.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -96.61 120.46 62.01 Favored Pre-proline 0 N--CA 1.42 -1.969 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.631 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 74.4 Cg_endo -73.71 41.66 0.64 Allowed 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 123.49 2.793 . . . . 0.0 112.485 -175.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.6 p -110.52 170.39 8.12 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.52 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.1 tp10 -81.47 -15.44 55.03 Favored 'General case' 0 C--O 1.17 -3.099 0 CA-C-N 119.934 1.243 . . . . 0.0 109.793 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.757 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 1.3 tmtt? -48.92 -63.6 1.05 Allowed 'General case' 0 C--O 1.269 2.122 0 C-N-CA 125.19 1.396 . . . . 0.0 114.534 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.991 ' HG2' ' HB3' ' A' ' 25' ' ' SER . 4.6 tp10 -67.76 -45.16 75.68 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -172.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 15.5 m -45.2 -58.56 3.17 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 112.071 -2.331 . . . . 0.0 109.689 172.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.757 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 10.8 pt-20 -58.38 -50.86 72.14 Favored 'General case' 0 C--O 1.26 1.61 0 C-N-CA 123.788 0.835 . . . . 0.0 112.751 -172.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.87 ' HG3' HG13 ' A' ' 36' ' ' ILE . 5.9 pt-20 -66.86 -47.67 71.2 Favored 'General case' 0 C--O 1.269 2.082 0 C-N-CA 117.959 -1.496 . . . . 0.0 109.626 -175.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.87 HG13 ' HG3' ' A' ' 35' ' ' GLU . 9.4 mt -76.05 -34.72 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.378 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.145 -172.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' A' ' 40' ' ' TRP . 44.7 p -68.61 -33.61 74.35 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 118.658 0.663 . . . . 0.0 110.82 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 m -63.16 -45.18 93.08 Favored 'General case' 0 C--O 1.258 1.53 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.57 -38.76 92.34 Favored 'General case' 0 C--N 1.378 1.805 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.769 ' HE1' ' HB3' ' A' ' 78' ' ' LEU . 14.1 m0 -65.67 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.248 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.697 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.384 0.0 OUTLIER -70.83 -14.26 62.34 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 117.992 -1.483 . . . . 0.0 112.357 -169.08 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.29 -53.04 38.8 Favored Glycine 0 C--N 1.366 2.243 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.549 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 80.5 p -72.32 -30.28 64.61 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.314 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.811 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 21.5 mt -62.44 -29.5 70.56 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.471 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.598 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 21.3 t80 -92.09 -30.86 15.77 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 24.7 t-20 -66.47 -34.83 78.81 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.153 0.581 . . . . 0.0 112.03 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.85 -1.29 57.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 56.25 56.41 5.83 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.194 1.398 . . . . 0.0 111.781 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -89.55 155.0 19.56 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.6 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 23.6 t70 -91.45 76.46 5.87 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 120.576 1.535 . . . . 0.0 110.252 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.5 m -139.5 167.19 20.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.565 -172.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 64' ' ' MET . 6.3 tt0 -120.9 122.13 39.56 Favored 'General case' 0 C--O 1.189 -2.115 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.811 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.72 128.29 36.59 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -177.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.907 ' H ' HG12 ' A' ' 62' ' ' ILE . 52.0 t80 -135.6 146.64 48.13 Favored 'General case' 0 C--N 1.272 -2.762 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.886 -167.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.3 mt -93.0 96.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 171.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.55 -34.64 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.53 -166.86 39.34 Favored Glycine 0 CA--C 1.479 -2.166 0 C-N-CA 118.721 -1.704 . . . . 0.0 113.8 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 49.7 m -69.95 123.63 22.0 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.631 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 5.1 t70 79.4 -1.99 2.19 Favored 'General case' 0 C--O 1.215 -0.752 0 O-C-N 124.542 1.152 . . . . 0.0 109.405 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -126.28 117.56 23.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.408 0.623 . . . . 0.0 111.92 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.83 165.19 25.57 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.907 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -143.74 153.64 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.663 0 C-N-CA 118.231 -1.388 . . . . 0.0 109.639 173.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.606 ' HA ' ' HG3' ' A' ' 53' ' ' ARG 0.28 10.0 p90 -131.9 104.19 6.73 Favored 'General case' 0 N--CA 1.402 -2.875 0 O-C-N 126.558 2.411 . . . . 0.0 107.155 161.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.532 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . 23.9 ttt -90.28 109.96 21.04 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.809 -176.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.683 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.265 3.9 mp -76.59 145.13 39.15 Favored 'General case' 0 CA--C 1.457 -2.634 0 C-N-CA 126.085 1.754 . . . . 0.0 110.892 -175.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.6 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.329 61.6 ttt180 -119.52 -58.42 1.91 Allowed 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 174.141 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 69' ' ' SER . 10.4 t70 -70.67 8.55 0.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.87 -24.78 0.02 OUTLIER Glycine 0 CA--C 1.559 2.837 0 CA-C-N 120.126 1.33 . . . . 0.0 116.244 -169.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 67' ' ' ASP . 6.3 m -87.05 15.71 5.77 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -169.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -164.23 135.21 4.37 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.718 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.811 ' HA ' HD12 ' A' ' 74' ' ' ILE . . . 156.37 -31.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 127.019 2.128 . . . . 0.0 111.708 172.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.699 ' CZ2' HD23 ' A' ' 89' ' ' LEU 0.272 13.7 m-90 -74.53 -30.86 61.94 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-O 121.722 0.772 . . . . 0.0 111.873 -174.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 36.8 tt0 -68.8 -37.51 79.3 Favored 'General case' 0 C--O 1.265 1.915 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.811 HD12 ' HA ' ' A' ' 71' ' ' ALA . 12.7 mt -61.62 -44.21 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.557 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.516 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.713 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.44 -27.9 64.62 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.822 -178.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.74 -48.71 79.46 Favored 'General case' 0 C--O 1.247 0.963 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.954 171.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.527 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 18.9 m-85 -55.64 -45.66 77.58 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.157 0.98 . . . . 0.0 109.923 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.769 ' HB3' ' HE1' ' A' ' 40' ' ' TRP 0.27 4.3 pp -63.96 -47.46 80.34 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.516 ' N ' HD12 ' A' ' 78' ' ' LEU 0.355 4.4 m -77.04 -1.8 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 116.63 -2.028 . . . . 0.0 112.685 176.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -85.57 -20.03 30.19 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.005 166.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.421 ' HG2' HG23 ' A' ' 36' ' ' ILE . 8.5 tp-100 -80.93 -17.53 50.22 Favored 'General case' 0 C--N 1.367 1.357 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 171.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.258 23.2 t70 88.99 -50.61 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 112.489 -2.141 . . . . 0.0 114.527 168.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.794 ' HB3' ' HB3' ' A' ' 25' ' ' SER . 33.3 mmt180 -84.79 76.6 10.21 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.658 ' HB3' HD13 ' A' ' 78' ' ' LEU . 61.3 m -154.91 37.62 0.41 Allowed 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 123.073 1.416 . . . . 0.0 110.406 -168.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -32.16 -45.92 0.11 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 131.009 3.723 . . . . 0.0 120.274 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.993 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 30.6 tt0 -146.71 123.58 11.3 Favored 'General case' 0 C--O 1.198 -1.629 0 C-N-CA 117.244 -1.782 . . . . 0.0 113.906 -164.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.625 ' HB ' HD11 ' A' ' 89' ' ' LEU . 16.3 m -113.55 131.69 64.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.447 ' C ' HD12 ' A' ' 89' ' ' LEU 0.265 16.7 p -117.77 120.84 39.16 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 122.917 1.341 . . . . 0.0 110.095 165.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.723 ' HG ' ' HG3' ' A' ' 20' ' ' MET . 5.1 mp . . . . . 0 C--N 1.262 -3.239 0 CA-C-N 112.708 -2.042 . . . . 0.0 106.638 -173.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 20.3 tptm . . . . . 0 C--O 1.225 -0.207 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.8 t -72.0 133.61 45.42 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.131 0.491 . . . . 0.0 109.854 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.933 HD21 ' HA ' ' A' ' 89' ' ' LEU . 13.3 tp -134.04 133.93 41.8 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.178 -177.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 86.7 mtp -83.56 100.27 10.69 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 104.47 -2.418 . . . . 0.0 104.47 164.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.556 ' CE ' ' HB1' ' A' ' 71' ' ' ALA . 53.7 ttp -86.45 119.97 27.29 Favored 'General case' 0 CA--C 1.475 -1.911 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.804 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 49.8 t80 -97.96 124.6 42.49 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.868 -1.969 . . . . 0.0 106.896 -174.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -129.37 125.9 62.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -173.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.051 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 86.8 m -77.05 120.61 22.39 Favored 'General case' 0 CA--C 1.587 2.4 0 C-N-CA 125.409 1.483 . . . . 0.0 110.891 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.659 HG21 HD13 ' A' ' 36' ' ' ILE . 10.3 p -114.48 125.09 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 170.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.87 13.05 4.01 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 115.73 -2.388 . . . . 0.0 113.54 -163.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.11 -37.91 93.48 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 119.198 -1.477 . . . . 0.0 109.895 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 1.127 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 23.6 t-20 -117.13 106.73 46.77 Favored Pre-proline 0 N--CA 1.423 -1.824 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -72.94 30.32 0.29 Allowed 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 123.569 2.846 . . . . 0.0 113.251 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -143.4 -171.16 3.44 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.411 ' O ' ' HB ' ' A' ' 33' ' ' THR . 33.2 tt0 -82.29 -7.05 59.62 Favored 'General case' 0 C--O 1.206 -1.199 0 CA-C-N 118.802 0.728 . . . . 0.0 112.537 -171.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.515 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 2.4 tmpt? -60.91 -45.59 94.02 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 118.235 0.47 . . . . 0.0 110.369 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 1.127 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.5 tp10 -67.59 -49.55 62.57 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 86.9 m -44.49 -52.13 8.19 Favored 'General case' 0 C--O 1.196 -1.738 0 C-N-CA 124.989 1.316 . . . . 0.0 112.409 172.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.515 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.3 pt-20 -67.84 -51.51 47.62 Favored 'General case' 0 C--O 1.253 1.273 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -59.02 -47.06 86.58 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.929 1.347 . . . . 0.0 108.071 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.895 HD12 ' HG3' ' A' ' 32' ' ' GLU . 10.1 mt -69.85 -40.61 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.58 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.804 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.876 HG21 HG12 ' A' ' 55' ' ' ILE . 12.9 p -69.61 -37.69 76.95 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 120.54 1.518 . . . . 0.0 111.047 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 p -64.75 -57.86 7.81 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 123.864 0.727 . . . . 0.0 109.668 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.1 tp -66.11 -43.21 87.88 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.745 ' HZ2' ' HB2' ' A' ' 82' ' ' ASP . 44.0 m0 -69.59 -69.12 0.36 Allowed 'General case' 0 C--O 1.197 -1.706 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.901 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.791 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.421 0.0 OUTLIER -68.97 -20.05 64.17 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 117.554 -1.659 . . . . 0.0 112.669 -171.827 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.46 -50.42 59.51 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 170.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.44 ' HA ' ' HB2' ' A' ' 46' ' ' ASN . 65.3 p -69.64 -25.39 63.91 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.082 -0.658 . . . . 0.0 110.644 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.791 ' HG ' ' HA ' ' A' ' 41' ' ' GLN . 20.1 mt -62.07 -31.15 71.54 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 174.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -77.45 -44.13 30.06 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.383 0.611 . . . . 0.0 110.479 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 84.8 m-20 -63.61 -30.59 71.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -172.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.18 2.52 54.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.15 0.5 . . . . 0.0 110.33 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 55.05 62.32 2.56 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.336 1.455 . . . . 0.0 111.826 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -98.54 152.12 19.91 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 120.664 -1.272 . . . . 0.0 108.211 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -87.26 82.56 7.58 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 120.343 1.429 . . . . 0.0 110.288 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 1.031 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.1 m -147.75 165.63 5.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.607 -174.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.444 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 1.9 mp0 -131.25 124.4 30.46 Favored 'General case' 0 C--O 1.194 -1.859 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 171.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.836 ' HG3' ' HA ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -124.56 138.99 54.28 Favored 'General case' 0 C--N 1.287 -2.133 0 O-C-N 121.47 -0.769 . . . . 0.0 109.259 -172.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.871 ' H ' HG12 ' A' ' 62' ' ' ILE . 21.0 t80 -134.93 151.4 50.83 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.781 -1.167 . . . . 0.0 113.294 -167.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.876 HG12 HG21 ' A' ' 37' ' ' THR . 48.9 mt -83.66 123.32 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 39.2 t -101.74 -38.85 6.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.94 -163.32 30.44 Favored Glycine 0 CA--C 1.481 -2.043 0 C-N-CA 119.329 -1.415 . . . . 0.0 113.12 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 m -52.96 119.1 4.25 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.943 0.897 . . . . 0.0 109.534 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER 73.59 13.9 4.35 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 121.896 0.855 . . . . 0.0 111.729 175.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.598 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -146.55 125.86 13.09 Favored 'General case' 0 CA--C 1.572 1.803 0 O-C-N 120.763 -1.211 . . . . 0.0 112.016 -177.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.98 163.5 32.81 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.871 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -137.55 156.24 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.178 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.652 173.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.836 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 1.1 m-30 -125.96 101.04 6.63 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 126.674 2.483 . . . . 0.0 104.926 167.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 26.5 ttt -83.97 100.34 10.98 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 117.816 -1.554 . . . . 0.0 108.305 176.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.031 ' HA ' HG12 ' A' ' 51' ' ' VAL . 2.6 pt? -97.28 148.3 23.26 Favored 'General case' 0 CA--C 1.45 -2.895 0 CA-C-O 122.484 1.135 . . . . 0.0 112.714 -175.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.358 16.0 ttp180 -109.06 -54.86 2.48 Favored 'General case' 1 C--N 1.24 -4.165 0 CA-C-N 113.066 -1.879 . . . . 0.0 115.6 -173.402 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.11 -8.67 0.5 Allowed 'General case' 0 CA--C 1.594 2.67 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 174.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.44 -31.09 2.98 Favored Glycine 0 C--N 1.359 1.835 0 O-C-N 120.049 -1.657 . . . . 0.0 113.533 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 36.4 p -81.4 -69.49 0.61 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -174.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.688 ' CE1' ' HB2' ' A' ' 65' ' ' LEU 0.297 0.2 OUTLIER -46.36 -28.98 1.49 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 120.687 3.588 . . . . 0.0 120.687 -162.632 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.867 ' HA ' HD12 ' A' ' 74' ' ' ILE . . . -64.14 -35.76 81.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 116.555 2.058 . . . . 0.0 116.555 -166.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.651 ' CZ2' ' HB2' ' A' ' 89' ' ' LEU 0.323 27.2 m-90 -83.36 -19.72 35.6 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.417 -1.313 . . . . 0.0 113.481 -173.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -74.55 -35.14 63.09 Favored 'General case' 0 C--O 1.28 2.693 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 170.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 71' ' ' ALA . 22.6 mt -65.0 -35.1 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.823 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.846 ' HG3' HG11 ' A' ' 87' ' ' VAL . 12.5 tmtt? -67.58 -33.18 74.49 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.761 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -58.46 -47.34 84.32 Favored 'General case' 0 C--O 1.263 1.769 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.113 170.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.578 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 5.7 m-30 -52.0 -47.06 65.12 Favored 'General case' 0 N--CA 1.513 2.709 0 CA-C-O 122.152 0.977 . . . . 0.0 109.64 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.674 ' CD1' ' HA ' ' A' ' 75' ' ' LYS . 30.9 mt -53.62 -63.6 1.1 Allowed 'General case' 0 CA--C 1.471 -2.093 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.423 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.6 m -69.04 -11.0 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 C-N-CA 119.553 -0.859 . . . . 0.0 112.537 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.7 m -94.44 -10.49 32.26 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.967 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.459 ' NE2' ' HB3' ' A' ' 77' ' ' PHE . 45.5 mt-30 -124.81 -28.68 3.48 Favored 'General case' 0 C--N 1.38 1.908 0 C-N-CA 116.137 -2.225 . . . . 0.0 112.112 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.745 ' HB2' ' HZ2' ' A' ' 40' ' ' TRP . 11.8 m-20 -133.17 167.56 20.13 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -83.19 63.07 6.99 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.176 1.353 . . . . 0.0 112.838 -174.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 40.5 t -82.43 176.71 9.21 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.683 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -167.73 -39.42 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -169.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.051 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 32.1 tt0 -147.55 121.85 9.61 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.612 -167.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.846 HG11 ' HG3' ' A' ' 75' ' ' LYS . 28.4 m -118.96 129.34 75.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.242 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.8 p -115.99 120.27 38.6 Favored 'General case' 0 C--O 1.281 2.714 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.933 ' HA ' HD21 ' A' ' 18' ' ' LEU 0.302 7.1 tp . . . . . 0 CA--C 1.577 1.994 0 CA-C-N 112.341 -2.209 . . . . 0.0 107.815 171.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.454 ' HE3' HD11 ' A' ' 89' ' ' LEU . 33.1 ttpt . . . . . 0 N--CA 1.438 -1.046 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.552 HG23 ' HA ' ' A' ' 66' ' ' ARG . 90.7 m -70.28 117.0 11.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 173.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 1.089 HD21 ' HA ' ' A' ' 89' ' ' LEU . 9.9 tp -133.59 140.39 47.11 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.903 -168.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.518 ' HG2' ' SD ' ' A' ' 64' ' ' MET . 81.3 mtp -83.01 100.63 10.58 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 162.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.644 ' HB3' HD23 ' A' ' 18' ' ' LEU . 2.1 ppp? -87.08 137.42 32.36 Favored 'General case' 0 C--O 1.259 1.605 0 C-N-CA 115.915 -2.314 . . . . 0.0 108.588 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -107.14 126.53 52.5 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.064 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.694 HG13 ' HB3' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -116.21 124.85 72.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.886 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.014 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 17.6 m -98.6 135.04 40.69 Favored 'General case' 0 CA--C 1.582 2.205 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.688 HG21 HD11 ' A' ' 36' ' ' ILE . 12.6 p -132.17 119.88 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.609 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 t -124.32 -1.98 8.09 Favored 'General case' 0 C--O 1.239 0.52 0 O-C-N 119.327 -2.108 . . . . 0.0 112.84 -165.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.91 -32.08 78.48 Favored Glycine 0 CA--C 1.506 -0.505 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.629 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.75 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 24.9 t-20 -117.14 106.74 46.76 Favored Pre-proline 0 N--CA 1.4 -2.939 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -85.75 32.02 0.47 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.7 p -135.53 -160.51 1.06 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.419 ' O ' ' HB ' ' A' ' 33' ' ' THR . 3.7 tp10 -84.44 -7.22 59.36 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -177.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 2.2 tmpt? -65.5 -49.8 67.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -172.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.75 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 16.4 tp10 -72.74 -35.5 67.53 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 117.663 -1.615 . . . . 0.0 108.129 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.547 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 84.3 m -49.61 -52.92 27.08 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.07 172.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.9 pt-20 -70.01 -37.86 75.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -62.42 -55.11 30.94 Favored 'General case' 0 C--O 1.209 -1.053 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.757 HG23 ' CE3' ' A' ' 40' ' ' TRP . 95.9 mt -58.13 -49.92 79.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.062 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.897 HG21 HG12 ' A' ' 55' ' ' ILE . 36.0 p -65.04 -56.81 10.87 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.522 -176.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 m -65.22 -48.43 73.35 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.452 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.2 mt -75.09 -52.93 9.82 Favored 'General case' 0 C--O 1.252 1.19 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.757 ' CE3' HG23 ' A' ' 36' ' ' ILE . 6.5 m0 -72.5 -60.69 2.11 Favored 'General case' 0 C--O 1.157 -3.767 0 CA-C-O 117.198 -1.382 . . . . 0.0 109.062 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.79 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.44 0.0 OUTLIER -64.4 -24.68 67.72 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-N 121.066 1.757 . . . . 0.0 112.893 -173.706 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.67 -47.48 90.17 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.87 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 54.5 p -77.62 -19.96 54.66 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 122.306 -0.526 . . . . 0.0 111.861 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.79 ' HG ' ' HA ' ' A' ' 41' ' ' GLN . 23.9 mt -65.05 -34.02 77.43 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.46 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 90.1 t80 -85.69 -33.61 21.49 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.854 173.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.87 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 15.2 t-20 -61.0 -39.21 88.83 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.44 6.48 33.73 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 122.0 -0.437 . . . . 0.0 110.585 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 58.9 41.24 21.57 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.914 0.886 . . . . 0.0 112.226 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.428 ' O ' HG13 ' A' ' 51' ' ' VAL . 18.3 m-85 -73.57 10.89 0.93 Allowed 'General case' 0 CA--C 1.582 2.178 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 45.32 70.34 0.36 Allowed 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 125.61 1.564 . . . . 0.0 112.253 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.933 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.2 m -147.13 176.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.289 -169.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.41 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 20.8 mt-30 -134.33 120.26 19.67 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.73 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -126.23 141.42 51.93 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -171.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.636 ' H ' HG12 ' A' ' 62' ' ' ILE . 39.8 m-85 -133.29 151.96 51.91 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -165.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.897 HG12 HG21 ' A' ' 37' ' ' THR . 19.5 mt -88.33 114.12 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 167.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.967 HG23 ' HB3' ' A' ' 60' ' ' ARG . 8.9 m -113.81 -21.6 5.35 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.726 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.347 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.21 171.16 36.14 Favored Glycine 0 C--O 1.209 -1.422 0 C-N-CA 117.666 -2.207 . . . . 0.0 114.759 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.547 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 42.3 m -66.38 118.5 10.13 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER 85.04 5.08 0.55 Allowed 'General case' 0 C--N 1.37 1.463 0 O-C-N 124.203 0.94 . . . . 0.0 110.229 -173.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.967 ' HB3' HG23 ' A' ' 56' ' ' VAL . 2.8 mpt_? -135.18 132.5 38.04 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.694 ' HB3' HG13 ' A' ' 22' ' ' VAL . . . -143.09 166.12 25.53 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.83 1.252 . . . . 0.0 108.178 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.636 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER -145.66 157.98 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.855 168.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.628 ' O ' ' HG3' ' A' ' 20' ' ' MET 0.385 11.8 p90 -134.08 104.01 6.04 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 125.575 1.797 . . . . 0.0 110.45 162.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.518 ' SD ' ' HG2' ' A' ' 19' ' ' MET . 24.1 ttt -84.59 110.86 19.03 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.015 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.942 HD13 ' HB2' ' A' ' 71' ' ' ALA . 2.1 pt? -102.11 148.09 25.82 Favored 'General case' 0 CA--C 1.486 -1.517 0 O-C-N 124.309 1.006 . . . . 0.0 113.013 -173.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.552 ' HA ' HG23 ' A' ' 17' ' ' THR 0.266 31.3 tpt180 -113.53 -62.18 1.63 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.271 -1.786 . . . . 0.0 115.44 -172.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -47.1 -17.65 0.06 Allowed 'General case' 0 CA--C 1.59 2.502 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.07 -16.18 17.69 Favored Glycine 0 C--N 1.358 1.78 0 O-C-N 120.727 -1.233 . . . . 0.0 114.498 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -118.97 33.37 5.68 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -167.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.669 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -156.86 2.58 0.13 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 117.913 2.561 . . . . 0.0 117.913 -174.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.942 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -79.1 -28.22 42.98 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 120.124 1.329 . . . . 0.0 113.6 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.613 ' CZ2' ' HB2' ' A' ' 89' ' ' LEU 0.475 28.0 m-90 -88.21 -12.44 43.81 Favored 'General case' 0 N--CA 1.41 -2.468 0 C-N-CA 117.31 -1.756 . . . . 0.0 113.992 -173.336 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 1.6 mp0 -75.35 -29.1 59.83 Favored 'General case' 0 C--O 1.274 2.388 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.699 ' HA ' ' HD2' ' A' ' 77' ' ' PHE . 85.6 mt -68.61 -32.85 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.062 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 174.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.807 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -59.01 -43.87 91.61 Favored 'General case' 0 C--O 1.285 2.943 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 22.9 t70 -50.28 -50.03 51.61 Favored 'General case' 0 C--O 1.26 1.607 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.19 172.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.699 ' HD2' ' HA ' ' A' ' 74' ' ' ILE . 53.6 m-85 -55.96 -43.61 77.7 Favored 'General case' 0 C--O 1.186 -2.279 0 C-N-CA 118.752 -1.179 . . . . 0.0 112.223 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.807 ' HG ' ' HA ' ' A' ' 75' ' ' LYS 0.28 4.9 mt -49.48 -60.38 2.9 Favored 'General case' 0 C--O 1.294 3.422 0 CA-C-O 123.258 1.504 . . . . 0.0 109.899 -178.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.681 HG12 ' CB ' ' A' ' 84' ' ' CYS . 24.1 m -75.15 -7.83 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 111.774 -2.466 . . . . 0.0 111.463 -171.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.0 m -104.83 -5.6 21.03 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.174 172.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 29.0 mm-40 -85.08 -56.47 3.54 Favored 'General case' 0 CA--C 1.47 -2.096 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.361 28.3 t70 -179.57 -84.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.733 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 24.5 mmt-85 -87.38 144.29 26.83 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.315 1.416 . . . . 0.0 109.202 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.681 ' CB ' HG12 ' A' ' 79' ' ' VAL . 8.6 p -159.23 147.83 18.05 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.37 -44.51 0.05 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.014 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 40.5 tt0 -140.17 118.77 12.3 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.054 -1.058 . . . . 0.0 110.528 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.411 HG21 ' HG3' ' A' ' 75' ' ' LYS . 2.2 p -113.09 102.62 14.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.731 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.9 p -119.82 124.75 46.88 Favored 'General case' 0 C--O 1.26 1.632 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.089 ' HA ' HD21 ' A' ' 18' ' ' LEU 0.268 5.1 tp . . . . . 0 CA--C 1.584 2.285 0 CA-C-N 113.624 -1.625 . . . . 0.0 106.87 171.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.603 ' HD2' ' HB2' ' A' ' 18' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.44 -0.958 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.7 m -80.79 110.63 16.49 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.671 HD23 ' HZ2' ' A' ' 72' ' ' TRP . 60.2 tp -134.28 118.42 17.52 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.47 -174.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.922 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 26.4 ptt? -83.61 104.83 14.05 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 117.213 -1.795 . . . . 0.0 106.481 165.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.576 ' HG3' ' HE1' ' A' ' 72' ' ' TRP . 14.2 tmm? -87.88 139.73 30.22 Favored 'General case' 0 C--O 1.268 2.053 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.47 -172.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -106.43 126.43 52.24 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 125.056 1.472 . . . . 0.0 110.085 -167.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.82 137.75 56.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.161 -174.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.044 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 54.2 m -107.72 131.31 54.57 Favored 'General case' 0 CA--C 1.628 3.95 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.222 170.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.57 HG12 ' HG2' ' A' ' 32' ' ' GLU . 80.5 t -115.36 94.26 3.02 Favored 'Isoleucine or valine' 0 C--N 1.405 2.998 0 C-N-CA 128.471 2.709 . . . . 0.0 106.598 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.73 35.99 4.53 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-N 122.098 2.226 . . . . 0.0 112.923 -174.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.573 ' HA3' ' HB2' ' A' ' 83' ' ' ARG . . . -59.87 -35.53 87.07 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 168.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.741 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -111.36 148.56 39.03 Favored Pre-proline 0 N--CA 1.42 -1.957 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 167.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -92.64 43.18 0.31 Allowed 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 121.642 1.561 . . . . 0.0 110.851 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -130.77 -146.25 0.3 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.5 -173.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.593 ' HG3' ' HA ' ' A' ' 58' ' ' SER . 30.2 tt0 -125.58 17.98 8.11 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 170.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.769 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 8.2 tmtt? -92.98 -37.93 11.94 Favored 'General case' 0 C--O 1.256 1.429 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.741 ' HB3' ' HB2' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -65.8 -44.15 86.54 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 175.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 84.8 m -49.38 -62.4 1.57 Allowed 'General case' 0 C--O 1.187 -2.199 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.211 169.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.769 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 11.7 pt-20 -51.64 -54.87 23.28 Favored 'General case' 0 C--O 1.26 1.641 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -174.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.872 ' HG3' HG13 ' A' ' 36' ' ' ILE . 11.9 pt-20 -65.23 -49.72 68.61 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.727 0.775 . . . . 0.0 109.445 -174.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.872 HG13 ' HG3' ' A' ' 35' ' ' GLU . 56.9 mt -71.55 -43.5 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.027 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.202 -172.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.4 p -66.79 -37.35 84.39 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 118.177 0.444 . . . . 0.0 111.254 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.6 m -67.55 -38.93 84.88 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.994 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 tp -67.55 -35.63 79.43 Favored 'General case' 0 C--N 1.365 1.268 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.657 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 11.9 m0 -68.85 -77.53 0.08 Allowed 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.953 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.677 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.351 0.0 OUTLIER -66.43 -20.89 66.18 Favored 'General case' 0 C--O 1.248 0.987 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.958 -171.571 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.87 -55.29 31.22 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.93 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 47.8 t -70.84 -26.93 63.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 116.708 0.254 . . . . 0.0 111.026 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.792 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 32.8 mt -61.03 -35.51 77.07 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.523 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 70.0 t80 -90.99 -27.29 18.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.93 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 21.8 t-20 -65.26 -33.59 76.36 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.485 0.714 . . . . 0.0 111.92 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.19 1.88 55.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.063 0.459 . . . . 0.0 109.855 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 53.91 66.13 1.32 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.521 1.529 . . . . 0.0 112.037 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -99.48 159.93 14.66 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -95.32 86.48 4.54 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 121.014 1.733 . . . . 0.0 109.801 -177.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.902 HG12 ' HA ' ' A' ' 65' ' ' LEU . 1.4 m -146.66 163.46 8.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.969 -174.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.55 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 13.5 mt-30 -128.59 115.83 18.69 Favored 'General case' 0 C--O 1.194 -1.839 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.792 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -121.41 139.33 53.59 Favored 'General case' 0 C--N 1.28 -2.451 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.663 -168.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.658 ' H ' HG12 ' A' ' 62' ' ' ILE . 83.0 m-85 -133.58 151.72 51.76 Favored 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -170.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.7 mt -94.09 96.3 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 167.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 60' ' ' ARG . 4.3 m -92.02 -24.48 5.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.97 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.03 173.61 40.89 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 117.016 -2.516 . . . . 0.0 114.158 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.593 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 30.8 t -70.32 115.78 9.91 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 24' ' ' VAL 0.268 0.6 OUTLIER 73.18 17.16 4.09 Favored 'General case' 0 C--O 1.207 -1.168 0 C-N-CA 125.8 1.64 . . . . 0.0 109.152 -178.607 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.47 ' HB3' HG23 ' A' ' 56' ' ' VAL . 9.1 mpt_? -131.88 132.12 43.35 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.075 0.95 . . . . 0.0 112.518 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.45 166.3 24.18 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.491 1.116 . . . . 0.0 109.145 -173.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.768 HD12 ' HB2' ' A' ' 19' ' ' MET . 1.0 OUTLIER -143.77 157.28 16.25 Favored 'Isoleucine or valine' 0 C--O 1.275 2.442 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.808 172.103 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.756 ' HZ ' HD21 ' A' ' 78' ' ' LEU . 2.2 m-30 -125.96 111.47 14.8 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 166.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.922 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 22.1 ttt -84.44 93.68 8.35 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 118.384 -1.326 . . . . 0.0 109.9 173.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.938 ' HG ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -98.65 146.93 25.34 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 124.805 1.242 . . . . 0.0 114.316 -174.103 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.464 7.6 ppt_? -117.28 -54.48 2.39 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -47.79 -19.71 0.24 Allowed 'General case' 0 CA--C 1.584 2.275 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.4 10.32 7.5 Favored Glycine 0 C--N 1.374 2.654 0 CA-C-N 120.101 1.319 . . . . 0.0 115.252 -178.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.3 m -128.23 40.01 3.74 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 118.359 1.08 . . . . 0.0 111.439 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.635 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -170.59 -7.28 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.864 0 O-C-N 121.769 -0.582 . . . . 0.0 111.487 -172.353 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.938 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -80.21 -42.84 22.53 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -166.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.671 ' HZ2' HD23 ' A' ' 18' ' ' LEU 0.311 9.2 m0 -92.75 -9.97 38.68 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 123.461 1.601 . . . . 0.0 110.44 -170.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.76 -38.65 73.48 Favored 'General case' 0 C--O 1.298 3.64 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 166.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 70' ' ' TYR . 42.8 mt -59.14 -38.32 73.53 Favored 'Isoleucine or valine' 0 C--N 1.389 2.301 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.855 ' HG3' HG21 ' A' ' 87' ' ' VAL . 12.6 tmtt? -58.0 -43.69 86.79 Favored 'General case' 0 C--O 1.288 3.126 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.582 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.92 -43.34 86.19 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.863 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -62.32 -31.83 72.49 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.416 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.779 ' HG ' ' HA ' ' A' ' 75' ' ' LYS . 55.6 mt -53.14 -58.83 5.67 Favored 'General case' 0 C--O 1.285 2.964 0 CA-C-O 122.87 1.319 . . . . 0.0 110.192 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.737 HG22 ' HB3' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -76.74 -13.4 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.875 -173.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.7 m -91.63 -7.54 49.76 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.756 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.512 ' NE2' HG12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -84.3 -50.98 7.35 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.408 11.9 t70 -152.58 -97.36 0.05 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.518 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.573 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 75.2 mtm180 -140.26 92.16 2.51 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 120.22 1.373 . . . . 0.0 111.626 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.737 ' HB3' HG22 ' A' ' 79' ' ' VAL . 2.3 t -93.88 161.42 14.32 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.611 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.68 -25.47 0.37 Allowed 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -167.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.044 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 34.6 tt0 -145.13 125.27 13.69 Favored 'General case' 0 CA--C 1.479 -1.765 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.366 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.855 HG21 ' HG3' ' A' ' 75' ' ' LYS . 14.0 p -128.07 103.9 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.9 0 CA-C-O 122.203 1.002 . . . . 0.0 109.685 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 m -100.89 109.36 21.31 Favored 'General case' 1 C--O 1.312 4.359 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.404 -175.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.699 ' CD1' HG22 ' A' ' 87' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.356 0.866 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? . . . . . 0 N--CA 1.425 -1.692 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -91.86 124.99 36.39 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.833 ' HB3' HD12 ' A' ' 89' ' ' LEU . 32.1 mt -130.86 118.51 20.86 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.162 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 24.9 ptm -84.14 111.55 19.44 Favored 'General case' 0 C--N 1.267 -2.982 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.235 171.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.848 ' HG2' HD11 ' A' ' 89' ' ' LEU . 11.3 mtt -84.2 103.19 13.19 Favored 'General case' 0 CA--C 1.46 -2.508 0 C-N-CA 118.499 -1.28 . . . . 0.0 109.38 171.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -89.52 98.07 11.56 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 175.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.418 ' HB ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -104.39 122.9 57.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.309 -170.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.983 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 93.2 m -81.11 134.87 35.73 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 174.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 32' ' ' GLU . 1.6 p -113.43 152.29 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.273 0 CA-C-N 120.721 1.601 . . . . 0.0 107.878 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.659 ' OG ' ' HB2' ' A' ' 85' ' ' ALA . 70.8 m -87.41 160.81 18.19 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 120.815 1.643 . . . . 0.0 107.283 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.798 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 78.39 72.24 1.18 Allowed Glycine 0 N--CA 1.414 -2.774 0 C-N-CA 118.313 -1.899 . . . . 0.0 111.088 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.487 ' OD1' ' HD3' ' A' ' 31' ' ' LYS . 16.7 t-20 -87.87 101.71 2.79 Favored Pre-proline 0 C--O 1.243 0.758 0 CA-C-N 118.262 1.031 . . . . 0.0 109.485 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.798 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 84.1 Cg_endo -118.79 -30.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.486 0 N-CA-C 116.659 1.754 . . . . 0.0 116.659 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.745 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 1.1 p -132.95 -99.47 0.28 Allowed 'General case' 1 N--CA 1.554 4.728 0 C-N-CA 113.73 -3.188 . . . . 0.0 116.339 -164.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.796 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . 4.2 tp10 -100.38 7.61 44.16 Favored 'General case' 0 N--CA 1.399 -3.024 1 N-CA-C 97.741 -4.911 . . . . 0.0 97.741 156.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.785 ' HA ' ' HD2' ' A' ' 28' ' ' PRO 0.435 0.2 OUTLIER 82.0 -175.16 0.04 OUTLIER 'General case' 1 N--CA 1.298 -8.066 1 C-N-CA 132.181 4.192 . . . . 0.0 116.226 170.356 . . . . . . . . 6 4 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.784 ' HG3' HD12 ' A' ' 36' ' ' ILE . 9.3 tp10 -61.13 -13.9 20.79 Favored 'General case' 2 N--CA 1.363 -4.817 0 CA-C-N 111.776 -2.465 . . . . 0.0 106.965 173.021 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 54.4 m -67.81 -48.57 65.87 Favored 'General case' 0 N--CA 1.411 -2.378 0 C-N-CA 125.021 1.328 . . . . 0.0 108.457 171.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.796 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 3.7 pt-20 -57.7 -48.85 78.38 Favored 'General case' 0 C--O 1.27 2.158 0 CA-C-O 120.78 0.324 . . . . 0.0 110.203 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -56.78 -56.49 20.84 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 123.496 1.617 . . . . 0.0 110.59 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.784 HD12 ' HG3' ' A' ' 32' ' ' GLU . 13.9 mt -70.54 -30.0 40.8 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.255 0 CA-C-N 112.03 -2.35 . . . . 0.0 112.96 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.814 HG21 HG12 ' A' ' 55' ' ' ILE . 8.1 p -71.82 -44.86 63.19 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 117.948 -1.501 . . . . 0.0 110.055 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.7 p -60.3 -59.67 5.04 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.188 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.3 tp -64.95 -49.72 69.24 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.882 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 37.0 m0 -74.75 -60.84 2.1 Favored 'General case' 0 C--O 1.168 -3.224 0 CA-C-O 117.763 -1.113 . . . . 0.0 110.152 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.757 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.382 0.0 OUTLIER -66.26 -22.31 66.31 Favored 'General case' 0 C--O 1.253 1.248 0 C-N-CA 117.372 -1.731 . . . . 0.0 111.803 -171.721 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.39 -55.83 26.89 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.588 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 37.8 p -67.66 -29.32 68.58 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 116.999 0.399 . . . . 0.0 111.707 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.837 HD12 ' HG2' ' A' ' 53' ' ' ARG . 20.6 mt -60.86 -35.34 76.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.241 0.616 . . . . 0.0 109.871 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.636 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 87.5 t80 -91.32 -27.01 18.66 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.222 175.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.588 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.2 t-20 -66.96 -28.88 68.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.859 0.361 . . . . 0.0 111.253 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.23 -3.49 50.64 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.567 0.699 . . . . 0.0 109.8 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.1 t30 55.88 43.93 26.71 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.267 1.427 . . . . 0.0 112.726 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.521 ' HB3' ' HE2' ' A' ' 70' ' ' TYR . 23.1 m-85 -66.78 5.85 0.57 Allowed 'General case' 0 CA--C 1.597 2.777 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.7 t70 57.2 70.81 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 125.314 1.446 . . . . 0.0 111.713 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.531 ' CG2' ' HD2' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -147.75 171.02 3.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 113.439 -1.71 . . . . 0.0 109.822 -175.168 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.655 ' HG2' ' HB3' ' A' ' 64' ' ' MET . 0.0 OUTLIER -132.54 126.73 33.52 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.837 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -131.9 134.52 45.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -169.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.806 ' H ' HG12 ' A' ' 62' ' ' ILE . 80.9 m-85 -134.89 152.62 51.9 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -165.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.814 HG12 HG21 ' A' ' 37' ' ' THR . 39.2 mt -89.62 95.11 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 166.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.03 -31.43 4.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.752 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.2 63.25 0.22 Allowed Glycine 0 N--CA 1.403 -3.503 0 C-N-CA 116.391 -2.814 . . . . 0.0 116.717 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.676 ' HB3' ' HE3' ' A' ' 31' ' ' LYS 0.313 13.8 m 21.04 88.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 125.488 1.346 . . . . 0.0 112.586 162.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.633 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER 110.0 -16.18 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 128.011 2.525 . . . . 0.0 106.766 -173.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -125.57 134.61 51.9 Favored 'General case' 0 CA--C 1.578 2.019 0 C-N-CA 126.163 1.785 . . . . 0.0 109.816 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.9 169.38 17.67 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.119 1.367 . . . . 0.0 108.141 -171.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.806 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER -141.96 155.9 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.054 0 CA-C-N 121.34 1.882 . . . . 0.0 111.634 173.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.559 ' HA ' ' HG3' ' A' ' 53' ' ' ARG 0.289 8.2 p90 -132.64 103.9 6.37 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 126.603 2.439 . . . . 0.0 108.254 161.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.655 ' HB3' ' HG2' ' A' ' 52' ' ' GLN . 27.0 ttt -91.22 108.84 20.15 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.311 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.758 HD22 HD12 ' A' ' 18' ' ' LEU 0.26 6.5 mp -66.85 144.84 56.04 Favored 'General case' 0 CA--C 1.472 -2.048 0 C-N-CA 127.97 2.508 . . . . 0.0 112.961 -177.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.4 33.7 ttp180 -122.35 -53.67 1.91 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 168.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.41 7.39 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.39 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 177.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.3 -31.94 0.09 OUTLIER Glycine 0 CA--C 1.569 3.434 0 N-CA-C 116.55 1.38 . . . . 0.0 116.55 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 70' ' ' TYR . 31.8 t -135.31 87.22 2.31 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 117.787 -1.101 . . . . 0.0 112.832 -170.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.521 ' HE2' ' HB3' ' A' ' 49' ' ' TYR . 0.1 OUTLIER 174.32 -0.69 0.0 OUTLIER 'General case' 0 C--N 1.409 3.184 0 CA-C-N 120.204 1.365 . . . . 0.0 113.241 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.733 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -88.22 -29.9 20.12 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -169.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.773 ' HZ2' ' HG ' ' A' ' 89' ' ' LEU . 28.1 m-90 -78.99 -15.12 58.7 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.133 -0.979 . . . . 0.0 110.341 -176.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.42 -44.15 79.46 Favored 'General case' 0 C--O 1.266 1.944 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 167.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.659 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.0 mt -59.67 -38.56 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.138 175.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.621 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 13.4 tmtt? -65.05 -37.97 89.33 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.529 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.95 -44.89 95.81 Favored 'General case' 0 C--O 1.262 1.72 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.328 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.659 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 12.0 m-85 -57.28 -48.06 79.87 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.773 0.797 . . . . 0.0 109.05 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.882 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 4.2 pp -63.13 -41.88 99.4 Favored 'General case' 0 C--O 1.293 3.345 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.996 HG12 ' HB2' ' A' ' 84' ' ' CYS . 32.6 m -76.29 -11.74 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 CA-C-O 121.838 0.828 . . . . 0.0 109.559 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.2 m -104.06 0.49 29.85 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.939 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.783 ' HG2' ' HE1' ' A' ' 40' ' ' TRP . 8.5 tp-100 -85.2 -53.5 5.21 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.341 1.9 p30 -176.64 -94.04 0.0 OUTLIER 'General case' 0 C--O 1.243 0.74 0 O-C-N 125.235 1.584 . . . . 0.0 113.939 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.588 ' HD2' ' HA3' ' A' ' 26' ' ' GLY 0.291 48.2 mtm180 -93.3 131.62 38.26 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 118.328 -1.349 . . . . 0.0 112.243 -177.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.996 ' HB2' HG12 ' A' ' 79' ' ' VAL . 4.5 p -154.78 154.51 32.92 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.612 -168.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.659 ' HB2' ' OG ' ' A' ' 25' ' ' SER . . . -159.56 -49.92 0.06 Allowed 'General case' 0 C--N 1.351 0.645 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -174.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.983 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 38.2 tt0 -154.52 127.11 8.02 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 119.517 1.053 . . . . 0.0 112.149 -172.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.418 HG12 ' HB ' ' A' ' 22' ' ' VAL . 12.8 m -111.36 103.79 16.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 173.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.437 ' C ' HD22 ' A' ' 89' ' ' LEU 0.274 23.4 p -102.9 136.49 42.62 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 117.991 -1.483 . . . . 0.0 112.497 177.366 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.848 HD11 ' HG2' ' A' ' 20' ' ' MET . 4.6 mm? . . . . . 0 N--CA 1.409 -2.491 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -167.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.1 tptt . . . . . 0 C--O 1.241 0.638 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -71.62 120.91 17.88 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.627 ' HB3' HD22 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -127.91 115.23 18.25 Favored 'General case' 0 C--O 1.197 -1.667 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -171.052 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 22.3 ttt -86.58 105.21 16.69 Favored 'General case' 0 C--N 1.281 -2.383 0 O-C-N 121.694 -0.629 . . . . 0.0 110.272 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.674 ' HE3' HD11 ' A' ' 65' ' ' LEU . 12.4 ttm -97.65 116.82 30.6 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 117.28 -1.768 . . . . 0.0 112.671 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -100.76 116.55 32.91 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 112.637 -2.074 . . . . 0.0 106.328 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.75 125.89 65.94 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 CA-C-O 121.457 0.646 . . . . 0.0 111.663 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.784 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 88.3 m -84.55 131.17 34.66 Favored 'General case' 0 CA--C 1.595 2.693 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.035 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.404 HG21 HD13 ' A' ' 36' ' ' ILE . 2.0 p -131.29 137.64 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.579 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.43 23.1 t -109.23 -96.62 0.39 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 122.858 2.572 . . . . 0.0 114.277 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.608 ' HA3' ' HG3' ' A' ' 83' ' ' ARG . . . 55.48 -67.14 0.01 OUTLIER Glycine 0 C--N 1.352 1.438 0 CA-C-N 119.654 1.116 . . . . 0.0 113.017 -168.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -118.56 137.49 24.86 Favored Pre-proline 0 N--CA 1.417 -2.1 0 CA-C-N 117.71 0.755 . . . . 0.0 109.323 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.75 40.45 0.91 Allowed 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 122.621 2.214 . . . . 0.0 107.577 170.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.0 m -140.08 143.31 36.25 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 -165.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.457 ' O ' ' HB ' ' A' ' 33' ' ' THR . 32.7 tt0 -68.2 -7.57 31.36 Favored 'General case' 0 C--N 1.371 1.538 0 CA-C-N 120.538 1.517 . . . . 0.0 111.22 -177.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 1.9 tmpt? -52.52 -40.43 62.44 Favored 'General case' 0 C--O 1.257 1.484 0 CA-C-O 121.321 0.581 . . . . 0.0 109.941 174.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.799 ' HG3' HD12 ' A' ' 36' ' ' ILE . 3.4 tp10 -69.23 -56.64 7.0 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 57.3 m -39.84 -47.77 2.18 Favored 'General case' 0 C--O 1.189 -2.111 0 C-N-CA 125.697 1.599 . . . . 0.0 111.897 171.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.4 pt-20 -70.99 -53.46 14.74 Favored 'General case' 0 C--O 1.253 1.275 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.65 -36.1 82.69 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.102 -1.439 . . . . 0.0 109.292 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.799 HD12 ' HG3' ' A' ' 32' ' ' GLU . 2.7 mt -68.0 -41.3 84.44 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.379 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.405 176.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.898 HG21 HG12 ' A' ' 55' ' ' ILE . 11.7 p -69.78 -40.09 76.25 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 120.299 1.409 . . . . 0.0 111.115 -176.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 p -64.72 -50.87 65.24 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 124.111 0.882 . . . . 0.0 110.039 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 mt -61.84 -49.42 76.36 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.048 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.629 ' CZ2' ' HB2' ' A' ' 78' ' ' LEU . 45.1 m0 -61.23 -71.97 0.13 Allowed 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 1.012 ' HB3' HH11 ' A' ' 53' ' ' ARG 0.314 0.0 OUTLIER -70.27 -18.65 63.13 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 117.521 -1.672 . . . . 0.0 112.078 -176.752 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.9 -48.44 80.78 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.412 173.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 54.3 p -79.01 -34.73 43.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 122.763 -0.257 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.984 HD12 ' HD2' ' A' ' 53' ' ' ARG . 11.4 mt -62.28 -33.17 74.13 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.894 0.378 . . . . 0.0 110.637 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -86.65 -30.07 22.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.408 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 9.2 t30 -66.17 -36.2 82.46 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.82 4.37 37.39 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.908 -0.495 . . . . 0.0 109.954 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.1 t30 58.57 47.9 12.65 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.471 1.108 . . . . 0.0 112.379 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -68.08 -13.13 61.96 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.578 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 26.5 t0 62.12 78.21 0.3 Allowed 'General case' 0 C--N 1.353 0.734 0 CA-C-O 122.755 1.264 . . . . 0.0 109.58 -176.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 m -140.84 177.38 3.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.13 -170.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -139.17 131.07 27.7 Favored 'General case' 0 C--O 1.177 -2.739 0 N-CA-C 104.001 -2.592 . . . . 0.0 104.001 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 1.012 HH11 ' HB3' ' A' ' 41' ' ' GLN . 23.2 mtp-105 -138.06 145.92 42.34 Favored 'General case' 0 C--N 1.273 -2.725 0 O-C-N 121.442 -0.786 . . . . 0.0 109.044 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.825 ' H ' HG12 ' A' ' 62' ' ' ILE . 15.1 t80 -134.67 151.2 50.85 Favored 'General case' 0 C--O 1.259 1.566 0 C-N-CA 118.028 -1.469 . . . . 0.0 113.3 -168.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.898 HG12 HG21 ' A' ' 37' ' ' THR . 58.0 mt -93.77 107.07 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 89.7 t -94.59 -48.16 13.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.484 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.35 177.95 40.49 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 117.553 -2.26 . . . . 0.0 114.962 -174.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.569 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 4.8 p -72.71 44.03 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 127.138 2.175 . . . . 0.0 114.192 -176.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' A' ' 58' ' ' SER . 2.5 p-10 148.58 6.18 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 125.73 1.612 . . . . 0.0 107.377 -169.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.515 ' HB3' ' HB ' ' A' ' 56' ' ' VAL . 7.2 mpt_? -127.9 133.34 49.28 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 123.959 0.904 . . . . 0.0 110.583 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.59 161.51 38.32 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.825 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -138.16 156.38 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.454 -2.725 0 C-N-CA 118.014 -1.474 . . . . 0.0 110.883 171.382 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.952 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 5.8 p90 -128.77 113.82 15.81 Favored 'General case' 0 N--CA 1.413 -2.287 0 O-C-N 126.88 2.612 . . . . 0.0 106.776 161.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.409 ' HB2' ' CD1' ' A' ' 62' ' ' ILE . 20.7 ttt -97.13 118.1 32.8 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 122.017 0.913 . . . . 0.0 111.413 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.674 HD11 ' HE3' ' A' ' 20' ' ' MET . 5.8 mp -73.4 145.88 45.52 Favored 'General case' 0 CA--C 1.47 -2.124 0 CA-C-N 112.189 -2.278 . . . . 0.0 111.54 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.578 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.362 58.8 ttt180 -118.2 -62.13 1.58 Allowed 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 176.098 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 69' ' ' SER . 9.4 t70 -71.9 17.59 0.09 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 120.267 1.394 . . . . 0.0 112.924 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.37 -32.71 0.02 OUTLIER Glycine 0 CA--C 1.551 2.34 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 -169.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.436 ' H ' ' C ' ' A' ' 67' ' ' ASP . 14.8 m -93.67 20.4 7.52 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -166.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.489 ' HE1' ' H ' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -148.25 125.44 11.48 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.597 -0.69 . . . . 0.0 111.069 178.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.555 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 171.91 -30.95 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 124.178 0.924 . . . . 0.0 112.227 176.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.59 ' NE1' ' HE1' ' A' ' 20' ' ' MET 0.428 5.3 m-90 -89.02 -28.3 20.27 Favored 'General case' 0 C--O 1.267 2.022 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -165.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 38.9 tt0 -72.43 -39.16 68.09 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 170.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 71' ' ' ALA . 30.5 mt -51.63 -48.86 36.15 Favored 'Isoleucine or valine' 0 C--O 1.286 3.024 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.9 173.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.608 ' O ' HG22 ' A' ' 79' ' ' VAL . 21.4 pttp -67.07 -37.85 84.72 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.75 -46.53 74.34 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.202 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.572 ' CZ ' ' HG2' ' A' ' 73' ' ' GLU . 18.0 m-85 -60.96 -59.23 5.71 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.922 0.868 . . . . 0.0 109.646 -175.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.629 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.1 pp -63.33 -40.42 97.26 Favored 'General case' 0 C--O 1.266 1.932 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -171.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.647 ' HB ' ' CB ' ' A' ' 84' ' ' CYS 0.265 27.6 m -80.36 -12.88 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 118.343 -1.343 . . . . 0.0 111.622 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.8 m -97.3 -0.05 47.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -87.99 -54.54 4.18 Favored 'General case' 0 CA--C 1.475 -1.942 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.472 38.0 t70 -137.71 -92.99 0.21 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 175.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.608 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 18.8 mmt180 -99.14 153.28 19.03 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 120.96 1.709 . . . . 0.0 110.955 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.647 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 24.8 p -152.07 154.97 37.0 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.251 -173.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.44 -51.16 0.02 OUTLIER 'General case' 0 C--N 1.355 0.84 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.784 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 36.9 tt0 -153.84 116.91 4.52 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.776 -173.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.96 101.68 12.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.258 23.5 p -105.19 120.62 41.98 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 123.1 1.429 . . . . 0.0 114.758 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.426 HD12 ' N ' ' A' ' 89' ' ' LEU . 1.2 mp . . . . . 0 C--N 1.282 -2.359 0 CA-C-N 112.155 -2.293 . . . . 0.0 106.527 177.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tptt . . . . . 0 N--CA 1.444 -0.732 0 N-CA-C 111.362 0.134 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -78.65 123.21 26.89 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.661 ' CD1' HD12 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -133.18 103.15 5.86 Favored 'General case' 0 C--O 1.191 -2.001 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -174.171 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.678 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 9.4 ptp -84.1 116.92 23.13 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.891 -1.13 . . . . 0.0 110.891 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.878 ' HG2' HD11 ' A' ' 89' ' ' LEU . 93.1 mtp -86.7 99.28 11.65 Favored 'General case' 0 CA--C 1.487 -1.466 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.246 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.458 ' CZ ' ' HD2' ' A' ' 60' ' ' ARG . 12.3 t80 -89.04 106.05 18.18 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.451 HG22 ' NE ' ' A' ' 83' ' ' ARG . 9.1 p -126.28 125.91 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.923 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.039 -165.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.073 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 31.4 m -92.88 142.31 27.46 Favored 'General case' 0 C--O 1.276 2.477 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.596 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.915 HG23 ' HA ' ' A' ' 83' ' ' ARG . 7.5 p -131.03 128.52 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 103.681 -2.711 . . . . 0.0 103.681 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.61 20.79 1.04 Allowed 'General case' 0 C--O 1.245 0.864 0 CA-C-N 122.478 2.399 . . . . 0.0 112.347 -171.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.64 -31.83 73.88 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 106.821 -2.511 . . . . 0.0 106.821 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.93 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 24.8 t-20 -118.46 104.58 47.48 Favored Pre-proline 0 N--CA 1.405 -2.711 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.54 32.23 0.45 Allowed 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.736 2.291 . . . . 0.0 112.395 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.41 ' HB ' ' H ' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -146.81 -161.24 1.28 Allowed 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.628 -173.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.7 tp10 -76.69 -18.29 58.62 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 5.0 tmtt? -64.56 -52.42 57.71 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.93 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.4 tp10 -71.01 -35.44 72.03 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 117.777 -1.569 . . . . 0.0 107.643 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 54.5 m -49.6 -57.52 6.99 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.029 172.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 15.2 pt-20 -65.98 -40.25 91.06 Favored 'General case' 0 C--O 1.255 1.371 0 C-N-CA 122.792 0.437 . . . . 0.0 111.784 -176.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -51.69 -63.0 1.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.695 HG23 ' CE3' ' A' ' 40' ' ' TRP . 35.4 mt -67.21 -44.46 87.66 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 112.384 -2.189 . . . . 0.0 112.957 -175.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.773 ' HB ' HG12 ' A' ' 55' ' ' ILE . 32.4 p -65.35 -53.49 42.87 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.547 -0.861 . . . . 0.0 112.011 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.9 t -70.55 -46.87 62.73 Favored 'General case' 0 C--O 1.257 1.46 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.429 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.73 -43.13 66.39 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.759 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.695 ' CE3' HG23 ' A' ' 36' ' ' ILE . 37.9 m0 -73.29 -61.75 1.71 Allowed 'General case' 0 C--O 1.167 -3.262 0 CA-C-O 117.486 -1.245 . . . . 0.0 109.65 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.828 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.377 0.0 OUTLIER -63.47 -25.69 68.38 Favored 'General case' 0 C--O 1.253 1.278 0 C-N-CA 117.871 -1.532 . . . . 0.0 112.608 -172.166 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.94 -50.92 59.47 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 171.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.741 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 58.7 p -74.06 -25.29 59.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.344 0.572 . . . . 0.0 111.404 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.782 HD12 ' HG2' ' A' ' 53' ' ' ARG . 32.5 mt -62.62 -33.51 75.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 176.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.536 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 89.9 t80 -87.97 -32.8 18.68 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.45 173.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.741 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 6.9 t30 -62.36 -36.96 83.87 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.11 3.21 52.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.277 0.561 . . . . 0.0 110.017 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.7 t30 53.24 51.89 14.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.226 1.41 . . . . 0.0 112.568 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -64.73 -7.02 9.25 Favored 'General case' 0 CA--C 1.595 2.69 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.0 t70 61.04 67.88 0.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.141 1.377 . . . . 0.0 110.037 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.669 HG23 ' HD2' ' A' ' 53' ' ' ARG . 2.6 m -147.92 175.42 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.249 -171.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.481 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 17.5 mt-30 -130.96 125.18 32.72 Favored 'General case' 0 C--O 1.189 -2.131 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 177.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.828 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -134.5 136.6 43.25 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -172.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.814 ' H ' HG12 ' A' ' 62' ' ' ILE . 47.9 t80 -135.03 150.49 50.31 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 118.187 -1.405 . . . . 0.0 113.579 -166.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.773 HG12 ' HB ' ' A' ' 37' ' ' THR . 19.1 mt -93.23 96.36 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 171.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -80.01 -33.85 14.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.81 -178.87 40.38 Favored Glycine 0 CA--C 1.484 -1.905 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.245 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -60.24 121.01 10.9 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.258 0.0 OUTLIER 79.3 8.67 1.77 Allowed 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 121.937 0.875 . . . . 0.0 111.379 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.458 ' HD2' ' CZ ' ' A' ' 21' ' ' PHE . 1.3 tpp180 -137.56 118.92 14.69 Favored 'General case' 0 CA--C 1.573 1.858 0 O-C-N 121.45 -0.781 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.07 162.1 34.27 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -175.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.814 HG12 ' H ' ' A' ' 54' ' ' PHE . 2.5 pt -142.49 157.13 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 C-N-CA 117.422 -1.711 . . . . 0.0 110.337 170.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.526 ' CE2' ' HB ' ' A' ' 74' ' ' ILE 0.296 9.0 p90 -133.02 101.33 5.18 Favored 'General case' 0 N--CA 1.426 -1.672 0 O-C-N 126.264 2.227 . . . . 0.0 108.394 161.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.678 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 25.0 ttt -87.17 113.88 23.3 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.73 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.687 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.315 2.3 mp -80.66 148.22 30.31 Favored 'General case' 0 CA--C 1.442 -3.173 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.287 -178.092 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -117.54 163.12 16.9 Favored 'General case' 0 C--N 1.252 -3.637 0 N-CA-C 104.513 -2.403 . . . . 0.0 104.513 169.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 76.98 -36.22 0.25 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.17 -29.13 7.87 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 119.895 -1.145 . . . . 0.0 114.16 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.9 m -96.07 32.95 1.81 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -167.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 41.9 p90 -178.43 137.07 0.16 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 117.029 -1.463 . . . . 0.0 109.744 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.687 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 164.0 -35.45 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.128 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 171.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.685 ' HZ2' ' HG ' ' A' ' 89' ' ' LEU 0.298 22.0 m-90 -80.36 -9.76 59.75 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 120.376 -1.453 . . . . 0.0 111.684 -172.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.14 -35.62 69.14 Favored 'General case' 0 C--O 1.299 3.684 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.526 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 67.3 mt -62.53 -39.35 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 174.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.659 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 12.4 tmtt? -61.53 -37.23 83.01 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.729 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.83 -48.15 81.86 Favored 'General case' 0 C--O 1.261 1.691 0 C-N-CA 119.619 -0.833 . . . . 0.0 110.138 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -57.48 -45.14 85.19 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.366 1.079 . . . . 0.0 110.11 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.714 HD12 HG13 ' A' ' 79' ' ' VAL 0.271 4.2 pp -61.06 -48.77 80.18 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -179.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.714 HG13 HD12 ' A' ' 78' ' ' LEU . 23.7 m -75.18 -6.87 9.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 117.458 -1.697 . . . . 0.0 112.22 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -96.59 -5.9 38.07 Favored 'General case' 0 N--CA 1.403 -2.792 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.721 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -100.75 -58.12 1.96 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.6 t70 164.16 173.11 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.484 1 N-CA-C 99.532 -4.247 . . . . 0.0 99.532 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.915 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER 74.23 89.75 0.09 Allowed 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -163.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.692 ' HA ' HG12 ' A' ' 79' ' ' VAL . 12.6 p -153.69 56.84 0.74 Allowed 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.787 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.77 -62.68 1.11 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.073 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 33.2 tt0 -134.44 125.28 27.13 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 120.65 1.568 . . . . 0.0 110.202 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.8 t -117.66 111.41 34.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.489 ' O ' HD22 ' A' ' 89' ' ' LEU . 38.8 p -124.95 129.19 49.86 Favored 'General case' 0 C--O 1.277 2.509 0 C-N-CA 118.751 -1.179 . . . . 0.0 112.726 174.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.878 HD11 ' HG2' ' A' ' 20' ' ' MET . 4.4 mm? . . . . . 0 N--CA 1.412 -2.35 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.985 -175.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.0 tptt . . . . . 0 N--CA 1.431 -1.417 0 CA-C-O 121.063 0.458 . . . . 0.0 110.237 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.6 m -67.15 123.13 19.42 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.48 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.598 ' O ' HD22 ' A' ' 65' ' ' LEU . 0.4 OUTLIER -122.76 121.23 35.82 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 -176.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.478 ' HB3' ' HG3' ' A' ' 64' ' ' MET . 14.9 ptt? -109.05 133.74 52.59 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.371 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.545 ' SD ' ' HA ' ' A' ' 89' ' ' LEU . 2.9 mpp? -108.86 118.93 38.07 Favored 'General case' 0 CA--C 1.46 -2.511 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.672 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -103.94 128.78 51.46 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 171.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.44 124.13 69.01 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.542 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.629 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.975 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 95.8 m -75.43 124.88 27.92 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 173.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.523 HG21 HD13 ' A' ' 36' ' ' ILE . 1.9 p -128.45 124.35 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.361 0 CA-C-N 120.319 1.418 . . . . 0.0 111.568 -169.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.941 ' HB2' ' HB2' ' A' ' 83' ' ' ARG . 33.0 t 70.68 -50.15 0.67 Allowed 'General case' 0 C--N 1.363 1.176 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 167.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.24 23.5 9.62 Favored Glycine 0 N--CA 1.415 -2.715 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.31 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.497 ' ND2' ' HB3' ' A' ' 32' ' ' GLU 0.251 9.2 p30 -116.65 111.08 41.72 Favored Pre-proline 0 N--CA 1.417 -2.101 0 C-N-CA 117.609 -1.636 . . . . 0.0 112.205 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.727 ' HA ' ' HB3' ' A' ' 58' ' ' SER . 12.6 Cg_exo -74.19 37.17 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.805 2.337 . . . . 0.0 109.598 176.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.2 m -88.62 52.7 2.5 Favored 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.239 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 30' ' ' GLU . 7.6 tp10 66.1 19.92 11.17 Favored 'General case' 0 C--N 1.414 3.377 0 CA-C-O 126.803 3.192 . . . . 0.0 103.328 -162.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.789 ' HB3' ' HA ' ' A' ' 58' ' ' SER 0.517 0.0 OUTLIER 62.42 144.8 0.02 OUTLIER 'General case' 2 N--CA 1.259 -10.019 0 CA-C-O 127.461 3.505 . . . . 0.0 114.104 -178.934 . . . . . . . . 5 4 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.896 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -66.98 -10.44 49.58 Favored 'General case' 2 N--CA 1.348 -5.543 0 CA-C-N 110.191 -3.186 . . . . 0.0 105.01 169.214 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.636 ' H ' ' HB2' ' A' ' 31' ' ' LYS . 94.3 m -69.18 -35.12 75.94 Favored 'General case' 1 N--CA 1.359 -4.976 0 C-N-CA 127.921 2.488 . . . . 0.0 108.463 174.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.604 ' HG3' ' N ' ' A' ' 35' ' ' GLU . 3.9 pt-20 -74.19 -40.77 62.28 Favored 'General case' 0 C--N 1.389 2.319 0 CA-C-N 121.487 1.949 . . . . 0.0 106.941 177.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.604 ' N ' ' HG3' ' A' ' 34' ' ' GLU . 9.7 tp10 -59.4 -56.69 18.78 Favored 'General case' 0 C--O 1.279 2.634 0 CA-C-O 124.087 1.899 . . . . 0.0 108.576 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.896 ' HB ' ' O ' ' A' ' 32' ' ' GLU . 1.1 mt -70.3 -25.17 26.73 Favored 'Isoleucine or valine' 0 C--O 1.163 -3.455 0 CA-C-N 111.74 -2.482 . . . . 0.0 112.305 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.537 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 6.7 p -74.04 -41.9 61.09 Favored 'General case' 0 CA--C 1.464 -2.328 0 CA-C-N 121.697 2.044 . . . . 0.0 109.466 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 m -60.18 -51.62 68.8 Favored 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.858 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.5 tp -72.32 -49.68 32.59 Favored 'General case' 0 C--O 1.25 1.123 0 C-N-CA 118.038 -1.465 . . . . 0.0 111.434 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.689 ' CZ2' ' HB2' ' A' ' 78' ' ' LEU . 51.0 m0 -69.27 -67.99 0.44 Allowed 'General case' 0 C--O 1.189 -2.106 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.409 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.555 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.36 0.0 OUTLIER -69.9 -20.36 63.37 Favored 'General case' 0 C--O 1.254 1.303 0 C-N-CA 118.516 -1.273 . . . . 0.0 112.075 -170.865 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.32 -53.36 45.03 Favored Glycine 0 C--N 1.365 2.18 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.653 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 36.7 p -69.83 -29.77 67.11 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.53 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.887 HD12 ' HG2' ' A' ' 53' ' ' ARG . 25.5 mt -59.64 -35.01 73.54 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.691 0.397 . . . . 0.0 110.547 177.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.57 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 82.3 t80 -91.08 -27.37 18.63 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.653 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 8.7 t30 -64.79 -34.89 79.41 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.692 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.24 0.53 57.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.865 0.365 . . . . 0.0 110.491 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.3 t30 53.24 57.79 5.9 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.967 1.307 . . . . 0.0 112.46 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.46 ' HB3' ' HE2' ' A' ' 70' ' ' TYR . 37.8 m-85 -73.8 -0.21 15.1 Favored 'General case' 0 CA--C 1.597 2.763 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.5 t70 62.05 67.78 0.72 Allowed 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 124.402 1.081 . . . . 0.0 110.792 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.628 HG12 ' HA ' ' A' ' 65' ' ' LEU . 6.7 m -147.36 174.83 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.502 -172.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.531 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 1.9 mp0 -131.51 131.68 43.62 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 172.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.887 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -129.74 129.85 44.68 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -174.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.864 ' H ' HG12 ' A' ' 62' ' ' ILE . 29.2 t80 -133.93 152.36 51.83 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 119.095 -1.042 . . . . 0.0 113.112 -159.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.587 HG23 HG21 ' A' ' 33' ' ' THR . 75.3 mt -88.17 107.32 17.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.877 175.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.756 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 97.1 t -81.47 -40.97 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.025 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.56 -171.34 43.63 Favored Glycine 0 CA--C 1.469 -2.825 0 C-N-CA 118.629 -1.748 . . . . 0.0 113.46 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.789 ' HA ' ' HB3' ' A' ' 31' ' ' LYS . 6.6 m -62.0 118.26 7.04 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 118.057 -0.973 . . . . 0.0 108.742 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' A' ' 58' ' ' SER . 2.4 t70 80.89 11.16 0.91 Allowed 'General case' 0 N--CA 1.408 -2.566 0 CA-C-O 122.545 1.164 . . . . 0.0 109.228 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.756 ' HB3' ' HB ' ' A' ' 56' ' ' VAL . 11.4 mpt_? -137.1 116.08 12.36 Favored 'General case' 0 CA--C 1.562 1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 112.149 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.62 163.1 22.68 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.129 0.972 . . . . 0.0 108.728 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.864 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.7 OUTLIER -139.52 158.08 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.223 0 C-N-CA 118.223 -1.391 . . . . 0.0 111.128 173.118 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.629 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 2.3 p90 -129.08 106.75 9.07 Favored 'General case' 0 N--CA 1.419 -2.009 0 O-C-N 126.485 2.365 . . . . 0.0 106.917 164.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.478 ' HG3' ' HB3' ' A' ' 19' ' ' MET . 23.1 ttt -94.99 117.04 29.48 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.273 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.727 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.484 0.0 OUTLIER -114.34 147.73 38.68 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -177.339 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.354 36.3 ttp180 -104.57 -62.6 1.31 Allowed 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -164.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -55.92 -8.08 0.39 Allowed 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.83 15.98 29.49 Favored Glycine 0 C--N 1.369 2.375 0 CA-C-N 120.194 1.361 . . . . 0.0 115.09 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.9 p -116.66 22.19 12.89 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 118.39 1.095 . . . . 0.0 113.597 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.46 ' HE2' ' HB3' ' A' ' 49' ' ' TYR . 2.3 p90 177.8 145.79 0.12 Allowed 'General case' 0 C--O 1.245 0.823 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -167.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.727 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 160.48 -28.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 125.166 1.541 . . . . 0.0 111.92 171.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.489 ' HA ' ' HG3' ' A' ' 75' ' ' LYS 0.522 7.1 m0 -89.48 -16.4 30.88 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 117.071 -1.852 . . . . 0.0 115.176 -169.196 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.92 -36.38 80.07 Favored 'General case' 0 C--O 1.257 1.457 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 165.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 57.2 mt -53.89 -50.13 54.76 Favored 'Isoleucine or valine' 0 C--O 1.29 3.204 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.795 174.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.618 ' O ' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -63.42 -36.11 82.65 Favored 'General case' 0 C--N 1.373 1.612 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.243 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.79 -47.07 83.6 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.84 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 13.9 m-85 -58.18 -60.25 4.04 Favored 'General case' 0 C--N 1.365 1.245 0 CA-C-O 122.35 1.071 . . . . 0.0 109.198 -175.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.689 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.6 pp -62.29 -38.46 89.44 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 75' ' ' LYS . 34.0 m -80.09 -9.75 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 118.203 -1.399 . . . . 0.0 111.431 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.0 m -105.8 3.29 28.62 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -107.3 -45.95 3.99 Favored 'General case' 0 CA--C 1.473 -2.014 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.269 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.78 -160.79 0.86 Allowed 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.941 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 24.2 mmt180 -80.35 159.67 25.68 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 120.127 1.33 . . . . 0.0 110.123 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.611 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 26.7 p -136.59 146.1 45.69 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.256 -172.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.27 -53.43 0.13 Allowed 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.975 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.5 tt0 -153.72 118.82 5.08 Favored 'General case' 0 C--O 1.195 -1.809 0 CA-C-N 119.806 1.184 . . . . 0.0 110.68 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.9 t -113.14 101.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.324 17.4 p -108.64 132.69 53.65 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 123.387 1.565 . . . . 0.0 114.489 177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.545 ' HA ' ' SD ' ' A' ' 20' ' ' MET . 3.7 mp . . . . . 0 C--N 1.263 -3.18 0 CA-C-N 110.807 -2.906 . . . . 0.0 108.093 -174.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.482 ' HE3' ' HB2' ' A' ' 18' ' ' LEU . 55.2 tptt . . . . . 0 N--CA 1.445 -0.714 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 20.8 p -108.21 110.02 21.54 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.426 0.69 . . . . 0.0 109.474 173.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.925 HD23 ' HH2' ' A' ' 72' ' ' TRP . 30.8 tp -135.0 124.51 24.97 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -171.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.703 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.1 ptp -85.39 109.26 18.3 Favored 'General case' 0 C--O 1.207 -1.148 0 O-C-N 121.47 -0.769 . . . . 0.0 111.487 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.626 ' HA ' ' CG ' ' A' ' 89' ' ' LEU . 4.5 mpp? -84.36 128.94 34.87 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.526 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 59.6 t80 -111.05 109.06 18.99 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 125.502 1.751 . . . . 0.0 108.46 -169.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.05 128.79 75.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 114.76 1.392 . . . . 0.0 114.76 -169.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.974 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 49.5 m -87.41 141.41 28.65 Favored 'General case' 0 CA--C 1.595 2.708 0 C-N-CA 127.322 2.249 . . . . 0.0 109.006 176.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 83' ' ' ARG . 35.9 t -132.0 97.33 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.014 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -166.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 83' ' ' ARG 0.324 60.8 m 62.3 -30.07 0.08 Allowed 'General case' 0 C--N 1.389 2.293 0 N-CA-C 119.085 2.995 . . . . 0.0 119.085 170.229 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.474 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 123.76 1.5 8.97 Favored Glycine 0 N--CA 1.426 -2.018 0 C-N-CA 118.39 -1.862 . . . . 0.0 115.269 175.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.575 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.3 t-20 -79.65 104.66 2.51 Favored Pre-proline 0 C--O 1.22 -0.452 0 CA-C-N 119.04 1.42 . . . . 0.0 107.862 173.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 82.2 Cg_endo -91.52 33.71 0.29 Allowed 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 123.348 2.699 . . . . 0.0 109.532 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 m -129.53 155.19 46.18 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -69.94 3.37 2.7 Favored 'General case' 0 C--O 1.182 -2.455 0 CA-C-N 121.741 2.064 . . . . 0.0 111.824 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.565 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 1.8 tmtt? -60.0 -55.48 33.44 Favored 'General case' 0 C--O 1.275 2.43 0 CA-C-O 121.947 0.88 . . . . 0.0 111.228 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.812 ' HG3' HD12 ' A' ' 36' ' ' ILE . 1.7 tp10 -65.2 -52.3 55.64 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -176.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 93.1 m -42.89 -52.76 4.99 Favored 'General case' 0 C--O 1.187 -2.213 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.765 172.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 11.9 pt-20 -62.4 -55.47 27.6 Favored 'General case' 0 C--O 1.263 1.811 0 CA-C-N 118.689 0.677 . . . . 0.0 112.071 -175.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' A' ' 34' ' ' GLU . 9.3 tp10 -58.93 -53.84 53.89 Favored 'General case' 0 C--O 1.254 1.311 0 CA-C-O 122.972 1.368 . . . . 0.0 108.235 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.812 HD12 ' HG3' ' A' ' 32' ' ' GLU . 5.3 mt -64.24 -40.95 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.368 0 CA-C-N 112.527 -2.124 . . . . 0.0 113.331 -176.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.888 HG21 HG12 ' A' ' 55' ' ' ILE . 21.5 p -70.47 -37.7 74.31 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 120.214 1.37 . . . . 0.0 110.048 -177.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.4 m -63.45 -46.29 86.96 Favored 'General case' 0 N--CA 1.417 -2.08 0 O-C-N 123.966 0.791 . . . . 0.0 109.417 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.2 tp -73.03 -43.83 61.57 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.97 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.734 ' CE3' HD12 ' A' ' 78' ' ' LEU . 48.1 m0 -66.89 -70.24 0.26 Allowed 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 119.353 -0.356 . . . . 0.0 111.067 -177.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.713 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.294 0.0 OUTLIER -73.06 -19.26 61.21 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.832 -173.222 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.32 -50.89 59.03 Favored Glycine 0 C--N 1.357 1.726 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 172.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 60.9 p -69.64 -28.95 66.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.466 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.936 HD12 ' HG2' ' A' ' 53' ' ' ARG . 15.5 mt -62.49 -32.89 73.86 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.743 176.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.554 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 83.5 t80 -87.11 -31.56 20.38 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.057 0.456 . . . . 0.0 109.872 176.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 25.8 t-20 -67.21 -30.26 70.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.126 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.2 4.81 44.33 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 122.3 -0.25 . . . . 0.0 111.106 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.2 t30 56.92 47.14 18.32 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.048 0.939 . . . . 0.0 112.687 174.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.51 151.62 19.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.54 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 28.6 t70 -92.98 95.52 9.53 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 121.751 2.069 . . . . 0.0 109.115 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.706 HG12 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -146.84 162.75 8.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.009 -173.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HB3' ' HE1' ' A' ' 54' ' ' PHE . 2.2 mp0 -126.38 121.34 32.22 Favored 'General case' 0 C--O 1.199 -1.574 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 174.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.936 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -127.9 136.99 52.13 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.708 ' H ' HG12 ' A' ' 62' ' ' ILE . 46.3 m-85 -133.3 152.63 51.94 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -163.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.888 HG12 HG21 ' A' ' 37' ' ' THR . 46.8 mt -91.53 96.89 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 169.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.2 m -102.67 -20.56 5.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.753 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.37 174.98 47.4 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 117.728 -2.177 . . . . 0.0 114.066 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 51.0 m -75.05 117.98 17.49 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 23' ' ' THR . 5.4 t70 80.02 7.69 1.61 Allowed 'General case' 0 C--N 1.365 1.26 0 O-C-N 124.272 0.982 . . . . 0.0 108.835 -174.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.526 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 1.5 tpp180 -130.37 117.46 19.76 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.669 -176.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.09 163.11 29.2 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.708 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -135.86 157.38 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.38 0 C-N-CA 117.739 -1.585 . . . . 0.0 110.106 174.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.609 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 2.4 p90 -134.61 106.97 7.24 Favored 'General case' 0 N--CA 1.428 -1.567 0 O-C-N 126.192 2.183 . . . . 0.0 107.923 162.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.703 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 23.6 ttt -90.23 116.37 28.16 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 119.039 -0.505 . . . . 0.0 109.975 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.79 HD23 ' H ' ' A' ' 18' ' ' LEU . 1.1 pt? -90.75 144.49 25.67 Favored 'General case' 0 C--O 1.259 1.594 0 O-C-N 124.972 1.42 . . . . 0.0 112.202 -174.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.544 ' HA ' HG22 ' A' ' 17' ' ' THR 0.285 2.7 tmt_? -118.09 -53.32 2.37 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 125.575 1.797 . . . . 0.0 114.666 177.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.573 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 32.6 t70 -43.96 -19.87 0.02 OUTLIER 'General case' 0 CA--C 1.586 2.334 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.71 -25.55 4.53 Favored Glycine 0 C--N 1.358 1.788 0 CA-C-N 120.322 1.419 . . . . 0.0 115.384 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 68.8 m -137.2 49.02 2.04 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -170.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.573 ' CE1' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -156.17 -0.48 0.14 Allowed 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.37 -0.831 . . . . 0.0 113.158 -176.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.545 ' CB ' HD13 ' A' ' 65' ' ' LEU . . . -86.11 -39.18 16.99 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 -169.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.925 ' HH2' HD23 ' A' ' 18' ' ' LEU 0.428 28.8 m-90 -80.95 -14.1 58.27 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 116.511 -2.076 . . . . 0.0 112.126 -171.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -71.88 -36.92 70.22 Favored 'General case' 0 C--O 1.279 2.653 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 166.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.629 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 73.7 mt -57.58 -42.83 82.08 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.991 ' HG3' HG21 ' A' ' 87' ' ' VAL . 22.5 ttpp -51.87 -52.37 50.14 Favored 'General case' 0 C--N 1.374 1.644 0 C-N-CA 125.067 1.347 . . . . 0.0 109.441 177.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.07 -34.92 70.65 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.801 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.629 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 14.9 m-85 -74.02 -57.65 3.83 Favored 'General case' 0 CA--C 1.466 -2.287 0 C-N-CA 118.522 -1.271 . . . . 0.0 107.907 -169.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.734 HD12 ' CE3' ' A' ' 40' ' ' TRP . 1.8 pt? -68.51 -35.57 77.66 Favored 'General case' 0 N--CA 1.4 -2.966 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.731 -169.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 75' ' ' LYS 0.286 23.1 m -78.2 -19.99 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 116.594 -2.042 . . . . 0.0 110.67 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.9 m -95.22 5.61 51.29 Favored 'General case' 0 N--CA 1.411 -2.401 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.96 169.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.522 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . 7.5 tp-100 -89.03 -41.9 12.06 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -176.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.553 ' OD2' ' HG2' ' A' ' 83' ' ' ARG 0.386 17.7 t70 -140.35 -85.77 0.21 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.553 ' HG2' ' OD2' ' A' ' 82' ' ' ASP . 21.4 mmt180 -110.35 165.39 11.81 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.96 1.709 . . . . 0.0 109.836 176.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.563 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 24.6 p -159.89 148.22 17.18 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.08 -54.31 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.862 1.265 . . . . 0.0 112.193 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.974 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 40.4 tt0 -154.96 123.15 5.9 Favored 'General case' 0 C--O 1.207 -1.173 0 C-N-CA 119.63 -0.828 . . . . 0.0 113.163 -169.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.991 HG21 ' HG3' ' A' ' 75' ' ' LYS . 62.0 t -112.0 104.51 17.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 173.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.525 ' O ' HD23 ' A' ' 89' ' ' LEU . 10.0 p -113.44 148.36 36.05 Favored 'General case' 0 C--O 1.266 1.954 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.74 ' CD1' ' HG ' ' A' ' 18' ' ' LEU 0.864 0.9 OUTLIER . . . . . 0 N--CA 1.44 -0.944 1 N-CA-C 122.567 4.284 . . . . 0.0 122.567 -177.612 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.2 tptt . . . . . 0 N--CA 1.438 -1.047 0 CA-C-O 120.677 0.275 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.774 HG22 ' HA ' ' A' ' 66' ' ' ARG . 19.3 p -72.33 135.65 45.97 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.428 174.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.622 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -134.24 116.6 15.5 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.2 ptm -94.63 119.1 32.75 Favored 'General case' 0 C--N 1.287 -2.125 0 O-C-N 121.623 -0.673 . . . . 0.0 109.195 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.915 ' HE2' HD23 ' A' ' 89' ' ' LEU . 1.3 pmm? -121.8 133.41 54.9 Favored 'General case' 0 C--O 1.281 2.753 0 C-N-CA 118.008 -1.477 . . . . 0.0 113.621 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -96.34 119.33 34.63 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.599 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -121.44 131.22 73.58 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.787 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.338 -176.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.077 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 97.1 m -99.46 151.88 20.62 Favored 'General case' 1 CA--C 1.648 4.748 0 C-N-CA 130.669 3.588 . . . . 0.0 112.31 -178.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.839 ' HB ' ' HG2' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -121.49 155.97 25.51 Favored 'Isoleucine or valine' 0 C--N 1.405 2.996 0 C-N-CA 126.246 1.818 . . . . 0.0 108.007 -168.415 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.672 ' OG ' ' HB2' ' A' ' 85' ' ' ALA . 54.2 m -108.18 168.92 8.95 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-N 120.628 1.558 . . . . 0.0 107.37 171.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.01 -88.5 0.47 Allowed Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 119.651 1.114 . . . . 0.0 112.198 174.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -115.78 113.04 42.47 Favored Pre-proline 0 N--CA 1.417 -2.076 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.75 30.27 0.32 Allowed 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 123.84 3.027 . . . . 0.0 112.982 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.538 ' OG1' ' HD2' ' A' ' 31' ' ' LYS . 70.2 p -128.41 -163.78 1.31 Allowed 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 33' ' ' THR . 37.9 tt0 -84.24 1.8 42.98 Favored 'General case' 0 N--CA 1.421 -1.907 0 O-C-N 121.382 -0.824 . . . . 0.0 111.49 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.552 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -69.66 -44.93 69.54 Favored 'General case' 0 C--O 1.281 2.717 0 O-C-N 120.987 -1.071 . . . . 0.0 112.181 -177.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.776 ' HG3' HD13 ' A' ' 36' ' ' ILE . 3.2 tp10 -69.99 -44.08 70.12 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.753 ' HA ' HH21 ' A' ' 60' ' ' ARG . 20.1 m -44.02 -63.67 0.82 Allowed 'General case' 0 C--O 1.183 -2.422 0 CA-C-N 112.616 -2.083 . . . . 0.0 111.338 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 13.1 pt-20 -58.2 -52.82 63.98 Favored 'General case' 0 C--O 1.255 1.354 0 O-C-N 124.419 1.075 . . . . 0.0 113.125 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.701 ' HG3' HD12 ' A' ' 36' ' ' ILE . 8.8 pt-20 -66.41 -44.29 83.4 Favored 'General case' 0 C--O 1.27 2.151 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.699 -176.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.776 HD13 ' HG3' ' A' ' 32' ' ' GLU . 1.3 mp -66.43 -44.1 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.795 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.473 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.779 HG21 HG12 ' A' ' 55' ' ' ILE . 33.4 p -68.09 -39.79 82.77 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 120.039 1.291 . . . . 0.0 111.618 -175.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.3 p -60.98 -54.0 50.33 Favored 'General case' 0 C--O 1.262 1.719 0 O-C-N 124.276 0.985 . . . . 0.0 109.6 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.09 -44.21 96.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.411 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.644 ' CE3' HD13 ' A' ' 78' ' ' LEU . 42.0 m0 -64.7 -74.99 0.09 Allowed 'General case' 0 C--O 1.205 -1.244 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.722 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.365 0.0 OUTLIER -70.68 -18.17 62.83 Favored 'General case' 0 C--O 1.255 1.349 0 C-N-CA 118.457 -1.297 . . . . 0.0 112.409 -172.185 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.9 -49.81 65.31 Favored Glycine 0 N--CA 1.432 -1.619 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 171.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 75.9 p -71.76 -26.83 62.61 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.333 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.761 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 28.7 mt -59.65 -37.88 79.91 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.702 176.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.51 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 86.6 t80 -86.26 -33.33 20.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.481 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 7.5 t30 -65.11 -34.66 78.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.07 9.1 20.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.926 0.393 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 59.88 35.49 21.81 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.709 1.203 . . . . 0.0 113.652 172.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . 0.497 ' O ' HG13 ' A' ' 51' ' ' VAL . 13.7 m-85 -78.05 25.23 0.22 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 25.67 76.65 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.678 0 C-N-CA 126.811 2.045 . . . . 0.0 113.671 -177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.989 HG12 ' HA ' ' A' ' 65' ' ' LEU . 1.5 m -146.5 175.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.134 -173.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 64' ' ' MET . 0.7 OUTLIER -134.33 120.9 20.47 Favored 'General case' 0 C--O 1.194 -1.853 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.761 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.75 131.16 35.19 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -169.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.814 ' H ' HG12 ' A' ' 62' ' ' ILE . 36.4 t80 -136.59 148.62 47.61 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 118.835 -1.146 . . . . 0.0 113.901 -164.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.779 HG12 HG21 ' A' ' 37' ' ' THR . 71.5 mt -80.39 123.28 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 170.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.21 -29.2 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.15 152.83 20.1 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.835 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 49.5 m -85.08 82.27 8.5 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.032 0.444 . . . . 0.0 110.505 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.477 ' HB2' HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER 158.81 -32.35 0.0 OUTLIER 'General case' 0 N--CA 1.384 -3.742 0 N-CA-C 101.467 -3.531 . . . . 0.0 101.467 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.839 ' HG2' ' HB ' ' A' ' 24' ' ' VAL 0.457 1.1 mmp_? -145.41 -179.64 6.79 Favored 'General case' 0 C--N 1.391 2.41 1 N-CA-C 124.954 5.168 . . . . 0.0 124.954 -167.91 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 60' ' ' ARG . . . -152.6 172.44 16.6 Favored 'General case' 0 C--N 1.382 2.002 0 CA-C-N 112.526 -2.125 . . . . 0.0 111.449 -160.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.814 HG12 ' H ' ' A' ' 54' ' ' PHE . 13.7 pt -123.12 158.55 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.439 -3.307 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.466 ' O ' ' SD ' ' A' ' 20' ' ' MET 0.288 4.0 p90 -123.21 121.15 35.2 Favored 'General case' 0 N--CA 1.401 -2.893 0 O-C-N 126.447 2.342 . . . . 0.0 105.742 160.45 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 52' ' ' GLN . 1.3 tmt? -105.6 117.48 34.13 Favored 'General case' 0 C--N 1.273 -2.752 0 O-C-N 120.98 -1.075 . . . . 0.0 109.528 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.989 ' HA ' HG12 ' A' ' 51' ' ' VAL . 2.4 pt? -104.53 148.31 26.62 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.774 ' HA ' HG22 ' A' ' 17' ' ' THR 0.28 45.7 ttm105 -112.88 -55.47 2.52 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.605 -2.543 . . . . 0.0 115.291 -174.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -44.86 -21.11 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.659 0 CA-C-N 120.6 1.545 . . . . 0.0 115.019 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 85.64 -31.93 3.79 Favored Glycine 0 N--CA 1.426 -1.968 0 O-C-N 120.907 -1.121 . . . . 0.0 113.965 -175.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 m -121.03 69.43 0.89 Allowed 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -166.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.956 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -179.82 2.14 0.01 OUTLIER 'General case' 0 C--N 1.381 1.965 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 179.376 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.938 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -85.18 -34.94 21.97 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -171.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.602 ' CE2' HD22 ' A' ' 89' ' ' LEU . 13.8 m-90 -72.4 -28.39 62.95 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-O 122.287 1.041 . . . . 0.0 110.343 -175.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.422 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 44.1 tt0 -69.03 -43.29 75.03 Favored 'General case' 0 C--O 1.258 1.552 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.55 171.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.502 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 84.2 mt -56.66 -42.15 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.109 0 CA-C-O 121.695 0.76 . . . . 0.0 109.787 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.688 ' HE2' ' HB ' ' A' ' 87' ' ' VAL . 52.7 tttm -56.49 -51.43 68.52 Favored 'General case' 0 C--O 1.282 2.802 0 C-N-CA 124.79 1.236 . . . . 0.0 109.707 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -55.15 -47.37 75.22 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.561 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 11.4 m-85 -53.55 -59.44 4.59 Favored 'General case' 0 C--N 1.366 1.292 0 O-C-N 123.872 0.733 . . . . 0.0 109.353 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.644 HD13 ' CE3' ' A' ' 40' ' ' TRP . 16.4 mt -52.89 -53.37 50.15 Favored 'General case' 0 C--O 1.3 3.732 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -172.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.478 ' HB ' ' CB ' ' A' ' 84' ' ' CYS 0.308 27.8 m -75.8 -9.38 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.198 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.873 -177.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.2 m -100.23 2.32 42.68 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.599 166.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 69.9 mm-40 -91.04 -40.89 11.38 Favored 'General case' 0 CA--C 1.439 -3.309 0 C-N-CA 118.909 -1.117 . . . . 0.0 109.519 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.412 35.6 t70 -155.91 -90.72 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.621 ' HB2' HG22 ' A' ' 24' ' ' VAL . 31.8 mmt180 -102.09 144.24 30.91 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 120.747 1.612 . . . . 0.0 110.559 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.478 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 10.6 p -140.59 135.64 31.98 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.672 ' HB2' ' OG ' ' A' ' 25' ' ' SER . . . -149.85 -51.67 0.15 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.077 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 32.9 tt0 -154.75 116.52 4.14 Favored 'General case' 0 C--O 1.181 -2.517 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.538 -173.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.688 ' HB ' ' HE2' ' A' ' 75' ' ' LYS . 14.2 t -111.4 102.21 13.64 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.7 p -109.84 125.19 52.5 Favored 'General case' 0 CA--C 1.473 -1.994 0 C-N-CA 117.619 -1.632 . . . . 0.0 112.023 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.915 HD23 ' HE2' ' A' ' 20' ' ' MET . 4.1 mp . . . . . 1 N--CA 1.371 -4.41 0 CA-C-N 112.257 -2.247 . . . . 0.0 107.667 -176.02 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.0 tptt . . . . . 0 C--O 1.205 -1.26 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 93.0 m -65.46 117.93 8.68 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.937 ' HG ' ' HH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -126.65 111.91 14.86 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.627 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 21.9 ptm -94.9 114.97 26.88 Favored 'General case' 0 C--N 1.277 -2.558 0 O-C-N 121.112 -0.992 . . . . 0.0 109.401 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.564 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 29.8 ttm -97.66 119.21 35.83 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.107 -176.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.436 ' HA ' HG22 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -107.02 119.17 38.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.022 1.729 . . . . 0.0 106.758 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.677 HG21 HG21 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -127.54 128.53 69.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -175.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.888 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 48.8 m -85.97 142.39 28.83 Favored 'General case' 0 CA--C 1.6 2.892 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.382 176.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 83' ' ' ARG 0.283 42.0 t -132.27 140.51 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 C-N-CA 125.414 1.486 . . . . 0.0 108.687 -170.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.526 20.8 t -109.55 -110.34 0.33 Allowed 'General case' 0 C--N 1.369 1.45 0 CA-C-N 122.957 2.617 . . . . 0.0 113.523 168.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.641 ' HA3' ' HG3' ' A' ' 83' ' ' ARG . . . 63.05 -72.34 0.03 OUTLIER Glycine 0 CA--C 1.543 1.827 0 CA-C-N 120.802 1.637 . . . . 0.0 112.402 -173.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.774 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 55.4 t30 -116.76 132.44 23.39 Favored Pre-proline 0 N--CA 1.416 -2.143 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 176.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -91.75 41.76 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.557 1.505 . . . . 0.0 113.298 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.5 p -125.18 -129.73 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 117.828 -1.549 . . . . 0.0 111.141 -173.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.543 ' O ' ' HB ' ' A' ' 33' ' ' THR . 31.2 tt0 -133.76 11.83 4.02 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 171.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.554 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 8.9 tmtt? -86.13 -36.95 19.26 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 122.231 1.015 . . . . 0.0 108.337 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.793 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -65.98 -46.07 79.37 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 175.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.543 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 58.8 m -45.28 -54.35 7.19 Favored 'General case' 0 C--O 1.193 -1.87 0 C-N-CA 125.696 1.598 . . . . 0.0 111.655 170.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.554 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.9 pt-20 -63.6 -49.72 72.23 Favored 'General case' 0 C--O 1.257 1.46 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -59.14 -55.66 32.09 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.749 1.261 . . . . 0.0 108.265 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.793 ' HB ' ' O ' ' A' ' 32' ' ' GLU . 3.1 mt -62.41 -42.81 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.123 0 CA-C-N 112.997 -1.911 . . . . 0.0 112.529 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.736 HG21 HG12 ' A' ' 55' ' ' ILE . 17.9 p -70.98 -39.56 72.41 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 120.819 1.645 . . . . 0.0 111.703 -176.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.8 p -63.27 -52.5 61.8 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.922 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.7 tp -63.7 -45.56 89.45 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.089 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.812 ' CD2' HD12 ' A' ' 78' ' ' LEU . 45.3 m0 -63.26 -74.52 0.09 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 119.364 -0.351 . . . . 0.0 111.52 -178.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.81 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.311 0.0 OUTLIER -71.06 -19.87 62.43 Favored 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.896 -1.122 . . . . 0.0 112.501 -172.279 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.45 -51.53 53.72 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 173.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.3 p -68.7 -30.92 69.68 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.261 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.774 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 33.5 mt -58.66 -37.16 75.37 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.319 177.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.689 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 64.1 t80 -85.64 -32.56 21.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.873 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.41 -37.4 86.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.4 2.03 51.63 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.123 0.487 . . . . 0.0 110.626 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.3 t30 58.99 51.8 6.9 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.951 1.3 . . . . 0.0 112.116 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -84.34 37.09 0.61 Allowed 'General case' 0 CA--C 1.558 1.258 0 O-C-N 120.903 -1.123 . . . . 0.0 113.473 175.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.2 t70 27.1 71.02 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 C-N-CA 126.397 1.879 . . . . 0.0 114.087 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 65' ' ' LEU . 1.3 m -147.66 169.57 3.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.329 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.501 ' O ' ' HB3' ' A' ' 64' ' ' MET . 0.5 OUTLIER -122.12 126.26 47.98 Favored 'General case' 0 C--O 1.189 -2.107 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 175.03 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.81 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -133.29 135.8 45.09 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -173.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.736 ' H ' HG12 ' A' ' 62' ' ' ILE . 44.5 t80 -135.4 151.55 50.57 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 119.245 -0.982 . . . . 0.0 113.208 -164.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.736 HG12 HG21 ' A' ' 37' ' ' THR . 43.2 mt -87.01 96.86 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 172.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 m -89.51 -32.28 5.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -163.3 167.68 37.68 Favored Glycine 0 CA--C 1.489 -1.573 0 C-N-CA 117.402 -2.333 . . . . 0.0 114.663 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -70.69 104.12 2.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 0.1 OUTLIER 91.99 18.73 0.03 OUTLIER 'General case' 0 C--N 1.36 1.027 0 C-N-CA 128.378 2.671 . . . . 0.0 110.101 -177.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.564 ' CG ' ' HA ' ' A' ' 23' ' ' THR . 17.8 mtm180 -146.07 132.0 19.17 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.53 165.36 25.07 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.251 -173.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.736 HG12 ' H ' ' A' ' 54' ' ' PHE . 6.0 pt -140.64 158.8 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.414 0 C-N-CA 118.283 -1.367 . . . . 0.0 110.634 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.501 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 1.1 p90 -133.81 106.72 7.47 Favored 'General case' 0 N--CA 1.423 -1.785 0 O-C-N 126.31 2.256 . . . . 0.0 108.065 162.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.627 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 1.2 tmt? -83.8 112.75 20.38 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 113.022 -1.899 . . . . 0.0 107.66 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.86 HD13 ' HB2' ' A' ' 71' ' ' ALA 0.329 2.3 pt? -109.26 147.73 32.15 Favored 'General case' 0 CA--C 1.468 -2.207 0 CA-C-O 123.487 1.613 . . . . 0.0 114.988 -177.183 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -100.82 -53.14 3.13 Favored 'General case' 0 C--N 1.252 -3.673 0 CA-C-N 110.365 -3.107 . . . . 0.0 112.539 -174.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.435 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 16.1 t70 -39.8 -24.85 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 114.725 1.379 . . . . 0.0 114.725 165.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.67 -34.19 0.71 Allowed Glycine 0 C--O 1.202 -1.901 0 C-N-CA 123.842 0.734 . . . . 0.0 114.761 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 15.2 p -96.96 -49.1 5.16 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 119.493 3.145 . . . . 0.0 119.493 -173.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.435 ' CE1' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -65.46 10.14 0.1 Allowed 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -172.21 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.86 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -84.71 -23.14 29.47 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 121.156 -0.965 . . . . 0.0 113.15 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.937 ' HH2' ' HG ' ' A' ' 18' ' ' LEU . 5.8 m-90 -67.63 -41.14 84.36 Favored 'General case' 0 C--O 1.277 2.547 0 CA-C-O 121.857 0.837 . . . . 0.0 111.035 -176.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 42.9 tt0 -67.21 -44.82 78.59 Favored 'General case' 0 C--O 1.295 3.461 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.616 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 90.5 mt -51.32 -49.75 29.9 Favored 'Isoleucine or valine' 0 C--O 1.281 2.762 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.719 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.533 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 21.2 pttp -63.57 -40.03 95.91 Favored 'General case' 0 C--N 1.383 2.063 0 CA-C-O 121.586 0.708 . . . . 0.0 110.522 -174.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.59 -34.41 72.7 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.496 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.616 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 21.6 m-85 -69.68 -69.61 0.33 Allowed 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -172.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.812 HD12 ' CD2' ' A' ' 40' ' ' TRP . 2.4 pt? -64.33 -34.71 78.78 Favored 'General case' 0 C--O 1.272 2.246 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.704 -167.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.677 HG21 HG21 ' A' ' 22' ' ' VAL . 34.6 t -83.63 -25.05 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 C-N-CA 117.903 -1.519 . . . . 0.0 109.304 -172.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.8 m -96.16 7.84 45.39 Favored 'General case' 0 N--CA 1.407 -2.615 0 C-N-CA 117.673 -1.611 . . . . 0.0 108.562 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.835 ' HA ' HE21 ' A' ' 81' ' ' GLN . 0.0 OUTLIER -91.12 -52.63 4.73 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.094 -178.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.451 ' OD1' ' HG2' ' A' ' 83' ' ' ARG 0.388 9.2 t70 -110.9 -95.13 0.43 Allowed 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.045 -1.062 . . . . 0.0 112.192 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.641 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 52.9 mmt-85 -112.98 152.86 28.91 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 121.425 1.921 . . . . 0.0 111.49 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.632 ' HB3' ' O ' ' A' ' 79' ' ' VAL . 13.0 p -138.03 160.67 38.75 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.011 -172.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.79 -54.39 0.02 OUTLIER 'General case' 0 C--N 1.379 1.865 0 C-N-CA 124.133 0.973 . . . . 0.0 113.001 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.888 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 34.8 tt0 -155.66 131.01 9.55 Favored 'General case' 0 C--O 1.208 -1.119 0 O-C-N 121.874 -0.516 . . . . 0.0 110.946 -170.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' A' ' 22' ' ' VAL . 16.0 m -115.01 115.28 49.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.222 172.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.495 ' C ' HD12 ' A' ' 89' ' ' LEU 0.28 32.2 p -112.28 123.91 51.3 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 123.207 1.479 . . . . 0.0 112.022 172.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.608 ' HB3' HD11 ' A' ' 18' ' ' LEU . 6.0 mp . . . . . 0 N--CA 1.39 -3.44 0 CA-C-N 113.091 -1.868 . . . . 0.0 110.271 -170.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.2 tptt . . . . . 0 N--CA 1.437 -1.123 0 CA-C-O 120.57 0.224 . . . . 0.0 110.633 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 p -117.33 121.46 41.2 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.742 HD11 ' C ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -134.59 108.14 7.89 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -173.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.1 ptm -84.1 100.95 11.45 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.548 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 0.3 OUTLIER -88.79 138.69 31.18 Favored 'General case' 0 C--O 1.25 1.123 0 C-N-CA 117.029 -1.868 . . . . 0.0 111.043 -171.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -109.52 113.45 26.25 Favored 'General case' 0 C--O 1.267 2.013 0 O-C-N 125.245 1.59 . . . . 0.0 108.723 -174.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -117.44 123.86 72.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.77 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.083 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 92.3 m -98.12 133.99 41.8 Favored 'General case' 0 CA--C 1.608 3.197 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.138 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.883 HG11 HD11 ' A' ' 36' ' ' ILE . 91.1 t -130.95 101.47 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.401 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 2.6 t -118.92 7.05 11.41 Favored 'General case' 0 C--N 1.361 1.108 0 CA-C-N 122.286 2.312 . . . . 0.0 114.042 -166.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.45 -46.21 52.87 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 174.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 1.076 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 16.4 t-20 -115.21 104.11 53.93 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 167.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 2.7 Cg_endo -82.23 24.52 0.71 Allowed 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 123.52 2.813 . . . . 0.0 113.351 -173.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.455 ' C ' ' HB3' ' A' ' 58' ' ' SER . 6.9 p -125.12 -162.51 1.11 Allowed 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.295 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -73.61 -29.22 62.25 Favored 'General case' 0 C--O 1.194 -1.844 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.617 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -59.56 -48.09 83.03 Favored 'General case' 0 C--O 1.263 1.768 0 CA-C-N 119.167 0.894 . . . . 0.0 112.726 -171.133 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 1.076 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 2.8 tp10 -64.01 -49.36 72.74 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.5 m -52.1 -46.06 65.12 Favored 'General case' 0 C--O 1.192 -1.93 0 CA-C-N 113.445 -1.707 . . . . 0.0 111.351 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.617 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 16.3 pt-20 -75.99 -31.32 58.92 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -75.55 -47.36 27.11 Favored 'General case' 0 C--O 1.279 2.651 0 N-CA-C 101.238 -3.616 . . . . 0.0 101.238 -174.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.883 HD11 HG11 ' A' ' 24' ' ' VAL 1.532 1.5 pp -57.19 -57.31 10.47 Favored 'Isoleucine or valine' 1 N--CA 1.309 -7.487 0 N-CA-C 120.917 3.673 . . . . 0.0 120.917 175.159 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.545 ' HA ' ' HB2' ' A' ' 40' ' ' TRP . 39.6 p -67.84 -31.42 71.24 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 t -64.85 -46.54 81.45 Favored 'General case' 0 N--CA 1.424 -1.737 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.074 176.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.7 mt -67.76 -46.29 72.46 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.901 178.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.729 ' HB3' ' NH1' ' A' ' 53' ' ' ARG . 37.8 m0 -57.3 -67.72 0.3 Allowed 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.943 -1.481 . . . . 0.0 114.837 -175.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.441 ' O ' ' HD1' ' A' ' 45' ' ' PHE 0.331 0.0 OUTLIER -78.9 -17.5 55.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 117.102 -1.839 . . . . 0.0 110.677 -176.513 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.95 -59.43 9.38 Favored Glycine 0 CA--C 1.472 -2.596 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 170.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.3 m -74.79 -36.85 62.49 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-N 113.245 -1.478 . . . . 0.0 112.496 -175.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.955 HD12 ' HD2' ' A' ' 53' ' ' ARG . 12.7 mt -61.1 -33.54 73.52 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.209 178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.441 ' HD1' ' O ' ' A' ' 41' ' ' GLN . 53.0 m-85 -87.11 -32.18 20.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.348 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -70.19 -29.98 66.98 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.12 8.4 15.67 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.079 0.466 . . . . 0.0 110.898 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 t30 67.38 52.21 0.83 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.176 1.391 . . . . 0.0 113.538 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -100.59 154.34 18.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.35 -1.469 . . . . 0.0 107.852 170.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.519 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 30.2 t70 -92.54 83.62 4.95 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 120.02 1.282 . . . . 0.0 109.407 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.77 174.36 12.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.205 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 0.9 OUTLIER -134.22 140.2 46.32 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 169.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 1.012 ' HG2' ' HA ' ' A' ' 63' ' ' PHE . 35.7 mtp180 -142.91 139.55 30.82 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 118.958 0.799 . . . . 0.0 109.735 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.671 ' H ' HG12 ' A' ' 62' ' ' ILE . 50.1 m-85 -132.33 151.38 51.87 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.044 -1.462 . . . . 0.0 114.099 -169.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 57.8 mt -99.19 96.41 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 170.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 60' ' ' ARG . 4.7 m -98.16 -23.14 4.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.048 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.94 161.57 35.39 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 118.524 -1.798 . . . . 0.0 112.159 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.455 ' HB3' ' C ' ' A' ' 29' ' ' THR . 51.1 m -75.64 106.48 7.23 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.498 ' O ' ' HD2' ' A' ' 60' ' ' ARG 0.271 0.0 OUTLIER 98.42 5.04 0.02 OUTLIER 'General case' 0 C--N 1.366 1.283 0 C-N-CA 127.0 2.12 . . . . 0.0 110.188 -174.167 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.498 ' HD2' ' O ' ' A' ' 59' ' ' ASP . 5.8 mpt_? -134.11 123.04 23.77 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.95 0.9 . . . . 0.0 112.131 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.09 168.18 17.16 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.671 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -141.16 153.24 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.45 -2.878 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.954 172.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.012 ' HA ' ' HG2' ' A' ' 53' ' ' ARG 0.27 31.2 p90 -129.45 108.62 10.41 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 127.114 2.759 . . . . 0.0 108.665 163.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.464 ' HB3' ' HB2' ' A' ' 52' ' ' GLN . 26.5 ttt -92.42 119.75 32.25 Favored 'General case' 0 C--O 1.27 2.158 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.643 HD22 ' CB ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -81.65 122.06 27.14 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 128.956 2.902 . . . . 0.0 110.161 178.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.519 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.253 23.6 ttt180 -105.44 -49.5 3.42 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 172.091 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . 0.445 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 25.9 t70 -75.87 50.88 0.6 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.079 1.309 . . . . 0.0 112.777 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.58 -34.66 0.02 OUTLIER Glycine 0 CA--C 1.55 2.233 0 N-CA-C 120.991 3.157 . . . . 0.0 120.991 173.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 62.0 m -163.07 51.65 0.17 Allowed 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 120.189 1.995 . . . . 0.0 116.384 -171.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.499 ' HE1' ' HA ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -122.01 13.83 10.6 Favored 'General case' 0 C--O 1.213 -0.849 0 O-C-N 120.286 -1.508 . . . . 0.0 112.306 177.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.928 ' HA ' HD12 ' A' ' 74' ' ' ILE . . . -102.14 -12.94 17.69 Favored 'General case' 0 C--O 1.197 -1.661 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -169.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.575 ' CE3' HD13 ' A' ' 89' ' ' LEU . 8.5 m95 -84.85 -31.0 24.02 Favored 'General case' 0 C--N 1.27 -2.872 0 O-C-N 120.536 -1.353 . . . . 0.0 109.102 -166.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 77' ' ' PHE . 18.5 tp10 -75.11 -33.81 61.64 Favored 'General case' 0 C--O 1.257 1.464 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.928 HD12 ' HA ' ' A' ' 71' ' ' ALA . 54.2 mt -59.01 -39.73 79.01 Favored 'Isoleucine or valine' 0 C--O 1.264 1.855 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.004 175.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.863 ' HD2' HD11 ' A' ' 89' ' ' LEU . 32.9 tttm -57.05 -53.21 60.62 Favored 'General case' 0 C--O 1.275 2.447 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.267 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -55.08 -46.94 75.49 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.821 1.326 . . . . 0.0 112.284 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.45 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 13.0 m-85 -56.74 -55.91 28.13 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.559 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.651 HD22 ' NE1' ' A' ' 40' ' ' TRP . 9.5 mt -58.53 -48.55 80.48 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 75' ' ' LYS 0.281 18.3 m -78.99 -6.26 9.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 116.558 -2.057 . . . . 0.0 113.136 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.0 m -106.68 4.02 27.37 Favored 'General case' 0 N--CA 1.423 -1.777 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.698 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -118.45 -25.02 6.62 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 117.374 -1.731 . . . . 0.0 111.149 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -139.73 -164.1 1.62 Allowed 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.711 ' HB3' HG13 ' A' ' 24' ' ' VAL . 23.2 tpp180 -60.56 136.15 57.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 118.858 0.754 . . . . 0.0 111.009 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 18.2 p -130.57 146.21 52.04 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -174.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.29 -38.62 0.09 Allowed 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 122.71 0.404 . . . . 0.0 111.157 170.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.083 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 39.9 tt0 -153.24 129.0 10.13 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.745 -176.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.16 92.68 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.3 p -116.78 111.34 19.61 Favored 'General case' 0 C--O 1.257 1.487 0 CA-C-O 121.926 0.869 . . . . 0.0 110.816 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.863 HD11 ' HD2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.408 -2.539 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.9 tptp . . . . . 0 N--CA 1.437 -1.086 0 CA-C-O 120.796 0.332 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.9 p -65.59 114.49 4.96 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.381 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.663 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -128.02 108.21 10.48 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.471 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 25.1 ptm -93.6 108.8 20.47 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.825 ' HB2' ' HA ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -106.93 143.09 35.52 Favored 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 116.703 -1.999 . . . . 0.0 112.742 -173.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.476 ' CE2' ' HD3' ' A' ' 60' ' ' ARG . 1.1 t80 -114.91 114.72 25.85 Favored 'General case' 0 C--O 1.26 1.609 0 C-N-CA 128.079 2.552 . . . . 0.0 109.863 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.745 HG23 ' SD ' ' A' ' 20' ' ' MET . 3.6 t -104.0 131.65 52.25 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.33 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 1.03 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 97.7 m -99.83 129.76 45.96 Favored 'General case' 0 CA--C 1.594 2.635 0 O-C-N 124.529 1.143 . . . . 0.0 108.375 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 59' ' ' ASP 0.295 93.5 t -122.38 101.82 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 C-N-CA 127.029 2.132 . . . . 0.0 106.8 -171.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -115.08 -1.01 13.14 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 122.471 2.396 . . . . 0.0 115.105 -168.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.749 ' HA3' ' HD2' ' A' ' 83' ' ' ARG . . . -56.51 -48.17 78.36 Favored Glycine 0 N--CA 1.474 1.226 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 4.9 t30 -115.75 116.67 40.67 Favored Pre-proline 0 N--CA 1.401 -2.878 0 N-CA-C 100.447 -3.909 . . . . 0.0 100.447 169.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -106.18 34.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.306 2.004 . . . . 0.0 111.305 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -129.5 54.5 1.82 Allowed 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 118.116 -1.434 . . . . 0.0 114.849 -168.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' ' HB ' ' A' ' 33' ' ' THR . 35.9 mt-10 59.92 -21.13 0.03 OUTLIER 'General case' 0 C--N 1.377 1.796 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 178.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.525 ' C ' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -69.68 -41.93 74.79 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.656 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 1.2 pm0 -68.31 -41.62 80.59 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 90.9 m -48.19 -53.08 18.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.15 0.98 . . . . 0.0 110.517 174.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.6 -49.12 57.06 Favored 'General case' 0 C--O 1.259 1.558 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -49.73 -60.0 3.29 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.232 1.413 . . . . 0.0 107.836 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.839 HG23 ' CE3' ' A' ' 40' ' ' TRP . 22.3 mt -64.76 -44.56 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.035 0 CA-C-N 112.135 -2.302 . . . . 0.0 113.01 -175.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.836 HG21 HG12 ' A' ' 55' ' ' ILE . 22.4 p -66.83 -48.86 67.6 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 117.87 -1.532 . . . . 0.0 111.826 -176.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.0 p -63.29 -57.2 11.2 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.592 0.557 . . . . 0.0 111.463 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.3 tp -67.18 -39.35 86.39 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.868 ' CE3' HD13 ' A' ' 78' ' ' LEU . 46.1 m0 -79.96 -48.6 13.12 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -174.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.453 ' O ' ' HD1' ' A' ' 45' ' ' PHE 0.286 0.0 OUTLIER -72.61 -23.42 60.94 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 116.686 -2.006 . . . . 0.0 109.857 178.828 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.59 -51.44 57.59 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 173.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 10.5 p -66.75 -38.95 87.64 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.052 HD12 ' HD2' ' A' ' 53' ' ' ARG . 19.3 mt -60.17 -35.57 75.65 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 177.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.453 ' HD1' ' O ' ' A' ' 41' ' ' GLN . 35.1 m-85 -85.81 -25.22 26.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.242 0.544 . . . . 0.0 110.521 176.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.4 t-20 -68.39 -31.84 71.48 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.372 0.669 . . . . 0.0 111.681 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.45 2.66 49.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.241 0.543 . . . . 0.0 110.307 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.7 t30 57.16 60.7 2.84 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.028 1.331 . . . . 0.0 114.238 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -100.32 167.82 10.17 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 166.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -97.8 100.8 12.18 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 120.22 1.373 . . . . 0.0 108.348 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 m -146.13 176.92 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.243 -171.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 22.9 mt-30 -140.58 145.5 36.81 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 173.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 1.052 ' HD2' HD12 ' A' ' 44' ' ' LEU . 21.6 mtp180 -143.53 144.14 31.84 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 118.943 0.792 . . . . 0.0 111.233 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.668 ' H ' HG12 ' A' ' 62' ' ' ILE . 80.7 m-85 -133.68 151.75 51.72 Favored 'General case' 0 C--O 1.261 1.661 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -170.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.836 HG12 HG21 ' A' ' 37' ' ' THR . 17.4 mt -92.56 102.86 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 167.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.714 HG23 ' HD2' ' A' ' 60' ' ' ARG . 6.9 m -112.51 -27.41 2.77 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.784 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.95 161.38 31.89 Favored Glycine 0 N--CA 1.419 -2.492 0 C-N-CA 118.158 -1.972 . . . . 0.0 113.681 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 m -64.4 125.17 23.79 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.641 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 p30 68.22 21.61 8.47 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 125.106 1.362 . . . . 0.0 109.556 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.714 ' HD2' HG23 ' A' ' 56' ' ' VAL . 1.1 tmm_? -153.6 119.77 5.44 Favored 'General case' 0 CA--C 1.583 2.215 0 CA-C-O 122.278 1.037 . . . . 0.0 113.327 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.29 168.75 13.08 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.527 1.131 . . . . 0.0 109.066 -171.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 20' ' ' MET . 0.2 OUTLIER -134.6 156.79 40.7 Favored 'Isoleucine or valine' 0 C--O 1.283 2.861 0 C-N-CA 117.474 -1.69 . . . . 0.0 110.993 175.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.017 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 49.0 p90 -123.24 109.82 14.44 Favored 'General case' 0 N--CA 1.422 -1.845 0 O-C-N 127.507 3.005 . . . . 0.0 107.309 163.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.642 ' HB2' HD11 ' A' ' 62' ' ' ILE . 23.7 ttt -95.87 110.81 22.93 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.303 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.843 ' HG ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -113.3 147.42 37.64 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -171.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.284 30.6 ttm180 -111.78 -58.51 2.11 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -176.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -44.46 -19.99 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.22 -9.13 3.32 Favored Glycine 0 C--N 1.358 1.767 0 CA-C-N 119.717 1.144 . . . . 0.0 114.903 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -117.05 32.46 6.15 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.301 1.051 . . . . 0.0 113.696 -168.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -166.68 12.98 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.606 -171.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.843 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -97.22 -37.77 9.95 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -166.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.612 ' CE2' HD22 ' A' ' 89' ' ' LEU . 9.0 m-90 -76.0 -27.53 57.45 Favored 'General case' 0 C--O 1.273 2.331 0 O-C-N 120.895 -1.128 . . . . 0.0 110.636 -174.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -63.62 -35.22 79.79 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 113.835 -1.529 . . . . 0.0 107.722 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.818 HD12 ' HA ' ' A' ' 71' ' ' ALA . 26.3 mt -67.58 -45.2 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.154 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HB2' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -57.71 -41.69 82.25 Favored 'General case' 0 C--O 1.283 2.851 0 CA-C-O 121.907 0.861 . . . . 0.0 109.387 -174.022 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.495 ' N ' ' HD2' ' A' ' 75' ' ' LYS . 17.1 t70 -61.46 -50.01 74.51 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 112.826 -1.988 . . . . 0.0 111.649 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.424 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 14.8 m-85 -62.09 -48.3 80.82 Favored 'General case' 0 C--O 1.197 -1.696 0 C-N-CA 118.47 -1.292 . . . . 0.0 110.383 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.868 HD13 ' CE3' ' A' ' 40' ' ' TRP . 4.3 mt -55.57 -54.5 43.3 Favored 'General case' 0 C--O 1.296 3.504 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.677 ' O ' ' HB3' ' A' ' 84' ' ' CYS 0.354 30.0 m -72.62 -19.1 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 C-N-CA 115.935 -2.306 . . . . 0.0 112.574 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.3 m -85.96 -4.3 59.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.148 171.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 21.7 mm-40 -90.43 -32.27 16.48 Favored 'General case' 0 CA--C 1.453 -2.78 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.073 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.507 ' OD2' ' HG2' ' A' ' 83' ' ' ARG 0.44 21.7 t70 -147.31 -94.58 0.09 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 116.913 -1.915 . . . . 0.0 114.628 -178.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.749 ' HD2' ' HA3' ' A' ' 26' ' ' GLY . 10.8 mmt180 -105.38 126.74 52.46 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 121.191 1.814 . . . . 0.0 109.264 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 0.677 ' HB3' ' O ' ' A' ' 79' ' ' VAL . 22.2 p -111.46 97.09 6.5 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -176.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.75 -42.37 2.42 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 1.03 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 37.2 tt0 -153.61 125.2 7.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 118.034 -1.466 . . . . 0.0 112.781 -174.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.579 HG12 HG22 ' A' ' 22' ' ' VAL . 2.9 m -112.75 93.44 2.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 p -105.44 99.4 9.01 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 118.413 -1.315 . . . . 0.0 112.208 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.825 ' HA ' ' HB2' ' A' ' 20' ' ' MET . 5.4 mp . . . . . 0 N--CA 1.384 -3.73 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.545 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.6 tptt . . . . . 0 N--CA 1.438 -1.042 0 CA-C-O 120.497 0.189 . . . . 0.0 110.758 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 6.3 m -85.58 111.36 19.97 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.835 ' HB3' HD21 ' A' ' 65' ' ' LEU . 21.8 tp -133.2 116.02 15.71 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -174.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.669 ' O ' HD21 ' A' ' 89' ' ' LEU . 19.6 ptm -83.56 103.13 12.64 Favored 'General case' 0 C--O 1.207 -1.171 0 O-C-N 121.502 -0.749 . . . . 0.0 112.792 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.623 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 12.3 mtm -84.56 126.01 32.94 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -174.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -108.8 115.0 29.25 Favored 'General case' 0 N--CA 1.432 -1.34 0 O-C-N 125.618 1.824 . . . . 0.0 108.606 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -115.25 125.52 72.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.485 -176.402 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.823 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 30.2 m -90.85 110.62 21.84 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 113.638 -1.619 . . . . 0.0 107.365 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 84' ' ' CYS . 75.5 t -103.77 92.55 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.341 0 CA-C-N 120.373 1.442 . . . . 0.0 109.145 -176.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 m -93.38 96.5 9.98 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 120.755 1.616 . . . . 0.0 110.292 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.21 -50.08 0.02 OUTLIER Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -116.47 106.12 49.16 Favored Pre-proline 0 CA--C 1.493 -1.212 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.58 42.44 0.27 Allowed 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 123.93 3.086 . . . . 0.0 114.111 -171.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.6 p -147.0 -176.5 5.23 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' HB ' ' A' ' 33' ' ' THR . 48.8 mt-10 -85.81 10.32 14.06 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 118.831 0.741 . . . . 0.0 110.225 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -77.74 -34.43 52.55 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.588 ' HG2' HD12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -71.26 -40.84 70.73 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.318 -0.953 . . . . 0.0 108.493 177.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 29.0 m -49.87 -55.63 13.58 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 125.866 1.666 . . . . 0.0 110.807 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.1 pt-20 -67.5 -43.95 79.66 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.867 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -50.71 -62.56 1.53 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 123.075 1.416 . . . . 0.0 107.474 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.87 HG23 ' CE3' ' A' ' 40' ' ' TRP . 25.0 mt -61.71 -44.38 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 112.067 -2.333 . . . . 0.0 112.981 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.812 HG21 HG12 ' A' ' 55' ' ' ILE . 25.1 p -68.28 -52.93 28.2 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.913 -175.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.4 p -62.79 -56.68 15.3 Favored 'General case' 0 C--O 1.256 1.432 0 O-C-N 123.618 0.574 . . . . 0.0 111.621 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.87 -49.6 74.22 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.87 ' CE3' HG23 ' A' ' 36' ' ' ILE . 50.8 m0 -75.14 -47.25 29.44 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -173.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.298 0.0 OUTLIER -73.98 -19.47 60.64 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 116.608 -2.037 . . . . 0.0 109.816 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.99 -52.87 49.61 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 170.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.521 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 9.6 p -69.73 -34.51 73.96 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 117.099 0.449 . . . . 0.0 112.01 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.986 HD12 ' HD2' ' A' ' 53' ' ' ARG . 9.2 mt -61.06 -35.28 76.53 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -87.99 -22.31 24.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.358 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 16.1 t-20 -65.53 -34.22 77.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.653 0.263 . . . . 0.0 110.984 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.99 5.05 27.13 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.411 0.624 . . . . 0.0 109.863 175.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 t30 51.77 45.4 28.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.342 1.857 . . . . 0.0 113.673 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -80.09 165.87 22.07 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -98.25 94.53 6.83 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 120.359 1.436 . . . . 0.0 108.656 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 m -135.12 173.09 14.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.592 -171.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -138.43 123.93 19.56 Favored 'General case' 0 C--O 1.196 -1.721 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 1.131 ' HG2' ' HA ' ' A' ' 63' ' ' PHE . 16.8 mtp180 -120.43 142.03 49.6 Favored 'General case' 0 C--N 1.268 -2.947 0 O-C-N 121.235 -0.915 . . . . 0.0 110.998 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.659 ' H ' HG12 ' A' ' 62' ' ' ILE . 41.1 m-85 -129.57 152.14 49.41 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -170.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.812 HG12 HG21 ' A' ' 37' ' ' THR . 29.8 mt -94.8 109.44 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.591 HG23 ' HB3' ' A' ' 60' ' ' ARG . 3.7 m -112.07 -16.19 9.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -175.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 161.97 177.12 34.75 Favored Glycine 0 CA--C 1.482 -2.022 0 C-N-CA 117.477 -2.297 . . . . 0.0 114.262 169.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.529 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 37.6 t -66.14 116.65 7.44 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.537 ' C ' ' HD2' ' A' ' 60' ' ' ARG . 0.2 OUTLIER 85.98 9.39 0.28 Allowed 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 125.41 1.484 . . . . 0.0 109.058 -178.378 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.591 ' HB3' HG23 ' A' ' 56' ' ' VAL . 3.8 mpt_? -138.68 124.26 19.57 Favored 'General case' 0 C--O 1.255 1.387 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.89 162.24 32.97 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.659 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -137.56 154.45 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.044 0 C-N-CA 117.969 -1.493 . . . . 0.0 111.545 174.08 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 1.131 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -126.65 112.65 15.71 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.223 2.827 . . . . 0.0 107.76 162.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.439 ' HB2' HD11 ' A' ' 62' ' ' ILE . 43.4 ttm -95.42 125.55 40.11 Favored 'General case' 0 C--O 1.258 1.544 0 O-C-N 121.332 -0.855 . . . . 0.0 109.805 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.835 HD21 ' HB3' ' A' ' 18' ' ' LEU . 1.2 pt? -102.2 144.62 30.51 Favored 'General case' 0 CA--C 1.494 -1.182 0 O-C-N 124.622 1.201 . . . . 0.0 110.669 -176.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.292 5.5 tmm_? -119.73 -49.22 2.34 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -46.78 -23.44 0.43 Allowed 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 171.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.42 -31.93 4.65 Favored Glycine 0 C--N 1.36 1.864 0 CA-C-N 120.231 1.378 . . . . 0.0 113.8 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.2 m -128.34 45.42 2.77 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -166.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.623 ' CE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -153.02 2.25 0.29 Allowed 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.239 -0.913 . . . . 0.0 112.562 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.728 ' HA ' HD12 ' A' ' 74' ' ' ILE . . . -94.52 -34.41 12.69 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 119.077 2.991 . . . . 0.0 119.077 -170.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TRP . . . . . 0.789 ' HD1' ' HD3' ' A' ' 75' ' ' LYS 0.512 9.3 m-90 -81.42 -16.81 50.99 Favored 'General case' 0 C--O 1.263 1.781 0 C-N-CA 116.494 -2.083 . . . . 0.0 114.85 -167.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -73.56 -29.73 62.61 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 168.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 71' ' ' ALA . 74.9 mt -61.23 -42.13 92.27 Favored 'Isoleucine or valine' 0 C--O 1.258 1.54 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.869 173.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.865 ' HB2' HG21 ' A' ' 87' ' ' VAL . 53.1 pttt -61.32 -41.45 97.04 Favored 'General case' 0 C--N 1.378 1.842 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.386 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.45 -52.02 65.0 Favored 'General case' 0 C--O 1.271 2.204 0 O-C-N 124.29 0.994 . . . . 0.0 110.582 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.471 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 8.0 m-85 -54.62 -47.54 73.32 Favored 'General case' 0 C--O 1.205 -1.288 0 O-C-N 123.553 0.533 . . . . 0.0 110.114 -178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . 0.79 HD13 ' CE3' ' A' ' 40' ' ' TRP . 10.3 mt -63.59 -51.58 64.69 Favored 'General case' 0 C--O 1.287 3.039 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -175.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 1.11 ' HA ' ' HB2' ' A' ' 84' ' ' CYS . 29.5 m -71.38 -6.6 7.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.547 0.689 . . . . 0.0 112.268 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 m -110.35 1.0 18.18 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.246 170.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 5.5 tp-100 -88.18 -36.99 16.5 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -177.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.486 10.5 t70 -142.37 -96.84 0.12 Allowed 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 117.954 2.575 . . . . 0.0 117.954 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -146.77 40.66 1.09 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' CYS . . . . . 1.11 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 55.5 m -79.45 12.03 2.68 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 111.158 -2.746 . . . . 0.0 115.669 -165.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . 0.314 . . 29.66 -58.99 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 173.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.823 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 6.2 tp10 -145.46 132.07 19.88 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 119.882 1.219 . . . . 0.0 111.676 -169.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.865 HG21 ' HB2' ' A' ' 75' ' ' LYS . 47.2 t -114.09 106.26 20.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 173.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.433 ' O ' HD23 ' A' ' 89' ' ' LEU . 14.3 p -118.98 146.98 44.55 Favored 'General case' 0 C--O 1.293 3.352 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.72 ' CD1' ' HG ' ' A' ' 18' ' ' LEU 0.758 2.7 mt . . . . . 0 N--CA 1.441 -0.879 0 N-CA-C 121.152 3.76 . . . . 0.0 121.152 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 0.14 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.27 -13.37 37.64 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 123.26 2.64 . . . . 0.0 113.161 -177.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -91.46 16.25 59.45 Favored Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 120.866 -0.683 . . . . 0.0 113.078 -177.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.429 ' HE2' ' OE2' ' A' ' 6' ' ' GLU . 26.1 pttm -73.27 134.2 80.34 Favored Pre-proline 0 C--N 1.317 -0.827 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.673 ' HG3' ' HA3' ' A' ' 96' ' ' GLY . 12.3 Cg_exo -70.11 95.18 0.57 Allowed 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.226 1.951 . . . . 0.0 112.599 -177.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.625 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 25.5 mm-40 -81.75 -22.83 37.02 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.78 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.434 ' HA ' ' HE2' ' A' ' 10' ' ' LYS . 5.5 p -53.64 -56.95 12.75 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 114.451 -1.25 . . . . 0.0 110.966 -179.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 pt -66.0 -41.75 90.34 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -175.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.66 HD12 ' HA ' ' A' ' 69' ' ' SER . 1.4 pt? -73.25 -37.35 66.37 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 117.852 -1.539 . . . . 0.0 111.553 -175.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.625 ' HG3' ' O ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -79.29 -27.02 42.23 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 118.116 -1.434 . . . . 0.0 112.17 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.418 ' N ' ' HD2' ' A' ' 10' ' ' LYS . 16.3 tpt -77.57 -33.12 54.09 Favored 'General case' 0 C--O 1.242 0.668 0 C-N-CA 121.074 -0.25 . . . . 0.0 111.091 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.8 m -81.56 -46.77 13.97 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.587 -0.845 . . . . 0.0 109.793 176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 22.2 pttp 45.93 -166.6 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 125.592 1.557 . . . . 0.0 113.838 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 53.8 tptt 64.81 23.96 12.74 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 123.793 0.837 . . . . 0.0 110.747 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 59.66 64.36 4.29 Favored Glycine 0 CA--C 1.558 2.763 0 C-N-CA 120.444 -0.884 . . . . 0.0 113.375 -177.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -82.82 123.49 29.41 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 119.496 1.648 . . . . 0.0 109.355 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 66' ' ' ARG . 8.0 m -67.44 116.77 8.55 Favored 'General case' 0 N--CA 1.423 -1.788 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.69 ' O ' HD13 ' A' ' 65' ' ' LEU . 1.0 OUTLIER -120.52 116.9 26.3 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 104.524 -2.399 . . . . 0.0 104.524 -177.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.44 ' HA ' ' HG3' ' A' ' 64' ' ' MET . 24.5 ptm -89.32 133.96 34.26 Favored 'General case' 0 C--N 1.28 -2.435 0 C-N-CA 119.014 -1.074 . . . . 0.0 108.271 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.438 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 8.0 ttm -123.58 121.71 36.3 Favored 'General case' 0 N--CA 1.405 -2.715 0 C-N-CA 116.246 -2.181 . . . . 0.0 112.944 179.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -94.54 126.16 39.64 Favored 'General case' 0 N--CA 1.42 -1.964 0 CA-C-N 113.08 -1.873 . . . . 0.0 106.226 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 61' ' ' ALA . 0.2 OUTLIER -120.83 130.55 74.49 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.474 0 CA-C-O 121.191 0.52 . . . . 0.0 110.071 -178.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.091 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 78.1 m -95.66 132.04 41.25 Favored 'General case' 0 N--CA 1.397 -3.093 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 172.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 1.026 HG23 ' HB2' ' A' ' 82' ' ' ASP . 2.5 p -131.41 127.83 60.42 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.077 0 N-CA-C 107.013 -1.477 . . . . 0.0 107.013 -172.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.549 ' HB3' ' OD2' ' A' ' 59' ' ' ASP . 15.5 p -142.69 33.01 1.43 Allowed 'General case' 0 C--O 1.241 0.65 0 CA-C-N 121.726 2.057 . . . . 0.0 115.356 -170.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -63.65 -34.76 90.8 Favored Glycine 0 C--O 1.219 -0.794 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 171.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.539 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 22.3 m-80 -118.13 122.69 30.13 Favored Pre-proline 0 N--CA 1.426 -1.67 0 N-CA-C 106.075 -1.824 . . . . 0.0 106.075 171.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.67 28.89 0.41 Allowed 'Trans proline' 0 CA--C 1.552 1.385 0 C-N-CA 122.763 2.308 . . . . 0.0 112.792 -177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 40.0 p -137.78 -157.13 0.75 Allowed 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.462 ' O ' ' HB ' ' A' ' 33' ' ' THR . 39.9 mt-10 -87.99 5.2 41.95 Favored 'General case' 0 C--O 1.207 -1.156 0 CA-C-O 119.263 -0.398 . . . . 0.0 111.384 175.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.582 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 5.7 tmtt? -70.92 -38.77 72.95 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.361 -178.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.606 ' HG3' HD13 ' A' ' 36' ' ' ILE . 6.2 tp10 -74.25 -41.04 61.93 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 178.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 96.5 m -44.6 -59.37 2.5 Favored 'General case' 0 C--O 1.204 -1.296 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.181 170.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.582 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.2 pt-20 -61.43 -45.7 93.2 Favored 'General case' 0 C--O 1.25 1.107 0 C-N-CA 122.935 0.494 . . . . 0.0 112.082 -177.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -52.91 -59.03 5.03 Favored 'General case' 0 C--O 1.254 1.317 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.728 HG23 ' CE3' ' A' ' 40' ' ' TRP . 2.0 mp -67.17 -46.18 84.84 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.735 0 CA-C-N 114.53 -1.213 . . . . 0.0 113.352 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.687 HG21 HG12 ' A' ' 55' ' ' ILE . 31.0 p -62.24 -52.61 63.05 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -176.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 20.1 m -70.82 -44.63 66.15 Favored 'General case' 0 C--O 1.26 1.646 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.973 -177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.0 tp -71.21 -43.55 67.14 Favored 'General case' 0 C--O 1.249 1.047 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.431 -176.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.728 ' CE3' HG23 ' A' ' 36' ' ' ILE . 43.8 m0 -76.07 -60.34 2.37 Favored 'General case' 0 C--O 1.161 -3.594 0 CA-C-O 117.485 -1.245 . . . . 0.0 111.057 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.606 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.404 0.0 OUTLIER -65.71 -22.23 66.6 Favored 'General case' 0 C--O 1.255 1.356 0 C-N-CA 117.017 -1.873 . . . . 0.0 112.044 -173.078 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.86 -54.13 39.5 Favored Glycine 0 C--N 1.359 1.851 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 168.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 27.8 p -70.38 -27.3 64.21 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 117.257 0.528 . . . . 0.0 111.976 177.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.805 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 17.5 mt -61.51 -31.79 71.8 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.301 0.64 . . . . 0.0 109.351 176.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 72.8 t80 -92.68 -28.33 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.355 174.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.676 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 10.2 t30 -68.43 -28.88 67.45 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 121.047 0.451 . . . . 0.0 111.564 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.4 12.12 19.42 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.373 0.606 . . . . 0.0 109.726 176.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.0 p30 48.25 48.7 18.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.888 1.675 . . . . 0.0 114.74 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.3 m-85 -91.45 159.58 15.88 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.62 88.81 3.71 Favored 'General case' 0 CA--C 1.503 -0.861 0 CA-C-N 120.606 1.548 . . . . 0.0 109.83 -176.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.002 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.7 m -146.79 169.83 4.69 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.049 -1.432 . . . . 0.0 110.559 -169.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.444 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 17.3 mt-30 -131.86 123.7 28.04 Favored 'General case' 0 C--O 1.2 -1.516 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 176.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.805 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -130.62 135.4 47.84 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.503 -173.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.732 ' H ' HG12 ' A' ' 62' ' ' ILE . 56.0 m-85 -133.83 153.19 51.91 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -165.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.687 HG12 HG21 ' A' ' 37' ' ' THR . 22.9 mt -87.24 108.23 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.706 0 N-CA-C 104.583 -2.377 . . . . 0.0 104.583 168.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.72 HG23 ' HB3' ' A' ' 60' ' ' ARG . 15.6 m -113.28 -11.73 11.91 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 116.583 -0.28 . . . . 0.0 111.711 -175.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 172.14 176.95 41.33 Favored Glycine 0 CA--C 1.504 -0.631 0 C-N-CA 117.163 -2.446 . . . . 0.0 115.362 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.0 m -68.36 110.78 4.26 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 175.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.549 ' OD2' ' HB3' ' A' ' 25' ' ' SER 0.257 0.0 OUTLIER 78.37 17.46 1.14 Allowed 'General case' 0 CA--C 1.561 1.372 0 CA-C-O 122.947 1.356 . . . . 0.0 109.938 -178.45 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.72 ' HB3' HG23 ' A' ' 56' ' ' VAL . 7.3 mpt_? -133.18 127.44 33.84 Favored 'General case' 0 CA--C 1.566 1.594 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.173 177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.413 ' O ' HG13 ' A' ' 22' ' ' VAL . . . -137.25 165.81 25.27 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.732 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.6 pt -144.53 157.81 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.464 -2.336 0 C-N-CA 117.962 -1.495 . . . . 0.0 110.62 168.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.734 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -132.1 105.89 7.65 Favored 'General case' 0 N--CA 1.414 -2.233 0 O-C-N 126.595 2.434 . . . . 0.0 105.979 164.509 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.44 ' HG3' ' HA ' ' A' ' 19' ' ' MET . 25.1 ttt -92.19 103.97 16.39 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.002 ' HA ' HG12 ' A' ' 51' ' ' VAL 0.277 0.0 OUTLIER -96.06 146.32 24.74 Favored 'General case' 0 CA--C 1.486 -1.491 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -171.834 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HA ' ' HA ' ' A' ' 17' ' ' THR 0.354 1.1 tmt_? -120.98 -59.09 1.76 Allowed 'General case' 0 C--N 1.276 -2.609 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -46.18 -9.25 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.992 0 N-CA-C 117.996 2.591 . . . . 0.0 117.996 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.87 28.96 64.07 Favored Glycine 0 C--N 1.344 1.001 0 CA-C-N 119.793 1.179 . . . . 0.0 113.668 -174.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.66 ' HA ' HD12 ' A' ' 9' ' ' LEU . 19.8 p -149.34 43.43 0.94 Allowed 'General case' 0 CA--C 1.565 1.547 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.613 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -173.49 -3.85 0.01 OUTLIER 'General case' 0 C--N 1.378 1.818 0 N-CA-C 117.732 2.494 . . . . 0.0 117.732 -176.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 1.0 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -74.31 -35.41 63.68 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 114.7 1.37 . . . . 0.0 114.7 -168.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.413 ' NE1' ' HE1' ' A' ' 20' ' ' MET 0.478 5.4 m-90 -88.23 -11.24 47.23 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 115.164 1.542 . . . . 0.0 115.164 -169.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -71.84 -38.71 70.08 Favored 'General case' 0 C--O 1.262 1.719 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 167.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.624 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 25.5 mt -64.7 -36.93 78.83 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.277 178.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.83 ' HE2' HG11 ' A' ' 87' ' ' VAL . 55.2 tttm -58.14 -42.58 86.16 Favored 'General case' 0 C--O 1.291 3.275 0 CA-C-O 122.081 0.943 . . . . 0.0 110.617 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -58.42 -46.98 85.41 Favored 'General case' 0 C--O 1.264 1.867 0 CA-C-N 114.669 -1.151 . . . . 0.0 110.288 175.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.624 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 11.0 m-85 -55.96 -43.99 78.06 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.981 -0.688 . . . . 0.0 110.264 177.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.635 ' HG ' ' HA ' ' A' ' 75' ' ' LYS . 11.5 mt -50.09 -64.61 0.76 Allowed 'General case' 0 CA--C 1.446 -3.05 0 O-C-N 123.835 0.71 . . . . 0.0 109.719 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . 0.303 25.7 m -77.24 -5.49 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.491 0 C-N-CA 118.113 -1.435 . . . . 0.0 114.42 -171.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 19.3 m -86.35 -22.33 26.74 Favored 'General case' 0 N--CA 1.423 -1.783 0 C-N-CA 119.685 -0.806 . . . . 0.0 109.758 167.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -117.26 -35.19 4.11 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 1.026 ' HB2' HG23 ' A' ' 24' ' ' VAL . 0.7 OUTLIER -80.28 24.95 0.41 Allowed 'General case' 0 N--CA 1.516 2.875 0 CA-C-N 119.811 1.187 . . . . 0.0 111.52 -175.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 42.8 ttm180 73.46 -81.97 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 -155.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.431 ' HA ' ' OD1' ' A' ' 82' ' ' ASP . 11.5 p 159.6 89.05 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 125.595 1.558 . . . . 0.0 112.305 171.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . 0.363 . . -109.31 -78.86 0.59 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 119.122 3.008 . . . . 0.0 119.122 177.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.091 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 33.8 tt0 -148.41 126.56 12.13 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 121.089 1.768 . . . . 0.0 112.993 -165.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.83 HG11 ' HE2' ' A' ' 75' ' ' LYS . 2.5 p -111.38 123.22 67.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.153 0 CA-C-N 114.756 -1.111 . . . . 0.0 109.782 175.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.423 ' O ' ' HG3' ' A' ' 20' ' ' MET 0.258 25.9 p -123.39 110.5 15.22 Favored 'General case' 0 C--O 1.264 1.834 0 CA-C-O 122.702 1.239 . . . . 0.0 113.042 171.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.508 HD12 HG22 ' A' ' 87' ' ' VAL . 1.7 mp -76.11 155.7 34.46 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 112.687 -2.052 . . . . 0.0 107.117 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.549 ' H ' HD13 ' A' ' 18' ' ' LEU . 23.8 tt0 -86.64 151.71 23.19 Favored 'General case' 0 C--N 1.28 -2.431 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 171.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 118.49 -172.9 14.66 Favored Glycine 0 CA--C 1.568 3.387 0 CA-C-O 118.724 -1.042 . . . . 0.0 111.846 176.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 27.3 tp60 -112.48 126.24 55.1 Favored 'General case' 0 C--N 1.367 1.349 0 CA-C-N 120.968 2.384 . . . . 0.0 109.988 177.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . 0.267 24.0 ptm 55.84 95.07 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 125.716 1.606 . . . . 0.0 114.265 174.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -95.0 119.21 66.22 Favored Pre-proline 0 C--N 1.303 -1.429 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -78.95 26.56 0.54 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 123.176 2.584 . . . . 0.0 113.8 -175.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.673 ' HA3' ' HG3' ' A' ' 5' ' ' PRO . . . -146.79 62.22 0.45 Allowed Glycine 0 N--CA 1.435 -1.433 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp . . . . . 0 C--N 1.305 -1.354 0 CA-C-O 118.707 -0.664 . . . . 0.0 110.038 179.842 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.299 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -66.29 -54.05 0.55 Allowed 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 123.025 2.483 . . . . 0.0 112.74 -179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 83.16 -58.39 5.04 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 109.119 -1.593 . . . . 0.0 109.119 -174.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.0 tttm -115.67 140.25 25.82 Favored Pre-proline 0 N--CA 1.429 -1.515 0 N-CA-C 105.599 -2.0 . . . . 0.0 105.599 171.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.448 ' HB2' ' HB2' ' A' ' 72' ' ' TRP . 64.8 Cg_endo -75.43 165.79 29.97 Favored 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 121.556 1.504 . . . . 0.0 114.199 -172.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.57 ' HA ' ' CE3' ' A' ' 72' ' ' TRP . 41.1 mt-10 83.56 10.69 0.48 Allowed 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 126.585 1.954 . . . . 0.0 112.06 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.5 p -61.9 -44.96 95.72 Favored 'General case' 0 N--CA 1.435 -1.186 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.718 178.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 5.9 pt -64.45 -38.07 81.63 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.381 0 CA-C-O 122.427 1.108 . . . . 0.0 110.862 -178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.7 tp -72.1 -47.64 49.83 Favored 'General case' 0 N--CA 1.384 -3.774 0 CA-C-N 112.915 -1.948 . . . . 0.0 111.377 -172.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 6' ' ' GLU . 22.4 pttp -86.9 -9.51 55.54 Favored 'General case' 0 N--CA 1.428 -1.545 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.205 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 49.8 ttm -79.5 -34.54 41.18 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 172.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 29.4 m -82.71 -51.35 7.79 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.308 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt 173.38 149.12 0.07 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -89.38 -175.88 4.88 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 177.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 48.0 40.69 20.57 Favored Glycine 0 CA--C 1.557 2.713 0 C-N-CA 120.783 -0.722 . . . . 0.0 113.954 -171.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -117.08 131.87 56.82 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 119.058 1.429 . . . . 0.0 108.838 -176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.2 m -68.44 121.46 16.38 Favored 'General case' 0 N--CA 1.411 -2.403 0 O-C-N 124.114 0.884 . . . . 0.0 109.34 176.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.703 HD12 ' SD ' ' A' ' 20' ' ' MET . 0.2 OUTLIER -133.56 116.49 15.98 Favored 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 103.85 -2.648 . . . . 0.0 103.85 176.052 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.453 ' H ' ' HB3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -113.57 140.99 47.71 Favored 'General case' 0 C--N 1.274 -2.708 0 O-C-N 120.921 -1.112 . . . . 0.0 109.306 179.059 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.703 ' SD ' HD12 ' A' ' 18' ' ' LEU . 2.9 mpp? -118.69 127.43 53.56 Favored 'General case' 0 CA--C 1.447 -3.006 0 C-N-CA 120.334 -0.547 . . . . 0.0 111.33 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . 0.293 30.4 p90 -98.87 123.42 43.12 Favored 'General case' 0 N--CA 1.413 -2.317 0 C-N-CA 117.354 -1.739 . . . . 0.0 106.729 168.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.9 p -114.89 122.15 68.41 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.89 0 CA-C-N 114.647 -1.16 . . . . 0.0 113.815 -167.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.036 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 24.4 m -75.32 135.76 40.88 Favored 'General case' 0 N--CA 1.407 -2.623 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 171.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.611 HG21 HD13 ' A' ' 36' ' ' ILE . 7.9 p -121.52 127.7 75.69 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.681 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -162.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.642 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 29.5 t 71.26 -48.78 0.68 Allowed 'General case' 0 C--N 1.374 1.663 0 N-CA-C 116.585 2.069 . . . . 0.0 116.585 164.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 126.11 -16.74 6.76 Favored Glycine 0 N--CA 1.421 -2.319 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -173.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.48 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.0 t-20 -72.39 110.22 7.61 Favored Pre-proline 0 N--CA 1.437 -1.087 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 177.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -85.7 23.65 0.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.89 2.393 . . . . 0.0 113.015 -172.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 72.8 p -123.32 -170.91 2.2 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -177.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -91.61 9.41 32.35 Favored 'General case' 0 N--CA 1.431 -1.395 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.555 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 3.9 tmtt? -67.52 -54.7 17.78 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-O 121.252 0.548 . . . . 0.0 110.395 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.719 ' HG3' HD12 ' A' ' 36' ' ' ILE . 3.4 tp10 -69.0 -40.14 78.91 Favored 'General case' 0 N--CA 1.43 -1.428 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -175.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 96.3 m -46.8 -56.29 6.5 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.668 171.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 15.4 pt-20 -62.78 -49.06 76.47 Favored 'General case' 0 C--O 1.249 1.045 0 C-N-CA 122.585 0.354 . . . . 0.0 111.628 -175.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -48.62 -58.48 4.65 Favored 'General case' 0 C--O 1.254 1.32 0 C-N-CA 125.656 1.583 . . . . 0.0 108.335 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.719 HD12 ' HG3' ' A' ' 32' ' ' GLU . 43.6 mt -72.24 -43.34 65.71 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.044 0 CA-C-N 111.647 -2.524 . . . . 0.0 113.617 -173.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.823 HG21 HG12 ' A' ' 55' ' ' ILE . 22.7 p -63.76 -48.77 75.64 Favored 'General case' 0 C--N 1.301 -1.539 0 C-N-CA 118.884 -1.126 . . . . 0.0 111.241 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 34.5 p -63.69 -62.98 1.3 Allowed 'General case' 0 C--O 1.263 1.766 0 O-C-N 123.323 0.39 . . . . 0.0 110.774 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 66.0 tp -63.14 -46.7 86.01 Favored 'General case' 0 C--O 1.252 1.212 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -175.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.682 ' CE3' HG23 ' A' ' 36' ' ' ILE . 29.4 m0 -74.89 -59.67 2.63 Favored 'General case' 0 C--O 1.165 -3.38 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.612 -176.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.807 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.375 0.0 OUTLIER -64.58 -25.56 68.02 Favored 'General case' 0 C--O 1.252 1.222 0 C-N-CA 117.214 -1.794 . . . . 0.0 112.027 -172.199 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.19 -53.71 42.47 Favored Glycine 0 N--CA 1.436 -1.302 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 171.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.527 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 35.5 p -70.89 -28.51 64.6 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-N 116.881 0.34 . . . . 0.0 111.732 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.965 HD12 ' HG2' ' A' ' 53' ' ' ARG . 18.2 mt -61.18 -35.13 76.3 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.276 0.631 . . . . 0.0 109.378 177.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.631 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 60.9 t80 -87.59 -30.14 20.72 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.465 -0.494 . . . . 0.0 109.913 177.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.527 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.2 t-20 -69.02 -27.71 65.92 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.134 0.492 . . . . 0.0 111.481 -177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.11 1.03 52.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.994 0.426 . . . . 0.0 110.557 177.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 60.34 35.06 20.69 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 124.686 1.194 . . . . 0.0 112.266 177.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -65.56 -2.35 3.36 Favored 'General case' 0 CA--C 1.611 3.31 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 179.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.9 t70 59.7 71.74 0.56 Allowed 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 125.396 1.478 . . . . 0.0 111.108 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.612 HG12 ' HA ' ' A' ' 65' ' ' LEU . 6.4 m -147.66 176.21 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-N 113.653 -1.612 . . . . 0.0 111.725 -170.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.574 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 12.8 mt-30 -135.96 133.35 37.49 Favored 'General case' 0 C--O 1.204 -1.304 0 N-CA-C 104.664 -2.347 . . . . 0.0 104.664 174.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.965 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -137.36 135.42 37.0 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -174.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.783 ' H ' HG12 ' A' ' 62' ' ' ILE . 36.7 t80 -134.36 151.57 51.3 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 117.797 -1.561 . . . . 0.0 113.737 -163.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.823 HG12 HG21 ' A' ' 37' ' ' THR . 25.7 mt -89.5 96.13 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 170.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.664 HG13 ' HB3' ' A' ' 60' ' ' ARG . 7.4 p -94.61 -25.43 4.65 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 CA-C-O 120.605 0.241 . . . . 0.0 110.912 -177.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.67 173.52 45.27 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 118.667 -1.73 . . . . 0.0 114.706 176.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.527 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 21.0 m -70.57 117.94 12.74 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 174.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.65 ' O ' ' HA ' ' A' ' 23' ' ' THR . 14.2 t70 82.47 9.98 0.7 Allowed 'General case' 0 C--O 1.188 -2.139 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.664 ' HB3' HG13 ' A' ' 56' ' ' VAL . 5.5 mpt_? -138.78 117.84 12.56 Favored 'General case' 0 CA--C 1.561 1.391 0 CA-C-O 122.247 1.022 . . . . 0.0 113.525 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -123.59 168.44 12.62 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 125.046 1.339 . . . . 0.0 107.445 177.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.783 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.5 pt -138.06 157.43 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.256 0 C-N-CA 117.305 -1.758 . . . . 0.0 110.072 171.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.451 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 0.7 OUTLIER -130.82 102.96 6.3 Favored 'General case' 0 N--CA 1.422 -1.841 0 O-C-N 126.807 2.567 . . . . 0.0 107.929 166.156 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.471 ' HB3' ' O ' ' A' ' 52' ' ' GLN . 1.0 OUTLIER -87.98 117.29 26.75 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 176.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.769 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.429 0.0 OUTLIER -121.03 148.46 44.1 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 115.314 1.598 . . . . 0.0 115.314 -178.646 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.324 26.3 ttp180 -112.64 -57.2 2.31 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -169.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.564 ' HB2' ' CE1' ' A' ' 70' ' ' TYR . 1.7 m-20 -50.23 -13.85 0.13 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 117.556 2.428 . . . . 0.0 117.556 175.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 58.15 29.11 62.21 Favored Glycine 0 C--N 1.36 1.887 0 CA-C-N 120.475 1.488 . . . . 0.0 115.702 178.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.402 ' H ' ' HD1' ' A' ' 70' ' ' TYR . 32.5 m -151.99 44.34 0.73 Allowed 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 118.733 1.266 . . . . 0.0 112.949 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 67' ' ' ASP . 14.8 p90 178.99 16.75 0.0 OUTLIER 'General case' 0 C--N 1.365 1.279 0 CA-C-N 119.075 0.852 . . . . 0.0 111.97 -169.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.769 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -100.11 -33.96 10.25 Favored 'General case' 0 C--O 1.267 1.995 0 CA-C-O 122.372 1.082 . . . . 0.0 113.867 -170.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.57 ' CE3' ' HA ' ' A' ' 6' ' ' GLU 0.496 13.0 m0 -89.19 -9.62 50.14 Favored 'General case' 0 C--N 1.287 -2.11 0 C-N-CA 116.88 -1.928 . . . . 0.0 112.447 -172.317 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -73.04 -26.66 61.38 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.356 164.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.615 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.0 mt -64.89 -38.01 81.68 Favored 'Isoleucine or valine' 0 C--N 1.37 1.462 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 171.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 78' ' ' LEU . 29.1 ttpp -57.7 -41.46 81.76 Favored 'General case' 1 C--O 1.317 4.607 0 CA-C-O 122.831 1.301 . . . . 0.0 110.829 175.422 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -57.72 -44.95 86.31 Favored 'General case' 0 C--N 1.319 -0.761 0 C-N-CA 118.881 -1.128 . . . . 0.0 110.47 173.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.748 ' HA ' ' HB3' ' A' ' 80' ' ' SER . 17.1 m-85 -62.13 -27.7 69.12 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.543 178.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.598 ' CD1' ' HA ' ' A' ' 75' ' ' LYS . 39.8 mt -56.19 -59.32 5.1 Favored 'General case' 0 C--O 1.275 2.446 0 CA-C-O 122.082 0.944 . . . . 0.0 109.199 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.684 HG13 ' SG ' ' A' ' 84' ' ' CYS 0.277 1.2 m -77.04 -4.43 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 C-N-CA 117.467 -1.693 . . . . 0.0 113.134 178.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.748 ' HB3' ' HA ' ' A' ' 77' ' ' PHE . 9.9 t -88.65 -14.32 37.68 Favored 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 114.142 -1.39 . . . . 0.0 108.41 171.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.567 ' HG3' ' NE1' ' A' ' 40' ' ' TRP . 78.3 mm-40 -90.44 -43.42 10.29 Favored 'General case' 0 C--N 1.38 1.892 0 C-N-CA 117.328 -1.749 . . . . 0.0 109.182 176.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.378 29.3 t70 -176.23 -82.52 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 O-C-N 124.662 1.226 . . . . 0.0 113.181 173.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 81.9 mtm180 -127.27 147.67 50.23 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 120.649 1.568 . . . . 0.0 109.399 176.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.684 ' SG ' HG13 ' A' ' 79' ' ' VAL . 0.9 OUTLIER -133.51 164.49 27.04 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 104.753 -2.314 . . . . 0.0 104.753 178.23 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -149.37 -51.12 0.15 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -171.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.036 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.1 tt0 -143.19 121.22 12.09 Favored 'General case' 0 CA--C 1.496 -1.13 0 O-C-N 120.757 -1.214 . . . . 0.0 112.103 -172.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 16.6 m -111.83 121.69 64.78 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.335 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.871 176.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 20' ' ' MET 0.293 22.3 p -106.36 114.41 28.52 Favored 'General case' 0 N--CA 1.406 -2.675 0 C-N-CA 117.348 -1.741 . . . . 0.0 109.656 165.044 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 94' ' ' TYR . 1.5 mm? -79.59 144.72 33.58 Favored 'General case' 0 N--CA 1.407 -2.603 0 CA-C-N 110.858 -2.883 . . . . 0.0 108.138 -175.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.481 ' H ' HD13 ' A' ' 18' ' ' LEU . 40.0 tt0 -86.82 177.62 7.24 Favored 'General case' 0 C--N 1.275 -2.642 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.49 -174.96 44.49 Favored Glycine 0 N--CA 1.425 -2.061 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -102.75 110.7 22.71 Favored 'General case' 0 N--CA 1.426 -1.647 0 CA-C-N 120.497 2.148 . . . . 0.0 105.653 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 49.5 ttm 60.93 46.4 8.56 Favored 'General case' 0 C--O 1.25 1.105 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 -172.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.61 ' HA ' ' HD3' ' A' ' 97' ' ' LYS . 89.6 t80 -55.84 -42.97 98.86 Favored Pre-proline 0 CA--C 1.559 1.297 0 CA-C-N 114.304 -1.316 . . . . 0.0 114.11 -177.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.472 ' HD2' ' N ' ' A' ' 94' ' ' TYR . 9.4 Cg_endo -55.1 -19.16 19.53 Favored 'Trans proline' 0 C--N 1.377 2.042 0 C-N-CA 122.342 2.028 . . . . 0.0 113.578 176.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -102.77 11.18 56.17 Favored Glycine 0 N--CA 1.442 -0.921 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.002 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.61 ' HD3' ' HA ' ' A' ' 94' ' ' TYR . 28.3 mtpp . . . . . 0 C--O 1.255 1.391 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.438 0 N-CA-C 110.523 -1.031 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.59 ' HG2' ' HE2' ' A' ' 16' ' ' LYS . 31.2 Cg_exo -63.78 -41.14 25.49 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.445 2.097 . . . . 0.0 110.573 175.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.58 -56.24 1.65 Allowed Glycine 0 CA--C 1.532 1.133 0 CA-C-N 115.33 -0.85 . . . . 0.0 114.599 177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 22.7 pttm -62.75 136.93 96.54 Favored Pre-proline 0 C--O 1.239 0.548 0 CA-C-N 118.362 1.081 . . . . 0.0 111.566 -175.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.519 ' HD3' ' O ' ' A' ' 92' ' ' GLN . 22.0 Cg_exo -69.25 114.63 3.69 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.5 2.133 . . . . 0.0 110.631 178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.66 67.32 0.71 Allowed 'General case' 0 C--O 1.271 2.203 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.412 -176.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.5 m 65.54 46.24 2.53 Favored 'General case' 0 C--N 1.38 1.893 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 175.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.421 HD11 ' CZ2' ' A' ' 72' ' ' TRP . 7.9 tp 49.94 54.05 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.392 2.435 0 C-N-CA 124.802 1.241 . . . . 0.0 109.523 -174.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.291 1.8 pp 46.95 60.21 3.53 Favored 'General case' 0 C--N 1.409 3.155 0 CA-C-O 122.849 1.309 . . . . 0.0 112.158 177.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . 0.306 18.6 ptpt 52.63 68.24 0.86 Allowed 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 112.311 -2.222 . . . . 0.0 113.415 -176.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.576 ' O ' ' HB ' ' A' ' 12' ' ' THR . 50.0 ttm 79.98 -24.24 0.21 Allowed 'General case' 0 C--O 1.243 0.758 0 CA-C-N 113.974 -1.467 . . . . 0.0 114.112 173.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.576 ' HB ' ' O ' ' A' ' 11' ' ' MET . 15.0 t 147.93 8.06 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 123.367 0.667 . . . . 0.0 112.027 -170.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.678 ' HG2' ' HB3' ' A' ' 69' ' ' SER . 7.1 tmtt? -154.35 100.24 2.27 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 117.036 -1.866 . . . . 0.0 112.731 -172.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -151.09 -97.79 0.06 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 170.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -173.5 71.32 0.1 OUTLIER Glycine 0 CA--C 1.56 2.893 0 CA-C-O 118.48 -1.178 . . . . 0.0 114.378 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.806 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 0.7 OUTLIER -129.57 153.93 47.56 Favored 'General case' 0 C--N 1.364 1.239 0 CA-C-N 120.007 1.904 . . . . 0.0 108.559 178.539 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.8 m -83.96 125.44 32.05 Favored 'General case' 0 C--N 1.29 -1.979 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 174.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.814 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -133.22 112.76 11.96 Favored 'General case' 0 C--O 1.19 -2.055 0 C-N-CA 119.327 -0.949 . . . . 0.0 108.483 -175.143 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 27.4 ptm -84.04 127.62 34.01 Favored 'General case' 0 C--N 1.278 -2.523 0 C-N-CA 119.444 -0.902 . . . . 0.0 108.762 174.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.514 ' HG3' ' CD1' ' A' ' 89' ' ' LEU . 27.3 ttm -101.06 107.91 19.48 Favored 'General case' 0 N--CA 1.424 -1.739 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.947 176.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -94.1 114.39 26.53 Favored 'General case' 0 CA--C 1.495 -1.154 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.5 p -127.15 125.65 66.62 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.514 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -169.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.101 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 18.8 m -84.71 142.07 30.12 Favored 'General case' 0 CA--C 1.588 2.419 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.608 174.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.66 HG21 HD13 ' A' ' 36' ' ' ILE . 8.5 p -125.82 129.39 72.51 Favored 'Isoleucine or valine' 0 C--N 1.378 1.829 0 N-CA-C 103.633 -2.729 . . . . 0.0 103.633 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -140.84 29.49 1.89 Allowed 'General case' 0 C--O 1.244 0.814 0 C-N-CA 115.385 -2.526 . . . . 0.0 114.104 -166.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -81.44 -34.45 25.68 Favored Glycine 0 C--N 1.303 -1.279 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 1.022 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 13.9 t-20 -116.95 121.64 32.39 Favored Pre-proline 0 N--CA 1.429 -1.487 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -85.43 27.28 0.61 Allowed 'Trans proline' 0 C--N 1.324 -0.742 0 C-N-CA 123.087 2.525 . . . . 0.0 114.067 -173.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.427 ' HB ' ' H ' ' A' ' 30' ' ' GLU . 22.4 p -144.9 -160.74 1.17 Allowed 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 -174.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.489 ' HA ' ' HB ' ' A' ' 33' ' ' THR . 40.4 tt0 -89.12 1.76 55.14 Favored 'General case' 0 N--CA 1.421 -1.878 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.017 -177.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 5.9 tmtt? -68.08 -50.46 54.88 Favored 'General case' 0 C--O 1.242 0.664 0 C-N-CA 118.823 -1.151 . . . . 0.0 110.896 -178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 1.022 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 1.7 tp10 -70.82 -42.37 70.34 Favored 'General case' 0 CA--C 1.491 -1.308 0 C-N-CA 118.575 -1.25 . . . . 0.0 107.703 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 30' ' ' GLU . 59.9 m -42.49 -51.58 4.99 Favored 'General case' 0 C--O 1.199 -1.591 0 CA-C-N 113.985 -1.461 . . . . 0.0 111.557 171.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 13.7 pt-20 -71.89 -48.37 46.15 Favored 'General case' 0 C--O 1.252 1.22 0 O-C-N 121.781 -0.574 . . . . 0.0 112.476 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -47.69 -57.77 5.12 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 125.522 1.529 . . . . 0.0 107.501 177.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.758 HG23 ' CD2' ' A' ' 40' ' ' TRP . 14.7 mt -69.14 -43.95 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.394 -3.268 0 CA-C-N 111.452 -2.613 . . . . 0.0 113.551 -176.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.595 HG21 HG23 ' A' ' 55' ' ' ILE . 19.8 p -67.5 -42.08 83.44 Favored 'General case' 0 C--O 1.251 1.162 0 CA-C-N 120.533 1.515 . . . . 0.0 111.315 -174.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 30.0 p -66.05 -55.64 15.61 Favored 'General case' 0 N--CA 1.425 -1.691 0 O-C-N 123.974 0.796 . . . . 0.0 110.138 178.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 56.6 tp -60.75 -46.17 91.47 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.985 0.365 . . . . 0.0 111.985 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.787 ' CZ3' HD13 ' A' ' 78' ' ' LEU . 44.0 m0 -68.67 -69.97 0.3 Allowed 'General case' 0 CA--C 1.494 -1.187 0 CA-C-O 118.872 -0.585 . . . . 0.0 111.36 -177.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.843 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.321 0.0 OUTLIER -69.31 -21.86 63.83 Favored 'General case' 0 C--O 1.255 1.377 0 C-N-CA 117.918 -1.513 . . . . 0.0 111.968 -171.462 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.11 -51.47 54.95 Favored Glycine 0 N--CA 1.428 -1.879 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 172.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 60.6 p -68.19 -32.66 73.05 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 117.191 0.495 . . . . 0.0 110.545 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.817 HD12 ' HG2' ' A' ' 53' ' ' ARG . 33.4 mt -60.53 -33.15 72.23 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.005 179.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.65 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 78.0 t80 -91.08 -30.13 16.92 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.991 175.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -66.06 -32.77 74.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -95.68 1.89 53.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.25 0.548 . . . . 0.0 109.802 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 t30 49.37 60.49 3.73 Favored 'General case' 0 CA--C 1.561 1.373 0 C-N-CA 125.65 1.58 . . . . 0.0 112.763 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -74.02 12.63 0.67 Allowed 'General case' 0 CA--C 1.583 2.224 0 N-CA-C 116.514 2.042 . . . . 0.0 116.514 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.8 t70 50.22 67.26 0.94 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.901 1.28 . . . . 0.0 112.517 -176.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.616 HG23 ' HD2' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -146.88 174.23 2.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.245 -177.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.474 ' HB3' ' HB3' ' A' ' 64' ' ' MET . 7.9 tt0 -131.1 117.97 19.85 Favored 'General case' 0 C--O 1.191 -1.986 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.843 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -128.17 141.17 51.55 Favored 'General case' 0 C--N 1.279 -2.474 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.213 -170.261 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.79 ' H ' HG12 ' A' ' 62' ' ' ILE . 16.8 m-85 -133.72 151.96 51.76 Favored 'General case' 0 CA--C 1.487 -1.467 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 -168.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.595 HG23 HG21 ' A' ' 37' ' ' THR . 21.5 mt -93.03 96.64 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 167.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 60' ' ' ARG . 8.2 m -91.1 -31.25 4.95 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.535 -179.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.33 173.73 45.68 Favored Glycine 0 CA--C 1.49 -1.493 0 C-N-CA 117.028 -2.51 . . . . 0.0 114.191 175.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.545 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 33.2 m -66.71 118.95 10.98 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 175.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.2 OUTLIER 85.25 9.08 0.36 Allowed 'General case' 0 C--N 1.363 1.173 0 CA-C-O 122.138 0.97 . . . . 0.0 109.129 -178.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.541 ' HB3' HG23 ' A' ' 56' ' ' VAL . 8.1 mpt_? -140.21 131.63 26.88 Favored 'General case' 0 CA--C 1.572 1.818 0 CA-C-N 115.432 -0.804 . . . . 0.0 113.13 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.05 165.92 26.05 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 106.638 -1.616 . . . . 0.0 106.638 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.79 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.0 OUTLIER -143.51 157.23 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.473 -1.99 0 C-N-CA 117.937 -1.505 . . . . 0.0 109.914 170.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.597 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -135.65 104.81 5.92 Favored 'General case' 0 N--CA 1.428 -1.552 0 O-C-N 126.196 2.185 . . . . 0.0 107.321 162.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 26.7 ttt -87.2 116.66 25.43 Favored 'General case' 0 C--N 1.292 -1.929 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.164 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.588 ' HA ' HG12 ' A' ' 51' ' ' VAL . 3.8 mp -82.88 145.55 29.37 Favored 'General case' 0 C--O 1.256 1.415 0 C-N-CA 126.077 1.751 . . . . 0.0 112.288 -175.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.298 72.3 ttt180 -110.15 -61.77 1.61 Allowed 'General case' 0 CA--C 1.587 2.395 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 175.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -57.03 -10.95 1.28 Allowed 'General case' 0 N--CA 1.527 3.384 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.806 ' HA3' ' H ' ' A' ' 16' ' ' LYS . . . 56.61 26.71 53.45 Favored Glycine 0 C--N 1.36 1.89 0 CA-C-N 119.491 1.041 . . . . 0.0 114.501 -173.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.678 ' HB3' ' HG2' ' A' ' 13' ' ' LYS . 18.0 m -143.06 38.93 1.45 Allowed 'General case' 0 CA--C 1.55 0.958 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -177.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -179.56 -176.18 0.37 Allowed 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 -167.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.573 ' HB1' ' CE2' ' A' ' 63' ' ' PHE . . . 98.06 -30.89 0.02 OUTLIER 'General case' 0 C--N 1.376 1.718 0 C-N-CA 126.574 1.95 . . . . 0.0 115.016 173.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.689 ' HH2' ' HG ' ' A' ' 18' ' ' LEU 0.294 17.5 m-90 -71.32 -30.17 65.89 Favored 'General case' 0 C--O 1.277 2.502 0 CA-C-O 121.794 0.807 . . . . 0.0 111.803 -177.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -66.16 -40.13 90.29 Favored 'General case' 0 C--O 1.266 1.963 0 CA-C-N 115.0 -1.0 . . . . 0.0 108.45 171.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.569 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 23.3 mt -54.98 -45.83 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.05 175.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.737 ' HE3' HG21 ' A' ' 87' ' ' VAL . 12.5 tmtt? -58.8 -42.88 90.14 Favored 'General case' 0 C--O 1.266 1.954 0 CA-C-O 121.372 0.606 . . . . 0.0 110.242 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -60.3 -42.96 96.6 Favored 'General case' 0 C--O 1.277 2.529 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.636 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 14.5 m-85 -55.85 -45.45 78.44 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.787 HD13 ' CZ3' ' A' ' 40' ' ' TRP . 20.1 mt -58.84 -46.82 86.8 Favored 'General case' 0 CA--C 1.488 -1.434 0 N-CA-C 113.825 1.046 . . . . 0.0 113.825 -176.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.789 HG22 ' HB3' ' A' ' 84' ' ' CYS . 2.1 t -70.29 -20.44 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 117.438 -1.705 . . . . 0.0 109.826 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 8.8 t -90.55 -8.16 50.97 Favored 'General case' 0 N--CA 1.419 -1.975 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 176.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -88.04 -38.39 15.5 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 -175.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.317 6.6 t70 -155.02 -104.35 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.727 176.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.406 ' HD2' ' HA ' ' A' ' 83' ' ' ARG . 23.5 tpt180 -143.32 84.35 1.81 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 121.115 1.78 . . . . 0.0 112.406 176.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.789 ' HB3' HG22 ' A' ' 79' ' ' VAL . 6.0 t -86.27 160.74 19.06 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.82 -40.33 0.09 Allowed 'General case' 0 N--CA 1.426 -1.639 0 N-CA-C 115.162 1.541 . . . . 0.0 115.162 -167.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.101 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 45.3 tt0 -126.49 116.67 21.47 Favored 'General case' 0 CA--C 1.47 -2.101 0 C-N-CA 118.187 -1.405 . . . . 0.0 109.719 -172.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.835 HG12 HD21 ' A' ' 89' ' ' LEU . 24.2 t -110.35 98.26 6.82 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.735 0 CA-C-N 114.768 -1.105 . . . . 0.0 108.797 -175.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.56 ' C ' HD22 ' A' ' 89' ' ' LEU . 38.6 p -111.08 142.73 42.85 Favored 'General case' 0 C--O 1.261 1.692 0 CA-C-O 121.657 0.742 . . . . 0.0 111.251 175.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.835 HD21 HG12 ' A' ' 87' ' ' VAL . 2.9 mm? -126.67 154.69 43.73 Favored 'General case' 0 N--CA 1.405 -2.704 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.967 -166.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.429 ' H ' HD13 ' A' ' 18' ' ' LEU . 13.8 tt0 -80.9 157.99 25.44 Favored 'General case' 0 C--N 1.252 -3.667 0 CA-C-N 112.699 -2.046 . . . . 0.0 109.583 -179.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.7 153.21 5.87 Favored Glycine 0 N--CA 1.412 -2.924 0 N-CA-C 108.434 -1.866 . . . . 0.0 108.434 176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.519 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 13.9 mm100 -87.49 123.48 32.45 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 120.796 2.298 . . . . 0.0 107.651 -178.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 50.4 ttp 82.81 4.89 0.97 Allowed 'General case' 0 CA--C 1.544 0.734 0 O-C-N 125.034 1.459 . . . . 0.0 109.535 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.706 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 0.6 OUTLIER -83.51 112.7 41.58 Favored Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 174.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -94.48 175.3 1.24 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.071 2.514 . . . . 0.0 112.999 -177.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 131.67 -30.44 3.26 Favored Glycine 0 C--N 1.312 -0.789 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.278 176.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 16.3 tppt? . . . . . 0 N--CA 1.432 -1.358 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 -179.305 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.329 0 N-CA-C 111.24 -0.744 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -62.12 -47.09 11.01 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.984 2.456 . . . . 0.0 112.032 -178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -92.41 51.35 2.72 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.508 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 21.2 ptmt -61.51 131.85 92.73 Favored Pre-proline 0 N--CA 1.445 -0.692 0 CA-C-N 116.944 0.372 . . . . 0.0 111.826 -177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 7.8 Cg_exo -77.33 -152.87 0.04 OUTLIER 'Trans proline' 0 C--O 1.242 0.706 0 C-N-CA 123.722 2.948 . . . . 0.0 111.656 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.618 ' HA ' ' HE3' ' A' ' 72' ' ' TRP . 54.2 mt-10 82.92 8.65 0.7 Allowed 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 126.163 1.785 . . . . 0.0 108.86 -176.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.2 p -63.86 -35.91 82.18 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 114.699 -1.137 . . . . 0.0 111.806 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.402 HG12 ' HZ3' ' A' ' 72' ' ' TRP . 0.0 OUTLIER -53.81 -50.58 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 177.93 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.427 ' H ' ' HG ' ' A' ' 9' ' ' LEU 0.29 0.6 OUTLIER -88.34 -30.57 19.46 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -171.615 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -82.53 -17.19 45.88 Favored 'General case' 0 C--N 1.318 -0.787 0 C-N-CA 120.101 -0.64 . . . . 0.0 110.383 -176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 52.7 tpp -100.95 -37.23 8.74 Favored 'General case' 0 N--CA 1.429 -1.48 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.843 176.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -111.68 -25.88 9.29 Favored 'General case' 0 C--O 1.243 0.763 0 N-CA-C 115.55 1.685 . . . . 0.0 115.55 -174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -164.8 110.24 0.95 Allowed 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 119.411 -0.916 . . . . 0.0 112.235 -171.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -77.56 -6.98 55.59 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.393 -173.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 67' ' ' ASP . . . -123.33 61.61 0.57 Allowed Glycine 0 CA--C 1.55 2.234 0 CA-C-O 119.256 -0.747 . . . . 0.0 113.169 -179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.701 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 27.0 tptp -123.02 112.9 18.34 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-N 119.571 1.686 . . . . 0.0 111.776 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 92.8 m -65.81 125.5 25.55 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 109.071 -0.715 . . . . 0.0 109.071 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.801 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -124.74 109.03 12.61 Favored 'General case' 0 C--O 1.237 0.433 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -177.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.619 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 22.3 ptm -96.6 102.98 14.86 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 176.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.678 ' HE3' HD11 ' A' ' 65' ' ' LEU . 7.4 ptp -114.75 135.14 54.5 Favored 'General case' 0 C--O 1.272 2.271 0 C-N-CA 116.789 -1.965 . . . . 0.0 112.83 -172.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.542 ' HA ' HG22 ' A' ' 62' ' ' ILE . 3.6 t80 -97.46 118.52 34.13 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.85 2.46 . . . . 0.0 107.71 -173.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -122.63 124.42 70.61 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.397 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -172.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.801 ' HA ' ' HG3' ' A' ' 60' ' ' ARG . 83.4 m -88.81 121.32 31.05 Favored 'General case' 0 CA--C 1.605 3.06 0 C-N-CA 125.923 1.689 . . . . 0.0 112.275 -177.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.681 HG13 ' HB2' ' A' ' 83' ' ' ARG 0.305 56.4 t -111.01 130.54 64.26 Favored 'Isoleucine or valine' 0 C--N 1.378 1.813 0 C-N-CA 127.668 2.387 . . . . 0.0 104.714 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.5 m -121.92 -5.86 9.03 Favored 'General case' 0 C--N 1.364 1.209 0 CA-C-N 122.658 2.481 . . . . 0.0 115.998 -169.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.31 -44.72 21.14 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 121.452 -0.404 . . . . 0.0 112.817 174.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.557 ' HB2' ' HB2' ' A' ' 32' ' ' GLU . 4.7 m-20 -106.07 154.16 39.75 Favored Pre-proline 0 CA--C 1.514 -0.436 0 CA-C-N 117.757 0.779 . . . . 0.0 109.271 172.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -111.12 40.77 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.289 0 C-N-CA 123.883 3.056 . . . . 0.0 110.882 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 15.3 p -131.89 -105.08 0.26 Allowed 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.647 -0.658 . . . . 0.0 112.72 -168.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.753 ' HA ' ' O ' ' A' ' 58' ' ' SER . 30.0 tt0 -167.19 15.74 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.72 0 C-N-CA 126.907 2.083 . . . . 0.0 106.669 170.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.591 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 9.5 tmtt? -86.78 -31.68 20.77 Favored 'General case' 0 C--O 1.259 1.556 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.359 -174.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 1.003 ' HG3' HD12 ' A' ' 36' ' ' ILE . 7.1 tp10 -73.32 -44.69 58.5 Favored 'General case' 0 N--CA 1.417 -2.112 0 N-CA-C 104.303 -2.481 . . . . 0.0 104.303 178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.814 ' OG1' ' HA ' ' A' ' 59' ' ' ASP . 59.6 m -44.2 -51.14 8.42 Favored 'General case' 0 C--O 1.179 -2.64 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.391 167.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.591 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.7 pt-20 -63.39 -52.33 62.09 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-N 119.631 1.105 . . . . 0.0 112.42 -178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -53.6 -60.03 3.83 Favored 'General case' 0 C--O 1.263 1.798 0 CA-C-O 123.315 1.531 . . . . 0.0 107.978 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.003 HD12 ' HG3' ' A' ' 32' ' ' GLU . 1.3 mt -60.43 -45.03 97.37 Favored 'Isoleucine or valine' 0 C--O 1.163 -3.464 0 CA-C-N 112.095 -2.32 . . . . 0.0 112.745 -176.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.854 HG21 HG12 ' A' ' 55' ' ' ILE . 19.2 p -68.76 -34.53 75.73 Favored 'General case' 0 CA--C 1.485 -1.527 0 CA-C-N 121.071 1.76 . . . . 0.0 110.869 -176.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.4 m -63.06 -51.13 67.88 Favored 'General case' 0 N--CA 1.407 -2.588 0 C-N-CA 119.551 -0.859 . . . . 0.0 109.819 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.5 mp -71.71 -43.06 66.59 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.366 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.693 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 43.4 m0 -62.44 -76.58 0.06 Allowed 'General case' 0 N--CA 1.437 -1.122 0 O-C-N 123.757 0.661 . . . . 0.0 111.251 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.634 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.323 0.0 OUTLIER -71.74 -19.66 62.01 Favored 'General case' 0 C--O 1.254 1.337 0 C-N-CA 118.648 -1.221 . . . . 0.0 111.976 -172.386 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.58 -51.82 55.1 Favored Glycine 0 N--CA 1.432 -1.598 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.751 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 32.0 t -72.47 -25.29 61.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.816 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 31.1 mt -62.78 -34.37 77.11 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 120.81 0.338 . . . . 0.0 110.242 176.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.568 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 70.8 t80 -91.24 -24.43 19.89 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.926 175.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.751 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 8.1 t30 -67.24 -31.62 72.1 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.698 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -98.22 5.08 48.79 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.271 0.558 . . . . 0.0 109.583 176.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.5 t30 46.67 55.39 7.74 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 126.516 1.927 . . . . 0.0 112.905 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -67.51 1.6 2.25 Favored 'General case' 0 CA--C 1.594 2.661 0 N-CA-C 116.331 1.975 . . . . 0.0 116.331 173.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 39.0 t70 56.58 69.48 0.74 Allowed 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.188 1.395 . . . . 0.0 110.951 -178.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.86 HG12 ' HA ' ' A' ' 65' ' ' LEU . 6.7 m -147.44 176.06 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-N 113.887 -1.506 . . . . 0.0 110.629 -172.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.535 ' O ' ' HB3' ' A' ' 64' ' ' MET . 25.7 tt0 -133.78 126.23 30.19 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.816 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -134.69 140.78 46.25 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.35 -0.844 . . . . 0.0 108.784 -170.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.71 ' H ' HG12 ' A' ' 62' ' ' ILE . 38.1 m-85 -133.8 153.15 51.93 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 116.663 2.097 . . . . 0.0 116.663 -166.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.854 HG12 HG21 ' A' ' 37' ' ' THR . 76.6 mt -86.42 112.42 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.34 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 166.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.8 m -130.12 -26.68 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -171.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.77 ' HA3' ' HB2' ' A' ' 60' ' ' ARG . . . -138.41 174.83 21.79 Favored Glycine 0 CA--C 1.48 -2.127 0 C-N-CA 118.643 -1.741 . . . . 0.0 112.058 -177.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.753 ' O ' ' HA ' ' A' ' 30' ' ' GLU . 5.2 m -39.02 -71.1 0.09 Allowed 'General case' 0 C--N 1.367 1.364 0 O-C-N 125.654 1.444 . . . . 0.0 109.417 -178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.814 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 21.4 m-20 -126.64 65.55 1.26 Allowed 'General case' 1 N--CA 1.363 -4.775 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 168.72 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.801 ' HG3' ' HA ' ' A' ' 23' ' ' THR . 4.1 mpt_? -134.18 137.0 44.14 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 112.896 -1.956 . . . . 0.0 108.823 -177.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.56 169.59 17.06 Favored 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -173.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.71 HG12 ' H ' ' A' ' 54' ' ' PHE . 9.8 pt -136.56 157.64 36.97 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.065 0 C-N-CA 118.472 -1.291 . . . . 0.0 109.553 172.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.504 ' HZ ' ' HB2' ' A' ' 75' ' ' LYS 0.28 6.7 p90 -125.81 109.38 12.47 Favored 'General case' 0 N--CA 1.408 -2.55 0 O-C-N 126.394 2.309 . . . . 0.0 107.909 164.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.591 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 21.4 ttt -100.04 104.5 16.09 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 114.076 -1.42 . . . . 0.0 110.416 178.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.931 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.34 0.0 OUTLIER -99.75 147.15 25.75 Favored 'General case' 0 CA--C 1.462 -2.405 0 CA-C-N 114.921 -1.036 . . . . 0.0 113.041 -178.962 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.367 20.8 ttp180 -105.13 -68.61 0.85 Allowed 'General case' 0 C--N 1.264 -3.147 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 -164.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.937 ' HB3' ' HE1' ' A' ' 70' ' ' TYR . 37.4 t70 -44.48 -24.51 0.19 Allowed 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.701 ' HA3' ' H ' ' A' ' 16' ' ' LYS . . . 69.78 12.29 67.36 Favored Glycine 0 C--N 1.366 2.196 0 CA-C-N 120.224 1.374 . . . . 0.0 115.996 -175.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.4 t -121.38 32.53 5.87 Favored 'General case' 0 CA--C 1.563 1.463 0 CA-C-N 118.649 1.224 . . . . 0.0 111.905 178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.937 ' HE1' ' HB3' ' A' ' 67' ' ' ASP . 45.0 p90 175.13 137.96 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -174.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.931 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 169.27 -33.3 0.0 OUTLIER 'General case' 0 N--CA 1.517 2.881 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.687 ' CZ2' HD13 ' A' ' 89' ' ' LEU 0.622 10.5 m0 -82.5 -11.73 58.28 Favored 'General case' 0 C--O 1.263 1.778 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 -168.359 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.468 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 43.6 tt0 -74.08 -36.82 64.32 Favored 'General case' 0 N--CA 1.425 -1.711 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 170.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 63.9 mt -55.11 -46.29 77.44 Favored 'Isoleucine or valine' 0 C--O 1.278 2.565 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 172.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HB2' ' HD1' ' A' ' 72' ' ' TRP . 13.9 tmtt? -56.73 -48.97 76.58 Favored 'General case' 0 C--O 1.282 2.793 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.124 -176.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -58.31 -47.39 83.84 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.211 -179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.468 ' CZ ' ' HG2' ' A' ' 73' ' ' GLU . 15.8 m-85 -52.59 -53.75 42.37 Favored 'General case' 0 C--N 1.371 1.54 0 O-C-N 123.73 0.644 . . . . 0.0 109.661 -179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.684 HD13 ' CE3' ' A' ' 40' ' ' TRP . 14.0 mt -60.46 -55.06 38.03 Favored 'General case' 0 C--O 1.302 3.816 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -174.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 75' ' ' LYS 0.308 27.4 m -78.29 -5.7 8.23 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.992 0 C-N-CA 117.986 -1.486 . . . . 0.0 113.217 -174.175 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.7 m -108.47 5.1 24.94 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.726 165.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.443 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 7.9 tp-100 -82.26 -45.1 15.46 Favored 'General case' 0 CA--C 1.456 -2.643 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.391 4.6 p30 -163.72 -94.14 0.02 OUTLIER 'General case' 0 C--O 1.245 0.863 0 N-CA-C 116.25 1.944 . . . . 0.0 116.25 175.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.681 ' HB2' HG13 ' A' ' 24' ' ' VAL . 21.2 mmt180 -91.22 129.77 37.17 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.406 -173.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 11.8 p -150.71 152.17 33.51 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.677 -174.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -153.79 -36.71 0.1 Allowed 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 123.301 0.64 . . . . 0.0 110.316 170.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.687 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 41.2 tt0 -154.29 129.95 10.0 Favored 'General case' 0 C--O 1.207 -1.135 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.647 -174.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.509 HG12 ' CD2' ' A' ' 89' ' ' LEU . 58.6 t -117.4 98.32 6.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 171.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.497 HG21 ' HD3' ' A' ' 97' ' ' LYS . 16.9 p -100.01 136.14 40.38 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 122.708 1.242 . . . . 0.0 111.848 178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.801 ' HB3' HD11 ' A' ' 18' ' ' LEU . 6.8 mt -108.08 155.3 20.54 Favored 'General case' 0 N--CA 1.398 -3.053 0 CA-C-N 113.663 -1.608 . . . . 0.0 110.078 -168.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.619 ' HB2' ' O ' ' A' ' 19' ' ' MET . 1.9 tm-20 -82.15 144.9 30.42 Favored 'General case' 0 C--N 1.27 -2.887 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.424 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -179.88 170.2 41.33 Favored Glycine 0 C--N 1.276 -2.75 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -81.72 109.26 15.97 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 121.353 2.577 . . . . 0.0 105.999 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 56.6 ttp 53.92 55.69 8.06 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 -173.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.54 ' CE2' ' HB2' ' A' ' 89' ' ' LEU . 40.4 t80 -58.38 125.63 76.22 Favored Pre-proline 0 C--O 1.248 1.008 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.565 -176.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.98 102.66 1.63 Allowed 'Trans proline' 0 C--O 1.249 1.035 0 C-N-CA 122.733 2.289 . . . . 0.0 111.329 179.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 166.27 -11.17 0.07 OUTLIER Glycine 0 C--N 1.301 -1.407 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.822 -177.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.497 ' HD3' HG21 ' A' ' 88' ' ' THR . 51.1 tptt . . . . . 0 N--CA 1.428 -1.541 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.622 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -70.74 -29.19 19.55 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.292 1.995 . . . . 0.0 112.591 -179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 85.3 -1.74 88.42 Favored Glycine 0 C--O 1.228 -0.267 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.45 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.9 ttmt -114.34 146.67 36.32 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.08 119.38 6.47 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.022 1.815 . . . . 0.0 110.012 175.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -78.34 10.87 2.72 Favored 'General case' 0 C--O 1.27 2.178 0 C-N-CA 123.151 0.581 . . . . 0.0 111.627 -179.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.3 m 62.07 46.92 6.07 Favored 'General case' 0 N--CA 1.438 -1.035 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.459 173.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.42 ' C ' ' HG ' ' A' ' 9' ' ' LEU . 5.5 tt 46.97 54.1 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.394 2.511 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.824 ' HB3' ' HB3' ' A' ' 16' ' ' LYS 0.317 3.3 pp 57.15 68.56 0.84 Allowed 'General case' 0 C--N 1.379 1.884 0 CA-C-O 122.965 1.364 . . . . 0.0 113.237 178.401 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.54 ' HG3' ' HB2' ' A' ' 13' ' ' LYS 0.293 18.7 ptpt 51.26 61.58 3.16 Favored 'General case' 0 C--N 1.306 -1.307 0 CA-C-N 113.476 -1.693 . . . . 0.0 115.086 178.687 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 49.4 ttm 67.53 37.51 3.38 Favored 'General case' 0 CA--C 1.556 1.187 0 C-N-CA 123.584 0.753 . . . . 0.0 110.543 174.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.2 m 71.34 36.66 1.3 Allowed 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 121.427 0.632 . . . . 0.0 110.803 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.54 ' HB2' ' HG3' ' A' ' 10' ' ' LYS . 56.8 mtpt -91.74 -98.44 0.12 Allowed 'General case' 0 N--CA 1.441 -0.911 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.04 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -155.42 -172.28 4.1 Favored 'General case' 0 CA--C 1.551 0.997 0 CA-C-N 118.053 0.388 . . . . 0.0 110.429 -175.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.32 -51.53 1.4 Allowed Glycine 0 C--N 1.356 1.644 0 N-CA-C 115.24 0.856 . . . . 0.0 115.24 172.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.824 ' HB3' ' HB3' ' A' ' 9' ' ' LEU . 49.6 tptt -83.78 135.93 34.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-N 118.215 1.007 . . . . 0.0 111.54 -176.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.617 HG23 ' HD2' ' A' ' 66' ' ' ARG . 30.3 m -69.73 115.16 8.65 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 174.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.032 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -110.96 102.9 11.34 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 122.853 1.311 . . . . 0.0 108.365 -176.433 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.813 ' H ' ' HB2' ' A' ' 90' ' ' GLU . 6.2 ttt -84.84 119.62 25.53 Favored 'General case' 0 C--N 1.27 -2.859 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.737 176.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.509 ' HE2' ' HB2' ' A' ' 20' ' ' MET . 26.0 ttm -110.46 110.04 20.64 Favored 'General case' 0 N--CA 1.415 -2.215 0 C-N-CA 118.729 -1.189 . . . . 0.0 111.077 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -91.77 115.93 28.47 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 104.322 -2.473 . . . . 0.0 104.322 175.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -128.72 130.69 68.82 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -169.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.073 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 18.3 m -84.9 143.63 28.89 Favored 'General case' 0 CA--C 1.604 3.034 0 O-C-N 124.77 1.294 . . . . 0.0 110.946 174.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.527 HG21 HD13 ' A' ' 36' ' ' ILE 0.288 6.9 t -126.74 135.48 63.6 Favored 'Isoleucine or valine' 0 CA--C 1.594 2.66 0 C-N-CA 130.069 3.348 . . . . 0.0 104.326 -176.287 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -117.13 -21.26 8.92 Favored 'General case' 0 C--N 1.372 1.545 0 CA-C-N 122.921 2.601 . . . . 0.0 117.062 -169.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -53.05 -45.19 62.66 Favored Glycine 0 CA--C 1.535 1.283 0 CA-C-N 119.021 0.828 . . . . 0.0 114.217 -176.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.859 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.5 t-20 -116.18 116.82 39.56 Favored Pre-proline 0 N--CA 1.433 -1.313 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -88.36 30.84 0.42 Allowed 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.901 2.401 . . . . 0.0 113.147 -176.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 14.6 p -139.1 -174.84 3.96 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.531 ' O ' ' HB ' ' A' ' 33' ' ' THR . 32.7 tt0 -77.27 0.37 22.31 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 118.573 0.624 . . . . 0.0 111.727 -173.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -68.26 -43.35 78.01 Favored 'General case' 0 N--CA 1.439 -1.004 0 O-C-N 122.049 -0.407 . . . . 0.0 110.601 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.859 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 0.7 OUTLIER -71.29 -39.32 71.58 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 118.086 -1.445 . . . . 0.0 108.314 -179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.531 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 61.1 m -45.04 -54.21 6.91 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 124.407 1.083 . . . . 0.0 111.482 172.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -70.63 -43.02 70.1 Favored 'General case' 0 C--O 1.265 1.882 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -52.72 -55.32 23.55 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.644 HG23 ' CE3' ' A' ' 40' ' ' TRP . 27.3 mt -62.59 -35.68 71.45 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.549 0 CA-C-N 112.574 -2.103 . . . . 0.0 112.932 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 23.2 m -61.77 -55.18 32.84 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 119.192 -1.003 . . . . 0.0 109.399 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.452 ' O ' ' HA3' ' A' ' 42' ' ' GLY . 34.2 m -65.54 -48.51 72.19 Favored 'General case' 0 N--CA 1.428 -1.559 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.592 -176.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.6 mt -66.0 -57.22 8.27 Favored 'General case' 0 CA--C 1.5 -0.967 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.112 -177.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.682 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 36.4 m0 -69.22 -74.03 0.14 Allowed 'General case' 0 N--CA 1.422 -1.841 0 CA-C-O 118.173 -0.917 . . . . 0.0 110.248 -177.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.675 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.405 0.0 OUTLIER -72.05 -15.74 62.03 Favored 'General case' 0 C--O 1.253 1.28 0 C-N-CA 116.957 -1.897 . . . . 0.0 112.773 -168.01 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.452 ' HA3' ' O ' ' A' ' 38' ' ' SER . . . -67.23 -51.3 39.15 Favored Glycine 0 N--CA 1.42 -2.401 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 171.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 39.9 t -70.32 -27.47 64.39 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.795 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 16.2 mt -64.2 -28.71 69.93 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 121.038 0.447 . . . . 0.0 110.075 177.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.562 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 75.9 t80 -94.31 -28.44 15.57 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 121.108 0.48 . . . . 0.0 110.43 174.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 20.8 t-20 -72.79 -29.73 63.51 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 120.801 0.334 . . . . 0.0 111.184 -176.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.96 11.94 19.01 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 176.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 45.5 44.62 9.95 Favored 'General case' 0 C--O 1.242 0.706 0 C-N-CA 125.751 1.62 . . . . 0.0 114.158 176.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -82.3 151.41 26.76 Favored 'General case' 0 N--CA 1.422 -1.852 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 177.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.92 87.62 7.36 Favored 'General case' 0 C--O 1.242 0.658 0 CA-C-N 120.726 1.603 . . . . 0.0 110.503 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.866 HG12 ' HA ' ' A' ' 65' ' ' LEU . 3.1 m -147.89 175.53 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.955 -173.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.448 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 26.8 tt0 -140.02 123.29 16.92 Favored 'General case' 0 C--O 1.201 -1.486 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.795 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -136.07 135.89 39.74 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -170.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.815 ' H ' HG12 ' A' ' 62' ' ' ILE . 16.7 m-85 -134.46 153.99 51.63 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 -165.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 80.2 mt -80.03 124.75 38.46 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 104.786 -2.302 . . . . 0.0 104.786 165.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.5 m -132.98 -15.46 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.254 0 CA-C-O 120.83 0.348 . . . . 0.0 110.739 -178.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.524 ' HA3' ' HG2' ' A' ' 60' ' ' ARG . . . -166.32 163.64 37.03 Favored Glycine 0 N--CA 1.44 -1.066 0 C-N-CA 118.051 -2.023 . . . . 0.0 113.905 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.478 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 37.3 m -77.91 45.85 0.54 Allowed 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 124.668 1.187 . . . . 0.0 111.579 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 58' ' ' SER . 3.1 p-10 158.63 14.92 0.0 OUTLIER 'General case' 0 C--O 1.196 -1.745 0 C-N-CA 126.904 2.082 . . . . 0.0 106.496 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.524 ' HG2' ' HA3' ' A' ' 57' ' ' GLY . 0.0 OUTLIER -149.02 147.76 28.93 Favored 'General case' 0 C--N 1.357 0.918 0 CA-C-O 121.669 0.747 . . . . 0.0 112.344 177.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.45 169.88 16.84 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 125.736 1.614 . . . . 0.0 106.874 -172.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.815 HG12 ' H ' ' A' ' 54' ' ' PHE . 1.7 pt -136.19 157.82 38.02 Favored 'Isoleucine or valine' 0 CA--C 1.453 -2.778 0 C-N-CA 118.377 -1.329 . . . . 0.0 109.559 172.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.557 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -134.33 109.23 8.67 Favored 'General case' 0 N--CA 1.423 -1.802 0 O-C-N 126.434 2.334 . . . . 0.0 106.362 162.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.594 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 23.3 ttt -97.83 108.96 21.79 Favored 'General case' 0 C--N 1.273 -2.752 0 CA-C-N 114.585 -1.188 . . . . 0.0 109.347 -179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.919 HD13 ' HB2' ' A' ' 71' ' ' ALA 0.306 2.3 pt? -98.47 147.94 24.23 Favored 'General case' 0 CA--C 1.464 -2.359 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -176.127 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.617 ' HD2' HG23 ' A' ' 17' ' ' THR 0.26 12.6 mmm180 -100.28 -53.41 3.13 Favored 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 111.578 -2.555 . . . . 0.0 113.576 -174.017 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -45.47 -27.46 0.72 Allowed 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 174.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.95 -31.31 5.37 Favored Glycine 0 C--N 1.353 1.504 0 CA-C-N 119.663 1.12 . . . . 0.0 111.936 -173.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.261 40.6 t -98.17 -61.61 1.36 Allowed 'General case' 0 CA--C 1.588 2.43 0 N-CA-C 118.29 2.7 . . . . 0.0 118.29 -175.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.479 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -64.42 34.46 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 118.948 2.944 . . . . 0.0 118.948 -168.62 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.919 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -103.16 -22.47 13.74 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 -178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.772 ' HH2' ' HG ' ' A' ' 18' ' ' LEU 0.504 13.6 m-90 -82.16 -28.93 31.84 Favored 'General case' 0 C--O 1.284 2.921 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -170.259 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -71.15 -27.57 63.64 Favored 'General case' 0 C--O 1.255 1.371 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.655 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.8 mt -62.22 -39.97 85.96 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.563 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 174.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.759 ' HA ' ' CD1' ' A' ' 78' ' ' LEU . 26.2 ttpp -58.54 -43.3 89.21 Favored 'General case' 0 C--O 1.288 3.089 0 CA-C-O 121.445 0.641 . . . . 0.0 110.595 177.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -56.41 -45.96 80.42 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 118.582 -1.247 . . . . 0.0 111.209 174.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.655 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 10.0 m-85 -60.38 -39.71 88.22 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.321 -177.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.759 ' CD1' ' HA ' ' A' ' 75' ' ' LYS 0.275 21.5 mt -52.46 -59.74 4.07 Favored 'General case' 0 CA--C 1.45 -2.877 0 C-N-CA 123.077 0.551 . . . . 0.0 110.205 177.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.825 HG22 ' HB3' ' A' ' 84' ' ' CYS . 1.6 t -77.94 -9.26 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 C-N-CA 118.923 -1.111 . . . . 0.0 110.684 -172.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.2 t -92.83 -12.24 31.62 Favored 'General case' 0 N--CA 1.414 -2.246 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.615 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -107.15 -39.11 5.81 Favored 'General case' 0 CA--C 1.473 -1.989 0 C-N-CA 117.799 -1.56 . . . . 0.0 108.637 -177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -141.43 -169.45 2.87 Favored 'General case' 0 N--CA 1.389 -3.488 0 CA-C-N 113.419 -1.719 . . . . 0.0 107.06 -175.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 49.8 ttt180 -108.32 76.92 1.06 Allowed 'General case' 0 N--CA 1.419 -1.983 0 CA-C-N 119.905 1.23 . . . . 0.0 110.645 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.825 ' HB3' HG22 ' A' ' 79' ' ' VAL . 3.8 t -70.49 157.53 37.68 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 113.518 -1.673 . . . . 0.0 109.645 176.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -154.75 -35.59 0.09 Allowed 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 -168.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.073 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.4 tt0 -135.51 125.22 25.38 Favored 'General case' 0 CA--C 1.491 -1.304 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.42 -171.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.438 ' HB ' HD21 ' A' ' 89' ' ' LEU . 18.7 m -123.26 113.12 36.39 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.42 ' C ' HD23 ' A' ' 89' ' ' LEU . 3.4 p -107.31 128.27 54.29 Favored 'General case' 0 CA--C 1.477 -1.831 0 CA-C-O 122.36 1.076 . . . . 0.0 109.841 168.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.032 ' HB3' HD11 ' A' ' 18' ' ' LEU . 3.3 mt -109.41 158.6 17.77 Favored 'General case' 0 C--N 1.259 -3.366 0 CA-C-N 113.434 -1.712 . . . . 0.0 108.731 -168.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.813 ' HB2' ' H ' ' A' ' 19' ' ' MET . 0.0 OUTLIER -78.38 146.92 34.34 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 123.733 0.645 . . . . 0.0 109.754 -172.006 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 114.04 101.99 2.47 Favored Glycine 0 N--CA 1.408 -3.214 0 N-CA-C 107.234 -2.346 . . . . 0.0 107.234 -174.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -59.4 110.88 1.19 Allowed 'General case' 0 C--N 1.378 1.815 0 CA-C-N 121.031 2.416 . . . . 0.0 108.667 179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 55.2 ttm 58.46 69.17 0.75 Allowed 'General case' 0 C--N 1.327 -0.37 0 O-C-N 124.43 1.081 . . . . 0.0 108.664 -170.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.658 ' CE2' HD12 ' A' ' 89' ' ' LEU . 11.7 p90 -71.12 -38.65 7.24 Favored Pre-proline 0 CA--C 1.568 1.663 0 CA-C-N 113.78 -1.554 . . . . 0.0 114.645 -177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.462 ' HD3' ' CD1' ' A' ' 94' ' ' TYR . 42.9 Cg_endo -102.0 -173.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.379 2.132 0 C-N-CA 122.118 1.879 . . . . 0.0 111.537 176.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 111.38 -4.74 28.21 Favored Glycine 0 CA--C 1.506 -0.472 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.97 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.564 ' C ' ' HE3' ' A' ' 97' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.556 0 N-CA-C 105.234 -2.135 . . . . 0.0 105.234 -178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 CA--C 1.506 -0.493 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 1' ' ' GLY . 27.0 Cg_exo -64.08 -22.64 67.65 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.464 2.776 . . . . 0.0 113.129 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.936 ' HA3' ' HA ' ' A' ' 95' ' ' PRO . . . -126.02 31.12 4.17 Favored Glycine 0 N--CA 1.434 -1.499 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.425 ' HG2' ' HD2' ' A' ' 5' ' ' PRO . 87.3 tttt -107.84 154.64 40.89 Favored Pre-proline 0 C--O 1.255 1.351 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 -177.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.425 ' HD2' ' HG2' ' A' ' 4' ' ' LYS . 46.7 Cg_exo -44.74 146.17 2.43 Favored 'Trans proline' 0 C--N 1.387 2.575 0 C-N-CA 123.545 2.83 . . . . 0.0 113.254 178.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.452 ' HA ' ' HG ' ' A' ' 9' ' ' LEU . 25.2 mm-40 73.09 -46.42 0.65 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 125.08 1.352 . . . . 0.0 113.016 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.9 m -69.52 -29.47 67.08 Favored 'General case' 0 N--CA 1.439 -1.01 0 O-C-N 121.181 -0.949 . . . . 0.0 109.851 -178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.604 HG13 ' CZ3' ' A' ' 72' ' ' TRP . 0.6 OUTLIER -71.33 -38.76 70.68 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.951 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.095 176.532 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.9 HD22 ' HA ' ' A' ' 69' ' ' SER . 3.4 pp -79.48 -11.08 59.91 Favored 'General case' 0 C--O 1.2 -1.532 0 C-N-CA 120.025 -0.67 . . . . 0.0 111.937 178.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -92.95 -23.96 18.56 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.397 174.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 26.0 ttt -78.51 -31.18 47.51 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.382 173.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.8 m -98.46 -19.35 17.73 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.018 -178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 mttp 75.72 169.28 0.27 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 124.885 1.274 . . . . 0.0 111.885 -178.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.624 ' HE2' ' HB2' ' A' ' 69' ' ' SER . 37.9 ttmt -75.84 142.64 42.15 Favored 'General case' 0 CA--C 1.577 1.999 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 178.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.659 ' H ' ' HA3' ' A' ' 68' ' ' GLY . . . 134.22 -54.38 0.76 Allowed Glycine 0 CA--C 1.556 2.621 0 C-N-CA 118.185 -1.96 . . . . 0.0 115.697 -175.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.4 tppt? -67.07 133.59 50.17 Favored 'General case' 0 C--N 1.364 1.198 0 CA-C-N 120.222 2.011 . . . . 0.0 112.488 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.6 m -78.61 124.27 27.99 Favored 'General case' 0 CA--C 1.55 0.964 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.813 ' HB3' HD22 ' A' ' 65' ' ' LEU . 25.6 tp -131.2 115.4 16.3 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 120.419 -0.513 . . . . 0.0 111.008 -174.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.678 ' HB3' ' SD ' ' A' ' 64' ' ' MET . 20.0 ptm -84.31 105.99 15.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.602 0.715 . . . . 0.0 112.282 176.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.831 ' HG3' ' HA ' ' A' ' 89' ' ' LEU . 3.6 mpp? -86.29 125.22 33.44 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.554 0.692 . . . . 0.0 112.261 176.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.635 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 47.2 t80 -106.06 112.92 26.17 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 127.246 2.218 . . . . 0.0 106.116 -176.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.78 130.36 74.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.772 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 -168.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.848 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 89.5 m -93.05 131.14 38.32 Favored 'General case' 0 CA--C 1.611 3.295 0 C-N-CA 126.151 1.781 . . . . 0.0 111.883 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.6 t -132.14 113.44 21.76 Favored 'Isoleucine or valine' 0 CA--C 1.586 2.358 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 -178.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -105.77 -18.98 13.89 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 122.01 2.187 . . . . 0.0 115.185 -164.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.45 ' HA3' ' HG2' ' A' ' 83' ' ' ARG . . . -39.17 -49.08 2.78 Favored Glycine 0 N--CA 1.487 2.035 0 O-C-N 123.419 0.449 . . . . 0.0 113.612 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 1.08 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 26.9 t-20 -115.86 104.74 52.35 Favored Pre-proline 0 N--CA 1.421 -1.881 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 172.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_exo -76.14 33.74 0.41 Allowed 'Trans proline' 0 N--CA 1.481 0.75 0 C-N-CA 123.888 3.059 . . . . 0.0 112.71 -174.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.3 p -148.43 -165.27 2.23 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -173.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.475 ' O ' ' HB ' ' A' ' 33' ' ' THR . 39.6 tt0 -81.05 -18.47 46.57 Favored 'General case' 0 C--O 1.19 -2.039 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -173.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.46 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 3.4 tmtt? -58.96 -41.25 87.03 Favored 'General case' 0 C--O 1.256 1.409 0 CA-C-N 119.032 0.833 . . . . 0.0 111.491 -177.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 1.08 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 5.9 tp10 -66.42 -61.49 1.97 Allowed 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 31.5 m -34.35 -50.25 0.41 Allowed 'General case' 0 C--O 1.19 -2.073 0 C-N-CA 127.158 2.183 . . . . 0.0 113.026 172.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.46 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.8 pt-20 -71.99 -49.66 35.26 Favored 'General case' 0 C--O 1.254 1.323 0 CA-C-N 118.124 0.42 . . . . 0.0 112.031 -177.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -54.24 -54.15 43.89 Favored 'General case' 0 C--O 1.263 1.801 0 CA-C-O 123.045 1.402 . . . . 0.0 107.296 179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.041 HD12 ' HG3' ' A' ' 32' ' ' GLU . 1.5 mt -66.83 -38.99 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.387 -3.584 0 CA-C-N 111.622 -2.536 . . . . 0.0 113.541 -177.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.744 HG21 HG12 ' A' ' 55' ' ' ILE . 11.3 p -73.82 -39.3 64.16 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-N 121.3 1.864 . . . . 0.0 110.946 -176.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.0 t -64.22 -47.83 78.2 Favored 'General case' 0 N--CA 1.412 -2.344 0 O-C-N 124.017 0.823 . . . . 0.0 109.659 178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.4 tp -68.75 -44.37 73.9 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 119.418 -0.913 . . . . 0.0 110.765 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.827 ' CE3' HD12 ' A' ' 78' ' ' LEU . 48.8 m0 -66.2 -74.02 0.12 Allowed 'General case' 0 CA--C 1.497 -1.061 0 CA-C-O 118.952 -0.547 . . . . 0.0 111.708 -177.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.693 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.339 0.0 OUTLIER -70.83 -19.29 62.68 Favored 'General case' 0 C--O 1.247 0.949 0 C-N-CA 118.044 -1.462 . . . . 0.0 111.884 -172.601 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -65.03 -48.91 65.57 Favored Glycine 0 C--N 1.356 1.646 0 N-CA-C 110.216 -1.153 . . . . 0.0 110.216 172.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.6 p -70.0 -29.63 66.75 Favored 'General case' 0 C--O 1.251 1.174 0 CA-C-N 117.442 0.621 . . . . 0.0 110.25 177.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.743 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 22.8 mt -61.07 -32.49 72.13 Favored 'General case' 0 C--N 1.347 0.491 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.003 176.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.651 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 80.5 t80 -92.11 -27.38 17.78 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.873 176.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -67.89 -30.67 70.08 Favored 'General case' 0 C--O 1.219 -0.534 0 CA-C-O 120.629 0.252 . . . . 0.0 111.004 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -93.69 -0.01 56.24 Favored 'General case' 0 C--O 1.241 0.622 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.6 t30 47.17 53.87 10.14 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.136 1.774 . . . . 0.0 112.006 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -65.58 0.69 1.5 Allowed 'General case' 0 CA--C 1.58 2.109 0 N-CA-C 116.426 2.009 . . . . 0.0 116.426 175.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.9 t70 59.3 70.87 0.61 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.305 1.042 . . . . 0.0 111.365 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.54 ' CG2' ' HD2' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -146.92 175.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 114.189 -1.369 . . . . 0.0 110.919 -172.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 -131.04 115.92 17.09 Favored 'General case' 0 C--O 1.194 -1.828 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.743 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -130.41 140.77 50.56 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -172.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.812 ' H ' HG12 ' A' ' 62' ' ' ILE . 24.4 m-85 -134.02 152.06 51.69 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 115.509 1.67 . . . . 0.0 115.509 -167.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.744 HG12 HG21 ' A' ' 37' ' ' THR . 19.9 mt -92.65 97.24 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 167.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 6.7 m -99.1 -22.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.181 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.84 169.03 40.81 Favored Glycine 0 CA--C 1.482 -1.975 0 C-N-CA 118.192 -1.956 . . . . 0.0 113.78 175.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.468 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 36.9 m -65.04 120.4 12.57 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.0 OUTLIER 78.79 14.76 1.19 Allowed 'General case' 0 C--N 1.371 1.541 0 CA-C-O 122.658 1.218 . . . . 0.0 108.823 -178.613 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.635 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 4.1 tpp85 -143.84 117.49 9.23 Favored 'General case' 0 CA--C 1.557 1.236 0 O-C-N 121.419 -0.8 . . . . 0.0 111.266 -178.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -129.96 166.44 20.06 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 -175.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.812 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -138.77 155.23 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.461 -2.464 0 C-N-CA 118.174 -1.41 . . . . 0.0 109.699 172.785 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.521 ' CE2' ' HB1' ' A' ' 71' ' ' ALA . 6.0 p90 -134.97 106.37 6.8 Favored 'General case' 0 N--CA 1.417 -2.093 0 O-C-N 126.335 2.272 . . . . 0.0 107.307 163.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.678 ' SD ' ' HB3' ' A' ' 19' ' ' MET . 20.2 ttt -92.15 110.22 21.6 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.45 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.813 HD22 ' HB3' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -75.12 132.38 41.18 Favored 'General case' 0 C--O 1.254 1.313 0 O-C-N 125.895 1.997 . . . . 0.0 110.952 -175.672 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.318 2.1 tmt_? -108.41 -54.95 2.44 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 178.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -41.24 -34.16 0.45 Allowed 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 172.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.659 ' HA3' ' H ' ' A' ' 15' ' ' GLY . . . 109.09 -31.1 7.97 Favored Glycine 0 N--CA 1.426 -2.024 0 C-N-CA 117.723 -2.18 . . . . 0.0 115.079 -173.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.9 ' HA ' HD22 ' A' ' 9' ' ' LEU . 56.9 m -158.66 60.17 0.43 Allowed 'General case' 0 CA--C 1.571 1.764 0 N-CA-C 114.738 1.384 . . . . 0.0 114.738 -171.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.457 ' OH ' HG13 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -152.81 21.38 0.6 Allowed 'General case' 0 C--O 1.218 -0.6 0 O-C-N 121.217 -0.927 . . . . 0.0 110.174 178.602 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.603 ' O ' ' HB ' ' A' ' 74' ' ' ILE . . . -103.19 -29.27 11.41 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 -168.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.604 ' CZ3' HG13 ' A' ' 8' ' ' ILE 0.512 8.1 m0 -87.18 -9.93 53.95 Favored 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 116.317 -2.153 . . . . 0.0 113.828 -171.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.566 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 35.0 tt0 -73.42 -43.12 61.1 Favored 'General case' 0 C--O 1.279 2.653 0 N-CA-C 105.072 -2.195 . . . . 0.0 105.072 166.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.603 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 61.0 mt -50.77 -47.0 29.36 Favored 'Isoleucine or valine' 0 C--O 1.278 2.578 0 CA-C-N 113.961 -1.472 . . . . 0.0 108.801 173.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.613 ' HG3' HG21 ' A' ' 87' ' ' VAL . 44.8 tttm -56.11 -50.61 70.58 Favored 'General case' 0 C--N 1.375 1.688 0 C-N-CA 125.807 1.643 . . . . 0.0 110.269 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -61.86 -25.64 67.65 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.566 ' CZ ' ' HG2' ' A' ' 73' ' ' GLU . 23.1 m-85 -73.76 -61.14 1.94 Allowed 'General case' 0 CA--C 1.48 -1.726 0 C-N-CA 118.382 -1.327 . . . . 0.0 108.35 -175.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.827 HD12 ' CE3' ' A' ' 40' ' ' TRP . 1.9 pt? -66.52 -32.71 74.23 Favored 'General case' 0 C--O 1.297 3.583 0 CA-C-N 114.99 -1.005 . . . . 0.0 112.001 -173.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.837 HG13 ' HB2' ' A' ' 84' ' ' CYS . 54.9 t -77.3 -21.55 14.28 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.977 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.414 -177.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.6 m -103.54 6.76 37.56 Favored 'General case' 0 N--CA 1.418 -2.032 0 C-N-CA 119.564 -0.854 . . . . 0.0 109.209 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.625 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . 6.2 tp-100 -77.3 -46.18 23.85 Favored 'General case' 0 CA--C 1.463 -2.371 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 -179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.455 2.3 p30 -165.26 -94.55 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 171.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.45 ' HG2' ' HA3' ' A' ' 26' ' ' GLY . 4.7 mpt_? -84.7 136.52 33.69 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 117.935 -1.506 . . . . 0.0 111.899 -174.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.837 ' HB2' HG13 ' A' ' 79' ' ' VAL . 7.9 p -152.66 150.84 29.9 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.403 -170.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -162.06 -41.15 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 174.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.848 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 7.6 tp10 -153.81 137.59 16.17 Favored 'General case' 0 C--O 1.21 -1.013 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.35 -176.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.613 HG21 ' HG3' ' A' ' 75' ' ' LYS . 48.7 t -131.68 94.15 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.734 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 175.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.332 0.8 OUTLIER -98.19 126.32 43.61 Favored 'General case' 0 N--CA 1.411 -2.376 0 CA-C-O 123.603 1.668 . . . . 0.0 113.006 176.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.831 ' HA ' ' HG3' ' A' ' 20' ' ' MET . 3.0 mp -75.88 155.34 35.35 Favored 'General case' 1 N--CA 1.374 -4.274 0 CA-C-N 111.223 -2.717 . . . . 0.0 106.16 178.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.691 ' HB3' ' CD1' ' A' ' 18' ' ' LEU . 11.8 tp10 -81.67 159.8 23.88 Favored 'General case' 0 C--N 1.266 -3.022 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 -176.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.91 57.05 3.34 Favored Glycine 0 N--CA 1.422 -2.238 0 CA-C-O 118.569 -1.129 . . . . 0.0 112.265 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.537 ' HA ' ' OE1' ' A' ' 92' ' ' GLN . 9.9 mm-40 -52.83 110.15 0.49 Allowed 'General case' 0 C--N 1.368 1.386 0 CA-C-N 118.784 1.292 . . . . 0.0 111.65 176.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 27.7 ttt 165.41 -25.48 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 112.737 -2.029 . . . . 0.0 106.222 -172.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.52 ' CD1' ' HD3' ' A' ' 95' ' ' PRO 0.295 23.5 p90 -50.57 -39.26 49.61 Favored Pre-proline 0 CA--C 1.563 1.465 0 N-CA-C 116.885 2.179 . . . . 0.0 116.885 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.936 ' HA ' ' HA3' ' A' ' 3' ' ' GLY . 1.0 OUTLIER -78.37 -18.09 12.63 Favored 'Trans proline' 0 C--N 1.377 2.04 0 CA-C-N 121.968 1.739 . . . . 0.0 111.301 177.674 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 122.44 -133.48 9.25 Favored Glycine 0 N--CA 1.406 -3.347 0 N-CA-C 108.103 -1.999 . . . . 0.0 108.103 -173.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt . . . . . 0 C--N 1.293 -1.862 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 177.962 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.882 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_exo -64.09 -23.02 67.42 Favored 'Trans proline' 0 CA--C 1.532 0.414 0 C-N-CA 122.964 2.442 . . . . 0.0 112.276 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -86.09 35.86 3.23 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 178.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 19.5 pttp -71.49 139.37 83.93 Favored Pre-proline 0 C--O 1.238 0.49 0 C-N-CA 123.777 0.831 . . . . 0.0 110.492 177.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.56 ' C ' ' H ' ' A' ' 7' ' ' SER . 5.7 Cg_exo -76.33 -158.64 0.08 OUTLIER 'Trans proline' 0 C--O 1.251 1.165 0 C-N-CA 122.622 2.215 . . . . 0.0 112.935 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.4 mm-40 71.72 -39.15 0.44 Allowed 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 125.565 1.546 . . . . 0.0 107.259 -160.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.56 ' H ' ' C ' ' A' ' 5' ' ' PRO . 8.8 t -76.58 170.95 15.46 Favored 'General case' 0 N--CA 1.383 -3.78 0 N-CA-C 103.749 -2.685 . . . . 0.0 103.749 173.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.11 HG23 ' HA ' ' A' ' 11' ' ' MET 0.297 8.7 tp 30.47 42.06 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.269 2.126 0 CA-C-O 121.886 0.851 . . . . 0.0 110.716 -157.31 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.868 HD13 ' HA ' ' A' ' 13' ' ' LYS . 1.7 pp 52.02 69.38 0.68 Allowed 'General case' 0 C--N 1.412 3.292 0 CA-C-O 122.925 1.345 . . . . 0.0 111.906 171.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 9' ' ' LEU 0.277 22.6 ptmt 61.9 28.21 17.19 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.611 -2.086 . . . . 0.0 112.098 -175.575 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 1.11 ' HA ' HG23 ' A' ' 8' ' ' ILE . 53.2 ttm 56.32 26.79 10.99 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 124.441 1.096 . . . . 0.0 110.251 -178.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.3 m -161.97 -65.67 0.05 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 120.949 -1.094 . . . . 0.0 112.088 -172.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.868 ' HA ' HD13 ' A' ' 9' ' ' LEU . 40.6 ttmt 174.94 116.24 0.02 OUTLIER 'General case' 0 C--N 1.352 0.705 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 -171.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.69 ' O ' ' HA3' ' A' ' 68' ' ' GLY . 65.8 pttt -166.46 168.63 14.64 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 169.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 67' ' ' ASP . . . -67.79 43.94 0.28 Allowed Glycine 0 CA--C 1.546 1.971 0 N-CA-C 116.291 1.277 . . . . 0.0 116.291 -176.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.723 ' HB3' ' HB3' ' A' ' 9' ' ' LEU . 17.0 tppt? -83.47 133.77 34.88 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 118.76 1.28 . . . . 0.0 109.401 178.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.4 m -85.44 130.76 34.51 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.337 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.691 HD12 ' HH2' ' A' ' 72' ' ' TRP . 94.4 mt -130.91 123.84 29.82 Favored 'General case' 0 CA--C 1.484 -1.582 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.422 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 22.0 ptm -84.54 107.5 16.81 Favored 'General case' 0 C--N 1.265 -3.079 0 C-N-CA 118.57 -1.252 . . . . 0.0 108.31 170.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.723 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 32.1 ttm -87.91 104.44 16.61 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 118.135 -1.426 . . . . 0.0 110.187 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -91.6 112.41 24.32 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 126.576 1.95 . . . . 0.0 106.298 -179.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 2.0 p -129.04 132.69 67.03 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -168.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.993 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 70.9 m -80.39 128.38 33.5 Favored 'General case' 0 CA--C 1.595 2.69 0 C-N-CA 125.429 1.492 . . . . 0.0 109.267 173.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 13.4 p -110.93 138.34 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.606 3.113 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 -176.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.991 ' HB3' ' HG2' ' A' ' 32' ' ' GLU . 85.7 p 52.64 -74.94 0.01 OUTLIER 'General case' 0 C--N 1.368 1.401 0 C-N-CA 126.481 1.913 . . . . 0.0 115.936 -169.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 143.68 -14.38 2.22 Favored Glycine 0 N--CA 1.417 -2.615 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -171.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -96.61 120.46 62.01 Favored Pre-proline 0 N--CA 1.42 -1.969 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 177.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.631 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 74.4 Cg_endo -73.71 41.66 0.64 Allowed 'Trans proline' 0 C--O 1.239 0.565 0 C-N-CA 123.49 2.793 . . . . 0.0 112.485 -175.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 69.6 p -110.52 170.39 8.12 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.52 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.1 tp10 -81.47 -15.44 55.03 Favored 'General case' 0 C--O 1.17 -3.099 0 CA-C-N 119.934 1.243 . . . . 0.0 109.793 -175.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.757 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 1.3 tmtt? -48.92 -63.6 1.05 Allowed 'General case' 0 C--O 1.269 2.122 0 C-N-CA 125.19 1.396 . . . . 0.0 114.534 -175.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.991 ' HG2' ' HB3' ' A' ' 25' ' ' SER . 4.6 tp10 -67.76 -45.16 75.68 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -172.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 15.5 m -45.2 -58.56 3.17 Favored 'General case' 0 N--CA 1.403 -2.796 0 CA-C-N 112.071 -2.331 . . . . 0.0 109.689 172.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.757 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 10.8 pt-20 -58.38 -50.86 72.14 Favored 'General case' 0 C--O 1.26 1.61 0 C-N-CA 123.788 0.835 . . . . 0.0 112.751 -172.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.87 ' HG3' HG13 ' A' ' 36' ' ' ILE . 5.9 pt-20 -66.86 -47.67 71.2 Favored 'General case' 0 C--O 1.269 2.082 0 C-N-CA 117.959 -1.496 . . . . 0.0 109.626 -175.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.87 HG13 ' HG3' ' A' ' 35' ' ' GLU . 9.4 mt -76.05 -34.72 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.378 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.145 -172.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.454 ' HA ' ' HB2' ' A' ' 40' ' ' TRP . 44.7 p -68.61 -33.61 74.35 Favored 'General case' 0 CA--C 1.501 -0.93 0 CA-C-N 118.658 0.663 . . . . 0.0 110.82 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.7 m -63.16 -45.18 93.08 Favored 'General case' 0 C--O 1.258 1.53 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 175.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.2 tp -63.57 -38.76 92.34 Favored 'General case' 0 C--N 1.378 1.805 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.769 ' HE1' ' HB3' ' A' ' 78' ' ' LEU . 14.1 m0 -65.67 -84.67 0.02 OUTLIER 'General case' 0 N--CA 1.417 -2.105 0 CA-C-N 115.727 -0.67 . . . . 0.0 112.248 -176.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.697 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.384 0.0 OUTLIER -70.83 -14.26 62.34 Favored 'General case' 0 N--CA 1.429 -1.516 0 C-N-CA 117.992 -1.483 . . . . 0.0 112.357 -169.08 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.29 -53.04 38.8 Favored Glycine 0 C--N 1.366 2.243 0 N-CA-C 109.763 -1.335 . . . . 0.0 109.763 170.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.549 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 80.5 p -72.32 -30.28 64.61 Favored 'General case' 0 C--N 1.347 0.489 0 C-N-CA 119.817 -0.753 . . . . 0.0 110.314 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.811 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 21.5 mt -62.44 -29.5 70.56 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.471 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.598 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 21.3 t80 -92.09 -30.86 15.77 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 176.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.549 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 24.7 t-20 -66.47 -34.83 78.81 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.153 0.581 . . . . 0.0 112.03 -177.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -86.85 -1.29 57.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 56.25 56.41 5.83 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.194 1.398 . . . . 0.0 111.781 177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -89.55 155.0 19.56 Favored 'General case' 0 N--CA 1.429 -1.514 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.6 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 23.6 t70 -91.45 76.46 5.87 Favored 'General case' 0 C--N 1.346 0.424 0 CA-C-N 120.576 1.535 . . . . 0.0 110.252 -176.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.573 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.5 m -139.5 167.19 20.13 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.565 -172.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.532 ' HB3' ' HB3' ' A' ' 64' ' ' MET . 6.3 tt0 -120.9 122.13 39.56 Favored 'General case' 0 C--O 1.189 -2.115 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.811 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -132.72 128.29 36.59 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -177.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.907 ' H ' HG12 ' A' ' 62' ' ' ILE . 52.0 t80 -135.6 146.64 48.13 Favored 'General case' 0 C--N 1.272 -2.762 0 C-N-CA 118.77 -1.172 . . . . 0.0 111.886 -167.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 44.3 mt -93.0 96.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 171.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 39.3 t -70.55 -34.64 58.21 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.293 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 173.53 -166.86 39.34 Favored Glycine 0 CA--C 1.479 -2.166 0 C-N-CA 118.721 -1.704 . . . . 0.0 113.8 176.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.467 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 49.7 m -69.95 123.63 22.0 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.631 ' HB2' ' HA ' ' A' ' 28' ' ' PRO . 5.1 t70 79.4 -1.99 2.19 Favored 'General case' 0 C--O 1.215 -0.752 0 O-C-N 124.542 1.152 . . . . 0.0 109.405 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.2 tpp180 -126.28 117.56 23.3 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 121.408 0.623 . . . . 0.0 111.92 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.83 165.19 25.57 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.907 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -143.74 153.64 16.0 Favored 'Isoleucine or valine' 0 CA--C 1.456 -2.663 0 C-N-CA 118.231 -1.388 . . . . 0.0 109.639 173.03 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.606 ' HA ' ' HG3' ' A' ' 53' ' ' ARG 0.28 10.0 p90 -131.9 104.19 6.73 Favored 'General case' 0 N--CA 1.402 -2.875 0 O-C-N 126.558 2.411 . . . . 0.0 107.155 161.341 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.532 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . 23.9 ttt -90.28 109.96 21.04 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 113.818 -1.537 . . . . 0.0 110.809 -176.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.683 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.265 3.9 mp -76.59 145.13 39.15 Favored 'General case' 0 CA--C 1.457 -2.634 0 C-N-CA 126.085 1.754 . . . . 0.0 110.892 -175.642 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.6 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.329 61.6 ttt180 -119.52 -58.42 1.91 Allowed 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 174.141 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.516 ' O ' ' HA2' ' A' ' 15' ' ' GLY . 10.4 t70 -70.67 8.55 0.83 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.203 1.557 . . . . 0.0 115.203 -176.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.69 ' HA3' ' O ' ' A' ' 14' ' ' LYS . . . 58.87 -24.78 0.02 OUTLIER Glycine 0 CA--C 1.559 2.837 0 CA-C-N 120.126 1.33 . . . . 0.0 116.244 -169.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.484 ' H ' ' C ' ' A' ' 67' ' ' ASP . 6.3 m -87.05 15.71 5.77 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -169.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -164.23 135.21 4.37 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-O 118.681 -0.676 . . . . 0.0 110.718 -176.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.811 ' HA ' HD12 ' A' ' 74' ' ' ILE . . . 156.37 -31.64 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 127.019 2.128 . . . . 0.0 111.708 172.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.699 ' CZ2' HD23 ' A' ' 89' ' ' LEU 0.272 13.7 m-90 -74.53 -30.86 61.94 Favored 'General case' 0 C--O 1.254 1.328 0 CA-C-O 121.722 0.772 . . . . 0.0 111.873 -174.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.427 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 36.8 tt0 -68.8 -37.51 79.3 Favored 'General case' 0 C--O 1.265 1.915 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 173.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.811 HD12 ' HA ' ' A' ' 71' ' ' ALA . 12.7 mt -61.62 -44.21 98.29 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.557 0 CA-C-N 113.892 -1.504 . . . . 0.0 110.516 177.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.713 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 0.0 OUTLIER -70.44 -27.9 64.62 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 120.307 -0.557 . . . . 0.0 110.822 -178.066 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -61.74 -48.71 79.46 Favored 'General case' 0 C--O 1.247 0.963 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.954 171.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.527 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 18.9 m-85 -55.64 -45.66 77.58 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-O 122.157 0.98 . . . . 0.0 109.923 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.769 ' HB3' ' HE1' ' A' ' 40' ' ' TRP 0.27 4.3 pp -63.96 -47.46 80.34 Favored 'General case' 0 N--CA 1.412 -2.373 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.516 ' N ' HD12 ' A' ' 78' ' ' LEU 0.355 4.4 m -77.04 -1.8 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.72 0 C-N-CA 116.63 -2.028 . . . . 0.0 112.685 176.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 50.4 m -85.57 -20.03 30.19 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-N 114.292 -1.322 . . . . 0.0 109.005 166.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.421 ' HG2' HG23 ' A' ' 36' ' ' ILE . 8.5 tp-100 -80.93 -17.53 50.22 Favored 'General case' 0 C--N 1.367 1.357 0 N-CA-C 105.182 -2.155 . . . . 0.0 105.182 171.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.258 23.2 t70 88.99 -50.61 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.888 0 CA-C-N 112.489 -2.141 . . . . 0.0 114.527 168.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.794 ' HB3' ' HB3' ' A' ' 25' ' ' SER . 33.3 mmt180 -84.79 76.6 10.21 Favored 'General case' 0 N--CA 1.431 -1.411 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -177.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.658 ' HB3' HD13 ' A' ' 78' ' ' LEU . 61.3 m -154.91 37.62 0.41 Allowed 'General case' 0 CA--C 1.556 1.175 0 CA-C-O 123.073 1.416 . . . . 0.0 110.406 -168.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -32.16 -45.92 0.11 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 131.009 3.723 . . . . 0.0 120.274 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.993 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 30.6 tt0 -146.71 123.58 11.3 Favored 'General case' 0 C--O 1.198 -1.629 0 C-N-CA 117.244 -1.782 . . . . 0.0 113.906 -164.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.625 ' HB ' HD11 ' A' ' 89' ' ' LEU . 16.3 m -113.55 131.69 64.63 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 177.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.447 ' C ' HD12 ' A' ' 89' ' ' LEU 0.265 16.7 p -117.77 120.84 39.16 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-O 122.917 1.341 . . . . 0.0 110.095 165.099 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.723 ' HG ' ' HG3' ' A' ' 20' ' ' MET . 5.1 mp -103.37 157.19 17.2 Favored 'General case' 0 C--N 1.262 -3.239 0 CA-C-N 112.708 -2.042 . . . . 0.0 106.638 -173.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.498 ' HB3' ' CD2' ' A' ' 18' ' ' LEU . 7.5 tt0 -78.18 146.55 34.94 Favored 'General case' 0 C--N 1.256 -3.463 0 CA-C-O 121.909 0.861 . . . . 0.0 111.98 -162.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 133.23 163.92 10.65 Favored Glycine 0 N--CA 1.416 -2.693 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -108.05 109.08 20.44 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 120.961 2.381 . . . . 0.0 106.717 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 53.19 73.04 0.39 Allowed 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 -170.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.723 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 3.4 p90 -101.7 149.18 36.22 Favored Pre-proline 0 C--N 1.297 -1.705 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.093 -172.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.42 ' HD2' ' OG ' ' A' ' 7' ' ' SER . 88.3 Cg_endo -84.7 151.79 11.51 Favored 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.191 1.927 . . . . 0.0 110.271 172.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 150.09 93.91 0.11 Allowed Glycine 0 C--N 1.297 -1.623 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 -179.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 3.6 mptp? . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 124.384 1.074 . . . . 0.0 110.88 -174.794 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.458 ' N ' ' HB2' ' A' ' 6' ' ' GLU . . . . . . . . 0 CA--C 1.493 -1.312 0 N-CA-C 109.805 -1.318 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.64 -13.45 37.2 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.574 2.183 . . . . 0.0 113.676 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -126.3 -35.35 0.58 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.233 178.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -100.16 140.12 21.24 Favored Pre-proline 0 C--O 1.246 0.903 0 O-C-N 122.461 -0.435 . . . . 0.0 110.991 -179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.613 ' HB3' ' HB2' ' A' ' 97' ' ' LYS . 35.1 Cg_exo -62.89 130.66 30.02 Favored 'Trans proline' 0 C--N 1.37 1.663 0 C-N-CA 122.887 2.391 . . . . 0.0 109.428 176.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HB2' ' N ' ' A' ' 1' ' ' GLY . 25.7 tt0 -107.99 11.13 28.1 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.302 -173.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 69.3 m 61.81 53.37 3.17 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.282 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.452 ' O ' HD12 ' A' ' 9' ' ' LEU . 5.8 tp 51.43 56.33 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.397 2.672 0 C-N-CA 124.076 0.95 . . . . 0.0 109.164 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 8' ' ' ILE 0.362 2.0 pp 51.63 65.31 1.53 Allowed 'General case' 0 C--N 1.391 2.41 0 CA-C-O 123.156 1.455 . . . . 0.0 114.125 179.211 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.416 ' HE2' ' HG3' ' A' ' 14' ' ' LYS 0.287 60.8 pttt 49.19 68.09 0.77 Allowed 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 112.615 -2.084 . . . . 0.0 114.297 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 84.0 mtp 65.8 30.59 10.01 Favored 'General case' 0 C--O 1.243 0.741 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.466 175.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.558 HG23 ' HE3' ' A' ' 72' ' ' TRP . 12.1 m 77.2 38.03 0.24 Allowed 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.706 0.802 . . . . 0.0 112.645 172.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -153.52 98.28 2.22 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 121.899 -0.501 . . . . 0.0 110.656 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HG3' ' HE2' ' A' ' 10' ' ' LYS . 78.2 tttt -148.71 16.37 0.99 Allowed 'General case' 0 CA--C 1.553 1.067 0 CA-C-O 121.397 0.618 . . . . 0.0 110.975 178.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.415 ' HA2' ' O ' ' A' ' 67' ' ' ASP . . . 53.66 51.6 47.51 Favored Glycine 0 CA--C 1.563 3.042 0 N-CA-C 118.006 1.962 . . . . 0.0 118.006 175.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.434 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 20.3 tptm -128.55 133.31 48.35 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 120.443 2.122 . . . . 0.0 109.348 175.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.8 t -72.0 133.61 45.42 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-O 121.131 0.491 . . . . 0.0 109.854 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.933 HD21 ' HA ' ' A' ' 89' ' ' LEU . 13.3 tp -134.04 133.93 41.8 Favored 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.178 -177.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 86.7 mtp -83.56 100.27 10.69 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 104.47 -2.418 . . . . 0.0 104.47 164.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.556 ' CE ' ' HB1' ' A' ' 71' ' ' ALA . 53.7 ttp -86.45 119.97 27.29 Favored 'General case' 0 CA--C 1.475 -1.911 0 C-N-CA 118.715 -1.194 . . . . 0.0 109.804 -178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.598 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 49.8 t80 -97.96 124.6 42.49 Favored 'General case' 0 C--N 1.282 -2.328 0 CA-C-N 112.868 -1.969 . . . . 0.0 106.896 -174.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -129.37 125.9 62.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 116.05 1.87 . . . . 0.0 116.05 -173.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.051 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 86.8 m -77.05 120.61 22.39 Favored 'General case' 0 CA--C 1.587 2.4 0 C-N-CA 125.409 1.483 . . . . 0.0 110.891 169.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.659 HG21 HD13 ' A' ' 36' ' ' ILE . 10.3 p -114.48 125.09 71.71 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.838 0 N-CA-C 103.463 -2.791 . . . . 0.0 103.463 170.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -133.87 13.05 4.01 Favored 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 115.73 -2.388 . . . . 0.0 113.54 -163.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.11 -37.91 93.48 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 119.198 -1.477 . . . . 0.0 109.895 176.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 1.127 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 23.6 t-20 -117.13 106.73 46.77 Favored Pre-proline 0 N--CA 1.423 -1.824 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -72.94 30.32 0.29 Allowed 'Trans proline' 0 N--CA 1.486 1.039 0 C-N-CA 123.569 2.846 . . . . 0.0 113.251 -176.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.2 p -143.4 -171.16 3.44 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 -176.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.411 ' O ' ' HB ' ' A' ' 33' ' ' THR . 33.2 tt0 -82.29 -7.05 59.62 Favored 'General case' 0 C--O 1.206 -1.199 0 CA-C-N 118.802 0.728 . . . . 0.0 112.537 -171.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.515 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 2.4 tmpt? -60.91 -45.59 94.02 Favored 'General case' 0 C--O 1.248 0.975 0 CA-C-N 118.235 0.47 . . . . 0.0 110.369 179.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 1.127 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.5 tp10 -67.59 -49.55 62.57 Favored 'General case' 0 C--O 1.213 -0.859 0 N-CA-C 106.9 -1.518 . . . . 0.0 106.9 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 86.9 m -44.49 -52.13 8.19 Favored 'General case' 0 C--O 1.196 -1.738 0 C-N-CA 124.989 1.316 . . . . 0.0 112.409 172.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.515 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.3 pt-20 -67.84 -51.51 47.62 Favored 'General case' 0 C--O 1.253 1.273 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -175.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -59.02 -47.06 86.58 Favored 'General case' 0 C--O 1.25 1.081 0 CA-C-O 122.929 1.347 . . . . 0.0 108.071 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.895 HD12 ' HG3' ' A' ' 32' ' ' GLU . 10.1 mt -69.85 -40.61 79.11 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.58 0 CA-C-N 113.401 -1.727 . . . . 0.0 112.804 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.876 HG21 HG12 ' A' ' 55' ' ' ILE . 12.9 p -69.61 -37.69 76.95 Favored 'General case' 0 C--O 1.248 1.002 0 CA-C-N 120.54 1.518 . . . . 0.0 111.047 -176.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.6 p -64.75 -57.86 7.81 Favored 'General case' 0 N--CA 1.427 -1.577 0 O-C-N 123.864 0.727 . . . . 0.0 109.668 178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.1 tp -66.11 -43.21 87.88 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.745 ' HZ2' ' HB2' ' A' ' 82' ' ' ASP . 44.0 m0 -69.59 -69.12 0.36 Allowed 'General case' 0 C--O 1.197 -1.706 0 CA-C-O 118.199 -0.905 . . . . 0.0 110.901 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.791 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.421 0.0 OUTLIER -68.97 -20.05 64.17 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 117.554 -1.659 . . . . 0.0 112.669 -171.827 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -64.46 -50.42 59.51 Favored Glycine 0 C--N 1.345 1.036 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 170.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.44 ' HA ' ' HB2' ' A' ' 46' ' ' ASN . 65.3 p -69.64 -25.39 63.91 Favored 'General case' 0 CA--C 1.54 0.565 0 O-C-N 122.082 -0.658 . . . . 0.0 110.644 176.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.791 ' HG ' ' HA ' ' A' ' 41' ' ' GLN . 20.1 mt -62.07 -31.15 71.54 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 174.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -77.45 -44.13 30.06 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 121.383 0.611 . . . . 0.0 110.479 169.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 43' ' ' SER . 84.8 m-20 -63.61 -30.59 71.68 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -172.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.18 2.52 54.08 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.15 0.5 . . . . 0.0 110.33 177.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 55.05 62.32 2.56 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.336 1.455 . . . . 0.0 111.826 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -98.54 152.12 19.91 Favored 'General case' 0 N--CA 1.427 -1.601 0 O-C-N 120.664 -1.272 . . . . 0.0 108.211 176.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -87.26 82.56 7.58 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 120.343 1.429 . . . . 0.0 110.288 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 1.031 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.1 m -147.75 165.63 5.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.607 -174.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.444 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 1.9 mp0 -131.25 124.4 30.46 Favored 'General case' 0 C--O 1.194 -1.859 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 171.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.836 ' HG3' ' HA ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -124.56 138.99 54.28 Favored 'General case' 0 C--N 1.287 -2.133 0 O-C-N 121.47 -0.769 . . . . 0.0 109.259 -172.488 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.871 ' H ' HG12 ' A' ' 62' ' ' ILE . 21.0 t80 -134.93 151.4 50.83 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 118.781 -1.167 . . . . 0.0 113.294 -167.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.876 HG12 HG21 ' A' ' 37' ' ' THR . 48.9 mt -83.66 123.32 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 39.2 t -101.74 -38.85 6.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 105.855 -1.906 . . . . 0.0 105.855 178.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 152.94 -163.32 30.44 Favored Glycine 0 CA--C 1.481 -2.043 0 C-N-CA 119.329 -1.415 . . . . 0.0 113.12 175.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 49.8 m -52.96 119.1 4.25 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 123.943 0.897 . . . . 0.0 109.534 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.512 ' HA ' ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER 73.59 13.9 4.35 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-O 121.896 0.855 . . . . 0.0 111.729 175.1 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.598 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -146.55 125.86 13.09 Favored 'General case' 0 CA--C 1.572 1.803 0 O-C-N 120.763 -1.211 . . . . 0.0 112.016 -177.719 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -140.98 163.5 32.81 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -175.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.871 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.8 OUTLIER -137.55 156.24 32.38 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.178 0 C-N-CA 118.24 -1.384 . . . . 0.0 110.652 173.72 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.836 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 1.1 m-30 -125.96 101.04 6.63 Favored 'General case' 0 N--CA 1.436 -1.142 0 O-C-N 126.674 2.483 . . . . 0.0 104.926 167.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 26.5 ttt -83.97 100.34 10.98 Favored 'General case' 0 C--N 1.288 -2.089 0 C-N-CA 117.816 -1.554 . . . . 0.0 108.305 176.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.031 ' HA ' HG12 ' A' ' 51' ' ' VAL . 2.6 pt? -97.28 148.3 23.26 Favored 'General case' 0 CA--C 1.45 -2.895 0 CA-C-O 122.484 1.135 . . . . 0.0 112.714 -175.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.358 16.0 ttp180 -109.06 -54.86 2.48 Favored 'General case' 1 C--N 1.24 -4.165 0 CA-C-N 113.066 -1.879 . . . . 0.0 115.6 -173.402 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.415 ' O ' ' HA2' ' A' ' 15' ' ' GLY . 14.8 t70 -56.11 -8.67 0.5 Allowed 'General case' 0 CA--C 1.594 2.67 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 174.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.44 -31.09 2.98 Favored Glycine 0 C--N 1.359 1.835 0 O-C-N 120.049 -1.657 . . . . 0.0 113.533 -176.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 12' ' ' THR . 36.4 p -81.4 -69.49 0.61 Allowed 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -174.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.688 ' CE1' ' HB2' ' A' ' 65' ' ' LEU 0.297 0.2 OUTLIER -46.36 -28.98 1.49 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 120.687 3.588 . . . . 0.0 120.687 -162.632 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.867 ' HA ' HD12 ' A' ' 74' ' ' ILE . . . -64.14 -35.76 81.84 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 116.555 2.058 . . . . 0.0 116.555 -166.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.651 ' CZ2' ' HB2' ' A' ' 89' ' ' LEU 0.323 27.2 m-90 -83.36 -19.72 35.6 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.417 -1.313 . . . . 0.0 113.481 -173.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 46.4 mm-40 -74.55 -35.14 63.09 Favored 'General case' 0 C--O 1.28 2.693 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 170.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 71' ' ' ALA . 22.6 mt -65.0 -35.1 74.68 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.286 0 CA-C-N 114.388 -1.278 . . . . 0.0 107.823 176.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.846 ' HG3' HG11 ' A' ' 87' ' ' VAL . 12.5 tmtt? -67.58 -33.18 74.49 Favored 'General case' 0 N--CA 1.409 -2.484 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.761 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -58.46 -47.34 84.32 Favored 'General case' 0 C--O 1.263 1.769 0 C-N-CA 119.871 -0.732 . . . . 0.0 109.113 170.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.578 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 5.7 m-30 -52.0 -47.06 65.12 Favored 'General case' 0 N--CA 1.513 2.709 0 CA-C-O 122.152 0.977 . . . . 0.0 109.64 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.674 ' CD1' ' HA ' ' A' ' 75' ' ' LYS . 30.9 mt -53.62 -63.6 1.1 Allowed 'General case' 0 CA--C 1.471 -2.093 0 CA-C-N 114.714 -1.13 . . . . 0.0 112.423 -178.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.6 m -69.04 -11.0 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.791 0 C-N-CA 119.553 -0.859 . . . . 0.0 112.537 -176.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 18.7 m -94.44 -10.49 32.26 Favored 'General case' 0 N--CA 1.416 -2.161 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.967 172.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.459 ' NE2' ' HB3' ' A' ' 77' ' ' PHE . 45.5 mt-30 -124.81 -28.68 3.48 Favored 'General case' 0 C--N 1.38 1.908 0 C-N-CA 116.137 -2.225 . . . . 0.0 112.112 -177.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.745 ' HB2' ' HZ2' ' A' ' 40' ' ' TRP . 11.8 m-20 -133.17 167.56 20.13 Favored 'General case' 0 C--N 1.285 -2.232 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 -173.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.444 ' NH1' ' HA ' ' A' ' 82' ' ' ASP . 0.0 OUTLIER -83.19 63.07 6.99 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 120.176 1.353 . . . . 0.0 112.838 -174.648 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 40.5 t -82.43 176.71 9.21 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.683 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -167.73 -39.42 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.275 0 N-CA-C 114.967 1.469 . . . . 0.0 114.967 -169.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.051 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 32.1 tt0 -147.55 121.85 9.61 Favored 'General case' 0 CA--C 1.503 -0.84 0 C-N-CA 118.001 -1.48 . . . . 0.0 112.612 -167.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.846 HG11 ' HG3' ' A' ' 75' ' ' LYS . 28.4 m -118.96 129.34 75.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.242 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.484 ' HA ' ' OH ' ' A' ' 94' ' ' TYR . 7.8 p -115.99 120.27 38.6 Favored 'General case' 0 C--O 1.281 2.714 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.933 ' HA ' HD21 ' A' ' 18' ' ' LEU 0.302 7.1 tp -79.39 91.68 5.11 Favored 'General case' 0 CA--C 1.577 1.994 0 CA-C-N 112.341 -2.209 . . . . 0.0 107.815 171.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.781 ' N ' HD11 ' A' ' 18' ' ' LEU . 2.4 tm-20 -80.65 123.96 28.6 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 126.953 2.101 . . . . 0.0 113.434 -166.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.72 -20.69 33.84 Favored Glycine 0 C--N 1.314 -0.648 0 N-CA-C 111.438 -0.665 . . . . 0.0 111.438 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.514 ' HB3' ' HG ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -95.81 111.66 23.58 Favored 'General case' 0 N--CA 1.413 -2.29 0 N-CA-C 103.775 -2.676 . . . . 0.0 103.775 176.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 14.1 tpt -69.85 101.77 1.81 Allowed 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 121.77 0.795 . . . . 0.0 110.464 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.484 ' OH ' ' HA ' ' A' ' 88' ' ' THR . 28.7 p90 -117.64 119.8 33.74 Favored Pre-proline 0 N--CA 1.389 -3.518 0 CA-C-N 114.375 -1.284 . . . . 0.0 107.951 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 94' ' ' TYR . 68.8 Cg_endo -97.39 94.76 0.07 OUTLIER 'Trans proline' 0 N--CA 1.429 -2.277 0 C-N-CA 122.386 2.057 . . . . 0.0 112.583 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.53 -82.04 1.66 Allowed Glycine 0 N--CA 1.426 -2.021 0 C-N-CA 120.499 -0.857 . . . . 0.0 113.014 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.613 ' HB2' ' HB3' ' A' ' 5' ' ' PRO . 12.3 mptt . . . . . 0 C--N 1.306 -1.323 0 CA-C-O 118.436 -0.792 . . . . 0.0 110.46 -175.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.415 0 N-CA-C 109.936 -1.266 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -88.41 -8.72 5.3 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.262 1.975 . . . . 0.0 111.822 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 80.37 -36.79 2.21 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-N 116.435 -0.348 . . . . 0.0 113.795 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -98.39 132.99 23.24 Favored Pre-proline 0 C--N 1.312 -1.035 0 O-C-N 122.098 -0.648 . . . . 0.0 110.799 -178.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -81.07 122.45 4.25 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.495 2.13 . . . . 0.0 109.878 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -106.92 14.87 26.04 Favored 'General case' 0 C--N 1.308 -1.236 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.736 -177.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.7 m 63.2 38.93 10.17 Favored 'General case' 0 C--N 1.347 0.463 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.886 HG23 ' HA ' ' A' ' 11' ' ' MET 0.277 11.3 tt 51.51 52.16 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.282 2.784 0 CA-C-O 122.572 1.177 . . . . 0.0 109.761 -172.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 8' ' ' ILE 0.314 1.9 pp 52.57 61.4 3.21 Favored 'General case' 0 C--N 1.4 2.79 0 CA-C-N 113.885 -1.507 . . . . 0.0 111.821 177.131 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.57 ' HG2' ' HG2' ' A' ' 13' ' ' LYS . 14.8 ptmm? 54.28 35.01 21.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 113.109 -1.86 . . . . 0.0 111.693 -175.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.886 ' HA ' HG23 ' A' ' 8' ' ' ILE . 45.4 ttm 65.89 14.3 9.5 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 125.973 1.709 . . . . 0.0 110.743 178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.9 m -170.02 -53.98 0.02 OUTLIER 'General case' 0 N--CA 1.509 2.522 0 N-CA-C 117.048 2.24 . . . . 0.0 117.048 -163.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.778 ' HG3' ' H ' ' A' ' 14' ' ' LYS 0.334 20.4 ptmt -39.67 -95.71 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 119.76 3.245 . . . . 0.0 119.76 -160.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.778 ' H ' ' HG3' ' A' ' 13' ' ' LYS . 86.4 tttt -168.16 147.86 4.72 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 -167.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 166.92 -79.81 0.11 Allowed Glycine 0 CA--C 1.552 2.351 0 C-N-CA 117.754 -2.165 . . . . 0.0 116.169 178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.711 ' HD2' ' HB2' ' A' ' 92' ' ' GLN . 33.1 ttpt -115.33 135.07 54.53 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 120.227 2.013 . . . . 0.0 113.924 -169.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.552 HG23 ' HA ' ' A' ' 66' ' ' ARG . 90.7 m -70.28 117.0 11.27 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 173.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 1.089 HD21 ' HA ' ' A' ' 89' ' ' LEU . 9.9 tp -133.59 140.39 47.11 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.233 -0.587 . . . . 0.0 111.903 -168.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.518 ' HG2' ' SD ' ' A' ' 64' ' ' MET . 81.3 mtp -83.01 100.63 10.58 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 104.082 -2.562 . . . . 0.0 104.082 162.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.644 ' HB3' HD23 ' A' ' 18' ' ' LEU . 2.1 ppp? -87.08 137.42 32.36 Favored 'General case' 0 C--O 1.259 1.605 0 C-N-CA 115.915 -2.314 . . . . 0.0 108.588 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.471 ' HB2' ' HG2' ' A' ' 90' ' ' GLU . 31.0 t80 -107.14 126.53 52.5 Favored 'General case' 0 N--CA 1.424 -1.751 0 CA-C-N 114.443 -1.253 . . . . 0.0 108.064 -175.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.694 HG13 ' HB3' ' A' ' 61' ' ' ALA . 0.1 OUTLIER -116.21 124.85 72.92 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.886 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.014 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 17.6 m -98.6 135.04 40.69 Favored 'General case' 0 CA--C 1.582 2.205 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 171.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.688 HG21 HD11 ' A' ' 36' ' ' ILE . 12.6 p -132.17 119.88 41.64 Favored 'Isoleucine or valine' 0 CA--C 1.593 2.609 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -176.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 t -124.32 -1.98 8.09 Favored 'General case' 0 C--O 1.239 0.52 0 O-C-N 119.327 -2.108 . . . . 0.0 112.84 -165.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -60.91 -32.08 78.48 Favored Glycine 0 CA--C 1.506 -0.505 0 C-N-CA 120.081 -1.057 . . . . 0.0 110.629 178.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.75 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 24.9 t-20 -117.14 106.74 46.76 Favored Pre-proline 0 N--CA 1.4 -2.939 0 N-CA-C 106.146 -1.798 . . . . 0.0 106.146 174.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -85.75 32.02 0.47 Allowed 'Trans proline' 0 C--N 1.323 -0.788 0 C-N-CA 122.647 2.231 . . . . 0.0 112.35 -175.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 35.7 p -135.53 -160.51 1.06 Allowed 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.419 ' O ' ' HB ' ' A' ' 33' ' ' THR . 3.7 tp10 -84.44 -7.22 59.36 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 -177.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.443 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 2.2 tmpt? -65.5 -49.8 67.68 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -172.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.75 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 16.4 tp10 -72.74 -35.5 67.53 Favored 'General case' 0 CA--C 1.506 -0.725 0 C-N-CA 117.663 -1.615 . . . . 0.0 108.129 -178.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.547 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 84.3 m -49.61 -52.92 27.08 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.07 172.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.9 pt-20 -70.01 -37.86 75.78 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -177.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -62.42 -55.11 30.94 Favored 'General case' 0 C--O 1.209 -1.053 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 177.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.757 HG23 ' CE3' ' A' ' 40' ' ' TRP . 95.9 mt -58.13 -49.92 79.97 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.795 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.062 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.897 HG21 HG12 ' A' ' 55' ' ' ILE . 36.0 p -65.04 -56.81 10.87 Favored 'General case' 0 C--N 1.294 -1.807 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.522 -176.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 14.0 m -65.22 -48.43 73.35 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 119.891 -0.724 . . . . 0.0 111.452 -177.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.2 mt -75.09 -52.93 9.82 Favored 'General case' 0 C--O 1.252 1.19 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -174.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.757 ' CE3' HG23 ' A' ' 36' ' ' ILE . 6.5 m0 -72.5 -60.69 2.11 Favored 'General case' 0 C--O 1.157 -3.767 0 CA-C-O 117.198 -1.382 . . . . 0.0 109.062 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.79 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.44 0.0 OUTLIER -64.4 -24.68 67.72 Favored 'General case' 0 C--N 1.365 1.26 0 CA-C-N 121.066 1.757 . . . . 0.0 112.893 -173.706 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.67 -47.48 90.17 Favored Glycine 0 C--N 1.355 1.586 0 N-CA-C 109.977 -1.249 . . . . 0.0 109.977 170.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.87 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 54.5 p -77.62 -19.96 54.66 Favored 'General case' 0 CA--C 1.551 1.017 0 O-C-N 122.306 -0.526 . . . . 0.0 111.861 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.79 ' HG ' ' HA ' ' A' ' 41' ' ' GLN . 23.9 mt -65.05 -34.02 77.43 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 176.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.46 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 90.1 t80 -85.69 -33.61 21.49 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.854 173.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.87 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 15.2 t-20 -61.0 -39.21 88.83 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.44 6.48 33.73 Favored 'General case' 0 C--N 1.32 -0.678 0 O-C-N 122.0 -0.437 . . . . 0.0 110.585 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 58.9 41.24 21.57 Favored 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 123.914 0.886 . . . . 0.0 112.226 174.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.428 ' O ' HG13 ' A' ' 51' ' ' VAL . 18.3 m-85 -73.57 10.89 0.93 Allowed 'General case' 0 CA--C 1.582 2.178 0 N-CA-C 116.988 2.218 . . . . 0.0 116.988 176.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.8 t70 45.32 70.34 0.36 Allowed 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 125.61 1.564 . . . . 0.0 112.253 176.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.933 HG12 ' HA ' ' A' ' 65' ' ' LEU . 2.2 m -147.13 176.34 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-N 114.281 -1.327 . . . . 0.0 112.289 -169.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.41 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 20.8 mt-30 -134.33 120.26 19.67 Favored 'General case' 0 C--O 1.193 -1.918 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 174.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.73 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -126.23 141.42 51.93 Favored 'General case' 0 C--N 1.274 -2.704 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -171.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.636 ' H ' HG12 ' A' ' 62' ' ' ILE . 39.8 m-85 -133.29 151.96 51.91 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.132 1.53 . . . . 0.0 115.132 -165.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.897 HG12 HG21 ' A' ' 37' ' ' THR . 19.5 mt -88.33 114.12 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.831 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 167.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.967 HG23 ' HB3' ' A' ' 60' ' ' ARG . 8.9 m -113.81 -21.6 5.35 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.726 0 C-N-CA 120.139 -0.624 . . . . 0.0 111.347 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 171.21 171.16 36.14 Favored Glycine 0 C--O 1.209 -1.422 0 C-N-CA 117.666 -2.207 . . . . 0.0 114.759 171.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.547 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 42.3 m -66.38 118.5 10.13 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 106.877 -1.527 . . . . 0.0 106.877 173.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.543 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER 85.04 5.08 0.55 Allowed 'General case' 0 C--N 1.37 1.463 0 O-C-N 124.203 0.94 . . . . 0.0 110.229 -173.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.967 ' HB3' HG23 ' A' ' 56' ' ' VAL . 2.8 mpt_? -135.18 132.5 38.04 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 114.238 1.199 . . . . 0.0 114.238 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.694 ' HB3' HG13 ' A' ' 22' ' ' VAL . . . -143.09 166.12 25.53 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 124.83 1.252 . . . . 0.0 108.178 -175.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.636 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.4 OUTLIER -145.66 157.98 12.65 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.48 0 C-N-CA 118.004 -1.478 . . . . 0.0 110.855 168.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.628 ' O ' ' HG3' ' A' ' 20' ' ' MET 0.385 11.8 p90 -134.08 104.01 6.04 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 125.575 1.797 . . . . 0.0 110.45 162.594 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.518 ' SD ' ' HG2' ' A' ' 19' ' ' MET . 24.1 ttt -84.59 110.86 19.03 Favored 'General case' 0 N--CA 1.485 1.289 0 CA-C-N 115.078 -0.965 . . . . 0.0 110.015 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.942 HD13 ' HB2' ' A' ' 71' ' ' ALA . 2.1 pt? -102.11 148.09 25.82 Favored 'General case' 0 CA--C 1.486 -1.517 0 O-C-N 124.309 1.006 . . . . 0.0 113.013 -173.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.552 ' HA ' HG23 ' A' ' 17' ' ' THR 0.266 31.3 tpt180 -113.53 -62.18 1.63 Allowed 'General case' 0 C--N 1.284 -2.26 0 CA-C-N 113.271 -1.786 . . . . 0.0 115.44 -172.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -47.1 -17.65 0.06 Allowed 'General case' 0 CA--C 1.59 2.502 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 81.07 -16.18 17.69 Favored Glycine 0 C--N 1.358 1.78 0 O-C-N 120.727 -1.233 . . . . 0.0 114.498 -175.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.457 ' OG ' ' HG3' ' A' ' 14' ' ' LYS . 1.2 m -118.97 33.37 5.68 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 114.784 1.402 . . . . 0.0 114.784 -167.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.669 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -156.86 2.58 0.13 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 117.913 2.561 . . . . 0.0 117.913 -174.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.942 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -79.1 -28.22 42.98 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 120.124 1.329 . . . . 0.0 113.6 -174.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.613 ' CZ2' ' HB2' ' A' ' 89' ' ' LEU 0.475 28.0 m-90 -88.21 -12.44 43.81 Favored 'General case' 0 N--CA 1.41 -2.468 0 C-N-CA 117.31 -1.756 . . . . 0.0 113.992 -173.336 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 1.6 mp0 -75.35 -29.1 59.83 Favored 'General case' 0 C--O 1.274 2.388 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 165.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.699 ' HA ' ' HD2' ' A' ' 77' ' ' PHE . 85.6 mt -68.61 -32.85 56.84 Favored 'Isoleucine or valine' 0 CA--C 1.579 2.062 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 174.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.807 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 0.4 OUTLIER -59.01 -43.87 91.61 Favored 'General case' 0 C--O 1.285 2.943 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 173.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.515 ' HB3' ' O ' ' A' ' 73' ' ' GLU . 22.9 t70 -50.28 -50.03 51.61 Favored 'General case' 0 C--O 1.26 1.607 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.19 172.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.699 ' HD2' ' HA ' ' A' ' 74' ' ' ILE . 53.6 m-85 -55.96 -43.61 77.7 Favored 'General case' 0 C--O 1.186 -2.279 0 C-N-CA 118.752 -1.179 . . . . 0.0 112.223 177.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.807 ' HG ' ' HA ' ' A' ' 75' ' ' LYS 0.28 4.9 mt -49.48 -60.38 2.9 Favored 'General case' 0 C--O 1.294 3.422 0 CA-C-O 123.258 1.504 . . . . 0.0 109.899 -178.484 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.681 HG12 ' CB ' ' A' ' 84' ' ' CYS . 24.1 m -75.15 -7.83 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.537 0 CA-C-N 111.774 -2.466 . . . . 0.0 111.463 -171.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 15.0 m -104.83 -5.6 21.03 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.174 172.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.585 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 29.0 mm-40 -85.08 -56.47 3.54 Favored 'General case' 0 CA--C 1.47 -2.096 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.361 28.3 t70 -179.57 -84.88 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.733 ' HB2' ' HG2' ' A' ' 32' ' ' GLU . 24.5 mmt-85 -87.38 144.29 26.83 Favored 'General case' 0 N--CA 1.431 -1.41 0 CA-C-N 120.315 1.416 . . . . 0.0 109.202 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.681 ' CB ' HG12 ' A' ' 79' ' ' VAL . 8.6 p -159.23 147.83 18.05 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -175.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -159.37 -44.51 0.05 Allowed 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 114.856 1.428 . . . . 0.0 114.856 -176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.014 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 40.5 tt0 -140.17 118.77 12.3 Favored 'General case' 0 N--CA 1.43 -1.473 0 C-N-CA 119.054 -1.058 . . . . 0.0 110.528 -173.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.411 HG21 ' HG3' ' A' ' 75' ' ' LYS . 2.2 p -113.09 102.62 14.19 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.434 0 CA-C-N 114.164 -1.38 . . . . 0.0 108.731 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.424 HG22 ' OH ' ' A' ' 94' ' ' TYR . 6.9 p -119.82 124.75 46.88 Favored 'General case' 0 C--O 1.26 1.632 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.089 ' HA ' HD21 ' A' ' 18' ' ' LEU 0.268 5.1 tp -75.74 89.98 2.85 Favored 'General case' 0 CA--C 1.584 2.285 0 CA-C-N 113.624 -1.625 . . . . 0.0 106.87 171.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.492 ' N ' HD11 ' A' ' 18' ' ' LEU . 7.7 tp10 -107.17 151.77 24.97 Favored 'General case' 0 CA--C 1.562 1.435 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -160.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 100.2 -64.01 0.62 Allowed Glycine 0 C--N 1.305 -1.144 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 -177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.711 ' HB2' ' HD2' ' A' ' 16' ' ' LYS . 48.9 mt-30 -111.43 109.87 20.04 Favored 'General case' 0 N--CA 1.42 -1.959 0 N-CA-C 103.863 -2.643 . . . . 0.0 103.863 169.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 16.7 mmt -75.65 173.7 10.72 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 114.424 1.268 . . . . 0.0 114.424 -169.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.424 ' OH ' HG22 ' A' ' 88' ' ' THR . 18.4 p90 -129.52 122.24 20.69 Favored Pre-proline 0 C--N 1.284 -2.264 0 CA-C-N 113.505 -1.68 . . . . 0.0 107.086 -178.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.49 105.11 1.01 Allowed 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.376 2.051 . . . . 0.0 110.194 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.42 -96.64 1.76 Allowed Glycine 0 N--CA 1.41 -3.068 0 C-N-CA 120.281 -0.961 . . . . 0.0 111.001 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? . . . . . 0 C--N 1.295 -1.775 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 176.487 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.773 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.559 ' HB2' ' HG3' ' A' ' 4' ' ' LYS . 12.5 Cg_exo -69.5 -39.26 7.23 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.199 1.933 . . . . 0.0 111.4 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.79 14.24 75.97 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.485 -0.646 . . . . 0.0 111.485 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.559 ' HG3' ' HB2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -66.96 140.51 96.13 Favored Pre-proline 0 C--N 1.317 -0.815 0 C-N-CA 123.424 0.69 . . . . 0.0 111.81 -178.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 36.2 Cg_exo -61.41 105.32 0.34 Allowed 'Trans proline' 0 C--N 1.366 1.485 0 C-N-CA 122.327 2.018 . . . . 0.0 111.569 179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -129.23 18.06 5.99 Favored 'General case' 0 C--N 1.311 -1.067 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.2 m 55.87 72.2 0.51 Allowed 'General case' 0 CA--C 1.575 1.917 0 C-N-CA 123.941 0.896 . . . . 0.0 110.326 -177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 1.034 HG23 ' HA ' ' A' ' 11' ' ' MET 0.279 12.8 tt 50.38 40.67 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.415 3.428 0 CA-C-O 122.99 1.376 . . . . 0.0 109.702 -175.68 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.591 ' O ' HD12 ' A' ' 9' ' ' LEU 0.28 3.5 pp 49.89 73.99 0.23 Allowed 'General case' 0 C--N 1.394 2.541 0 CA-C-N 112.957 -1.929 . . . . 0.0 111.843 175.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.433 ' NZ ' ' HB3' ' A' ' 10' ' ' LYS 0.252 0.5 OUTLIER 53.72 33.53 16.97 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.719 -1.582 . . . . 0.0 112.026 -176.51 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 1.034 ' HA ' HG23 ' A' ' 8' ' ' ILE . 25.7 mmt 61.9 14.95 6.74 Favored 'General case' 0 C--N 1.349 0.566 0 C-N-CA 125.114 1.366 . . . . 0.0 112.295 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 93.7 m -175.87 -45.32 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.731 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 -165.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 68' ' ' GLY . 87.6 tttt -136.25 153.2 51.27 Favored 'General case' 0 CA--C 1.553 1.08 0 N-CA-C 113.896 1.073 . . . . 0.0 113.896 -166.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 14' ' ' LYS 0.965 72.6 mmtt 129.2 -79.59 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.649 1 N-CA-C 121.895 4.035 . . . . 0.0 121.895 173.793 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 172.24 81.01 0.05 OUTLIER Glycine 0 CA--C 1.553 2.41 0 C-N-CA 115.98 -3.009 . . . . 0.0 118.248 179.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.603 ' HD2' ' HB2' ' A' ' 18' ' ' LEU . 0.0 OUTLIER -130.59 143.29 50.66 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 120.841 2.321 . . . . 0.0 107.614 168.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.7 m -80.79 110.63 16.49 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.671 HD23 ' HZ2' ' A' ' 72' ' ' TRP . 60.2 tp -134.28 118.42 17.52 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.47 -174.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.922 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 26.4 ptt? -83.61 104.83 14.05 Favored 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 117.213 -1.795 . . . . 0.0 106.481 165.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.576 ' HG3' ' HE1' ' A' ' 72' ' ' TRP . 14.2 tmm? -87.88 139.73 30.22 Favored 'General case' 0 C--O 1.268 2.053 0 CA-C-N 114.687 -1.142 . . . . 0.0 109.47 -172.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -106.43 126.43 52.24 Favored 'General case' 0 N--CA 1.445 -0.69 0 O-C-N 125.056 1.472 . . . . 0.0 110.085 -167.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -124.82 137.75 56.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.161 -174.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.044 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 54.2 m -107.72 131.31 54.57 Favored 'General case' 0 CA--C 1.628 3.95 0 CA-C-O 118.733 -0.651 . . . . 0.0 110.222 170.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.57 HG12 ' HG2' ' A' ' 32' ' ' GLU . 80.5 t -115.36 94.26 3.02 Favored 'Isoleucine or valine' 0 C--N 1.405 2.998 0 C-N-CA 128.471 2.709 . . . . 0.0 106.598 -178.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.73 35.99 4.53 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-N 122.098 2.226 . . . . 0.0 112.923 -174.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.573 ' HA3' ' HB2' ' A' ' 83' ' ' ARG . . . -59.87 -35.53 87.07 Favored Glycine 0 N--CA 1.445 -0.748 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 168.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.741 ' HB2' ' HB3' ' A' ' 32' ' ' GLU . 0.9 OUTLIER -111.36 148.56 39.03 Favored Pre-proline 0 N--CA 1.42 -1.957 0 N-CA-C 104.171 -2.529 . . . . 0.0 104.171 167.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -92.64 43.18 0.31 Allowed 'Trans proline' 0 C--N 1.298 -2.115 0 C-N-CA 121.642 1.561 . . . . 0.0 110.851 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 67.7 p -130.77 -146.25 0.3 Allowed 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 117.736 -1.585 . . . . 0.0 109.5 -173.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.593 ' HG3' ' HA ' ' A' ' 58' ' ' SER . 30.2 tt0 -125.58 17.98 8.11 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 106.433 -1.692 . . . . 0.0 106.433 170.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.769 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 8.2 tmtt? -92.98 -37.93 11.94 Favored 'General case' 0 C--O 1.256 1.429 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.741 ' HB3' ' HB2' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -65.8 -44.15 86.54 Favored 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 175.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 84.8 m -49.38 -62.4 1.57 Allowed 'General case' 0 C--O 1.187 -2.199 0 CA-C-N 114.034 -1.439 . . . . 0.0 110.211 169.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.769 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 11.7 pt-20 -51.64 -54.87 23.28 Favored 'General case' 0 C--O 1.26 1.641 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 -174.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.872 ' HG3' HG13 ' A' ' 36' ' ' ILE . 11.9 pt-20 -65.23 -49.72 68.61 Favored 'General case' 0 C--O 1.256 1.401 0 CA-C-O 121.727 0.775 . . . . 0.0 109.445 -174.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.872 HG13 ' HG3' ' A' ' 35' ' ' GLU . 56.9 mt -71.55 -43.5 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.027 0 CA-C-N 114.298 -1.319 . . . . 0.0 112.202 -172.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.4 p -66.79 -37.35 84.39 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 118.177 0.444 . . . . 0.0 111.254 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.6 m -67.55 -38.93 84.88 Favored 'General case' 0 N--CA 1.426 -1.65 0 C-N-CA 119.217 -0.993 . . . . 0.0 109.994 178.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.9 tp -67.55 -35.63 79.43 Favored 'General case' 0 C--N 1.365 1.268 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 177.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.657 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 11.9 m0 -68.85 -77.53 0.08 Allowed 'General case' 0 N--CA 1.406 -2.653 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.953 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.677 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.351 0.0 OUTLIER -66.43 -20.89 66.18 Favored 'General case' 0 C--O 1.248 0.987 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.958 -171.571 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -59.87 -55.29 31.22 Favored Glycine 0 N--CA 1.431 -1.69 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.93 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 47.8 t -70.84 -26.93 63.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 116.708 0.254 . . . . 0.0 111.026 178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.792 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 32.8 mt -61.03 -35.51 77.07 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 178.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.523 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 70.0 t80 -90.99 -27.29 18.75 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.93 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 21.8 t-20 -65.26 -33.59 76.36 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.485 0.714 . . . . 0.0 111.92 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.19 1.88 55.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.063 0.459 . . . . 0.0 109.855 178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 53.91 66.13 1.32 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.521 1.529 . . . . 0.0 112.037 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -99.48 159.93 14.66 Favored 'General case' 0 N--CA 1.417 -2.109 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 169.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -95.32 86.48 4.54 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-N 121.014 1.733 . . . . 0.0 109.801 -177.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.902 HG12 ' HA ' ' A' ' 65' ' ' LEU . 1.4 m -146.66 163.46 8.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 114.354 -1.294 . . . . 0.0 110.969 -174.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.55 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 13.5 mt-30 -128.59 115.83 18.69 Favored 'General case' 0 C--O 1.194 -1.839 0 N-CA-C 105.612 -1.996 . . . . 0.0 105.612 176.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.792 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -121.41 139.33 53.59 Favored 'General case' 0 C--N 1.28 -2.451 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.663 -168.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.658 ' H ' HG12 ' A' ' 62' ' ' ILE . 83.0 m-85 -133.58 151.72 51.76 Favored 'General case' 0 CA--C 1.485 -1.555 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -170.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 67.7 mt -94.09 96.3 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.834 0 N-CA-C 104.468 -2.419 . . . . 0.0 104.468 167.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 60' ' ' ARG . 4.3 m -92.02 -24.48 5.42 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.334 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.97 -176.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.03 173.61 40.89 Favored Glycine 0 N--CA 1.431 -1.699 0 C-N-CA 117.016 -2.516 . . . . 0.0 114.158 178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.593 ' HA ' ' HG3' ' A' ' 30' ' ' GLU . 30.8 t -70.32 115.78 9.91 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 176.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.501 ' HB2' ' O ' ' A' ' 24' ' ' VAL 0.268 0.6 OUTLIER 73.18 17.16 4.09 Favored 'General case' 0 C--O 1.207 -1.168 0 C-N-CA 125.8 1.64 . . . . 0.0 109.152 -178.607 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.47 ' HB3' HG23 ' A' ' 56' ' ' VAL . 9.1 mpt_? -131.88 132.12 43.35 Favored 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 124.075 0.95 . . . . 0.0 112.518 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.45 166.3 24.18 Favored 'General case' 0 C--O 1.243 0.731 0 C-N-CA 124.491 1.116 . . . . 0.0 109.145 -173.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.768 HD12 ' HB2' ' A' ' 19' ' ' MET . 1.0 OUTLIER -143.77 157.28 16.25 Favored 'Isoleucine or valine' 0 C--O 1.275 2.442 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.808 172.103 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.756 ' HZ ' HD21 ' A' ' 78' ' ' LEU . 2.2 m-30 -125.96 111.47 14.8 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 105.048 -2.204 . . . . 0.0 105.048 166.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.922 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 22.1 ttt -84.44 93.68 8.35 Favored 'General case' 0 C--N 1.279 -2.473 0 C-N-CA 118.384 -1.326 . . . . 0.0 109.9 173.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.938 ' HG ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -98.65 146.93 25.34 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 124.805 1.242 . . . . 0.0 114.316 -174.103 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.464 7.6 ppt_? -117.28 -54.48 2.39 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 117.235 2.309 . . . . 0.0 117.235 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -47.79 -19.71 0.24 Allowed 'General case' 0 CA--C 1.584 2.275 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 178.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 13' ' ' LYS . . . 58.4 10.32 7.5 Favored Glycine 0 C--N 1.374 2.654 0 CA-C-N 120.101 1.319 . . . . 0.0 115.252 -178.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.3 m -128.23 40.01 3.74 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 118.359 1.08 . . . . 0.0 111.439 -176.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.635 ' O ' HG13 ' A' ' 74' ' ' ILE . 0.1 OUTLIER -170.59 -7.28 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.864 0 O-C-N 121.769 -0.582 . . . . 0.0 111.487 -172.353 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.938 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -80.21 -42.84 22.53 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -166.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.671 ' HZ2' HD23 ' A' ' 18' ' ' LEU 0.311 9.2 m0 -92.75 -9.97 38.68 Favored 'General case' 0 C--N 1.292 -1.91 0 CA-C-O 123.461 1.601 . . . . 0.0 110.44 -170.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -70.76 -38.65 73.48 Favored 'General case' 0 C--O 1.298 3.64 0 N-CA-C 104.921 -2.252 . . . . 0.0 104.921 166.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 70' ' ' TYR . 42.8 mt -59.14 -38.32 73.53 Favored 'Isoleucine or valine' 0 C--N 1.389 2.301 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.855 ' HG3' HG21 ' A' ' 87' ' ' VAL . 12.6 tmtt? -58.0 -43.69 86.79 Favored 'General case' 0 C--O 1.288 3.126 0 CA-C-N 114.537 -1.21 . . . . 0.0 113.582 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -57.92 -43.34 86.19 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 119.147 -1.021 . . . . 0.0 109.863 173.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -62.32 -31.83 72.49 Favored 'General case' 0 N--CA 1.509 2.508 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.416 176.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.779 ' HG ' ' HA ' ' A' ' 75' ' ' LYS . 55.6 mt -53.14 -58.83 5.67 Favored 'General case' 0 C--O 1.285 2.964 0 CA-C-O 122.87 1.319 . . . . 0.0 110.192 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.737 HG22 ' HB3' ' A' ' 84' ' ' CYS . 0.4 OUTLIER -76.74 -13.4 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.875 -173.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.7 m -91.63 -7.54 49.76 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.756 172.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.512 ' NE2' HG12 ' A' ' 36' ' ' ILE . 0.7 OUTLIER -84.3 -50.98 7.35 Favored 'General case' 0 CA--C 1.478 -1.827 0 N-CA-C 104.165 -2.531 . . . . 0.0 104.165 -179.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.408 11.9 t70 -152.58 -97.36 0.05 Allowed 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 114.623 -1.171 . . . . 0.0 113.518 174.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.573 ' HB2' ' HA3' ' A' ' 26' ' ' GLY . 75.2 mtm180 -140.26 92.16 2.51 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 120.22 1.373 . . . . 0.0 111.626 -177.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.737 ' HB3' HG22 ' A' ' 79' ' ' VAL . 2.3 t -93.88 161.42 14.32 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 113.796 -1.547 . . . . 0.0 107.611 175.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -147.68 -25.47 0.37 Allowed 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -167.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.044 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 34.6 tt0 -145.13 125.27 13.69 Favored 'General case' 0 CA--C 1.479 -1.765 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.366 -175.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.855 HG21 ' HG3' ' A' ' 75' ' ' LYS . 14.0 p -128.07 103.9 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.9 0 CA-C-O 122.203 1.002 . . . . 0.0 109.685 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.4 m -100.89 109.36 21.31 Favored 'General case' 1 C--O 1.312 4.359 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.404 -175.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.895 ' HA ' ' HE2' ' A' ' 94' ' ' TYR . 0.0 OUTLIER -139.51 146.59 40.15 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.547 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.645 ' HB2' ' CD2' ' A' ' 94' ' ' TYR . 52.6 mm-40 -146.68 135.43 22.23 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 127.966 2.507 . . . . 0.0 105.667 171.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.726 ' HA3' ' HA ' ' A' ' 8' ' ' ILE . . . -94.21 -13.08 55.37 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 119.048 -1.549 . . . . 0.0 110.098 175.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -110.45 115.64 30.0 Favored 'General case' 0 N--CA 1.426 -1.636 0 O-C-N 122.679 -0.307 . . . . 0.0 110.322 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 59.5 ttp 57.89 75.47 0.38 Allowed 'General case' 0 C--O 1.244 0.777 0 O-C-N 124.62 1.2 . . . . 0.0 111.339 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.895 ' HE2' ' HA ' ' A' ' 89' ' ' LEU . 2.2 t80 -172.6 102.65 0.34 Allowed Pre-proline 0 C--N 1.316 -0.86 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -178.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' A' ' 19' ' ' MET . 2.7 Cg_exo -81.32 -32.85 0.83 Allowed 'Trans proline' 0 CA--C 1.504 -0.986 0 C-N-CA 122.763 2.309 . . . . 0.0 110.929 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.49 -142.93 10.42 Favored Glycine 1 N--CA 1.395 -4.076 0 N-CA-C 106.299 -2.721 . . . . 0.0 106.299 -173.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 68.8 mttm . . . . . 0 C--N 1.279 -2.474 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.153 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.617 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -58.81 -47.22 19.23 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.098 2.532 . . . . 0.0 112.878 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 133.06 -37.12 2.05 Favored Glycine 0 C--N 1.314 -0.663 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.2 tttp -114.62 140.65 25.56 Favored Pre-proline 0 N--CA 1.433 -1.292 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 174.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -95.96 38.01 0.13 Allowed 'Trans proline' 0 CA--C 1.552 1.399 0 C-N-CA 122.855 2.37 . . . . 0.0 116.073 -172.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' HB3' ' HE3' ' A' ' 10' ' ' LYS . 41.3 mt-10 -112.13 -37.77 4.95 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.005 -1.078 . . . . 0.0 112.798 177.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.3 m -61.56 -30.67 70.81 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 111.739 0.274 . . . . 0.0 111.739 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.8 pt -60.71 -47.67 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 120.902 0.382 . . . . 0.0 110.829 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.267 3.1 pp -85.22 -13.94 48.35 Favored 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 -178.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.462 ' HE3' ' HB3' ' A' ' 6' ' ' GLU . 93.6 mttt -93.79 -20.5 20.03 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.689 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 50.7 ttm -90.75 -32.27 16.21 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.414 176.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.753 HG21 ' HB2' ' A' ' 16' ' ' LYS . 3.8 m -94.2 -40.25 10.11 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 119.509 -0.876 . . . . 0.0 111.655 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 69' ' ' SER 0.307 68.6 mttm 81.55 -88.79 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 116.397 1.999 . . . . 0.0 116.397 176.327 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 67' ' ' ASP . 24.0 ttmm -130.58 -27.98 2.1 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.873 -1.131 . . . . 0.0 112.83 -173.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.09 47.0 3.1 Favored Glycine 0 C--N 1.286 -2.23 0 C-N-CA 119.532 -1.318 . . . . 0.0 115.255 -174.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.753 ' HB2' HG21 ' A' ' 12' ' ' THR . 16.8 tppt? -129.07 120.93 26.79 Favored 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 118.686 1.243 . . . . 0.0 109.376 173.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -91.86 124.99 36.39 Favored 'General case' 0 C--N 1.287 -2.121 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.833 ' HB3' HD12 ' A' ' 89' ' ' LEU . 32.1 mt -130.86 118.51 20.86 Favored 'General case' 0 C--O 1.2 -1.524 0 C-N-CA 120.306 -0.558 . . . . 0.0 112.162 -176.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 24.9 ptm -84.14 111.55 19.44 Favored 'General case' 0 C--N 1.267 -2.982 0 C-N-CA 119.203 -0.999 . . . . 0.0 109.235 171.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.848 ' HG2' HD11 ' A' ' 89' ' ' LEU . 11.3 mtt -84.2 103.19 13.19 Favored 'General case' 0 CA--C 1.46 -2.508 0 C-N-CA 118.499 -1.28 . . . . 0.0 109.38 171.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 19.2 t80 -89.52 98.07 11.56 Favored 'General case' 0 N--CA 1.418 -2.065 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 175.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.418 ' HB ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -104.39 122.9 57.88 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.329 0 CA-C-N 114.15 -1.386 . . . . 0.0 113.309 -170.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.983 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 93.2 m -81.11 134.87 35.73 Favored 'General case' 0 N--CA 1.417 -2.124 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 174.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.487 HG11 ' HB3' ' A' ' 32' ' ' GLU . 1.6 p -113.43 152.29 15.16 Favored 'Isoleucine or valine' 0 CA--C 1.584 2.273 0 CA-C-N 120.721 1.601 . . . . 0.0 107.878 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.659 ' OG ' ' HB2' ' A' ' 85' ' ' ALA . 70.8 m -87.41 160.81 18.19 Favored 'General case' 0 C--N 1.356 0.87 0 CA-C-N 120.815 1.643 . . . . 0.0 107.283 175.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.798 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 78.39 72.24 1.18 Allowed Glycine 0 N--CA 1.414 -2.774 0 C-N-CA 118.313 -1.899 . . . . 0.0 111.088 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.487 ' OD1' ' HD3' ' A' ' 31' ' ' LYS . 16.7 t-20 -87.87 101.71 2.79 Favored Pre-proline 0 C--O 1.243 0.758 0 CA-C-N 118.262 1.031 . . . . 0.0 109.485 175.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.798 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 84.1 Cg_endo -118.79 -30.6 0.0 OUTLIER 'Trans proline' 0 N--CA 1.426 -2.486 0 N-CA-C 116.659 1.754 . . . . 0.0 116.659 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.745 ' H ' ' HG3' ' A' ' 31' ' ' LYS . 1.1 p -132.95 -99.47 0.28 Allowed 'General case' 1 N--CA 1.554 4.728 0 C-N-CA 113.73 -3.188 . . . . 0.0 116.339 -164.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.796 ' HB3' ' HB3' ' A' ' 34' ' ' GLU . 4.2 tp10 -100.38 7.61 44.16 Favored 'General case' 0 N--CA 1.399 -3.024 1 N-CA-C 97.741 -4.911 . . . . 0.0 97.741 156.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.785 ' HA ' ' HD2' ' A' ' 28' ' ' PRO 0.435 0.2 OUTLIER 82.0 -175.16 0.04 OUTLIER 'General case' 1 N--CA 1.298 -8.066 1 C-N-CA 132.181 4.192 . . . . 0.0 116.226 170.356 . . . . . . . . 6 4 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.784 ' HG3' HD12 ' A' ' 36' ' ' ILE . 9.3 tp10 -61.13 -13.9 20.79 Favored 'General case' 2 N--CA 1.363 -4.817 0 CA-C-N 111.776 -2.465 . . . . 0.0 106.965 173.021 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.442 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 54.4 m -67.81 -48.57 65.87 Favored 'General case' 0 N--CA 1.411 -2.378 0 C-N-CA 125.021 1.328 . . . . 0.0 108.457 171.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.796 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 3.7 pt-20 -57.7 -48.85 78.38 Favored 'General case' 0 C--O 1.27 2.158 0 CA-C-O 120.78 0.324 . . . . 0.0 110.203 177.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -56.78 -56.49 20.84 Favored 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 123.496 1.617 . . . . 0.0 110.59 -177.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.784 HD12 ' HG3' ' A' ' 32' ' ' GLU . 13.9 mt -70.54 -30.0 40.8 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.255 0 CA-C-N 112.03 -2.35 . . . . 0.0 112.96 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.814 HG21 HG12 ' A' ' 55' ' ' ILE . 8.1 p -71.82 -44.86 63.19 Favored 'General case' 0 CA--C 1.481 -1.68 0 C-N-CA 117.948 -1.501 . . . . 0.0 110.055 178.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.7 p -60.3 -59.67 5.04 Favored 'General case' 0 N--CA 1.429 -1.519 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.188 177.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 60.3 tp -64.95 -49.72 69.24 Favored 'General case' 0 C--O 1.256 1.413 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -177.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.882 ' CH2' ' HB2' ' A' ' 78' ' ' LEU . 37.0 m0 -74.75 -60.84 2.1 Favored 'General case' 0 C--O 1.168 -3.224 0 CA-C-O 117.763 -1.113 . . . . 0.0 110.152 -176.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.757 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.382 0.0 OUTLIER -66.26 -22.31 66.31 Favored 'General case' 0 C--O 1.253 1.248 0 C-N-CA 117.372 -1.731 . . . . 0.0 111.803 -171.721 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.39 -55.83 26.89 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.588 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 37.8 p -67.66 -29.32 68.58 Favored 'General case' 0 CA--C 1.554 1.124 0 CA-C-N 116.999 0.399 . . . . 0.0 111.707 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.837 HD12 ' HG2' ' A' ' 53' ' ' ARG . 20.6 mt -60.86 -35.34 76.32 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 123.241 0.616 . . . . 0.0 109.871 178.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.636 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 87.5 t80 -91.32 -27.01 18.66 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.604 -0.439 . . . . 0.0 110.222 175.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.588 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.2 t-20 -66.96 -28.88 68.64 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.859 0.361 . . . . 0.0 111.253 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -94.23 -3.49 50.64 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.567 0.699 . . . . 0.0 109.8 176.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.1 t30 55.88 43.93 26.71 Favored 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 125.267 1.427 . . . . 0.0 112.726 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.521 ' HB3' ' HE2' ' A' ' 70' ' ' TYR . 23.1 m-85 -66.78 5.85 0.57 Allowed 'General case' 0 CA--C 1.597 2.777 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 35.7 t70 57.2 70.81 0.62 Allowed 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 125.314 1.446 . . . . 0.0 111.713 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.531 ' CG2' ' HD2' ' A' ' 53' ' ' ARG . 0.2 OUTLIER -147.75 171.02 3.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 113.439 -1.71 . . . . 0.0 109.822 -175.168 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.655 ' HG2' ' HB3' ' A' ' 64' ' ' MET . 0.0 OUTLIER -132.54 126.73 33.52 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 173.67 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.837 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -131.9 134.52 45.77 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 -169.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.806 ' H ' HG12 ' A' ' 62' ' ' ILE . 80.9 m-85 -134.89 152.62 51.9 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -165.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.814 HG12 HG21 ' A' ' 37' ' ' THR . 39.2 mt -89.62 95.11 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 N-CA-C 104.586 -2.376 . . . . 0.0 104.586 166.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 15.9 m -96.03 -31.43 4.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.562 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.752 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.2 63.25 0.22 Allowed Glycine 0 N--CA 1.403 -3.503 0 C-N-CA 116.391 -2.814 . . . . 0.0 116.717 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.676 ' HB3' ' HE3' ' A' ' 31' ' ' LYS 0.313 13.8 m 21.04 88.76 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 125.488 1.346 . . . . 0.0 112.586 162.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.633 ' HB3' ' O ' ' A' ' 58' ' ' SER . 0.3 OUTLIER 110.0 -16.18 0.01 OUTLIER 'General case' 0 CA--C 1.574 1.884 0 C-N-CA 128.011 2.525 . . . . 0.0 106.766 -173.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -125.57 134.61 51.9 Favored 'General case' 0 CA--C 1.578 2.019 0 C-N-CA 126.163 1.785 . . . . 0.0 109.816 170.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -135.9 169.38 17.67 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 125.119 1.367 . . . . 0.0 108.141 -171.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.806 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.6 OUTLIER -141.96 155.9 19.75 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.054 0 CA-C-N 121.34 1.882 . . . . 0.0 111.634 173.736 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.559 ' HA ' ' HG3' ' A' ' 53' ' ' ARG 0.289 8.2 p90 -132.64 103.9 6.37 Favored 'General case' 0 N--CA 1.435 -1.205 0 O-C-N 126.603 2.439 . . . . 0.0 108.254 161.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.655 ' HB3' ' HG2' ' A' ' 52' ' ' GLN . 27.0 ttt -91.22 108.84 20.15 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.311 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.758 HD22 HD12 ' A' ' 18' ' ' LEU 0.26 6.5 mp -66.85 144.84 56.04 Favored 'General case' 0 CA--C 1.472 -2.048 0 C-N-CA 127.97 2.508 . . . . 0.0 112.961 -177.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.4 33.7 ttp180 -122.35 -53.67 1.91 Allowed 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 115.763 1.764 . . . . 0.0 115.763 168.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.457 ' O ' ' HA ' ' A' ' 14' ' ' LYS . 15.0 t70 -54.41 7.39 0.01 OUTLIER 'General case' 0 N--CA 1.527 3.39 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 177.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 64.3 -31.94 0.09 OUTLIER Glycine 0 CA--C 1.569 3.434 0 N-CA-C 116.55 1.38 . . . . 0.0 116.55 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 13' ' ' LYS . 31.8 t -135.31 87.22 2.31 Favored 'General case' 0 CA--C 1.579 2.068 0 CA-C-O 117.787 -1.101 . . . . 0.0 112.832 -170.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.521 ' HE2' ' HB3' ' A' ' 49' ' ' TYR . 0.1 OUTLIER 174.32 -0.69 0.0 OUTLIER 'General case' 0 C--N 1.409 3.184 0 CA-C-N 120.204 1.365 . . . . 0.0 113.241 178.112 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.733 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -88.22 -29.9 20.12 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -169.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.773 ' HZ2' ' HG ' ' A' ' 89' ' ' LEU . 28.1 m-90 -78.99 -15.12 58.7 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.133 -0.979 . . . . 0.0 110.341 -176.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.42 -44.15 79.46 Favored 'General case' 0 C--O 1.266 1.944 0 N-CA-C 106.875 -1.528 . . . . 0.0 106.875 167.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.659 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 96.0 mt -59.67 -38.56 76.31 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.336 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.138 175.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.621 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 13.4 tmtt? -65.05 -37.97 89.33 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.529 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -61.95 -44.89 95.81 Favored 'General case' 0 C--O 1.262 1.72 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.328 175.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.659 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 12.0 m-85 -57.28 -48.06 79.87 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.773 0.797 . . . . 0.0 109.05 179.292 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.882 ' HB2' ' CH2' ' A' ' 40' ' ' TRP . 4.2 pp -63.13 -41.88 99.4 Favored 'General case' 0 C--O 1.293 3.345 0 N-CA-C 114.249 1.203 . . . . 0.0 114.249 -174.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.996 HG12 ' HB2' ' A' ' 84' ' ' CYS . 32.6 m -76.29 -11.74 14.07 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 CA-C-O 121.838 0.828 . . . . 0.0 109.559 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 22.2 m -104.06 0.49 29.85 Favored 'General case' 0 N--CA 1.411 -2.424 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.939 172.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.783 ' HG2' ' HE1' ' A' ' 40' ' ' TRP . 8.5 tp-100 -85.2 -53.5 5.21 Favored 'General case' 0 N--CA 1.404 -2.74 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.341 1.9 p30 -176.64 -94.04 0.0 OUTLIER 'General case' 0 C--O 1.243 0.74 0 O-C-N 125.235 1.584 . . . . 0.0 113.939 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.588 ' HD2' ' HA3' ' A' ' 26' ' ' GLY 0.291 48.2 mtm180 -93.3 131.62 38.26 Favored 'General case' 0 CA--C 1.497 -1.066 0 C-N-CA 118.328 -1.349 . . . . 0.0 112.243 -177.179 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.996 ' HB2' HG12 ' A' ' 79' ' ' VAL . 4.5 p -154.78 154.51 32.92 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.484 -1.234 . . . . 0.0 109.612 -168.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.659 ' HB2' ' OG ' ' A' ' 25' ' ' SER . . . -159.56 -49.92 0.06 Allowed 'General case' 0 C--N 1.351 0.645 0 N-CA-C 115.056 1.502 . . . . 0.0 115.056 -174.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.983 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 38.2 tt0 -154.52 127.11 8.02 Favored 'General case' 0 C--O 1.204 -1.334 0 CA-C-N 119.517 1.053 . . . . 0.0 112.149 -172.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.418 HG12 ' HB ' ' A' ' 22' ' ' VAL . 12.8 m -111.36 103.79 16.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 173.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.437 ' C ' HD22 ' A' ' 89' ' ' LEU 0.274 23.4 p -102.9 136.49 42.62 Favored 'General case' 0 N--CA 1.427 -1.61 0 C-N-CA 117.991 -1.483 . . . . 0.0 112.497 177.366 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.848 HD11 ' HG2' ' A' ' 20' ' ' MET . 4.6 mm? -116.73 157.4 25.54 Favored 'General case' 0 N--CA 1.409 -2.491 0 N-CA-C 115.37 1.619 . . . . 0.0 115.37 -167.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.557 ' HB3' HD23 ' A' ' 18' ' ' LEU 0.265 0.1 OUTLIER -79.31 164.24 24.25 Favored 'General case' 0 C--N 1.252 -3.661 0 CA-C-N 110.866 -2.879 . . . . 0.0 109.084 -175.102 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 94.27 84.35 1.61 Allowed Glycine 0 N--CA 1.415 -2.76 0 CA-C-O 117.816 -1.547 . . . . 0.0 110.799 176.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -57.87 109.13 0.67 Allowed 'General case' 0 C--N 1.372 1.58 0 CA-C-N 120.048 1.924 . . . . 0.0 107.597 174.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.467 ' SD ' ' HD2' ' A' ' 97' ' ' LYS . 15.1 tpt 155.92 -41.65 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 105.242 -2.132 . . . . 0.0 105.242 -169.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.644 ' HB3' ' HD3' ' A' ' 95' ' ' PRO . 81.1 t80 -49.21 -59.07 7.12 Favored Pre-proline 0 CA--C 1.563 1.47 0 C-N-CA 126.001 1.72 . . . . 0.0 113.767 -177.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.644 ' HD3' ' HB3' ' A' ' 94' ' ' TYR . 11.6 Cg_endo -91.92 10.88 2.47 Favored 'Trans proline' 0 C--N 1.361 1.21 0 C-N-CA 121.853 1.702 . . . . 0.0 112.589 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -108.39 -47.66 0.91 Allowed Glycine 0 N--CA 1.427 -1.909 0 C-N-CA 120.32 -0.943 . . . . 0.0 112.415 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' HD2' ' SD ' ' A' ' 93' ' ' MET . 96.2 mttt . . . . . 0 C--N 1.308 -1.228 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 -176.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.848 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.23 -173.51 1.88 Allowed 'Trans proline' 0 CA--C 1.554 1.503 0 C-N-CA 121.847 1.698 . . . . 0.0 109.724 177.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 110.67 28.79 3.84 Favored Glycine 0 N--CA 1.438 -1.204 0 C-N-CA 119.155 -1.497 . . . . 0.0 110.725 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.485 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 36.8 ttmt -96.93 144.85 28.57 Favored Pre-proline 0 N--CA 1.434 -1.266 0 N-CA-C 110.313 -0.254 . . . . 0.0 110.313 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.551 ' HB3' HD21 ' A' ' 89' ' ' LEU . 5.2 Cg_exo -77.22 -148.74 0.03 OUTLIER 'Trans proline' 0 CA--C 1.553 1.449 0 C-N-CA 123.128 2.552 . . . . 0.0 111.362 176.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.525 ' H ' HD11 ' A' ' 8' ' ' ILE . 44.0 mt-10 74.23 -8.21 1.5 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.134 1.374 . . . . 0.0 113.82 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -61.27 -21.72 64.18 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 121.825 0.821 . . . . 0.0 109.65 177.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.662 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.0 OUTLIER -57.66 -57.19 11.35 Favored 'Isoleucine or valine' 0 C--O 1.241 0.656 0 C-N-CA 124.881 1.272 . . . . 0.0 110.77 173.844 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.688 ' HB2' ' HA ' ' A' ' 14' ' ' LYS . 3.9 pp -77.52 -18.67 56.8 Favored 'General case' 0 N--CA 1.428 -1.545 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.724 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 7' ' ' SER . 68.4 mttm -79.95 -22.39 42.69 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.729 -0.388 . . . . 0.0 111.534 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.0 ttt -97.43 -29.49 13.46 Favored 'General case' 0 C--N 1.314 -0.967 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.787 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.435 HG21 ' HD3' ' A' ' 16' ' ' LYS . 20.9 m -84.18 -64.28 1.19 Allowed 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.831 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm 175.34 -73.36 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.64 0.776 . . . . 0.0 109.752 -174.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.688 ' HA ' ' HB2' ' A' ' 9' ' ' LEU . 87.5 tttt 179.7 -71.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 122.807 0.443 . . . . 0.0 110.037 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -72.18 56.09 1.49 Allowed Glycine 0 CA--C 1.546 1.973 0 C-N-CA 124.032 0.825 . . . . 0.0 114.523 -176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.435 ' HD3' HG21 ' A' ' 12' ' ' THR . 57.1 tptt -95.55 133.42 39.59 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 118.842 1.321 . . . . 0.0 109.651 178.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.7 m -71.62 120.91 17.88 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 175.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.627 ' HB3' HD22 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -127.91 115.23 18.25 Favored 'General case' 0 C--O 1.197 -1.667 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 -171.052 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.53 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 22.3 ttt -86.58 105.21 16.69 Favored 'General case' 0 C--N 1.281 -2.383 0 O-C-N 121.694 -0.629 . . . . 0.0 110.272 -179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.674 ' HE3' HD11 ' A' ' 65' ' ' LEU . 12.4 ttm -97.65 116.82 30.6 Favored 'General case' 0 CA--C 1.482 -1.658 0 C-N-CA 117.28 -1.768 . . . . 0.0 112.671 -177.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -100.76 116.55 32.91 Favored 'General case' 0 C--N 1.293 -1.862 0 CA-C-N 112.637 -2.074 . . . . 0.0 106.328 -176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.4 p -127.75 125.89 65.94 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.719 0 CA-C-O 121.457 0.646 . . . . 0.0 111.663 -174.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.784 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 88.3 m -84.55 131.17 34.66 Favored 'General case' 0 CA--C 1.595 2.693 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.035 176.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.404 HG21 HD13 ' A' ' 36' ' ' ILE . 2.0 p -131.29 137.64 55.08 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.579 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 -177.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.43 23.1 t -109.23 -96.62 0.39 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 122.858 2.572 . . . . 0.0 114.277 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.608 ' HA3' ' HG3' ' A' ' 83' ' ' ARG . . . 55.48 -67.14 0.01 OUTLIER Glycine 0 C--N 1.352 1.438 0 CA-C-N 119.654 1.116 . . . . 0.0 113.017 -168.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -118.56 137.49 24.86 Favored Pre-proline 0 N--CA 1.417 -2.1 0 CA-C-N 117.71 0.755 . . . . 0.0 109.323 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -83.75 40.45 0.91 Allowed 'Trans proline' 0 CA--C 1.55 1.287 0 C-N-CA 122.621 2.214 . . . . 0.0 107.577 170.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 12.0 m -140.08 143.31 36.25 Favored 'General case' 0 N--CA 1.424 -1.755 0 N-CA-C 106.487 -1.672 . . . . 0.0 106.487 -165.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.457 ' O ' ' HB ' ' A' ' 33' ' ' THR . 32.7 tt0 -68.2 -7.57 31.36 Favored 'General case' 0 C--N 1.371 1.538 0 CA-C-N 120.538 1.517 . . . . 0.0 111.22 -177.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.493 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 1.9 tmpt? -52.52 -40.43 62.44 Favored 'General case' 0 C--O 1.257 1.484 0 CA-C-O 121.321 0.581 . . . . 0.0 109.941 174.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.799 ' HG3' HD12 ' A' ' 36' ' ' ILE . 3.4 tp10 -69.23 -56.64 7.0 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -176.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 57.3 m -39.84 -47.77 2.18 Favored 'General case' 0 C--O 1.189 -2.111 0 C-N-CA 125.697 1.599 . . . . 0.0 111.897 171.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.4 pt-20 -70.99 -53.46 14.74 Favored 'General case' 0 C--O 1.253 1.275 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -65.65 -36.1 82.69 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 118.102 -1.439 . . . . 0.0 109.292 -178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.799 HD12 ' HG3' ' A' ' 32' ' ' GLU . 2.7 mt -68.0 -41.3 84.44 Favored 'Isoleucine or valine' 0 C--O 1.184 -2.379 0 CA-C-N 114.396 -1.275 . . . . 0.0 111.405 176.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.898 HG21 HG12 ' A' ' 55' ' ' ILE . 11.7 p -69.78 -40.09 76.25 Favored 'General case' 0 CA--C 1.499 -0.986 0 CA-C-N 120.299 1.409 . . . . 0.0 111.115 -176.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 19.8 p -64.72 -50.87 65.24 Favored 'General case' 0 N--CA 1.427 -1.621 0 O-C-N 124.111 0.882 . . . . 0.0 110.039 178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.8 mt -61.84 -49.42 76.36 Favored 'General case' 0 C--N 1.344 0.352 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.048 177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.629 ' CZ2' ' HB2' ' A' ' 78' ' ' LEU . 45.1 m0 -61.23 -71.97 0.13 Allowed 'General case' 0 C--O 1.207 -1.135 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -177.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 1.012 ' HB3' HH11 ' A' ' 53' ' ' ARG 0.314 0.0 OUTLIER -70.27 -18.65 63.13 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 117.521 -1.672 . . . . 0.0 112.078 -176.752 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.9 -48.44 80.78 Favored Glycine 0 N--CA 1.437 -1.291 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.412 173.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 54.3 p -79.01 -34.73 43.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 122.763 -0.257 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.984 HD12 ' HD2' ' A' ' 53' ' ' ARG . 11.4 mt -62.28 -33.17 74.13 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 120.894 0.378 . . . . 0.0 110.637 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -86.65 -30.07 22.04 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.531 -0.304 . . . . 0.0 110.408 175.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 9.2 t30 -66.17 -36.2 82.46 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.82 4.37 37.39 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.908 -0.495 . . . . 0.0 109.954 177.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 47.1 t30 58.57 47.9 12.65 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.471 1.108 . . . . 0.0 112.379 174.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -68.08 -13.13 61.96 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 117.191 2.293 . . . . 0.0 117.191 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.578 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 26.5 t0 62.12 78.21 0.3 Allowed 'General case' 0 C--N 1.353 0.734 0 CA-C-O 122.755 1.264 . . . . 0.0 109.58 -176.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 m -140.84 177.38 3.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 113.291 -1.777 . . . . 0.0 111.13 -170.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -139.17 131.07 27.7 Favored 'General case' 0 C--O 1.177 -2.739 0 N-CA-C 104.001 -2.592 . . . . 0.0 104.001 174.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 1.012 HH11 ' HB3' ' A' ' 41' ' ' GLN . 23.2 mtp-105 -138.06 145.92 42.34 Favored 'General case' 0 C--N 1.273 -2.725 0 O-C-N 121.442 -0.786 . . . . 0.0 109.044 -176.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.825 ' H ' HG12 ' A' ' 62' ' ' ILE . 15.1 t80 -134.67 151.2 50.85 Favored 'General case' 0 C--O 1.259 1.566 0 C-N-CA 118.028 -1.469 . . . . 0.0 113.3 -168.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.898 HG12 HG21 ' A' ' 37' ' ' THR . 58.0 mt -93.77 107.07 18.78 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.908 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 174.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 89.7 t -94.59 -48.16 13.08 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.287 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.484 -177.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -165.35 177.95 40.49 Favored Glycine 0 N--CA 1.433 -1.51 0 C-N-CA 117.553 -2.26 . . . . 0.0 114.962 -174.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.569 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 4.8 p -72.71 44.03 0.12 Allowed 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 127.138 2.175 . . . . 0.0 114.192 -176.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' A' ' 58' ' ' SER . 2.5 p-10 148.58 6.18 0.0 OUTLIER 'General case' 0 CA--C 1.574 1.888 0 C-N-CA 125.73 1.612 . . . . 0.0 107.377 -169.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.515 ' HB3' ' HB ' ' A' ' 56' ' ' VAL . 7.2 mpt_? -127.9 133.34 49.28 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 123.959 0.904 . . . . 0.0 110.583 176.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -143.59 161.51 38.32 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 -176.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.825 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -138.16 156.38 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.454 -2.725 0 C-N-CA 118.014 -1.474 . . . . 0.0 110.883 171.382 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.952 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 5.8 p90 -128.77 113.82 15.81 Favored 'General case' 0 N--CA 1.413 -2.287 0 O-C-N 126.88 2.612 . . . . 0.0 106.776 161.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.409 ' HB2' ' CD1' ' A' ' 62' ' ' ILE . 20.7 ttt -97.13 118.1 32.8 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-O 122.017 0.913 . . . . 0.0 111.413 -178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.674 HD11 ' HE3' ' A' ' 20' ' ' MET . 5.8 mp -73.4 145.88 45.52 Favored 'General case' 0 CA--C 1.47 -2.124 0 CA-C-N 112.189 -2.278 . . . . 0.0 111.54 -176.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.578 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.362 58.8 ttt180 -118.2 -62.13 1.58 Allowed 'General case' 0 C--N 1.277 -2.553 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 176.098 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 69' ' ' SER . 9.4 t70 -71.9 17.59 0.09 Allowed 'General case' 0 N--CA 1.499 2.014 0 CA-C-N 120.267 1.394 . . . . 0.0 112.924 -178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.644 ' HA3' ' O ' ' A' ' 14' ' ' LYS . . . 58.37 -32.71 0.02 OUTLIER Glycine 0 CA--C 1.551 2.34 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 -169.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.436 ' H ' ' C ' ' A' ' 67' ' ' ASP . 14.8 m -93.67 20.4 7.52 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 115.866 1.802 . . . . 0.0 115.866 -166.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.489 ' HE1' ' H ' ' A' ' 66' ' ' ARG . 0.6 OUTLIER -148.25 125.44 11.48 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.597 -0.69 . . . . 0.0 111.069 178.361 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.555 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 171.91 -30.95 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.528 0 O-C-N 124.178 0.924 . . . . 0.0 112.227 176.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.59 ' NE1' ' HE1' ' A' ' 20' ' ' MET 0.428 5.3 m-90 -89.02 -28.3 20.27 Favored 'General case' 0 C--O 1.267 2.022 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -165.859 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 38.9 tt0 -72.43 -39.16 68.09 Favored 'General case' 0 C--N 1.295 -1.791 0 N-CA-C 105.539 -2.023 . . . . 0.0 105.539 170.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 71' ' ' ALA . 30.5 mt -51.63 -48.86 36.15 Favored 'Isoleucine or valine' 0 C--O 1.286 3.024 0 CA-C-N 114.221 -1.354 . . . . 0.0 110.9 173.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.608 ' O ' HG22 ' A' ' 79' ' ' VAL . 21.4 pttp -67.07 -37.85 84.72 Favored 'General case' 0 C--N 1.369 1.444 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 -176.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.75 -46.53 74.34 Favored 'General case' 0 C--O 1.251 1.178 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.202 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.572 ' CZ ' ' HG2' ' A' ' 73' ' ' GLU . 18.0 m-85 -60.96 -59.23 5.71 Favored 'General case' 0 CA--C 1.499 -0.994 0 CA-C-O 121.922 0.868 . . . . 0.0 109.646 -175.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.629 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.1 pp -63.33 -40.42 97.26 Favored 'General case' 0 C--O 1.266 1.932 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -171.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.647 ' HB ' ' CB ' ' A' ' 84' ' ' CYS 0.265 27.6 m -80.36 -12.88 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 118.343 -1.343 . . . . 0.0 111.622 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.8 m -97.3 -0.05 47.22 Favored 'General case' 0 N--CA 1.417 -2.12 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 168.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -87.99 -54.54 4.18 Favored 'General case' 0 CA--C 1.475 -1.942 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.472 38.0 t70 -137.71 -92.99 0.21 Allowed 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 175.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.608 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 18.8 mmt180 -99.14 153.28 19.03 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 120.96 1.709 . . . . 0.0 110.955 -178.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.647 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 24.8 p -152.07 154.97 37.0 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.251 -173.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -168.44 -51.16 0.02 OUTLIER 'General case' 0 C--N 1.355 0.84 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 176.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.784 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 36.9 tt0 -153.84 116.91 4.52 Favored 'General case' 0 C--O 1.209 -1.077 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.776 -173.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 40.0 t -107.96 101.68 12.89 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.258 23.5 p -105.19 120.62 41.98 Favored 'General case' 0 C--O 1.249 1.052 0 CA-C-O 123.1 1.429 . . . . 0.0 114.758 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.551 HD21 ' HB3' ' A' ' 5' ' ' PRO . 1.2 mp -75.25 156.78 35.35 Favored 'General case' 0 C--N 1.282 -2.359 0 CA-C-N 112.155 -2.293 . . . . 0.0 106.527 177.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.559 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 40.5 tt0 -95.29 159.69 14.89 Favored 'General case' 0 C--N 1.278 -2.514 0 C-N-CA 124.031 0.932 . . . . 0.0 108.992 175.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 71.59 68.93 1.49 Allowed Glycine 0 CA--C 1.526 0.729 0 CA-C-O 118.325 -1.264 . . . . 0.0 111.728 173.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.492 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 98.2 mt-30 -50.07 108.96 0.25 Allowed 'General case' 0 C--N 1.374 1.645 0 CA-C-N 118.541 1.171 . . . . 0.0 113.568 -173.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.448 ' O ' ' HB2' ' A' ' 7' ' ' SER . 60.1 mtt -158.03 17.48 0.24 Allowed 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 127.354 2.262 . . . . 0.0 106.533 177.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.492 ' CE2' ' HA ' ' A' ' 92' ' ' GLN . 7.5 p90 -123.3 92.22 49.13 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 114.782 -1.099 . . . . 0.0 111.356 -171.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -93.12 -3.7 3.27 Favored 'Trans proline' 0 C--O 1.247 0.973 0 C-N-CA 122.398 2.065 . . . . 0.0 112.012 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.22 80.31 1.06 Allowed Glycine 0 N--CA 1.423 -2.196 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 -176.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt . . . . . 0 C--N 1.298 -1.642 0 CA-C-O 117.934 -1.031 . . . . 0.0 110.512 -177.879 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.551 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -79.53 3.23 7.7 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.254 2.636 . . . . 0.0 112.844 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.12 -36.48 93.0 Favored Glycine 0 N--CA 1.449 -0.491 0 N-CA-C 111.063 -0.815 . . . . 0.0 111.063 177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.1 pttt -88.34 140.19 30.29 Favored Pre-proline 0 N--CA 1.434 -1.257 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 176.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.86 33.7 0.24 Allowed 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.22 2.613 . . . . 0.0 115.559 -175.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.601 ' HB3' ' HB2' ' A' ' 10' ' ' LYS . 34.2 mm-40 -72.05 -20.96 61.6 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 101.75 -3.426 . . . . 0.0 101.75 156.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.7 m 73.49 167.19 0.3 Allowed 'General case' 1 N--CA 1.37 -4.449 0 CA-C-N 112.809 -1.996 . . . . 0.0 109.768 167.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.423 HG13 ' H ' ' A' ' 8' ' ' ILE . 2.2 mt -46.24 -25.23 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-O 121.644 0.735 . . . . 0.0 112.324 174.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.031 ' HB3' ' HA ' ' A' ' 69' ' ' SER . 0.0 OUTLIER -73.63 -58.75 3.09 Favored 'General case' 0 N--CA 1.421 -1.886 0 C-N-CA 124.268 1.027 . . . . 0.0 109.974 -173.197 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.601 ' HB2' ' HB3' ' A' ' 6' ' ' GLU . 94.6 mttt -76.21 -22.88 54.72 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.095 -1.042 . . . . 0.0 109.778 -175.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 14.9 tpt -70.61 -42.88 70.37 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.657 175.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 24.5 m -145.85 -33.09 0.34 Allowed 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 113.203 0.816 . . . . 0.0 113.203 -173.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.54 ' HB2' ' HA ' ' A' ' 9' ' ' LEU . 72.8 mmtt -104.22 87.85 2.85 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 -166.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.487 ' HD3' ' HA ' ' A' ' 10' ' ' LYS . 3.5 mmmp? -110.23 -19.69 12.92 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.327 174.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.74 60.87 0.51 Allowed Glycine 0 CA--C 1.55 2.265 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.57 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 49.5 tptt -131.2 134.53 46.56 Favored 'General case' 0 C--N 1.365 1.253 0 CA-C-N 120.157 1.978 . . . . 0.0 111.362 -178.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.4 m -78.65 123.21 26.89 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.661 ' CD1' HD12 ' A' ' 89' ' ' LEU . 0.9 OUTLIER -133.18 103.15 5.86 Favored 'General case' 0 C--O 1.191 -2.001 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -174.171 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.678 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 9.4 ptp -84.1 116.92 23.13 Favored 'General case' 0 CA--C 1.503 -0.851 0 O-C-N 120.891 -1.13 . . . . 0.0 110.891 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.878 ' HG2' HD11 ' A' ' 89' ' ' LEU . 93.1 mtp -86.7 99.28 11.65 Favored 'General case' 0 CA--C 1.487 -1.466 0 C-N-CA 120.584 -0.446 . . . . 0.0 110.246 -178.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.458 ' CZ ' ' HD2' ' A' ' 60' ' ' ARG . 12.3 t80 -89.04 106.05 18.18 Favored 'General case' 0 C--O 1.257 1.462 0 N-CA-C 104.955 -2.239 . . . . 0.0 104.955 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.451 HG22 ' NE ' ' A' ' 83' ' ' ARG . 9.1 p -126.28 125.91 68.44 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.923 0 CA-C-N 114.642 -1.163 . . . . 0.0 112.039 -165.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.073 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 31.4 m -92.88 142.31 27.46 Favored 'General case' 0 C--O 1.276 2.477 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.596 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.915 HG23 ' HA ' ' A' ' 83' ' ' ARG . 7.5 p -131.03 128.52 62.43 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.224 0 N-CA-C 103.681 -2.711 . . . . 0.0 103.681 -177.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.61 20.79 1.04 Allowed 'General case' 0 C--O 1.245 0.864 0 CA-C-N 122.478 2.399 . . . . 0.0 112.347 -171.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -68.64 -31.83 73.88 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 106.821 -2.511 . . . . 0.0 106.821 172.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.93 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 24.8 t-20 -118.46 104.58 47.48 Favored Pre-proline 0 N--CA 1.405 -2.711 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 174.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -78.54 32.23 0.45 Allowed 'Trans proline' 0 C--N 1.322 -0.834 0 C-N-CA 122.736 2.291 . . . . 0.0 112.395 -175.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.41 ' HB ' ' H ' ' A' ' 30' ' ' GLU . 0.8 OUTLIER -146.81 -161.24 1.28 Allowed 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.628 -173.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' ' HB ' ' A' ' 33' ' ' THR . 2.7 tp10 -76.69 -18.29 58.62 Favored 'General case' 0 C--O 1.204 -1.311 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -173.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.489 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 5.0 tmtt? -64.56 -52.42 57.71 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -172.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.93 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 3.4 tp10 -71.01 -35.44 72.03 Favored 'General case' 0 C--N 1.321 -0.668 0 C-N-CA 117.777 -1.569 . . . . 0.0 107.643 -177.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 54.5 m -49.6 -57.52 6.99 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-N 114.174 -1.375 . . . . 0.0 111.029 172.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 15.2 pt-20 -65.98 -40.25 91.06 Favored 'General case' 0 C--O 1.255 1.371 0 C-N-CA 122.792 0.437 . . . . 0.0 111.784 -176.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -51.69 -63.0 1.28 Allowed 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.695 HG23 ' CE3' ' A' ' 40' ' ' TRP . 35.4 mt -67.21 -44.46 87.66 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 112.384 -2.189 . . . . 0.0 112.957 -175.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.773 ' HB ' HG12 ' A' ' 55' ' ' ILE . 32.4 p -65.35 -53.49 42.87 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.547 -0.861 . . . . 0.0 112.011 -176.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 44.9 t -70.55 -46.87 62.73 Favored 'General case' 0 C--O 1.257 1.46 0 C-N-CA 120.224 -0.591 . . . . 0.0 111.429 -176.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.6 tp -71.73 -43.13 66.39 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.759 -175.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.695 ' CE3' HG23 ' A' ' 36' ' ' ILE . 37.9 m0 -73.29 -61.75 1.71 Allowed 'General case' 0 C--O 1.167 -3.262 0 CA-C-O 117.486 -1.245 . . . . 0.0 109.65 -178.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.828 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.377 0.0 OUTLIER -63.47 -25.69 68.38 Favored 'General case' 0 C--O 1.253 1.278 0 C-N-CA 117.871 -1.532 . . . . 0.0 112.608 -172.166 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -62.94 -50.92 59.47 Favored Glycine 0 N--CA 1.437 -1.267 0 N-CA-C 110.378 -1.089 . . . . 0.0 110.378 171.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.741 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 58.7 p -74.06 -25.29 59.76 Favored 'General case' 0 CA--C 1.548 0.891 0 CA-C-N 117.344 0.572 . . . . 0.0 111.404 177.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.782 HD12 ' HG2' ' A' ' 53' ' ' ARG . 32.5 mt -62.62 -33.51 75.17 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 176.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.536 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 89.9 t80 -87.97 -32.8 18.68 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.45 173.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.741 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 6.9 t30 -62.36 -36.96 83.87 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -89.11 3.21 52.59 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.277 0.561 . . . . 0.0 110.017 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 60.7 t30 53.24 51.89 14.66 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 125.226 1.41 . . . . 0.0 112.568 177.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -64.73 -7.02 9.25 Favored 'General case' 0 CA--C 1.595 2.69 0 N-CA-C 116.24 1.941 . . . . 0.0 116.24 172.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.0 t70 61.04 67.88 0.78 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 125.141 1.377 . . . . 0.0 110.037 -177.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.669 HG23 ' HD2' ' A' ' 53' ' ' ARG . 2.6 m -147.92 175.42 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.249 -171.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.481 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 17.5 mt-30 -130.96 125.18 32.72 Favored 'General case' 0 C--O 1.189 -2.131 0 N-CA-C 105.317 -2.105 . . . . 0.0 105.317 177.731 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.828 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -134.5 136.6 43.25 Favored 'General case' 0 C--N 1.285 -2.229 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 -172.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.814 ' H ' HG12 ' A' ' 62' ' ' ILE . 47.9 t80 -135.03 150.49 50.31 Favored 'General case' 0 C--N 1.289 -2.043 0 C-N-CA 118.187 -1.405 . . . . 0.0 113.579 -166.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.773 HG12 ' HB ' ' A' ' 37' ' ' THR . 19.1 mt -93.23 96.36 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 171.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 24.9 t -80.01 -33.85 14.81 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 165.81 -178.87 40.38 Favored Glycine 0 CA--C 1.484 -1.905 0 C-N-CA 119.102 -1.523 . . . . 0.0 113.245 175.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.3 m -60.24 121.01 10.9 Favored 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 177.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . 0.258 0.0 OUTLIER 79.3 8.67 1.77 Allowed 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 121.937 0.875 . . . . 0.0 111.379 -178.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.458 ' HD2' ' CZ ' ' A' ' 21' ' ' PHE . 1.3 tpp180 -137.56 118.92 14.69 Favored 'General case' 0 CA--C 1.573 1.858 0 O-C-N 121.45 -0.781 . . . . 0.0 111.287 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -137.07 162.1 34.27 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -175.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.814 HG12 ' H ' ' A' ' 54' ' ' PHE . 2.5 pt -142.49 157.13 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.466 -2.274 0 C-N-CA 117.422 -1.711 . . . . 0.0 110.337 170.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.526 ' CE2' ' HB ' ' A' ' 74' ' ' ILE 0.296 9.0 p90 -133.02 101.33 5.18 Favored 'General case' 0 N--CA 1.426 -1.672 0 O-C-N 126.264 2.227 . . . . 0.0 108.394 161.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.678 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 25.0 ttt -87.17 113.88 23.3 Favored 'General case' 0 C--N 1.294 -1.82 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.73 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.687 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.315 2.3 mp -80.66 148.22 30.31 Favored 'General case' 0 CA--C 1.442 -3.173 0 CA-C-N 114.153 -1.385 . . . . 0.0 111.287 -178.092 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -117.54 163.12 16.9 Favored 'General case' 0 C--N 1.252 -3.637 0 N-CA-C 104.513 -2.403 . . . . 0.0 104.513 169.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 76.98 -36.22 0.25 Allowed 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 116.1 1.889 . . . . 0.0 116.1 175.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.17 -29.13 7.87 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 119.895 -1.145 . . . . 0.0 114.16 -179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 1.031 ' HA ' ' HB3' ' A' ' 9' ' ' LEU . 38.9 m -96.07 32.95 1.81 Allowed 'General case' 0 CA--C 1.552 1.052 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 -167.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 71' ' ' ALA . 41.9 p90 -178.43 137.07 0.16 Allowed 'General case' 0 N--CA 1.481 1.119 0 CA-C-O 117.029 -1.463 . . . . 0.0 109.744 177.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.687 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 164.0 -35.45 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.128 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 171.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.685 ' HZ2' ' HG ' ' A' ' 89' ' ' LEU 0.298 22.0 m-90 -80.36 -9.76 59.75 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 120.376 -1.453 . . . . 0.0 111.684 -172.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -72.14 -35.62 69.14 Favored 'General case' 0 C--O 1.299 3.684 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 169.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.526 ' HB ' ' CE2' ' A' ' 63' ' ' PHE . 67.3 mt -62.53 -39.35 84.15 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 174.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.659 ' HA ' ' HG ' ' A' ' 78' ' ' LEU . 12.4 tmtt? -61.53 -37.23 83.01 Favored 'General case' 0 C--N 1.363 1.156 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.729 177.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -61.83 -48.15 81.86 Favored 'General case' 0 C--O 1.261 1.691 0 C-N-CA 119.619 -0.833 . . . . 0.0 110.138 177.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -57.48 -45.14 85.19 Favored 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 122.366 1.079 . . . . 0.0 110.11 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.714 HD12 HG13 ' A' ' 79' ' ' VAL 0.271 4.2 pp -61.06 -48.77 80.18 Favored 'General case' 0 N--CA 1.418 -2.034 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 -179.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.714 HG13 HD12 ' A' ' 78' ' ' LEU . 23.7 m -75.18 -6.87 9.25 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 C-N-CA 117.458 -1.697 . . . . 0.0 112.22 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.1 t -96.59 -5.9 38.07 Favored 'General case' 0 N--CA 1.403 -2.792 0 CA-C-N 115.196 -0.911 . . . . 0.0 109.721 172.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -100.75 -58.12 1.96 Allowed 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -178.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.6 t70 164.16 173.11 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.484 1 N-CA-C 99.532 -4.247 . . . . 0.0 99.532 178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.915 ' HA ' HG23 ' A' ' 24' ' ' VAL . 0.0 OUTLIER 74.23 89.75 0.09 Allowed 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 106.517 -1.66 . . . . 0.0 106.517 -163.547 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.692 ' HA ' HG12 ' A' ' 79' ' ' VAL . 12.6 p -153.69 56.84 0.74 Allowed 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.787 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -126.77 -62.68 1.11 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -176.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.073 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 33.2 tt0 -134.44 125.28 27.13 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-N 120.65 1.568 . . . . 0.0 110.202 -175.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 68.8 t -117.66 111.41 34.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.489 ' O ' HD22 ' A' ' 89' ' ' LEU . 38.8 p -124.95 129.19 49.86 Favored 'General case' 0 C--O 1.277 2.509 0 C-N-CA 118.751 -1.179 . . . . 0.0 112.726 174.096 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.878 HD11 ' HG2' ' A' ' 20' ' ' MET . 4.4 mm? -129.84 155.8 45.41 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 112.914 -1.948 . . . . 0.0 110.985 -175.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -81.53 157.48 24.79 Favored 'General case' 0 C--N 1.245 -3.956 0 CA-C-N 112.433 -2.167 . . . . 0.0 110.88 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 134.38 173.4 13.13 Favored Glycine 0 CA--C 1.548 2.15 0 CA-C-O 118.48 -1.178 . . . . 0.0 110.999 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -95.11 132.62 39.83 Favored 'General case' 0 C--N 1.363 1.159 0 CA-C-N 120.25 2.025 . . . . 0.0 109.06 178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.8 tpt 54.54 56.67 6.55 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 122.187 0.994 . . . . 0.0 109.805 -176.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.81 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 83.7 t80 -80.95 -49.69 1.04 Allowed Pre-proline 0 C--N 1.304 -1.397 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.448 179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 94' ' ' TYR . 22.7 Cg_endo -59.84 140.2 91.99 Favored 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.2 1.933 . . . . 0.0 112.331 179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 154.22 -71.71 0.27 Allowed Glycine 0 N--CA 1.417 -2.61 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.444 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 17.8 tppt? . . . . . 0 C--N 1.302 -1.475 0 CA-C-O 118.104 -0.95 . . . . 0.0 108.734 177.82 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 110.366 -1.094 . . . . 0.0 110.366 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -80.52 -8.14 13.7 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.613 2.209 . . . . 0.0 113.09 -179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 137.07 -43.11 1.25 Allowed Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.443 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 62.9 pttt -114.32 129.73 24.61 Favored Pre-proline 0 N--CA 1.432 -1.366 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 174.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 6.2 Cg_exo -76.49 165.17 29.54 Favored 'Trans proline' 0 C--O 1.248 1.002 0 C-N-CA 122.906 2.404 . . . . 0.0 112.903 -177.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.616 ' HA ' ' CE3' ' A' ' 72' ' ' TRP . 92.2 mt-10 66.68 10.37 7.41 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.438 177.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.4 p -66.93 -34.55 78.01 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.684 -178.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.619 ' CG2' ' HA ' ' A' ' 97' ' ' LYS . 1.5 pt -59.45 -49.67 82.73 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.899 177.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.559 HD12 ' HG3' ' A' ' 10' ' ' LYS 0.364 1.3 pp -81.68 -31.24 32.32 Favored 'General case' 0 N--CA 1.424 -1.741 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.559 ' HG3' HD12 ' A' ' 9' ' ' LEU . 54.8 mtpt -86.57 -21.88 26.6 Favored 'General case' 0 C--N 1.31 -1.124 0 C-N-CA 119.206 -0.997 . . . . 0.0 110.928 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.2 ttt -99.5 -36.23 9.62 Favored 'General case' 0 N--CA 1.424 -1.727 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.635 175.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.6 m -88.9 -50.25 6.31 Favored 'General case' 0 CA--C 1.554 1.118 0 C-N-CA 118.55 -1.26 . . . . 0.0 112.944 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.88 113.29 0.49 Allowed 'General case' 0 C--O 1.253 1.284 0 CA-C-N 119.131 0.878 . . . . 0.0 113.173 -175.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.57 ' HD2' ' HB3' ' A' ' 69' ' ' SER . 53.7 mtmt -94.34 -176.3 3.91 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 174.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.13 -36.86 1.3 Allowed Glycine 0 CA--C 1.546 1.993 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.95 -175.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -68.35 121.9 17.25 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 117.604 0.702 . . . . 0.0 110.237 177.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 59.6 m -67.15 123.13 19.42 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.48 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.683 HD13 ' H ' ' A' ' 90' ' ' GLU . 0.4 OUTLIER -122.76 121.23 35.82 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 105.395 -2.076 . . . . 0.0 105.395 -176.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.478 ' HB3' ' HG3' ' A' ' 64' ' ' MET . 14.9 ptt? -109.05 133.74 52.59 Favored 'General case' 0 C--N 1.3 -1.564 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.371 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.545 ' SD ' ' HA ' ' A' ' 89' ' ' LEU . 2.9 mpp? -108.86 118.93 38.07 Favored 'General case' 0 CA--C 1.46 -2.511 0 C-N-CA 120.195 -0.602 . . . . 0.0 111.672 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -103.94 128.78 51.46 Favored 'General case' 0 N--CA 1.406 -2.636 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 171.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.44 124.13 69.01 Favored 'Isoleucine or valine' 0 C--N 1.255 -3.542 0 CA-C-N 114.681 -1.145 . . . . 0.0 111.629 -171.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.975 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 95.8 m -75.43 124.88 27.92 Favored 'General case' 0 N--CA 1.403 -2.799 0 N-CA-C 105.059 -2.2 . . . . 0.0 105.059 173.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.523 HG21 HD13 ' A' ' 36' ' ' ILE . 1.9 p -128.45 124.35 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.361 0 CA-C-N 120.319 1.418 . . . . 0.0 111.568 -169.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.941 ' HB2' ' HB2' ' A' ' 83' ' ' ARG . 33.0 t 70.68 -50.15 0.67 Allowed 'General case' 0 C--N 1.363 1.176 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 167.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.24 23.5 9.62 Favored Glycine 0 N--CA 1.415 -2.715 0 C-N-CA 120.625 -0.798 . . . . 0.0 113.31 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.497 ' ND2' ' HB3' ' A' ' 32' ' ' GLU 0.251 9.2 p30 -116.65 111.08 41.72 Favored Pre-proline 0 N--CA 1.417 -2.101 0 C-N-CA 117.609 -1.636 . . . . 0.0 112.205 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.727 ' HA ' ' HB3' ' A' ' 58' ' ' SER . 12.6 Cg_exo -74.19 37.17 0.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 122.805 2.337 . . . . 0.0 109.598 176.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 13.2 m -88.62 52.7 2.5 Favored 'General case' 0 N--CA 1.509 2.489 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.239 -170.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.603 ' HG3' ' O ' ' A' ' 30' ' ' GLU . 7.6 tp10 66.1 19.92 11.17 Favored 'General case' 0 C--N 1.414 3.377 0 CA-C-O 126.803 3.192 . . . . 0.0 103.328 -162.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.789 ' HB3' ' HA ' ' A' ' 58' ' ' SER 0.517 0.0 OUTLIER 62.42 144.8 0.02 OUTLIER 'General case' 2 N--CA 1.259 -10.019 0 CA-C-O 127.461 3.505 . . . . 0.0 114.104 -178.934 . . . . . . . . 5 4 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.896 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 0.0 OUTLIER -66.98 -10.44 49.58 Favored 'General case' 2 N--CA 1.348 -5.543 0 CA-C-N 110.191 -3.186 . . . . 0.0 105.01 169.214 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.636 ' H ' ' HB2' ' A' ' 31' ' ' LYS . 94.3 m -69.18 -35.12 75.94 Favored 'General case' 1 N--CA 1.359 -4.976 0 C-N-CA 127.921 2.488 . . . . 0.0 108.463 174.572 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.604 ' HG3' ' N ' ' A' ' 35' ' ' GLU . 3.9 pt-20 -74.19 -40.77 62.28 Favored 'General case' 0 C--N 1.389 2.319 0 CA-C-N 121.487 1.949 . . . . 0.0 106.941 177.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.604 ' N ' ' HG3' ' A' ' 34' ' ' GLU . 9.7 tp10 -59.4 -56.69 18.78 Favored 'General case' 0 C--O 1.279 2.634 0 CA-C-O 124.087 1.899 . . . . 0.0 108.576 -176.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.896 ' HB ' ' O ' ' A' ' 32' ' ' GLU . 1.1 mt -70.3 -25.17 26.73 Favored 'Isoleucine or valine' 0 C--O 1.163 -3.455 0 CA-C-N 111.74 -2.482 . . . . 0.0 112.305 -179.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.537 ' O ' ' HG3' ' A' ' 41' ' ' GLN . 6.7 p -74.04 -41.9 61.09 Favored 'General case' 0 CA--C 1.464 -2.328 0 CA-C-N 121.697 2.044 . . . . 0.0 109.466 178.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.3 m -60.18 -51.62 68.8 Favored 'General case' 0 N--CA 1.41 -2.45 0 C-N-CA 119.358 -0.937 . . . . 0.0 109.858 177.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 55.5 tp -72.32 -49.68 32.59 Favored 'General case' 0 C--O 1.25 1.123 0 C-N-CA 118.038 -1.465 . . . . 0.0 111.434 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.689 ' CZ2' ' HB2' ' A' ' 78' ' ' LEU . 51.0 m0 -69.27 -67.99 0.44 Allowed 'General case' 0 C--O 1.189 -2.106 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.409 -177.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.555 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.36 0.0 OUTLIER -69.9 -20.36 63.37 Favored 'General case' 0 C--O 1.254 1.303 0 C-N-CA 118.516 -1.273 . . . . 0.0 112.075 -170.865 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.32 -53.36 45.03 Favored Glycine 0 C--N 1.365 2.18 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 169.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.653 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 36.7 p -69.83 -29.77 67.11 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 120.482 -0.487 . . . . 0.0 111.53 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.887 HD12 ' HG2' ' A' ' 53' ' ' ARG . 25.5 mt -59.64 -35.01 73.54 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 122.691 0.397 . . . . 0.0 110.547 177.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.57 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 82.3 t80 -91.08 -27.37 18.63 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 175.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.653 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 8.7 t30 -64.79 -34.89 79.41 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.692 -177.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -91.24 0.53 57.51 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.865 0.365 . . . . 0.0 110.491 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.3 t30 53.24 57.79 5.9 Favored 'General case' 0 CA--C 1.554 1.12 0 C-N-CA 124.967 1.307 . . . . 0.0 112.46 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.46 ' HB3' ' HE2' ' A' ' 70' ' ' TYR . 37.8 m-85 -73.8 -0.21 15.1 Favored 'General case' 0 CA--C 1.597 2.763 0 N-CA-C 116.55 2.056 . . . . 0.0 116.55 171.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 34.5 t70 62.05 67.78 0.72 Allowed 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 124.402 1.081 . . . . 0.0 110.792 -179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.628 HG12 ' HA ' ' A' ' 65' ' ' LEU . 6.7 m -147.36 174.83 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.502 -172.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.531 ' C ' ' HD3' ' A' ' 53' ' ' ARG . 1.9 mp0 -131.51 131.68 43.62 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 172.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.887 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -129.74 129.85 44.68 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -174.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.864 ' H ' HG12 ' A' ' 62' ' ' ILE . 29.2 t80 -133.93 152.36 51.83 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 119.095 -1.042 . . . . 0.0 113.112 -159.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.587 HG23 HG21 ' A' ' 33' ' ' THR . 75.3 mt -88.17 107.32 17.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 115.275 -0.875 . . . . 0.0 108.877 175.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.756 ' HB ' ' HB3' ' A' ' 60' ' ' ARG . 97.1 t -81.47 -40.97 18.47 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.025 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 176.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 170.56 -171.34 43.63 Favored Glycine 0 CA--C 1.469 -2.825 0 C-N-CA 118.629 -1.748 . . . . 0.0 113.46 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.789 ' HA ' ' HB3' ' A' ' 31' ' ' LYS . 6.6 m -62.0 118.26 7.04 Favored 'General case' 0 C--O 1.26 1.609 0 CA-C-O 118.057 -0.973 . . . . 0.0 108.742 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.569 ' HB3' ' O ' ' A' ' 58' ' ' SER . 2.4 t70 80.89 11.16 0.91 Allowed 'General case' 0 N--CA 1.408 -2.566 0 CA-C-O 122.545 1.164 . . . . 0.0 109.228 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.756 ' HB3' ' HB ' ' A' ' 56' ' ' VAL . 11.4 mpt_? -137.1 116.08 12.36 Favored 'General case' 0 CA--C 1.562 1.441 0 O-C-N 121.097 -1.002 . . . . 0.0 112.149 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -124.62 163.1 22.68 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.129 0.972 . . . . 0.0 108.728 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.864 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.7 OUTLIER -139.52 158.08 27.6 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.223 0 C-N-CA 118.223 -1.391 . . . . 0.0 111.128 173.118 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.629 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 2.3 p90 -129.08 106.75 9.07 Favored 'General case' 0 N--CA 1.419 -2.009 0 O-C-N 126.485 2.365 . . . . 0.0 106.917 164.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.478 ' HG3' ' HB3' ' A' ' 19' ' ' MET . 23.1 ttt -94.99 117.04 29.48 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.273 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.727 ' HG ' ' HB2' ' A' ' 71' ' ' ALA 0.484 0.0 OUTLIER -114.34 147.73 38.68 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 -177.339 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.354 36.3 ttp180 -104.57 -62.6 1.31 Allowed 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -164.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -55.92 -8.08 0.39 Allowed 'General case' 0 CA--C 1.579 2.073 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.474 ' O ' HD13 ' A' ' 9' ' ' LEU . . . 58.83 15.98 29.49 Favored Glycine 0 C--N 1.369 2.375 0 CA-C-N 120.194 1.361 . . . . 0.0 115.09 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.57 ' HB3' ' HD2' ' A' ' 14' ' ' LYS . 15.9 p -116.66 22.19 12.89 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 118.39 1.095 . . . . 0.0 113.597 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.46 ' HE2' ' HB3' ' A' ' 49' ' ' TYR . 2.3 p90 177.8 145.79 0.12 Allowed 'General case' 0 C--O 1.245 0.823 0 N-CA-C 106.657 -1.609 . . . . 0.0 106.657 -167.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.727 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . 160.48 -28.4 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 125.166 1.541 . . . . 0.0 111.92 171.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.616 ' CE3' ' HA ' ' A' ' 6' ' ' GLU 0.522 7.1 m0 -89.48 -16.4 30.88 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 117.071 -1.852 . . . . 0.0 115.176 -169.196 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -67.92 -36.38 80.07 Favored 'General case' 0 C--O 1.257 1.457 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 165.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.627 ' HB ' ' O ' ' A' ' 71' ' ' ALA . 57.2 mt -53.89 -50.13 54.76 Favored 'Isoleucine or valine' 0 C--O 1.29 3.204 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.795 174.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.618 ' O ' HG22 ' A' ' 79' ' ' VAL . 0.0 OUTLIER -63.42 -36.11 82.65 Favored 'General case' 0 C--N 1.373 1.612 0 C-N-CA 119.56 -0.856 . . . . 0.0 111.243 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -57.79 -47.07 83.6 Favored 'General case' 0 C--O 1.246 0.871 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.84 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.522 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 13.9 m-85 -58.18 -60.25 4.04 Favored 'General case' 0 C--N 1.365 1.245 0 CA-C-O 122.35 1.071 . . . . 0.0 109.198 -175.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.689 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 2.6 pp -62.29 -38.46 89.44 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 -174.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.618 HG22 ' O ' ' A' ' 75' ' ' LYS . 34.0 m -80.09 -9.75 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 C-N-CA 118.203 -1.399 . . . . 0.0 111.431 178.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 10.0 m -105.8 3.29 28.62 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 171.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -107.3 -45.95 3.99 Favored 'General case' 0 CA--C 1.473 -2.014 0 C-N-CA 119.027 -1.069 . . . . 0.0 109.269 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -120.78 -160.79 0.86 Allowed 'General case' 0 C--N 1.269 -2.92 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.941 ' HB2' ' HB2' ' A' ' 25' ' ' SER . 24.2 mmt180 -80.35 159.67 25.68 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 120.127 1.33 . . . . 0.0 110.123 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.611 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 26.7 p -136.59 146.1 45.69 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.256 -172.2 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -151.27 -53.43 0.13 Allowed 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 114.897 1.443 . . . . 0.0 114.897 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.975 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 28.5 tt0 -153.72 118.82 5.08 Favored 'General case' 0 C--O 1.195 -1.809 0 CA-C-N 119.806 1.184 . . . . 0.0 110.68 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 50.9 t -113.14 101.78 12.98 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.92 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . 0.324 17.4 p -108.64 132.69 53.65 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-O 123.387 1.565 . . . . 0.0 114.489 177.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.545 ' HA ' ' SD ' ' A' ' 20' ' ' MET . 3.7 mp -88.31 156.75 19.01 Favored 'General case' 0 C--N 1.263 -3.18 0 CA-C-N 110.807 -2.906 . . . . 0.0 108.093 -174.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.683 ' H ' HD13 ' A' ' 18' ' ' LEU . 10.6 tp10 -80.82 155.3 26.69 Favored 'General case' 0 C--N 1.272 -2.785 0 O-C-N 121.429 -0.795 . . . . 0.0 108.93 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 69.67 53.01 17.77 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 110.251 -1.14 . . . . 0.0 110.251 -178.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.606 ' HA ' ' CE2' ' A' ' 94' ' ' TYR . 0.1 OUTLIER -65.9 107.43 1.84 Allowed 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 118.116 0.958 . . . . 0.0 112.148 -176.312 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 23.4 mmt -169.08 30.54 0.02 OUTLIER 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 128.479 2.712 . . . . 0.0 105.031 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.606 ' CE2' ' HA ' ' A' ' 92' ' ' GLN . 2.5 p90 -111.37 100.64 48.26 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.133 -0.94 . . . . 0.0 112.509 -173.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -96.34 25.73 0.27 Allowed 'Trans proline' 0 C--O 1.249 1.068 0 C-N-CA 123.598 2.866 . . . . 0.0 110.575 179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 127.05 -62.88 0.61 Allowed Glycine 0 N--CA 1.421 -2.306 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 -174.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.619 ' HA ' ' CG2' ' A' ' 8' ' ' ILE . 6.6 ttpm? . . . . . 0 C--N 1.314 -0.958 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 176.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.256 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.4 -1.76 9.53 Favored 'Trans proline' 0 C--O 1.246 0.898 0 C-N-CA 123.429 2.753 . . . . 0.0 113.702 -176.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.94 -37.03 74.13 Favored Glycine 0 N--CA 1.442 -0.932 0 C-N-CA 121.35 -0.452 . . . . 0.0 112.594 179.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 21.6 pttp -101.19 133.67 20.81 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 117.219 0.51 . . . . 0.0 110.219 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.646 ' C ' ' H ' ' A' ' 7' ' ' SER . 4.9 Cg_exo -80.55 -165.82 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.144 2.562 . . . . 0.0 112.846 -179.062 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 72.66 -27.94 0.19 Allowed 'General case' 0 N--CA 1.518 2.946 0 C-N-CA 127.355 2.262 . . . . 0.0 107.35 -164.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.646 ' H ' ' C ' ' A' ' 5' ' ' PRO . 26.1 t -80.5 -176.07 5.52 Favored 'General case' 1 N--CA 1.357 -5.084 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 173.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.537 ' O ' HD12 ' A' ' 9' ' ' LEU . 10.0 tp 38.11 45.22 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 C-N-CA 123.977 0.911 . . . . 0.0 109.433 -164.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.026 HD13 ' HG2' ' A' ' 13' ' ' LYS 0.394 1.8 pp 64.37 67.67 0.57 Allowed 'General case' 0 C--N 1.389 2.3 0 CA-C-O 123.46 1.6 . . . . 0.0 113.959 171.658 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.499 ' HE3' ' HB3' ' A' ' 13' ' ' LYS 0.36 0.0 OUTLIER 54.27 43.49 30.46 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 111.978 -2.374 . . . . 0.0 113.093 -179.516 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.617 ' SD ' ' HB3' ' A' ' 5' ' ' PRO . 1.7 tpt 65.25 57.45 0.93 Allowed 'General case' 0 CA--C 1.548 0.9 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.21 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.804 HG22 ' HA ' ' A' ' 69' ' ' SER . 24.3 m 68.38 55.43 0.51 Allowed 'General case' 0 CA--C 1.596 2.715 0 O-C-N 122.127 -0.358 . . . . 0.0 111.879 170.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.026 ' HG2' HD13 ' A' ' 9' ' ' LEU . 21.8 ptmt -46.77 125.24 7.02 Favored 'General case' 0 C--N 1.387 2.213 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 176.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -76.02 -14.41 60.22 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 124.083 0.953 . . . . 0.0 112.752 -171.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.3 44.49 1.48 Allowed Glycine 0 C--N 1.285 -2.265 0 C-N-CA 119.547 -1.311 . . . . 0.0 113.609 179.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.482 ' HE3' ' HB2' ' A' ' 18' ' ' LEU . 55.2 tptt -130.41 133.57 46.46 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 119.027 1.414 . . . . 0.0 112.632 -176.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 20.8 p -108.21 110.02 21.54 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.426 0.69 . . . . 0.0 109.474 173.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.925 HD23 ' HH2' ' A' ' 72' ' ' TRP . 30.8 tp -135.0 124.51 24.97 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 -171.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.703 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 11.1 ptp -85.39 109.26 18.3 Favored 'General case' 0 C--O 1.207 -1.148 0 O-C-N 121.47 -0.769 . . . . 0.0 111.487 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.626 ' HA ' ' CG ' ' A' ' 89' ' ' LEU . 4.5 mpp? -84.36 128.94 34.87 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.526 ' CE1' ' HD2' ' A' ' 60' ' ' ARG . 59.6 t80 -111.05 109.06 18.99 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 125.502 1.751 . . . . 0.0 108.46 -169.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -123.05 128.79 75.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 114.76 1.392 . . . . 0.0 114.76 -169.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.974 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 49.5 m -87.41 141.41 28.65 Favored 'General case' 0 CA--C 1.595 2.708 0 C-N-CA 127.322 2.249 . . . . 0.0 109.006 176.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.553 HG13 ' HB2' ' A' ' 83' ' ' ARG . 35.9 t -132.0 97.33 2.76 Favored 'Isoleucine or valine' 0 CA--C 1.603 3.014 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -166.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.513 ' OG ' ' HB3' ' A' ' 83' ' ' ARG 0.324 60.8 m 62.3 -30.07 0.08 Allowed 'General case' 0 C--N 1.389 2.293 0 N-CA-C 119.085 2.995 . . . . 0.0 119.085 170.229 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.474 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 123.76 1.5 8.97 Favored Glycine 0 N--CA 1.426 -2.018 0 C-N-CA 118.39 -1.862 . . . . 0.0 115.269 175.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.575 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 28.3 t-20 -79.65 104.66 2.51 Favored Pre-proline 0 C--O 1.22 -0.452 0 CA-C-N 119.04 1.42 . . . . 0.0 107.862 173.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 82.2 Cg_endo -91.52 33.71 0.29 Allowed 'Trans proline' 0 CA--C 1.513 -0.564 0 C-N-CA 123.348 2.699 . . . . 0.0 109.532 -173.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 23.9 m -129.53 155.19 46.18 Favored 'General case' 0 N--CA 1.414 -2.262 0 N-CA-C 103.523 -2.769 . . . . 0.0 103.523 -171.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -69.94 3.37 2.7 Favored 'General case' 0 C--O 1.182 -2.455 0 CA-C-N 121.741 2.064 . . . . 0.0 111.824 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.565 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 1.8 tmtt? -60.0 -55.48 33.44 Favored 'General case' 0 C--O 1.275 2.43 0 CA-C-O 121.947 0.88 . . . . 0.0 111.228 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.812 ' HG3' HD12 ' A' ' 36' ' ' ILE . 1.7 tp10 -65.2 -52.3 55.64 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -176.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.482 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 93.1 m -42.89 -52.76 4.99 Favored 'General case' 0 C--O 1.187 -2.213 0 CA-C-N 113.785 -1.552 . . . . 0.0 112.765 172.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 11.9 pt-20 -62.4 -55.47 27.6 Favored 'General case' 0 C--O 1.263 1.811 0 CA-C-N 118.689 0.677 . . . . 0.0 112.071 -175.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.472 ' N ' ' HG3' ' A' ' 34' ' ' GLU . 9.3 tp10 -58.93 -53.84 53.89 Favored 'General case' 0 C--O 1.254 1.311 0 CA-C-O 122.972 1.368 . . . . 0.0 108.235 -176.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.812 HD12 ' HG3' ' A' ' 32' ' ' GLU . 5.3 mt -64.24 -40.95 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.368 0 CA-C-N 112.527 -2.124 . . . . 0.0 113.331 -176.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.888 HG21 HG12 ' A' ' 55' ' ' ILE . 21.5 p -70.47 -37.7 74.31 Favored 'General case' 0 CA--C 1.489 -1.373 0 CA-C-N 120.214 1.37 . . . . 0.0 110.048 -177.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 11.4 m -63.45 -46.29 86.96 Favored 'General case' 0 N--CA 1.417 -2.08 0 O-C-N 123.966 0.791 . . . . 0.0 109.417 178.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 63.2 tp -73.03 -43.83 61.57 Favored 'General case' 0 N--CA 1.445 -0.718 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.97 -178.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.734 ' CE3' HD12 ' A' ' 78' ' ' LEU . 48.1 m0 -66.89 -70.24 0.26 Allowed 'General case' 0 N--CA 1.435 -1.199 0 CA-C-O 119.353 -0.356 . . . . 0.0 111.067 -177.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.713 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.294 0.0 OUTLIER -73.06 -19.26 61.21 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.832 -173.222 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.32 -50.89 59.03 Favored Glycine 0 C--N 1.357 1.726 0 N-CA-C 110.189 -1.165 . . . . 0.0 110.189 172.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 60.9 p -69.64 -28.95 66.33 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 120.292 -0.563 . . . . 0.0 110.466 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.936 HD12 ' HG2' ' A' ' 53' ' ' ARG . 15.5 mt -62.49 -32.89 73.86 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.743 176.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.554 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 83.5 t80 -87.11 -31.56 20.38 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.057 0.456 . . . . 0.0 109.872 176.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 25.8 t-20 -67.21 -30.26 70.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.126 -176.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -88.2 4.81 44.33 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 122.3 -0.25 . . . . 0.0 111.106 178.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 57.2 t30 56.92 47.14 18.32 Favored 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 124.048 0.939 . . . . 0.0 112.687 174.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 -95.51 151.62 19.15 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 175.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.54 ' O ' ' HB3' ' A' ' 66' ' ' ARG . 28.6 t70 -92.98 95.52 9.53 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-N 121.751 2.069 . . . . 0.0 109.115 -177.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.706 HG12 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -146.84 162.75 8.58 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 CA-C-N 114.345 -1.298 . . . . 0.0 110.009 -173.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.408 ' HB3' ' HE1' ' A' ' 54' ' ' PHE . 2.2 mp0 -126.38 121.34 32.22 Favored 'General case' 0 C--O 1.199 -1.574 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 174.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.936 ' HG2' HD12 ' A' ' 44' ' ' LEU . 0.0 OUTLIER -127.9 136.99 52.13 Favored 'General case' 0 C--N 1.283 -2.315 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 -172.29 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.708 ' H ' HG12 ' A' ' 62' ' ' ILE . 46.3 m-85 -133.3 152.63 51.94 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 116.204 1.927 . . . . 0.0 116.204 -163.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.888 HG12 HG21 ' A' ' 37' ' ' THR . 46.8 mt -91.53 96.89 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.588 0 N-CA-C 105.901 -1.889 . . . . 0.0 105.901 169.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.2 m -102.67 -20.56 5.58 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.753 -178.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.37 174.98 47.4 Favored Glycine 0 CA--C 1.492 -1.381 0 C-N-CA 117.728 -2.177 . . . . 0.0 114.066 175.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 51.0 m -75.05 117.98 17.49 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 176.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.524 ' O ' ' HA ' ' A' ' 23' ' ' THR . 5.4 t70 80.02 7.69 1.61 Allowed 'General case' 0 C--N 1.365 1.26 0 O-C-N 124.272 0.982 . . . . 0.0 108.835 -174.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.526 ' HD2' ' CE1' ' A' ' 21' ' ' PHE . 1.5 tpp180 -130.37 117.46 19.76 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.669 -176.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -132.09 163.11 29.2 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 -177.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.708 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.3 OUTLIER -135.86 157.38 38.57 Favored 'Isoleucine or valine' 0 CA--C 1.463 -2.38 0 C-N-CA 117.739 -1.585 . . . . 0.0 110.106 174.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.609 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 2.4 p90 -134.61 106.97 7.24 Favored 'General case' 0 N--CA 1.428 -1.567 0 O-C-N 126.192 2.183 . . . . 0.0 107.923 162.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.703 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 23.6 ttt -90.23 116.37 28.16 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 119.039 -0.505 . . . . 0.0 109.975 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.79 HD23 ' H ' ' A' ' 18' ' ' LEU . 1.1 pt? -90.75 144.49 25.67 Favored 'General case' 0 C--O 1.259 1.594 0 O-C-N 124.972 1.42 . . . . 0.0 112.202 -174.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.544 ' HA ' HG22 ' A' ' 17' ' ' THR 0.285 2.7 tmt_? -118.09 -53.32 2.37 Favored 'General case' 0 CA--C 1.565 1.531 0 O-C-N 125.575 1.797 . . . . 0.0 114.666 177.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.573 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 32.6 t70 -43.96 -19.87 0.02 OUTLIER 'General case' 0 CA--C 1.586 2.334 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 82.71 -25.55 4.53 Favored Glycine 0 C--N 1.358 1.788 0 CA-C-N 120.322 1.419 . . . . 0.0 115.384 176.155 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.804 ' HA ' HG22 ' A' ' 12' ' ' THR . 68.8 m -137.2 49.02 2.04 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -170.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.573 ' CE1' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -156.17 -0.48 0.14 Allowed 'General case' 0 N--CA 1.448 -0.57 0 O-C-N 121.37 -0.831 . . . . 0.0 113.158 -176.877 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.545 ' CB ' HD13 ' A' ' 65' ' ' LEU . . . -86.11 -39.18 16.99 Favored 'General case' 0 C--O 1.207 -1.156 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 -169.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.925 ' HH2' HD23 ' A' ' 18' ' ' LEU 0.428 28.8 m-90 -80.95 -14.1 58.27 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 116.511 -2.076 . . . . 0.0 112.126 -171.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -71.88 -36.92 70.22 Favored 'General case' 0 C--O 1.279 2.653 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 166.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.629 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 73.7 mt -57.58 -42.83 82.08 Favored 'Isoleucine or valine' 0 C--N 1.369 1.456 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.991 ' HG3' HG21 ' A' ' 87' ' ' VAL . 22.5 ttpp -51.87 -52.37 50.14 Favored 'General case' 0 C--N 1.374 1.644 0 C-N-CA 125.067 1.347 . . . . 0.0 109.441 177.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -58.07 -34.92 70.65 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 114.525 -1.216 . . . . 0.0 111.801 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.629 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 14.9 m-85 -74.02 -57.65 3.83 Favored 'General case' 0 CA--C 1.466 -2.287 0 C-N-CA 118.522 -1.271 . . . . 0.0 107.907 -169.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.734 HD12 ' CE3' ' A' ' 40' ' ' TRP . 1.8 pt? -68.51 -35.57 77.66 Favored 'General case' 0 N--CA 1.4 -2.966 0 CA-C-N 114.22 -1.354 . . . . 0.0 112.731 -169.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.582 HG22 ' O ' ' A' ' 75' ' ' LYS 0.286 23.1 m -78.2 -19.99 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.443 0 C-N-CA 116.594 -2.042 . . . . 0.0 110.67 179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 43.9 m -95.22 5.61 51.29 Favored 'General case' 0 N--CA 1.411 -2.401 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.96 169.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.522 ' HB2' ' HA ' ' A' ' 78' ' ' LEU . 7.5 tp-100 -89.03 -41.9 12.06 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -176.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.553 ' OD2' ' HG2' ' A' ' 83' ' ' ARG 0.386 17.7 t70 -140.35 -85.77 0.21 Allowed 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.553 ' HG2' ' OD2' ' A' ' 82' ' ' ASP . 21.4 mmt180 -110.35 165.39 11.81 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 120.96 1.709 . . . . 0.0 109.836 176.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.563 ' HB3' ' HB ' ' A' ' 79' ' ' VAL . 24.6 p -159.89 148.22 17.18 Favored 'General case' 0 CA--C 1.56 1.331 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -173.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -163.08 -54.31 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 124.862 1.265 . . . . 0.0 112.193 174.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.974 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 40.4 tt0 -154.96 123.15 5.9 Favored 'General case' 0 C--O 1.207 -1.173 0 C-N-CA 119.63 -0.828 . . . . 0.0 113.163 -169.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.991 HG21 ' HG3' ' A' ' 75' ' ' LYS . 62.0 t -112.0 104.51 17.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 173.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.525 ' O ' HD23 ' A' ' 89' ' ' LEU . 10.0 p -113.44 148.36 36.05 Favored 'General case' 0 C--O 1.266 1.954 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -176.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.74 ' CD1' ' HG ' ' A' ' 18' ' ' LEU 0.864 0.9 OUTLIER -137.63 156.68 47.79 Favored 'General case' 0 N--CA 1.44 -0.944 1 N-CA-C 122.567 4.284 . . . . 0.0 122.567 -177.612 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.631 ' H ' HD22 ' A' ' 89' ' ' LEU 0.254 27.7 tt0 -81.63 160.08 23.86 Favored 'General case' 0 C--N 1.286 -2.186 0 CA-C-N 110.652 -2.976 . . . . 0.0 110.026 -177.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 128.29 152.51 7.82 Favored Glycine 0 CA--C 1.545 1.957 0 CA-C-O 117.759 -1.579 . . . . 0.0 109.4 175.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.9 mp0 -79.11 113.47 17.26 Favored 'General case' 0 C--N 1.366 1.289 0 CA-C-N 120.946 2.373 . . . . 0.0 107.054 178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 52.7 ttm 67.35 84.36 0.15 Allowed 'General case' 0 C--N 1.316 -0.882 0 O-C-N 124.648 1.217 . . . . 0.0 109.971 -174.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.575 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 73.9 t80 -105.28 106.43 55.83 Favored Pre-proline 0 C--N 1.299 -1.608 0 CA-C-N 114.379 -1.282 . . . . 0.0 109.234 -179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -96.19 10.64 1.4 Allowed 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 123.309 2.672 . . . . 0.0 113.749 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -96.64 37.49 3.42 Favored Glycine 0 C--O 1.241 0.592 0 N-CA-C 110.689 -0.965 . . . . 0.0 110.689 179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 87.1 tttt . . . . . 0 C--O 1.259 1.559 0 C-N-CA 123.583 0.753 . . . . 0.0 110.163 -175.0 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.466 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.77 -25.28 14.73 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.828 2.352 . . . . 0.0 113.394 -177.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 145.45 -37.97 1.26 Allowed Glycine 0 N--CA 1.442 -0.935 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 20.2 pttp -110.37 121.42 41.48 Favored Pre-proline 0 N--CA 1.437 -1.084 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 173.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 5.4 Cg_exo -81.52 110.52 2.2 Favored 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.278 2.652 . . . . 0.0 112.457 -174.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.34 -26.73 4.59 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.787 179.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.0 m -62.69 -20.83 65.25 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.171 -177.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.845 HG23 HD12 ' A' ' 9' ' ' LEU . 3.9 tp -47.69 -66.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.155 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.317 172.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.845 HD12 HG23 ' A' ' 8' ' ' ILE . 3.1 mp -84.96 -32.8 22.84 Favored 'General case' 0 CA--C 1.48 -1.737 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.109 -176.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -68.18 -15.8 63.73 Favored 'General case' 0 N--CA 1.433 -1.323 0 O-C-N 123.871 0.732 . . . . 0.0 112.333 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 28.2 ttt -112.45 -34.42 5.87 Favored 'General case' 0 C--N 1.319 -0.742 0 C-N-CA 120.508 -0.477 . . . . 0.0 111.207 173.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.1 m -89.85 -55.6 3.57 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 -176.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.541 ' HD2' ' HB2' ' A' ' 16' ' ' LYS . 12.1 tmtt? 173.37 116.46 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 -172.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.771 ' HA ' ' HB3' ' A' ' 9' ' ' LEU . 34.5 mtmm -82.61 169.9 15.75 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-O 119.07 -0.491 . . . . 0.0 110.22 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 49.29 55.44 12.67 Favored Glycine 0 CA--C 1.559 2.824 0 C-N-CA 120.556 -0.83 . . . . 0.0 113.116 -173.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.541 ' HB2' ' HD2' ' A' ' 13' ' ' LYS . 54.2 tptt -128.28 122.93 32.82 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 119.345 1.573 . . . . 0.0 111.004 -177.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.774 HG22 ' HA ' ' A' ' 66' ' ' ARG . 19.3 p -72.33 135.65 45.97 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.428 174.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.622 ' O ' HD23 ' A' ' 65' ' ' LEU . 0.3 OUTLIER -134.24 116.6 15.5 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -176.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.2 ptm -94.63 119.1 32.75 Favored 'General case' 0 C--N 1.287 -2.125 0 O-C-N 121.623 -0.673 . . . . 0.0 109.195 174.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.915 ' HE2' HD23 ' A' ' 89' ' ' LEU . 1.3 pmm? -121.8 133.41 54.9 Favored 'General case' 0 C--O 1.281 2.753 0 C-N-CA 118.008 -1.477 . . . . 0.0 113.621 -178.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -96.34 119.33 34.63 Favored 'General case' 0 C--O 1.255 1.361 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 177.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.599 ' O ' ' HB3' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -121.44 131.22 73.58 Favored 'Isoleucine or valine' 0 C--N 1.249 -3.787 0 CA-C-N 114.379 -1.282 . . . . 0.0 108.338 -176.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.077 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 97.1 m -99.46 151.88 20.62 Favored 'General case' 1 CA--C 1.648 4.748 0 C-N-CA 130.669 3.588 . . . . 0.0 112.31 -178.355 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.839 ' HB ' ' HG2' ' A' ' 60' ' ' ARG . 0.3 OUTLIER -121.49 155.97 25.51 Favored 'Isoleucine or valine' 0 C--N 1.405 2.996 0 C-N-CA 126.246 1.818 . . . . 0.0 108.007 -168.415 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.672 ' OG ' ' HB2' ' A' ' 85' ' ' ALA . 54.2 m -108.18 168.92 8.95 Favored 'General case' 0 CA--C 1.567 1.605 0 CA-C-N 120.628 1.558 . . . . 0.0 107.37 171.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 115.01 -88.5 0.47 Allowed Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 119.651 1.114 . . . . 0.0 112.198 174.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 35.8 t-20 -115.78 113.04 42.47 Favored Pre-proline 0 N--CA 1.417 -2.076 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -73.75 30.27 0.32 Allowed 'Trans proline' 0 N--CA 1.483 0.901 0 C-N-CA 123.84 3.027 . . . . 0.0 112.982 -175.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.538 ' OG1' ' HD2' ' A' ' 31' ' ' LYS . 70.2 p -128.41 -163.78 1.31 Allowed 'General case' 0 N--CA 1.424 -1.774 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 33' ' ' THR . 37.9 tt0 -84.24 1.8 42.98 Favored 'General case' 0 N--CA 1.421 -1.907 0 O-C-N 121.382 -0.824 . . . . 0.0 111.49 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.552 ' O ' ' HG2' ' A' ' 34' ' ' GLU . 0.1 OUTLIER -69.66 -44.93 69.54 Favored 'General case' 0 C--O 1.281 2.717 0 O-C-N 120.987 -1.071 . . . . 0.0 112.181 -177.857 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.776 ' HG3' HD13 ' A' ' 36' ' ' ILE . 3.2 tp10 -69.99 -44.08 70.12 Favored 'General case' 0 C--O 1.211 -0.949 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.753 ' HA ' HH21 ' A' ' 60' ' ' ARG . 20.1 m -44.02 -63.67 0.82 Allowed 'General case' 0 C--O 1.183 -2.422 0 CA-C-N 112.616 -2.083 . . . . 0.0 111.338 173.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 31' ' ' LYS . 13.1 pt-20 -58.2 -52.82 63.98 Favored 'General case' 0 C--O 1.255 1.354 0 O-C-N 124.419 1.075 . . . . 0.0 113.125 -173.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.701 ' HG3' HD12 ' A' ' 36' ' ' ILE . 8.8 pt-20 -66.41 -44.29 83.4 Favored 'General case' 0 C--O 1.27 2.151 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.699 -176.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.776 HD13 ' HG3' ' A' ' 32' ' ' GLU . 1.3 mp -66.43 -44.1 90.74 Favored 'Isoleucine or valine' 0 N--CA 1.403 -2.795 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.473 179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.779 HG21 HG12 ' A' ' 55' ' ' ILE . 33.4 p -68.09 -39.79 82.77 Favored 'General case' 0 CA--C 1.489 -1.375 0 CA-C-N 120.039 1.291 . . . . 0.0 111.618 -175.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.3 p -60.98 -54.0 50.33 Favored 'General case' 0 C--O 1.262 1.719 0 O-C-N 124.276 0.985 . . . . 0.0 109.6 177.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.2 tp -63.09 -44.21 96.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 119.846 -0.742 . . . . 0.0 111.411 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.644 ' CE3' HD13 ' A' ' 78' ' ' LEU . 42.0 m0 -64.7 -74.99 0.09 Allowed 'General case' 0 C--O 1.205 -1.244 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.722 ' HA ' ' HG ' ' A' ' 44' ' ' LEU 0.365 0.0 OUTLIER -70.68 -18.17 62.83 Favored 'General case' 0 C--O 1.255 1.349 0 C-N-CA 118.457 -1.297 . . . . 0.0 112.409 -172.185 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.9 -49.81 65.31 Favored Glycine 0 N--CA 1.432 -1.619 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 171.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 75.9 p -71.76 -26.83 62.61 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.333 177.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.761 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 28.7 mt -59.65 -37.88 79.91 Favored 'General case' 0 C--N 1.35 0.619 0 CA-C-N 116.619 -0.264 . . . . 0.0 110.702 176.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.51 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 86.6 t80 -86.26 -33.33 20.72 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 120.187 -0.605 . . . . 0.0 110.481 177.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 7.5 t30 -65.11 -34.66 78.92 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.07 9.1 20.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.926 0.393 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 34.4 m-80 59.88 35.49 21.81 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.709 1.203 . . . . 0.0 113.652 172.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . 0.497 ' O ' HG13 ' A' ' 51' ' ' VAL . 13.7 m-85 -78.05 25.23 0.22 Allowed 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 116.06 1.874 . . . . 0.0 116.06 -177.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.3 t70 25.67 76.65 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.678 0 C-N-CA 126.811 2.045 . . . . 0.0 113.671 -177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.989 HG12 ' HA ' ' A' ' 65' ' ' LEU . 1.5 m -146.5 175.57 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.134 -173.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.462 ' O ' ' HB3' ' A' ' 64' ' ' MET . 0.7 OUTLIER -134.33 120.9 20.47 Favored 'General case' 0 C--O 1.194 -1.853 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.761 ' HG2' ' CD1' ' A' ' 44' ' ' LEU . 0.0 OUTLIER -135.75 131.16 35.19 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -169.737 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.814 ' H ' HG12 ' A' ' 62' ' ' ILE . 36.4 t80 -136.59 148.62 47.61 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 118.835 -1.146 . . . . 0.0 113.901 -164.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.779 HG12 HG21 ' A' ' 37' ' ' THR . 71.5 mt -80.39 123.28 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 170.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.21 -29.2 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -174.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -131.15 152.83 20.1 Favored Glycine 0 N--CA 1.424 -2.145 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.835 -178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 59' ' ' ASP . 49.5 m -85.08 82.27 8.5 Favored 'General case' 0 C--N 1.294 -1.844 0 CA-C-O 121.032 0.444 . . . . 0.0 110.505 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.477 ' HB2' HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER 158.81 -32.35 0.0 OUTLIER 'General case' 0 N--CA 1.384 -3.742 0 N-CA-C 101.467 -3.531 . . . . 0.0 101.467 178.942 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.839 ' HG2' ' HB ' ' A' ' 24' ' ' VAL 0.457 1.1 mmp_? -145.41 -179.64 6.79 Favored 'General case' 0 C--N 1.391 2.41 1 N-CA-C 124.954 5.168 . . . . 0.0 124.954 -167.91 . . . . . . . . 4 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.401 ' H ' ' HB3' ' A' ' 60' ' ' ARG . . . -152.6 172.44 16.6 Favored 'General case' 0 C--N 1.382 2.002 0 CA-C-N 112.526 -2.125 . . . . 0.0 111.449 -160.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.814 HG12 ' H ' ' A' ' 54' ' ' PHE . 13.7 pt -123.12 158.55 27.93 Favored 'Isoleucine or valine' 0 CA--C 1.439 -3.307 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 176.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.466 ' O ' ' SD ' ' A' ' 20' ' ' MET 0.288 4.0 p90 -123.21 121.15 35.2 Favored 'General case' 0 N--CA 1.401 -2.893 0 O-C-N 126.447 2.342 . . . . 0.0 105.742 160.45 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.462 ' HB3' ' O ' ' A' ' 52' ' ' GLN . 1.3 tmt? -105.6 117.48 34.13 Favored 'General case' 0 C--N 1.273 -2.752 0 O-C-N 120.98 -1.075 . . . . 0.0 109.528 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.989 ' HA ' HG12 ' A' ' 51' ' ' VAL . 2.4 pt? -104.53 148.31 26.62 Favored 'General case' 0 CA--C 1.468 -2.209 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 -177.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.774 ' HA ' HG22 ' A' ' 17' ' ' THR 0.28 45.7 ttm105 -112.88 -55.47 2.52 Favored 'General case' 0 C--N 1.28 -2.44 0 CA-C-N 111.605 -2.543 . . . . 0.0 115.291 -174.474 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -44.86 -21.11 0.05 OUTLIER 'General case' 0 N--CA 1.512 2.659 0 CA-C-N 120.6 1.545 . . . . 0.0 115.019 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.416 ' O ' HD21 ' A' ' 9' ' ' LEU . . . 85.64 -31.93 3.79 Favored Glycine 0 N--CA 1.426 -1.968 0 O-C-N 120.907 -1.121 . . . . 0.0 113.965 -175.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.9 m -121.03 69.43 0.89 Allowed 'General case' 0 CA--C 1.573 1.833 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -166.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.956 ' HE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -179.82 2.14 0.01 OUTLIER 'General case' 0 C--N 1.381 1.965 0 N-CA-C 115.371 1.619 . . . . 0.0 115.371 179.376 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.938 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -85.18 -34.94 21.97 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 -171.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.602 ' CE2' HD22 ' A' ' 89' ' ' LEU . 13.8 m-90 -72.4 -28.39 62.95 Favored 'General case' 0 C--O 1.264 1.835 0 CA-C-O 122.287 1.041 . . . . 0.0 110.343 -175.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.422 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 44.1 tt0 -69.03 -43.29 75.03 Favored 'General case' 0 C--O 1.258 1.552 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.55 171.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.502 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 84.2 mt -56.66 -42.15 75.92 Favored 'Isoleucine or valine' 0 CA--C 1.58 2.109 0 CA-C-O 121.695 0.76 . . . . 0.0 109.787 176.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.688 ' HE2' ' HB ' ' A' ' 87' ' ' VAL . 52.7 tttm -56.49 -51.43 68.52 Favored 'General case' 0 C--O 1.282 2.802 0 C-N-CA 124.79 1.236 . . . . 0.0 109.707 -179.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -55.15 -47.37 75.22 Favored 'General case' 0 C--O 1.263 1.814 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.561 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 11.4 m-85 -53.55 -59.44 4.59 Favored 'General case' 0 C--N 1.366 1.292 0 O-C-N 123.872 0.733 . . . . 0.0 109.353 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.644 HD13 ' CE3' ' A' ' 40' ' ' TRP . 16.4 mt -52.89 -53.37 50.15 Favored 'General case' 0 C--O 1.3 3.732 0 N-CA-C 114.495 1.295 . . . . 0.0 114.495 -172.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.478 ' HB ' ' CB ' ' A' ' 84' ' ' CYS 0.308 27.8 m -75.8 -9.38 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.198 0 C-N-CA 118.272 -1.371 . . . . 0.0 112.873 -177.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 16.2 m -100.23 2.32 42.68 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.599 166.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 69.9 mm-40 -91.04 -40.89 11.38 Favored 'General case' 0 CA--C 1.439 -3.309 0 C-N-CA 118.909 -1.117 . . . . 0.0 109.519 -177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.412 35.6 t70 -155.91 -90.72 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 115.432 1.642 . . . . 0.0 115.432 178.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.621 ' HB2' HG22 ' A' ' 24' ' ' VAL . 31.8 mmt180 -102.09 144.24 30.91 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 120.747 1.612 . . . . 0.0 110.559 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.478 ' CB ' ' HB ' ' A' ' 79' ' ' VAL . 10.6 p -140.59 135.64 31.98 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.167 -172.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.672 ' HB2' ' OG ' ' A' ' 25' ' ' SER . . . -149.85 -51.67 0.15 Allowed 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.077 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 32.9 tt0 -154.75 116.52 4.14 Favored 'General case' 0 C--O 1.181 -2.517 0 C-N-CA 120.181 -0.607 . . . . 0.0 110.538 -173.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.688 ' HB ' ' HE2' ' A' ' 75' ' ' LYS . 14.2 t -111.4 102.21 13.64 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 74.7 p -109.84 125.19 52.5 Favored 'General case' 0 CA--C 1.473 -1.994 0 C-N-CA 117.619 -1.632 . . . . 0.0 112.023 178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.915 HD23 ' HE2' ' A' ' 20' ' ' MET . 4.1 mp -106.72 154.14 21.39 Favored 'General case' 1 N--CA 1.371 -4.41 0 CA-C-N 112.257 -2.247 . . . . 0.0 107.667 -176.02 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.415 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 0.4 OUTLIER -81.29 163.03 23.23 Favored 'General case' 0 C--N 1.261 -3.272 0 C-N-CA 124.792 1.237 . . . . 0.0 109.695 -175.407 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.87 172.36 22.54 Favored Glycine 0 N--CA 1.425 -2.074 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 177.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -88.24 109.0 19.58 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 121.169 2.484 . . . . 0.0 106.714 176.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 27.2 ttt 54.98 75.91 0.28 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.392 1.057 . . . . 0.0 108.213 -171.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 54.7 t80 -80.77 117.67 69.0 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 115.382 -0.826 . . . . 0.0 111.467 -175.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 94' ' ' TYR . 40.0 Cg_endo -103.37 162.14 0.25 Allowed 'Trans proline' 0 CA--C 1.553 1.475 0 C-N-CA 123.679 2.919 . . . . 0.0 112.237 173.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 89.55 79.99 1.33 Allowed Glycine 0 C--N 1.313 -0.726 0 C-N-CA 120.828 -0.701 . . . . 0.0 113.288 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HE2' ' HB3' ' A' ' 97' ' ' LYS . 37.8 ttpt . . . . . 0 C--N 1.302 -1.491 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 177.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.416 ' HA3' ' SD ' ' A' ' 93' ' ' MET . . . . . . . . 0 CA--C 1.505 -0.542 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -70.87 -25.5 23.38 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.71 2.274 . . . . 0.0 112.909 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 71.74 28.16 69.57 Favored Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.371 -0.692 . . . . 0.0 111.371 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -75.75 137.72 70.09 Favored Pre-proline 0 N--CA 1.439 -0.979 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -174.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.98 40.81 0.98 Allowed 'Trans proline' 0 C--N 1.353 0.783 0 C-N-CA 123.437 2.758 . . . . 0.0 114.034 -171.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 10' ' ' LYS . 47.7 mt-10 -82.03 -14.74 55.48 Favored 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 102.978 -2.971 . . . . 0.0 102.978 158.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 51.0 m -58.21 158.37 7.17 Favored 'General case' 0 CA--C 1.589 2.467 0 CA-C-N 112.415 -2.175 . . . . 0.0 105.772 167.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.889 HG23 ' HA ' ' A' ' 11' ' ' MET 0.296 8.8 tp 40.56 46.79 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.285 2.959 0 C-N-CA 124.577 1.151 . . . . 0.0 111.462 -167.306 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.799 HD13 ' HA ' ' A' ' 13' ' ' LYS 0.276 1.6 pp 51.43 63.05 2.4 Favored 'General case' 0 C--N 1.399 2.754 0 CA-C-O 122.717 1.246 . . . . 0.0 112.635 171.409 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER 61.93 32.63 17.79 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 112.367 -2.197 . . . . 0.0 111.885 -177.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.889 ' HA ' HG23 ' A' ' 8' ' ' ILE . 56.1 ttm 58.72 24.19 11.94 Favored 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.743 -177.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.4 m -158.92 -67.26 0.08 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.208 -1.557 . . . . 0.0 114.245 -170.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.799 ' HA ' HD13 ' A' ' 9' ' ' LEU . 59.8 tttp -179.52 124.81 0.08 Allowed 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 118.069 0.395 . . . . 0.0 110.313 -174.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 7.9 mtpm? -151.12 179.59 8.15 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.673 -1.603 . . . . 0.0 106.673 173.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.04 52.17 0.86 Allowed Glycine 0 CA--C 1.536 1.36 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 176.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -89.07 135.76 33.38 Favored 'General case' 0 C--O 1.205 -1.26 0 CA-C-N 117.726 0.763 . . . . 0.0 109.84 -174.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 93.0 m -65.46 117.93 8.68 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 176.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.937 ' HG ' ' HH2' ' A' ' 72' ' ' TRP . 0.2 OUTLIER -126.65 111.91 14.86 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -178.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.627 ' HA ' ' HA ' ' A' ' 64' ' ' MET . 21.9 ptm -94.9 114.97 26.88 Favored 'General case' 0 C--N 1.277 -2.558 0 O-C-N 121.112 -0.992 . . . . 0.0 109.401 176.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.564 ' HG3' ' HG ' ' A' ' 89' ' ' LEU . 29.8 ttm -97.66 119.21 35.83 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 119.891 -0.724 . . . . 0.0 112.107 -176.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.436 ' HA ' HG22 ' A' ' 62' ' ' ILE . 0.3 OUTLIER -107.02 119.17 38.64 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 126.022 1.729 . . . . 0.0 106.758 -179.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.677 HG21 HG21 ' A' ' 79' ' ' VAL . 0.2 OUTLIER -127.54 128.53 69.83 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -175.505 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.888 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 48.8 m -85.97 142.39 28.83 Favored 'General case' 0 CA--C 1.6 2.892 0 CA-C-N 113.938 -1.483 . . . . 0.0 109.382 176.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' A' ' 83' ' ' ARG 0.283 42.0 t -132.27 140.51 47.59 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.604 0 C-N-CA 125.414 1.486 . . . . 0.0 108.687 -170.778 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . 0.526 20.8 t -109.55 -110.34 0.33 Allowed 'General case' 0 C--N 1.369 1.45 0 CA-C-N 122.957 2.617 . . . . 0.0 113.523 168.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.641 ' HA3' ' HG3' ' A' ' 83' ' ' ARG . . . 63.05 -72.34 0.03 OUTLIER Glycine 0 CA--C 1.543 1.827 0 CA-C-N 120.802 1.637 . . . . 0.0 112.402 -173.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.774 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 55.4 t30 -116.76 132.44 23.39 Favored Pre-proline 0 N--CA 1.416 -2.143 0 N-CA-C 104.339 -2.467 . . . . 0.0 104.339 176.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -91.75 41.76 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 121.557 1.505 . . . . 0.0 113.298 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 55.5 p -125.18 -129.73 0.25 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 117.828 -1.549 . . . . 0.0 111.141 -173.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.543 ' O ' ' HB ' ' A' ' 33' ' ' THR . 31.2 tt0 -133.76 11.83 4.02 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 171.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.554 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 8.9 tmtt? -86.13 -36.95 19.26 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 122.231 1.015 . . . . 0.0 108.337 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.793 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 0.2 OUTLIER -65.98 -46.07 79.37 Favored 'General case' 0 C--N 1.284 -2.253 0 N-CA-C 105.831 -1.914 . . . . 0.0 105.831 175.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.543 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 58.8 m -45.28 -54.35 7.19 Favored 'General case' 0 C--O 1.193 -1.87 0 C-N-CA 125.696 1.598 . . . . 0.0 111.655 170.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.554 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.9 pt-20 -63.6 -49.72 72.23 Favored 'General case' 0 C--O 1.257 1.46 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -176.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -59.14 -55.66 32.09 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.749 1.261 . . . . 0.0 108.265 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.793 ' HB ' ' O ' ' A' ' 32' ' ' GLU . 3.1 mt -62.41 -42.81 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.123 0 CA-C-N 112.997 -1.911 . . . . 0.0 112.529 -177.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.736 HG21 HG12 ' A' ' 55' ' ' ILE . 17.9 p -70.98 -39.56 72.41 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 120.819 1.645 . . . . 0.0 111.703 -176.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 25.8 p -63.27 -52.5 61.8 Favored 'General case' 0 N--CA 1.432 -1.342 0 C-N-CA 120.341 -0.544 . . . . 0.0 109.922 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 69.7 tp -63.7 -45.56 89.45 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.089 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.812 ' CD2' HD12 ' A' ' 78' ' ' LEU . 45.3 m0 -63.26 -74.52 0.09 Allowed 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 119.364 -0.351 . . . . 0.0 111.52 -178.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.81 ' HB2' ' HB2' ' A' ' 53' ' ' ARG 0.311 0.0 OUTLIER -71.06 -19.87 62.43 Favored 'General case' 0 C--O 1.251 1.136 0 C-N-CA 118.896 -1.122 . . . . 0.0 112.501 -172.279 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -63.45 -51.53 53.72 Favored Glycine 0 N--CA 1.436 -1.356 0 N-CA-C 110.259 -1.137 . . . . 0.0 110.259 173.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 61.3 p -68.7 -30.92 69.68 Favored 'General case' 0 C--O 1.242 0.669 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.261 177.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.774 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 33.5 mt -58.66 -37.16 75.37 Favored 'General case' 0 C--O 1.239 0.506 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.319 177.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.689 ' HB2' ' NH2' ' A' ' 53' ' ' ARG . 64.1 t80 -85.64 -32.56 21.96 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.171 -0.612 . . . . 0.0 109.873 177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -65.41 -37.4 86.85 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 112.653 0.612 . . . . 0.0 112.653 -176.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.4 2.03 51.63 Favored 'General case' 0 C--O 1.242 0.708 0 CA-C-O 121.123 0.487 . . . . 0.0 110.626 179.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.3 t30 58.99 51.8 6.9 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 124.951 1.3 . . . . 0.0 112.116 175.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -84.34 37.09 0.61 Allowed 'General case' 0 CA--C 1.558 1.258 0 O-C-N 120.903 -1.123 . . . . 0.0 113.473 175.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.2 t70 27.1 71.02 0.05 OUTLIER 'General case' 0 N--CA 1.514 2.748 0 C-N-CA 126.397 1.879 . . . . 0.0 114.087 179.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 65' ' ' LEU . 1.3 m -147.66 169.57 3.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.329 -174.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.501 ' O ' ' HB3' ' A' ' 64' ' ' MET . 0.5 OUTLIER -122.12 126.26 47.98 Favored 'General case' 0 C--O 1.189 -2.107 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 175.03 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.81 ' HB2' ' HB2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -133.29 135.8 45.09 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -173.377 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.736 ' H ' HG12 ' A' ' 62' ' ' ILE . 44.5 t80 -135.4 151.55 50.57 Favored 'General case' 0 C--N 1.291 -1.937 0 C-N-CA 119.245 -0.982 . . . . 0.0 113.208 -164.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.736 HG12 HG21 ' A' ' 37' ' ' THR . 43.2 mt -87.01 96.86 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 172.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 12.7 m -89.51 -32.28 5.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -163.3 167.68 37.68 Favored Glycine 0 CA--C 1.489 -1.573 0 C-N-CA 117.402 -2.333 . . . . 0.0 114.663 -179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.8 m -70.69 104.12 2.75 Favored 'General case' 0 N--CA 1.43 -1.463 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 176.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 0.1 OUTLIER 91.99 18.73 0.03 OUTLIER 'General case' 0 C--N 1.36 1.027 0 C-N-CA 128.378 2.671 . . . . 0.0 110.101 -177.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.564 ' CG ' ' HA ' ' A' ' 23' ' ' THR . 17.8 mtm180 -146.07 132.0 19.17 Favored 'General case' 0 C--N 1.363 1.162 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -133.53 165.36 25.07 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.251 -173.243 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.736 HG12 ' H ' ' A' ' 54' ' ' PHE . 6.0 pt -140.64 158.8 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.414 0 C-N-CA 118.283 -1.367 . . . . 0.0 110.634 175.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.501 ' HA ' ' HG3' ' A' ' 53' ' ' ARG . 1.1 p90 -133.81 106.72 7.47 Favored 'General case' 0 N--CA 1.423 -1.785 0 O-C-N 126.31 2.256 . . . . 0.0 108.065 162.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.627 ' HA ' ' HA ' ' A' ' 19' ' ' MET . 1.2 tmt? -83.8 112.75 20.38 Favored 'General case' 0 C--N 1.277 -2.586 0 CA-C-N 113.022 -1.899 . . . . 0.0 107.66 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.86 HD13 ' HB2' ' A' ' 71' ' ' ALA 0.329 2.3 pt? -109.26 147.73 32.15 Favored 'General case' 0 CA--C 1.468 -2.207 0 CA-C-O 123.487 1.613 . . . . 0.0 114.988 -177.183 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.2 ttm180 -100.82 -53.14 3.13 Favored 'General case' 0 C--N 1.252 -3.673 0 CA-C-N 110.365 -3.107 . . . . 0.0 112.539 -174.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.435 ' HB3' ' CE1' ' A' ' 70' ' ' TYR . 16.1 t70 -39.8 -24.85 0.02 OUTLIER 'General case' 0 CA--C 1.574 1.872 0 N-CA-C 114.725 1.379 . . . . 0.0 114.725 165.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 72.67 -34.19 0.71 Allowed Glycine 0 C--O 1.202 -1.901 0 C-N-CA 123.842 0.734 . . . . 0.0 114.761 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . 0.274 15.2 p -96.96 -49.1 5.16 Favored 'General case' 0 CA--C 1.581 2.143 0 N-CA-C 119.493 3.145 . . . . 0.0 119.493 -173.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.435 ' CE1' ' HB3' ' A' ' 67' ' ' ASP . 0.0 OUTLIER -65.46 10.14 0.1 Allowed 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 117.877 2.547 . . . . 0.0 117.877 -172.21 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.86 ' HB2' HD13 ' A' ' 65' ' ' LEU . . . -84.71 -23.14 29.47 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 121.156 -0.965 . . . . 0.0 113.15 -175.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.937 ' HH2' ' HG ' ' A' ' 18' ' ' LEU . 5.8 m-90 -67.63 -41.14 84.36 Favored 'General case' 0 C--O 1.277 2.547 0 CA-C-O 121.857 0.837 . . . . 0.0 111.035 -176.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HG2' ' CZ ' ' A' ' 77' ' ' PHE . 42.9 tt0 -67.21 -44.82 78.59 Favored 'General case' 0 C--O 1.295 3.461 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 175.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.616 ' HA ' ' CD2' ' A' ' 77' ' ' PHE . 90.5 mt -51.32 -49.75 29.9 Favored 'Isoleucine or valine' 0 C--O 1.281 2.762 0 CA-C-N 114.342 -1.299 . . . . 0.0 110.719 177.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.533 ' HB3' ' SD ' ' A' ' 20' ' ' MET . 21.2 pttp -63.57 -40.03 95.91 Favored 'General case' 0 C--N 1.383 2.063 0 CA-C-O 121.586 0.708 . . . . 0.0 110.522 -174.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -59.59 -34.41 72.7 Favored 'General case' 0 C--O 1.253 1.285 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.496 177.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.616 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 21.6 m-85 -69.68 -69.61 0.33 Allowed 'General case' 0 CA--C 1.471 -2.09 0 N-CA-C 107.332 -1.359 . . . . 0.0 107.332 -172.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.812 HD12 ' CD2' ' A' ' 40' ' ' TRP . 2.4 pt? -64.33 -34.71 78.78 Favored 'General case' 0 C--O 1.272 2.246 0 CA-C-N 112.89 -1.959 . . . . 0.0 112.704 -167.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.677 HG21 HG21 ' A' ' 22' ' ' VAL . 34.6 t -83.63 -25.05 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.903 0 C-N-CA 117.903 -1.519 . . . . 0.0 109.304 -172.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 23.8 m -96.16 7.84 45.39 Favored 'General case' 0 N--CA 1.407 -2.615 0 C-N-CA 117.673 -1.611 . . . . 0.0 108.562 171.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.835 ' HA ' HE21 ' A' ' 81' ' ' GLN . 0.0 OUTLIER -91.12 -52.63 4.73 Favored 'General case' 0 CA--C 1.484 -1.56 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.094 -178.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.451 ' OD1' ' HG2' ' A' ' 83' ' ' ARG 0.388 9.2 t70 -110.9 -95.13 0.43 Allowed 'General case' 0 C--N 1.301 -1.5 0 C-N-CA 119.045 -1.062 . . . . 0.0 112.192 178.57 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.641 ' HG3' ' HA3' ' A' ' 26' ' ' GLY . 52.9 mmt-85 -112.98 152.86 28.91 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 121.425 1.921 . . . . 0.0 111.49 177.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.632 ' HB3' ' O ' ' A' ' 79' ' ' VAL . 13.0 p -138.03 160.67 38.75 Favored 'General case' 0 CA--C 1.558 1.255 0 CA-C-O 119.194 -0.431 . . . . 0.0 112.011 -172.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -170.79 -54.39 0.02 OUTLIER 'General case' 0 C--N 1.379 1.865 0 C-N-CA 124.133 0.973 . . . . 0.0 113.001 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.888 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 34.8 tt0 -155.66 131.01 9.55 Favored 'General case' 0 C--O 1.208 -1.119 0 O-C-N 121.874 -0.516 . . . . 0.0 110.946 -170.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.498 HG12 ' HB ' ' A' ' 22' ' ' VAL . 16.0 m -115.01 115.28 49.0 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 C-N-CA 120.087 -0.645 . . . . 0.0 110.222 172.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.495 ' C ' HD12 ' A' ' 89' ' ' LEU 0.28 32.2 p -112.28 123.91 51.3 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-O 123.207 1.479 . . . . 0.0 112.022 172.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.695 ' HB2' ' CZ ' ' A' ' 94' ' ' TYR . 6.0 mp -113.19 156.48 23.17 Favored 'General case' 0 N--CA 1.39 -3.44 0 CA-C-N 113.091 -1.868 . . . . 0.0 110.271 -170.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.564 ' HB3' HD13 ' A' ' 18' ' ' LEU . 9.1 tp10 -81.06 167.9 19.24 Favored 'General case' 0 C--N 1.257 -3.415 0 C-N-CA 125.615 1.566 . . . . 0.0 111.607 -174.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 146.66 171.11 15.64 Favored Glycine 0 CA--C 1.54 1.606 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -87.22 109.17 19.3 Favored 'General case' 0 C--N 1.364 1.215 0 CA-C-N 121.777 2.788 . . . . 0.0 107.667 175.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.416 ' SD ' ' HA3' ' A' ' 1' ' ' GLY . 47.4 ttm 54.18 77.7 0.18 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 122.037 0.922 . . . . 0.0 109.737 -171.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.695 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 26.9 t80 -83.65 114.25 52.43 Favored Pre-proline 0 C--N 1.298 -1.643 0 CA-C-N 114.317 -1.31 . . . . 0.0 110.741 -175.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 94' ' ' TYR . 4.2 Cg_endo -89.87 -21.11 1.07 Allowed 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.879 2.386 . . . . 0.0 111.988 177.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.503 ' HA2' ' CZ ' ' A' ' 94' ' ' TYR . . . 133.37 -131.49 6.11 Favored Glycine 0 N--CA 1.411 -3.003 0 N-CA-C 107.714 -2.155 . . . . 0.0 107.714 -173.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? . . . . . 0 C--N 1.281 -2.391 0 CA-C-O 117.011 -1.471 . . . . 0.0 109.211 178.771 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.705 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.84 -25.73 23.29 Favored 'Trans proline' 0 C--O 1.236 0.42 0 C-N-CA 122.716 2.277 . . . . 0.0 112.314 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.09 29.11 9.82 Favored Glycine 0 C--O 1.243 0.668 0 CA-C-N 116.247 -0.433 . . . . 0.0 112.475 -177.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.468 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 21.6 ptmt -66.14 136.99 95.55 Favored Pre-proline 0 C--O 1.254 1.311 0 C-N-CA 123.17 0.588 . . . . 0.0 110.129 178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 31.6 Cg_exo -62.41 150.02 88.78 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.519 2.146 . . . . 0.0 113.368 -177.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.683 ' HA ' HD21 ' A' ' 9' ' ' LEU 0.251 42.9 mt-10 73.79 -39.41 0.43 Allowed 'General case' 0 C--O 1.244 0.786 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 176.788 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.526 ' HA ' ' HG3' ' A' ' 10' ' ' LYS . 66.2 m -63.94 -36.39 83.78 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 -177.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . 0.265 0.4 OUTLIER -70.05 -38.71 75.92 Favored 'Isoleucine or valine' 0 C--O 1.255 1.351 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -178.39 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.683 HD21 ' HA ' ' A' ' 6' ' ' GLU . 2.4 pt? -79.21 -29.31 42.74 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 118.316 -1.353 . . . . 0.0 111.273 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.526 ' HG3' ' HA ' ' A' ' 7' ' ' SER . 0.0 OUTLIER -74.77 -21.21 59.45 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 118.771 -1.171 . . . . 0.0 110.158 175.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 25.3 ttt -76.96 -44.23 32.1 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.089 175.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.64 HG21 ' HD3' ' A' ' 16' ' ' LYS . 18.1 m -97.69 -10.36 25.13 Favored 'General case' 0 CA--C 1.563 1.47 0 C-N-CA 119.221 -0.991 . . . . 0.0 113.386 -176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.9 pttt 52.34 -155.52 0.17 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 125.15 1.38 . . . . 0.0 112.92 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.787 ' HA ' ' HA3' ' A' ' 68' ' ' GLY . 37.3 ttpt -67.65 -11.05 57.36 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 121.676 0.75 . . . . 0.0 111.332 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.31 40.45 2.84 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.761 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.64 ' HD3' HG21 ' A' ' 12' ' ' THR . 58.2 tptt -129.97 143.77 50.97 Favored 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 117.775 0.788 . . . . 0.0 110.633 -175.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.3 p -117.33 121.46 41.2 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 169.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.742 HD11 ' C ' ' A' ' 89' ' ' LEU . 0.3 OUTLIER -134.59 108.14 7.89 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -173.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 21.1 ptm -84.1 100.95 11.45 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 171.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.548 ' O ' ' HB ' ' A' ' 62' ' ' ILE . 0.3 OUTLIER -88.79 138.69 31.18 Favored 'General case' 0 C--O 1.25 1.123 0 C-N-CA 117.029 -1.868 . . . . 0.0 111.043 -171.533 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -109.52 113.45 26.25 Favored 'General case' 0 C--O 1.267 2.013 0 O-C-N 125.245 1.59 . . . . 0.0 108.723 -174.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 1.5 p -117.44 123.86 72.3 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 CA-C-N 114.553 -1.203 . . . . 0.0 110.77 -174.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.083 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 92.3 m -98.12 133.99 41.8 Favored 'General case' 0 CA--C 1.608 3.197 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.138 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.883 HG11 HD11 ' A' ' 36' ' ' ILE . 91.1 t -130.95 101.47 5.53 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 -177.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.401 ' HA ' ' HB2' ' A' ' 59' ' ' ASP . 2.6 t -118.92 7.05 11.41 Favored 'General case' 0 C--N 1.361 1.108 0 CA-C-N 122.286 2.312 . . . . 0.0 114.042 -166.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.45 -46.21 52.87 Favored Glycine 0 N--CA 1.475 1.27 0 N-CA-C 110.333 -1.107 . . . . 0.0 110.333 174.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 1.076 ' HB3' ' HB2' ' A' ' 32' ' ' GLU . 16.4 t-20 -115.21 104.11 53.93 Favored Pre-proline 0 N--CA 1.436 -1.172 0 N-CA-C 104.568 -2.382 . . . . 0.0 104.568 167.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.493 ' HA ' ' HB3' ' A' ' 59' ' ' ASP . 2.7 Cg_endo -82.23 24.52 0.71 Allowed 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 123.52 2.813 . . . . 0.0 113.351 -173.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.455 ' C ' ' HB3' ' A' ' 58' ' ' SER . 6.9 p -125.12 -162.51 1.11 Allowed 'General case' 0 N--CA 1.417 -2.078 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.295 -179.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -73.61 -29.22 62.25 Favored 'General case' 0 C--O 1.194 -1.844 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.617 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 0.4 OUTLIER -59.56 -48.09 83.03 Favored 'General case' 0 C--O 1.263 1.768 0 CA-C-N 119.167 0.894 . . . . 0.0 112.726 -171.133 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 1.076 ' HB2' ' HB3' ' A' ' 27' ' ' ASN . 2.8 tp10 -64.01 -49.36 72.74 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 -178.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 29.5 m -52.1 -46.06 65.12 Favored 'General case' 0 C--O 1.192 -1.93 0 CA-C-N 113.445 -1.707 . . . . 0.0 111.351 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.617 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 16.3 pt-20 -75.99 -31.32 58.92 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -173.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -75.55 -47.36 27.11 Favored 'General case' 0 C--O 1.279 2.651 0 N-CA-C 101.238 -3.616 . . . . 0.0 101.238 -174.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.883 HD11 HG11 ' A' ' 24' ' ' VAL 1.532 1.5 pp -57.19 -57.31 10.47 Favored 'Isoleucine or valine' 1 N--CA 1.309 -7.487 0 N-CA-C 120.917 3.673 . . . . 0.0 120.917 175.159 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.545 ' HA ' ' HB2' ' A' ' 40' ' ' TRP . 39.6 p -67.84 -31.42 71.24 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.2 t -64.85 -46.54 81.45 Favored 'General case' 0 N--CA 1.424 -1.737 0 C-N-CA 119.789 -0.764 . . . . 0.0 109.074 176.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 74.7 mt -67.76 -46.29 72.46 Favored 'General case' 0 C--N 1.364 1.213 0 C-N-CA 119.437 -0.905 . . . . 0.0 108.901 178.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.729 ' HB3' ' NH1' ' A' ' 53' ' ' ARG . 37.8 m0 -57.3 -67.72 0.3 Allowed 'General case' 0 N--CA 1.424 -1.745 0 CA-C-N 113.943 -1.481 . . . . 0.0 114.837 -175.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.441 ' O ' ' HD1' ' A' ' 45' ' ' PHE 0.331 0.0 OUTLIER -78.9 -17.5 55.45 Favored 'General case' 0 N--CA 1.43 -1.446 0 C-N-CA 117.102 -1.839 . . . . 0.0 110.677 -176.513 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -52.95 -59.43 9.38 Favored Glycine 0 CA--C 1.472 -2.596 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 170.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.3 m -74.79 -36.85 62.49 Favored 'General case' 0 N--CA 1.395 -3.209 0 CA-C-N 113.245 -1.478 . . . . 0.0 112.496 -175.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.955 HD12 ' HD2' ' A' ' 53' ' ' ARG . 12.7 mt -61.1 -33.54 73.52 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 120.275 -0.57 . . . . 0.0 112.209 178.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.441 ' HD1' ' O ' ' A' ' 41' ' ' GLN . 53.0 m-85 -87.11 -32.18 20.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 120.201 -0.6 . . . . 0.0 111.348 176.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -70.19 -29.98 66.98 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -178.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -84.12 8.4 15.67 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 121.079 0.466 . . . . 0.0 110.898 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.7 t30 67.38 52.21 0.83 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 125.176 1.391 . . . . 0.0 113.538 172.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -100.59 154.34 18.65 Favored 'General case' 0 N--CA 1.43 -1.431 0 O-C-N 120.35 -1.469 . . . . 0.0 107.852 170.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.519 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 30.2 t70 -92.54 83.62 4.95 Favored 'General case' 0 C--O 1.214 -0.774 0 CA-C-N 120.02 1.282 . . . . 0.0 109.407 -178.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.2 m -129.77 174.36 12.69 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.567 0 CA-C-N 115.129 -0.941 . . . . 0.0 112.205 -170.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.464 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 0.9 OUTLIER -134.22 140.2 46.32 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 169.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 1.012 ' HG2' ' HA ' ' A' ' 63' ' ' PHE . 35.7 mtp180 -142.91 139.55 30.82 Favored 'General case' 0 C--N 1.27 -2.848 0 CA-C-N 118.958 0.799 . . . . 0.0 109.735 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.671 ' H ' HG12 ' A' ' 62' ' ' ILE . 50.1 m-85 -132.33 151.38 51.87 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 118.044 -1.462 . . . . 0.0 114.099 -169.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 57.8 mt -99.19 96.41 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.63 0 N-CA-C 104.526 -2.398 . . . . 0.0 104.526 170.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 60' ' ' ARG . 4.7 m -98.16 -23.14 4.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.246 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.048 -175.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -166.94 161.57 35.39 Favored Glycine 0 N--CA 1.423 -2.184 0 C-N-CA 118.524 -1.798 . . . . 0.0 112.159 176.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.455 ' HB3' ' C ' ' A' ' 29' ' ' THR . 51.1 m -75.64 106.48 7.23 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 175.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.498 ' O ' ' HD2' ' A' ' 60' ' ' ARG 0.271 0.0 OUTLIER 98.42 5.04 0.02 OUTLIER 'General case' 0 C--N 1.366 1.283 0 C-N-CA 127.0 2.12 . . . . 0.0 110.188 -174.167 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.498 ' HD2' ' O ' ' A' ' 59' ' ' ASP . 5.8 mpt_? -134.11 123.04 23.77 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.95 0.9 . . . . 0.0 112.131 178.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -130.09 168.18 17.16 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 -176.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.671 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -141.16 153.24 20.15 Favored 'Isoleucine or valine' 0 CA--C 1.45 -2.878 0 C-N-CA 118.622 -1.231 . . . . 0.0 110.954 172.291 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.012 ' HA ' ' HG2' ' A' ' 53' ' ' ARG 0.27 31.2 p90 -129.45 108.62 10.41 Favored 'General case' 0 N--CA 1.43 -1.433 0 O-C-N 127.114 2.759 . . . . 0.0 108.665 163.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.464 ' HB3' ' HB2' ' A' ' 52' ' ' GLN . 26.5 ttt -92.42 119.75 32.25 Favored 'General case' 0 C--O 1.27 2.158 0 N-CA-C 113.691 0.997 . . . . 0.0 113.691 -177.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.643 HD22 ' CB ' ' A' ' 18' ' ' LEU . 0.2 OUTLIER -81.65 122.06 27.14 Favored 'General case' 0 C--O 1.251 1.181 0 C-N-CA 128.956 2.902 . . . . 0.0 110.161 178.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.519 ' HD3' ' OD2' ' A' ' 50' ' ' ASP 0.253 23.6 ttt180 -105.44 -49.5 3.42 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 172.091 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.445 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 25.9 t70 -75.87 50.88 0.6 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 120.079 1.309 . . . . 0.0 112.777 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.787 ' HA3' ' HA ' ' A' ' 14' ' ' LYS . . . 58.58 -34.66 0.02 OUTLIER Glycine 0 CA--C 1.55 2.233 0 N-CA-C 120.991 3.157 . . . . 0.0 120.991 173.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.416 ' HB3' HD12 ' A' ' 9' ' ' LEU . 62.0 m -163.07 51.65 0.17 Allowed 'General case' 0 N--CA 1.507 2.409 0 CA-C-N 120.189 1.995 . . . . 0.0 116.384 -171.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.499 ' HE1' ' HA ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -122.01 13.83 10.6 Favored 'General case' 0 C--O 1.213 -0.849 0 O-C-N 120.286 -1.508 . . . . 0.0 112.306 177.861 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.928 ' HA ' HD12 ' A' ' 74' ' ' ILE . . . -102.14 -12.94 17.69 Favored 'General case' 0 C--O 1.197 -1.661 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -169.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.661 ' CD1' HD13 ' A' ' 9' ' ' LEU . 8.5 m95 -84.85 -31.0 24.02 Favored 'General case' 0 C--N 1.27 -2.872 0 O-C-N 120.536 -1.353 . . . . 0.0 109.102 -166.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.404 ' HG3' ' CZ ' ' A' ' 77' ' ' PHE . 18.5 tp10 -75.11 -33.81 61.64 Favored 'General case' 0 C--O 1.257 1.464 0 N-CA-C 107.202 -1.406 . . . . 0.0 107.202 172.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.928 HD12 ' HA ' ' A' ' 71' ' ' ALA . 54.2 mt -59.01 -39.73 79.01 Favored 'Isoleucine or valine' 0 C--O 1.264 1.855 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.004 175.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.863 ' HD2' HD11 ' A' ' 89' ' ' LEU . 32.9 tttm -57.05 -53.21 60.62 Favored 'General case' 0 C--O 1.275 2.447 0 CA-C-N 114.196 -1.365 . . . . 0.0 109.267 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -55.08 -46.94 75.49 Favored 'General case' 0 N--CA 1.45 -0.453 0 O-C-N 124.821 1.326 . . . . 0.0 112.284 177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.45 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 13.0 m-85 -56.74 -55.91 28.13 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 119.806 -0.757 . . . . 0.0 110.559 -177.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.651 HD22 ' NE1' ' A' ' 40' ' ' TRP . 9.5 mt -58.53 -48.55 80.48 Favored 'General case' 0 CA--C 1.47 -2.127 0 N-CA-C 113.939 1.089 . . . . 0.0 113.939 -175.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 75' ' ' LYS 0.281 18.3 m -78.99 -6.26 9.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 C-N-CA 116.558 -2.057 . . . . 0.0 113.136 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.0 m -106.68 4.02 27.37 Favored 'General case' 0 N--CA 1.423 -1.777 0 C-N-CA 119.975 -0.69 . . . . 0.0 110.698 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 76.8 mt-30 -118.45 -25.02 6.62 Favored 'General case' 0 CA--C 1.464 -2.357 0 C-N-CA 117.374 -1.731 . . . . 0.0 111.149 -178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -139.73 -164.1 1.62 Allowed 'General case' 0 N--CA 1.402 -2.87 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 176.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.711 ' HB3' HG13 ' A' ' 24' ' ' VAL . 23.2 tpp180 -60.56 136.15 57.97 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 118.858 0.754 . . . . 0.0 111.009 -172.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . . . . . . . . . 18.2 p -130.57 146.21 52.04 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -174.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -155.29 -38.62 0.09 Allowed 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 122.71 0.404 . . . . 0.0 111.157 170.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.083 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 39.9 tt0 -153.24 129.0 10.13 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.745 -176.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -128.16 92.68 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 174.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 20.3 p -116.78 111.34 19.61 Favored 'General case' 0 C--O 1.257 1.487 0 CA-C-O 121.926 0.869 . . . . 0.0 110.816 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.863 HD11 ' HD2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -103.47 89.27 3.32 Favored 'General case' 0 N--CA 1.408 -2.539 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 -176.384 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.904 ' HB3' ' HB3' ' A' ' 94' ' ' TYR . 10.3 tp10 -149.56 172.63 14.7 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 163.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -83.11 -55.75 2.86 Favored Glycine 0 N--CA 1.415 -2.755 0 C-N-CA 119.044 -1.55 . . . . 0.0 109.435 172.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -113.02 158.61 20.08 Favored 'General case' 0 C--N 1.354 0.788 0 CA-C-N 118.496 1.148 . . . . 0.0 111.16 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 15.0 tpt 71.12 -71.14 0.14 Allowed 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.429 1.492 . . . . 0.0 113.182 174.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.904 ' HB3' ' HB3' ' A' ' 90' ' ' GLU . 14.2 t80 -49.39 -46.99 78.13 Favored Pre-proline 0 CA--C 1.563 1.447 0 C-N-CA 124.614 1.166 . . . . 0.0 112.471 -176.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.602 ' HG3' ' O ' ' A' ' 90' ' ' GLU . 4.3 Cg_endo -102.46 19.5 0.2 Allowed 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 121.978 1.785 . . . . 0.0 113.743 177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -166.68 55.16 0.24 Allowed Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 119.674 -1.25 . . . . 0.0 111.836 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.5 ttpt . . . . . 0 C--N 1.293 -1.863 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.515 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.277 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.591 ' HD2' ' HB2' ' A' ' 7' ' ' SER . 4.7 Cg_exo -78.77 -163.88 0.25 Allowed 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.481 2.787 . . . . 0.0 111.904 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.02 -41.28 4.09 Favored Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.227 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.498 ' HD2' ' HG2' ' A' ' 6' ' ' GLU . 30.3 ttmt -86.15 138.33 34.67 Favored Pre-proline 0 N--CA 1.44 -0.931 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -178.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 5.5 Cg_endo -80.36 40.87 1.03 Allowed 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 123.126 2.551 . . . . 0.0 112.789 -178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.498 ' HG2' ' HD2' ' A' ' 4' ' ' LYS . 10.0 pt-20 -85.47 -4.26 59.11 Favored 'General case' 0 C--O 1.247 0.96 0 N-CA-C 103.837 -2.653 . . . . 0.0 103.837 160.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.591 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 85.2 p -75.76 174.2 10.14 Favored 'General case' 1 N--CA 1.375 -4.221 0 CA-C-N 111.87 -2.423 . . . . 0.0 106.676 -175.617 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.404 HD11 ' CD2' ' A' ' 72' ' ' TRP 0.264 8.7 tp 31.95 49.66 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -1.985 0 C-N-CA 126.256 1.822 . . . . 0.0 111.617 -164.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.53 HD12 ' HA ' ' A' ' 12' ' ' THR 0.348 2.9 pp 55.82 64.77 1.63 Allowed 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 122.971 1.367 . . . . 0.0 114.516 174.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.4 mtpt 63.39 47.78 3.79 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 113.401 -1.727 . . . . 0.0 111.531 175.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 62.0 mtt 67.58 34.11 4.73 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 123.598 0.561 . . . . 0.0 110.201 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.805 HG22 ' HA ' ' A' ' 69' ' ' SER . 6.1 m 74.44 25.26 1.67 Allowed 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.893 1.277 . . . . 0.0 110.362 177.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -137.37 92.3 2.69 Favored 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.213 -0.929 . . . . 0.0 113.013 -174.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.453 ' HG2' ' HB2' ' A' ' 9' ' ' LEU . 17.6 ptpt -155.69 -6.05 0.12 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.718 -0.673 . . . . 0.0 111.483 173.064 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 60.04 69.62 1.24 Allowed Glycine 0 CA--C 1.559 2.837 0 C-N-CA 120.509 -0.853 . . . . 0.0 111.342 -175.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -125.79 133.02 52.17 Favored 'General case' 0 N--CA 1.437 -1.086 0 CA-C-N 119.822 1.811 . . . . 0.0 111.251 -174.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.9 p -65.59 114.49 4.96 Favored 'General case' 0 N--CA 1.42 -1.937 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.381 176.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.663 HD11 ' HB3' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -128.02 108.21 10.48 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 -179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.506 ' O ' ' HB2' ' A' ' 90' ' ' GLU . 25.1 ptm -93.6 108.8 20.47 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 178.354 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.825 ' HB2' ' HA ' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -106.93 143.09 35.52 Favored 'General case' 0 N--CA 1.424 -1.762 0 C-N-CA 116.703 -1.999 . . . . 0.0 112.742 -173.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.476 ' CE2' ' HD3' ' A' ' 60' ' ' ARG . 1.1 t80 -114.91 114.72 25.85 Favored 'General case' 0 C--O 1.26 1.609 0 C-N-CA 128.079 2.552 . . . . 0.0 109.863 -174.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.745 HG23 ' SD ' ' A' ' 20' ' ' MET . 3.6 t -104.0 131.65 52.25 Favored 'Isoleucine or valine' 0 C--O 1.25 1.112 0 CA-C-N 114.272 -1.331 . . . . 0.0 111.33 -177.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 1.03 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 97.7 m -99.83 129.76 45.96 Favored 'General case' 0 CA--C 1.594 2.635 0 O-C-N 124.529 1.143 . . . . 0.0 108.375 176.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 59' ' ' ASP 0.295 93.5 t -122.38 101.82 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.842 0 C-N-CA 127.029 2.132 . . . . 0.0 106.8 -171.426 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.4 m -115.08 -1.01 13.14 Favored 'General case' 0 C--N 1.35 0.59 0 CA-C-N 122.471 2.396 . . . . 0.0 115.105 -168.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.749 ' HA3' ' HD2' ' A' ' 83' ' ' ARG . . . -56.51 -48.17 78.36 Favored Glycine 0 N--CA 1.474 1.226 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 178.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 32' ' ' GLU . 4.9 t30 -115.75 116.67 40.67 Favored Pre-proline 0 N--CA 1.401 -2.878 0 N-CA-C 100.447 -3.909 . . . . 0.0 100.447 169.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -106.18 34.34 0.05 OUTLIER 'Trans proline' 0 C--N 1.3 -1.98 0 C-N-CA 122.306 2.004 . . . . 0.0 111.305 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.9 m -129.5 54.5 1.82 Allowed 'General case' 0 CA--C 1.578 2.044 0 C-N-CA 118.116 -1.434 . . . . 0.0 114.849 -168.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' ' HB ' ' A' ' 33' ' ' THR . 35.9 mt-10 59.92 -21.13 0.03 OUTLIER 'General case' 0 C--N 1.377 1.796 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 178.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.525 ' C ' ' HD3' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -69.68 -41.93 74.79 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 178.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.656 ' O ' ' HB ' ' A' ' 36' ' ' ILE . 1.2 pm0 -68.31 -41.62 80.59 Favored 'General case' 0 C--N 1.279 -2.487 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -179.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.481 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 90.9 m -48.19 -53.08 18.1 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 124.15 0.98 . . . . 0.0 110.517 174.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -69.6 -49.12 57.06 Favored 'General case' 0 C--O 1.259 1.558 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -177.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -49.73 -60.0 3.29 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 125.232 1.413 . . . . 0.0 107.836 179.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.839 HG23 ' CE3' ' A' ' 40' ' ' TRP . 22.3 mt -64.76 -44.56 96.45 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.035 0 CA-C-N 112.135 -2.302 . . . . 0.0 113.01 -175.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.836 HG21 HG12 ' A' ' 55' ' ' ILE . 22.4 p -66.83 -48.86 67.6 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 117.87 -1.532 . . . . 0.0 111.826 -176.094 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 35.0 p -63.29 -57.2 11.2 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.592 0.557 . . . . 0.0 111.463 -179.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 68.3 tp -67.18 -39.35 86.39 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -175.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.868 ' CE3' HD13 ' A' ' 78' ' ' LEU . 46.1 m0 -79.96 -48.6 13.12 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -174.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.453 ' O ' ' HD1' ' A' ' 45' ' ' PHE 0.286 0.0 OUTLIER -72.61 -23.42 60.94 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 116.686 -2.006 . . . . 0.0 109.857 178.828 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -61.59 -51.44 57.59 Favored Glycine 0 N--CA 1.428 -1.895 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 173.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 10.5 p -66.75 -38.95 87.64 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 178.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.052 HD12 ' HD2' ' A' ' 53' ' ' ARG . 19.3 mt -60.17 -35.57 75.65 Favored 'General case' 0 C--O 1.241 0.631 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 177.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.453 ' HD1' ' O ' ' A' ' 41' ' ' GLN . 35.1 m-85 -85.81 -25.22 26.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.242 0.544 . . . . 0.0 110.521 176.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 27.4 t-20 -68.39 -31.84 71.48 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 123.372 0.669 . . . . 0.0 111.681 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -87.45 2.66 49.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.241 0.543 . . . . 0.0 110.307 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 52.7 t30 57.16 60.7 2.84 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.028 1.331 . . . . 0.0 114.238 176.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -100.32 167.82 10.17 Favored 'General case' 0 N--CA 1.428 -1.538 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 166.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -97.8 100.8 12.18 Favored 'General case' 0 CA--C 1.507 -0.71 0 CA-C-N 120.22 1.373 . . . . 0.0 108.348 -179.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 m -146.13 176.92 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.243 -171.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 64' ' ' MET . 22.9 mt-30 -140.58 145.5 36.81 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 103.881 -2.637 . . . . 0.0 103.881 173.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 1.052 ' HD2' HD12 ' A' ' 44' ' ' LEU . 21.6 mtp180 -143.53 144.14 31.84 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 118.943 0.792 . . . . 0.0 111.233 179.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.668 ' H ' HG12 ' A' ' 62' ' ' ILE . 80.7 m-85 -133.68 151.75 51.72 Favored 'General case' 0 C--O 1.261 1.661 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 -170.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.836 HG12 HG21 ' A' ' 37' ' ' THR . 17.4 mt -92.56 102.86 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 104.252 -2.499 . . . . 0.0 104.252 167.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.714 HG23 ' HD2' ' A' ' 60' ' ' ARG . 6.9 m -112.51 -27.41 2.77 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.784 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -175.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -158.95 161.38 31.89 Favored Glycine 0 N--CA 1.419 -2.492 0 C-N-CA 118.158 -1.972 . . . . 0.0 113.681 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.3 m -64.4 125.17 23.79 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 174.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.641 ' HB2' ' O ' ' A' ' 24' ' ' VAL . 1.2 p30 68.22 21.61 8.47 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 125.106 1.362 . . . . 0.0 109.556 178.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.714 ' HD2' HG23 ' A' ' 56' ' ' VAL . 1.1 tmm_? -153.6 119.77 5.44 Favored 'General case' 0 CA--C 1.583 2.215 0 CA-C-O 122.278 1.037 . . . . 0.0 113.327 -177.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -125.29 168.75 13.08 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 124.527 1.131 . . . . 0.0 109.066 -171.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.681 ' HB ' ' O ' ' A' ' 20' ' ' MET . 0.2 OUTLIER -134.6 156.79 40.7 Favored 'Isoleucine or valine' 0 C--O 1.283 2.861 0 C-N-CA 117.474 -1.69 . . . . 0.0 110.993 175.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.017 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 49.0 p90 -123.24 109.82 14.44 Favored 'General case' 0 N--CA 1.422 -1.845 0 O-C-N 127.507 3.005 . . . . 0.0 107.309 163.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.642 ' HB2' HD11 ' A' ' 62' ' ' ILE . 23.7 ttt -95.87 110.81 22.93 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.303 -178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.843 ' HG ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -113.3 147.42 37.64 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -171.818 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.284 30.6 ttm180 -111.78 -58.51 2.11 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 -176.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -44.46 -19.99 0.03 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 70.22 -9.13 3.32 Favored Glycine 0 C--N 1.358 1.767 0 CA-C-N 119.717 1.144 . . . . 0.0 114.903 -175.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.805 ' HA ' HG22 ' A' ' 12' ' ' THR . 1.3 m -117.05 32.46 6.15 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 118.301 1.051 . . . . 0.0 113.696 -168.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -166.68 12.98 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.639 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.606 -171.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.843 ' HB2' ' HG ' ' A' ' 65' ' ' LEU . . . -97.22 -37.77 9.95 Favored 'General case' 0 CA--C 1.563 1.458 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 -166.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.612 ' CE2' HD22 ' A' ' 89' ' ' LEU . 9.0 m-90 -76.0 -27.53 57.45 Favored 'General case' 0 C--O 1.273 2.331 0 O-C-N 120.895 -1.128 . . . . 0.0 110.636 -174.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 -63.62 -35.22 79.79 Favored 'General case' 0 N--CA 1.422 -1.858 0 CA-C-N 113.835 -1.529 . . . . 0.0 107.722 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.818 HD12 ' HA ' ' A' ' 71' ' ' ALA . 26.3 mt -67.58 -45.2 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.154 178.55 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.579 ' HB2' HG11 ' A' ' 87' ' ' VAL . 0.0 OUTLIER -57.71 -41.69 82.25 Favored 'General case' 0 C--O 1.283 2.851 0 CA-C-O 121.907 0.861 . . . . 0.0 109.387 -174.022 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.495 ' N ' ' HD2' ' A' ' 75' ' ' LYS . 17.1 t70 -61.46 -50.01 74.51 Favored 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 112.826 -1.988 . . . . 0.0 111.649 177.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.424 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 14.8 m-85 -62.09 -48.3 80.82 Favored 'General case' 0 C--O 1.197 -1.696 0 C-N-CA 118.47 -1.292 . . . . 0.0 110.383 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.868 HD13 ' CE3' ' A' ' 40' ' ' TRP . 4.3 mt -55.57 -54.5 43.3 Favored 'General case' 0 C--O 1.296 3.504 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -175.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.677 ' O ' ' HB3' ' A' ' 84' ' ' CYS 0.354 30.0 m -72.62 -19.1 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.272 0 C-N-CA 115.935 -2.306 . . . . 0.0 112.574 -179.315 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 25.3 m -85.96 -4.3 59.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.148 171.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.424 ' HG2' ' O ' ' A' ' 77' ' ' PHE . 21.7 mm-40 -90.43 -32.27 16.48 Favored 'General case' 0 CA--C 1.453 -2.78 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.073 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.507 ' OD2' ' HG2' ' A' ' 83' ' ' ARG 0.44 21.7 t70 -147.31 -94.58 0.09 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 116.913 -1.915 . . . . 0.0 114.628 -178.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.749 ' HD2' ' HA3' ' A' ' 26' ' ' GLY . 10.8 mmt180 -105.38 126.74 52.46 Favored 'General case' 0 CA--C 1.505 -0.763 0 CA-C-N 121.191 1.814 . . . . 0.0 109.264 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 0.677 ' HB3' ' O ' ' A' ' 79' ' ' VAL . 22.2 p -111.46 97.09 6.5 Favored 'General case' 0 N--CA 1.424 -1.762 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -176.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -121.75 -42.37 2.42 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 113.802 1.038 . . . . 0.0 113.802 173.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 1.03 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 37.2 tt0 -153.61 125.2 7.64 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 118.034 -1.466 . . . . 0.0 112.781 -174.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.579 HG12 HG22 ' A' ' 22' ' ' VAL . 2.9 m -112.75 93.44 2.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 172.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 p -105.44 99.4 9.01 Favored 'General case' 0 N--CA 1.413 -2.322 0 C-N-CA 118.413 -1.315 . . . . 0.0 112.208 177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.825 ' HA ' ' HB2' ' A' ' 20' ' ' MET . 5.4 mp -78.43 156.27 29.5 Favored 'General case' 0 N--CA 1.384 -3.73 0 CA-C-N 112.932 -1.94 . . . . 0.0 106.545 176.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.572 ' H ' ' CD1' ' A' ' 18' ' ' LEU . 2.8 tm-20 -77.62 140.59 39.65 Favored 'General case' 0 C--N 1.276 -2.602 0 C-N-CA 123.546 0.738 . . . . 0.0 109.326 -166.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.636 ' HA3' ' HB3' ' A' ' 94' ' ' TYR . . . 134.59 91.9 0.41 Allowed Glycine 0 N--CA 1.404 -3.461 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 -178.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -56.88 109.74 0.69 Allowed 'General case' 0 C--N 1.373 1.627 0 CA-C-N 120.771 2.285 . . . . 0.0 108.895 174.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . 0.522 ' O ' ' HD3' ' A' ' 95' ' ' PRO . 14.4 tpt 61.54 72.84 0.5 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.827 -168.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.636 ' HB3' ' HA3' ' A' ' 91' ' ' GLY . 6.5 p90 -101.73 96.27 6.31 Favored Pre-proline 0 N--CA 1.444 -0.768 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.522 ' HD3' ' O ' ' A' ' 93' ' ' MET . 88.4 Cg_endo -95.2 8.54 1.89 Allowed 'Trans proline' 0 N--CA 1.443 -1.449 0 C-N-CA 122.228 1.952 . . . . 0.0 111.43 -177.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.59 -37.07 3.06 Favored Glycine 0 N--CA 1.432 -1.602 0 C-N-CA 121.102 -0.571 . . . . 0.0 112.021 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 59.5 pttt . . . . . 0 N--CA 1.436 -1.151 0 C-N-CA 122.418 0.287 . . . . 0.0 110.452 179.028 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.517 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -56.07 -19.5 26.82 Favored 'Trans proline' 0 N--CA 1.485 1.018 0 C-N-CA 123.958 3.105 . . . . 0.0 114.159 -177.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.2 -25.36 75.73 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 121.605 -0.331 . . . . 0.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.463 ' HG2' ' HG3' ' A' ' 6' ' ' GLU . 61.2 tttp -85.11 133.1 43.58 Favored Pre-proline 0 N--CA 1.435 -1.178 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.384 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 4' ' ' LYS . 6.6 Cg_endo -82.05 57.31 6.19 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 123.508 2.805 . . . . 0.0 113.279 -175.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.463 ' HG3' ' HG2' ' A' ' 4' ' ' LYS . 35.8 mt-10 -81.89 -13.74 57.15 Favored 'General case' 0 C--O 1.256 1.444 0 N-CA-C 102.5 -3.148 . . . . 0.0 102.5 159.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.531 ' HB2' ' CD2' ' A' ' 9' ' ' LEU . 49.2 m 65.89 163.77 0.17 Allowed 'General case' 0 N--CA 1.382 -3.853 0 CA-C-N 110.675 -2.966 . . . . 0.0 109.952 171.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.8 pt -43.83 -25.33 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.095 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 173.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.531 ' CD2' ' HB2' ' A' ' 7' ' ' SER . 2.5 pt? -78.51 -57.82 3.57 Favored 'General case' 0 C--O 1.195 -1.782 0 C-N-CA 119.249 -0.981 . . . . 0.0 111.069 -174.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -78.0 -14.94 59.34 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 118.285 -1.366 . . . . 0.0 111.399 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 45.6 ttm -82.76 -36.97 25.23 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 120.193 -0.603 . . . . 0.0 112.03 177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.8 m -130.85 -24.09 2.45 Favored 'General case' 0 CA--C 1.557 1.241 0 C-N-CA 118.594 -1.242 . . . . 0.0 113.953 -176.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.441 ' HD2' ' HB3' ' A' ' 16' ' ' LYS . 47.6 mmtm -102.15 97.36 7.68 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.115 -0.991 . . . . 0.0 110.94 -175.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.2 mtmp? -109.47 -23.24 11.62 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.082 0.467 . . . . 0.0 110.79 -178.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -157.85 64.1 0.31 Allowed Glycine 0 CA--C 1.553 2.426 0 CA-C-O 118.939 -0.923 . . . . 0.0 112.764 174.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.441 ' HB3' ' HD2' ' A' ' 13' ' ' LYS . 52.6 tptt -130.36 134.08 46.89 Favored 'General case' 0 C--N 1.363 1.192 0 CA-C-N 119.741 1.771 . . . . 0.0 110.758 -176.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.545 ' HA ' ' O ' ' A' ' 65' ' ' LEU . 6.3 m -85.58 111.36 19.97 Favored 'General case' 0 N--CA 1.432 -1.369 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 176.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.835 ' HB3' HD21 ' A' ' 65' ' ' LEU . 21.8 tp -133.2 116.02 15.71 Favored 'General case' 0 CA--C 1.576 1.958 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -174.185 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.669 ' O ' HD21 ' A' ' 89' ' ' LEU . 19.6 ptm -83.56 103.13 12.64 Favored 'General case' 0 C--O 1.207 -1.171 0 O-C-N 121.502 -0.749 . . . . 0.0 112.792 -176.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.623 ' HA ' ' HG ' ' A' ' 89' ' ' LEU . 12.3 mtm -84.56 126.01 32.94 Favored 'General case' 0 CA--C 1.477 -1.838 0 N-CA-C 113.475 0.917 . . . . 0.0 113.475 -174.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -108.8 115.0 29.25 Favored 'General case' 0 N--CA 1.432 -1.34 0 O-C-N 125.618 1.824 . . . . 0.0 108.606 -171.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -115.25 125.52 72.54 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.485 -176.402 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.823 ' HB ' ' HB3' ' A' ' 86' ' ' GLU . 30.2 m -90.85 110.62 21.84 Favored 'General case' 0 N--CA 1.41 -2.428 0 CA-C-N 113.638 -1.619 . . . . 0.0 107.365 -178.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.658 HG13 ' HA ' ' A' ' 84' ' ' CYS . 75.5 t -103.77 92.55 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.392 -3.341 0 CA-C-N 120.373 1.442 . . . . 0.0 109.145 -176.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.6 m -93.38 96.5 9.98 Favored 'General case' 0 N--CA 1.414 -2.24 0 CA-C-N 120.755 1.616 . . . . 0.0 110.292 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -150.21 -50.08 0.02 OUTLIER Glycine 0 N--CA 1.423 -2.218 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -116.47 106.12 49.16 Favored Pre-proline 0 CA--C 1.493 -1.212 0 N-CA-C 104.996 -2.224 . . . . 0.0 104.996 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.58 42.44 0.27 Allowed 'Trans proline' 0 N--CA 1.485 0.972 0 C-N-CA 123.93 3.086 . . . . 0.0 114.111 -171.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 81.6 p -147.0 -176.5 5.23 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 -176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' HB ' ' A' ' 33' ' ' THR . 48.8 mt-10 -85.81 10.32 14.06 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 118.831 0.741 . . . . 0.0 110.225 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.528 ' HA ' ' HG2' ' A' ' 34' ' ' GLU . 0.3 OUTLIER -77.74 -34.43 52.55 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 179.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.588 ' HG2' HD12 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -71.26 -40.84 70.73 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 119.318 -0.953 . . . . 0.0 108.493 177.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.529 ' OG1' ' HA ' ' A' ' 58' ' ' SER . 29.0 m -49.87 -55.63 13.58 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 125.866 1.666 . . . . 0.0 110.807 174.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.528 ' HG2' ' HA ' ' A' ' 31' ' ' LYS . 12.1 pt-20 -67.5 -43.95 79.66 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.867 -177.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -50.71 -62.56 1.53 Allowed 'General case' 0 N--CA 1.481 1.084 0 CA-C-O 123.075 1.416 . . . . 0.0 107.474 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.87 HG23 ' CE3' ' A' ' 40' ' ' TRP . 25.0 mt -61.71 -44.38 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.551 0 CA-C-N 112.067 -2.333 . . . . 0.0 112.981 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.812 HG21 HG12 ' A' ' 55' ' ' ILE . 25.1 p -68.28 -52.93 28.2 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 119.31 -0.956 . . . . 0.0 111.913 -175.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 46.4 p -62.79 -56.68 15.3 Favored 'General case' 0 C--O 1.256 1.432 0 O-C-N 123.618 0.574 . . . . 0.0 111.621 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.2 mp -62.87 -49.6 74.22 Favored 'General case' 0 C--O 1.244 0.799 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -176.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.87 ' CE3' HG23 ' A' ' 36' ' ' ILE . 50.8 m0 -75.14 -47.25 29.44 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 113.866 1.061 . . . . 0.0 113.866 -173.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.298 0.0 OUTLIER -73.98 -19.47 60.64 Favored 'General case' 0 C--N 1.346 0.44 0 C-N-CA 116.608 -2.037 . . . . 0.0 109.816 -179.5 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -60.99 -52.87 49.61 Favored Glycine 0 N--CA 1.432 -1.574 0 N-CA-C 110.081 -1.207 . . . . 0.0 110.081 170.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.521 ' HA ' ' HB3' ' A' ' 46' ' ' ASN . 9.6 p -69.73 -34.51 73.96 Favored 'General case' 0 C--O 1.25 1.101 0 CA-C-N 117.099 0.449 . . . . 0.0 112.01 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.986 HD12 ' HD2' ' A' ' 53' ' ' ARG . 9.2 mt -61.06 -35.28 76.53 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 176.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -87.99 -22.31 24.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.358 175.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.521 ' HB3' ' HA ' ' A' ' 43' ' ' SER . 16.1 t-20 -65.53 -34.22 77.76 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.653 0.263 . . . . 0.0 110.984 177.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -83.99 5.05 27.13 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.411 0.624 . . . . 0.0 109.863 175.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 66.5 t30 51.77 45.4 28.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.342 1.857 . . . . 0.0 113.673 176.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -80.09 165.87 22.07 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 173.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -98.25 94.53 6.83 Favored 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 120.359 1.436 . . . . 0.0 108.656 178.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.3 m -135.12 173.09 14.93 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.501 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.592 -171.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -138.43 123.93 19.56 Favored 'General case' 0 C--O 1.196 -1.721 0 N-CA-C 106.565 -1.643 . . . . 0.0 106.565 169.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 1.131 ' HG2' ' HA ' ' A' ' 63' ' ' PHE . 16.8 mtp180 -120.43 142.03 49.6 Favored 'General case' 0 C--N 1.268 -2.947 0 O-C-N 121.235 -0.915 . . . . 0.0 110.998 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.659 ' H ' HG12 ' A' ' 62' ' ' ILE . 41.1 m-85 -129.57 152.14 49.41 Favored 'General case' 0 C--O 1.257 1.48 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -170.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.812 HG12 HG21 ' A' ' 37' ' ' THR . 29.8 mt -94.8 109.44 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 N-CA-C 104.987 -2.227 . . . . 0.0 104.987 170.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.591 HG23 ' HB3' ' A' ' 60' ' ' ARG . 3.7 m -112.07 -16.19 9.45 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -175.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 161.97 177.12 34.75 Favored Glycine 0 CA--C 1.482 -2.022 0 C-N-CA 117.477 -2.297 . . . . 0.0 114.262 169.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.529 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 37.6 t -66.14 116.65 7.44 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.537 ' C ' ' HD2' ' A' ' 60' ' ' ARG . 0.2 OUTLIER 85.98 9.39 0.28 Allowed 'General case' 0 C--O 1.208 -1.128 0 C-N-CA 125.41 1.484 . . . . 0.0 109.058 -178.378 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.591 ' HB3' HG23 ' A' ' 56' ' ' VAL . 3.8 mpt_? -138.68 124.26 19.57 Favored 'General case' 0 C--O 1.255 1.387 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -177.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -134.89 162.24 32.97 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.659 HG12 ' H ' ' A' ' 54' ' ' PHE . 0.1 OUTLIER -137.56 154.45 29.75 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.044 0 C-N-CA 117.969 -1.493 . . . . 0.0 111.545 174.08 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 1.131 ' HA ' ' HG2' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -126.65 112.65 15.71 Favored 'General case' 0 N--CA 1.43 -1.441 0 O-C-N 127.223 2.827 . . . . 0.0 107.76 162.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.439 ' HB2' HD11 ' A' ' 62' ' ' ILE . 43.4 ttm -95.42 125.55 40.11 Favored 'General case' 0 C--O 1.258 1.544 0 O-C-N 121.332 -0.855 . . . . 0.0 109.805 179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.835 HD21 ' HB3' ' A' ' 18' ' ' LEU . 1.2 pt? -102.2 144.62 30.51 Favored 'General case' 0 CA--C 1.494 -1.182 0 O-C-N 124.622 1.201 . . . . 0.0 110.669 -176.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . 0.292 5.5 tmm_? -119.73 -49.22 2.34 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 176.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -46.78 -23.44 0.43 Allowed 'General case' 0 CA--C 1.577 2.013 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 171.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.42 -31.93 4.65 Favored Glycine 0 C--N 1.36 1.864 0 CA-C-N 120.231 1.378 . . . . 0.0 113.8 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 64.2 m -128.34 45.42 2.77 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 -166.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.623 ' CE1' ' HB2' ' A' ' 65' ' ' LEU . 0.1 OUTLIER -153.02 2.25 0.29 Allowed 'General case' 0 CA--C 1.544 0.747 0 O-C-N 121.239 -0.913 . . . . 0.0 112.562 -178.489 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.728 ' HA ' HD12 ' A' ' 74' ' ' ILE . . . -94.52 -34.41 12.69 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 119.077 2.991 . . . . 0.0 119.077 -170.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TRP . . . . . 0.789 ' HD1' ' HD3' ' A' ' 75' ' ' LYS 0.512 9.3 m-90 -81.42 -16.81 50.99 Favored 'General case' 0 C--O 1.263 1.781 0 C-N-CA 116.494 -2.083 . . . . 0.0 114.85 -167.712 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -73.56 -29.73 62.61 Favored 'General case' 0 C--O 1.257 1.494 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 168.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 71' ' ' ALA . 74.9 mt -61.23 -42.13 92.27 Favored 'Isoleucine or valine' 0 C--O 1.258 1.54 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.869 173.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.865 ' HB2' HG21 ' A' ' 87' ' ' VAL . 53.1 pttt -61.32 -41.45 97.04 Favored 'General case' 0 C--N 1.378 1.842 0 C-N-CA 119.43 -0.908 . . . . 0.0 109.386 -177.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -55.45 -52.02 65.0 Favored 'General case' 0 C--O 1.271 2.204 0 O-C-N 124.29 0.994 . . . . 0.0 110.582 178.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.471 ' CD2' ' HA ' ' A' ' 74' ' ' ILE . 8.0 m-85 -54.62 -47.54 73.32 Favored 'General case' 0 C--O 1.205 -1.288 0 O-C-N 123.553 0.533 . . . . 0.0 110.114 -178.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.79 HD13 ' CE3' ' A' ' 40' ' ' TRP . 10.3 mt -63.59 -51.58 64.69 Favored 'General case' 0 C--O 1.287 3.039 0 N-CA-C 114.476 1.288 . . . . 0.0 114.476 -175.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 1.11 ' HA ' ' HB2' ' A' ' 84' ' ' CYS . 29.5 m -71.38 -6.6 7.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-O 121.547 0.689 . . . . 0.0 112.268 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 13.3 m -110.35 1.0 18.18 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.023 -0.99 . . . . 0.0 110.246 170.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.439 ' HB2' ' O ' ' A' ' 77' ' ' PHE . 5.5 tp-100 -88.18 -36.99 16.5 Favored 'General case' 0 CA--C 1.479 -1.785 0 N-CA-C 106.179 -1.786 . . . . 0.0 106.179 -177.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . 0.486 10.5 t70 -142.37 -96.84 0.12 Allowed 'General case' 0 CA--C 1.558 1.283 0 N-CA-C 117.954 2.575 . . . . 0.0 117.954 177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -146.77 40.66 1.09 Allowed 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 -174.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' CYS . . . . . 1.11 ' HB2' ' HA ' ' A' ' 79' ' ' VAL . 55.5 m -79.45 12.03 2.68 Favored 'General case' 0 C--N 1.278 -2.536 0 CA-C-N 111.158 -2.746 . . . . 0.0 115.669 -165.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . 0.314 . . 29.66 -58.99 0.0 OUTLIER 'General case' 0 CA--C 1.567 1.601 0 N-CA-C 121.776 3.991 . . . . 0.0 121.776 173.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.823 ' HB3' ' HB ' ' A' ' 23' ' ' THR . 6.2 tp10 -145.46 132.07 19.88 Favored 'General case' 0 C--O 1.208 -1.121 0 CA-C-N 119.882 1.219 . . . . 0.0 111.676 -169.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.865 HG21 ' HB2' ' A' ' 75' ' ' LYS . 47.2 t -114.09 106.26 20.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 173.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.433 ' O ' HD23 ' A' ' 89' ' ' LEU . 14.3 p -118.98 146.98 44.55 Favored 'General case' 0 C--O 1.293 3.352 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 179.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.72 ' CD1' ' HG ' ' A' ' 18' ' ' LEU 0.758 2.7 mt -138.2 157.56 46.04 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 121.152 3.76 . . . . 0.0 121.152 -180.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.51 ' H ' HD22 ' A' ' 89' ' ' LEU 0.318 27.3 tt0 -79.99 155.65 27.55 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 110.586 -3.006 . . . . 0.0 109.16 -176.147 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 124.47 -179.64 16.07 Favored Glycine 0 CA--C 1.549 2.173 0 CA-C-O 118.748 -1.029 . . . . 0.0 111.336 177.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -111.09 138.81 47.06 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 119.648 1.724 . . . . 0.0 107.214 179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' MET . . . . . . . . . . . . . 25.5 ttt 61.05 33.16 19.71 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.453 1.121 . . . . 0.0 109.236 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.631 ' CZ ' ' HB2' ' A' ' 89' ' ' LEU . 83.0 t80 -66.67 -52.28 35.24 Favored Pre-proline 0 CA--C 1.57 1.738 0 CA-C-N 114.498 -1.228 . . . . 0.0 112.831 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -81.14 -178.95 4.68 Favored 'Trans proline' 0 C--N 1.371 1.761 0 C-N-CA 121.42 1.413 . . . . 0.0 111.229 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 114.63 81.16 0.96 Allowed Glycine 0 N--CA 1.428 -1.854 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 18.2 tppt? . . . . . 0 C--N 1.303 -1.456 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.478 . . . . . . . . 0 0 . 1 stop_ save_